<SEC-DOCUMENT>0001093557-23-000174.txt : 20230727
<SEC-HEADER>0001093557-23-000174.hdr.sgml : 20230727
<ACCEPTANCE-DATETIME>20230727170803
ACCESSION NUMBER:		0001093557-23-000174
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		79
CONFORMED PERIOD OF REPORT:	20230630
FILED AS OF DATE:		20230727
DATE AS OF CHANGE:		20230727

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DEXCOM INC
		CENTRAL INDEX KEY:			0001093557
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330857544
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51222
		FILM NUMBER:		231119354

	BUSINESS ADDRESS:	
		STREET 1:		6340 SEQUENCE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8582000200

	MAIL ADDRESS:	
		STREET 1:		6340 SEQUENCE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>dxcm-20230630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:3f233038-1297-4d40-b9d2-42700d6fe8fe,g:c1345a4d-d54c-45d2-818f-78cac7edf10e,d:ce0ef719e77e40b5a387f5daee547017--><html xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:dxcm="http://www.dexcom.com/20230630" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2023" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dxcm-20230630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-25">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-26">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-27">Q2</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-28">0001093557</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-29">12/31</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-160" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="f-811">0.0243476</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-178" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="f-812">0.0061571</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-172" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="f-813">0.006662</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-197" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-814">0.5</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dxcm-20230630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-10</xbrli:startDate><xbrli:endDate>2022-06-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementApprovalMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-01</xbrli:startDate><xbrli:endDate>2018-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="purchaser"><xbrli:measure>dxcm:purchaser</xbrli:measure></xbrli:unit><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-01</xbrli:startDate><xbrli:endDate>2018-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-02</xbrli:startDate><xbrli:endDate>2023-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dxcm:SimpleRiskFreeRateRFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dxcm:SimpleRiskFreeRateRFRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dxcm:FederalReserveBankOfNewYorkRateNYFRBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-26</xbrli:startDate><xbrli:endDate>2022-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>dxcm:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:DonaldMAbbeyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:DonaldMAbbeyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:StevenRAltmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:StevenRAltmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:BridgettePHellerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:BridgettePHellerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ice0ef719e77e40b5a387f5daee547017_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.306%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C.&#160;20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:522.00pt"><tr><td style="width:1.0pt"></td><td style="width:28.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:490.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">June&#160;30, 2023</ix:nonNumeric></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160; &#160;&#160;&#160;&#160;&#160;</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number: &#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">000-51222</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><img src="dxcm-20230630_g1.jpg" alt="dexcom-logo-green-rgb (1).jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:215px"/></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">DEXCOM, INC.</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.590%"><tr><td style="width:1.0%"></td><td style="width:45.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">33-0857544</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.590%"><tr><td style="width:1.0%"></td><td style="width:45.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">6340 Sequence Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">San Diego</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-11">CA</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">92121</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">858</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">200-0200</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.945%"><tr><td style="width:1.0%"></td><td style="width:30.986%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.986%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.988%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common Stock, $0.001 Par Value Per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">DXCM</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;                                                     &#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-bottom:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;                                                                                                                   &#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-bottom:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.338%"><tr><td style="width:1.0%"></td><td style="width:28.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.073%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-21">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.       &#160;&#9744;&#160;&#160;</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#160;&#9746;</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">July&#160;20, 2023, there were</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">387,871,796</ix:nonFraction> shares of the registrant&#8217;s common stock outstanding.</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.081%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;border-top:1pt solid #58a618;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="15" style="background-color:#32ad10;border-bottom:1pt solid #58a618;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Table of Contents</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Page</span></td></tr><tr><td colspan="9" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_13">PART I. FINANCIAL INFORMATION</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_10">ITEM&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_10">Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_13">Consolidated Balance Sheets (unaudited) as of </a>June&#160;30, 2023<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_13"> and </a>December&#160;31, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_16">Consolidated Statements of Operations (unaudited) for the </a>three and six m<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_16">onths ended </a>June&#160;30, 2023<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_16"> and </a>2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_16">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_19">Consolidated Statements of Comprehensive Income (unaudited) for the </a>three and six<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_19"> months ended </a>June&#160;30, 2023<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_19"> and </a>2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_19">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_22">Consolidated Statements of Stockholders&#8217; Equity (unaudited) for the </a>three and six<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_22"> months ended </a>June&#160;30, 2023<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_22"> and </a>2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_22">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_28">Consolidated Statements of Cash Flows (unaudited) for the </a>six months ended<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_28"> </a>June&#160;30, 2023<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_28"> and </a>2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_28">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_31">Notes to Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_31">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_142">ITEM&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_142">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_142">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_181">ITEM&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_181">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_181">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_193">ITEM&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_193">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_193">39</a></span></div></td></tr><tr><td colspan="9" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_196">PART II. OTHER INFORMATION</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_199">ITEM&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_199">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_199">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_202">ITEM&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_202">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_202">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_253">ITEM&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_253">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_253">84</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_259">ITEM&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_259">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_259">84</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_262">ITEM&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_262">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_262">84</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_265">ITEM&#160;5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_265">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_265">84</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_268">ITEM&#160;6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_268">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_268">86</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ice0ef719e77e40b5a387f5daee547017_271">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_271">88</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_2000"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for historical financial information contained herein, the matters discussed in this Quarterly Report on Form 10-Q may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and subject to the safe harbor created by the Securities Litigation Reform Act of 1995. Such statements include declarations regarding our intent, belief, or current expectations and those of our management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks, uncertainties and other factors, some of which are beyond our control; actual results could differ materially from those indicated by such forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, but are not limited to: (i) that the information is of a preliminary nature and may be subject to further adjustment; (ii) those risks and uncertainties identified under &#8220;Risk Factors&#8221;; and (iii) the other risks detailed from time-to-time in our reports and registration statements filed with the Securities and Exchange Commission, or the SEC. Except as required by law, we undertake no obligation to revise or update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AVAILABLE INFORMATION</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our website address is located at dexcom.com and our investor relations website is located at investors.dexcom.com. We file electronically with the SEC our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, or the Exchange Act. We make available on our website, free of charge, copies of these reports and other information as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We announce material information to the public about us, our products, and other matters through a variety of means, including filings with the SEC, press releases, public conference calls, presentations, webcasts, and our investor relations website in order to achieve broad, non-exclusionary distribution of information to the public and to comply with our disclosure obligations under Regulation FD. Except as expressly set forth in this Quarterly Report on Form 10-Q, the contents of our website is not incorporated by reference into, or otherwise to be regarded as part of, this Quarterly Report on Form 10-Q or in any other report or document we file with the SEC, and any references to our website is intended to be inactive textual references only.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information disclosed by the foregoing channels could be deemed to be material information. As such, we encourage investors, the media, and others to follow the channels listed above and review the information disclosed through such channels.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PART I. FINANCIAL INFORMATION</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #32ad10;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 1. FINANCIAL STATEMENTS</span></div></td></tr></table></div><div id="ice0ef719e77e40b5a387f5daee547017_13"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consolidated Balance Sheets</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited)</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.861%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except par value data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-30">1,194.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-31">642.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities" format="ixt:num-dot-decimal" scale="6" id="f-32">2,441.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities" format="ixt:num-dot-decimal" scale="6" id="f-33">1,813.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-34">750.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-35">713.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-36">421.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-37">306.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-38">195.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-39">192.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-40">5,002.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-41">3,668.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-42">1,077.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-43">1,055.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-44">76.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-45">80.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-46">25.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-47">25.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-48">154.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-49">173.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="f-50">417.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="f-51">341.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-52">66.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-53">47.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-54">6,820.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-55">5,391.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-56">1,156.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="6" id="f-57">901.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and related expenses</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-58">108.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-59">134.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ConvertibleNotesPayableCurrent" scale="6" id="f-60">773.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ConvertibleNotesPayableCurrent" scale="6" id="f-61">772.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term operating lease liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-62">21.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-63">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-64">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-65">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-66">2,069.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-67">1,839.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ConvertibleLongTermNotesPayable" format="ixt:num-dot-decimal" scale="6" id="f-68">2,430.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ConvertibleLongTermNotesPayable" format="ixt:num-dot-decimal" scale="6" id="f-69">1,197.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-70">86.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-71">94.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-72">133.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-73">128.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-74">4,720.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-75">3,259.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-76"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-77"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-78"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-79">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-80"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-81">5.0</ix:nonFraction></ix:nonFraction> million shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="f-82"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="f-83"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="f-84"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="f-85">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at June&#160;30, 2023 and December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PreferredStockValueOutstanding" format="ixt:fixed-zero" scale="6" id="f-86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PreferredStockValueOutstanding" format="ixt:fixed-zero" scale="6" id="f-87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-88"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-89">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-90"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-91">800.0</ix:nonFraction></ix:nonFraction> million shares authorized;</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="f-92">394.6</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-93">386.1</ix:nonFraction> million shares issued and outstanding, respectively, at June&#160;30, 2023; and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="f-94">393.2</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-95">386.3</ix:nonFraction> million shares issued and outstanding, respectively, at December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockValueOutstanding" scale="6" id="f-96">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockValueOutstanding" scale="6" id="f-97">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-98">2,269.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-99">2,258.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-100">29.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-101">11.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-102">644.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-103">479.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="6" id="f-104">8.5</ix:nonFraction> million shares at June&#160;30, 2023 and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="6" id="f-105">6.9</ix:nonFraction> million shares at December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:TreasuryStockCommonValue" scale="6" id="f-106">784.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:TreasuryStockCommonValue" scale="6" id="f-107">595.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-108">2,100.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-109">2,131.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-110">6,820.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-111">5,391.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consolidated Statements of Operations</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited)</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-112">871.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-113">696.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-114">1,612.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-115">1,325.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-116">324.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-117">246.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-118">603.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-119">477.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-120">546.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-121">449.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-122">1,009.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-123">847.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-124">119.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-125">121.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-126">238.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-127">257.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-128">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-129">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-130">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-131">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-132">297.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-133">248.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-134">591.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-135">467.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="f-136">418.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="f-137">372.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="f-138">833.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="f-139">729.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-140">128.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-141">77.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-142">175.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-143">118.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-144">5.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-145">4.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-146">10.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-147">9.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from equity investments</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DebtAndEquitySecuritiesGainLoss" format="ixt:fixed-zero" scale="6" id="f-148">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DebtAndEquitySecuritiesGainLoss" format="ixt:fixed-zero" scale="6" id="f-149">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DebtAndEquitySecuritiesGainLoss" format="ixt:fixed-zero" scale="6" id="f-150">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="f-151">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-152">37.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-153">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-154">59.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-155">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-156">159.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-157">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-158">223.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-159">111.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-160">43.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-161">24.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-162">59.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-163">36.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-164">115.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-165">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-166">164.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-167">148.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-168">0.30</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-169">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-170">0.43</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-171">0.38</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used to compute basic net income per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-172">386.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-173">392.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-174">386.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-175">390.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-176">0.28</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-177">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-178">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-179">0.36</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used to compute diluted net income per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-180">431.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-181">421.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-182">426.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-183">429.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consolidated Statements of Comprehensive Income</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited)</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-184">115.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-185">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-186">164.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-187">148.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-188">20.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-189">13.9</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-190">18.8</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-191">15.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on marketable debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-192">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-193">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-194">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-195">8.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-196">22.8</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-197">16.9</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-198">17.7</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-199">23.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-200">93.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-201">34.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-202">146.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-203">124.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consolidated Statements of Stockholders&#8217; Equity</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2023</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at March 31, 2023</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-204">387.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-205">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-206">2,305.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-207">6.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-208">528.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-209">595.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-210">2,233.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under equity incentive plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="6" id="f-211">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-14" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-212">1.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-213">189.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-214">189.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of capped call transactions, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" scale="6" id="f-215">76.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" scale="6" id="f-216">76.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-217">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-218">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-219">115.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-220">115.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-221">22.8</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-222">22.8</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-223">386.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-224">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-225">2,269.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-226">29.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-227">644.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-228">784.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-229">2,100.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at March 31, 2022 </span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-24" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-230">392.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-231">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-232">1,996.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-233">6.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-234">236.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-235">37.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-236">2,189.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under equity incentive plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-30" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="6" id="f-237">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-238">32.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-239">32.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-240">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-241">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-242">16.9</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-243">16.9</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at June 30, 2022 </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-34" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-244">392.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-245">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-246">2,028.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-247">23.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-248">286.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-249">37.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-250">2,255.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consolidated Statements of Stockholders&#8217; Equity</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-40" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-251">386.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-252">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-253">2,258.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-254">11.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-255">479.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-256">595.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-257">2,131.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under equity incentive plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-45" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="6" id="f-258">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock for Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-45" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="f-259">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-260">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-261">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-45" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-262">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-263">189.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-264">189.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of capped call transactions, net of tax</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" scale="6" id="f-265">76.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" scale="6" id="f-266">76.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-267">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-268">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-269">164.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-270">164.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-271">17.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-272">17.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at June 30, 2023</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-273">386.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-274">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-275">2,269.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-276">29.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-277">644.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-278">784.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-279">2,100.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2021 </span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-50" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-280">388.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-281">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-282">2,108.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-283">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-284">138.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-285">206.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-286">2,042.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under equity incentive plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-56" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="6" id="f-287">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock for Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-56" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="f-288">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-289">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-290">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-56" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone" scale="6" id="f-291">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" sign="-" name="dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone" scale="6" id="f-292">189.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone" scale="6" id="f-293">189.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone" scale="6" id="f-294">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Conversions of 2023 Notes</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-56" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="6" id="f-295">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="f-296">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="f-297">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="f-298">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit of note hedge upon conversions of 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-56" decimals="-5" name="dxcm:SharesReceivedFromExerciseOfNoteHedge" scale="6" id="f-299">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="dxcm:SharesReceivedFromBenefitOfNoteHedgeValue" scale="6" id="f-300">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" sign="-" name="dxcm:SharesReceivedFromBenefitOfNoteHedgeValue" scale="6" id="f-301">33.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:SharesReceivedFromBenefitOfNoteHedgeValue" format="ixt:fixed-zero" scale="6" id="f-302">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-303">61.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-304">61.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-305">148.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-306">148.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-307">23.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-308">23.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at June 30, 2022 </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-34" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-309">392.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-310">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-311">2,028.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-312">23.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-313">286.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-314">37.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-315">2,255.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consolidated Statements of Cash Flows</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited)</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-316">164.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-317">148.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to cash provided by operating activities:</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-318">85.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-319">80.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-320">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-321">61.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaidInKindInterest" scale="6" id="f-322">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaidInKindInterest" scale="6" id="f-323">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized (gain) loss on equity investment</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="f-324">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="f-325">0.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-326">51.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-327">19.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash income and expenses</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-328">29.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-329">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-330">37.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-331">47.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-332">115.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-333">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-334">3.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-335">82.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets and liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" scale="6" id="f-336">2.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" scale="6" id="f-337">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="f-338">277.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="f-339">96.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued payroll and related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="f-340">25.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="f-341">31.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue and other liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="6" id="f-342">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="6" id="f-343">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-344">345.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-345">243.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-346">2,149.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-347">1,143.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale and maturity of marketable securities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="f-348">1,557.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="f-349">785.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-350">133.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-351">193.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="f-352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="f-353">3.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-354">16.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-355">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-356">742.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-357">556.7</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds from issuance of common stock</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="f-358">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="f-359">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-360">188.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="f-361">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of senior convertible notes, net of issuance costs</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="f-362">1,230.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="6" id="f-363">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of capped call transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:PaymentsForPurchasesOfCappedCallTransactions" scale="6" id="f-364">101.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:PaymentsForPurchasesOfCappedCallTransactions" format="ixt:fixed-zero" scale="6" id="f-365">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing activities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-366">2.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-367">9.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-368">950.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-369">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-370">1.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-371">5.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-372">552.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-373">317.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-374">643.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-375">1,053.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-376">1,196.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-377">736.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation of cash, cash equivalents and restricted cash, end of period:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-378">1,194.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-379">735.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RestrictedCash" scale="6" id="f-380">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-5" name="us-gaap:RestrictedCash" scale="6" id="f-381">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-382">1,196.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-383">736.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental disclosure of non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares issued for conversions of 2023 Notes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:fixed-zero" scale="6" id="f-384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="6" id="f-385">35.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares received under note hedge upon conversion of 2023 Notes</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge" format="ixt:fixed-zero" scale="6" id="f-386">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge" scale="6" id="f-387">33.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition of property and equipment included in accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="6" id="f-388">53.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="6" id="f-389">59.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease liabilities</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" scale="6" id="f-390">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="dxcm:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" scale="6" id="f-391">0.8</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for finance lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="f-392">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="f-393">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Notes to Consolidated Financial Statements</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited)</span></td></tr></table></div><div id="ice0ef719e77e40b5a387f5daee547017_34"></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-394" continuedAt="ib86da005716c49e58d76b62aa579cd91" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;border-bottom:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1. Organization and Significant Accounting Policies</span></td></tr></table></ix:nonNumeric></div><div id="ice0ef719e77e40b5a387f5daee547017_37"></div><ix:continuation id="ib86da005716c49e58d76b62aa579cd91" continuedAt="i43e9b3667d4c4cf0a4fea632788697cf"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Organization and Business</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DexCom, Inc. is a medical device company that develops and markets continuous glucose monitoring, or CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;Dexcom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div></ix:continuation><div id="ice0ef719e77e40b5a387f5daee547017_40"></div><ix:continuation id="i43e9b3667d4c4cf0a4fea632788697cf" continuedAt="i4a9f06bf48e943c2b6aa37659317f54c"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-395" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-396" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Basis of Presentation and Principles of Consolidation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating results for the three and six months ended June&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December&#160;31, 2022 included in the Annual Report on Form 10-K that we filed with the SEC on February&#160;9, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2022, the Company effected a <ix:nonFraction unitRef="number" contextRef="c-61" decimals="INF" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" format="ixt-sec:numwordsen" scale="0" id="f-397">four</ix:nonFraction>-for-one forward stock split of its common stock to shareholders of record as of May 19, 2022. The par value of the common stock remains $<ix:nonFraction unitRef="usdPerShare" contextRef="c-62" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-398">0.001</ix:nonFraction> per share. Accordingly, an amount equal to the par value of the increased shares resulting from the stock split was reclassified from &#8220;Additional paid-in capital&#8221; to &#8220;Common stock.&#8221; All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in interest and other income, net in our consolidated statements of operations.</span></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div id="ice0ef719e77e40b5a387f5daee547017_43"></div><ix:continuation id="i4a9f06bf48e943c2b6aa37659317f54c" continuedAt="i7b0aee5fc6a043678470828360abe930"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Seasonality</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the revenue we generate from the sales of our products will fluctuate from quarter to quarter. We typically experience seasonality, with lower sales in the first quarter of each year compared to the immediately preceding fourth quarter. This seasonal sales pattern relates to U.S. annual insurance deductible resets and unfunded flexible spending accounts.</span></div></ix:continuation><div id="ice0ef719e77e40b5a387f5daee547017_46"></div><ix:continuation id="i7b0aee5fc6a043678470828360abe930" continuedAt="i80f2a3ef943e4cdc93074518734242d6"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Significant Accounting Policies</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material changes to our significant accounting policies as described in Note 1 to the financial statements in Part II, Item 8 of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 during the six months ended June&#160;30, 2023.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><ix:continuation id="i80f2a3ef943e4cdc93074518734242d6" continuedAt="id9254df8023244398caf59454fd1788c"><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-399" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Use of Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div></ix:nonNumeric></ix:continuation><div id="ice0ef719e77e40b5a387f5daee547017_52"></div><ix:continuation id="id9254df8023244398caf59454fd1788c" continuedAt="icdfbf5f7ff6941229f9ca82bb59402de"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-400" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Concentration of Credit Risk</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</span></div></ix:nonNumeric></ix:continuation><div id="ice0ef719e77e40b5a387f5daee547017_58"></div><ix:continuation id="icdfbf5f7ff6941229f9ca82bb59402de" continuedAt="ifc21e831e9434a8da933968e3f203aa0"><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-401" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Contract Balances</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from <ix:nonNumeric contextRef="c-63" name="dxcm:ContractPaymentTermsNumberofDays" format="ixt-sec:durday" id="f-402">30</ix:nonNumeric> to <ix:nonNumeric contextRef="c-64" name="dxcm:ContractPaymentTermsNumberofDays" format="ixt-sec:durday" id="f-403">90</ix:nonNumeric> days.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable as of June&#160;30, 2023 included unbilled accounts receivable of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:UnbilledContractsReceivable" scale="6" id="f-404">9.2</ix:nonFraction> million. We expect to invoice and collect all unbilled accounts receivable within twelve months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance obligations are generally satisfied within twelve months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after twelve months was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-405">21.4</ix:nonFraction> million as of June&#160;30, 2023 and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-406">19.0</ix:nonFraction> million as of December&#160;31, 2022. These balances are included in other long-term liabilities in our consolidated balance sheets.</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized in the period from performance obligations satisfied in previous periods was not material for the periods presented.</span></div></ix:nonNumeric></ix:continuation><div id="ice0ef719e77e40b5a387f5daee547017_61"></div><ix:continuation id="ifc21e831e9434a8da933968e3f203aa0" continuedAt="i7a1c55faddc94b46833ec1557784dbfa"><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-407" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Net Income Per Share</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share attributable to common stockholders is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares consist of shares issuable from restricted stock units, or RSUs, performance stock units, or PSUs, warrants, and our senior convertible notes. Potentially dilutive common shares issuable upon vesting of RSUs, PSUs, and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><ix:continuation id="i7a1c55faddc94b46833ec1557784dbfa" continuedAt="i17ef73bb814b44c0af28900fbbb52588"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-408" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per share for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-409">115.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-410">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-411">164.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-412">148.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="6" id="f-413">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="6" id="f-414">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="6" id="f-415">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="6" id="f-416">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income - diluted</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLossAttributableToParentDiluted" scale="6" id="f-417">119.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLossAttributableToParentDiluted" scale="6" id="f-418">52.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLossAttributableToParentDiluted" scale="6" id="f-419">170.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLossAttributableToParentDiluted" scale="6" id="f-420">153.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-421">0.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-422">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-423">0.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-424">0.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-425">0.28</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-426">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-427">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-428">0.36</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-429">386.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-430">392.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-431">386.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-432">390.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential common stock outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-65" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-433">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-66" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-434">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-67" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-435">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-68" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-436">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-69" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-437">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-70" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-438">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-71" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-439">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-72" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-440">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior convertible notes</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-73" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-441">31.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-74" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-442">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-75" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-443">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-76" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-444">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-445">431.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-446">421.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-447">426.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-448">429.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-449" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding anti-dilutive securities not included in the diluted net income per share attributable to common stockholders calculations were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-77" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="f-450">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-78" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-451">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-79" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="f-452">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-80" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-453">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-73" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="f-454">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-74" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-455">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-75" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-456">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-76" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="f-457">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="f-458">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-459">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-460">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-461">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ice0ef719e77e40b5a387f5daee547017_67"></div><ix:continuation id="i17ef73bb814b44c0af28900fbbb52588"><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-462" continuedAt="ieeb2fde4c8074ddca8b5110075580136" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Recent Accounting Guidance</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU No. 2021-08,</span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This guidance is intended improve the accounting for acquired revenue contracts with customers in a business combination. The new guidance requires that the acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. ASU 2021-08 is effective for public business entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The amendments should be applied prospectively to business combinations occurring on or after the adoption date. We adopted ASU 2021-08 in the first quarter of 2023 and there was no impact to our consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ieeb2fde4c8074ddca8b5110075580136">We do not expect any recently issued accounting pronouncements will have a material effect on our consolidated financial statements</ix:continuation>.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="f-463" continuedAt="ia9c934aeed8f409db1e17fd5c3b2e3c0" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2. Development and Other Agreements</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Collaboration with Verily Life Sciences</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, &#8220;Verily&#8221;), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily dated August 10, 2015, as amended in October 2016, including the royalty obligations provisions under that original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily have agreed to continue to jointly develop a certain next-generation CGM product, and potentially one or more additional CGM products, for which we will have exclusive commercialization rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Collaboration Agreement also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside of the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#8217;s other intellectual property rights to develop, manufacture and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. The Restated Collaboration Agreement requires us to use commercially reasonable efforts to develop, launch and commercialize the CGM product(s) that are the subject of the collaboration according to certain timing and other objectives, and provides for one executive sponsor from each of Dexcom and Verily to meet periodically and make decisions related to the collaboration (within a limited scope of authority) by consensus.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of Verily&#8217;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we made upfront, incentive, and the product regulatory approval payments, and will make potential payments for contingent sales-based milestones upon the achievement of certain revenue targets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for the contingent milestones payable in shares of our common stock as equity instruments within the scope of ASC Topic 718. The product regulatory approval and sales-based milestones are accounted for as performance-based awards that vest when the performance conditions have been achieved and are recognized when the achievement of the respective contingent milestone is deemed probable. The value of the contingent milestones is based on our closing stock price on December 28, 2018, which was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-81" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-464">29.57</ix:nonFraction> per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Upfront and Incentive payments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the fourth quarter of 2018, we made an initial payment for an upfront fee of $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="dxcm:CollaborativeArrangementUpfrontFee" scale="6" id="f-465">250.0</ix:nonFraction> million through the issuance of <ix:nonFraction unitRef="shares" contextRef="c-83" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-466">7,363,772</ix:nonFraction> shares of our common stock. We recorded a $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="dxcm:CollaborativeResearchAndDevelopmentFee" scale="6" id="f-467">217.7</ix:nonFraction> million charge in our consolidated statements of operations during 2018 relating to the issuance of this common stock because this milestone payment did not meet the capitalization criteria. The value of the charge was based on our closing stock price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-81" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-468">29.57</ix:nonFraction> per share on December 28, 2018, the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. In 2019, we made a cash incentive payment of $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="dxcm:CollaborativeResearchAndDevelopmentFee" format="ixt:num-dot-decimal" scale="6" id="f-469">3.2</ix:nonFraction> million due to the completion of certain development obligations and we recorded these payments as research and development expense in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent milestones</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2021, we determined the achievement of the regulatory approval milestone to be probable and recorded an $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="dxcm:CollaborativeResearchAndDevelopmentFee" format="ixt:num-dot-decimal" scale="6" id="f-470">87.1</ix:nonFraction> million research and development charge in our consolidated statements of operations. This charge is associated with IPR&amp;D obtained in an asset acquisition prior to regulatory approval and therefore does not have an alternative future use.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we received regulatory approval and issued <ix:nonFraction unitRef="shares" contextRef="c-86" decimals="INF" name="dxcm:PotentialFutureCommonStockIssuableSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-471">2,945,508</ix:nonFraction> shares of our common stock in connection with our achievement of the related milestone.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2022, we received FDA approval and determined the achievement of the sales-based milestones to be probable. As such, we capitalized the full value of the sales-based milestones, $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-472">152.4</ix:nonFraction> million, as an intangible asset. The sales-based milestones are contingent upon the achievement of certain revenue targets. The value of the sales based milestones is based on: 1) <ix:nonFraction unitRef="shares" contextRef="c-88" decimals="INF" name="dxcm:PotentialFutureCommonStockIssuableSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-473">5,154,640</ix:nonFraction> shares of our common stock, as agreed upon in November 2018 and 2) our closing stock price on December 28, 2018 of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-81" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-474">29.57</ix:nonFraction> per share. December 28, 2018 is the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. The intangible asset will be amortized using the straight-line method over its estimated useful </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><ix:continuation id="ia9c934aeed8f409db1e17fd5c3b2e3c0"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">life of <ix:nonNumeric contextRef="c-89" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:durmonth" id="f-475">64</ix:nonNumeric> months through March 2028. The related amortization expense is recognized in Cost of Sales in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All milestones may be paid in cash or shares of our common stock, at our election. If we elect to make these milestone payments in cash, any such cash payment would be equal to the number of shares that would otherwise be issued for the given milestone payment multiplied by the value of our stock on the date the relevant milestone is achieved, and adjusted to give effect to any stock splits, dividends, or similar events. We intend to pay the sales-based contingent milestones in shares of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Collaboration Agreement will continue until December 31, 2028, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party. Upon achievement of the first sales-based milestone event and payment of the corresponding milestone fee by us, the term of the Restated Collaboration Agreement will be extended until December 31, 2033, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party.</span></div></ix:continuation><div id="ice0ef719e77e40b5a387f5daee547017_79"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="f-476" continuedAt="i73ab65e116e746f0967807496e8db442" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3. Fair Value Measurements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement dates, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values provided by our investment managers.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="f-477" continuedAt="i0f8342893c6749f88b485ec02ecabb0d" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of June&#160;30, 2023, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-478">911.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-479">40.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-480">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-481">952.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-482">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-483">1,640.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-484">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-485">1,640.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-486">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-487">419.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-488">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-489">419.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-490">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-491">381.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-492">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-493">381.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-494">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-495">2,441.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-496">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-497">2,441.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="f-498">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-499">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-500">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="f-501">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-502">925.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-503">2,482.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-504">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-505">3,407.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><ix:continuation id="i73ab65e116e746f0967807496e8db442" continuedAt="ieb5e3c7e43514e79ab6724cec2a9cf67"><ix:continuation id="i0f8342893c6749f88b485ec02ecabb0d"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2022, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-506">375.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-507">44.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-508">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-509">420.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-510">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-511">1,530.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-512">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-513">1,530.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-514">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-515">119.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-516">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-517">119.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-518">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-519">163.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-520">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-521">163.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-522">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-523">1,813.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-524">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-525">1,813.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="f-526">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-527">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-528">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="f-529">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-530">386.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-531">1,858.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-532">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-533">2,244.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="dxcm:FairValueAssetsLevel3TransfersAmount" format="ixt:fixed-zero" scale="0" id="f-534"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="dxcm:FairValueAssetsLevel3TransfersAmount" format="ixt:fixed-zero" scale="0" id="f-535"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="dxcm:FairValueAssetsLevel3TransfersAmount" format="ixt:fixed-zero" scale="0" id="f-536"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="dxcm:FairValueAssetsLevel3TransfersAmount" format="ixt:fixed-zero" scale="0" id="f-537">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> transfers into or out of Level 3 securities during the three and six months ended June&#160;30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Senior Convertible Notes</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="f-538" continuedAt="if1f7d43c2af5467a93049732ff4065ab" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using Level 1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-539">2,418.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-540">2,136.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-541">1,290.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-542">1,314.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-543">1,279.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:fixed-zero" scale="6" id="f-544">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of outstanding senior convertible notes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-545">4,988.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-546">3,451.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on the carrying values of our senior convertible notes, see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Convertible Notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Note 5 &#8220;Debt&#8221; to the consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency and Derivative Financial Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency forward contracts to hedge monetary assets and liabilities denominated in foreign currencies. Our foreign currency forward contracts are not designated as hedging instruments. Therefore, changes in the fair values of these contracts are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. The duration of these contracts is generally one month. The derivative gains and losses are included in interest and other income, net in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023 and December&#160;31, 2022, the notional amounts of outstanding foreign currency forward contracts were $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-547">61.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-548">62.0</ix:nonFraction> million, respectively. The resulting impact on our consolidated financial statements from currency hedging activities was not significant for the three and six months ended June&#160;30, 2023 and June&#160;30, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency exposures vary but are primarily concentrated in the Australian Dollar, the British Pound, the Canadian Dollar, the Euro, and the Malaysian Ringgit. We monitor the costs and the impact of foreign currency risks upon our financial results as part of our risk management program. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management. We do not require and are not required to pledge collateral for these financial instruments and we do not carry any master netting arrangements to mitigate the credit risk.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><ix:continuation id="ieb5e3c7e43514e79ab6724cec2a9cf67"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with authoritative guidance, we measure certain non-financial assets and liabilities at fair value on a non-recurring basis. These measurements are usually performed using the discounted cash flow method or cost method and Level 3 inputs. These include items such as non-financial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment.&#160;In general, non-financial assets, including goodwill, intangible assets, and property and equipment, are measured at fair value when there are indicators of impairment and are recorded at fair value only when an impairment is recognized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="f-549">35.0</ix:nonFraction>&#160;million as of June&#160;30, 2023 and $<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="f-550">19.0</ix:nonFraction> million as of December&#160;31, 2022. We include them in other assets in our consolidated balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant effect on the fair values.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="0" id="f-551"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="0" id="f-552"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="0" id="f-553"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="0" id="f-554">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> significant impairment losses during the three and six months ended June&#160;30, 2023 and June&#160;30, 2022.</span></div></ix:continuation><div id="ice0ef719e77e40b5a387f5daee547017_85"></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="f-555" continuedAt="ia9342c2ec0014c87a18116bf389852e3" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4. Balance Sheet Details</span></td></tr></table></ix:nonNumeric></div><div id="ice0ef719e77e40b5a387f5daee547017_88"></div><ix:continuation id="ia9342c2ec0014c87a18116bf389852e3" continuedAt="i0fe3dad462b24b388723a676981a2252"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Short-Term Marketable Securities</span></td></tr></table></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="f-556" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term marketable securities, consisting of available-for-sale debt securities, were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-557">1,643.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-558">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-559">3.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-560">1,640.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-561">419.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-562">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-563">0.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-564">419.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-565">381.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-566">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-567">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-568">381.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-569">2,444.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-570">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-571">4.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-572">2,441.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-573">1,535.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-574">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-575">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-576">1,530.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-577">119.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-578">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-579">0.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-580">119.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-581">164.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-582">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-583">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-584">163.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-585">1,819.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-586">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-587">5.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-588">1,813.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the estimated market value of our short-term debt securities with contractual maturities up to 12 months was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-7" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="9" id="f-589">2.44</ix:nonFraction>&#160;billion. As of December&#160;31, 2022, the estimated market value of our short-term debt securities with contractual maturities up to 12 months was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-7" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="9" id="f-590">1.81</ix:nonFraction>&#160;billion. Gross realized gains and losses on sales of our short-term debt securities for the three and six months ended June&#160;30, 2023 and June&#160;30, 2022 were not significant.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically review our portfolio of debt securities to determine if any investment is impaired due to credit loss or other potential valuation concerns. For debt securities where the fair value of the investment is less than the amortized cost basis, we have assessed at the individual security level for various quantitative factors including, but not limited to, the nature of the investments, changes in credit ratings, interest rate fluctuations, industry analyst </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0fe3dad462b24b388723a676981a2252" continuedAt="i7cd5d6beb36446868faab87be1c6a710">reports, and the severity of impairment. Unrealized losses on available-for-sale debt securities at June&#160;30, 2023 were primarily due to increases in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, we have not recorded an allowance for credit losses. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.</ix:continuation></span></div><div id="ice0ef719e77e40b5a387f5daee547017_91"></div><ix:continuation id="i7cd5d6beb36446868faab87be1c6a710" continuedAt="i4e55a0de2554454097d193f8cd27491f"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Inventory</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-591" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-592">240.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-593">159.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-594">36.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-595">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-596">144.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-597">130.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-598">421.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-599">306.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="ice0ef719e77e40b5a387f5daee547017_94"></div><ix:continuation id="i4e55a0de2554454097d193f8cd27491f" continuedAt="i50ae343a78e248668069602d7007f922"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Prepaid and Other Current Assets</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="c-1" name="dxcm:PrepaidAndOtherCurrentAssetsTableTextBlock" id="f-600" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-601">55.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-602">48.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:PrepaidInventoryCurrent" scale="6" id="f-603">62.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:PrepaidInventoryCurrent" scale="6" id="f-604">67.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:DeferredCompensationPlanAssetsCurrent" scale="6" id="f-605">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:DeferredCompensationPlanAssetsCurrent" scale="6" id="f-606">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:IncomeTaxesReceivable" scale="6" id="f-607">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncomeTaxesReceivable" scale="6" id="f-608">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-609">57.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-610">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-611">195.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-612">192.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="ice0ef719e77e40b5a387f5daee547017_97"></div><ix:continuation id="i50ae343a78e248668069602d7007f922" continuedAt="i8d5949e09fc348f296a03639b15adce3"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Property and Equipment</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-613" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and land improvements</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-614">29.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-615">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-616">139.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-617">54.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-618">34.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-619">32.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-620">58.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-621">48.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-622">549.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-623">449.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-624">273.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-625">264.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-626">420.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-627">542.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-628">1,505.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-629">1,418.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="6" id="f-630">428.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="6" id="f-631">363.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-632">1,077.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-633">1,055.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="ice0ef719e77e40b5a387f5daee547017_103"></div><ix:continuation id="i8d5949e09fc348f296a03639b15adce3" continuedAt="i4543f15a79d2447e9926c94cfb952a97"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" id="f-634" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Other Assets</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermInvestments" scale="6" id="f-635">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermInvestments" scale="6" id="f-636">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:LongTermDeposits" scale="6" id="f-637">19.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:LongTermDeposits" scale="6" id="f-638">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:OtherLongTermAssets" scale="6" id="f-639">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:OtherLongTermAssets" scale="6" id="f-640">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-641">66.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-642">47.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><ix:continuation id="i4543f15a79d2447e9926c94cfb952a97" continuedAt="i344b8cbb33b547b1a9d0aac9c998e658"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Accounts Payable and Accrued Liabilities</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="f-643" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable trade</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="f-644">269.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="f-645">237.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued tax, audit, and legal fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:AccruedTaxAuditAndLegalFees" scale="6" id="f-646">60.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:AccruedTaxAuditAndLegalFees" scale="6" id="f-647">44.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:PharmacyRebates" scale="6" id="f-648">763.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:PharmacyRebates" scale="6" id="f-649">556.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="f-650">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="f-651">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DeferredCompensationLiabilityCurrent" scale="6" id="f-652">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredCompensationLiabilityCurrent" scale="6" id="f-653">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="f-654">37.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="f-655">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-656">1,156.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="6" id="f-657">901.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="ice0ef719e77e40b5a387f5daee547017_109"></div><ix:continuation id="i344b8cbb33b547b1a9d0aac9c998e658" continuedAt="i202530d1527644e8b08ae5e14c695e1b"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Accrued Payroll and Related Expenses</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="c-1" name="dxcm:ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" id="f-658" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued wages, bonus and taxes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:AccruedWagesBonusesAndTaxesCurrent" scale="6" id="f-659">76.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:AccruedWagesBonusesAndTaxesCurrent" scale="6" id="f-660">96.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="6" id="f-661">31.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="6" id="f-662">37.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued payroll and related expenses</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-663">108.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-664">134.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="ice0ef719e77e40b5a387f5daee547017_112"></div><ix:continuation id="i202530d1527644e8b08ae5e14c695e1b"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:18pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Other Long-Term Liabilities</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" id="f-665" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></div></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-666">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-667">59.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-668">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-669">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-670">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-671">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:OtherTaxLiabilitiesNoncurrent" scale="6" id="f-672">35.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:OtherTaxLiabilitiesNoncurrent" scale="6" id="f-673">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="f-674">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="f-675">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-676">133.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-677">128.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="ice0ef719e77e40b5a387f5daee547017_118"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-678" continuedAt="id1e03c21b73540eaa8427fc6cee71e25" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5. Debt</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Senior Convertible Notes</span></td></tr></table></div><ix:continuation id="if1f7d43c2af5467a93049732ff4065ab"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-679">774.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-680">774.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-681">1,207.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-682">1,207.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-683">1,250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:fixed-zero" scale="6" id="f-684">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal amount</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-685">3,232.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-686">1,982.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="f-687">27.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="f-688">12.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of senior convertible notes</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:ConvertibleNotesPayable" format="ixt:num-dot-decimal" scale="6" id="f-689">3,204.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:ConvertibleNotesPayable" format="ixt:num-dot-decimal" scale="6" id="f-690">1,970.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ConvertibleDebtTableTextBlock" id="f-691" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal was as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" format="ixt:num-dot-decimal" scale="6" id="f-692">1,649.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" format="ixt:num-dot-decimal" scale="6" id="f-693">1,361.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" scale="6" id="f-694">84.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" scale="6" id="f-695">33.6</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" scale="6" id="f-696">56.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" format="ixt:fixed-zero" scale="6" id="f-697">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total by which the notes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> if-converted value exceeds their principal amount</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" format="ixt:num-dot-decimal" scale="6" id="f-698">1,790.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" format="ixt:num-dot-decimal" scale="6" id="f-699">1,395.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><ix:continuation id="id1e03c21b73540eaa8427fc6cee71e25" continuedAt="ibe63eb7ccef0434b83bad2523ca62820"><ix:nonNumeric contextRef="c-1" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" id="f-700" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual coupon interest </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="f-701">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="f-702">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="f-703">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="f-704">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-705">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-706">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-707">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-708">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense recognized on senior notes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-709">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-710">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-711">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-712">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rate:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-154" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-713">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-155" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-714">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-154" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-715">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-155" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-716">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-156" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-717">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-157" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-718">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-156" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-719">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-157" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-720">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-158" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-721">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-158" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-722">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:22.5pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year. Interest on the 2028 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-159" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-723">0.75</ix:nonFraction>% Senior Convertible Notes due 2023</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we completed an offering of&#160;$<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-724">850.0</ix:nonFraction> million&#160;aggregate principal amount of unsecured senior convertible notes with a stated interest rate of&#160;<ix:nonFraction unitRef="number" contextRef="c-159" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-725">0.75</ix:nonFraction>%&#160;and a maturity date of&#160;December&#160;1, 2023&#160;(the &#8220;2023 Notes&#8221;). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and costs directly related to the offering, were approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="f-726">836.6</ix:nonFraction> million. The initial conversion rate of the 2023 Notes is&#160;24.3476&#160;shares per&#160;$1,000 principal amount of notes, which is equivalent to a conversion price of approximately&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="c-159" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-727">41.07</ix:nonFraction>&#160;per share, subject to adjustments. We entered into transactions for a convertible note hedge (the &#8220;2023 Note Hedge&#8221;) and warrants (the &#8220;2023 Warrants&#8221;) concurrently with the issuance of the 2023 Notes. The 2023 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2023 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2023 Notes includes customary terms and covenants, including certain events of default after which the 2023 Notes may be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2022, holders of $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" format="ixt:num-dot-decimal" scale="6" id="f-728">17.5</ix:nonFraction>&#160;million in aggregate principal amount of the 2023 Notes elected conversion at their option. We settled these conversions using treasury stock. We issued <ix:nonFraction unitRef="shares" contextRef="c-161" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-729">425,552</ix:nonFraction> shares to settle the converted 2023 Notes. We received <ix:nonFraction unitRef="shares" contextRef="c-147" decimals="INF" name="dxcm:SharesReceivedFromExerciseOfNoteHedge" format="ixt:num-dot-decimal" scale="0" id="f-730">287,492</ix:nonFraction> shares of common stock from the exercise of a portion of the 2023 Note Hedge that we purchased concurrently with the issuance of the 2023 Notes, as described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">second quarter of 2023, holders of $<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" format="ixt:num-dot-decimal" scale="6" id="f-731">532.2</ix:nonFraction>&#160;million in aggregate principal amount of the 2023 Notes exercised their conversion option. We elected to settle these conversions through a combination of cash for the principal amount and common stock for any amount due in excess of the principal amount. The conversions will settle in the third quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From July 1, 2023 through July&#160;26, 2023, holders of $<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" format="ixt:num-dot-decimal" scale="6" id="f-732">7.8</ix:nonFraction> million in aggregate principal amount of the 2023 Notes exercised their conversion option.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes have the right to require us to repurchase for cash all or a portion of their notes at <ix:nonFraction unitRef="number" contextRef="c-120" decimals="INF" name="dxcm:DebtInstrumentCovenantRepurchasePricePercentage" scale="-2" id="f-733">100</ix:nonFraction>% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the notes). We will also be required to increase the conversion rate for holders who convert their 2023 Notes in connection with certain fundamental changes occurring prior to the maturity date or following the delivery by Dexcom of a notice of redemption.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><ix:continuation id="ibe63eb7ccef0434b83bad2523ca62820" continuedAt="i89fe05c547684a58996350ca5cf03ea3"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert all or a portion of their notes at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding September&#160;1, 2023, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during any calendar quarter commencing after March&#160;31, 2019 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least <ix:nonFraction unitRef="d" contextRef="c-164" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-734">20</ix:nonFraction> trading days (whether or not consecutive) during the period of <ix:nonFraction unitRef="d" contextRef="c-165" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-735">30</ix:nonFraction> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="c-164" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-736">130</ix:nonFraction>% of the applicable conversion price of the 2023 Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during the <ix:nonFraction unitRef="d" contextRef="c-166" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-737">five</ix:nonFraction> business day period after any <ix:nonFraction unitRef="d" contextRef="c-167" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-738">five</ix:nonFraction> consecutive trading day period in which the trading price per $1,000 principal amount of the 2023 Notes for each day of that <ix:nonFraction unitRef="d" contextRef="c-167" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-739">five</ix:nonFraction>-day consecutive trading day period was less than <ix:nonFraction unitRef="number" contextRef="c-167" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-740">98</ix:nonFraction>% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the 2023 Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">if we call any or all of the 2023 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after September&#160;1, 2023, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2023 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Circumstance (1) listed above occurred during the quarters ended December&#160;31, 2022 and March&#160;31, 2023. As a result, the 2023 Notes were convertible at the option of the holder from January&#160;1, 2023 through June&#160;30, 2023. Circumstance (1) listed above also occurred during the quarter ended June&#160;30, 2023 and as a result, the 2023 Notes will remain convertible at the option of the holder from July 1, 2023 through September 30, 2023. See above for a description of conversion activity related to the 2023 Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom did not have a right to redeem the 2023 Notes prior to December&#160;1, 2021. On or after December&#160;1, 2021 and prior to September&#160;1, 2023, Dexcom may redeem for cash all or part of the 2023 Notes, at its option, if the last reported sale price of our common stock has been at least <ix:nonFraction unitRef="number" contextRef="c-146" decimals="2" name="dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" scale="-2" id="f-741">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="d" contextRef="c-164" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-742">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="d" contextRef="c-165" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-743">30</ix:nonFraction> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to <ix:nonFraction unitRef="number" contextRef="c-146" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-744">100</ix:nonFraction>% of the principal amount of the 2023 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Note Hedge</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions with <ix:nonFraction unitRef="purchaser" contextRef="c-168" decimals="INF" name="dxcm:NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" format="ixt-sec:numwordsen" scale="0" id="f-745">two</ix:nonFraction> of the initial purchasers of the 2023 Notes (the &#8220;2023 Counterparties&#8221;) entitling us to purchase up to&#160;<ix:nonFraction unitRef="shares" contextRef="c-169" decimals="-5" name="dxcm:DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" format="ixt:num-dot-decimal" scale="6" id="f-746">20.7</ix:nonFraction> million&#160;shares of our common stock at an initial price of&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="c-159" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-747">41.07</ix:nonFraction>&#160;per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was&#160;$<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="f-748">218.9</ix:nonFraction> million and we accounted for it as an equity instrument by recognizing $<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="f-749">218.9</ix:nonFraction> million in&#160;additional paid-in capital&#160;during 2018. The 2023 Note Hedge will expire on December&#160;1, 2023. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge.&#160;The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. An assumed exercise of the 2023 Note Hedge by us is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share. See above for a description of conversion activity related to the 2023 Notes and shares received as the result of exercising a portion of the 2023 Note Hedge.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Warrants</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we also sold warrants to the 2023 Counterparties to acquire up to&#160;<ix:nonFraction unitRef="shares" contextRef="c-160" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="6" id="f-750">20.7</ix:nonFraction> million shares of our common stock. The 2023 Warrants require net share settlement and a pro rated number of warrants will expire on each of the <ix:nonFraction unitRef="d" contextRef="c-160" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-751">60</ix:nonFraction> scheduled trading days starting on March&#160;1, 2024. We received&#160;$<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="6" id="f-752">183.8</ix:nonFraction> million&#160;in cash proceeds from the sale of the 2023 Warrants, which we recorded in&#160;additional paid-in capital during 2018. The 2023 Warrants could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2023 Warrants. The strike price of the 2023 Warrants is initially $<ix:nonFraction unitRef="usdPerShare" contextRef="c-159" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-753">49.60</ix:nonFraction> per share and is subject to certain adjustments under the terms of the warrant agreements. We use </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><ix:continuation id="i89fe05c547684a58996350ca5cf03ea3" continuedAt="i688dbd8923c9484fa287baf244c18ede"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the treasury share method for assumed conversion of the 2023 Warrants when computing the weighted average common shares outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-171" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-754">0.25</ix:nonFraction>% Senior Convertible Notes due 2025</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we completed an offering of $<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-7" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="f-755">1.21</ix:nonFraction> billion aggregate principal amount of unsecured senior convertible notes with a stated interest rate of <ix:nonFraction unitRef="number" contextRef="c-171" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-756">0.25</ix:nonFraction>% and a maturity date of November&#160;15, 2025 (the &#8220;2025 Notes&#8221;). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and estimated costs directly related to the offering, were approximately $<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-7" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="9" id="f-757">1.19</ix:nonFraction> billion. The initial conversion rate of the 2025 Notes is 6.6620 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="c-171" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-758">150.11</ix:nonFraction> per share, subject to adjustments. The 2025 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2025 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on the 2025 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2025 Notes includes customary terms and covenants, including certain events of default after which the 2025 Notes may be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a fundamental change (as defined in the indenture related to the 2025 Notes), holders of the 2025 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to <ix:nonFraction unitRef="number" contextRef="c-173" decimals="INF" name="dxcm:DebtInstrumentCovenantRepurchasePricePercentage" scale="-2" id="f-759">100</ix:nonFraction>% of the principal amount of the 2025 Notes, plus any accrued and unpaid interest. Holders of the 2025 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 5:00 p.m., New York City time, on the business day immediately preceding August&#160;15, 2025, holders of the 2025 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during any calendar quarter commencing after September&#160;30, 2020 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least <ix:nonFraction unitRef="d" contextRef="c-174" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-760">20</ix:nonFraction> trading days (whether or not consecutive) during the period of <ix:nonFraction unitRef="d" contextRef="c-175" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-761">30</ix:nonFraction> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="c-174" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-762">130</ix:nonFraction>% of the applicable conversion price of the Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during the <ix:nonFraction unitRef="d" contextRef="c-176" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-763">five</ix:nonFraction> business day period after any <ix:nonFraction unitRef="d" contextRef="c-177" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-764">five</ix:nonFraction> consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that <ix:nonFraction unitRef="d" contextRef="c-177" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-765">five</ix:nonFraction> day consecutive trading day period was less than <ix:nonFraction unitRef="number" contextRef="c-177" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-766">98</ix:nonFraction>% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;On or after August&#160;15, 2025, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2025 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom may not redeem the 2025 Notes prior to May&#160;20, 2023. On or after May&#160;20, 2023 and prior to August&#160;15, 2025, Dexcom may redeem for cash all or part of the 2025 Notes, at its option, if the last reported sale price of our common stock has been at least <ix:nonFraction unitRef="number" contextRef="c-148" decimals="2" name="dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" scale="-2" id="f-767">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="d" contextRef="c-174" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-768">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="d" contextRef="c-175" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-769">30</ix:nonFraction> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to <ix:nonFraction unitRef="number" contextRef="c-150" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-770">100</ix:nonFraction>% of the principal amount of the 2025 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-173" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-771">0.375</ix:nonFraction>% Senior Convertible Notes due 2028</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, we completed an offering of $<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-7" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="f-772">1.25</ix:nonFraction>&#160;billion aggregate principal amount of unsecured senior convertible notes with a stated interest rate of <ix:nonFraction unitRef="number" contextRef="c-173" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-773">0.375</ix:nonFraction>% and a maturity date of May&#160;15, 2028 (the &#8220;2028 Notes&#8221;). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and estimated costs directly related to </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><ix:continuation id="i688dbd8923c9484fa287baf244c18ede" continuedAt="ic4a04a11aa0542bcbe16d4a7f463bdf1"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the offering, were approximately $<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-7" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="9" id="f-774">1.23</ix:nonFraction>&#160;billion. The initial conversion rate of the 2028 Notes is 6.1571 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="c-173" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-775">162.41</ix:nonFraction> per share, subject to adjustments. The 2028 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2028 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on the 2028 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2028 Notes includes customary terms and covenants, including certain events of default after which the 2028 Notes may be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a fundamental change (as defined in the indenture related to the 2028 Notes), holders of the 2028 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to <ix:nonFraction unitRef="number" contextRef="c-173" decimals="INF" name="dxcm:DebtInstrumentCovenantRepurchasePricePercentage" scale="-2" id="f-776">100</ix:nonFraction>% of the principal amount of the 2028 Notes, plus any accrued and unpaid interest. Holders of the 2028 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 5:00 p.m., New York City time, on the business day immediately preceding February&#160;15, 2028, holders of the 2028 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during any calendar quarter commencing after September&#160;30, 2023 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least <ix:nonFraction unitRef="d" contextRef="c-179" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-777">20</ix:nonFraction> trading days (whether or not consecutive) during the period of <ix:nonFraction unitRef="d" contextRef="c-180" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-778">30</ix:nonFraction> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="c-179" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-779">130</ix:nonFraction>% of the applicable conversion price of the Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during the <ix:nonFraction unitRef="d" contextRef="c-181" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-780">five</ix:nonFraction> business day period after any <ix:nonFraction unitRef="d" contextRef="c-182" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-781">five</ix:nonFraction> consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that <ix:nonFraction unitRef="d" contextRef="c-182" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-782">five</ix:nonFraction> day consecutive trading day period was less than <ix:nonFraction unitRef="number" contextRef="c-182" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-783">98</ix:nonFraction>% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after February&#160;15, 2028, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2028 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom may not redeem the 2028 Notes prior to May&#160;20, 2026. On or after May&#160;20, 2026 and prior to February&#160;15, 2028, Dexcom may redeem for cash all or part of the 2028 Notes, at its option, if the last reported sale price of our common stock has been at least <ix:nonFraction unitRef="number" contextRef="c-150" decimals="2" name="dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" scale="-2" id="f-784">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="d" contextRef="c-179" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-785">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="d" contextRef="c-180" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-786">30</ix:nonFraction> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to <ix:nonFraction unitRef="number" contextRef="c-150" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-787">100</ix:nonFraction>% of the principal amount of the 2028 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Capped Call Transactions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, in connection with the offering of the 2028 Notes, we entered into privately negotiated capped call transactions (the &#8220;2028 Capped Calls&#8221;) with certain financial institutions. The 2028 Capped Calls will cover, subject to anti-dilution adjustments substantially similar to those applicable to the 2028 Notes, the number of shares of our common stock that will initially underlie the 2028 Notes. The 2028 Capped Calls are expected generally to reduce potential dilution to our common stock upon conversion of the 2028 Notes and/or offset any cash payments that we are required to make in excess of the principal amount of converted 2028 Notes, as the case may be, with such reduction and/or offset subject to a cap. The 2028 Capped Calls have an initial cap price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-183" decimals="INF" name="dxcm:DebtInstrumentCapCallTransactionCapPricePerShare" scale="0" id="f-788">212.62</ix:nonFraction> per share, subject to adjustments, which represents a premium of <ix:nonFraction unitRef="number" contextRef="c-183" decimals="INF" name="dxcm:DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" scale="-2" id="f-789">80</ix:nonFraction>% over the closing price of our common stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-184" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-790">118.12</ix:nonFraction> per share on the Nasdaq Global Select Market on May&#160;2, 2023. The cost to purchase the 2028 Capped Calls of </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><ix:continuation id="ic4a04a11aa0542bcbe16d4a7f463bdf1"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="dxcm:PaymentsForPurchasesOfCappedCallTransactions" format="ixt:num-dot-decimal" scale="6" id="f-791">101.3</ix:nonFraction> million was recorded as a reduction to additional paid-in capital in our consolidated balance sheets as the 2028 Capped Calls met the criteria for classification in stockholders&#8217; equity.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Revolving Credit Agreement</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms of the Revolving Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, we entered into the First Amendment to the Second Amended and Restated Credit Agreement (the "Amended Credit Agreement"), which we had previously entered into in October 2021. The Amended Credit Agreement is a <ix:nonNumeric contextRef="c-185" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-792">five-year</ix:nonNumeric> revolving credit facility, that provides for an available principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-186" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-793">200.0</ix:nonFraction> million which can be increased up to $<ix:nonFraction unitRef="usd" contextRef="c-186" decimals="INF" name="dxcm:LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" format="ixt:num-dot-decimal" scale="6" id="f-794">500.0</ix:nonFraction> million at our option subject to customary conditions and approval of our lenders (the &#8220;Credit Facility&#8221;). The Amended Credit Agreement will mature on October&#160;13, 2026. Borrowings under the Amended Credit Agreement are available for general corporate purposes, including working capital and capital expenditures.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" id="f-795" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to availability and outstanding borrowings on our Amended Credit Agreement is as follows as of the date indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.959%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available principal amount </span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-796">200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letters of credit sub-facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-797">25.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding borrowings </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="f-798">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding letters of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="f-799">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available balance</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="f-800">192.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans under the Amended Credit Agreement bear interest at our choice of one of three base rates plus a range of applicable rates that are based on our leverage ratio. The first base rate is the Alternate Base Rate (&#8220;ABR&#8221;) and loans comprising each ABR borrowing shall bear interest at the ABR plus the applicable rate between <ix:nonFraction unitRef="number" contextRef="c-188" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-801">0.375</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-189" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-802">1.000</ix:nonFraction>%. The ABR is the highest of (a) the prime rate last quoted by The Wall Street Journal, (b) the Federal Reserve Bank of New York rate plus one half of 1%, and (c) the Adjusted Term Secured Overnight Financing Rate (&#8220;Term SOFR&#8221;) for a one month interest period plus <ix:nonFraction unitRef="number" contextRef="c-190" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-803">1</ix:nonFraction>%. The second base rate is the Term Benchmark rate and loans comprising each Term Benchmark borrowing shall bear interest at the Adjusted Term SOFR, the Adjusted Euro Interbank Offered Rate, the Adjusted Stockholm Interbank Offered Rate, the Adjusted Canadian Dollar Offered Rate, Adjusted Australian Dollar Rate, the Adjusted Bank Bill Benchmark Rate or the Adjusted Tokyo Interbank Offered Rate, as applicable based on the currency denomination borrowed, plus the applicable rate between <ix:nonFraction unitRef="number" contextRef="c-191" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-804">1.375</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-192" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-805">2.000</ix:nonFraction>%. The third base rate is the Adjusted Daily Simple RepoFunds Rate (&#8220;RFR&#8221;) and loans comprising each Daily Simple RFR Loan shall bear interest at a rate per annum equal to the applicable Daily Simple RFR for Sterling or Dollars (as applicable) plus the applicable rate between <ix:nonFraction unitRef="number" contextRef="c-193" decimals="6" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-806">0.0326</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-194" decimals="5" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-807">0.100</ix:nonFraction>% depending on the loan denomination. We will also pay a commitment fee of between <ix:nonFraction unitRef="number" contextRef="c-195" decimals="5" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-808">0.175</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-196" decimals="5" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-809">0.250</ix:nonFraction>%, payable quarterly in arrears, on the average daily unused amount of the revolving facility based on our leverage ratio.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Amended Credit Agreement are guaranteed by our existing and future wholly-owned domestic subsidiaries, and are secured by a first-priority security interest in substantially all of the assets of Dexcom and the guarantors, including all or a portion of the equity interests of our domestic subsidiaries and first-tier foreign subsidiaries but excluding real property and intellectual property (which is subject to a negative pledge). The Amended Credit Agreement contains covenants that limit certain indebtedness, liens, investments, transactions with affiliates, dividends and other restricted payments, subordinated indebtedness and amendments to subordinated indebtedness documents, and sale and leaseback transactions of Dexcom or any of its domestic subsidiaries. The Amended Credit Agreement also requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of June&#160;30, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, we also have a guarantee facility related to our international operations which is collateralized by a $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DepositAssets" format="ixt:num-dot-decimal" scale="6" id="f-810">5.5</ix:nonFraction>&#160;million term deposit that is included in non-current &#8220;Other assets&#8221; on our consolidated balance sheets.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="f-815" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6. Contingencies</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Litigation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability, intellectual property and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2023, we and certain Abbott Diabetes Care, Inc. (&#8220;Abbott&#8221;) entities have previously served complaints for patent infringement, validity and other patent related actions against each other in multiple jurisdictions, inside and outside the United States. In June and July 2021, we initiated patent infringement litigation against Abbott in the United States and in Germany over certain of Abbott's continuous glucose monitoring products. In both the United States and Germany, we seek injunctive relief and monetary damages. In July 2021, Abbott initiated patent infringement litigation against Dexcom in the United States, United Kingdom, and in Germany over certain of Dexcom's continuous glucose monitoring products. Abbott seeks injunctive relief and monetary damages. In response to the suits in the United Kingdom, Dexcom brought infringement counterclaims there. One trial on liability has already been conducted in the United Kingdom, and the parties are awaiting a ruling.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, Abbott filed a breach of contract suit against Dexcom in the United States alleging that Dexcom breached the parties' 2014 Settlement and License Agreement. Dexcom&#8217;s patent infringement claims in the United States are stayed pending resolution of Abbott&#8217;s breach of contract claims. A jury trial on Abbott&#8217;s breach of contract claims commenced on July 10, 2023. On July 14, 2023, the jury awarded a verdict finding Abbott was not licensed to several claims of certain Dexcom patents and that Abbott was licensed to a few claims. We will continue to enforce the remaining claims in the patents asserted in Delaware and elsewhere.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott&#8217;s U.S. patent infringement action against Dexcom is currently scheduled for trial on November 5, 2023. In February and March of 2023, Abbott initiated additional patent infringement litigation against Dexcom in both the United States and in Germany. Abbott seeks injunctive relief and monetary damages. Due to uncertainty surrounding patent litigation processes in the U.S. and Europe, we are unable to reasonably estimate the ultimate outcome of any of the litigation matters at this time. We intend to protect our intellectual property and defend against Abbott&#8217;s claims vigorously in all of these actions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe we are party to any other currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition or results of operations.</span></div></ix:nonNumeric><div id="ice0ef719e77e40b5a387f5daee547017_130"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-816" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7. Income Taxes</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate our annual effective tax rate to be <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="dxcm:EstimatedAnnualEffectiveIncomeTaxRatePercent" scale="-2" id="f-817">28.5</ix:nonFraction>% for the full year 2023, which differs from the U.S. federal statutory rate due to state and foreign income taxes, nondeductible executive compensation, and increases to unrecognized tax benefits, partially offset by federal tax credits generated. Our actual effective tax rate of</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-818">26.5</ix:nonFraction>% for the six months ended June&#160;30, 2023 was primarily due to income tax expense from normal, recurring operations, partially offset by discrete excess tax benefits recognized for share-based compensation for employees, net of disallowed executive compensation.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-819" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8. Stockholders&#8217; Equity</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-820" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our share-based compensation expense is associated with RSUs, PSUs, and our Employee Stock Purchase Plan, or ESPP. The following table summarizes our share-based compensation expense included in our consolidated statements of operations for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-821">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-822">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-823">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-824">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-825">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-826">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-827">22.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-828">21.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-829">24.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-830">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-831">44.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-832">35.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-833">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-834">32.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-835">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-836">61.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2023, unrecognized estimated compensation costs related to RSUs, PSUs and ESPP totaled $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="f-837">272.5</ix:nonFraction> million and are expected to be recognized through 2027.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Award Activity</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total vest date fair value of RSUs and PSUs that vested during the six months ended June&#160;30, 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-838">127.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-839">9.9</ix:nonFraction> million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program and Treasury Shares</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 26, 2022, a duly authorized committee of our Board of Directors authorized and approved a share repurchase program of up to $<ix:nonFraction unitRef="usd" contextRef="c-212" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-840">700.0</ix:nonFraction>&#160;million of our outstanding common stock, with a repurchase period ending no later than June 30, 2023 (the &#8220;Share Repurchase Program&#8221;). Shares of common stock repurchased under the Share Repurchase Program become treasury shares. Repurchases of our common stock under the Share Repurchase Program may be made from time to time, on the open market, in privately negotiated transactions or by other methods, at our discretion, and in accordance with the limitations set forth in Rule 10b-18 promulgated under the Exchange Act, and other applicable federal and state laws and regulations. We repurchased approximately $<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-841">557.7</ix:nonFraction> million of our outstanding common stock throughout the duration of the Share Repurchase Program. The Share Repurchase Program and the remaining authorization of approximately $<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="f-842">142.3</ix:nonFraction>&#160;million expired on June 30, 2023. There were <ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="0" id="f-843">no</ix:nonFraction> share repurchases under the Share Repurchase Program in 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, we used a portion of the proceeds of the 2028 Notes to repurchase <ix:nonFraction unitRef="shares" contextRef="c-216" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="f-844">1.6</ix:nonFraction> million shares of our common stock for $<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-845">188.7</ix:nonFraction> million for an average per share price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-216" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="f-846">118.12</ix:nonFraction>, via privately negotiated transactions, independent of the Share Repurchase Program.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repurchased shares of our common stock are held as treasury shares until they are reissued or retired. We have not yet determined the ultimate disposition of repurchased shares and consequently we continue to hold them as treasury shares rather than retiring them. Authorization of future stock repurchase programs is subject to the final determination of our Board of Directors.</span></div></ix:nonNumeric><div id="ice0ef719e77e40b5a387f5daee547017_136"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-847" continuedAt="ifc71cbb891f24b51855e9ec1b1ea3a9e" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9. Business Segment and Geographic Information</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reportable Segments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An operating segment is identified as a component of a business that has discrete financial information available and for which the chief operating decision maker must decide the level of resource allocation. In addition, the guidance for segment reporting indicates certain quantitative materiality thresholds. None of the components of our business meet the definition of an operating segment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently consider our operations to be, and manage our business globally within, <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-848">one</ix:nonFraction> reportable segment, which is consistent with how our President and Chief Executive Officer, who is our chief operating decision maker, reviews our business, makes investment and resource allocation decisions, and assesses operating performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate revenue by geographic region and by major sales channel. We have determined that disaggregating revenue into these categories achieves the ASC Topic 606 disclosure objectives of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><ix:continuation id="ifc71cbb891f24b51855e9ec1b1ea3a9e"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by geographic region</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2023 and June&#160;30, 2022, no individual country outside the United States generated revenue that represented more than 10% of our total revenue. <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="f-849" continuedAt="i5da6013c105e4f9eb848f87ee055beb7" escape="true">The following table sets forth revenue by our two primary geographical markets, the United States and International, based on the geographic location to which we deliver the components, for the periods shown:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="i5da6013c105e4f9eb848f87ee055beb7"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-850">616.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-217" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-851">71</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-852">511.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-218" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-853">73</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-854">254.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-219" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-855">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-856">185.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-220" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-857">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-858">871.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-859">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-860">696.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-861">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-862">1,142.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-221" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-863">71</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-864">962.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-222" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-865">73</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-866">470.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-223" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-867">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-868">362.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-224" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-869">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-870">1,612.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-871">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-872">1,325.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-873">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by customer sales channel</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our CGM systems through a direct sales organization and through distribution arrangements that allow distributors to sell our products. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-874" continuedAt="if1af5ea3ff9740bd82a4f9f562efd6db" escape="true">The following table sets forth revenue by major sales channel for the periods shown:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="if1af5ea3ff9740bd82a4f9f562efd6db"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-875">738.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-225" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-876">85</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-877">585.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-226" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-878">84</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-879">132.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-227" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-880">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-881">111.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-228" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-882">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-883">871.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-884">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-885">696.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-886">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-887">1,357.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-229" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-888">84</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-889">1,112.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-230" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-890">84</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-891">255.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-892">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-893">212.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-232" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-894">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-895">1,612.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-896">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-897">1,325.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-898">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 2 - MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div></td></tr></table></div><div id="ice0ef719e77e40b5a387f5daee547017_148"></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Overview</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Who We Are</span></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received approval from the Food and Drug Administration, or FDA, and commercialized our first product in 2006. We launched our latest generation system, the Dexcom G6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> integrated Continuous Glucose Monitoring System, or G6, in 2018 and more recently received marketing clearance from the FDA on the Dexcom G7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in December 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;Dexcom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Global Presence</span></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built a direct sales organization in North America and certain international markets to call on health care professionals, such as endocrinologists, physicians and diabetes educators, who can educate and influence patient adoption of continuous glucose monitoring. To complement our direct sales efforts, we have entered into distribution arrangements in North America and several international markets that allow distributors to sell our products.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Future Developments</span></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Development:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to develop future generations of technologies that are focused on improved performance and convenience and that will enable intelligent insulin administration. Over the longer term, we plan to continue to develop and improve networked platforms with open architecture, connectivity and transmitters capable of communicating with other devices. We also intend to expand our efforts to accumulate CGM patient data and metrics and apply predictive modeling and machine learning to generate interactive CGM insights that can inform patient behavior.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Partnerships:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We also continue to pursue and support development partnerships with insulin pump companies and companies or institutions developing insulin delivery systems, including automated insulin delivery systems.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Opportunities:</span><span style="color:#e98300;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exploring how to extend our offerings to other opportunities, including for people with Type 2 diabetes that are non-insulin using, people with pre-diabetes, people who are obese, people who are pregnant, and people in the hospital setting. Eventually, we may apply our technological expertise to products beyond glucose monitoring.</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="ice0ef719e77e40b5a387f5daee547017_154"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Critical Accounting Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which we have prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements as well as the reported revenue and expenses during the reporting periods. On an ongoing basis, we evaluate our estimates and judgments. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the estimates, assumptions and judgments involved in the accounting policies described in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 have the greatest potential impact on our financial statements, so we consider them to be our critical accounting policies and estimates. There were no material changes to our critical accounting estimates during the six months ended June&#160;30, 2023.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.473%"></td><td style="width:0.1%"></td></tr><tr><td colspan="39" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Overview of Financial Results</span></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most important financial indicators that we use to assess our business are revenue, gross profit, operating income, net income, and operating cash flow.</span></div></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Key Highlights for the Three Months Ended June&#160;30, 2023 include the following:</span></div></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="39" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Gross Profit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Operating Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Net Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Operating <br/>Cash Flow</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">$871.3 million</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">$546.4 million</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">$128.1 million</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">$115.9 million</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">$190.3 million</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">up 25% from the same period 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">up 22% from the same period 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">up 66% from the same period 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">up 128% from the same period 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">up 10% from the same period 2022</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We ended the second quarter of 2023 with cash, cash equivalents and short-term marketable securities totaling $3.64 billion.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Business Trends</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Looking ahead we expect our business could be affected by the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Increase in the worldwide incidence of people diagnosed with diabetes and costs related to the management and treatment of diabetes.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Changes in medical reimbursement policies and programs.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Growing demand for digital health technologies by both healthcare providers and consumers to reduce costs.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">An expected interest in empowering consumers to make better-informed decisions about their own health and new potential options for facilitating prevention, early diagnosis of life-threatening diseases, and management of chronic conditions outside of traditional health care settings.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Growing research and interest in the use of CGM technology outside of the ambulatory care setting, including use by hospital systems.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Continued product innovation and competition from other CGM device makers.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our ability to scale efficiently with our Malaysia manufacturing facility.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Results of Operations</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><img src="dxcm-20230630_g2.jpg" alt="6" style="height:320px;margin-bottom:5pt;vertical-align:text-bottom;width:500px"/><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Financial Overview</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Three Months Ended June&#160;30, 2023 Compared to Three Months Ended June&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 - 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income, net</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.16&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The sum of the individual percentages may not equal the total due to rounding.</span></div></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">** Not meaningful</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the revenue we generate from the sales of our products will fluctuate from quarter to quarter. We typically experience seasonality, with lower sales in the first quarter of each year compared to the immediately preceding fourth quarter. This seasonal sales pattern relates to U.S. annual insurance deductible resets and unfunded flexible spending accounts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales includes direct labor and materials costs related to each product sold or produced, including assembly, test labor and scrap, as well as factory overhead supporting our manufacturing operations. Factory overhead includes facilities, material procurement and control, manufacturing engineering, quality assurance, supervision and management. These costs are primarily salary, fringe benefits, share-based compensation, facility expense, supplies and purchased services. All of our manufacturing costs are included in cost of sales. In addition, amortization of certain licensing related intangibles are also included in cost of sales.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses primarily consist of engineering and research expenses related to our continuous glucose monitoring technology, clinical trials, regulatory expenses, quality assurance programs, materials and products for clinical trials. Research and development expenses are primarily related to employee compensation, including salary, fringe benefits, share-based compensation, and temporary employee expenses. We also incur significant expenses to operate our clinical trials including budgeted clinical site compensation and reimbursement, study monitoring and oversight expenses, clinical trial product and associated travel expenses. Our research and development expenses also include fees for design services, contractors and development materials.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of intangible assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amortization expense primarily relates to acquired technology and intellectual property and other acquired intangible assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our selling, general and administrative expenses primarily consist of salary, fringe benefits and share-based compensation for our executive, financial, sales, marketing, information technology and administrative functions. Other significant expenses include commissions, marketing and advertising, IT software license costs, insurance, professional fees for our outside legal counsel and independent auditors, litigation expenses, patent application expenses and consulting expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense is comprised primarily of costs related to our senior convertible notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income from equity investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from equity investments is comprised of realized gains from the sale of an equity investment.</span></div><div style="margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest and other income, net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income, net consists primarily of interest income on our cash, cash equivalents and short-term marketable securities portfolio and foreign currency transaction gains and losses due to the effects of foreign currency fluctuations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:17.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-top:9pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June&#160;30, 2023 Compared to </span></div><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June&#160;30, 2022 </span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue increase was primarily driven by increased sales volume of our disposable sensors due to the continued growth of our worldwide customer base, partially offset by mix shift and price associated with the evolution of our channel and product strategy.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disposable sensor and other revenue comprised approximately 89% of total revenue and Reusable Hardware revenue comprised approximately 11% of total revenue for the three months ended June&#160;30, 2023. Disposable sensor and other revenue comprised approximately 86% of total revenue and Reusable Hardware revenue comprised approximately 14% of total revenue for the three months ended June&#160;30, 2022.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cost of sales &amp; Gross profit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales and gross profit increased primarily due to an increase in sales volume.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in gross profit margin percentage in the second quarter of 2023 compared to the second quarter of 2022 was primarily driven by price, product, and channel mix changes, amortization of an intangible asset, and impact of foreign currencies on revenue.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Research and development expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense decreased primarily due to $7.8&#160;million of lower third party and consulting fees, most notably related to software development for new products and significant enhancements</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $4.0&#160;million</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in lower costs related to set-up and validation costs for new CGM equipment, partially offset by $6.5 million in compensation-related costs primarily due to higher headcount.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to believe that focused investments in research and development are critical to our future growth and competitive position in the marketplace, and to the development of new and updated products and services that are central to our core business strategy.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Selling, general and administrative expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expense increased primarily due to $22.4 million in compensation-related costs most notably due to higher headcount,</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$13.5 million in legal expense primarily related to a patent infringement lawsuit, and $10.3 million in advertising and marketing costs as a result of an increase in worldwide marketing campaigns.</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Interest and other income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income, net, increased primarily due to $33.7&#160;million in interest income on our cash, cash equivalents, and marketable securities portfolio. The increase in interest income was related to a significant increase in market interest rates, as well as an increase in the average invested balances compared to the same period in 2022.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Income tax expense (benefit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimated annual effective tax rate from normal, recurring operations decreased from 30.9% to 28.5% during the three months ended June&#160;30, 2023 primarily due to impacts of foreign operations. There were no significant discrete items recognized during the three months ended June&#160;30, 2023.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax expense recorded for the three months ended June&#160;30, 2022 was primarily attributable to income tax expense from normal, recurring operations.</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_166"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><img src="dxcm-20230630_g3.jpg" alt="4" style="height:320px;margin-bottom:5pt;vertical-align:text-bottom;width:500px"/></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Six Months Ended June&#160;30, 2023 Compared to Six Months Ended June&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 - 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,612.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from equity investments</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The sum of the individual percentages may not equal the total due to rounding.</span></div></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">** Not meaningful</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.264%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June&#160;30, 2023 Compared to </span></div><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June&#160;30, 2022</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue increase was primarily driven by</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased sales volume of our disposable sensors due to the continued growth of our worldwide customer base, partially offset by mix shift and price associated with the evolution of our channel and product strategy.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disposable sensor and other revenue comprised approximately 89% of total revenue and Reusable Hardware revenue comprised approximately 11% of total revenue for the six months ended June&#160;30, 2023. Disposable sensor and other revenue comprised approximately 86% of total revenue and Reusable Hardware revenue comprised approximately 14% of total revenue for the six months ended June&#160;30, 2022.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cost of sales &amp; Gross profit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales and gross profit increased primarily due to an increase in sales volume.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in gross profit margin percentage in 2023 compared to 2022 was primarily driven by price, product, and channel mix changes, amortization of an intangible asset, and impact of foreign currencies on revenue.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Research and development expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense decreased primarily due to $16.0&#160;million of lower third party and consulting fees most notably related to software development for new products and significant enhancements and $12.5 million in lower costs related to set-up and validation costs for new CGM equipment, partially offset by $13.2 million in compensation-related costs primarily due to higher headcount.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to believe that focused investments in research and development are critical to our future growth and competitive position in the marketplace, and to the development of new and updated products and services that are central to our core business strategy.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Selling, general and administrative expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expense increased primarily due to $41.7&#160;million in compensation-related costs most notably due to higher headcount, $30.4 million in legal expense primarily related to a patent infringement lawsuit, and $32.0 million in advertising and marketing costs due to an increase in worldwide marketing campaigns.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Interest and other income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income, net, increased primarily due to $55.0 million in interest income on our cash, cash equivalents, and marketable securities portfolio. The increase in interest income was related to a significant increase in market interest rates, as well as an increase in the average invested balances compared to the same period in 2022.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Income tax expense (benefit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax expense recorded for the six months ended June&#160;30, 2023 is primarily attributable to income tax expense from normal, recurring operations, partially offset by excess tax benefits recognized for share-based compensation for employees (net of disallowed executive compensation), and generation of research and development tax credits.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax benefit recorded for the six months ended June&#160;30, 2022 is primarily attributable to income tax expense from normal, recurring operations, offset by excess tax benefits recognized for share-based compensation for employees (net of disallowed executive compensation) and the Verily milestone payment, and generation of research and development tax credits.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_172"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Liquidity and Capital Resources</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Overview, Capital Resources, and Capital Requirements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal sources of liquidity are our existing cash, cash equivalents and marketable securities, cash generated from operations, proceeds from our senior convertible notes issuances, and access to our Credit Facility. Our primary uses of cash have been for research and development programs, selling and marketing activities, capital expenditures, acquisitions of businesses, and debt service costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that cash provided by our operations may fluctuate in future periods as a result of a number of factors, including fluctuations in our operating results, working capital requirements and capital deployment decisions. We have historically invested our cash primarily in U.S. dollar-denominated, investment grade, highly liquid obligations of U.S. government agencies, commercial paper, corporate debt, and money market funds. Certain of these investments are subject to general credit, liquidity and other market risks. The general condition of the financial markets and the economy may increase those risks and may affect the value and liquidity of investments and restrict our ability to access the capital markets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors, including but not limited to:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:29.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.737%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.737%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.399%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The evolution of the international expansion of our business and the revenue generated by sales of our approved products and other future products;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our ability to efficiently scale our operations to meet demand for our current and any future products;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The success of our research and development efforts;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The expenses we incur in manufacturing, developing, selling and marketing our products;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The costs, timing and risks of delays of additional regulatory approvals;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The quality levels of our products and services;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The emergence of competing or complementary technological developments;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The terms and timing of any collaborative, licensing and other arrangements that we may establish; and</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The third-party reimbursement of our products for our customers;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The rate of progress and cost of our clinical trials and other development activities;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The acquisition of businesses, products and technologies and our ability to integrate and manage any acquired businesses, products and technologies.</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that existing cash and short-term investments and cash flows from our future operations will generally be sufficient to fund our ongoing core business. As current borrowing sources become due, we may be required to access the capital markets for additional funding. As we assess inorganic growth strategies, we may need to supplement our internally generated cash flow with outside sources. In the event that we are required to access the debt market, we believe that we will be able to secure reasonable borrowing rates. As part of our liquidity strategy, we will continue to monitor our current level of earnings and cash flow generation as well as our ability to access the market in light of those earning levels.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A substantial portion of our operations are located in the United States, and the majority of our sales since inception have been made in U.S. dollars. We will be exposed to additional foreign currency exchange risk related to our international operations as we expand our manufacturing internationally and as our business continues to increase in international markets. See &#8220;Foreign Currency Exchange Risk&#8221; in Part II, Item 7A of our Annual Report for more information.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Main Sources of Liquidity</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash, cash equivalents and short-term marketable securities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalents and short-term marketable securities totaled $3.64 billion as of June&#160;30, 2023. None of those funds were restricted and $3.47 billion (approximately 95%) of those funds were located in the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash flow from Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2023, we had positive cash flows of $345.7 million from operating activities. We anticipate that we will continue to generate positive cash flows from operations for the foreseeable future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Convertible Notes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received net proceeds of $836.6 million in November 2018 from the 2023 Notes offering, net proceeds of $1.19 billion in May 2020 from the 2025 Notes offering, and net proceeds of $1.23&#160;billion from the 2028 Notes offering. We used $100.0&#160;million of the net proceeds from the offering of the 2023 Notes to repurchase a portion of our common stock in 2018. We used $282.6 million of the net proceeds from the offering of the 2025 Notes to repurchase a portion of our senior convertible notes due in 2022. We used $289.9 million of the net proceeds from the offering of the 2028 Notes to purchase capped call transactions and repurchase shares of our common stock in May 2023. We intend to use the remainder of the net proceeds from the 2023 Notes, 2025 Notes, and 2028 Notes offerings for general corporate purposes and capital expenditures, including working capital needs. We may also use the net proceeds to expand our current business through in-licensing or acquisitions of, or investments in, other businesses, products or technologies; however, we do not have any significant commitments with respect to any such acquisitions or investments at this time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2023 Notes and 2028 Notes offerings, we purchased the 2023 Note Hedge and 2028 Capped Calls, respectively. See Note 5 &#8220;Debt&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report for conversion activity related to the 2023 Notes and shares received as the result of exercising a portion of the 2023 Note Hedge as well as for more information about our senior convertible notes, the 2023 Note Hedge, the 2023 Warrants, and the 2028 Capped Calls.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, we had no outstanding borrowings, $7.3 million in outstanding letters of credit, and a total available balance of $192.7 million under the Amended Credit Agreement. We monitor counterparty risk associated with the institutional lenders that are providing the Credit Facility. We currently believe that the Credit Facility will be available to us should we choose to borrow under it. Revolving loans will be available for general corporate purposes, including working capital and capital expenditures. See Note 5 &#8220;Debt&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report for more details on the Revolving Credit Agreement.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Liquidity Requirements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term liquidity requirements primarily consist of regular operating costs, interest payments related to our senior convertible notes, capital expenditures for the development of our manufacturing facilities and office spaces, and short-term material cash requirements as described below. As of June&#160;30, 2023, we had a working capital ratio of 2.42 and a quick ratio of 2.12, which indicates that our current assets are more than enough to cover our short-term liabilities. We expect to have significant capital expenditures for the next year to drive our strategic initiative of building out our manufacturing facilities and/or equipment in Malaysia and Ireland and the capacity scale-up in Mesa, Arizona.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash, cash equivalents, and marketable securities balances, projected cash contributions from our commercial operations, and borrowings under our Credit Facility will be sufficient to meet our anticipated seasonal working capital needs, all capital expenditure requirements, material cash requirements as described below, and other liquidity requirements associated with our operations for at least the next 12 months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may use cash for strategic initiatives that strengthen our foundation for long-term growth. On July 26, 2022, a duly authorized committee of our Board of Directors authorized a share repurchase program of up to $700.0 million of our outstanding common stock, with a repurchase period ending no later than June 30, 2023. The Share Repurchase Program and the remaining authorization of approximately $142.3&#160;million expired on June 30, 2023.</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 &#8220;Stockholders&#8217; Equity&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report for more details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, we have outstanding senior convertible notes that will mature in December 2023.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">second quarter of 2023, holders of $532.2&#160;million in aggregate principal amount of the 2023 Notes exercised their conversion option. We elected to settle these conversions through a combination of cash for the principal amount and common stock for any amount due in excess of the principal amount. The conversions will settle in the third quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From July 1, 2023 through July&#160;26, 2023, holders of $7.8 million in aggregate principal amount of the 2023 Notes exercised their conversion option.</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may elect to settle the remaining principal amount outstanding of the 2023 Notes with cash and/or shares of our common stock prior to maturity once certain conditions are met.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Liquidity Requirements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term liquidity requirements primarily consist of interest and principal payments related to our senior convertible notes, capital expenditures for the development of our manufacturing facilities and office spaces, and long-term material cash requirements as described below. As of June&#160;30, 2023, we had a debt-to-assets ratio of 0.47, which indicates that our total assets are more than enough to cover our short-term and long-term debts. As demand grows for our products, we will continue to expand global operations to meet demand through investments in manufacturing and operations. We expect to meet our long-term liquidity requirements from our main sources of liquidity as described above to support our future operations, capital expenditures, acquisitions, and other liquidity requirements associated with our operations beyond the next 12 months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, we have outstanding senior convertible notes that will mature in November 2025 and May 2028. However, the outstanding principal of our senior convertible notes could be converted into cash and/or shares of our common stock prior to maturity once certain conditions are met. See Note 5 &#8220;Debt&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report for information on conversion rights prior to maturity.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Cash Requirements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time in the ordinary course of business, we enter into a variety of purchase arrangements including but not limited to, purchase arrangements related to capital expenditures, components used in manufacturing for the United States and Malaysia, and research and development activities. See &#8220;Contractual Obligations&#8221; below in Part I, Item 2 of this Quarterly Report for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued senior convertible notes in November 2018, May 2020, and May 2023. These obligations include both principal and interest for these notes. Although these notes mature in December 2023, November 2025, and May 2028, respectively, they may be converted into cash and/or shares of our common stock prior to maturity if certain conditions are met. Any conversion prior to maturity can result in repayment of the principal amounts sooner than the scheduled repayment. As of June&#160;30, 2023, we had outstanding letters of credit of $7.3 million for which we cannot forecast with certainty the amount and timing of repayments. See Note 5 &#8220;Debt&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report for further discussion of the terms of our senior convertible notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to various leasing arrangements, primarily for office, manufacturing and warehouse space that expire at various times through December 2030, excluding any renewal options. We also have land leases in Penang, Malaysia for the build-out of our international manufacturing facility lease that expire through 2082. We anticipate incurring significant expenditures related to the build-out of the Malaysia manufacturing facility and equipment over the next year and the build-out of the Ireland manufacturing facility and equipment over the next five years. See Note 6 &#8220;Leases and Other Commitments&#8221; to the consolidated financial statements in Part II, Item 8 of our Annual Report for more information about our leases.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 5 &#8220;Debt&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report for more information about the terms of the Credit Agreement, our senior convertible notes, the 2023 Note Hedge, the 2023 Warrants, and the 2028 Capped Calls.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Cash Flows</span></div></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of our cash flows for the periods indicated. See the consolidated financial statements in Part I, Item 1 of this Quarterly Report for complete consolidated statements of cash flows for these periods.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><img src="dxcm-20230630_g4.jpg" alt="9743" style="height:400px;margin-bottom:5pt;vertical-align:text-bottom;width:700px"/></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, we had $3.64 billion in cash, cash equivalents and short-term marketable securities, which is an increase of $1.18 billion compared to $2.46 billion as of December&#160;31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary cash flows during the six months ended June&#160;30, 2023 and June&#160;30, 2022 are described below. See the consolidated financial statements in Part I, Item 1 of this Quarterly Report for complete consolidated statements of cash flows for these periods.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:208.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:208.75pt"></td><td style="width:1.0pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr style="height:50pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Cash Flows</span></td><td colspan="3" rowspan="2" style="border-right:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#32ad10;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$164.5 million of net income, $82.9 million of net non-cash adjustments, and a net increase of $98.3 million in changes of working capital balances</span></div></td><td colspan="3" rowspan="2" style="border-right:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#32ad10;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$148.2 million of net income and $141.3 million of net non-cash adjustments, partially offset by $45.7 million of net changes in working capital balances</span></div></td></tr><tr style="height:38pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net non-cash adjustments were primarily related to share-based compensation and depreciation and amortization.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net non-cash adjustments were primarily related to share-based compensation and depreciation and amortization.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr style="height:26pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Cash Flows</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$592.9 million in net purchases of marketable securities</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$358.1 million in net purchases of marketable securities</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$133.7 million in capital expenditures</span></div></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$193.1 million in capital expenditures</span></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.0 million in purchases of equity investments</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr style="height:38pt"><td colspan="3" rowspan="5" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Cash Flows</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#32ad10;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.23 billion in proceeds from issuance of senior convertible notes, net of issuance costs</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#32ad10;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$10.1 million in proceeds from issuance of common stock under our employee stock plans</span></div></td></tr><tr style="height:38pt"><td colspan="3" rowspan="4" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#32ad10;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$12.3 million in proceeds from issuance of common stock under our employee stock plans</span></div></td><td colspan="3" rowspan="4" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$7.7&#160;million in payments for financing leases</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$188.7 million</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in purchases of treasury stock</span></div></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:26pt"><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$101.3 million in purchases of capped call transactions</span></div></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="ice0ef719e77e40b5a387f5daee547017_175"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Contractual Obligations</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We presented our contractual obligations as of December&#160;31, 2022 in Note 6 &#8220;Leases and Other Commitments&#8221; in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022. There were no significant changes to our lease obligations during the six months ended June&#160;30, 2023. As of June&#160;30, 2023, we had approximately $295.9&#160;million of open purchase orders and contractual obligations in the ordinary course of business, the majority of which are due within one year. See Note 5 &#8220;Debt&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report for conversion activity related to our senior convertible notes.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_178"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Recent Accounting Guidance</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of recently issued accounting pronouncements and the potential impact on our consolidated financial statements, if any, see&#160;Note 1&#160;&#8220;Organization and Significant Accounting Policies&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_181"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 3 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material changes to our quantitative and qualitative disclosures about market risk during the six months ended June&#160;30, 2023. See Part II, Item 7A of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 for a detailed discussion of our market risks.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_193"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 4 - CONTROLS AND PROCEDURES</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulations under the Exchange Act require public companies to maintain &#8220;disclosure controls and procedures,&#8221; which are defined to mean a company&#8217;s controls and other procedures that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act, is accumulated and timely communicated to management, including our Chief Executive Officer and Chief Financial Officer, recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms. Our management, including our Chief Executive Officer and our Chief Financial Officer, conducted an evaluation as of the end of the period covered by this report of the effectiveness of our disclosure controls and procedures. Based on their evaluation as of June&#160;30, 2023, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of such date for this purpose.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limitation on Effectiveness of Controls</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system are met. The design of any control system is based, in part, upon the benefits of the control system relative to its costs. Control systems can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. In addition, over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of these and other inherent limitations of control systems, we cannot guarantee that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_196"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PART II. OTHER INFORMATION</span></td></tr></table></div><div id="ice0ef719e77e40b5a387f5daee547017_199"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 1 - LEGAL PROCEEDINGS</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:23.15pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability, intellectual property and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2023, we and certain Abbott Diabetes Care, Inc. (&#8220;Abbott&#8221;) entities have previously served complaints for patent infringement, validity and other patent related actions against each other in multiple jurisdictions, inside and outside the United States. In June and July 2021, we initiated patent infringement litigation against Abbott in the United States and in Germany over certain of Abbott's continuous glucose monitoring products. In both the United States and Germany, we seek injunctive relief and monetary damages. In July 2021, Abbott initiated patent infringement litigation against Dexcom in the United States, United Kingdom, and in Germany over certain of Dexcom's continuous glucose monitoring products. Abbott seeks injunctive relief and monetary damages. In response to the suits in the United Kingdom, Dexcom brought infringement counterclaims there. One trial on liability has already been conducted in the United Kingdom, and the parties are awaiting a ruling.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, Abbott filed a breach of contract suit against Dexcom in the United States alleging that Dexcom breached the parties' 2014 Settlement and License Agreement. Dexcom&#8217;s patent infringement claims in the United States are stayed pending resolution of Abbott&#8217;s breach of contract claims. A jury trial on Abbott&#8217;s breach of contract claims commenced on July 10, 2023. On July 14, 2023, the jury awarded a verdict finding Abbott was not licensed to several claims of certain Dexcom patents and that Abbott was licensed to a few claims. We will continue to enforce the remaining claims in the patents asserted in Delaware and elsewhere.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott&#8217;s U.S. patent infringement action against Dexcom is currently scheduled for trial on November 5, 2023. In February and March of 2023, Abbott initiated additional patent infringement litigation against Dexcom in both the United States and in Germany. Abbott seeks injunctive relief and monetary damages. Due to uncertainty surrounding patent litigation processes in the U.S. and Europe, we are unable to reasonably estimate the ultimate outcome of any of the litigation matters at this time. We intend to protect our intellectual property and defend against Abbott&#8217;s claims vigorously in all of these actions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe we are party to any other currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition or results of operations.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_202"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 1A - RISK FACTORS</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our short and long-term success is subject to numerous risks and uncertainties, many of which involve factors that are difficult to predict or beyond our control. Before making a decision to invest in, hold or sell our common stock, stockholders and potential stockholders should carefully consider the risks and uncertainties described below, in addition to the other information contained in or incorporated by reference into this Quarterly Report on Form 10-Q, as well as the other information we file with the SEC. If any of the following risks are realized, our business, financial condition, results of operations and prospects could be materially and adversely affected. In that case, the value of our common stock could decline and stockholders may lose all or part of their investment. Furthermore, additional risks and uncertainties of which we are currently unaware, or which we currently consider to be immaterial, could have a material adverse effect on our business, financial condition or results of operations. Refer to our disclaimer regarding forward-looking statements at the beginning of Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in Part I, Item 2 of this Quarterly Report.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_205"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Summary of Risk Factors</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below summary of risk factors provides an overview of many of the risks we are exposed to in the normal course of our business activities. As a result, the below summary risks do not contain all of the information that may be important to you, and you should read the summary risks together with the more detailed discussion of risks set forth following this section under the heading &#8220;Risk Factors,&#8221; as well as elsewhere in this Quarterly Report on Form 10-Q.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional risks, beyond those summarized below or discussed elsewhere in this Quarterly Report on Form 10-Q, may apply to our activities or operations as currently conducted or as we may conduct them in the future or in the markets in which we operate or may in the future operate. Consistent with the foregoing, we are exposed to a variety of risks, including risks associated with the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If we experience decreasing prices for our products and we are unable to reduce our expenses, including the per unit cost of producing our products, there may be a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We are subject to cost-containment efforts by third-party payors that could result in reduced product pricing and/or sales of our products and cause a reduction in future revenue.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Although many third-party payors have adopted some form of coverage policy for continuous glucose monitoring devices, our products do not always have such coverage, including simple broad-based contractual coverage with third-party payors, and we frequently experience administrative challenges in obtaining coverage or reimbursement for our products. If we are unable to obtain adequately broad coverage or reimbursement for our products or any future products from third-party payors, our revenue may be negatively impacted.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The research and development efforts we undertake independently, and in some instances in connection with our collaborations with third parties, may not result in the development of commercially viable products, the generation of significant future revenues or adequate profitability.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our products may not achieve or maintain market acceptance.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If our manufacturing capabilities are insufficient to produce an adequate supply of product at appropriate quality levels, our growth could be limited and our business could be harmed.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Manufacturing difficulties and/or any disruption at our facilities may adversely affect our manufacturing operations and related product sales, and increase our expenses.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We depend upon third-party suppliers and outsource to other parties, making us vulnerable to supply disruptions, suboptimal quality, non-compliance and/or price fluctuations, which could harm our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If we are unable to establish and maintain adequate sales, marketing and distribution capabilities or enter into and maintain arrangements with third parties to sell, market and distribute our products, we may have difficulty achieving market awareness and selling our products in the future.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We operate in a highly competitive market and face competition from large, well-established companies with significant resources, and, as a result, we may not be able to compete effectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Global pandemics or similar public health crises, could have a material adverse impact on our business, financial condition and results of operations, including our manufacturing, commercial operations and sales.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We are subject to a variety of risks due to our international operations that could adversely affect our business, our operations or profitability and operating results.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We have incurred significant losses in the past and may incur losses in the future.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We are subject to complex and evolving U.S. and foreign laws and regulations and other requirements regarding privacy, data protection, security, and other matters. Many of these laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, monetary penalties, increased cost of operations, or declines in user growth or engagement, or otherwise harm our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Cybersecurity risks and cyber incidents could result in the compromise of confidential data or critical data systems and give rise to potential harm to customers, remediation and other expenses, expose us to liability under HIPAA, consumer protection laws, or other common law theories, subject us to litigation and federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business and operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We conduct business in a heavily regulated industry and if we fail to comply with applicable laws and government regulations, we could become subject to penalties, be excluded from participation in government programs, and/or be required to make significant changes to our operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Managed care trends and consolidation in the health care industry could have an adverse effect on our revenues and results of operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Health care policy changes, including U.S. health care reform legislation, may have a material adverse effect on our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If we are unable to successfully complete the pre-clinical studies or clinical trials necessary to support additional PMA, de novo, or 510(k) applications or supplements, we may be unable to commercialize our CGM systems under development, which could impair our business, financial condition and operating results.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We are subject to claims of infringement or misappropriation of the intellectual property rights of others, which could prohibit us from shipping affected products, require us to obtain licenses from third parties or to develop non-infringing alternatives, and subject us to substantial monetary damages and injunctive relief. We may also be subject to other claims or suits.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our inability to adequately protect our intellectual property could allow our competitors and others to produce products based on our technology, which could substantially impair our ability to compete.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We face the risk of product liability claims and may be subject to damages, fines, penalties and injunctions, among other things.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We could become the subject of governmental investigations, claims and litigation.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our stock price is highly volatile and investing in our stock involves a high degree of risk, which could result in substantial losses for investors.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We have indebtedness in the form of convertible senior notes, which could adversely affect our financial health and our ability to respond to changes in our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Environmental, social and governance, or ESG, regulations, policies and provisions could expose us to numerous risks.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_208"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Our Business and Operations</span></td></tr></table></div><div id="ice0ef719e77e40b5a387f5daee547017_211"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risks Related to Pricing and Reimbursement</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we experience decreasing prices for our products and we are unable to reduce our expenses, including the per unit cost of producing our products, there may be a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced, and anticipate that we will continue to experience, decreasing prices for our products due to pricing pressure from managed care organizations and other third-party payors, increased market power of our payors, and increased competition among suppliers, including manufacturing services providers, as the medical device industry consolidates. If the prices for our products and services decrease and we are unable to reduce our expenses, including the cost of sourcing materials, logistics and the cost to manufacture our products, our business, results of operations, financial condition and cash flows will be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to cost-containment efforts by third-party payors that could result in reduced product pricing and/or sales of our products and cause a reduction in future revenue.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States and other countries, government and private sector access to health care products continues to be a subject of focus, and efforts to reduce health care costs are being made by third-party payors. Most of our customers rely on third-party payors, including government programs and private health insurance plans, to cover the cost of our products. We expect that the continuing cost reduction and containment measures may reduce the cost or utilization of health care products and could lead to patients being unable to obtain approval for coverage or payment from these third-party payors or to costs being shifted to patients for our products. Additionally, as a result of the economic slowdown, some customers have lost access and others may lose access to their private health insurance plan if they lose their job, and an impact to job status may extend for a prolonged period of time, beyond possible coverage periods through COBRA, or where the cost to maintain coverage may not be affordable to our customer. As most of our customers rely on third-party payors, including government programs and private health insurance plans, to cover the cost of our products, our customers may lose coverage or reimbursement for our products, which may harm our business and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced, and anticipate that we will continue to experience, downward pressure on product pricing. To the extent these cost containment efforts are not offset by greater patient access to our products, our future revenue may be reduced and our business may be harmed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Although many third-party payors have adopted some form of coverage policy for continuous glucose monitoring devices, our products do not always have such coverage, including simple broad-based contractual coverage with third-party payors, and we frequently experience administrative challenges in obtaining coverage or reimbursement for our products. If we are unable to obtain adequately broad coverage or reimbursement for our products or any future products from third-party payors, our revenue may be negatively impacted.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a medical device company, reimbursement from government and/or commercial third-party healthcare payors, including Medicare and Medicaid, is an important element of our success. The Centers for Medicare &amp; Medicaid Services, or CMS, provides coverage for &#8220;Therapeutic Continuous Glucose Monitors&#8221; as durable medical equipment eligible for coverage under Medicare Part B. Coverage criteria for therapeutic CGMs is determined by CMS under national coverage determinations as well as by local Medicare Administrative Contractors under local coverage determinations. Therefore, Medicare reimbursement for our CGM devices is subject to various coverage conditions and often requires a patient-specific coverage analysis. Medicare does not cover any items or services that are not &#8220;reasonable and necessary.&#8221; Medicare covers the CGM system, which includes supplies necessary for the use of the device, under the Durable Medical Equipment, or DME, benefit category. In order to be covered under this benefit, one component of the CGM system must meet the criteria for a durable medical device. To date, the receiver satisfied this criteria. To the extent that a receiver is not used by a Medicare beneficiary or CMS otherwise determines that the items and supplies ordered are not medically necessary, Medicare may not cover that CGM system or any associated supplies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of regulatory and commercial hurdles remain relating to wide-scale sales where a government or commercial third-party payor provides reimbursement, including sales to Medicare beneficiaries. If we are unable to successfully address these hurdles, reimbursement of our products may be limited to a smaller subset of people with diabetes covered by Medicare or to those people with diabetes covered by other third-party payors that have adopted policies for CGM devices allowing for coverage of these devices if certain conditions are met. Adverse coverage or reimbursement decisions relating to our products, or rescission or limitation of favorable determinations, by CMS, its Medicare Administrative Contractors, other state, federal or international payors, and/or third-party commercial payors could significantly reduce reimbursement, which could have an impact on the acceptance of, and demand for, our products and the prices that our customers are willing to pay for them.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the eight largest private third-party payors, in terms of the number of covered lives, have issued coverage policies for the category of CGM devices. In addition, we have negotiated contracted rates with all of those third-party payors for the purchase of our current CGM systems by their members. Nevertheless, coverage and reimbursement-related barriers remain. Among other things, people with diabetes without insurance that covers our products bear the entire financial cost of using our products. In addition, in the United States, people with diabetes using existing single-point finger stick devices are generally reimbursed all or part of the product cost by Medicare or other third-party payors, which may be perceived as more advantageous for consumers. Further, while many third-party payors have adopted some form of coverage policy on CGM devices, in a sizeable percentage of cases, under durable medical equipment benefits, those coverage policies frequently are restrictive and require significant medical documentation and other requirements in order for policy holders to obtain reimbursement, and as a result, we have difficulty improving the efficiency of our customer service group. Moreover, it is not uncommon for governmental, including federal and/or state, agencies and their contractors to conduct periodic routine billing and compliance reviews that may entail extensive documentation requests, cooperation with which may require significant time and resources, and may result in identification of overpayments that may need to be refunded. The commercial success of our products in both domestic and international markets will substantially depend on whether timely and comprehensive third-party reimbursement is widely available for individuals that use them.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS has adopted coverage guidelines for CGMs, which could have a favorable impact on us.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Previously, Medicare coverage for CGM was only available to Medicare patients who take at least three doses of insulin a day, limiting CGM reimbursement for Medicare beneficiaries with intensive Type 1 and 2 diabetes. The Local Coverage Determination, or LCD, that CMS released in April 2023 extends Medicare CGM coverage to patients who use insulin at least once per day. Further, the LCD also allows coverage for patients not taking insulin if the patient has a history of problematic hypoglycemia.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nevertheless, third-party payors are increasingly attempting to contain healthcare costs by limiting both coverage and the level of reimbursement of new and existing medical devices, and, as a result, they may be </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">restrictive, or they may not cover or provide adequate payment for our products. In order to obtain additional reimbursement arrangements, including under pharmacy benefits, we may have to agree to a net sales price lower than the net sales price we might charge in other sales channels. Our revenue may be limited by the continuing efforts of government and third-party payors to contain or reduce the costs of healthcare through various increasingly sophisticated means, such as leveraging increased competition, increasing eligibility requirements such as second opinions and other documentation, purchasing in a bundle, or redesigning benefits. In December 2021, CMS published a final rule expanding the classification of DME under Medicare Parts B &amp; C to include adjunctive CGMs (i.e., CGMs that do not replace standard blood glucose monitors for treatment decisions) and related supplies. This final rule expands coverage of CGMs to include a large competitor&#8217;s competing device, which may negatively impact our sales. We are unable to predict what effect the current or any future healthcare reform will have on our business, or the effect these matters will have on our customers. Our dependence on the commercial success of our current CGM systems makes us particularly susceptible to any cost containment or reduction efforts. Accordingly, unless government and other third-party payors provide adequate coverage and reimbursement for our current CGM systems, people without coverage who have diabetes may not use our products. Furthermore, payors are increasingly basing reimbursement rates on factors such as prior approvals and the effectiveness of the product, clinical outcomes associated with the product, and any factors that negatively impact the effectiveness or clinical outcomes (or cause a perception of any such negative impact), such as the results of a clinical trial, a product defect, or a product recall, which could negatively impact the reimbursement rate. Also, the trends toward managed healthcare in the United States and legislative efforts intended to reduce the cost of government insurance programs could significantly influence the purchase of healthcare services and products and may result in lower prices for our products or the exclusion of our products from reimbursement programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some foreign markets, pricing and profitability of medical devices are subject to government control. We are susceptible to changes in government-mandated coverage requirements and other controls which could impact access to and affordability of our products. In the United States, we expect that there will continue to be federal and state proposals for similar controls.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_214"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risks Related to Product Development</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The research and development efforts we undertake independently, and in some instances in connection with our collaborations with third parties, may not result in the development of commercially viable products, the generation of significant future revenues or adequate profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to address the anticipated needs of our customers, pursue new markets for our existing products, and remain competitive, we focus our research and development efforts and strategic third-party collaboration activities on the enhancement of our current CGM products, the development of next-generation products and the development of novel technologies and services.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development of new products, or novel technologies and services and the enhancement of our current CGM products (including seeking and potentially obtaining new indications for use), requires significant investment in research and development, intellectual property protection, clinical trials, regulatory approvals and third party reimbursement. The results of our product development and commercialization efforts may be affected by a range of factors, including our ability to anticipate customer needs, innovate and develop new products (whether independently or with our partners), determine a feasible or timely regulatory pathway or approach, and launch those products cost effectively into multiple markets and geographies. If we are unable to successfully anticipate customer needs, innovate, develop new products and successfully launch them, we may not be able to generate significant future revenues or profits from these efforts. Failing to timely launch our products may cause them to become obsolete and materially and adversely affect our business and financial position.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development and commercial launch timelines for our products depend a great deal on our ability to achieve clinical endpoints and satisfy regulatory requirements and to overcome technology challenges, and may be delayed due to scheduling issues with patients and investigators, requests from institutional review boards, or inquiries from regulators about our independent and collaborative product development activities, product performance and manufacturing supply constraints, among other factors. In addition, support of these clinical trials requires significant resources from employees involved in the production of our products, including research and development, manufacturing, quality assurance, and clinical and regulatory personnel. Even if our development and clinical trial efforts appear successful to us and our regulatory submission appears satisfactory to us, the FDA may disagree and may decide not to grant marketing authorization for the products or may require additional product testing or clinical trials or other data to be developed and submitted before approving the products, which would result in product launch delays and additional expense. Even if a product receives marketing authorization from the FDA, it may not be accepted in the marketplace by physicians and people with diabetes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business we enter into collaborative arrangements with third parties to expand into new markets, including with insulin device manufacturers such as Eli Lilly, Insulet, Novo Nordisk, Tandem Diabetes and The Ypsomed Group to integrate our CGM technology into their insulin delivery systems. We have also entered into collaborations with several organizations that are currently using, or are developing, programs for the treatment of Type 2 diabetes that utilize our current CGM systems. As a result of these relationships, our operating results depend, to some extent, on the ability of our partners to successfully commercialize their insulin delivery systems or monitoring products. Any factors that may limit our partners&#8217; ability to achieve widespread adoption of their systems, including competitive pressures, technological breakthroughs for the treatment or prevention of diabetes, adverse regulatory or legal actions relating to insulin pump products, or changes in reimbursement rates or policies of third-party payors relating to insulin pumps or similar products, could have an adverse impact on our operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the companies that we collaborate with are also competitors or potential competitors who may decide to terminate our collaborative arrangement. In the event of such a termination, we may be required to devote additional resources to product development and commercialization, we may need to cancel some development programs and we may face increased competition. Additionally, collaborations may not result in the development of products that achieve commercial success and could be terminated prior to developing any products. Former collaborators may use the experience and insights they develop in the course of their collaborations with us to initiate or accelerate their development of products that compete with our products, which may create competitive disadvantages for us. Accordingly, we cannot provide assurance that any of our collaborations will result in the successful development of a commercially viable product or result in significant additional future revenues.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products may not achieve or maintain market acceptance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that sales of our current CGM systems will account for substantially all of our product revenue for the foreseeable future. If and when we receive FDA or other regulators&#8217; marketing authorization for, and begin commercialization of, our next-generation CGM systems, we expect most patients will migrate onto those systems. In the periods leading up to the launch of new or upgraded versions of our CGM systems, however, our customers&#8217; anticipation of the release of those products may cause them to cancel, change or delay current period purchases of our current products, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding our prior experience in marketing and selling our products, we might be unable to successfully expand the commercialization of our existing products or begin commercialization of our next-generation CGM systems on a wide-scale for a number of reasons, including the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our G6 and G7 systems prompt the user to replace the sensor no later than the tenth day, which might make it expensive for users;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">widespread market acceptance of our products by physicians and people with diabetes will largely depend on our ability to demonstrate their relative safety, effectiveness, reliability, cost-effectiveness and ease of use;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the limited size of our sales force;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we may not have sufficient financial or other resources to adequately expand the commercialization efforts for our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">expanded coverage opportunities for our competitors&#8217; CGM devices and supplies, including coverage for adjunctive CGMs, increasing competition in the marketplace;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our FDA and other regulatory authority marketing application submissions and reviews may be delayed, or cleared or approved with limited product indications and labeling;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we may not be able to manufacture our products in commercial quantities commensurate with demand or at an acceptable cost;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">for people with Type 2 diabetes, current reimbursement from third-party payors is generally limited to people on intensive insulin therapy;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the uncertainties associated with establishing and qualifying new manufacturing facilities;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">people with diabetes may need to incur the costs of single-point finger stick devices, in addition to our systems;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the relative immaturity of the CGM market internationally, and limited international reimbursement of CGM systems by third-party payors and government healthcare providers outside the United States;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the introduction and market acceptance of competing products and technologies, which may have a lower cost or price, allow for a convenience improvement and/or allow for improved accuracy and reliability;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">greater name or brand recognition and more established medical product distribution channels by some of our competitors;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our inability to obtain sufficient quantities of supplies timely and at appropriate quality levels from our single- or sole-source and other key suppliers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our inability to manufacture products that perform in accordance with expectations of consumers; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">rapid technological change may make our technology and our products obsolete.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the risks outlined above, our G6 and G7 systems are more invasive than many other self-monitored glucose testing systems, including single-point finger stick devices, and people with diabetes may be unwilling to insert a sensor in their body, especially if their current diabetes management involves no more than two finger sticks per day. Moreover, people with diabetes may not perceive the benefits of CGM and may be unwilling to change their current treatment regimens. Physicians may not recommend or prescribe our products unless and until (i)&#160;there is more long-term clinical evidence to convince them to alter their existing treatment methods, (ii)&#160;there are additional recommendations from prominent physicians that our products are effective in monitoring glucose levels, and (iii)&#160;reimbursement or insurance coverage is more widely available. In addition, market acceptance of our products by physicians and people with diabetes in Europe or other countries will largely depend on our ability to demonstrate their relative safety, effectiveness, reliability, cost-effectiveness and ease of use. If we are unable to do so, we may not be able to generate product revenue from our sales efforts in Europe or other countries. We cannot predict when, if ever, healthcare professionals, including physicians, and people with diabetes may adopt more widespread use of CGM systems, including our systems. If our CGM systems do not achieve and maintain an adequate level of acceptance by people with diabetes, healthcare professionals, including physicians, and third party payors, our future revenue may be reduced and our business may be harmed.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_217"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Manufacturing, Commercial Operations and Commercialization</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our manufacturing capabilities are insufficient to produce an adequate supply of product at appropriate quality levels, our growth could be limited and our business could be harmed.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our existing manufacturing facilities are designed to manufacture current and next-generation CGM systems, but may not be scaled quickly enough to permit us to manufacture one or more of our CGM systems in quantities sufficient to meet market demand. In the past, we have had difficulty scaling our manufacturing operations to provide a sufficient supply of product to support market demand and our commercialization efforts. From time to time, we have also experienced brief periods of backorder and, at times, have had to limit the efforts of our sales force to introduce our products to new customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have focused significant effort on continual improvement programs in our manufacturing operations intended to improve quality, yields and throughput. We have made progress in manufacturing to enable us to supply adequate amounts of product to support our commercialization efforts; however, we cannot guarantee that supply will not be constrained in the future. We may not adequately predict the market demand for our products, in order to produce our products in the quantities we anticipate will be necessary to meet market demand. We will need to adequately predict the market demand for our products and increase our manufacturing capacity by a significant factor over the current level to meet or exceed the anticipated market demand by product. In addition, we may have to modify our manufacturing design, reliability and process for next-generation products that may hereafter be approved, cleared or otherwise authorized by the applicable regulatory body and commercialized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are technical challenges to increasing manufacturing capacity, including equipment design, automation, validation and installation, contractor issues and delays, licensing and permitting delays or rejections, materials procurement, manufacturing site expansion, problems with production yields and quality control and assurance. Continuing to develop commercial-scale manufacturing facilities will require the investment of substantial additional funds and the hiring and retention of additional management, quality assurance, quality control and technical personnel who have the necessary manufacturing experience. Delays in the launch of next-generation products may result in unanticipated continuing increases in demand for current-generation products (to substitute for the unavailability of the next-generation products) which, if not adequately prepared for, may result in deficits in our ability to produce adequate amounts of the prior-generation products to meet demand at appropriate prices.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scaling of manufacturing capacity is subject to numerous risks and uncertainties, and may lead to variability in product quality or reliability, increased construction timelines, as well as resources required to design, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">install and maintain manufacturing equipment, among others, all of which can lead to unexpected delays in manufacturing output. In addition, any changes to our manufacturing processes may trigger the need for submissions or notifications to, and in some cases advance approval from, the FDA or other regulatory authorities because of the potential impact of changes on our previously cleared, approved and/or authorized devices. Our facilities are subject to inspections by the FDA and corresponding state agencies on an ongoing basis, and we must comply with Good Manufacturing Practices and the FDA Quality System Regulation, as well as certain state requirements. We may be unable to adequately maintain, develop and expand our manufacturing process and operations or maintain compliance with FDA and state agency requirements, and manufacturing issues could impact our cleared and approved products. If we are unable to manufacture a sufficient supply of our current products or any future products for which we may receive approval or clearance, maintain control over expenses or otherwise adapt to anticipated growth, or if we underestimate growth, we may not have the capability to satisfy market demand, contractual obligations, and our business will suffer.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Manufacturing difficulties and/or any disruption at our facilities may adversely affect our manufacturing operations and related product sales, and increase our expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are manufactured at certain facilities, with limited alternate facilities. If an event occurs at one of our facilities that results in damage to, restrictions on the use of, or closure of, one or more of such facilities, or if our distributions from those facilities are limited or restricted in any way, we may be unable to manufacture the relevant products at the previous levels or at all. Because of the time required to approve and lease a manufacturing facility, an alternate facility and/or a third-party may not be available on a timely basis to replace production capacity in the event manufacturing capacity is lost.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the majority of our operations are conducted at facilities located in San Diego, California, Mesa, Arizona and, beginning in 2023, Penang Malaysia. We take precautions to safeguard our facilities, which include manufacturing protocols, insurance, health and safety protocols, and off-site storage of data. However, a natural or man-made disaster, such as fire, flood, earthquake, act of terrorism, cyber-attack or other disruptive event, such as a public health emergency, could cause substantial delays in our operations, damage, destroy or limit our manufacturing equipment, inventory, or records and cause us to incur additional expenses. Earthquakes are of particular significance since our manufacturing facilities in California are located in an earthquake-prone area. Wildfires are also increasingly more common in southern California and present risk to our manufacturing operations. Our Arizona facility may confront water supply issues resulting from the ongoing drought in the Western United States and our Malaysia facility may confront issues related to its construction on a reclaimed wetland and the political stability of the Malaysia government. In the event our existing manufacturing facilities or equipment are affected by man-made or natural disasters, we may be unable to manufacture products for sale or meet customer demands or sales projections. If our manufacturing operations were curtailed or ceased, it would seriously harm our business. The insurance we maintain against fires, floods, earthquakes and other natural disasters and similar events may not be adequate to cover our losses in any particular case.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend upon third-party suppliers and outsource to other parties, making us vulnerable to supply disruptions, suboptimal quality, non-compliance and/or price fluctuations, which could harm our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture the majority of our products and procure important third-party services, such as sterilization services, at numerous facilities worldwide. We purchase many of the components, materials and services needed to manufacture these products from numerous suppliers in various countries. We have generally been able to obtain adequate supplies of such materials, components and services. However, we also rely on single and/or sole sources for certain components and materials used in manufacturing, such as for the application-specific integrated circuit that is incorporated into the transmitter and certain polymers used to synthesize the polymeric biointerface membranes for our products. In some cases, our agreements with these and other suppliers can be terminated by either party upon short notice. Our contract manufacturers may also rely on single- or sole- source suppliers to manufacture some of the components used in our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we work with our suppliers to try to ensure continuity of supply while maintaining quality, timeliness and reliability, the supply of these components, materials and services has in some cases been, and may continue to be impacted, interrupted or insufficient. Our manufacturers and suppliers may also encounter problems during manufacturing for a variety of reasons. They may fail to follow specific protocols and procedures, fail to comply with applicable regulations, or be the subject of FDA or other regulatory authority audits or inspections that result in allegations of non-compliance (for example, resulting in Form 483 Observations, Warning Letters, or other FDA enforcement actions). Our manufacturers and suppliers may also experience or be impacted by equipment malfunction, environmental factors, and public health emergencies, any of which could delay or impede their ability to meet our demand.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, if our sole- or single-source suppliers shift their manufacturing and assembly sites to other locations, depending on the circumstances and nature of the item supplied, in addition to quality system activities such as verification and validation, there could be a need for FDA notifications or submissions, and the new locations could be subject to regulatory inspections. If there are regulatory delays or impediments impacting our suppliers or us for any reason, we may not be able to quickly establish additional or replacement suppliers, particularly for our single-source components, in part because of the custom nature of various parts we design. Any interruption or delay in the supply of components or materials, or our inability to obtain components or materials from alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to cancel orders or switch to competitive products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reliance on these outside manufacturers and suppliers also subjects us to other risks that could harm our business, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we may experience a reduction or interruption in supply, and may not be able to obtain adequate supply in a timely manner or on commercially reasonable terms from additional or replacement sources;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our products are technologically complex and it is difficult to develop alternative supply sources;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we are not a major customer of many of our suppliers, and these suppliers may therefore give other customers&#8217; needs higher priority than ours;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our suppliers may make errors in manufacturing components that could negatively affect the quality, effectiveness or safety of our products or cause delays in shipment of our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we may have difficulty locating and qualifying alternative suppliers for our single-source supplies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">switching components may require product redesign and submission to the FDA of new applications (such as new 510(k) submissions or PMA supplements) which could significantly delay production;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our suppliers manufacture products for a range of customers, and fluctuations in demand for the products these suppliers manufacture for others may affect their ability to deliver components to us in a timely manner or at the current pricing;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our suppliers may discontinue the production of components that are critical to our products; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our suppliers may encounter financial and/or other hardships unrelated to our demand for components, including those related to changes in global economic conditions and/or disease outbreaks, which could inhibit their ability to fulfill our orders and meet our requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also outsource certain services to other parties, including inside sales, certain transaction processing, accounting, information technology, manufacturing, and other areas. Outsourcing of services to third parties could expose us to suboptimal quality of service delivery or deliverables and potentially result in repercussions such as missed deadlines or other timeliness issues, erroneous data, supply disruptions, non-compliance (including with applicable legal or regulatory requirements and industry standards) and/or reputational harm, with potential negative effects on our results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also require the suppliers, service providers and business partners of components or services for our products and related services to comply with law and certain of our policies regarding sourcing practices, but we do not control them or their practices. If any supplier, service provider or business partner violates laws or implements unethical practices, there could be disruptions to our supply chain, cancellation of our orders, a termination of the relationship with the partner or damage to our reputation, and the FDA or other regulators could seek to hold us responsible for such violations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to establish and maintain adequate sales, marketing and distribution capabilities or enter into and maintain arrangements with third parties to sell, market and distribute our products, we may have difficulty achieving market awareness and selling our products in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must continue to develop and grow our sales and marketing organization and enter into partnerships or other arrangements to market and sell our products and/or collaborate with third parties, including distributors and others, to market and sell our products to maintain the commercial success of our current systems and to achieve commercial success for any of our future products. If we are unable to establish and maintain adequate sales, marketing and distribution capabilities, independently or with others, our future revenue may be reduced and our business may be harmed.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developing and managing a direct sales organization is a difficult, expensive and time-consuming process.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To continue to develop our sales and marketing organization to successfully achieve market awareness and sell our products, we must:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">recruit and retain adequate numbers of effective and experienced sales and marketing personnel;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">effectively train our sales and marketing personnel in the benefits and risks of our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">establish and maintain successful sales, marketing, training and education programs that educate health care professionals, including endocrinologists, physicians and diabetes educators, so they can appropriately inform their patients about our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">manage geographically dispersed sales and marketing operations; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">effectively train our sales and marketing personnel on the applicable advertising and promotion, and fraud and abuse laws that govern interactions with healthcare professionals and institutions as well as current and prospective patients and maintain active oversight and auditing measures to ensure continued compliance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently employ sales and marketing personnel for the direct sale and marketing of our products in North America, Asia Pacific, Europe and the Middle East. Our direct sales and marketing team calls on healthcare providers and people with diabetes throughout the applicable country, to the extent permissible, to raise awareness and initiate sales of our products. Our sales and marketing organization competes with the experienced, larger and well-funded marketing and sales operations of our competitors. We may not be able to successfully manage our dispersed sales force or increase our product sales at acceptable rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also entered into distribution arrangements to leverage existing distributors (including wholesalers) already engaged in the distribution of drugs, devices and/or products in the diabetes marketplace. Some of our U.S distributors are focused on accessing underrepresented regions and or third-party payors that contract exclusively with distributors in the United States, while some of our international distributors call directly on healthcare providers and patients to market and sell our products. Because of the competition for their services, we may&#160;be unable to partner with or retain additional qualified distributors. Further, we may&#160;not be able to enter into agreements with distributors on commercially reasonable terms, if at all. Our distributors might not have the resources to continue to support our recent rapid growth.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span id="i4e900cac0fdd4b9e9ed11cf482692194_28398"></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our distribution agreements with AmerisourceBergen, Byram and affiliates, Cardinal Health and affiliates (including Edgepark Medical Supplies), and McKesson, our most significant wholesalers and distributors, each generated 10% or more of our total revenue during the six months ended June&#160;30, 2023. We cannot guarantee that these relationships will continue or that we will be able to maintain this volume of sales from these relationships in the future. A substantial decrease or loss of these sales could have a material adverse effect on our financial results and operating performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into arrangements with pharmacy organizations in various countries to dispense our products directly to patients. Because of the competition for their services, we may be unable to enter into new partnerships or otherwise expand our pharmacy network on commercially reasonable terms, if at all. In addition, we cannot guarantee that our existing pharmacy relationships will continue, or that we will be able to maintain or increase sales volume from these relationships in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that we enter into additional arrangements with third parties to perform sales, marketing, distribution and billing services, our product margins could be lower than if we directly marketed and sold our products. To the extent that we enter into co-promotion or other marketing and sales arrangements with other companies, any revenue received will depend on the skills and efforts of others, and we cannot predict whether these efforts will be successful.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not adequately predict market demand or otherwise optimize and operate our distribution channel successfully, it could result in excess or insufficient inventory or fulfillment capacity, increased costs, immediate shortages in product or component supply, or harm our business in other ways.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We operate in a highly competitive market and face competition from large, well-established companies with significant resources, and, as a result, we may not be able to compete effectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for glucose monitoring devices is intensely competitive, subject to rapid change and significantly affected by new product introductions and other market activities of industry participants, including enhanced software capabilities, and related data and IT platforms. Our products are based on our proprietary technology, but a number of companies and medical researchers are pursuing new technologies for the monitoring of glucose levels. FDA or other regulatory approval of a commercially viable continuous glucose monitor or sensor produced by one of our competitors could significantly reduce market acceptance of our systems. In addition, certain development efforts throughout the diabetes industry, including that of the National Institutes of Health and other supporters of diabetes research are continually seeking ways to prevent, cure or improve treatment of diabetes. Therefore, our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products may be rendered obsolete by technological breakthroughs in diabetes monitoring, treatment, prevention or cure.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In selling our current CGM systems, we compete directly with the Diabetes Care division of Abbott Laboratories; Medtronic plc&#8217;s Diabetes Group; Roche Diabetes Care, a division of Roche Diagnostics; privately-held LifeScan, Inc.; and Ascensia Diabetes Care, each of which manufactures and markets products for the single-point finger stick device market. Collectively, these companies currently account for the majority of the worldwide sales of self-monitored glucose testing systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors manufacturing adjunctive CGMs have also recognized expanded Medicare coverage of their CGM devices and supplies following CMS&#8217; December 2021 final rule expanding the classification of DME under Medicare Parts B &amp; C to include adjunctive CGMs. These devices now directly compete with our CGM products in the Medicare market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several companies are developing and/or commercializing products for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin that compete directly with our products. We have competed with Abbott for several years and their Libre family of CGM products. Medtronic markets and sells one or more standalone glucose monitoring products both internationally and in the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic and other third parties have developed or are developing insulin pumps integrated with CGM systems that provide, among other things, the ability to suspend insulin administration while the user&#8217;s glucose levels are low and to automate basal and bolus insulin dosing.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have begun to become aware of companies outside the traditional medical device sector that are attempting to develop competitive products and services, including for general health and wellness, or population health.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the companies developing or marketing competing devices are large and well-known publicly traded companies, and these companies may possess competitive advantages over us, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">greater name recognition;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">established relations with healthcare professionals, customers and third-party payors;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">established distribution networks;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">additional lines of products, and the ability to bundle products to offer higher discounts or incentives to gain a competitive advantage;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">greater experience in conducting research and development, manufacturing, clinical trials, obtaining regulatory approval for products and marketing approved products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">duration of sensor life;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the ability to integrate multiple products to provide additional features beyond CGM systems; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">greater financial and human resources for product development, manufacturing, sales and marketing, and patent litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we may not be able to compete effectively against these companies or their products, which may adversely impact our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks associated with public health issues, including pandemics, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to risks associated with public health issues, such as the recent COVID-19 pandemic, and other events beyond our control. Public health issues and crises may adversely impact our operations, supply chain and logistics network if the locations where we operate, manufacture or distribute our products; where our raw materials or products are sourced, manufactured or distributed; or where our third-party distributors, suppliers and other service providers operate, are disrupted, temporarily closed or experience worker shortages for a sustained period of time. In addition, public health issues and crises may adversely impact our customers and/or their businesses due to lockdowns, labor shortages, lost access to private health insurance plans or modified spending priorities, all of which could cause a decline in demand for our products. These disruptions could also cause economic slowdowns or increased economic uncertainty.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we largely navigated disruptions to our business as a result of the COVID-19 pandemic, a future public health issue, pandemic or outbreak of COVID-19 could lead to delays in the manufacturing and supply of products, which could have a material adverse effect on our business, financial condition and results of operations. Moreover, any future public health issue, such as a resurgence in COVID-19 infections, including due to new variants of the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">virus for which current vaccines may not be effective, could result in the imposition of new governmental restrictions, quarantine requirements or other measures to slow the spread of the virus, which could result in closures or other restrictions that significantly disrupt our operations or those of our third-party distributors, suppliers or other service providers, or otherwise adversely affect our customers or their businesses or operations, or result in economic weakness or slowdowns in one or more of our key geographies, any of which could adversely affect our business, financial condition and results of operations.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_220"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to our International Operations</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to a variety of risks due to our international operations that could adversely affect our business, our operations or profitability and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations in countries outside the United States, which accounted for approximately 29% of our revenue for the six months ended June&#160;30, 2023, are accompanied by certain financial and other risks. In addition to our offices with manufacturing and administrative and operations in countries throughout the world, we intend to continue to pursue growth opportunities in sales outside the United States, especially in Asia and Europe. Additionally, we may increase our use of administrative and support functions from locations outside the United States. These business activities could expose us to greater risks associated with our sales and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we pursue opportunities outside the United States, we may become more exposed to these risks and our ability to scale our operations effectively may be affected. For example, we are building out a manufacturing facility in Malaysia.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international expansion efforts, including our new and proposed manufacturing facilities in Malaysia and Ireland, respectively, may not be successful and we may experience difficulties in scaling these functions from locations outside the United States and may not experience the expected cost efficiencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our profitability and international operations are, and will continue to be, subject to a number of risks and potential costs, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">local product preferences and product requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">longer-term receivables than are typical in the United States;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">fluctuations in foreign currency exchange rates;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">less intellectual property protection in some countries outside the United States than exists in the United States;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">trade protection measures and import and export licensing requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">workforce instability;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">fluctuations in trade policy and tariff regulations; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">political and economic instability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, the tax laws in which we and our subsidiaries do business could change on a prospective or retroactive basis, and any such changes could adversely affect our business and financial condition. We have a significant presence in the European Union, as well as significant sales in the European Union, such that any changes in tax laws in the European Union will impact our business. The overall impact of such legislation in European Union member states is uncertain, and our business and financial condition could be adversely affected by any laws impacting our tax rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While it is impossible for us to predict whether these and other proposals will be implemented, or how they will ultimately impact us, they may materially impact our results of operations if, for example, our profits earned abroad are subject to U.S. income tax, or we are otherwise disallowed deductions as a result of these profits.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in foreign currency exchange rates may reduce the reported value of our foreign currency denominated revenues, expenses, and cash flows. We cannot predict changes in currency exchange rates, the impact of exchange rate changes, nor the degree to which we will be able to manage the impact of currency exchange rate changes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following a 2016 referendum of voters in the United Kingdom, or the U.K, to exit from the European Union, or the E.U., the U.K. left the E.U. on January 31, 2020, which began a transition period that ended on December 31, 2020. In December 2020, the U.K. and E.U. agreed on a trade and cooperation agreement that was ratified by the parties in May 2021. The agreement sets out certain procedures for approval and recognition of medical products in each jurisdiction. Any delay in obtaining, or an inability to obtain, any marketing approvals, as a result of the trade </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and cooperation agreement or otherwise, could prevent us from marketing our CGM systems in the U.K. and/or the E.U. and restrict our ability to generate revenue and achieve and sustain profitability. Under the trade and cooperation agreement, U.K. service suppliers no longer benefit from automatic access to the entire E.U. single market, U.K. goods no longer benefit from the free movement of goods and there is no longer the free movement of people between the U.K. and the E.U. Depending on the application of the terms of the trade and cooperation agreement, we could face new regulatory costs and challenges which could have a material adverse effect on our business, results of operations, or financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and regulations governing the export of our products could adversely impact our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Department of the Treasury&#8217;s Office of Foreign Assets Control, and the Bureau of Industry and Security at the U.S. Department of Commerce, administer certain laws and regulations that restrict U.S. persons and, in some instances, non-U.S. persons, in conducting activities, and transacting business with or making investments in certain countries, governments, entities and individuals subject to U.S. economic sanctions. Due to our international operations, we are subject to such laws and regulations, which are complex, restrict our business dealings with certain countries and individuals, and are constantly changing. Further restrictions may be enacted, amended, enforced or interpreted in a manner that materially impacts our operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of these regulations are punishable by civil penalties, including fines, denial of export privileges, injunctions, asset seizures, debarment from government contracts and revocations or restrictions of licenses, as well as criminal fines and imprisonment. We have established procedures designed to assist with our compliance with such laws and regulations. However, we have only limited experience dealing with these laws and regulations and we cannot guarantee that our procedures will effectively prevent us from violating these regulations in every transaction in which we may engage. Any such violation could adversely affect our reputation, business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The failure to comply with U.S. Foreign Corrupt Practices Act and similar worldwide anti-bribery laws in non-U.S. jurisdictions could materially adversely affect our business and result in civil and/or criminal sanctions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Foreign Corrupt Practices Act, the UK Bribery Act and similar worldwide anti-bribery laws in non-U.S. jurisdictions generally prohibit companies and their intermediaries from making improper payments to non-U.S. government officials and, in some instances, other persons for the purpose of obtaining or retaining business. Because of the predominance of government-sponsored healthcare systems around the world, most of our customer relationships outside of the United States are with governmental entities and are therefore potentially subject to such anti-bribery laws. Global enforcement of anti-corruption laws has increased substantially in recent years, with more frequent voluntary self-disclosures by companies, aggressive investigations and enforcement proceedings by U.S. and foreign governmental agencies, and assessment of significant fines and penalties against companies and individuals. Our international operations create the risk of unauthorized payments or offers of payments by one of our employees, consultants, sales agents, or distributors, because these parties are not always subject to our direct oversight and control. It is our policy to implement safeguards to educate our employees and agents on these legal requirements and discourage improper practices. However, our existing safeguards and any future improvements may prove to be less than effective, and our employees, consultants, sales agents, or distributors may engage in conduct for which we might be held responsible. In addition, the government agencies may seek to hold us liable for successor liability for anti-corruption law violations committed by any companies in which we invest or that we acquire. Any alleged or actual violations of these regulations may subject us to government scrutiny, severe criminal or civil sanctions and other liabilities, including exclusion from government contracting, and could disrupt our business, and result in a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current uncertainty in global economic and political conditions makes it particularly difficult to predict product demand and other related matters and makes it more likely that our actual results could differ materially from expectations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and performance depend on worldwide economic and political conditions. These conditions have been adversely impacted by continued global economic uncertainty, political instability and military hostilities in multiple geographies, including the current conflict in Ukraine, concerns over continued sovereign debt, monetary and financial uncertainties in Europe and other foreign countries, and global health pandemics. These include potential reductions in the overall stability and suitability of the Euro as a single currency, given the economic and political challenges facing individual Eurozone countries. These conditions have made and may continue to make it difficult for our customers and potential customers to afford our products, and could cause our customers to stop using our products or to use them less frequently. If that were to occur, our revenue may decrease and our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance may be negatively impacted. In addition, the pressure on consumers to absorb more of their own health care costs has resulted in some cases in higher deductibles and limits on durable medical equipment, which may cause seasonality in purchasing patterns. Furthermore, during economic uncertainty, our customers have had job losses and may continue to have issues gaining timely access to sufficient health insurance or credit, which could result in their unwillingness to purchase products or impair their ability to make timely payments to us. In addition, a recession, depression or other sustained adverse market event could materially and adversely affect our access to capital on favorable terms or at all, our business and the value of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the reoccurrence of any economic slowdown or the strength or sustainability of the economic recovery, worldwide, in the United States, or in our industry. These and other economic factors could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to obtain any required regulatory authorization in foreign jurisdictions will prevent us from marketing our products abroad.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct limited commercial and marketing efforts in certain international markets in the Asia-Pacific, North America and Europe, Middle East and Africa regions, with respect to our CGM systems and may seek to market our products in other regions in the future. Outside the United States, we can market a product only if we receive a marketing authorization and, in some cases, pricing approval, from the appropriate regulatory authorities. The marketing authorization procedures vary among countries and can involve additional testing, and the time required to obtain any required authorization or approval may differ from that required to obtain FDA marketing authorization(s). Foreign regulatory authorization or approval processes may include all of the risks associated with obtaining FDA marketing authorization(s) in addition to other risks. We may not obtain foreign regulatory authorizations or approvals on a timely basis, if at all. Obtaining a marketing authorization from the FDA does not ensure authorization or approval by regulatory authorities in other countries will follow, and authorization or approval by one foreign regulatory authority does not ensure authorization or approval by regulatory authorities in other foreign countries or by the FDA. In addition, in order to obtain the authorization to market our products in certain foreign jurisdictions, in some cases we may need to obtain a Certificate to Foreign Government from the FDA. The FDA may refuse to issue a Certificate to Foreign Government if significant compliance-related concerns are identified. As a result, there are a range of factors that could preclude or impede our ability to file for regulatory approvals or marketing authorizations or to receive necessary approvals or authorizations to commercialize our products in any market outside the United States on a timely basis, or at all.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_223"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Privacy and Security</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to complex and evolving U.S. and foreign laws and regulations and other requirements regarding privacy, data protection, security, and other matters. Many of these laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, monetary penalties, increased cost of operations, or declines in user growth or engagement, or otherwise harm our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a number of foreign, federal and state laws and regulations protecting the use, disclosure, and confidentiality of certain patient health and personal information, including patient records, and restricting the use and disclosure of that protected information, including state breach notification laws, the Health Insurance Portability and Accountability Act, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, the European Union&#8217;s General Data Protection Regulation, or GDPR, the UK Data Protection Act and the UK GDPR, and the California Consumer Privacy Act, or CCPA, among others. As our customer base grows to include U.S. federal government agencies, Dexcom may also need comply with Federal Risk and Authorization Management Program and Cybersecurity Maturity Model Certification requirements. These frameworks, in addition to similar laws being enacted by other states and counties, impose stringent cybersecurity standards and potentially significant non-compliance penalties, involve the expenditure of significant resources, the investment of significant resources and the investment of significant time and effort to comply. As these laws and regulations continue develop in the United States and internationally, we may be required to expend significant time and resources in order to update existing processes or implement additional mechanisms as necessary to ensure compliance with such cybersecurity laws.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, foreign data protection, privacy, and other laws and regulations can be more restrictive than those in the United States. For example, data localization laws in some countries generally mandate that certain types of data collected in a particular country be stored and/or processed within that country. We may be subject to inquiries, investigations and audits in Europe and around the world, particularly in the areas of consumer and data protection, which will arise in the ordinary course of business and may increase in frequency as we continue to grow and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expand our operations. Legislators and regulators may make legal and regulatory changes, or interpret and apply existing laws, in ways that make our products less useful to our customers, require us to incur substantial costs, expose us to unanticipated civil or criminal liability, or cause us to change our business practices. These changes or increased costs could negatively impact our business and results of operations in material ways.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect and store sensitive data, such as our proprietary business information and that of our clients, contractors, vendors and others as well as personally identifiable information of our customers, vendors and others, which data may include full names, social security numbers, addresses, and birth dates, in our data centers and on our networks. Our employees, contractor and vendors may also have access to and may use personal health information in the ordinary course of our business. The secure processing, maintenance and transmission of this information is critical to our operations. Despite our security measures and business controls, our information technology and infrastructure may be vulnerable to attacks by hackers, breaches due to employee, contractor or vendor error, or malfeasance or other disruptions or subject to the inadvertent or intentional unauthorized release of information. Any such occurrence could compromise our networks and the information stored thereon could be accessed, publicly disclosed, lost or stolen. Any such access, disclosure or other loss of information could result in legal claims or proceedings, and liability under laws that protect the privacy of personal information and regulatory penalties, disrupt our operations and the services we provide to our clients or damage our reputation, any of which could adversely affect our profitability, revenue and competitive position.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we grow and expand our administrative, customer support or IT support services, we may also utilize the services of personnel and contractors located outside of the United States to perform certain functions. While we make every effort to review our applicable contracts and other payor requirements, a local, state, or federal government agency or one of our customers may find the use of offshore resources to be a violation of a legal or contractual requirement, which could result in termination of the contractual relationship, penalties, or changes in our business operations that could adversely affect our business, financial condition, and results of operations. Additionally, while we have implemented industry standard security measures for offshore access to protected health information and other personal information, unauthorized access or disclosure of such information by offshore personnel could result in legal claims or proceedings, and liability under laws that protect the privacy of personal information and regulatory penalties, disrupt our operations and the services we provide to our clients, damage to our reputation or result in the termination of contractual relationships, penalties or the loss of coverage, any of which could adversely affect our profitability, revenue and competitive position.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security breaches and other disruptions that compromise our information and expose us to liability could cause our business and reputation to suffer and could subject us to substantial liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrative Simplification Provisions of the Health Insurance Portability and Accountability Act of 1996, as amended and implemented, or HIPAA, extensively regulates the use and disclosure of certain personal information (&#8220;protected health information&#8221;) and requires covered entities, including health plans and most health care providers, to implement administrative, physical and technical safeguards to protect the security of such information. Certain provisions of the security and privacy regulations apply to business associates (entities that handle protected health information on behalf of covered entities), and business associates are subject to direct liability for violation of these provisions. In addition, a covered entity may be subject to penalties as a result of a business associate violating HIPAA, if the business associate is found to be an agent of the covered entity. Dexcom is a covered entity under HIPAA and may also function in a business associate capacity to other covered entities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Covered entities must report breaches of unsecured protected health information to affected individuals without unreasonable delay and notification must also be made to the U.S. Department of Health &amp; Human Services, Office for Civil Rights, or OCR and, in certain situations involving large breaches, to the media. Various U.S. state laws and regulations may also require us to notify affected individuals and state agencies in the event of a data breach involving individually identifiable information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of the HIPAA privacy and security regulations may result in criminal and civil penalties. The OCR enforces the regulations and performs compliance audits. In addition to enforcement by OCR, state attorneys general are authorized to bring civil actions seeking either injunction or damages in response to violations that threaten the privacy of state residents. We follow and maintain a HIPAA compliance plan, which we believe complies with the HIPAA privacy and security regulations, but there can be no assurance that OCR or other regulators will agree. The HIPAA privacy regulations and security regulations have and will continue to impose significant costs on us in order to comply with these standards.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous other laws and legislative and regulatory initiatives at the federal and state levels addressing privacy and security concerns. For example, from time-to-time, the OCR issues bulletins that outline its interpretations of HIPAA as applied to specific use cases. On December 1, 2022, OCR issued a bulletin on the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requirements under HIPAA for online tracking technologies (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, cookies, pixels) to protect the privacy and security of health information. This bulletin outlined OCR&#8217;s position on the use of online tracking technology vendors, when certain information received by such vendors constitutes protected health information under HIPAA, and accordingly, when business associate agreements must be executed between covered entities, like Dexcom, and such vendors. Dexcom has assessed its responsibilities under the bulletin and undertaken a number of initiatives to support its compliance with HIPAA and other requirements relating to online tracking technologies, including updates to its cookie banners and preference center. These steps are in addition to measures Dexcom had taken previously and the company continues to evaluate its compliance with applicable laws and adjust its practices to address developments in the field over time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also remain subject to federal or state privacy-related laws outside of the privacy regulations issued under HIPAA. These laws vary and could impose additional penalties. For example, the Federal Trade Commission uses its consumer protection authority to initiate enforcement actions in response to alleged privacy and data security violations. California enacted the CCPA, which came into effect January 1, 2020, was amended and expanded by the CPRA, passed on November 3, 2020, which took effect January 1, 2023. The CCPA and CPRA, among other things, create data privacy obligations for covered companies and provide privacy rights to California residents, including the right to opt out of certain disclosures of their information. The CCPA also creates a private right of action with statutory damages for certain data breaches, thereby potentially increasing risks associated with a data breach. In addition, other states have, or may, enact similar legislation. It remains unclear what, if any, additional modifications will be made to this legislation or how it will be interpreted. The effects of the CCPA and CPRA are significant and will likely require us to modify our data processing practices, and may cause us to incur substantial costs and expenses to comply, particularly given our base of operations in California. There are also a number of other legislative proposals worldwide, including in the United States at both the federal and state level, that could impose additional and potentially conflicting obligations in areas affecting our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to laws and regulations in foreign countries covering data privacy and other protection of health and employee information that may be more onerous than corresponding U.S. laws, including in particular the laws of Europe.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instance, in the European Union, increasingly stringent data protection and privacy rules that have and will continue to have substantial impact on the use of patient data across the healthcare industry became effective in May 2018. The GDPR applies across the European Union and includes, among other things, a requirement for prompt notice of data breaches to data subjects and supervisory authorities in certain circumstances and significant fines for non-compliance. The GDPR fine framework can be up to 20 million euros, or up to 4% of the company&#8217;s total global turnover of the preceding fiscal year, whichever is higher. The GDPR also requires companies processing personal data of individuals residing in the European Union to comply with EU privacy and data protection rules, even if the company itself does not have a physical presence in the European Union. Noncompliance could result in the imposition of fines, penalties, or orders to stop noncompliant activities. Due to the strong consumer protection aspects of the GDPR, companies subject to its purview are allocating substantial legal costs to the development of necessary policies and procedures and overall compliance efforts. Data transfer risk remains a potential issue as certain Data Protection Authorities continue to raise concerns about the transfer of data to the United States. Though a new framework to permit cross-border transfers - the EU-US Data Privacy Framework - recently came into effect, it may be challenged as well. We expect continued costs associated with maintaining compliance with GDPR into the future, and these provisions as interpreted by EU agencies, could negatively impact our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the laws discussed above, we may see more stringent state and federal privacy legislation in the future. We cannot predict where new legislation might arise, the scope of such legislation, or the potential impact to our business and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybersecurity risks and cyber incidents could result in the compromise of confidential data or critical data systems and give rise to potential harm to customers, remediation and other expenses, expose us to liability under HIPAA, consumer protection laws, or other common law theories, subject us to litigation and federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous and evolving risks to our cybersecurity and privacy from cyber threat actors. These cyber threat actors, whether internal of external to the Company, are becoming more frequent, sophisticated and coordinated in their attempts to access data, including third parties with whom the Company conducts business through, without limitation, malicious software; data privacy breaches by employees, insiders or others with authorized access; cyber of phishing-attacks; ransomware; attempts to gain unauthorized access to our data and systems; and other electronic security breaches. In the ordinary course of business, we collect and store sensitive </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">information on our network, including intellectual property, proprietary business information and personally identifiable information of individuals, such as our customers and employees. The secure maintenance of this information and technology is critical to our business operations. We have implemented and deploy multiple layers of security measures to protect the confidentiality, integrity and availability of this data and the systems and devices that store and transmit such data. We utilize current security technologies, and our defenses are monitored and routinely tested internally and by external parties. Despite these efforts, threats from malicious persons and groups, new vulnerabilities and advanced new attacks against information systems create risk of cybersecurity incidents. These incidents can include, but are not limited to, gaining unauthorized access to digital systems for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption. Because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and may not immediately produce signs of intrusion, we may be unable to anticipate these incidents or techniques, timely discover them, or implement adequate preventative measures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in response to the onset of the COVID-19 pandemic, we modified our business practices and initially implemented telework policies for certain categories of &#8220;non-essential&#8221; employees to the extent possible. We have since adopted a hybrid workplace model for our employees. Our hybrid workplace allows us to work together globally to bring our life-changing products to as many people as possible. This means we have some employees who work primarily onsite, some who work primarily offsite, and others who flex in and out of the office based on the needs of the business and the individual. We recognized the need for flexibility in our physical workplace during the COVID-19 pandemic, but also noted the potential benefits of a hybrid workplace to expand and retain our talent pool and reduce our real estate needs. The hybrid workplace does, however, introduce additional operational risk, including increased cybersecurity risk. These cyber risks include, among other risks, increased phishing, malware, and other cybersecurity attacks, vulnerability to, or disruptions of, our information technology infrastructure and systems to support remote operations, increased risk of unauthorized access, use or dissemination of confidential information, limited ability to restore the systems in the event of a systems failure or interruption, greater risk of a security breach resulting in destruction, alteration or misuse of valuable information, including proprietary business information and personally identifiable information of individuals, all of which could expose us to risks of data or financial loss, litigation and liability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These threats can come from a variety of sources, including criminal hackers, state-sponsored intrusions, industrial espionage and employee malfeasance. Cyber threats may be generic, or they may be custom-crafted against our information systems. Over the past several years, cyberattacks have become more prevalent and much harder to detect and defend against. These threat actors may be able to penetrate our security measures, breach our information technology systems, misappropriate or compromise confidential and proprietary information of our company and our customers, cause system disruptions and shutdowns, or introduce ransomware, malware, or vulnerabilities into our products, systems, and networks or those of our customers and partners. Our network and storage applications, as well as those of our contractors, may be vulnerable to cyber-attack, malicious intrusion, malfeasance, loss of data privacy or other significant disruption and may be subject to unauthorized access by hackers, employees, consultants or other service providers. In addition, hardware, software or applications we develop or procure from third parties may contain defects in design or manufacture or other problems that could unexpectedly compromise information security or other problems that unexpectedly could interfere with the operation of our products. Unauthorized parties may also attempt to gain access to our systems or facilities through fraud, trickery or other forms of deceiving our employees, contractors and temporary staff.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we maintain cybersecurity insurance coverage there is no guarantee that it will be sufficient to cover the financial, legal, business, or reputational losses that may result from an interruption or breach of our systems. Our cybersecurity insurance includes coverage for a breach event covering expenses for notification, credit monitoring, investigation, crisis management, public relations and legal advice. Our cybersecurity insurance also provides coverage in relation to regulatory action defense including oversight, investigations and disclosure obligations as well as fines and penalties, potential payment card industry fines and penalties and costs related to cyber extortion; however, damages and claims arising from such incidents may not be covered and/or may exceed the amount of any coverage and do not cover the time and effort we incur investigating and responding to any incidents, which may be significant.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are and may continue to be subject to cybersecurity incidents that bypass our security measures. Such incidents may impact the integrity, availability or privacy of personal health information or other data subject to privacy laws or disrupt our information systems, devices or business, including our ability to deliver services to our customers. As a result, cybersecurity, physical security and the continued development and enhancement of our controls, processes and practices designed to protect our enterprise, information systems and data from attack, damage or unauthorized access remain a priority for us. As cyber threats continue to evolve, we may be required to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expend significant additional resources to continue to modify or enhance our protective measures or to investigate and remediate any cybersecurity vulnerabilities. The occurrence of any of these events could result in:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">harm to customers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">business interruptions and delays;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the loss, misappropriation, corruption or unauthorized access of data, confidential information or intellectual property;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">litigation, including potential class action litigation, and potential liability under privacy, security and consumer protection laws or other applicable laws;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reputational damage;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">significant remediation costs, including liability for stolen customer or employee information, repairing system damage, or providing benefit to affected customers or employees;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">increase to insurance premiums; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">foreign, federal and state governmental inquiries, violations or sanctions, any of which could have a material, adverse effect on our financial position and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to protect our information technology infrastructure against cyberattacks, network security breaches, service interruptions, or data corruption could significantly disrupt our operations and adversely affect our business and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on information technology and telephone networks and systems, including the Internet, to process and transmit sensitive electronic information and to manage or support a variety of business processes and activities, including sales, billing, customer service, procurement and supply chain, manufacturing, and distribution. We use enterprise information technology systems to record, process, and summarize financial information and results of operations for internal reporting purposes and to comply with regulatory financial reporting, legal, and tax requirements. System failures or outages, including any potential disruptions due to significantly increased global demand on certain cloud-based systems, or failures to adequately scale our data platforms and architectures support patient care could compromise our ability to perform these functions in a timely manner, which could harm our ability to conduct business or delay our financial reporting. Such failures could materially adversely affect our operating results and financial condition. Our information technology systems, some of which are managed by third parties, may be susceptible to damage, disruptions or shutdowns due to computer viruses, denial-of-service attacks, phishing attacks, ransomware or other malware, attacks by computer hackers, failures during the process of upgrading or replacing software, databases or components thereof, power outages, hardware failures, telecommunication failures, user errors or catastrophic events. Although we have developed systems and processes that are designed to protect customer information and prevent data loss and other security breaches, including systems and processes designed to reduce the impact of a security breach at a third-party vendor, such measures cannot provide absolute security. In addition, certain countries have implemented or may implement legislative and technological actions that either do or can effectively regulate access to the internet, including the ability of internet service providers to limit access to specific websites or content. Other countries have attempted or are attempting to change or limit the legal protections available to businesses that depend on the internet for the delivery of their services. If our systems are breached or suffer severe damage, disruption or shutdown and we are unable to effectively resolve the issues in a timely manner, our business and operating results may significantly suffer and we may be subject to litigation, government enforcement actions and other actions for which we could face financial liability and other adverse consequences which may include:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">additional government oversight of our operations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">loss of existing customers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">difficulty in attracting new customers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">problems in determining product cost estimates and establishing appropriate pricing;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">difficulty in preventing, detecting, and controlling fraud;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">disputes with customers, physicians, and other health care professionals;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">increases in operating expenses, incurrence of expenses, including notification and remediation costs;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regulatory fines or penalties;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">individual actions or class actions for damages;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">loss of revenues (including through loss of coverage or reimbursement);</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">product development delays;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">disruption of key business operations; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">diversion of attention of management and key information technology resources.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cyberattacks aimed at accessing our devices, products, and services, or related devices, products, and services, and modifying or using them in a way inconsistent with our FDA clearances and approvals could create risks to users.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical devices are increasingly connected to the internet, hospital networks, and other medical devices to provide features that improve healthcare and increase the ability of healthcare providers to treat patients and patients to manage their conditions. For example, we are pursuing collaborations to enable the connectivity and interoperability of our current and next-generation sensors and transmitters with third-party patient monitoring products, which may in turn be connected with the internet, hospital networks and in some cases, other medical devices. These same features may also increase cybersecurity risks and the risks of unauthorized access and use by third parties. As such, a cyberattack which intrudes, disrupts, or corrupts our devices, products, and services, or related devices, products, and services could impact the quality-of-care patients receive or the confidentiality of patient information. Additionally, modifying or using any such devices, products, or services in a way inconsistent with our FDA clearances and approvals, which may create risks to users and potential exposure to the company.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_226"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Non-Compliance with Laws, Regulations and Contractual Requirements and Healthcare Industry Shifts</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We conduct business in a heavily regulated industry and if we fail to comply with applicable laws and government regulations, we could become subject to penalties, be excluded from participation in government programs, and/or be required to make significant changes to our operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry generally, and our business specifically, is subject to extensive foreign, federal, state and local laws and regulations, including those relating to:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">authorizations necessary for the clinical investigation and commercial marketing of products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the pricing of our products and services;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the distribution of our products and services;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the dispensing of our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">billing for or causing the submission of claims for our products and services;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">financial relationships with physicians and other referral sources;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">inducements and courtesies given to physicians and other health care providers and patients;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">labeling, advertising and promoting products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the characteristics and quality of our products and services;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">communications with payors and physicians and other healthcare stakeholders;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">confidentiality, maintenance and security issues associated with medical records and individually identifiable health and other personal information;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">medical device adverse event reporting;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">prohibitions on kickbacks, including the Anti-Kickback Statute and related laws and/or regulations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">any scheme to defraud any healthcare benefit program;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">physician and other healthcare professional payment disclosure requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">use and disclosure of personal health information;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">privacy of health information and personal information;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">data protection and data localization;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">mobile communications;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patient access and non-discrimination;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patient consent;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">false claims; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">licensure.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws and regulations are extremely complex and, in many cases, still evolving. If our operations are found to violate any of the foreign, federal, state or local laws and regulations which govern our activities, we may </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be subject to litigation, government enforcement actions, and applicable penalties associated with the violation, potentially including civil and criminal penalties, damages, fines, exclusion from participation in certain payor programs or curtailment of our operations. Compliance obligations under these various laws are oftentimes detailed and onerous, further contributing to the risk that we could be found to be out of compliance with particular requirements. The risk of being found in violation of these laws and regulations is further increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, particularly with respect to new and emerging technologies and remote delivery of services, and their provisions are open to a variety of interpretations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA, CMS, OIG, OCR, FTC, Department of Justice, states&#8217; attorneys general and other governmental authorities actively enforce the laws and regulations discussed above. In the United States, medical device manufacturers have been the target of numerous government prosecutions and investigations alleging violations of law, including claims asserting impermissible off-label promotion of medical devices, payments intended to influence the referral of federal or state healthcare business, and submission of false claims for government reimbursement. While we make every effort to comply with applicable laws, we cannot rule out the possibility that the government or other third parties could interpret these laws differently and challenge our practices under one or more of these laws. This likelihood of allegations of non-compliance is increased by the fact that under certain federal and state laws applicable to our business, individuals may bring an action on behalf of the government alleging violations of such laws, and potentially be awarded a share of any damages or penalties ultimately awarded to the applicable government body.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA and the FTC share oversight of medical device promotion. The FDA has broad authority over device marketing (including assessment and oversight of safety and effectiveness) and over FDA-approved &#8220;promotional labeling,&#8221; while the FTC has authority over &#8220;advertising&#8221; for most medical devices (i.e., non-&#8220;restricted&#8221; devices, such as ours).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any action against us alleging a violation of these laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s time and attention from the operation of our business, and have a material effect on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the laws and regulations impacting or affecting our business may change significantly in the future, which may adversely affect our business. A review of our business by courts or regulatory authorities may result in a determination that could adversely affect our operations. Also, the regulatory environment applicable to our business may change in a way that restricts or adversely impacts our operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we or our suppliers or distributors fail to comply with ongoing regulatory requirements, or if we have unanticipated problems with our products, the products could be subject to restrictions or withdrawal from the market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any product for which we obtain marketing approval, clearance or authorization (and the activities related to its production, distribution, and promotion, sale, and marketing)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">will be subject to continual review and periodic inspections by the FDA and other regulatory bodies, which may include inspection of our manufacturing processes, complaint handling and adverse event reporting, post-approval clinical data and promotional activities for such product. The FDA&#8217;s Medical Device Reporting, or MDR, regulations require that we report to the FDA any incident in which our product may have caused or contributed to a death or serious injury, or in which our product malfunctioned and, if the malfunction were to recur, it would likely cause or contribute to a death or serious injury.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA determines that there is a reasonable probability that a device intended for human use would cause serious, adverse health consequences or death, the agency may issue a cease distribution and notification order and a mandatory recall order. We may also decide to recall a product voluntarily if we find a material deficiency, including unacceptable risks to health, manufacturing defects, design errors, component failures, labeling defects, or other issues. Recalls of our products could divert the attention of our management and have an adverse effect on our reputation, financial condition, and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and certain of our suppliers are also required to comply with the FDA&#8217;s Quality System Regulation, or QSR, and other regulations which cover the methods and documentation of the design, testing, production, control, selection and oversight of suppliers or contractors, quality assurance, labeling, packaging, storage, complaint handling, shipping and servicing of our products. The FDA may enforce the QSR through announced (through prior notification) or unannounced inspections.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with ongoing regulatory requirements can be complex, expensive and time-consuming. Failure by us or one of our suppliers or distributors to comply with statutes and regulations administered by the FDA, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">competent authorities and other regulatory bodies, or failure to take adequate response to any observations, could result in, among other things, any of the following actions:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">warning letters or untitled letters that require corrective action;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">delays in approving, or refusal to approve, our CGM systems;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">fines and civil or criminal penalties;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">unanticipated expenditures;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">FDA refusal to issue certificates to foreign governments needed to export our products for sale in other countries;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">suspension or withdrawal of clearance or approval by the FDA or other regulatory bodies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">product recall or seizure;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">administrative detention;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">interruption of production, partial suspension, or complete shutdown of production;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">interruption of the supply of components from our key component suppliers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">operating restrictions;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">court consent decrees;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">FDA orders to repair, replace, or refund the cost of devices;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">injunctions; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">criminal prosecution.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potential effect of these events can in some cases be difficult to quantify. If any of these actions were to occur, it would harm our reputation and cause our product sales and profitability to suffer. In addition, we believe events that could be classified as reportable events pursuant to MDR regulations are generally underreported by physicians and users, and any underlying problems could be of a larger magnitude than suggested by the number or types of MDRs filed by us. Furthermore, our key component suppliers may not currently be or may not continue to be in compliance with applicable regulatory requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if regulatory approval or clearance of a product is granted, the approval or clearance may be subject to limitations on the indicated uses for which the product may be marketed or contain requirements for costly post-marketing testing or surveillance to monitor the safety or effectiveness of the product. Later discovery of previously unknown problems with our products, including software bugs, unanticipated adverse events or adverse events of unanticipated severity or frequency, manufacturing problems, or failure to comply with regulatory requirements such as the QSR, MDR reporting, or other post-market requirements may result in restrictions on such products or manufacturing processes, withdrawal of the products from the market, voluntary or mandatory recalls (through corrections or removals), fines, suspension of regulatory approvals, product seizures, injunctions, the imposition of civil or criminal penalties, or criminal prosecution. In addition, our distributors have rights to create marketing materials for their sales of our products, and may not adhere to contractual, legal or regulatory limitations that are imposed on their marketing efforts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quality problems could lead to recalls or safety alerts, reputational harm, and could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quality is very important to us and our customers due to the serious and costly consequences of product failure, and our business exposes us to potential product liability risks that are inherent in the design, manufacture, and marketing of medical devices. Since the first commercial launch of our products in 2006, we have had periodic field failures related to our products and associated services, including reports of sensor errors, sensor failures, broken sensors, receiver malfunctions, audible alarms and alert failures, as well as server and transmitter failures. To comply with the FDA&#8217;s medical device reporting requirements, for example, we have filed reports of applicable field failures. Although we believe we have taken and are taking appropriate action aimed at reducing and/or eliminating field failures, we may have other product failures in the future. Product or component failures, manufacturing nonconformances, design defects, off-label use, or inadequate disclosure of product-related risks or product-related information with respect to our products, if they were to occur, could result in an unsafe condition or injury to, or death of, a patient. These problems could lead to recalls, corrections or removals of, or issuance of a safety alert relating to, our products, and could result in product liability claims and lawsuits.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the production of our products must occur in a highly controlled and clean environment to minimize particles and other yield- and quality-limiting contaminants. Weaknesses in process control or minute impurities in materials may cause a substantial percentage of defective products. If we are not able to maintain </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stringent quality controls, or if contamination problems arise, our clinical development and commercialization efforts could be delayed, which would harm our business and our results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to meet any applicable product quality standards and our products are the subject of recalls or safety alerts, our reputation could be damaged, we could lose customers, our reputation could be harmed and our revenue and results of operations could decline.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential long-term complications from our current or future products or other CGM systems under development may not be revealed by our clinical experience to date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our experience, complications from use of our products may include sensor errors, sensor failures, broken sensors, lodged sensors or skin irritation under the adhesive dressing of the sensor. Inflammation or redness, swelling, minor infection, and minor bleeding at the sensor insertion site are also possible risks with an individual&#8217;s use of our products. However, if unanticipated long-term side-effects result from the use of our products or other glucose monitoring systems we have under development, we could be subject to liability and the adoption of our systems may become more limited. With respect to our G6 systems, our clinical trials have been limited to ten days of continuous use. It is possible that the data from our clinical studies and trials may not be indicative of long-term patient outcomes. We cannot assure you that repeated, long-term use would not result in unanticipated adverse effects, potentially even after the sensor is removed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may never receive approval, marketing authorization or clearance from the U.S. FDA and other governmental agencies to market additional CGM systems, expanded indications for use of current and future generation CGM systems, future software platforms, or any other products under development.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, via the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> process, the FDA classified the G6 and substantially equivalent devices of this generic type (i.e., &#8220;integrated continuous glucose monitoring systems&#8221; or &#8220;iCGMs&#8221;) into Class II, meaning that going forward products of this generic type may utilize the 510(k) pathway. Since then we have received 510(k) clearances for modifications to the G6 and approval for G7.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any subsequent modifications of our cleared products that could significantly affect their safety or effectiveness (for example, a significant change in design or manufacture), or that would constitute a major change in its intended use, will require us to obtain a new 510(k) clearance or could require a new </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> submission or a PMA. The FDA requires each manufacturer to make this determination initially, but the FDA may review any such decision and may disagree with a manufacturer&#8217;s determination. If the FDA disagrees with a manufacturer&#8217;s determination, the FDA may require the manufacturer to cease marketing and/or recall the modified device until appropriate clearance or approval is obtained. Under these circumstances, the FDA may also subject a manufacturer to significant regulatory fines or other penalties.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If future product candidates are not deemed by the FDA to meet the criteria for submission under the 510(k) pathway, or for down-classification under the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> process or otherwise, we would need to pursue a PMA. The PMA process requires us to prove the safety and effectiveness of our systems to the FDA&#8217;s satisfaction. This process can be expensive, prolonged and uncertain, requires detailed and comprehensive scientific and human clinical data, and may never result in the FDA granting a PMA. The FDA&#8217;s </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification of our G6 system under the generic name </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">integrated continuous glucose monitoring system,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> makes it a predicate device for future 510(k) submissions. Complying with this classification requires ongoing compliance with the general controls required by the federal Food Drug and Cosmetic Act and the special controls specified by the FDA&#8217;s G6 order as a Class II device. Any future system or expanded indications for use of current generation systems will require approval of the applicable regulatory authorities. In addition, we intend to seek either 510(k) clearances or PMA approvals for certain changes and modifications to our existing software platform, but cannot predict when, if ever, those changes and modifications will be approved.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA can refuse to grant a 510(k) clearance or a </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> request for marketing authorization, or delay, limit or deny approval of a PMA application or supplement for many reasons, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the system may not be deemed by the FDA to be substantially equivalent to appropriate predicate devices under the 510(k) pathway;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the system may not satisfy the FDA&#8217;s safety or effectiveness requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the data from pre-clinical studies and clinical trials may be insufficient to support clearance or approval;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the manufacturing process or facilities used may not meet applicable requirements; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in FDA approval policies or adoption of new regulations may require additional data.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if approved or cleared by the FDA or foreign regulatory agencies, future generations of our CGM systems, expanded indications for use of current and future generation CGM systems, our software platforms or any other CGM system under development, may not be cleared or approved for the indications that are necessary or desirable for successful commercialization. We may not obtain the necessary regulatory approvals or clearances to market these CGM systems in the United States or outside of the United States. Any delay in, or failure to receive or maintain, clearance or approval for our products could prevent us from generating revenue from these products. The uncertain timing of regulatory approvals for future generations of our products could subject our current inventory to excess or obsolescence charges, which could have an adverse effect on our business, financial condition and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to comply with laws, regulations and contract requirements relating to reimbursement of health care goods and services may subject us to penalties and adversely impact our reputation, business, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to laws, regulations and contractual requirements regulating the provision of, and reimbursement for, health care goods and services in our capacity as a medical device manufacturer. The laws and regulations of health care goods and services that apply to us, including those described above, are subject to evolving interpretations and enforcement discretion. We have in place a compliance program, through which we seek to reduce common industry risks of noncompliance with U.S. federal and state and applicable foreign laws in areas such as sales contracts, marketing materials, referral source relationships, programmatic offerings, and billing practices (among others), monitor for compliance, and address non-compliance if identified. If a governmental authority were to conclude that we are not in compliance with applicable laws and regulations, we and our officers, directors and employees could be subject to criminal and civil penalties, as well as administrative sanctions such as exclusion from participation in federal healthcare programs, including but not limited to Medicare and Medicaid. Any failure to comply with laws, regulations or contractual requirements relating to reimbursement and health care goods and services could adversely affect our reputation, business, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are purchased principally by individual patients, who may be eligible for insurance coverage of their devices from various third-party payors, such as governmental programs (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Medicare, Medicaid, TRICARE, other federal and state health benefit plans, and comparable non-U.S. programs), private insurance plans, and managed care plans. The ability of our customers to obtain appropriate reimbursement for products and services from third-party payors is critical because it affects which products customers purchase and the prices they are willing to pay. As a result, our products are subject to regulation regarding quality and cost by the U.S. Department of Health &amp; Human Services, including CMS, as well as comparable state and non-U.S. agencies responsible for reimbursement and regulation of health care goods and services. The principal U.S. federal laws relating to reimbursement include those that prohibit (i) the filing of false or improper claims for federal payment, known as the federal civil False Claims Act, (ii) unlawful inducements for the referral of items and services reimbursed by Federal health care programs, known as the federal Anti-Kickback Statute, and (iii) the Civil Monetary Penalties Law, including its prohibitions on Beneficiary Inducement. Many states have similar laws that apply to reimbursement by state Medicaid and other government-funded programs, as well as, in some cases, to all payors, including self-pay patients. Insurance companies can also bring a private cause of action claiming treble damages against a manufacturer for causing a false claim to be filed under the federal Racketeer Influenced and Corrupt Organizations Act, or RICO. Additionally, as a manufacturer of FDA&#8209;approved or -cleared devices reimbursable by federal healthcare programs, we are subject to the federal Physician Payments Sunshine Act, which requires us to annually report certain payments and other transfers of value we make to certain U.S.-licensed health care professionals and U.S. teaching hospitals, and under an expansion of the law to physician assistants, nurse practitioners, and other mid-level practitioners.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the federal Anti-Kickback Statute, Congress and the OIG have established a large number of statutory exceptions and regulatory safe harbors that protect financial relationships with our customers and referral sources. An arrangement that fits squarely into an exception or safe harbor will not be deemed to violate the Anti-Kickback Statute.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We train and educate employees and marketing representatives on the Anti-Kickback Statute and their obligations thereunder, and we endeavor to comply with the applicable safe harbors. However, some of our arrangements, like many other common and non-abusive arrangements, may implicate the Anti-Kickback Statute and are not covered by a safe harbor, but nevertheless we do not believe them to present a significant risk to beneficiaries or federal healthcare programs and, as such, appear unlikely to invite government scrutiny or prosecution, warrant the imposition of sanctions, or be found to violate the statute. However, we cannot offer assurance that the government or a whistleblower would agree with our position that certain arrangements fall within a safe harbor, or that arrangements that do not squarely meet an exception or safe harbor will not be found to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">violate the Anti-Kickback Statute. Allegations of violations of the Anti-Kickback Statute can also trigger liability under the federal Civil Monetary Penalty Law and federal civil False Claims Act, thereby increasing the penalty structure for these violations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period in which we directly billed Medicare, our financial relationships with referring physicians and their immediate family members were required to comply with the federal Physician Self-Referral law, commonly referred to as the Stark Law, by meeting an applicable exception. Unlike the Anti-Kickback Statute, failure to meet an exception under the Stark Law results in a violation of the Stark Law, even if such violation is unintentional. Violations of the Stark Law create overpayment liability under the federal civil False Claims Act and can also trigger separate penalties under the Civil Monetary Penalties Law. Knowing violations of the Stark Law carry increased civil monetary penalties and would likely be classified as the knowing submission of a false claim or knowingly making a false statement to the government, triggering liability under the federal civil False Claims Act. Certain Stark Law violations can also trigger exclusion from participation in federal healthcare programs. Historical violations of the Stark Law, if any, could continue to give rise to liability during the six year statute of limitations period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Managed care trends and consolidation in the health care industry could have an adverse effect on our revenues and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Private third-party payors and other managed care organizations, such as pharmacy benefit managers, continue to take action to manage utilization and control costs. Consolidation among managed care organizations has increased the negotiating power of managed care organizations and other private third-party payors. Private third-party payors, as well as governments, increasingly employ formularies to control costs by taking into account discounts in connection with decisions about formulary inclusion or favorable formulary placement. Failure to obtain or maintain timely adequate pricing or favorable formulary placement for our products, or failure to obtain such formulary placement at favorable pricing, could adversely impact revenue. Private third-party payors, including self-insured employers, often implement formularies with co-payment tiers to encourage utilization of certain products and have also been raising co-payments required from beneficiaries, particularly for higher-cost products. Private third-party payors also use additional measures such as value-based pricing/contracting to improve their cost-containment efforts. Private third-party payors also are increasingly imposing utilization management tools, such as requiring prior authorization or requiring the patient to first fail on a lower-cost product before permitting access to a higher-cost product.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many health care industry companies, including health care systems, distributors, manufacturers, providers, and insurers, are also consolidating or vertically integrating, or have formed strategic alliances. As the health care industry consolidates, competition to provide goods and services to industry participants may become more intense. This consolidation will continue to create larger enterprises with greater negotiating power, which they can try to use to negotiate price concessions or reductions for medical devices and components produced by us.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the U.S. payor market consolidates further and we face greater pricing pressure from private third-party payors, who will continue to drive more of their patients to use lower cost alternatives, we may lose customers, our revenues may decrease and our business, financial condition, results of operations and cash flows may suffer.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully complete the pre-clinical studies or clinical trials necessary to support additional PMA, de novo,&#160;or&#160;510(k) applications or supplements, we may be unable to commercialize our CGM systems under development, which could impair our business, financial condition and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To support current and any future additional PMA, 510(k), </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applications or supplements, we together with our partners, must successfully complete pre-clinical studies, bench-testing, and in some cases clinical trials that will demonstrate that the product is safe and effective. Product development, including pre-clinical studies and clinical trials, is a long, expensive and uncertain process and is subject to delays and failure at any stage. Furthermore, the data obtained from the studies and trials may be inadequate to support approval of an application and the FDA may request additional clinical data in support of those applications, which may result in significant additional clinical expenses and may delay product approvals. While we have in the past obtained, and may in the future obtain, an investigational device exemption, or IDE, prior to commencing clinical trials for our products, FDA approval of an IDE application permitting us to conduct testing does not mean that the FDA will consider the data gathered in the trial to be sufficient to support approval of a PMA, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or 510(k) application or supplement, even if the trial&#8217;s intended safety and effectiveness endpoints are achieved.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes to the regulatory landscape may impact our ability to obtain marketing authorization for future product developments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development or changes to the FDA or foreign regulatory approval standards and processes, including both legal and policy changes, could also delay or prevent the approval of our products submitted for review. For example, medical device cybersecurity continues to be an area of focus for and evolving guidance from FDA.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, at the end of 2022, Congress passed the Food and Drug Omnibus Reform Act of 2022, or FDORA which (among other things), and similarly to the 2022 FDA Guidance, requires device sponsors to submit clinical trial diversity action plans outlining the goals for increasing representation of participants from racial and ethnic minority populations that have been underrepresented in clinical trials.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any change in the laws or regulations that govern the clearance and approval processes relating to our current and future products could make it more difficult and costly to obtain clearance or approval for new products, or to produce, market and distribute existing products. The data contained in our submissions, including data drawn from our clinical trials, may not be sufficient to support clearance or approval of our products or additional or expanded indications. Medical device company stock prices have declined significantly in certain circumstances where companies have failed to meet expectations in regards to the timing of regulatory approval. If the FDA&#8217;s response causes product approval delays, or is not favorable for any of our products, our stock price (and the market price of our senior convertible notes) could decline substantially. It is uncertain how these potential changes may impact our ability to gain clearance or approval from FDA for our products in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The commencement or completion of any of our clinical trials may be delayed or halted, or be inadequate to support approval of FDA marketing applications or supplements, for numerous reasons, including, but not limited to, the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the FDA or other regulatory authorities do not approve a clinical trial protocol or a clinical trial, or place a clinical trial on hold;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients do not enroll in clinical trials at the rate we expect;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients or study site personnel who do not comply with clinical trial protocols;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patient follow-up does not occur at the rate we expect;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients experience adverse side effects;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients die during a clinical trial, even though their death may not be related to our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">institutional review boards and third-party clinical investigators may delay or reject our clinical trial protocol;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">third-party clinical investigators decline to participate in a trial or do not perform a trial on our anticipated schedule or consistent with the investigator agreements, clinical trial protocol, good clinical practices or other FDA or institutional review board requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we or third-party organizations do not perform data collection, monitoring or analysis in a timely or accurate manner or consistent with the clinical trial protocol or investigational or statistical plans;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">third-party clinical investigators have significant financial interests related to us or the study that the FDA deems to make the study results unreliable, or we or clinical investigators fail to disclose such interests;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regulatory inspections of our clinical trials or manufacturing facilities may results in allegations or findings of noncompliance and, among other things, require us to undertake corrective action or suspend or terminate our clinical trials;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in governmental regulations, policies or administrative actions applicable to our trial protocols;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the interim or final results of the clinical trial are inconclusive or unfavorable as to safety or efficacy; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the FDA concludes that the results from our trial and/or trial design are inadequate to demonstrate safety and effectiveness of the product.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, health epidemics could limit or restrict our ability to initiate, conduct or continue our clinical trials. Delays and disruption in our clinical trials could results in delays for expanded FDA clearance or approval of our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of pre-clinical studies or other forms of early product testing do not necessarily predict future clinical trial results, and prior clinical trial results might not be repeated in subsequent clinical trials. Additionally, the FDA may disagree with our interpretation of the data from our pre-clinical studies, product testing, and clinical trials, or may find the clinical trial design, conduct or results inadequate to prove safety or effectiveness, and may require us to pursue the development of additional data, which could further delay the approval of our products. If we are </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unable to demonstrate the safety and effectiveness of our products in our clinical trials to the FDA&#8217;s satisfaction, where clinical data are required, we will be unable to obtain regulatory approval to market our products in the United States. In addition, the data we collect from our current clinical trials, our pre-clinical studies and other clinical trials may not be sufficient to support FDA approval, even if our endpoints are met.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also conduct clinical studies to demonstrate the relative or comparative effectiveness of CGM systems for the treatment of diabetes. These types of studies, which often require substantial investment and effort, may not show adequate, or any, clinical benefit or value for the use of CGM systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our CGM systems currently have regulatory marketing authorization limited to individual patient home-use, and have otherwise not received clearance or approval from the FDA or other regulators for use in hospital or other in-patient facility settings, although the FDA has advised us that it will not object to the use of our CGM systems in such settings during the COVID-19 pandemic. Our potential supply of our CGM systems for use in this environment during the COVID-19 pandemic may present risks to our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received, and may continue to receive, numerous inquiries from hospitals around the country about the use of our CGM devices to remotely monitor COVID-19 patients admitted into the hospital.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following direct communication with the FDA regarding the potential use of our CGM devices in a hospital or other in-patient setting, the FDA notified us on April 1, 2020 that in an exercise of its enforcement discretion it will not object, in the context of the COVID-19 pandemic, to Dexcom providing CGM devices and support to users to enable real-time remote patient monitoring in hospitals and other healthcare facilities, to support COVID-19 healthcare-related efforts, so long as we provide certain FDA-specified information with respect to the unique challenges that CGM technologies can raise in the hospital environment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a condition of its exercise of enforcement discretion, the FDA has advised that we communicate the following information related to implementing the use of CGM systems for remote monitoring of hospitalized patients:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Hospitals should consider whether they have the resources and expertise necessary to adequately implement CGM use and provide appropriate training to healthcare providers.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">CGM glucose results are less accurate than blood glucose results obtained using traditional testing methods (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, lab glucose, blood glucose meters). Users should consider all CGM glucose information (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, trend) along with individual glucose values, and interpret CGM results in the context of the full clinical picture.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">CGM systems are subject to interferences that may generate falsely high and falsely low glucose readings. Levels of interference depend on drug concentration; substances that may not significantly interfere in non-hospitalized patients may interfere when used in the hospital setting because of higher dose levels. Most drugs used in hospital or critical care settings have not been evaluated and their interference with CGM systems is unknown. Known interferences vary by CGM brand, and can include Acetaminophen, Ascorbic acid, Hydroxyurea, or other reducing drugs/ compounds.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Poor peripheral blood perfusion may cause inaccurate sensor readings.&#160;CGM results should be interpreted considering accompanying patient conditions and medications. Other clinical conditions may also cause inaccurate readings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision of our CGM systems to hospitals and other healthcare facilities for use during have and will continue to have the above notice.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, we received Breakthrough Device designation for our G6 CGM system in the hospital setting. The FDA&#8217;s Breakthrough Device designation is designed to expedite the development and regulatory review of medical devices that hold the potential for more effective treatment or diagnosis of life-threatening or irreversibly debilitating disease or condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not actively promoting nor do we plan to actively promote our CGM devices (and related support) for inpatient use, but if we supply them to such facilities as currently permitted by the FDA, this supply could present an increased risk of product liability claims and associated damages should an adverse event occur. Given that our CGM devices have not yet been fully evaluated or tested by either us or the FDA to the extent that would be required in standard circumstances for product development and marketing authorization, there could be unknown or unanticipated risks presented by use in this environment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA can also decide, at any time, to change its position regarding its Breakthrough Device Designation and/or enforcement discretion for our devices, and require that we seek marketing authorization for this additional intended use by submitting a 510(k) premarket notification, or that we seek and obtain Emergency Use </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Authorization. The COVID-19 public health emergency declared by the Department of Health and Human Services expired on May 11, 2023. While the end of the public health emergency does not by itself impact the FDA's ability to authorize devices for emergency use, and the FDA has published guidance for transition plans for medical devices that fall within enforcement policies issued during the COVID-19 pandemic. We will continue to closely monitor regulatory developments that impact our products, business, or financial results, including those relating to FDA enforcement discretion and Breakthrough Device Designation for the provision of our CGM systems in the hospital setting.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on clinical investigators and clinical sites to enroll patients in our clinical trials and other third parties to manage the trials and to perform related data collection and analysis, and, as a result, we may face costs and delays that are outside of our control.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on clinical investigators and clinical sites to enroll patients in our clinical trials, and other third parties to manage the trial and to perform related data collection and analysis. However, we may not be able to control the amount and timing of resources that clinical sites may devote to our clinical trials. If these clinical investigators and clinical sites fail to enroll a sufficient number of patients in our clinical trials or fail to ensure compliance by patients with clinical protocols or fail to comply with regulatory requirements, we will be unable to complete these trials, which could prevent us from obtaining regulatory approvals for our products. Our agreements with clinical investigators and clinical sites for clinical testing place substantial responsibilities on these parties and, if these parties fail to perform as expected, our trials could be delayed or terminated. If these clinical investigators, clinical sites or other third parties do not carry out their contractual duties or obligations or fail to meet expected deadlines, or if the quality or accuracy of the clinical data they obtain is compromised due to their failure to adhere to our clinical protocols, regulatory requirements or for other reasons, our clinical trials may be extended, delayed or terminated, or the clinical data may be rejected by the FDA, and we may be unable to obtain regulatory approval for, or successfully commercialize, our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health care policy changes, including U.S. health care reform legislation, may have a material adverse effect on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to perceived increases in health care costs in recent years, there have been and continue to be proposals by the federal government, state governments, regulators, and third-party payors to control these costs and, more generally, to reform the U.S. health care system. Certain of these proposals could limit the prices we are able to charge for our products or the amounts of reimbursement available for our products and could limit the acceptance and availability of our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, the OIG published a Special Fraud Alert addressing manufacturer Speaker Programs, signaling both a more narrow government view of AKS compliance with respect to such programs as well as the potential for increased enforcement in this space by government oversight agencies such as the OIG and DOJ. On March 18, 2022, the Advanced Medical Technology Association, or AdvaMed, announced revisions to its Code of Ethics on Interactions with Health Care Professionals, or Code. The revised Code, effective June 1, 2022, addressed concerns noted in the OIG&#8217;s Special Fraud Alert, addressing things like virtual meetings, speaker programs and alcohol at events. The revised Code also addresses value-based care arrangements. We continue to assess industry responses to the Special Fraud Alert and have and may continue to make modifications to certain aspects of our speaker programs, which may have a detrimental impact on our ability to educate healthcare providers about our products and to promote use of our products, which may lead to decreased product sales and negatively impact our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive healthcare legislation, signed into law in the United States in March 2010, titled the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act of 2010, collectively, the ACA, imposes certain stringent compliance, recordkeeping, and reporting requirements on companies in various sectors of the life sciences industry, and enhanced penalties for non-compliance. Despite the ACA going into effect over a decade ago, there have been numerous legal and Congressional challenges to the law&#8217;s provisions and the effect of certain provisions have made compliance costly.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict what additional new legislation, agency priorities, and rulemaking may be on the horizon as the United States continue to reassess how it pays for healthcare. As a result, we cannot quantify or predict what impact any changes might have on our business and results of operations. However, any changes that lower reimbursement for our products could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other legal, regulatory and commercial policy influences are subjecting our industry to significant changes, and we cannot predict whether new regulations or policies will emerge from U.S. federal or state governments, foreign governments, or third-party payors. Government and commercial payors may, in the future, consider healthcare </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">policies and proposals intended to curb rising healthcare costs, including those that could significantly affect reimbursement for healthcare products such as our systems. These policies have included, and may in the future include: basing reimbursement policies and rates on clinical outcomes, the comparative effectiveness, and costs, of different treatment technologies and modalities; imposing price controls and taxes on medical device providers; and other measures. Future significant changes in the healthcare systems in the United States or elsewhere could also have a negative impact on the demand for our current and future products. These include changes that may reduce reimbursement rates for our products and changes that may be proposed or implemented by the current or future laws or regulations.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_229"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Intellectual Property Protection and Use</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to claims of infringement or misappropriation of the intellectual property rights of others, which could prohibit us from shipping affected products, require us to obtain licenses from third parties or to develop non-infringing alternatives, and subject us to substantial monetary damages and injunctive relief. We may also be subject to other claims or suits.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties have asserted, and may assert, infringement or misappropriation claims against us with respect to our current or future products. We are aware of numerous patents issued to third parties that may relate to aspects of our business, including the design and manufacture of CGM sensors and membranes, as well as methods for continuous glucose monitoring. Whether a product infringes a patent involves complex legal and factual issues, the determination of which is often uncertain. Therefore, we cannot be certain that we have not infringed the intellectual property rights of such third parties or others. Our competitors may assert that our CGM systems or the methods we employ in the use of our systems are covered by U.S. or foreign patents held by them. We have in the past settled some such allegations and may need to do so again in the future. This risk is exacerbated by the fact that there are numerous issued patents and pending patent applications relating to self-monitored glucose testing systems in the medical technology field. Because patent applications may take years to issue, there may be applications now pending of which we are unaware that may later result in issued patents that our products infringe. There could also be existing patents of which we are unaware that one or more components of our system may inadvertently infringe. As the number of competitors in the market for CGM systems grows, the possibility of patent infringement by us or a patent infringement claim against us increases. If we are unable to successfully defend any such claims as they may arise or enter into or extend settlement and license agreements on acceptable terms or at all, our business operations may be harmed. We have been involved in various patent infringement actions in the past. For example, in July 2014, we entered into a Settlement and License Agreement with Abbott to settle all pending patent infringement legal proceedings brought by Abbott against us, which expired on March 31, 2021. Since the expiration of that agreement, we and certain Abbott entities have served complaints for patent infringement, validity, and other patent-related actions against each other in multiple jurisdictions, inside and outside the United States. We intend to vigorously pursue our claims and defenses in these cases to protect our intellectual property and to defend against Abbott&#8217;s infringement allegations. See &#8220;Legal Proceedings&#8221; in Part I, Item 1 above for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any infringement or misappropriation claim could cause us to incur significant costs, place significant strain on our financial resources, divert management&#8217;s attention from our business and harm our reputation. In addition, if the relevant patents are upheld as valid and enforceable and we are found to infringe such patents, we could be prohibited from selling any of our products that is found to infringe unless we could obtain licenses to use the technology covered by the patent or are able to design around the patent. We may be unable to obtain a license on terms acceptable to us, if at all, and we may not be able to redesign our products to avoid infringement. We may be unable to maintain or renew licenses on terms acceptable to us, if at all, and we may be prohibited from selling any of our products that required the technology covered by the relevant licensed patents. Even if we are able to redesign our products to avoid an infringement claim, we may not receive FDA approval for such changes in a timely manner or at all.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any adverse determination in litigation or interference proceedings to which we are or may become a party relating to patents or other intellectual property rights could subject us to significant liabilities to third parties or require us to seek licenses from other third parties. If we are found to infringe third-party patents, a court could order us to pay damages to compensate the patent owner for the infringement, such as a reasonable royalty amount and/or profits lost by the patent owners, along with prejudgment and/or post-judgment interest. Furthermore, if we are found to willfully infringe third-party patents, we could, in addition to other penalties, be required to pay treble damages; and if the court finds the case to be exceptional, we may be required to pay attorneys&#8217; fees for the prevailing party. If we are found to infringe third-party copyrights or trademarks or misappropriate third-party trade secrets, based on the intellectual property at issue, a court could order us to pay statutory damages, actual damages, or profits, such as reasonable royalty or lost profits of the owners, unjust enrichment, disgorgement of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">profits, and/or a reasonable royalty, and the court could potentially award attorneys&#8217; fees or exemplary or enhanced damages. Although patent and intellectual property disputes in the medical device area have often been settled through licensing or similar arrangements, costs associated with such arrangements may be substantial and would likely include ongoing royalties. We may be unable to obtain necessary intellectual property licenses on satisfactory terms. If we do not obtain any such necessary licenses, we may not be able to redesign our products to avoid infringement and any redesign may not receive FDA approval or other requisite marketing authorization in a timely manner or at all. Adverse determinations in a judicial or administrative proceeding or failure to obtain necessary intellectual property licenses could prevent us from manufacturing and selling our products, which would have a significant adverse impact on our business. If litigation were to be initiated by intellectual property owners, there could significant legal fees and costs incurred in defending litigation (which may include filing administrative actions to attack the intellectual property) as well as a potential monetary settlement payment to the owners, even if the matter is resolved before going to trial. Moreover, the owners may take an overly aggressive approach and/or include multiple allegations in a single litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from time to time, we are subject to various claims, complaints and legal actions arising out of the ordinary course of business, including commercial insurance, product liability or employment-related matters. Also, from time to time, we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment-related matters. We do not believe we are party to any currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our inability to adequately protect our intellectual property could allow our competitors and others to produce products based on our technology, which could substantially impair our ability to compete.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success and our ability to compete depend, in part, upon our ability to maintain the proprietary nature of our technologies. We rely on a combination of patent, copyright and trademark law, and trade secrets and nondisclosure agreements to protect our intellectual property. However, such methods may not be adequate to protect us or permit us to gain or maintain a competitive advantage. Our patent applications may not issue as patents in a form that will be advantageous to us, or at all. Our issued patents, and those that may issue in the future, may be challenged, invalidated or circumvented, which could limit our ability to stop competitors from marketing related products. In addition, there are numerous recent changes to the patent laws and proposed changes to the rules of the U.S. Patent and Trademark Office, which may have a significant impact on our ability to protect our technology and enforce our intellectual property rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To protect our proprietary rights, we may in the future need to assert claims of infringement against third parties. The outcome of litigation to enforce our intellectual property rights in patents, copyrights, trade secrets or trademarks is highly unpredictable, could result in substantial costs and diversion of resources, and could have a material adverse effect on our business, financial condition and results of operations regardless of the final outcome of such litigation. In the event of an adverse judgment, a court could hold that some or all of our asserted intellectual property rights are not infringed, or are invalid or unenforceable, and could award attorney fees.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite our efforts to safeguard our unpatented and unregistered intellectual property rights, we may not succeed in doing so or the steps taken by us in this regard may not be adequate to detect or deter misappropriation of our technology or to prevent an unauthorized third party from copying or otherwise obtaining and using our products, technology or other information that we regard as proprietary. In addition, third parties may be able to design around our patents. Furthermore, the laws of foreign countries may not protect our proprietary rights to the same extent as the laws of the United States.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_232"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Litigation Risks</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face the risk of product liability claims and may be subject to damages, fines, penalties and injunctions, among other things.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business exposes us to the risk of product liability claims that is inherent in the testing, manufacturing and marketing of medical devices, including those which may arise from the misuse (including system hacking or other unauthorized access by third parties to our systems) or malfunction of, or design flaws in, our products. This liability may vary based on the FDA classification associated with our devices. Notably, the classification of our G6 and G7 systems as Class II medical devices is likely to weaken our ability to rely on federal preemption of state law claims that assert liability against us for harms arising from use of those systems. We may be subject to product liability claims if our products cause, or merely appear to have caused, an injury. Claims may be made by customers, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">healthcare providers or others selling our products. The risk of product liability claims may increase given that G6 and G7 do not require confirmatory finger sticks when making treatment decisions or finger stick tests each day for calibration, although it does require finger stick tests when symptoms do not match readings and when readings are unavailable. The risk of claims may also increase if our products are subject to a product recall or seizure. An example of the difficulty of complying with the regulatory requirements associated with the manufacture of our products, we issued notifications to our customers regarding the audible alarms and alerts associated with our receivers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have insurance at levels that we believe is appropriate, this insurance is subject to deductibles and coverage limitations. Our current product liability insurance may not continue to be available to us on acceptable terms, if at all, and, if available, the coverage may not be adequate to protect us against any future product liability claims. Further, if additional products are approved for marketing, we may seek additional insurance coverage. If we are unable to obtain insurance at an acceptable cost or on acceptable terms with adequate coverage or otherwise protect against potential product liability claims, we will be exposed to significant liabilities, which may harm our business. A product liability claim, recall or other claims with respect to uninsured liabilities or for amounts in excess of insured liabilities could result in significant costs and significant harm to our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to claims against us even if the apparent injury is due to the actions of others or misuse of the device or a partner device. Our customers, either on their own or following the advice of their physicians, may use our products in a manner not described in the products&#8217; labeling and that differs from the manner in which it was used in clinical studies and approved by the FDA. For example, our current systems are designed to be used by an individual continuously for up to 10 days for our G6 and G7 systems, but the individual might be able to circumvent the safeguards designed into the systems and use the products for longer than 10 days. Off-label use of products by customers is common, and any such off-label use of our products could subject us to additional liability, or require design changes to limit this potential off-label use once discovered. In addition, other regulatory agencies may in the future approve similar diabetes treatment indications. We expect that such diabetes treatment indications could expose us to additional liability. These liabilities could prevent or interfere with our product commercialization efforts. Defending a suit, regardless of merit, could be costly, could divert management attention and might result in adverse publicity, which could result in the withdrawal of, or inability to recruit, clinical trial volunteers or result in reduced acceptance of our products in the market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the recent COVID-19 pandemic, we have received and continue to receive, numerous requests from hospitals and healthcare facilities around the country regarding the use of our CGM devices to remotely monitor COVID-19 patients admitted into the hospital. As noted above, in 2020, the FDA informed us that they intend to exercise enforcement discretion and will not object to our provision of G6 CGM systems to such facilities for use in the inpatient setting during the pandemic. However, our CGM devices are currently approved only for in-home use by patients for the purpose of personal diabetes management and have not otherwise been cleared or approved by the FDA for hospital use. Given that the G6 CGM has not yet been fully evaluated or tested (by us or by the FDA) to the extent that would be required in standard circumstances for product development and marketing authorization, there could be unknown or unanticipated risks presented by use in this environment. To the extent that inpatient use of our CGM systems causes or contributes to an adverse event, we may be subjected to additional product liability lawsuits. Defending a suit, regardless of merit, could be costly, could divert management attention and might result in adverse publicity, which could result in reduced acceptance of our products in the market.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could become the subject of governmental investigations, claims and litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare companies are subject to numerous investigations and inquiries by various governmental agencies. Further, under the False Claims Act, private parties have the right to bring&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or &#8220;whistleblower,&#8221; suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Depending upon whether the underlying conduct alleged in such inquiries or investigations could be considered systemic, any resolution of any such investigations could have a material, adverse effect on our financial position and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governmental agencies and their agents, such as CMS Medicare Administrative Contractors and other CMS contractors, as well as the OIG, state Medicaid programs, and other state and federal agencies may conduct audits of our operations, relating to covered items and services including those furnished to beneficiaries, health care providers and distributors. Commercial and government-funded managed care payors may conduct similar post-payment audits. Depending on the nature of the conduct found in such audits and whether the underlying conduct could be considered systemic, the resolution of these audits could have a material adverse effect on our financial position and results of operations. Our compliance program includes internal audit and monitoring functions designed to identify potential issues and facilitate remediation as appropriate.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any future investigations of our executives, our managers or us could result in significant liabilities or penalties to us, as well as adverse publicity. Even if we are found to have complied with applicable law, the investigation or litigation may pose a considerable expense and would divert management&#8217;s attention, and have a potentially negative impact on the public&#8217;s perception of us, all of which could negatively impact our financial position and results of operations. Further, should we be found out of compliance with any of these laws, regulations or programs, depending on the nature of the findings, our business, our financial position and our results of operations could be negatively impacted.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to fines, penalties and injunctions if we are determined to be promoting the use of our products for unapproved or improper off-label uses or determined to have made claims that are untruthful or misleading or not adequately substantiated.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our marketing, promotional and educational materials and practices are subject to FDCA, Federal Trade Commission Act, and other applicable laws and regulations, as may be amended from time to time. If the FDA, FTC or other regulatory body with competent jurisdiction over us, our activities or products takes the position that our marketing, promotional or other materials or activities constitute improper promotion or marketing of an unapproved or improper use, or that they contain untruthful, misleading, or inadequately substantiated statements or claims, such regulatory body could request that we modify our materials or practices, or subject us to regulatory enforcement actions, including the issuance, depending on the regulatory body and the nature of the alleged violation, of a warning letter, injunction, seizure, civil fine and criminal penalties. It is also possible that other federal, state or foreign enforcement authorities might take action if they consider promotional, marketing or other materials or activities to constitute improper promotion of an unapproved use, which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting false claims for reimbursement. Recent court decisions have impacted the FDA&#8217;s enforcement activity regarding off-label promotion in light of First Amendment considerations; however, there are still significant risks in this area in part due to the potential False Claims Act exposure and the FDA&#8217;s continued focus on ensuring devices are marketed in a manner consistent with their FDA-required labeling.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not actively promoting nor do we plan to actively promote our G6 or G7 systems for inpatient use, but if we supply them to such facilities as currently permitted by FDA, this supply could present an increased risk of product liability claims and associated damages should an adverse event occur. Given that the G6 and G7 systems have not yet been fully evaluated or tested (by us or by the FDA) to the extent that would be required in standard circumstances for product development and marketing authorization, there could be unknown or unanticipated risks presented by use in this environment.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In some instances in our advertising and promotion, we may make claims regarding our product as compared to competing products, which may subject us to heightened regulatory scrutiny, enforcement risk, and litigation risks.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA applies a heightened level of scrutiny to comparative claims when applying its statutory standards for advertising and promotion, including with regard to its requirement that promotional labeling be truthful and not misleading. There is potential for differing interpretations of whether certain communications are consistent with a product&#8217;s FDA-required labeling, and FDA will evaluate communications on a fact-specific basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, making comparative claims may draw concerns from our competitors.&#160;Where a company makes a claim in advertising or promotion that its product is superior to the product of a competitor (or that the competitor&#8217;s product is inferior), this creates a risk of a lawsuit by the competitor under federal and state false advertising or unfair and deceptive trade practices law, and possibly also state libel law.&#160;Such a suit may seek injunctive relief against further advertising, a court order directing corrective advertising, and compensatory and punitive damages where permitted by law.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Direct-to-consumer marketing and social media efforts may expose us to additional regulatory scrutiny.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our efforts to promote our products via direct-to-consumer marketing and social media initiatives may subject us to additional scrutiny of our practices of effective communication of risk information, benefits or claims, under the oversight of the FDA, FTC, HHS-OCR, or others.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_235"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Other Risks Related to Our Business and Financial Condition</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred significant losses in the past and may incur losses in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant operating losses in the past. We have financed our operations primarily through private and public offerings of equity securities and debt and the sales of our products. We have devoted substantial resources to:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">research and development relating to our continuous glucose monitoring systems;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">sales and marketing and manufacturing expenses associated with the commercialization of our G6 and G7 systems; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">expansion of our workforce.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our research and development expenses to increase in connection with our clinical trials and other development activities related to our products, including our next-generation sensors, transmitters and receivers, as well as other collaborations. We also expect that our general and administrative expenses will continue to increase due, among other things, to the additional operational and regulatory burdens applicable to public healthcare and medical device companies. As a result, it is possible that we could incur operating losses in the future. These losses, among other things, may have an adverse effect on our stockholders&#8217; equity.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success will depend on our ability to attract and retain our personnel and manage our human capital, while controlling labor costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend to a significant degree on our senior management, especially Kevin Sayer, our President and Chief Executive Officer. Our success will depend on our ability to retain our senior management and to attract and retain qualified personnel in the future, including salespersons, scientists, clinicians, engineers and other highly skilled personnel. Competition for senior management personnel, as well as salespersons, scientists, clinicians and engineers, is intense and we may not be able to retain our personnel. The loss of the services of members of our senior management, scientists, clinicians or engineers could prevent the implementation and completion of our objectives, including the commercialization of our current products and the development and introduction of additional products. The loss of a member of our senior management or our professional staff would require the remaining executive officers to divert immediate and substantial attention to seeking a replacement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our officers may terminate their employment at any time without notice and without cause or good reason. Additionally, volatility or a lack of positive performance in our stock price may adversely affect our ability to retain key employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to expand our operations and grow our research and development, manufacturing, sales and marketing, product development and administrative operations. We expect this expansion to place a significant strain on our management and it will require hiring a significant number of qualified personnel. Accordingly, recruiting and retaining such personnel will be critical to our success. There is intense competition from other companies and research and academic institutions for qualified personnel in the areas of our activities. If we fail to identify, attract, retain and motivate these skilled personnel, we may be unable to continue our development and commercialization activities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may undertake reorganizations of our workforce, which may result in a temporary reduction in the number of employees in certain locations. We would undertake a reorganization to reduce operating expenses or achieve other business objectives, though we cannot guarantee any specific amount of long-term cost savings. Further, the turnover in our employee base could result in operational and administrative inefficiencies, which could adversely impact the results of our operations, stock price and customer relationships, and could make recruiting for future management and other positions more difficult.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may conduct additional financings to continue the development or commercialization of our current or future generation CGM systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations have consumed substantial amounts of cash since inception. We expect to continue to spend substantial amounts on commercialization of our products, including growth of our manufacturing capacity, on research and development, and conducting clinical trials for our next-generation ambulatory CGM sensors and systems. Although we raised substantial net proceeds through the private sale of our convertible notes, we could need funds to continue the commercialization of our current products and to develop and commercialize our next-generation sensors and systems or pursue other strategic initiatives. Additional financing may not be available on a timely basis on terms acceptable to us, or at all. Any additional financing may be dilutive to stockholders or may </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">require us to grant a lender a security interest in our assets. The amount of funding we may need will depend on many factors, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the revenue generated by sales of our products and other future products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the costs, timing and risks of delay of additional regulatory approvals;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the expenses we incur in manufacturing, developing, selling and marketing our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our ability to scale our manufacturing operations to meet demand for our current and any future products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the costs to produce our continuous glucose monitoring systems;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the rate of progress and cost of our clinical trials and other development activities;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the success of our research and development efforts;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the emergence of competing or complementary technologies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the terms and timing of any collaborative, licensing and other arrangements that we may establish;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the cost of ongoing compliance with legal and regulatory requirements, and third-party payors&#8217; policies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the cost of obtaining and maintaining regulatory or payor clearance or approval for our current or future products including those integrated with other companies&#8217; products; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the acquisition of business, products and technologies, although we currently have no commitments or agreements relating to any of these types of transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If adequate funds are not available, we may not be able to commercialize our products at the rate we desire and/or we may have to delay the development or commercialization of our products or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize. We also may have to reduce sales, marketing, customer support or other resources devoted to our products. Any of these factors could harm our business and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uncollectible uninsured and patient due accounts could adversely affect our results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary collection risks for our accounts receivable relate to the uninsured patient accounts and patient accounts for which the primary insurance carrier has paid the amounts covered by the applicable agreement, but patient responsibility amounts (exclusions, deductibles and copayments) remain outstanding. In addition, as a result of the economic slowdown, some customers have, and others may, lose access to their private health insurance plan if they lose their job. As most of our customers rely on third-party payors, including private health insurance plans, to cover the cost of our products, there has been, and may continue to be, a shift in financial responsibility to our customers for the amounts previously covered by their primary insurance carrier.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we are unsuccessful in collecting payments owed by patients, and/or experience increases in the amount, or deterioration in the collectability, of uninsured and patient due accounts receivable, this could adversely affect our cash flows and results of operations. We may also be adversely affected by the growth in patient responsibility accounts, as a result of increases in the adoption of plan structures, due to evolving health care policy and insurance landscapes that shift greater responsibility for care to individuals through greater exclusions, prior authorizations, and copayment and deductible amounts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in our business strategy or restructuring of our businesses may increase our costs or otherwise affect the profitability of our businesses or the value of our assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As changes in our business environment occur we have adjusted, and may further, adjust our business strategies to meet these changes and we may otherwise decide to further restructure our operations or particular businesses or assets. Our new organization and strategies may not produce the anticipated benefits, such as supporting our growth strategies and enhancing shareholder value. Our new organization and strategies could be less successful than our previous organizational structure and strategies. In addition, external events including changing technology, changing consumer patterns, acceptance of our products and changes in macroeconomic conditions may impair the value of our assets. When these changes or events occur, we may incur costs to change our business strategy and may need to write-down the value of assets. For example, current economic conditions, including rising interest rates, inflation and a potential recession, as well as our business decisions, may reduce the value of some of our assets. We also make investments in existing or new businesses, including investments in the international expansion of our sales efforts and the build-out of our manufacturing facility in Malaysia as well as our proposed facility in Ireland. Additionally, we also invest in early to late-stage companies for strategic reasons and to support key business initiatives, and we may not realize a return on our equity investments. Many such companies </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">generate net losses and the market for their products, services, or technologies may be slow to develop or never materialize. We are subject to risks associated with our equity investments including partial or complete loss of invested capital, and significant changes in the fair value of this portfolio could adversely impact our financial results. Some of these investments may have returns that are negative or low, the ultimate business prospects of the businesses related to these investments may be uncertain, and these risks may be exacerbated by current macroeconomic conditions. In any of these events, our costs may increase or returns on new investments may be lower than prior to the change in strategy or restructuring.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_238"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Relating to Our Public Company Status, Tax Laws and Growth Through Acquisition</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may face risks associated with acquisitions of companies, products and technologies and our business could be harmed if we are unable to address these risks.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are presented with appropriate opportunities, we could acquire or make other investments in complementary companies, products or technologies. We may not realize the anticipated benefit of our acquisitions, or the realization of the anticipated benefits may require greater expenditures than anticipated by us. We will likely face risks, uncertainties and disruptions associated with the integration process, including difficulties in the integration of the operations and services of any acquired company, integration of acquired technology with our products, diversion of our management&#8217;s attention from other business concerns, the potential loss of key employees or customers of the acquired businesses and impairment charges if future acquisitions are not as successful as we originally anticipated. If we fail to successfully integrate other companies, products or technologies that we acquire, our business could be harmed. Furthermore, we may have to incur debt or issue equity or equity-linked securities to pay for any future acquisitions or investments, the issuance of which could be dilutive to our existing stockholders. In addition, our operating results may suffer because of acquisition-related costs, amortization expenses or charges relating to acquired intangible assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with regulations relating to public company corporate governance matters and reporting may strain our resources and divert management&#8217;s attention.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many laws and regulations, notably those adopted in connection with the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, new SEC regulations and The Nasdaq Stock Market listing rules, impose obligations on public companies, such as ours, which have increased the scope, complexity and cost of corporate governance, reporting and disclosure practices. Compliance with these laws and regulations, including enhanced new disclosures, has required and will continue to require substantial management time and oversight and the incurrence of significant accounting and legal costs. The effects of new laws and regulations remain unclear and will likely require substantial management time and oversight and require us to incur significant additional accounting and legal costs. Additionally, changes to existing accounting rules or standards, such as the potential requirement that U.S. registrants prepare financial statements in accordance with International Financial Reporting Standards, may adversely impact our reported financial results and business, and may require us to incur greater accounting fees. These laws, regulations, and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to continue to invest resources to comply with evolving laws, regulations, and standards, and this investment may result in increased general and administrative expenses and a diversion of management&#8217;s time and attention from revenue-generating activities to compliance activities. If our efforts to comply with new laws, regulations, and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our business may be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could be subject to changes in our tax rates, new U.S. or international tax legislation or additional tax liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxes in the United States and numerous foreign jurisdictions, where a number of our subsidiaries are organized. The tax laws in the United States and in other countries in which we and our subsidiaries do business could change on a prospective or retroactive basis, and any such changes could adversely affect our business and financial condition. Further, due to economic and political conditions, tax rates in various jurisdictions may be subject to change. Our effective tax rates could be affected by numerous factors, including changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, and changes in tax laws or their interpretation, both in and outside the United States.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is growing pressure in many jurisdictions, including the United States, and from multinational organizations such as the OECD and the European Union to amend existing international tax rules in order to render them more responsive to current global business practices.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tax returns and other tax matters also are subject to examination by the U.S. Internal Revenue Service and other tax authorities and governmental bodies. We regularly assess the likelihood of an adverse outcome resulting from these examinations to determine the adequacy of our provision for taxes. We cannot guarantee the outcome of these examinations. If our effective tax rates were to increase, particularly in the United States, or in other countries implementing legislation to reform existing tax legislation, including the European Union and Germany, or if the ultimate determination of our taxes owed is for an amount in excess of amounts previously accrued, our financial condition, operating results and cash flows could be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use our net operating losses to offset future taxable income may be subject to certain limitations which could subject our business to higher tax liability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to use our net operating losses, or NOLs, to offset future taxable income may be subject to certain limitations which could subject our business to higher tax liability. We may be limited in the portion of NOL carryforwards that we can use in the future to offset taxable income for U.S. federal and state income tax purposes, and federal tax credits to offset federal tax liabilities. Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, and similar state law provisions, limit the use of NOLs and tax credits after a cumulative change in corporate ownership of more than 50% occurs within a three-year period. The statutes place a formula limit on how much NOLs and tax credits a corporation can use in a tax year after a change in ownership. Avoiding an ownership change is generally beyond our control. Although the ownership changes we experienced in the past have not prevented us from using all NOLs and tax credits accumulated before such ownership changes, we could experience another ownership change that might limit our use of NOLs and tax credits in the future. In addition, realization of deferred tax assets, including net operating loss carryforwards, depends upon our future earnings in applicable tax jurisdictions. If we have insufficient future taxable income in the applicable tax jurisdiction for any reason, including any future corporate reorganization or restructuring activities, we may be limited in our ability to utilize some or all of our net operating losses to offset such income and reduce our tax liability in that jurisdiction. We utilized that the majority of our remaining NOLs by the end of 2021, with the exception of the NOLs limited by Section 382 of the Internal Revenue Code of 1986. See Note 8 &#8220;Income Taxes&#8221; to the consolidated financial statements for the fiscal year ended December 31, 2022 in Part II, Item 8 of our Annual Report on Form 10-K that we filed with the SEC on February 9, 2023 for additional information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is also a risk that due to regulatory changes or changes to federal or state law, such as suspensions on the use of NOLs, or other unforeseen reasons, our existing NOLs could expire or otherwise be unavailable either in whole or in part to offset future income tax liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of share-based payments, which we are required to perform for purposes of recording compensation expense under authoritative guidance for share-based payment, involves assumptions that are subject to change and difficult to predict.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record compensation expense in the consolidated statements of operations for share-based payments, such as employee stock options, restricted stock units and employee stock purchase plan shares, using the fair value method. The requirements of the authoritative guidance for share-based payment have and will continue to have a material effect on our future financial results reported under U.S. generally accepted accounting principles, or GAAP, and make it difficult for us to accurately predict the impact on our future financial results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instance, estimating the fair value of share-based payments is highly dependent on assumptions regarding the future exercise behavior of our employees and changes in our stock price. If there are errors in our input assumptions for our valuations models, we may inaccurately calculate actual or estimated compensation expense for share-based payments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance for share-based payment could also adversely impact our ability to provide accurate guidance on our future financial results as assumptions that are used to estimate the fair value of share-based payments are based on estimates and judgments that may differ from period to period. We may also be unable to accurately predict the amount and timing of the recognition of tax benefits associated with share-based payments as they are highly dependent on the exercise behavior of our employees and the price of our stock relative to the exercise price of each outstanding stock option.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For those reasons, among others, the authoritative guidance for share-based payment may create variability and uncertainty in the share-based compensation expense we will record in future periods, which could adversely impact our stock price and increase our expected stock price volatility as compared to prior periods.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_241"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Our Common Stock</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price is highly volatile and investing in our stock involves a high degree of risk, which could result in substantial losses for investors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, the market price of our common stock, like the securities of many other medical products companies, fluctuates and could continue to be volatile in the future, especially as our business continues to grow and our business plan continues to evolve. From January&#160;1, 2023 through June&#160;30, 2023, the closing price of our common stock on the Nasdaq Global Select Market was as high as $130.98 per share and as low as $104.00 per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our common stock is influenced by many factors that are beyond our control, including the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">securities analyst coverage or lack of coverage of our common stock or changes in their estimates of our financial performance;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">variations in quarterly operating results;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">future sales of our common stock by our stockholders;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">investor perception of us and our industry;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">announcements by us or our competitors of significant agreements, acquisitions, or capital commitments or product launches or discontinuations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in market valuation or earnings of our competitors;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">negative business or financial announcements regarding our partners;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">general economic conditions;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regulatory actions;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">legislation and political conditions;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">global health pandemics, such as the recent COVID-19 pandemic; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">other events or factors, including the, ongoing conflict in Ukraine, recessions, rising interest rates, inflation, local and national elections, international currency fluctuations, corruption, political instability and acts of war or terrorism</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please also refer to the factors described elsewhere in this &#8220;Risk Factors&#8221; section. In addition, the stock market in general has experienced extreme price and volume fluctuations that have often been unrelated and disproportionate to the operating performance of companies in our industry. These broad market and industry factors may materially reduce the market price of our common stock, regardless of our operating performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities class action litigation has often been brought against public companies that experience periods of volatility in the market prices of their securities. Securities class action litigation could result in substantial costs and a diversion of our management&#8217;s attention and resources.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The issuance of shares by us in the future or sales of shares by our stockholders may cause the market price of our common stock to drop significantly, even if our business is performing well.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This issuance of shares by us in the future, including by conversion of our senior convertible notes in certain circumstances, the issuance of shares of our common stock to partners, including up to 5,154,640 shares of our common stock that we may issue to Verily pursuant to the Restated Collaboration Agreement, or sales of shares by our stockholders may cause the market price of our common stock to decline, perhaps significantly, even if our business is performing well. The market price of our common stock could also decline if there is a perception that sales of our shares are likely to occur in the future. This might also make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate. Also, we may issue securities in connection with future financings and acquisitions, and those shares could dilute the holdings of other stockholders.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not intend to pay dividends for the foreseeable future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid cash dividends on our capital stock. We currently intend to retain any future earnings to finance the operation and expansion of our business, and we do not expect to declare or pay any dividends in the foreseeable future and the terms of our credit agreement restrict our ability to declare or pay any dividends. As a result, stockholders (including holders of our senior convertible notes who receive shares of our common stock, if any, upon conversion of their notes) may only receive a return on their investment in our common stock if the market price of our common stock increases.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover effects of our charter documents and Delaware law could make a merger, tender offer or proxy contest difficult, thereby depressing the trading price of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are provisions in our certificate of incorporation and bylaws, as well as provisions in the Delaware General Corporation Law, that may discourage, delay or prevent a change of control that might otherwise be beneficial to stockholders. For example:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our Board of Directors may, without stockholder approval, issue shares of preferred stock with special voting or economic rights;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our stockholders do not have cumulative voting rights and, therefore, each of our directors can only be elected by holders of a majority of our outstanding common stock;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">a special meeting of stockholders may only be called by a majority of our Board of Directors, the Chairman of our Board of Directors, our Chief Executive Officer, our President or our Lead Independent Director;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our stockholders may not take action by written consent;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our Board of Directors is divided into three classes, only one of which is elected each year (however, over a three year period beginning with the 2022 annual meeting of stockholders the Board will be declassified and by the conclusion of this process all directors will be elected annually; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we require advance notice for nominations for election to the Board of Directors or for proposing matters that can be acted upon by stockholders at stockholder meetings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all claims brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. In September 2020, we amended and restated our restated bylaws to provide that the federal district courts of the United States will, to the fullest extent permitted by law, be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act, or a Federal Forum Provision. Our decision to adopt a Federal Forum Provision followed a decision by the Supreme Court of the State of Delaware holding that such provisions are facially valid under Delaware law. While there can be no assurance that federal or state courts will follow the holding of the Delaware Supreme Court or determine that the Federal Forum Provision should be enforced in a particular case, application of the Federal Forum Provision means that suits brought by our stockholders to enforce any duty or liability created by the Securities Act must be brought in federal court and cannot be brought in state court. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all claims brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. Neither the exclusive forum provision nor the Federal Forum Provision applies to suits brought to enforce any duty or liability created by the Exchange Act. Accordingly, actions by our stockholders to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder must be brought in federal court.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, our stockholders will not be deemed to have waived our compliance with the federal securities laws and the regulations promulgated thereunder.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any person or entity purchasing or otherwise acquiring or holding any interest in any of our securities shall be deemed to have notice of and consented to our exclusive forum provisions, including the Federal Forum Provision. The exclusive forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, or other employees, which may discourage lawsuits with respect to such claims. Alternatively, if a court were to find the choice of forum provisions contained in our restated certificate of incorporation or amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, operating results, and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, Section 203 of the Delaware General Corporation Law may discourage, delay, or prevent a change of control of our company. Section 203 imposes certain restrictions on mergers, business combinations, and other transactions between us and holders of 15% or more of our common stock.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_244"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Our Debt</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increasing our financial leverage could affect our operations and profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, we entered into the First Amendment to our Second Amended and Restated Credit Agreement, or the Amended Credit Agreement, with JPMorgan Chase and other syndicate lenders, which amended and restated the credit agreement, or the Credit Agreement, we had previously entered into in December 2018 and amended in May 2020 and October 2021, respectively. The Amended Credit Agreement is a five-year $200.0 million </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revolving credit facility, or the Credit Facility. As of June&#160;30, 2023, we had no outstanding borrowings, $7.3 million in outstanding letters of credit, and a total available balance of $192.7 million under the Amended Credit Agreement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leverage ratio may affect the availability to us of additional capital resources as well as our operations in several ways, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the terms on which credit may be available to us could be less attractive, both in the economic terms of the credit and the legal covenants;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the possible lack of availability of additional credit;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the potential for higher levels of interest expense to service or maintain our outstanding debt;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the possibility of additional borrowings in the future to repay our indebtedness when it comes due; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the possible diversion of capital resources from other uses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe we will have the ability to service our debt and obtain additional resources in the future if and when needed, that will depend upon our results of operations and financial position at the time, the then-current state of the credit and financial markets, and other factors that may be beyond our control. Therefore, we cannot give assurances that sufficient credit will be available on terms that we consider attractive, or at all, if and when necessary or beneficial to us.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with covenants in the Amended Credit Agreement could result in our inability to borrow additional funds and adversely impact our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement imposes numerous financial and other restrictive covenants on our operations, including covenants relating to our general profitability and our liquidity. As of June&#160;30, 2023, we were in compliance with the covenants imposed by the Amended Credit Agreement. If we violate these or any other covenants, any outstanding amounts under the Amended Credit Agreement could become due and payable prior to their stated maturity dates, each lender could proceed against any collateral in our operating accounts and our ability to borrow funds in the future may be restricted or eliminated. These restrictions may also limit our ability to borrow additional funds and pursue other business opportunities or strategies that we would otherwise consider to be in our best interests.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have indebtedness in the form of convertible senior notes, which could adversely affect our financial health and our ability to respond to changes in our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we completed an offering of $850.0 million aggregate principal amount of 0.75% senior convertible notes due 2023, or 2023 Notes, which offering we refer to as the 2018 Notes Offering. In May 2020, we completed an offering of approximately $1.21 billion aggregate principal amount of 0.25% senior convertible notes due 2025, or 2025 Notes, which offering we refer to as the 2020 Notes Offering. In May 2023, we completed an offering of approximately $1.25&#160;billion aggregate principal amount of 0.375% senior convertible notes due 2028, or 2028 Notes, which offering we refer to as the 2023 Notes Offering. We refer to the 2018 Notes Offering, the 2020 Notes Offering, and the 2023 Notes Offering, collectively, as the Notes Offerings, and we refer to the 2023 Notes, the 2025 Notes, and the 2028 Notes, collectively, as the Notes. As a result of the Notes Offerings, we incurred $3.31 billion principal amount of indebtedness, the principal amount of which we may be required to pay at maturity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require us to repurchase their notes upon the occurrence of a fundamental change (as defined in the indenture for each of the Notes) at a purchase price equal to 100% of the principal amount of the notes to be purchased, plus accrued and unpaid interest, if any. In addition, each indenture for the Notes provides that we are required to repay amounts due under each indenture in the event that there is an event of default for the Notes that results in the principal, premium, if any, and interest, if any, becoming due prior to the maturity date for the Notes. There can be no assurance that we will be able to repay this indebtedness when due, or that we will be able to refinance this indebtedness on acceptable terms or at all.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our level of increased debt after the completion of the Notes Offerings:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our vulnerability to adverse general economic conditions and competitive pressures will be heightened;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we will be required to dedicate a larger portion of our cash flow from operations to interest payments, limiting the availability of cash for other purposes;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our flexibility in planning for, or reacting to, changes in our business and industry may be more limited; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions, general corporate purposes or other purposes may be impaired.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot be sure that our leverage resulting from the level of increased debt after the completion of the Notes Offerings will not materially and adversely affect our ability to finance our operations or capital needs or to engage in other business activities. In addition, we cannot be sure that additional financing will be available when required or, if available, will be on terms satisfactory to us. Further, even if we are able to obtain additional financing, we may be required to use such proceeds to repay a portion of our debt.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to repurchase the Notes upon a fundamental change when required by the holders or repay prior to maturity any accelerated amounts due under the notes upon an event of default or redeem the Notes unless specified conditions are met under our Credit Facility, and our future debt may contain additional limitations on our ability to pay cash upon conversion, repurchase or repayment of the Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require us to repurchase their Notes upon the occurrence of a fundamental change at a purchase price equal to 100% of the principal amount of the Notes to be purchased, plus accrued and unpaid interest, if any, to, but not including, the fundamental change purchase date. In addition, each indenture for the Notes provides that we are required to repay amounts due under each indenture in the event that there is an event of default for the Notes that results in the principal, premium, if any, and interest, if any, becoming due prior to the maturity date for the Notes. In addition, upon conversion of the Notes, unless we elect to deliver solely shares of our common stock to settle such conversion (other than cash in lieu of any fractional share), we will be required to make cash payments in respect of the Notes being converted. However, we may not have enough available cash or be able to obtain financing at the time we are required to repurchase Notes surrendered upon a fundamental change or repay prior to maturity any accelerated amounts or pay cash for Notes being converted.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our ability to purchase the Notes or repay prior to maturity any accelerated amounts under the Notes upon an event of default or pay cash upon conversions of the Notes may be limited by law, by regulatory authority or by agreements governing our indebtedness outstanding at the time, including our Credit Facility. Under our Credit Facility, we are only permitted to use cash to purchase the Notes or repay prior to maturity any accelerated amounts under the Notes if we meet certain conditions that are defined under the Credit Agreement. We may not meet these conditions in the future. Our failure to repurchase Notes at a time when the repurchase is required by the respective indenture (whether upon a fundamental change or otherwise under each indenture) or pay cash payable on future conversions of the Notes as required by the indenture would constitute a default under each indenture. A default under each indenture or the fundamental change itself could also lead to a default under agreements governing our existing or future indebtedness, including our Credit Facility. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness, repurchase the Notes or make cash payments upon conversions thereof.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may still incur substantially more debt or take other actions which would intensify the risks discussed above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may incur substantial additional debt in the future, subject to the restrictions contained in our debt instruments, some of which may be secured debt. We are not restricted under the terms of the indentures governing the Notes from incurring additional debt, securing existing or future debt, recapitalizing our debt, or taking a number of other actions that are not limited by the terms of the indenture governing the convertible senior notes that could have the effect of diminishing our ability to make payments on the Notes when due.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The capped call transactions we entered into in connection with the pricing of the 2028 Notes may affect the value of our 2028 Notes and common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the pricing of the 2028 Notes, we entered into capped call transactions, or the 2028 Capped Calls, relating to such 2028 Notes with the option counterparties. The 2028 Capped Calls relating to the 2028 Notes cover, subject to customary adjustments, the number of shares of our common stock that initially underlie the 2028 Notes. The 2028 Capped Calls are generally expected to reduce the potential dilution to stockholders upon any conversion of the 2028 Notes, and/or offset any cash payments that we are required to make in excess of the principal amount upon any conversion of the 2028 Notes, with such reduction and/or offset subject to a cap.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock in secondary market transactions following the pricing of the 2028 Notes, as applicable, and prior to the maturity of the 2028 Notes (and are likely to do so during any observation period related to a conversion of such Notes or following any repurchase of such notes by us on any fundamental change repurchase date or otherwise). This activity could also cause or avoid an increase or a decrease in the market price of our 2028 Notes or common stock, which could affect a holder&#8217;s ability to convert its 2028 Notes and, to the extent the activity occurs during any observation period related to a conversion of the 2028 Notes, it could affect the amount and value of the consideration that a holder will receive upon conversion of such 2028 Notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potential effect, if any, of these transactions and activities on the market price of the 2028 Notes or our common stock will depend in part on market conditions and cannot be ascertained at this time. Any of these activities could adversely affect the value of 2028 Notes or our common stock (and as a result, the amount and value of the consideration that a holder would receive upon the conversion of any 2028 Notes) and, under certain circumstances, a holder&#8217;s ability to convert its notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not make any representation or prediction as to the direction or magnitude of any potential effect that the transactions described above may have on the price of the 2028 Notes or our common stock. In addition, we do not make any representation that the option counterparties or their respective affiliates will engage in these transactions or that these transactions, once commenced, will not be discontinued without notice.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The convertible note hedge and warrant transactions may affect the value of the 2023 Notes and our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the 2023 Notes, we entered into convertible note hedge, or the 2023 Note Hedge, transactions with certain financial institutions, or option counterparties. We also entered into warrant transactions with the option counterparties pursuant to which we sold warrants for the purchase of our common stock, or the 2023 Warrants. The 2023 Note Hedge transactions are expected generally to reduce the potential dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes. The 2023 Warrant transactions could separately have a dilutive effect to the extent that the market price per share of our common stock exceeds the exercise price of the 2023 Warrants, which is $49.60.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The option counterparties and/or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock in secondary market transactions prior to the maturity of 2023 Notes (and are likely to do so during any observation period related to a conversion of 2023 Notes, or following any repurchase of Notes by us on any fundamental change repurchase date (as defined in the indenture for the 2023 Notes) or otherwise). This activity could also cause or avoid an increase or a decrease in the market price of our common stock or the 2023 Notes, which could affect note holders&#8217; ability to convert the 2023 Notes and, to the extent the activity occurs during any observation period related to a conversion of the 2023 Notes, it could affect the amount and value of the consideration that note holders will receive upon conversion of the 2023 Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potential effect, if any, of these transactions and activities on the market price of our common stock or the 2023 Notes will depend in part on market conditions and cannot be ascertained at this time. Any of these activities could adversely affect the value of our common stock and the value of the 2023 Notes (and as a result, the value of the consideration, the amount of cash and/or the number of shares, if any, that note holders would receive upon the conversion of the 2023 Notes) and, under certain circumstances, the ability of the note holders to convert the 2023 Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not make any representation or prediction as to the direction or magnitude of any potential effect that the transactions described above may have on the price of the 2023 Notes or our common stock. In addition, we do not make any representation that the option counterparties will engage in these transactions or that these transactions, once commenced, will not be discontinued without notice.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to counterparty risk with respect to the 2023 Note Hedge transactions and the 2028 Capped Calls.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The option counterparties to the 2023 Note Hedge transactions and 2028 Capped Calls are financial institutions, and we will be subject to the risk that any or all of them may default under the 2023 Note Hedge transactions and 2028 Capped Calls, respectively. Our exposure to the credit risk of these counterparties is not secured by any collateral. Recent global economic conditions have resulted in the actual or perceived failure or financial difficulties of many financial institutions. If a counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings, with a claim equal to our exposure at that time under our transactions with that option counterparty. Our exposure will depend on many factors but, generally, an increase in our exposure will be correlated to an increase in the market price and in the volatility of our common stock. In addition, upon a default by an option counterparty, we may suffer adverse tax consequences and more dilution than we currently anticipate with respect to our common stock. We can provide no assurances as to the financial stability or viability of the counterparties with respect to the 2023 Note Hedge transactions and 2028 Capped Calls.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Servicing our debt requires a significant amount of cash, and we may not have sufficient cash flow from our business to pay our substantial debt.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to make scheduled payments of the principal of, to pay interest on or to refinance our indebtedness, including the Notes, depends on our future financial condition and operating performance, which is subject to economic, financial, competitive and other factors beyond our control. Our business may not continue to generate cash flow from operations in the future sufficient to satisfy our obligations under the Notes, our existing indebtedness and any future indebtedness we may incur and to make necessary capital expenditures. We may not maintain a level of cash flows from operating activities sufficient to permit us to pay the principal, premium, if any, and interest on (as well as any cash due upon conversion of) our debt, including the Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to generate such cash flow, we may be required to adopt one or more alternatives, such as reducing or delaying investments or capital expenditures, selling assets, refinancing or obtaining additional equity capital on terms that may be onerous or highly dilutive. These alternative measures may not be successful and may not permit us to meet our scheduled debt servicing obligations. Further, we may need to refinance all or a portion of our debt on or before maturity, and our ability to refinance the Notes, existing indebtedness or future indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities on commercially reasonable terms or at all, which could result in a default on the Notes or our current and future indebtedness.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Credit Facility imposes restrictions on us that may adversely affect our ability to operate our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Credit Facility contains restrictive covenants relating to our capital raising activities and other financial and operational matters which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. In addition, our Credit Facility and the agreements governing the notes each contain cross-default provisions whereby a default under one agreement would likely result in cross defaults under agreements covering other borrowings. For example, the occurrence of a default with respect to any indebtedness or any failure to repay debt when due in an amount in excess of $25.0 million, in the case of the 2023 Notes, $50.0 million, in the case of the 2025 Notes, and $50.0 million, in the case of the 2028 Notes, that causes such indebtedness to become due prior to its scheduled maturity date would cause a cross-default under the indenture governing the Notes. In addition, the occurrence of a default with respect to any indebtedness or any failure to repay debt when due in an amount in excess of $25.0 million that causes such indebtedness to become due prior to its scheduled maturity date would cause a default under our Credit Facility. The occurrence of a default under any of these borrowing arrangements would permit the holders of the Notes or the lenders under our Credit Facility to declare all amounts outstanding under those borrowing arrangements to be immediately due and payable. If the Note holders or the trustee under the indenture governing the Notes or the lenders under our Credit Facility accelerate the repayment of borrowings, we cannot assure you that we will have sufficient assets to repay those borrowings.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion of the Notes will, to the extent we deliver shares upon conversion of such Notes, dilute the ownership interest of existing stockholders, including holders who had previously converted their Notes, or may otherwise depress our stock price.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion of some or all of the Notes will dilute the ownership interests of existing stockholders to the extent we deliver shares upon conversion of any of the Notes. Any sales in the public market of the common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of the Notes may encourage short selling by market participants because the conversion of the Notes could be used to satisfy short positions, or anticipated conversion of the Notes into shares of our common stock could depress our stock price.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The conditional conversion feature of the Notes, if triggered, may adversely affect our financial condition and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event the conditional conversion feature of the Notes is triggered, holders of the Notes will be entitled to convert the Notes at any time during specified periods at their option. If one or more holders elect to convert their Notes, unless we elect to satisfy our conversion obligation by delivering solely shares of our common stock (other than cash in lieu of any fractional share), we would be required to settle a portion or all of our conversion obligation through the payment of cash, which could adversely affect our liquidity. In addition, even if holders of the Notes do not elect to convert their Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The accounting method for convertible debt securities that may be settled in cash, such as the Notes, may have a material effect on our reported financial results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the conditional conversion feature of the Notes is triggered, holders of the Notes will be entitled to convert the Notes at any time during specified periods at their option. If one or more holders elect to convert their Notes, unless we elect to satisfy our conversion obligation by delivering solely shares of our common stock (other than by paying cash in lieu of delivering any fractional share), we may settle all or a portion of our conversion obligation in cash, which could adversely affect our liquidity. In addition, the consideration received upon the unwind or termination of the capped call transactions may not completely offset, and may be substantially less than, any cash payments in excess of the principal amount of the Notes we are required to make upon conversion of the Notes. Even if holders do not elect to convert their Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The fundamental change repurchase feature of the Notes may delay or prevent an otherwise beneficial attempt to take over Dexcom.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the Notes require us to repurchase the Notes in the event of a fundamental change. A takeover of Dexcom would trigger an option of the holders of the Notes to require us to repurchase the Notes. In addition, if a make-whole fundamental change occurs prior to the maturity date of the Notes, we will in some cases be required to increase the conversion rate for a holder that elects to convert its Notes in connection with such make-whole fundamental change. Furthermore, each indenture for the Notes prohibits us from engaging in certain mergers or acquisitions unless, among other things, the surviving entity assumes our obligations under the notes. These and other provisions of each indenture may have the effect of delaying or preventing a takeover of Dexcom.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_247"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Environmental, Social and Governance Matters</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental, social and governance, or ESG, regulations, policies and provisions could expose us to numerous risks.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increasingly, regulators, customers, investors, employees and other stakeholders are focusing on ESG matters and related disclosures. These changing rules, regulations and stakeholder expectations have resulted in, and are likely to continue to result in, increased general and administrative expenses and increased management time and attention spent complying with or meeting such regulations and expectations. For example, collecting, measuring and reporting ESG-related data and information is subject to evolving reporting standards, including the SEC&#8217;s proposed climate-related reporting requirements, and similar proposals by other international regulatory bodies. In addition, a number of our customers who are payors or distributors have adopted, or may adopt, procurement policies that include ESG provisions that their suppliers or manufacturers must comply with, or they may seek to include such provisions in their terms and conditions. An increasing number of participants in the medical device industry are also joining voluntary ESG groups or organizations, such as the Responsible Business Alliance. These ESG provisions and initiatives are subject to change, can be unpredictable, and may be difficult and expensive for us to comply with, given the complexity of our supply chain and the outsourced manufacturing of certain components of our products. If we are unable to comply, or are unable to cause our suppliers to comply, with such policies or provisions, a customer may stop purchasing products from us, and may take legal action against us, which could harm our reputation, revenue and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be negatively impacted by evolving expectations and challenges relating to implementing ESG initiatives, setting ESG-related goals, collecting ESG-related data, and disclosing ESG-related information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may communicate certain initiatives and goals regarding ESG-related matters in our SEC filings or in other public disclosures. These ESG-related initiatives and goals could be difficult and expensive to implement, the technologies needed to implement them may not be cost effective and may not advance at a sufficient pace, and we could be criticized for the accuracy, adequacy or completeness of the disclosure. Further, statements about our ESG-related initiatives and goals, and progress against those goals, may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. In addition, we could be criticized for the scope or nature of such initiatives or goals, or for any revisions to these goals. If our ESG-related data, processes and reporting are incomplete or inaccurate, or if we fail to achieve progress with respect to our ESG-related goals on a timely basis, or at all, our reputation, business, financial performance and growth could be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Climate change may have a long-term impact on our business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we seek to partner with organizations that mitigate their business risks associated with climate change, we recognize that there are inherent risks related to climate change wherever business is conducted. Access to clean water and reliable energy in the communities where we conduct our business, whether for our offices or for our vendors, is a priority. Our manufacturing sites in California, Arizona and Malaysia and our operations in the Philippines are vulnerable to climate change effects. For example, in California and Arizona, increasing intensity of droughts throughout the states and annual periods of wildfire danger increase the probability of planned and unplanned power outages in the communities where we work and live. While this danger has a low-assessed risk of disrupting normal business operations, it has the potential impact on employees&#8217; abilities to commute to work or to work from home and stay connected effectively. Climate-related events, including the increasing frequency of extreme weather events and their impact on the U.S., the Philippines, Malaysia and other major regions&#8217; critical infrastructure, have the potential to disrupt our business, our third-party suppliers, and/or the business of our customers, and may cause us to experience higher attrition, losses, and additional costs to maintain or resume operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be liable for contamination or other harm caused by materials that we handle, and changes in environmental regulations could cause us to incur additional expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development and clinical processes involve the handling of potentially harmful biological materials as well as hazardous materials. We are subject to international and domestic (including federal, state and local) laws, rules and regulations governing the use, handling, storage and disposal of hazardous and biological materials and we incur expenses relating to compliance with these laws and regulations. If violations of environmental, health and safety laws occur, we could be held liable for damages, penalties and costs of remedial actions. These expenses or this liability could have a significant negative impact on our financial condition. We may violate environmental, health and safety laws in the future as a result of human error, equipment failure or other causes. Environmental laws could become more stringent over time, imposing greater compliance costs and increasing risks and penalties associated with violations. We are subject to potentially conflicting and changing regulatory agendas of political, business and environmental groups. Changes to or restrictions on permitting requirements or processes, hazardous or biological material storage or handling might require unplanned capital investment or relocation. Failure to comply with new or existing laws or regulations could harm our business, financial condition and results of operations.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_250"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:115%">General Risk Factors</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current uncertainty in domestic and global economic and political conditions makes it particularly difficult to predict product demand and other related matters and makes it more likely that our actual results could differ materially from expectations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and performance depend on worldwide economic and political conditions. These conditions have been adversely impacted by continued global economic uncertainty, political instability and military hostilities in multiple geographies (including the conflict between Ukraine and Russia), monetary and financial uncertainties in Europe and other foreign countries, global health pandemics, rising interest rates, and domestic and global inflationary trends. These include potential reductions in the overall stability and suitability of the Euro as a single currency, given the economic and political challenges facing individual Eurozone countries. These conditions have made and may continue to make it difficult for our customers and potential customers to afford our products, and could cause our customers to stop using our products or to use them less frequently. If that were to occur, our revenue may decrease and our performance may be negatively impacted. In addition, the pressure on consumers to absorb more of their own health care costs has resulted in some cases in higher deductibles and limits on durable medical equipment, which may cause seasonality in purchasing patterns. Furthermore, during economic uncertainty, our customers have had job losses and may continue to have issues gaining timely access to sufficient health insurance or credit, which could result in their unwillingness to purchase products or impair their ability to make timely payments to us. A recession, depression or other sustained adverse market event could materially and adversely affect our business and the value of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the reoccurrence of any economic slowdown or the strength or sustainability of the economic recovery, worldwide, in the United States, or in our industry. These and other economic factors could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely affected by the effects of inflation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inflation has the potential to adversely affect our liquidity, business, financial condition and results of operations by increasing our overall cost structure. The existence of inflation in the economy has resulted in, and may continue to result in, higher interest rates and capital costs, supply shortages, increased costs of labor, components, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufacturing and shipping, as well as weakening exchange rates and other similar effects. As a result of inflation, we have experienced and may continue to experience cost increases. Although we may take measures to mitigate the effects of inflation, if these measures are not effective, our business, financial condition, results of operations and liquidity could be materially adversely affected. Even if such measures are effective, there could be a difference between the timing of when these beneficial actions impact our results of operations and when the cost of inflation is incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully maintain effective internal control over financial reporting, investors may lose confidence in our reported financial information and our stock price and our business may be adversely impacted.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we are required to maintain internal control over financial reporting and our management is required to evaluate the effectiveness of our internal control over financial reporting as of the end of each fiscal year. If we are not successful in maintaining effective internal control over financial reporting, there could be inaccuracies or omissions in the consolidated financial information we are required to file with the SEC. Additionally, even if there are no inaccuracies or omissions, we will be required to publicly disclose the conclusion of our management that our internal control over financial reporting or disclosure controls and procedures are not effective. These events could cause investors to lose confidence in our reported financial information, adversely impact our stock price, result in increased costs to remediate any deficiencies, attract regulatory scrutiny or lawsuits that could be costly to resolve and distract management&#8217;s attention, limit our ability to access the capital markets or cause our stock to be delisted from The Nasdaq Stock Market or any other securities exchange on which it is then listed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in financial accounting standards or practices or existing taxation rules or practices may cause adverse unexpected revenue and/or expense fluctuations and affect our reported results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A change in accounting standards or practices or a change in existing taxation rules or practices can have a significant effect on our reported results and may even affect our reporting of transactions completed before the change is effective. New accounting pronouncements and taxation rules and varying interpretations of accounting pronouncements and taxation practice have occurred and may occur in the future. The method in which we market and sell our products may have an impact on the manner in which we recognize revenue. In addition, changes to existing rules or the questioning of current practices may adversely affect our reported financial results or the way we conduct our business. Additionally, changes to existing accounting rules or standards, such as the potential requirement that U.S. registrants prepare financial statements in accordance with International Financial Reporting Standards, may adversely impact our reported financial results and business, and may further require us to incur greater accounting fees.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our financial performance fails to meet the expectations of investors and public market analysts, the market price of our common stock could decline.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues and operating results may fluctuate significantly from quarter to quarter. We believe that period-to-period comparisons of our operating results may not be meaningful and should not be relied on as an indication of our future performance. If quarterly revenues or operating results fall below the expectations of investors or public market analysts, the trading price of our common stock could decline substantially. Factors that might cause quarterly fluctuations in our operating results include:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our inability to manufacture an adequate supply of product at appropriate quality levels and acceptable costs;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">possible delays in our research and development programs or in the completion of any clinical trials;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">a lack of acceptance of our products in the marketplace by physicians and people with diabetes;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the inability of customers to receive reimbursements from third-party payors;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the purchasing patterns of our customers, including as a result of seasonality;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failures to comply with regulatory requirements, which could lead to withdrawal of products from the market;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our failure to continue the commercialization of any of our CGM systems;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">competition;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">inadequate financial and other resources; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">global political and economic conditions, political instability and military hostilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_253"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 2 - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchases of Equity Securities by the Issuer</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2022, we announced that a duly authorized committee of our Board of Directors authorized and approved a share repurchase program of up to $700.0 million of our outstanding common stock, with a repurchase period ending no later than June 30, 2023 (the &#8220;Share Repurchase Program&#8221;). The Share Repurchase Program and the remaining authorization of approximately $142.3&#160;million expired on June 30, 2023. There were no share repurchases under the Share Repurchase Program for the three months ended June 30, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about purchases by the Company of its shares of common stock during the three months ended June&#160;30, 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price paid per share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares purchased as part of publicly announced program</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum dollar value of shares that may yet to be purchased under the program</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">(in millions)</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2023 - 4/30/2023</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2023 - 5/31/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/1/2023 - 6/30/2023</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-9.36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In May 2023, we used a portion of the proceeds of the 2028 Notes to repurchase 1.6 million shares of our common stock for $188.7 million for an average per share price of $118.12, via privately negotiated transactions, independent of the Share Repurchase Program. See Note 5, &#8220;Debt&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report for information about the 2028 Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8, &#8220;Stockholders&#8217; Equity&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report for information about the Share Repurchase Program.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_259"></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 3 - DEFAULTS UPON SENIOR SECURITIES</span></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_262"></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 4 - MINE SAFETY DISCLOSURES</span></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ice0ef719e77e40b5a387f5daee547017_265"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 5 - OTHER INFORMATION</span></td></tr></table></div><ix:nonNumeric contextRef="c-1" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-899" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trading Plans</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023, none of our directors or officers informed us of the <ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-900">adoption</ix:nonNumeric> or <ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-901">termination</ix:nonNumeric> of a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;non-Rule 10b5-1 trading arrangement,&#8221; as those terms are defined in Regulation S-K, Item 408, except as described in the table below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Character of Trading Arrangement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adoption Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rule 10b5-1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Rule 10b5-1**</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Shares to be Sold</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expiration Date</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-233" name="ecd:TrdArrIndName" id="f-902">Donald M. Abbey</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-233" name="ecd:TrdArrIndTitle" id="f-903">Executive Vice President, Global Business Services, IT Quality and Regulatory Affairs</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-233" name="ecd:TrdArrAdoptionDate" id="f-904">5/5/2023</ix:nonNumeric></span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-234" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" id="f-905">3,258</ix:nonFraction></span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-233" name="ecd:TrdArrTerminationDate" id="f-906">5/6/2024</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-235" name="ecd:TrdArrIndName" id="f-907">Steven R. Altman</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-235" name="ecd:TrdArrIndTitle" id="f-908">Director</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-235" name="ecd:TrdArrAdoptionDate" id="f-909">5/30/2023</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-236" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" id="f-910">9,568</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-235" name="ecd:TrdArrTerminationDate" id="f-911">5/30/2025</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-237" name="ecd:TrdArrIndName" id="f-912">Bridgette P. Heller</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-237" name="ecd:TrdArrIndTitle" id="f-913">Director</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-237" name="ecd:TrdArrAdoptionDate" id="f-914">6/13/2023</ix:nonNumeric></span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-238" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" id="f-915">600</ix:nonFraction></span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-237" name="ecd:TrdArrTerminationDate" id="f-916">6/13/2024</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">* Intended to satisfy the affirmative defense of Rule 10b5-1(c)</span></div></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">** Not intended to satisfy the affirmative defense of Rule 10b5-1(c)</span></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Except as indicated by footnote, each trading arrangement permitted or permits transactions through and including the earlier to occur of (a) the completion of all purchases or sales or (b) the date listed in the table.</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each new Rule 10b5-1 Plan that was adopted in the above table includes a representation from Ms. Heller, and Messrs. Abbey and Altman respectively, to the broker administering the plan that he or she was not in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">possession of any material nonpublic information regarding Dexcom or the securities subject to the Rule 10b5-1 Plan at the time the Rule 10b5-1 Plan was entered into. A similar representation was made to Dexcom in connection with the adoption of the Rule 10b5-1 Plan under Dexcom&#8217;s insider trading policy. Those representations were made as of the Adoption Date set forth above, and speak only as of that date. In making those representations, there is no assurance with respect to any material nonpublic information of which the directors and officers was unaware, or with respect to any material nonpublic information acquired by the above directors and officers or Dexcom after the date of the representation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once executed, transactions under a Rule 10b5-1 Plan adopted during the period described above will be disclosed publicly through Form 4 and/or Form 144 filings with the SEC in accordance with applicable securities laws, rules, and regulations. Except as may be required by law, Dexcom does not undertake any obligation to update or report any modification, termination, or other activity under current or future Rule 10b5-1 plans that may be adopted by Ms. Heller, Messrs. Abbey and Altman, respectively, or other officers or directors of Dexcom.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_268"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="-sec-extract:exhibit;color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="-sec-extract:exhibit;color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 6 - EXHIBITS</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date&#160;of<br/>First<br/>Filing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provided<br/>Herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312522171920/d368741dex31.htm">3.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312522171920/d368741dex31.htm">Restated Certificate of Incorporation of DexCom, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 10, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312523137248/d300995dex41.htm">4.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312523137248/d300995dex41.htm">Indenture dated May 5, 2023 between DexCom, Inc. and U.S. Bank Trust Company, National Association (including the form of 0.375% Convertible Senior Notes due 2028).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 5, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312523149463/d446905dex101.htm">10.01</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312523149463/d446905dex101.htm">DexCom, Inc. Amended and Restated Severance and Change in Control Plan effective June 1, 2017, and as amended on May 18, 2023.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-51222</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 19, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1002-edgepark.htm">10.02*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1002-edgepark.htm">Amendment Number </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1002-edgepark.htm">Eleven </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1002-edgepark.htm">to</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1002-edgepark.htm"> Non-Exclusive Distribution Agreement, dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1002-edgepark.htm">March 15</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1002-edgepark.htm">, 2023, by and between DexCom, Inc. and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1002-edgepark.htm">RGH E</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1002-edgepark.htm">nterprises</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1002-edgepark.htm">,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1002-edgepark.htm"> LLC</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1002-edgepark.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1003-byramhea.htm">10.0</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1003-byramhea.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1003-byramhea.htm">*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1003-byramhea.htm">Amendment Number Fourteen to Amended and Restated Non-Exclusive Distribution Agreement, dated April 1, 2023, by and between DexCom, Inc. and Byram Healthcare.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1004-edgepark.htm">10.0</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1004-edgepark.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1004-edgepark.htm">*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1004-edgepark.htm">Amendment Number </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1004-edgepark.htm">Twelve</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1004-edgepark.htm"> to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1004-edgepark.htm">Non-Exclusive Distribution Agreement, dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1004-edgepark.htm">May 15</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1004-edgepark.htm">, 2023, by and between DexCom, Inc. and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1004-edgepark.htm">RGH Enterprises, LLC</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1004-edgepark.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1005-byramhea.htm">10.0</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1005-byramhea.htm">5</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1005-byramhea.htm">*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1005-byramhea.htm">Amendment Number </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1005-byramhea.htm">Thirteen</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1005-byramhea.htm"> to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1005-byramhea.htm">Amended and Restated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1005-byramhea.htm">Non-Exclusive Distribution Agreement, dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1005-byramhea.htm">June</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1005-byramhea.htm"> 1, 2023, by and between DexCom, Inc. and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1005-byramhea.htm">Byram Healthcare.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1006-firstame.htm">10.0</a>6</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1006-firstame.htm">First Amendment to Second Amended and Restated Credit Agreement, dated June 1, 2023 by and between DexCom, Inc. and JPMorgan Chase Bank National Association</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1007-byramhea.htm">10.0</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1007-byramhea.htm">7</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1007-byramhea.htm">*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1007-byramhea.htm">Amendment Number </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1007-byramhea.htm">Fif</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1007-byramhea.htm">teen</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1007-byramhea.htm"> to Amended and Restated Non-Exclusive Distribution Agreement, dated June 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1007-byramhea.htm">5</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023ex1007-byramhea.htm">, 2023, by and between DexCom, Inc. and Byram Healthcare.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="-sec-extract:exhibit;color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="-sec-extract:exhibit;color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date&#160;of<br/>First<br/>Filing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provided<br/>Herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023exhibit3101.htm">31.01</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm6302023exhibit3101.htm">Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a).</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023exhibit3102.htm">31.02</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm6302023exhibit3102.htm">Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a).</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023exhibit3201.htm">32.01**</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm6302023exhibit3201.htm">Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm6302023exhibit3202.htm">32.02**</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm6302023exhibit3202.htm">Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File - the cover page from the Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2023 is formatted in Inline XBRL</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.866%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">This certification is not deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that Dexcom specifically incorporates it by reference.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><div id="ice0ef719e77e40b5a387f5daee547017_271"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ice0ef719e77e40b5a387f5daee547017_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SIGNATURES</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.810%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.734%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.504%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DEXCOM, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 27, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ KEVIN R. SAYER</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Kevin R. Sayer,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Chairman of the Board of Directors,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">President and Chief Executive Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Principal Executive Officer)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 27, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ JEREME M. SYLVAIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Jereme M. Sylvain,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Principal Financial and Accounting Officer)</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.02
<SEQUENCE>2
<FILENAME>dxcm6302023ex1002-edgepark.htm
<DESCRIPTION>EX-10.02
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie0716a0e2fbc46bfa9fbde62f871fbb3_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 10.02</font></div><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY &#91;******&#93;, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.</font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">AMENDMENT NUMBER ELEVEN</font></div><div style="text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">TO THE NON-EXCLUSIVE DISTRIBUTION AGREEMENT</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This AMENDMENT NUMBER ELEVEN TO THE NON-EXCLUSIVE DISTRIBUTION AGREEMENT (&#8220;</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is made effective as of March 15, 2023 (&#8220;</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment Effective Date</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) by and between DexCom, Inc. (&#8220;</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DexCom</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">RGH Enterprises, LLC dba Edgepark Medical Supplies</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#8220;Distributor</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Capitalized terms used herein but not defined shall have the meaning ascribed to them in the Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RECITALS</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, DexCom and Distributor previously entered into that certain Non-Exclusive Distribution Agreement entered into by the Parties as of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">April 30, 2008 </font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(as the same has been and may be amended from time to time, the &#8220;Agreement&#8221;)&#59; </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, DexCom and Distributor desire to further amend the Agreement, as more fully described herein.</font></div><div style="text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW THEREFORE, DexCom and Distributor agree as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">Schedule 9, Market Share Report.</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 9</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, including </font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 9-A</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, which is attached hereto, is hereby added to the Agreement.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">No Further Modification</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except to the extent set forth in this Amendment, all other terms and conditions of the Agreement shall remain unmodified and in full force and effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Remainder of Page Intentionally Blank&#59; <br>Signature Page Follows</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="padding-left:18pt;text-align:justify"><font style="color:#2c2c2c;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF, </font><font style="color:#2c2c2c;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the parties have executed this Amendment effective as of the Amendment Effective Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;padding-left:18pt"><font><br></font></div><div style="margin-bottom:0.08pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.428%"><tr><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">DexCom, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Distributor</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Christophe Cantenot</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Gordon Harris</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Christophe Cantenot</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gordon Harris</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VP, Finance and Corporate Controller</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Senior Director, Strategic Sourcing</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">4&#47;4&#47;2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">3&#47;23&#47;2023</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="ie0716a0e2fbc46bfa9fbde62f871fbb3_31"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">SCHEDULE 9</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">DexCom Market Share Report</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#91;******&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="ie0716a0e2fbc46bfa9fbde62f871fbb3_44"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">SCHEDULE 9-A</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">DexCom Market Share Report Format</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#91;******&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.03
<SEQUENCE>3
<FILENAME>dxcm6302023ex1003-byramhea.htm
<DESCRIPTION>EX-10.03
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i552897f539c54d598fb55a1aa72e5fad_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 10.03</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY &#91;******&#93;, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.</font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">AMENDMENT NUMBER FOURTEEN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">TO THE AMENDED AND RESTATED NON-EXCLUSIVE DISTRIBUTION AGREEMENT</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This AMENDMENT NUMBER FOURTEEN TO THE AMENDED AND RESTATED NON-EXCLUSIVE DISTRIBUTION AGREEMENT (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is made effective as of April 1, 2023 (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) by and between DexCom, Inc. (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DexCom</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and Byram Healthcare (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#8220;Distributor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Capitalized terms used herein but not defined shall have the meaning ascribed to them in the Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RECITALS</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, DexCom and Distributor previously entered into that certain Amended and Restated Non-Exclusive Distribution Agreement entered into by the Parties as of February 1, 2016 (as the same has been and may be amended from time to time, the &#8220;Agreement&#8221;)&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, DexCom and Distributor desire to further amend the Agreement, as more fully described herein.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW THEREFORE, DexCom and Distributor agree as follows&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">Schedule 1, The Products and The Prices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt;text-decoration:underline">Schedule 1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement is hereby updated in its entirety.</font></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">Exhibit 5, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">&#91;******&#93; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Rebate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt;text-decoration:underline">Exhibit 5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto is hereby appended to the Agreement and made a part hereof. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">No Further Modification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except to the extent set forth in this Amendment, all other terms and conditions of the Agreement shall remain unmodified and in full force and effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Remainder of Page Intentionally Blank&#59; <br>Signature Page Follows</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the parties have executed this Amendment effective as of the Amendment Effective Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.428%"><tr><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">DexCom, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Distributor</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Christophe Cantenot</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Neel Vadhan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Christophe Cantenot</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Neel Vadhan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VP, Finance and Corporate Controller</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VP, Purchasing</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">4&#47;28&#47;2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">4&#47;28&#47;2023</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><div id="i552897f539c54d598fb55a1aa72e5fad_51"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">SCHEDULE 1</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">The Products and The Prices</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#91;******&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><div id="i552897f539c54d598fb55a1aa72e5fad_62"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">EXHIBIT 5</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">&#91;******&#93; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">Rebate</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#91;******&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.04
<SEQUENCE>4
<FILENAME>dxcm6302023ex1004-edgepark.htm
<DESCRIPTION>EX-10.04
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic22691ded0a34d2cbd910f709e94a5ca_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 10.04</font></div><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY &#91;******&#93;, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.</font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">AMENDMENT NUMBER TWELVE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">TO THE NON-EXCLUSIVE DISTRIBUTION AGREEMENT</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This AMENDMENT NUMBER TWELVE TO THE NON-EXCLUSIVE DISTRIBUTION AGREEMENT (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is made effective as of May 15, 2023 (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) by and between DexCom, Inc. (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DexCom</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and RGH Enterprises, LLC dba Edgepark Medical Supplies (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#8220;Distributor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Capitalized terms used herein but not defined shall have the meaning ascribed to them in the Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RECITALS</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, DexCom and Distributor previously entered into that certain Non-Exclusive Distribution Agreement entered into by the Parties as of April 30, 2008 (as the same has been and may be amended from time to time, the &#8220;Agreement&#8221;)&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, DexCom and Distributor desire to further amend the Agreement, as more fully described herein.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW THEREFORE, DexCom and Distributor agree as follows&#58;</font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">Definitions and Interpretation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Section 1.1.8 of the Agreement is hereby added in its entirety&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1.8 </font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;Commercial&#8221; shall mean a sale to a Customer whose medical benefit is not paid in whole or in part by any Federal Health Care Program, as that term is defined by 42 U.S.C. &#167; 1320a-7b(f).</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">Exhibit 6, &#91;******&#93; Rebate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt;text-decoration:underline">Exhibit 6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto is hereby appended to the Agreement and made a part hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">No Further Modification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except to the extent set forth in this Amendment, all other terms and conditions of the Agreement shall remain unmodified and in full force and effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Remainder of Page Intentionally Blank&#59; <br>Signature Page Follows</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the parties have executed this Amendment effective as of the Amendment Effective Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.428%"><tr><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">DexCom, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Distributor</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Christophe Cantenot</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; E Wadlinger</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Christophe Cantenot</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">E Wadlinger</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VP, Finance and Corporate Controller</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VP. Marketing and Portfolio Management</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">6&#47;5&#47;2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">6&#47;2&#47;2023</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><div id="ic22691ded0a34d2cbd910f709e94a5ca_31"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">EXHIBIT 6</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">&#91;******&#93; Rebate</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#91;******&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.05
<SEQUENCE>5
<FILENAME>dxcm6302023ex1005-byramhea.htm
<DESCRIPTION>EX-10.05
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i51270a46aa1d4a0a896d35e07f4c92ab_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 10.05</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY &#91;******&#93;, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.</font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">AMENDMENT NUMBER THIRTEEN</font></div><div style="text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">TO THE AMENDED AND RESTATED NON-EXCLUSIVE DISTRIBUTION AGREEMENT</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This AMENDMENT NUMBER THIRTEEN TO THE AMENDED AND RESTATED NON-EXCLUSIVE DISTRIBUTION AGREEMENT (&#8220;</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is made effective as of June 1, 2023 (&#8220;</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment Effective Date</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) by and between DexCom, Inc. (&#8220;</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DexCom</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and Byram Healthcare (</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#8220;Distributor</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Capitalized terms used herein but not defined shall have the meaning ascribed to them in the Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RECITALS</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, DexCom and Distributor previously entered into that certain Amended and Restated Non-Exclusive Distribution Agreement entered into by the Parties as of February 1, 2016 (as the same has been and may be amended from time to time, the &#8220;Agreement&#8221;)&#59; and </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, DexCom and Distributor desire to further amend the Agreement, as more fully described herein.</font></div><div style="text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW THEREFORE, DexCom and Distributor agree as follows&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">1.</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">Schedule 1, The Products and The Prices</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">a.</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt;text-decoration:underline">Schedule 1</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement is hereby deleted and replaced in its entirety and is updated to include the changes to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;******&#93;</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Rebates and their associated terms listed therein.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">2.</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">No Further Modification</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except to the extent set forth in this Amendment, all other terms and conditions of the Agreement shall remain unmodified and in full force and effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Remainder of Page Intentionally Blank&#59; <br>Signature Page Follows</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="padding-left:18pt;text-align:justify"><font style="color:#2c2c2c;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF, </font><font style="color:#2c2c2c;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the parties have executed this Amendment effective as of the Amendment Effective Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.428%"><tr><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">DexCom, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Distributor</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Christophe Cantenot</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Neel Vadhan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Christophe Cantenot</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Neel Vadhan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VP, Finance and Corporate Controller</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VP, Purchasing</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">4&#47;25&#47;2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">4&#47;20&#47;2023</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><div id="i51270a46aa1d4a0a896d35e07f4c92ab_31"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">SCHEDULE 1</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">The Products and The Prices</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#91;******&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.06
<SEQUENCE>6
<FILENAME>dxcm6302023ex1006-firstame.htm
<DESCRIPTION>EX-10.06
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6f60c3db2b834874baac87815ad2054f_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT 10.06</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THIS FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), dated as of June 1, 2023, is entered into by and among DEXCOM, INC., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Lenders described below party hereto, and JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, a national banking association (individually, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">JPMorgan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), as administrative agent for the Lenders (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Unless otherwise specified herein, capitalized terms used in this Amendment shall have the meanings ascribed to them in the Credit Agreement (as hereinafter defined).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Borrower, certain financial institutions parties thereto (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Administrative Agent, JPMorgan and Merrill Lynch, Pierce, Fenner &#38; Smith Inc., as Joint Bookrunners and Joint Lead Arrangers, and Bank of America, N.A. and Silicon Valley Bank, as Co-Syndication Agents, are parties to that certain Second Amended and Restated Credit Agreement, dated as of October 13, 2021 (as amended, restated, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Borrower has requested that the Administrative Agent and the Lenders amend the Credit Agreement as set forth herein&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, on the terms and conditions set forth herein, the Administrative Agent and the Lenders have agreed to amend the Credit Agreement as set forth herein.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW, THEREFORE, for and in consideration of the premises and mutual agreements herein contained and for the purposes of setting forth the terms and conditions of this Amendment and for other valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be bound, hereby agree as follows&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.84pt;text-decoration:underline">Amendments to Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Subject to the terms and conditions of this Amendment, the Credit Agreement is hereby amended to delete the stricken text (indicated textually in the same manner as the following example&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:line-through">stricken text</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:line-through">stricken text</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and to add the double-underlined text (indicated textually in the same manner as the following example&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">double-underlined text</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">double-underlined text</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) as set forth in the pages of the Credit Agreement attached as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit I</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereto.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.84pt;text-decoration:underline">Conditions Precedent to Effectiveness</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Amendment shall not become effective unless (a) the Administrative Agent shall have received a copy of this Amendment, in form and substance acceptable to the Administrative Agent, executed by the Borrower and each Lender, (b) the representations and warranties contained herein shall be true and correct and no Default or Event of Default shall exist on the date hereof and (c) the Borrower shall have paid all reasonable out of pocket costs and expenses of or incurred by the Administrative Agent, including but not limited to, fees and disbursements of counsel to the Administrative Agent, in connection with the preparation, negotiation, execution and delivery of this Amendment, in each case that have been invoiced prior to the date of this Amendment.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.84pt;text-decoration:underline">Representations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Borrower hereby represents and warrants to the Administrative Agent and the Lenders that&#58; (a) it has all necessary power and authority to execute and deliver this Amendment and perform its obligations hereunder, (b) no Default or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Event of Default exists both before and after giving effect to this Amendment, (c) this Amendment and the Credit Agreement, as amended hereby, constitute the legal, valid and binding obligations of the Borrower and are enforceable against the Borrower in accordance with their terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors&#8217; rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law, (d) all Liens created under the Loan Documents continue to be first-priority (subject only to Permitted Encumbrances) perfected Liens, (e) all representations and warranties of the Borrower contained in the Credit Agreement, as amended hereby, are true and correct in all material respects (without duplication of any materiality qualifiers set forth therein) as though made on and as of the date hereof (except to the extent such representations and warranties relate to an earlier date, in which case they are true and correct in all material respects (without duplication of any materiality qualifiers set forth therein) as of such date) and (f) the execution and delivery of this Amendment will not contravene or result in a violation of any material contract or agreement to which the Borrower is a party.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.84pt;text-decoration:underline">Ratification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Except as expressly modified by this Amendment, all of the terms, provisions and conditions of the Credit Agreement, as heretofore amended, shall remain unchanged and in full force and effect.  Except as herein specifically agreed, the Credit Agreement and each other Loan Document are hereby ratified and confirmed and shall remain in full force and effect according to their terms.  Except as specifically set forth herein, the execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power, privilege or remedy of the Administrative Agent or the Lenders under the Credit Agreement or any of the other Loan Documents, or constitute a waiver of any provision of the Credit Agreement or any of the other Loan Documents.  This Amendment shall not constitute a course of dealing with the Administrative Agent or the Lenders at variance with the Credit Agreement or the other Loan Documents such as to require further notice by such Person to require strict compliance with the terms of the Credit Agreement and the other Loan Documents in the future.  The Borrower acknowledges and expressly agrees that the Administrative Agent and each Lender reserves the right to, and does in fact, require strict compliance with all terms and provisions of the Credit Agreement (as expressly modified by this Amendment) and the other Loan Documents.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.84pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Amendment shall be construed in accordance with and governed by the law of the State of New York.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt;text-decoration:underline">WAIVER OF JURY TRIAL</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AMENDMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY).  EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AMENDMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Counterparts&#59; Effectiveness</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Amendment may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract.  This Amendment shall become effective as provided in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereof and when the Administrative Agent shall have received counterparts hereof which, when taken together, bear the signatures of each of the other parties hereto, and thereafter shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns. Delivery of an executed counterpart of a signature page of this Amendment by telecopy or other electronic transmission shall be effective as delivery of a manually executed counterpart of this Amendment.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Amendment and the other Loan Documents constitute the entire understanding of the parties hereto and thereto with respect to the subject matter hereof and thereof and any prior agreements, whether written or oral, with respect thereto are superseded hereby.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt;text-decoration:underline">Severability of Provisions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Any provision of this Amendment held to be invalid, illegal or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the remaining provisions hereof&#59; and the invalidity of a particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The provisions of this Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted under the Credit Agreement.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The parties acknowledge and agree that this Amendment shall not be construed more favorably in favor of any party hereto based upon which party drafted the same, it being acknowledged that all parties hereto contributed substantially to the negotiation of this Amendment.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt;text-decoration:underline">Incorporation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Amendment shall form a part of the Credit Agreement, and all references to the Credit Agreement shall mean that document as hereby modified.  Upon the effectiveness of this Amendment, each reference in the Credit Agreement to &#8220;this Agreement&#8221;, &#8220;hereunder&#8221;, &#8220;hereof&#8221;, &#8220;herein&#8221; or words of similar import shall mean and be a reference to the Credit Agreement as amended hereby.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.24pt;text-decoration:underline">No Prejudice&#59; No Impairment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Amendment shall not prejudice, limit, restrict or impair any rights, privileges, powers or remedies of the Administrative Agent or the Lenders under the Credit Agreement or any other Loan Documents as hereby amended.  The Administrative Agent and each Lender reserves, without limitation, all rights which the Administrative Agent and each Lender has now or in the future against any guarantor or endorser of the Obligations.</font></div><div id="i6f60c3db2b834874baac87815ad2054f_916"></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">&#91;Signatures Immediately Follow&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_900"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">IN WITNESS WHEREOF, the undersigned have executed this First Amendment to Second Amended and Restated Credit Agreement as of the date first written above.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.000%"><tr><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">BORROWER&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">DEXCOM, INC.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#47;s&#47; Jereme Sylvain</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Name&#58; Jereme Sylvain</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Title&#58; EVP, CFO</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to First Amendment to Second Amended and Restated Credit Agreement</font></div><div style="text-align:center"><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_853"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.000%"><tr><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">LENDERS&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">JPMORGAN CHASE BANK, N.A., individually and as Administrative Agent</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#47;s&#47; Ling Li</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Name&#58; Ling Li</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Title&#58; Executive Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to First Amendment to Second Amended and Restated Credit Agreement</font></div><div style="text-align:center"><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_861"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.000%"><tr><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">BANK OF AMERICA N.A., as a Lender</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Sebastian Lurie</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Name&#58; Sebastian Lurie<br>Title&#58; SVP</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to First Amendment to Second Amended and Restated Credit Agreement</font></div><div style="text-align:center"><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_869"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.000%"><tr><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">FEDERAL DEPOSIT INSURANCE CORPORATION AS RECEIVER FOR SILICON VALLEY BANK, as a Lender</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Edward M. Mertic</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Name&#58; Edward M. Mertic<br>Title&#58; Authorized Representative&#47;Attorney-in-Fact</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to First Amendment to Second Amended and Restated Credit Agreement</font></div><div style="text-align:center"><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_877"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.000%"><tr><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">UNICREDIT BANK AG, NEW YORK BRANCH, as a Lender</font></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Christine Macinnes</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Name&#58; Christine Macinnes<br>Title&#58; Director</font></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Laura Shelmerdine</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Name&#58; Laura Shelmerdine<br>Title&#58; Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to First Amendment to Second Amended and Restated Credit Agreement</font></div><div style="text-align:center"><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_885"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.282%"><tr><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">SANTANDER BANK, N.A., as a Lender</font></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Irv Roa</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Name&#58; Irv Roa<br>Title&#58; Managing Director</font></td></tr></table></div><div style="text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to First Amendment to Second Amended and Restated Credit Agreement</font></div><div style="text-align:center"><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_956"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">EXHIBIT I TO</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_42"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXHIBIT I</font></div><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt double #000000;border-top:2pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;padding-left:1.37pt;padding-right:1.37pt;text-align:center"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:31px;margin-bottom:5pt;vertical-align:text-bottom;width:166px"></div><div style="margin-bottom:23pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECOND AMENDED AND RESTATED CREDIT AGREEMENT</font></div><div style="margin-bottom:23pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">dated as of </font></div><div style="margin-bottom:23pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">October 13, 2021 </font></div><div style="margin-bottom:23pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by and among</font></div><div style="margin-bottom:23pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">DEXCOM, INC.,<br>as Borrower,</font></div><div style="margin-bottom:23pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Lenders party hereto,</font></div><div style="margin-bottom:23pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font></div><div style="margin-bottom:23pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">JPMORGAN CHASE BANK,<br>NATIONAL ASSOCIATION,<br>as Administrative Agent</font></div><div style="margin-bottom:23pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">___________________________</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and<br>MERRILL LYNCH, PIERCE, FENNER &#38; SMITH INC.,</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as Joint Bookrunners and Joint Lead Arrangers</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BANK OF AMERICA, N.A.,<br>and<br>SILICON VALLEY BANK,<br>as Co-Syndication Agents<br></font></div></td></tr></table></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_53"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:92.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE I<br>DEFINITIONS</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 1.01. Defined Terms</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 1.02. Classification of Loans and Borrowings</font></div></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">36</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 1.03. Terms Generally</font></div></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">36</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 1.04. Accounting Terms&#59; GAAP</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">37</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 1.05. Exchange Rates&#59; Currency Equivalents</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">38</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 1.06. Interest Rates&#59; Benchmark Notification</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">38</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 1.07. Letter of Credit Amounts</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">38</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 1.08. Pro Forma Adjustments for Acquisitions and Dispositions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">39</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 1.09. Status of Obligations</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">39</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE II<br>THE CREDITS</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.01. Commitments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">39</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.02. Loans and Borrowings</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">39</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.03. Requests for Revolving Borrowings</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">40</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.04. &#91;Intentionally Omitted&#93;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">41</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.05. &#91;Intentionally Omitted&#93;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">41</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.06. Letters of Credit</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">41</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.07. Funding of Borrowings</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">45</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.08. Interest Elections</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">46</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.09. Termination and Reduction of Commitments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">47</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.10. Repayment of Loans&#59; Evidence of Debt</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">48</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.11. Prepayment of Loans</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">48</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.12. Fees</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">49</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.13. Interest</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">50</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.14. Alternate Rate of Interest</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">50</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.15. Increased Costs</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">54</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.16. Break Funding Payments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">55</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.17. Payments Free of Taxes</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">55</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.18. Payments Generally&#59; Pro Rata Treatment&#59; Sharing of Set-offs</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">58</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.19. Mitigation Obligations&#59; Replacement of Lenders</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">60</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.20. Defaulting Lenders</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">61</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.21. Increase in Commitments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">62</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.22. Returned Payments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">63</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2.23. Banking Services and Swap Agreements</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">63</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE III<br>REPRESENTATIONS AND WARRANTIES</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.01. Organization&#59; Powers</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">64</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.02. Authorization&#59; Enforceability</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">64</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.03. Governmental Approvals&#59; No Conflicts</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">64</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.04. Financial Condition&#59; No Material Adverse Change</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">64</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:92.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.05. Properties</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">64</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.06. Litigation and Environmental Matters</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">65</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.07. Compliance with Laws and Agreements</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">65</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.08. Investment Company Status</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">65</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.09. Taxes</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">65</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.10. ERISA</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">65</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.11. Disclosure</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">66</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.12. Anti-Corruption Laws and Sanctions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">66</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.13. Affected Financial Institutions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">66</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.14. Capitalization and Subsidiaries</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">66</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.15. Employment Matters</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">66</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.16. Federal Reserve Regulations</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">66</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.17. Use of Proceeds</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">66</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.18. Security Interest in Collateral</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">67</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.19. Plan Assets&#59; Prohibited Transactions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">67</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3.20. Solvency</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">67</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE IV<br>CONDITIONS</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 4.01. Restatement Effective Date</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">67</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 4.02. Each Credit Event</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">69</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE V<br>AFFIRMATIVE COVENANTS</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5.01. Financial Statements&#59; Ratings Change and Other Information</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">69</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5.02. Notices of Material Events</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">70</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5.03. Existence&#59; Conduct of Business</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">71</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5.04. Payment of Obligations</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">71</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5.05. Maintenance of Properties&#59; Insurance</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">71</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5.06. Books and Records&#59; Inspection Rights</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">71</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5.07. Compliance with Laws</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">72</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5.08. Use of Proceeds and Letters of Credit</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">72</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5.09. Accuracy of Information</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">72</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5.10. Additional Collateral&#59; Further Assurances</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">72</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5.11. Intellectual Property</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">74</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5.12. Post-Closing Matters</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">74</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE VI<br>NEGATIVE COVENANTS</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6.01. Indebtedness</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">74</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6.02. Liens</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">75</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6.03. Fundamental Changes</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">76</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6.04. Investments, Loans, Advances, Guarantees and Acquisitions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">77</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6.05. Swap Agreements</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">78</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6.06. Restricted Payments&#59; Certain Payments of Indebtedness</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">78</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ii</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:92.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6.07. Transactions with Affiliates</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">79</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6.08  Restrictive Agreements</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">79</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6.09. Sale and Leaseback Transactions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">80</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6.10. Amendment of Material Documents</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">80</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6.11. Fiscal Year</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">80</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6.12. Anti-Corruption Laws and Sanctions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">80</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6.13. Financial Covenants</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">80</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE VII<br>EVENTS OF DEFAULT</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE VIII<br>THE ADMINISTRATIVE AGENT&#59; CREDIT BIDDING</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 8.01. The Administrative Agent</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">84</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 8.02. Administrative Agent&#8217;s Reliance, Limitation of Liability, Etc.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">86</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 8.03. Posting of Communications.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">87</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 8.04. The Administrative Agent Individually</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">88</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 8.05. Successor Administrative Agent.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">89</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 8.06. Acknowledgements of Lenders and Issuing Banks.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">90</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 8.07. Collateral Matters.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">91</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 8.08. Credit Bidding</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">92</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 8.09. Certain ERISA Matters</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">93</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 8.10. Flood Laws</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">94</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE IX<br>MISCELLANEOUS</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.01. Notices</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">94</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.02. Waivers&#59; Amendments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">96</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.03. Expenses&#59; Limitation of Liability&#59; Indemnity, Etc.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">98</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.04. Successors and Assigns</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">99</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.05. Survival</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">102</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.06. Counterparts&#59; Integration&#59; Effectiveness&#59; Electronic Execution</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">103</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.07. Severability</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">104</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.08. Right of Setoff</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">104</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.09. Governing Law&#59; Jurisdiction&#59; Consent to Service of Process</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">104</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.10. WAIVER OF JURY TRIAL</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">105</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.11. Headings</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">105</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.12. Confidentiality</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">105</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.13. Material Non-Public Information</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">106</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.14. Interest Rate Limitation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">106</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.15. USA PATRIOT Act</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">106</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.16. Acknowledgement and Consent to Bail-In of Affected Financial Institutions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">106</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.17. No Fiduciary Duty, etc</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">107</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">iii</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:92.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.18. Amendment and Restatement&#59; Reaffirmation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">107</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9.19. Acknowledgement Regarding Any Supported QFCs</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">108</font></div></td></tr></table></div><div style="margin-bottom:11pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">iv</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SCHEDULES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 2.01&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Commitment Schedule</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 3.05&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Intellectual Property</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 3.06&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Disclosed Matters</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 3.14&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Capitalization and Subsidiaries</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 6.01&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Existing Indebtedness</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 6.02&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Existing Liens</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 6.04&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Existing Investments</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 6.08&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Existing Restrictions</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EXHIBITS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font></div><div><font><br></font></div><div style="padding-left:144pt;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit A&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Assignment and Assumption</font></div><div style="padding-left:144pt;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit B&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;RESERVED&#93;</font></div><div style="padding-left:144pt;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit C-1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;U.S. Tax Compliance Certificate (For Foreign Lenders That Are Not Partnerships for U.S. Federal Income Tax Purposes)</font></div><div style="padding-left:144pt;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit C-2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;U.S. Tax Compliance Certificate (For Foreign Lenders That Are Partnerships for U.S. Federal Income Tax Purposes)</font></div><div style="padding-left:144pt;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit C-3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;U.S. Tax Compliance Certificate (For Foreign Participants That Are Not Partnerships for U.S. Federal Income Tax Purposes)</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit C-4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;U.S. Tax Compliance Certificate (For Foreign Participants That Are Partnerships for U.S. Federal Income Tax Purposes)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">v</font></div><div style="text-align:center"><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_284"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECOND AMENDED AND RESTATED CREDIT AGREEMENT dated as of October 13, 2021 (as it may be amended, restated, supplemented or otherwise modified from time to time, this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), by and among DEXCOM, INC., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Lenders party hereto, and JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, as Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">R E C I T A L S&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Borrower is a party to that certain Amended and Restated Credit Agreement dated as of December 19, 2018 by and among the Borrower, the lenders party thereto (collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and JPMorgan, as administrative agent, (as amended, restated, supplemented or otherwise modified prior to the date hereof, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), pursuant to which the Existing Lenders provided certain loans and other financial accommodations to the Borrower&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the parties hereto desire to amend and restate the Existing Credit Agreement to, among other things, extend the maturity of the Loans&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, in connection with the foregoing, the parties hereto agree that upon satisfaction of the conditions set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 4.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">4.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Existing Credit Agreement shall be amended and restated in its entirety and superseded by this Agreement&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the obligation to repay the Obligations under the Existing Credit Agreement shall continue in full force and effect and shall be governed by the terms of this Agreement and corresponding Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">AGREEMENT&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the foregoing Recitals and the mutual covenants set forth below, and intending to be legally bound, the parties hereto agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE I<br><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 1.01.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  As used in this Agreement, the following terms have the meanings specified below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">2018 Call Spread</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means call or capped call options (or a substantively equivalent derivative transaction) on Borrower&#8217;s common stock purchased by, and warrants (if any) on the Borrower&#8217;s common stock issued by, the Borrower, in each case, on or after the Second Amendment Effective Date and prior to December 31, 2018, with respect to its Equity Interests, such that (i) in the case of a purchase of a call option, the initial strike price per share is approximately equal to the initial conversion price of the 2018 Convertible Notes, (ii) the purpose of which is to hedge certain of the Borrower&#8217;s obligations in respect of the 2018 Convertible Notes and (iii) the net premium payable (based on the aggregate premium paid by the Borrower for such purchased call options less the aggregate premium received by the Borrower for any such warrants) shall not exceed $75,000,000.  As used herein, references to the &#8220;2018 Call Spread&#8221; include any component thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">2018 Convertible Notes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the unsecured convertible notes issued by the Borrower in November 2018, maturing December 1, 2023 and in an aggregate principal amount as of the Restatement Effective Date of $850,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">2020 Convertible Notes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the unsecured convertible notes issued by the Borrower in May 2020, maturing November 15, 2025 and in an aggregate principal amount as of the Restatement Effective Date of $1,207,500,000.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">ABR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, when used in reference to any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such Borrowing, bear interest at a rate determined by reference to the Alternate Base Rate.  All ABR Loans shall be denominated in Dollars.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Adjusted AUD Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in Australian Dollars for any Interest Period, an interest rate </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> equal to (a)&#160;the AUD Rate for such Interest Period multiplied by (b) the Statutory Reserve Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Adjusted BKBM Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in New Zealand Dollars for any Interest Period, an interest rate per annum equal to (a) the BKBM Rate for such Interest Period multiplied by (b) the Statutory Reserve Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Adjusted CDOR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in Canadian Dollars for any interest period, an interest rate per annum equal to (a) the CDOR for such interest period multiplied by (b) the Statutory Reserve Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Adjusted Daily Simple RFR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, (i) with respect to any RFR Borrowing denominated in Sterling, an interest rate per annum equal to (a) the Daily Simple RFR for Sterling </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (b) 0.0326% and (ii) with respect to any RFR Borrowing denominated in Dollars, an interest rate per annum equal to (a) the Daily Simple RFR for Dollars, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (b) 0.10%&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided that</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> if the Adjusted Daily Simple RFR Rate as so determined in clause (ii) would be less than the Floor, such rate shall be deemed to be equal to the Floor for the purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Adjusted EURIBOR Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in Euros for any Interest Period, an interest rate </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> equal to (a)&#160; the EURIBOR Rate for such Interest Period multiplied by (b) the Statutory Reserve Rate&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided that</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> if the Adjusted EURIBOR Rate as so determined would be less than the Floor, such rate shall be deemed to be equal to the Floor for the purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Adjusted STIBOR Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in Swedish Kroner for any interest period, an interest rate per annum equal to (a) the STIBOR Rate for such interest period multiplied by (b) the Statutory Reserve Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Adjusted Term SOFR Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in Dollars for any Interest Period, an interest rate per annum equal to (a) the Term SOFR Rate for such Interest Period, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (b) 0.10%&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> provided that</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> if the Adjusted Term SOFR Rate as so determined would be less than the Floor, such rate shall be deemed to be equal to the Floor  for the purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Adjusted TIBOR Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in Yen for any Interest Period, an interest rate per annum equal to (a) the TIBOR Rate for such Interest Period multiplied by (b) the Statutory Reserve Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Administrative Agent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means JPMorgan Chase Bank, N.A. (or any of its designated branch offices or affiliates), in its capacity as administrative agent for the Lenders hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Administrative Questionnaire</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an Administrative Questionnaire in a form supplied by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Affected Financial Institution</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) any EEA Financial Institution or (b) any UK Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Affiliate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to a specified Person, another Person that directly, or indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with the Person specified.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Agent-Related Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.03(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Agreed Currencies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Dollars and each other Applicable Currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Alternate Base Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any day, a rate </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> equal to the greatest of (a)&#160;the Prime Rate in effect on such day, (b)&#160;the NYFRB Rate in effect on such day plus &#189; of 1% and (c)&#160;the Adjusted Term SOFR Rate for a one month Interest Period as published two U.S. Government Securities Business Days prior to such day (or if such day is not a U.S. Government Securities Business Day, the immediately preceding U.S. Government Securities Business Day) plus 1%&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, for the purpose of this definition, the Adjusted Term SOFR Rate for any day shall be based on the Term SOFR Reference Rate at approximately 5&#58;00 a.m. Chicago time on such day (or any amended publication time for the Term SOFR Reference Rate, as specified by the CME Term SOFR Administrator in the Term SOFR Reference Rate methodology.  Any change in the Alternate Base Rate due to a change in the Prime Rate, the NYFRB Rate or the Adjusted Term SOFR Rate shall be effective from and including the effective date of such change in the Prime Rate, the NYFRB Rate or the Adjusted Term SOFR Rate, respectively.  If the Alternate Base Rate is being used as an alternate rate of interest pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (for the avoidance of doubt, only until the Benchmark Replacement has been determined pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), then the Alternate Base Rate shall be the greater of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above and shall be determined without reference to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above.  For the avoidance of doubt, if the Alternate Base Rate as determined pursuant to the foregoing would be less than 1.00%, such rate shall be deemed to be 1.00% for purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Ancillary Document</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.06(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Anti-Corruption Laws</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all laws, rules, and regulations of any jurisdiction applicable to the Borrower or any of its Subsidiaries from time to time concerning or relating to bribery or corruption.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Applicable Currency</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means dollars, Canadian Dollars, Euros, British Pounds, Swedish Kroner, Japanese Yen, Australian Dollars, New Zealand Dollars and any other currency determined after the Restatement Effective Date by mutual agreement of the Borrower, the Administrative Agent and each of the Lenders&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that at all times each of the foregoing currencies (other than dollars) is a lawful currency that is readily available, freely transferable and not restricted, able to be converted into dollars and available in the London interbank deposit market.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Applicable Percentage</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Lender, the percentage of the total Commitments represented by such Lender&#8217;s Commitment&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that in the case of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.20</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> when a Defaulting Lender shall exist, &#8220;Applicable Percentage&#8221; shall mean the percentage of the total Commitments (disregarding any Defaulting Lender&#8217;s Commitment) represented by such Lender&#8217;s Commitment.  If the Commitments have terminated or expired, the Applicable Percentages shall be determined based upon the Commitments most recently in effect, giving effect to any assignments and to any Lender&#8217;s status as a Defaulting Lender at the time of determination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Applicable Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any day, with respect to any ABR&#160;Loan or, Term Benchmark Revolving Loan, RFR Revolving Loan or with respect to the commitment fees payable hereunder, as the case may be, the applicable rate </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> set forth below under the caption &#8220;ABR&#160;Spread&#8221;, &#8220;Term Benchmark&#47;CDOR Spread&#8221;, &#8220;RFR Spread&#8221;, or &#8220;Unused Commitment Fee Rate&#8221;, as the case may be, based upon Total Leverage Ratio as of the most recent determination date, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that until the delivery to the Administrative Agent, pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, of the Borrower&#8217;s consolidated financial information for the fiscal quarter ending September 30, 2021, the &#8220;Applicable Rate&#8221; shall be the applicable rates per annum set forth below in Level I&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:66.95pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.634%"><tr><td style="width:1.0%"></td><td style="width:12.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.721%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:2pt double #000000;border-top:2pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Level&#58;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:2pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Total Leverage Ratio</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:2pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ABR<br>Spread</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:2pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term Benchmark &#47;CDOR&#47; RFR Loans <br>Spread</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:2pt double #000000;border-top:2pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Unused Commitment Fee Rate</font></td></tr><tr><td colspan="3" style="border-left:2pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level I</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less than 1.00 to 1.00</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.375%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.375%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:2pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.175%</font></td></tr><tr><td colspan="3" style="border-left:2pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level II</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Greater than or equal to 1.00 to 1.00 but less than 2.00 to 1.00</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.500%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.500%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:2pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.200%</font></td></tr><tr><td colspan="3" style="border-left:2pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level III</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Greater than or equal to 2.00 to 1.00 but less than 3.00 to 1.00</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.750%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.750%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:2pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.225%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:2pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level IV</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Greater than or equal to 3.00 to 1.00</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.000%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.000%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:2pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.250%</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of the foregoing, (a) the Applicable Rate shall be determined as of the end of each fiscal quarter of the Borrower, based upon the Borrower&#8217;s annual or quarterly consolidated financial statements delivered pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (b) each change in the Applicable Rate resulting from a change in the Total Leverage Ratio shall be effective during the period commencing on and including the date of delivery to the Administrative Agent of such consolidated financial statements indicating such change and ending on the date immediately preceding the effective date of the next such change, provided that (A) at any time that an Event of Default has occurred and is continuing or (B) at the option of the Administrative Agent or at the request of the Required Lenders, if the Borrower fails to deliver the annual or quarterly consolidated financial statements required to be delivered by it pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Total Leverage Ratio shall be deemed to be in Level IV during the period from the expiration of the time for delivery thereof until such consolidated financial statements are delivered.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If at any time the Administrative Agent determines that the financial statements upon which the Applicable Rate was determined were incorrect (whether based on a restatement, fraud or otherwise), the Borrower shall be required to retroactively pay any additional amount that the Borrower would have been required to pay if such financial statements had been accurate at the time they were delivered.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Applicable Time</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Borrowings and payments in any Applicable Currency, the local time in the place of settlement for such Applicable Currency as may be determined by the Administrative Agent or the Issuing Bank, as the case may be, to be necessary for timely settlement on the relevant date in accordance with normal banking procedures in the place of payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Approved Electronic Platform</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.03(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Approved Fund</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.04(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Assignment and Assumption</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an assignment and assumption entered into by a Lender and an assignee (with the consent of any party whose consent is required by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;9.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), and accepted by the Administrative Agent, in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or any other form (including electronic records generated by the use of an electronic platform) approved by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">AUD Interpolated Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, with respect to any Term Benchmark Borrowing denominated in Australian Dollars and for any Interest Period, the rate per annum (rounded to the same number of decimal places as the AUD Screen Rate) determined by the Administrative Agent (which determination shall be conclusive and binding absent manifest error) to be equal to the rate that results from interpolating on a linear basis between&#58; (a) the AUD Screen Rate for the longest period (for which the AUD Screen Rate is available for Australian Dollars) that is shorter than the Impacted AUD Rate Interest Period&#59; and (b) the AUD Screen Rate for the shortest period (for which the AUD Screen Rate is available for Australian Dollars) that exceeds the Impacted AUD Rate Interest Period, in each case, at such time&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if any AUD Interpolated Rate shall be less than zero, such rate shall be deemed to be zero for the purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">AUD Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in Australian Dollars and for any Interest Period, the AUD Screen Rate at approximately 11&#58;00 a.m., Local Time, two Business Days prior to the commencement of such Interest Period&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if the AUD Screen Rate shall not be available at such time for such Interest Period (an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Impacted AUD Rate Interest Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) with respect to Australian Dollars then the AUD Rate shall be the AUD Interpolated Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">AUD Screen Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means with respect to any Interest Period, the average bid reference rate administered by ASX Benchmarks Pty Limited (ACN 616 075 417) (or any other Person that takes over the administration of such rate) for Australian dollar bills of exchange with a tenor equal in length to such Interest Period as displayed on page BBSY of the Reuters screen (or, in the event such rate does not appear on such Reuters page, on any successor or substitute page on such screen that displays such rate, or on the appropriate page of such other information service that publishes such rate as shall be selected by the Administrative Agent from time to time in its reasonable discretion) at or about 11&#58;00 a.m. (Local Time) on the first day of such Interest Period.  If the AUD Screen Rate shall be less than zero, the AUD Screen Rate shall be deemed to be zero for purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Availability Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the period from and including the Restatement Effective Date to but excluding the earlier of the Maturity Date and the date of termination of the Commitments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Available Tenor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination and with respect to the then-current Benchmark for any Agreed Currency, as applicable, any tenor for such Benchmark (or component thereof) or payment period for interest calculated with reference to such Benchmark (or component thereof), as applicable, that is or may be used for determining the length of an Interest Period for any term rate or otherwise, for determining any frequency of making payments of interest calculated pursuant to this Agreement as of such date and not including, for the avoidance of doubt, any tenor for such Benchmark that is then-removed from the definition of &#8220;Interest Period&#8221; pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Bail-In Action</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the exercise of any Write-Down and Conversion Powers by the applicable Resolution Authority in respect of any liability of an Affected Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Bail-In Legislation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to any EEA Member Country implementing Article 55 of Directive 2014&#47;59&#47;EU of the European Parliament and of the Council of the European Union, the implementing law, regulation rule or requirement for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule and (b) with </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">respect to the United Kingdom,  Part I of the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation or rule applicable in the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Banking Services</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each and any of the following bank services provided to any Loan Party or any of their Subsidiaries by any Lender or any of its Affiliates&#58; (a) credit cards for commercial customers (including, without limitation, &#8220;commercial credit cards&#8221; and purchasing cards), (b) stored value cards, (c) merchant processing services, and (d) treasury management services (including, without limitation, controlled disbursement, automated clearinghouse transactions, return items, any direct debit scheme  or arrangement, overdrafts and interstate depository network services).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Banking Services Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any and all obligations of the Loan Parties or their Subsidiaries, whether absolute or contingent and howsoever and whensoever created, arising, evidenced or acquired (including all renewals, extensions and modifications thereof and substitutions therefor) in connection with Banking Services.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Bankruptcy Code</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the provisions of Title 11 of the United States Code, 11 U.S.C. &#167;&#167; 101 et seq. or other applicable bankruptcy, insolvency or similar laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Bankruptcy Event</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, such Person becomes the subject of a bankruptcy or insolvency proceeding, or has had a receiver, conservator, trustee, administrator, custodian, assignee for the benefit of creditors or similar Person charged with the reorganization or liquidation of its business appointed for it, or, in the good faith determination of the Administrative Agent, has taken any action in furtherance of, or indicating its consent to, approval of, or acquiescence in, any such proceeding or appointment, provided that a Bankruptcy Event shall not result solely by virtue of any ownership interest, or the acquisition of any ownership interest, in such Person by a Governmental Authority or instrumentality thereof, unless such ownership interest results in or provides such Person with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Person (or such Governmental Authority or instrumentality) to reject, repudiate, disavow or disaffirm any contracts or agreements made by such Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Benchmark</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, initially, with respect to any (i) RFR Loan in any Agreed Currency, the applicable Relevant Rate for such Agreed Currency or (ii) Term Benchmark Loan, the Relevant Rate for such Agreed Currency&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if a Benchmark Transition Event, and the related Benchmark Replacement Date have occurred with respect to the applicable Relevant Rate or the then-current Benchmark for such Agreed Currency, then &#8220;Benchmark&#8221; means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Benchmark Replacement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any Available Tenor, the first alternative set forth in the order below that can be determined by the Administrative Agent for the applicable Benchmark Replacement Date&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, in the case of any Loan denominated in a Foreign Currency, &#8220;Benchmark Replacement&#8221; shall mean the alternative set forth in (ii) below&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (i)&#160;&#160;&#160;&#160;in the case of any Loan denominated in Dollars, the Adjusted Daily Simple SOFR&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;the sum of&#58; (a) the alternate benchmark rate that has been selected by the Administrative Agent and the Borrower as the replacement for the then-current Benchmark for the applicable Corresponding Tenor giving due consideration to (A) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body or (B) any evolving or then-prevailing market convention for determining a benchmark rate as a replacement for the then-current Benchmark for syndicated credit facilities denominated </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in the applicable Agreed Currency at such time in the United States and (b) the related Benchmark Replacement Adjustment&#59;</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If the Benchmark Replacement as determined pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above would be less than the Floor, the Benchmark Replacement will be deemed to be the Floor for the purposes of this Agreement and the other Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Benchmark Replacement Adjustment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any replacement of the then-current Benchmark with an Unadjusted Benchmark Replacement for any applicable Interest Period and Available Tenor for any setting of such Unadjusted Benchmark Replacement, the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) that has been selected by the Administrative Agent and the Borrower for the applicable Corresponding Tenor giving due consideration to (i) any selection or recommendation of a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement by the Relevant Governmental Body on the applicable Benchmark Replacement Date and&#47;or (ii) any evolving or then-prevailing market convention for determining a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement for syndicated credit facilities denominated in the applicable Agreed Currency at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Benchmark Replacement Conforming Changes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Benchmark Replacement, and &#47; or any Term Benchmark Revolving Loan denominated in Dollars, any technical, administrative or operational changes (including changes to the definition of &#8220;Alternate Base Rate,&#8221; the definition of &#8220;Business Day,&#8221; the definition of &#8220;U.S. Government Securities Business Day,&#8221; the definition of &#8220;RFR Business Day,&#8221; the definition of &#8220;Interest Period,&#8221; timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, length of lookback periods, the applicability of breakage provisions, and other technical, administrative or operational matters) that the Administrative Agent decides may be appropriate to reflect the adoption and implementation of such Benchmark and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent determines that no market practice for the administration of such Benchmark exists, in such other manner of administration as the Administrative Agent decides is reasonably necessary in connection with the administration of this Agreement and the other Loan Documents).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Benchmark Replacement Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Benchmark, the earliest to occur of the following events with respect to such then-current Benchmark&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;in the case of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the definition of &#8220;Benchmark Transition Event,&#8221; the later of (a) the date of the public statement or publication of information referenced therein and (b) the date on which the administrator of such Benchmark (or the published component used in the calculation thereof) permanently or indefinitely ceases to provide all Available Tenors of such Benchmark (or such component thereof)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;in the case of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the definition of &#8220;Benchmark Transition Event,&#8221; the first date on which such Benchmark (or the published component used in the calculation thereof) has been determined and announced by the regulatory supervisor for the administrator of such Benchmark (or such component thereof) to be no longer representative&#59; provided, that such non-representativeness will be determined by reference to the most recent statement or publication referenced in such </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and even if any Available Tenor of such Benchmark (or such component thereof) continues to be provided on such date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For the avoidance of doubt, (i) if the event giving rise to the Benchmark Replacement Date occurs on the same day as, but earlier than, the Reference Time in respect of any determination, the Benchmark Replacement Date will be deemed to have occurred prior to the Reference Time for such determination and (ii) the &#8220;Benchmark Replacement Date&#8221; will be deemed to have occurred in the case of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to any Benchmark upon the occurrence of the applicable event or events set forth therein with respect to all then-current Available Tenors of such Benchmark (or the published component used in the calculation thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Benchmark Transition Event</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Benchmark, the occurrence of one or more of the following events with respect to such then-current Benchmark&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;a public statement or publication of information by or on behalf of the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that such administrator has ceased or will cease to provide all Available Tenors of such Benchmark (or such component thereof), permanently or indefinitely, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof), the Federal Reserve Board, the NYFRB, the CME Term SOFR Administrator, the central bank for the Agreed Currency applicable to such Benchmark, an insolvency official with jurisdiction over the administrator for such Benchmark (or such component), a resolution authority with jurisdiction over the administrator for such Benchmark (or such component) or a court or an entity with similar insolvency or resolution authority over the administrator for such Benchmark (or such component), in each case, which states that the administrator of such Benchmark (or such component) has ceased or will cease to provide all Available Tenors of such Benchmark (or such component thereof) permanently or indefinitely&#59; provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that all Available Tenors of such Benchmark (or such component thereof) are no longer, or as of a specified future date will no longer be, representative.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For the avoidance of doubt, a &#8220;Benchmark Transition Event&#8221; will be deemed to have occurred with respect to any Benchmark if a public statement or publication of information set forth above has occurred with respect to each then-current Available Tenor of such Benchmark (or the published component used in the calculation thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Benchmark Unavailability Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Benchmark, the period (if any) (x) beginning at the time that a Benchmark Replacement Date pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of that definition has occurred if, at such time, no Benchmark Replacement has replaced such then-current Benchmark for all purposes hereunder and under any Loan Document in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (y) ending at the time that a Benchmark Replacement has replaced such then-current Benchmark for all purposes hereunder and under any Loan Document in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Beneficial Ownership Certification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a certification regarding beneficial ownership or control as required by the Beneficial Ownership Regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Beneficial Ownership Regulation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means 31 C.F.R. &#167; 1010.230.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Benefit Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any of (a) an &#8220;employee benefit plan&#8221; (as defined in Section 3(3) of ERISA) that is subject to Title I of ERISA, (b) a &#8220;plan&#8221; as defined in Section 4975 of the Code to which Section 4975 of the Code applies, and (c) any Person whose assets include (for purposes of the Plan Asset Regulations or otherwise for purposes of Title I of ERISA or Section 4975 of the Code) the assets of any such &#8220;employee benefit plan&#8221; or &#8220;plan&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">BKBM Interpolated Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, with respect to any Term Benchmark Borrowing denominated in New Zealand Dollars and for any Interest Period, the rate per annum (rounded to the same number of decimal places as the BKBM Screen Rate) determined by the Administrative Agent (which determination shall be conclusive and binding absent manifest error) to be equal to the rate that results from interpolating on a linear basis between&#58; (a) the BKBM Screen Rate for the longest period (for which the BKBM Screen Rate is available for New Zealand Dollars) that is shorter than the Impacted BKBM Rate Interest Period&#59; and (b) the BKBM Screen Rate for the shortest period (for which the BKBM Screen Rate is available for New Zealand Dollars) that exceeds the Impacted BKBM Rate Interest Period, in each case, at such time&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if any BKBM Interpolated Rate shall be less than zero, such rate shall be deemed to be zero for the purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">BKBM Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in New Zealand Dollars and for any Interest Period, the BKBM Screen Rate at approximately 11&#58;00 a.m., Local Time, two Business Days prior to the commencement of such Interest Period&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if the BKBM Screen Rate shall not be available at such time for such Interest Period (an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Impacted BKBM Rate Interest Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) with respect to New Zealand Dollars then the BKBM Rate shall be the BKBM Interpolated Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">BKBM Screen Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Interest Period, the rate per annum determined by the Administrative Agent which is equal to the average bank bill reference rate as administered by the New Zealand Financial Markets Association (or any other person that takes over the administration of such rate) for bills of exchange with a tenor equal in length to such Interest Period as displayed on page BKBM of the Reuters screen (or, in the event such rate does not appear on such page, on any successor or substitute page on such screen that displays such rate, or on the appropriate page of such other information service that publishes such rate, or on the appropriate page of such other information service that publishes such rate as shall be selected by the Administrative Agent from time to time in its reasonable discretion) at or about 11&#58;00 a.m. (Local Time) on the first day of such Interest Period.  If the BKBM Screen Rate shall be less than zero, the BKBM Screen Rate shall be deemed to be zero for purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in the preamble hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Borrowing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Revolving Loans of the same Type, made, converted or continued on the same date and, in the case of Term Benchmark Loans, as to which a single Interest Period is in effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Borrowing Availability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination, the total Commitments minus the sum of the Total Revolving Credit Exposures (including, without duplication, the outstanding balance of Letter of Credit Obligations then outstanding).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Borrowing Request</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a request by the Borrower for a Revolving Borrowing in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Business Day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any day (other than a Saturday or a Sunday) on which banks are open for business in New&#160;York City&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the term &#8220;Business Day&#8221; means, (a) in relation to Loans referencing the Adjusted Term SOFR Rate and any interest rate settings, fundings, disbursements, settlements or payments of any such Loans referencing the Adjusted Term SOFR Rate or any other dealings of such Loans referencing the Adjusted Term SOFR Rate, any such day that is a U.S. Government Securities Business Day, (b) in relation to Loans denominated in Sterling, any day (other than a Saturday or a Sunday) on which banks are open </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">for business in London, (c) in relation to Loans denominated in Yen and in relation to the calculation or computation of TIBOR or the Japanese Prime Rate, any day (other than a Saturday or a Sunday) on which banks are open for business in Japan, (d) in relation to Loans denominated in Euros and in relation to the calculation or computation of EURIBOR, any day which is a TARGET Day, (e) if such day relates to the making of a Loan denominated in Canadian Dollars, a day on which commercial banks are open for business in Toronto, Ontario, (f) if such day relates to the making of a Loan denominated in Australian Dollars, a day on which commercial banks are open for business in Sydney, Australia,  (g) in relation to RFR Loans and any interest rate settings, fundings, disbursements, settlements or payments of any such RFR Loan, or any other dealings in the applicable Applicable Currency of such RFR Loan, any such day that is only an RFR Business Day, (h) if such day relates to an interest rate setting for a Loan denominated in a currency other than Dollars, Canadian Dollars, British Pounds Sterling or Euro, any such day on which dealings in deposits in the relevant currency are conducted by and between banks in the London or other applicable offshore interbank market for such currency and (i) if such day relates to the making of a Loan denominated in a currency other than Dollars, Canadian Dollars, British Pounds Sterling or Euro (but not an interest rate setting), any such day on which banks are open for foreign exchange business in the principal financial center of the country of such currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Finance Leases Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of any Person means the amount of the obligations of such Person under finance leases which would be shown as a liability on a balance sheet of such Person prepared in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">CBR Loan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Loan that bears interest at a rate determined by reference to the Central Bank Rate or the Japanese Prime Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">CBR Spread</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any CBR Loan, the Applicable Rate applicable to the Loan that was replaced by such CBR Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">CDOR Interpolated Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, with respect to any Term Benchmark Borrowing denominated in Canadian Dollars and for any Interest Period, the rate per annum (rounded to the same number of decimal places as the CDOR Screen Rate) determined by the Administrative Agent (which determination shall be conclusive and binding absent manifest error) to be equal to the rate that results from interpolating on a linear basis between&#58; (a) the CDOR Screen Rate for the longest period (for which the CDOR Screen Rate is available for Canadian Dollars) that is shorter than the Impacted CDOR Rate Interest Period&#59; and (b) the CDOR Screen Rate for the shortest period (for which the CDOR Screen Rate is available for Canadian Dollars) that exceeds the Impacted CDOR Rate Interest Period, in each case, at such time&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if any CDOR Interpolated Rate shall be less than zero, such rate shall be deemed to be zero for the purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">CDOR Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in Canadian Dollars and for any Interest Period, the CDOR Screen Rate at approximately 11&#58;00 a.m., Local Time, two Business Days prior to the commencement of such Interest Period&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if the CDOR Screen Rate shall not be available at such time for such Interest Period (an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Impacted CDOR Rate Interest Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) with respect to Canadian Dollars then the CDOR Rate shall be the CDOR Interpolated Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">CDOR Screen Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means on any day for the relevant Interest Period, the annual rate of interest equal to the average rate applicable to Canadian dollar Canadian bankers&#8217; acceptances for the applicable period that appears on the &#8220;Reuters Screen CDOR Page&#8221; as defined in the International Swap Dealer Association, Inc. definitions, as modified and amended from time to time (or, in the event such rate does not appear on such page or screen, on any successor or substitute page or screen that displays such rate, or on the appropriate page of such other information service that publishes such rate from time to time, as selected by the Administrative Agent in its reasonable discretion), rounded to the nearest 1&#47;100</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of 1% (with .005% being rounded up), as of 10&#58;15 a.m. Toronto local time on the first day of such Interest Period and, if such day is not a business day, then on the immediately preceding </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">business day (as adjusted by Administrative Agent after 10&#58;15 a.m. Toronto local time to reflect any error in the posted rate of interest or in the posted average annual rate of interest).  If the CDOR Screen Rate shall be less than zero, the CDOR Screen Rate shall be deemed to be zero for purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Central Bank Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, the greater of (I)(A)&#160;for any Loan denominated in (a) Sterling, the Bank of England (or any successor thereto)&#8217;s &#8220;Bank Rate&#8221; as published by the Bank of England (or any successor thereto) from time to time, (b) Euro, one of the following three rates as may be selected by the Administrative Agent in its reasonable discretion&#58; (1) the fixed rate for the main refinancing operations of the European Central Bank (or any successor thereto), or, if that rate is not published, the minimum bid rate for the main refinancing operations of the European Central Bank (or any successor thereto), each as published by the European Central Bank (or any successor thereto) from time to time, (2) the rate for the marginal lending facility of the European Central Bank (or any successor thereto), as published by the European Central Bank (or any successor thereto) from time to time or (3) the rate for the deposit facility of the central banking system of the Participating Member States, as published by the European Central Bank (or any successor thereto) from time to time, and (c) any other Foreign Currency, a central bank rate as determined by the Administrative Agent in its reasonable discretion&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (B) the applicable Central Bank Rate Adjustment and (ii) the Floor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Central Bank Rate Adjustment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any day, for any Loan denominated in (a) Euro, a rate equal to the difference (which may be a positive or negative value or zero) of (i) the average of the Adjusted EURIBOR Rate for the five most recent Business Days preceding such day for which the EURIBOR Screen Rate was available (excluding, from such averaging, the highest and the lowest Adjusted EURIBOR Rate applicable during such period of five Business Days) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">minus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (ii) the Central Bank Rate in respect of Euro in effect on the last Business Day in such period, (b) Sterling, a rate equal to the difference (which may be a positive or negative value or zero) of (i) the average of SONIA for the five most recent RFR Business Days preceding such day for which SONIA was available (excluding, from such averaging, the highest and the lowest SONIA applicable during such period of five RFR Business Days) minus (ii) the Central Bank Rate in respect of Sterling in effect on the last RFR Business Day in such period, and (c) any other Applicable Currency, a Central Bank Rate Adjustment as determined by the Administrative Agent in its reasonable discretion. For purposes of this definition, (x) the term Central Bank Rate shall be determined disregarding clause (B) of the definition of such term and (y) the EURIBOR Rate on any day shall be based on the EURIBOR Screen Rate, on such day at approximately the time referred to in the definition of such term for deposits in the applicable Applicable Currency for a maturity of one month.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">CFC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in the definition of &#8220;Excluded Subsidiary.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">CFC Holdco</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in the definition of &#8220;Excluded Subsidiary.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Change in Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the acquisition of ownership, directly or indirectly, beneficially or of record, by any Person or group (within the meaning of the Securities Exchange Act of 1934 and the rules of the SEC thereunder as in effect on the date hereof), of Equity Interests representing more than 40% of the aggregate ordinary voting power represented by the issued and outstanding Equity Interests of the Borrower. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Change in Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the occurrence after the date of this Agreement or, with respect to any Lender, such later date on which such Lender becomes a party to this Agreement, of (a) the adoption of or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation or treaty or in the administration, interpretation, implementation or application thereof by any Governmental Authority or (c) compliance by any Lender or the Issuing Bank (or, for purposes of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.15(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, by any lending office of such Lender or by such Lender&#8217;s or the Issuing Bank&#8217;s holding company, if any) with any request, guideline, requirement or directive (whether or not having the force of law) of any Governmental Authority made or issued after the date of this Agreement&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, notwithstanding anything herein to the contrary,  (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">guidelines, requirements or directives thereunder or issued in connection therewith or in the implementation thereof and (y) all requests, rules, guidelines, requirements or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall be deemed to be a &#8220;Change in Law,&#8221; regardless of the date enacted, adopted or issued or implemented.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Charges</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">CME Term SOFR Administrator</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means CME Group Benchmark Administration Limited as administrator of the forward-looking term Secured Overnight Financing Rate (SOFR) (or a successor administrator).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Collateral</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any and all property owned, leased or operated by a Person covered by the Collateral Documents and any and all other property of any Loan Party, now existing or hereafter acquired, that may at any time be, become or be intended to be, subject to a security interest or Lien in favor of the Administrative Agent, on behalf of itself and the Lenders and other Secured Parties, to secure the Secured Obligations, which, for the avoidance of doubt, shall not include any copyrights, patents, trademarks or other Intellectual Property or any other Excluded Assets (as defined in the Security Agreement).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Collateral Documents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, collectively, the Security Agreement and any other agreements, instruments and documents executed in connection with this Agreement that are intended to create, perfect or evidence Liens to secure the Secured Obligations, including, without limitation, all other security agreements, pledge agreements, mortgages, deeds of trust, loan agreements, pledges, powers of attorney, financing statements and all other written matter whether theretofore, now or hereafter executed by any Loan Party and delivered to the Administrative Agent. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Commitment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to each Lender, the commitment of such Lender to make Revolving Loans and to acquire participations in Letters of Credit hereunder, expressed as an amount representing the maximum aggregate amount of such Lender&#8217;s Revolving Credit Exposure hereunder, as such commitment may be (a)&#160;reduced from time to time pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.09</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (b) increased pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.21</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (c)&#160;reduced or increased from time to time pursuant to assignments by or to such Lender pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;9.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The initial amount of each Lender&#8217;s Commitment is set forth on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 2.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or in the Assignment and Assumption pursuant to which such Lender shall have assumed its Commitment, as applicable.  The initial aggregate principal amount of the Lenders&#8217; Commitments is $200,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Commodity Exchange Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Commodity Exchange Act (7 U.S.C. &#167; 1 et seq.), as amended from time to time, and any successor statute.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Communications</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.03(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Connection Income Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Other Connection Taxes that are imposed on or measured by net income (however denominated) or that are franchise Taxes or branch profits Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a Person, whether through the ability to exercise voting power, by contract or otherwise.  &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Controlling</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Controlled</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; have meanings correlative thereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Corresponding Tenor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; with respect to any Available Tenor means, as applicable, either a tenor (including overnight) or an interest payment period having approximately the same length (disregarding business day adjustment) as such Available Tenor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Convertible Notes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means the 2018 Convertible Notes, the 2020 Convertible Notes and any other unsecured convertible notes issued by the Borrower from time to time to the extent such issuance is permitted under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Copyrights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, all of such Person&#8217;s right, title, and interest in and to the following&#58;  (a) all copyrights, rights and interests in copyrights, works protectable by copyright, copyright registrations, and copyright applications&#59; (b) all renewals of any of the foregoing&#59; (c) all income, royalties, damages, and payments now or hereafter due and&#47;or payable under any of the foregoing, including, without limitation, damages or payments for past or future infringements for any of the foregoing&#59; (d) the right to sue for past, present, and future infringements of any of the foregoing&#59; and (e) all rights corresponding to any of the foregoing throughout the world.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Covered Entity</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any of the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b)&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Covered Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.19</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Credit Event</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Borrowing, the issuance, amendment, renewal or extension of a Letter of Credit, an LC Disbursement or any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Credit Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Administrative Agent, each Issuing Bank or any other Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Daily Simple RFR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means, for any day (an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">RFR Interest Day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), an interest rate per annum equal to, for any RFR Loan denominated in (i) Sterling, the greater of (x) SONIA for the day that is five (5) RFR Business Days prior to (A) if such RFR Interest Day is an RFR Business Day, such RFR Interest Day or (B) if such RFR Interest Day is not an RFR Business Day, the RFR Business Day immediately preceding such RFR Interest Day and (y) zero and (ii) Dollars, Daily Simple SOFR.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Daily Simple SOFR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any day (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">SOFR Rate Day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), a rate per annum equal to SOFR for the day (such day &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">SOFR Determination Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) that is five (5) RFR Business Days prior to (i) if such SOFR Rate Day is an RFR Business Day, such SOFR Rate Day or (ii) if such SOFR Rate Day is not an RFR Business Day, the RFR Business Day immediately preceding such SOFR Rate Day, in each case, as such SOFR is published by the SOFR Administrator on the SOFR Administrator&#8217;s Website.  Any change in Daily Simple SOFR due to a change in SOFR shall be effective from and including the effective date of such change in SOFR without notice to the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Default</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any event or condition which constitutes an Event of Default or which upon notice, lapse of time or both would, unless cured or waived, become an Event of Default.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Default Right</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Defaulting Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Lender that (a) has failed, within two (2) Business Days of the date required to be funded or paid, to (i) fund any portion of its Loans, (ii) fund any portion of its participations in Letters of Credit or (iii) pay over to any Credit Party any other amount required to be paid by it hereunder, unless, in the case of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above, such Lender notifies the Administrative Agent in writing that such failure is the result of such Lender&#8217;s good faith determination that a condition precedent to funding (specifically identified and including the particular default, if any) has not been satisfied, (b) has notified the Borrower or any Credit Party in writing, or has made a public statement to the effect, that it does not intend or expect to comply with any of its funding obligations under this Agreement (unless such writing or public statement indicates that such position is based on such Lender&#8217;s good faith determination that a condition precedent (specifically identified and including the particular default, if any) to funding a Loan under this Agreement cannot be satisfied) or generally under other agreements in which it commits to extend credit, (c) has failed, within three (3) Business Days after request by the Borrower or a Credit Party, acting in good faith, to provide a certification in writing from an authorized officer of such Lender that it will comply with its obligations (and is financially able to meet such obligations as of the date of certification) to fund prospective Loans and participations in then outstanding Letters of Credit under this Agreement, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Lender shall cease to be a Defaulting Lender pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> upon such Credit Party&#8217;s receipt of such certification in form and substance satisfactory to it and the Administrative Agent, or (d) has become the subject of (i) a Bankruptcy Event or (ii) a&#160;Bail-In Action.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Disclosed Matters</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the actions, suits and proceedings and the environmental matters disclosed in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3.06</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Dividing Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in the definition of &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Division</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Division</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the division of the assets, liabilities and&#47;or obligations of a Person (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Dividing Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) among two or more Persons (whether pursuant to a &#8220;plan of division&#8221; or similar arrangement), which may or may not include the Dividing Person and pursuant to which the Dividing Person may or may not survive. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Division Successor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Person that, upon the consummation of a Division of a Dividing Person, holds all or any portion of the assets, liabilities and&#47;or obligations previously held by such Dividing Person immediately prior to the consummation of such Division. A Dividing Person which retains any of its assets, liabilities and&#47;or obligations after a Division shall be deemed a Division Successor upon the occurrence of such Division. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Dollar Equivalent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any amount, at the time of determination thereof, (a) if such amount is expressed in dollars, such amount, (b) if such amount is expressed in a Foreign Currency, the equivalent of such amount in dollars determined by using the rate of exchange for the purchase of dollars with the Foreign Currency last provided (either by publication or otherwise provided to the Administrative Agent) by the applicable Thompson Reuters Corp. (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Reuters</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) source on the Business Day (New York City time)  immediately preceding the date of determination or if such service ceases to be available or ceases to provide a rate of exchange for the purchase of dollars with the Foreign Currency, as provided by such other publicly available information service which provides that rate of exchange at such time in place of Reuters chosen by the Administrative Agent in its sole discretion (or if such service ceases to be available or ceases to provide such rate of exchange, the equivalent of such amount in dollars as determined by the Administrative Agent using any method of determination it deems appropriate in its sole discretion) and (c) if such amount is denominated in any other currency, the equivalent of such amount in dollars as determined by the Administrative Agent using any method of determination it deems appropriate in its sole discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Dollars</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">dollars</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">$</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; refers to lawful money of the United&#160;States of America.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">EBITDA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any period, Net Income for such period </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (a) without duplication and to the extent deducted in determining Net Income for such period, the sum of (i) Interest </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expense for such period, (ii) income tax expense for such period, (iii) all amounts attributable to depreciation and amortization expense for such period, (iv) expenses relating to share-based compensation and (v) any other non-cash charges, non-cash losses or non-cash expenses for such period (but excluding any non-cash charge, loss or expense in respect of an item that was included in Net Income in a prior period), (vi) costs arising from or related to mergers, acquisitions, divestitures, or similar transactions permitted hereunder (including transition, retention and integration), in each case regardless of whether such transactions have been consummated, (vii) expenses with respect to earn-outs payable as a purchase price (or a portion thereof) in acquisitions, (viii) extraordinary, unusual and&#47;or non-recurring charges, costs, credits or items or loss, determined on a consolidated basis in accordance with GAAP, (ix) any expenses or charges related to any equity financing or offering, investment, indebtedness or restricted payment permitted hereunder, or any modification to any instrument of indebtedness permitted hereunder, in each case regardless of whether such transaction has been consummated and including the Transaction Costs, (x) all expenses or charges (including deferred financing costs written off and premiums paid) in connection with any early extinguishment of debt, including hedging obligations or other derivative instruments, (xi) restructuring costs, reorganization costs, integration costs and other related one-time charges, provided that, for any trailing twelve month period, the aggregate amount added pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (xi)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (xii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not exceed 15% of EBITDA for the applicable Reference Period (calculated before giving effect to such addbacks), (xii) pro forma cost savings and synergies that are reasonably identifiable and factually supportable and realizable within 12 months of the closing of the applicable acquisition to which such add backs relate, provided that, for any trailing twelve month period, the aggregate amount added pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (xii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (xi)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not exceed 15% of EBITDA for the applicable Reference Period (calculated before giving effect to such addbacks), and (xiii) cash expenses or charges to the extent fully indemnified by a third party or covered by insurance, but only to the extent (1) the applicable indemnification obligation or insurance policy remains in full force and effect, and (2) the counterparty to such indemnification obligation or applicable insurance provider has not refused or challenged a claim in writing for such indemnification or insurance payment, without duplication of any gains from such indemnification payment or insurance proceeds received in any subsequent period, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">minus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (b) without duplication and to the extent included in Net Income, (i) any cash payments made during such period in respect of non-cash charges described in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> taken in a prior period and (ii) any non-cash items of income for such period, all calculated for the Borrower and its Subsidiaries on a consolidated basis in accordance with GAAP. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">ECP</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an &#8220;eligible contract participant&#8221; as defined in Section 1(a)(18) of the Commodity Exchange Act or any regulations promulgated thereunder and the applicable rules issued by the Commodity Futures Trading Commission and&#47;or the SEC.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">EEA Financial Institution</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this definition, or (c) any financial institution established in an EEA Member Country which is a subsidiary of an institution described in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this definition and is subject to consolidated supervision with its parent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">EEA Member Country</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any of the member states of the European Union, Iceland, Liechtenstein, and Norway.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">EEA Resolution Authority</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any public administrative authority or any Person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Electronic Signature</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an electronic sound, symbol, or process attached to, or associated with, a contract or other record and adopted by a Person with the intent to sign, authenticate or accept such contract or record.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Electronic System</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any electronic system, including e-mail, e-fax, web portal access for the Borrower and any other Internet or extranet-based site, whether such electronic system is owned, operated or hosted by the Administrative Agent or any Issuing Bank and any of its respective Related Parties or any other Person, providing for access to data protected by passcodes or other security system.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Environmental Laws</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all laws, rules, regulations, codes, ordinances, orders, decrees, judgments, injunctions, notices or binding agreements issued, promulgated or entered into by any Governmental Authority, relating in any way to the environment, preservation or reclamation of natural resources, the management, Release or threatened Release of any Hazardous Material or to health and safety matters.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Environmental Liability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any liability, contingent or otherwise (including any liability for damages, costs of environmental remediation, fines, penalties or indemnities), of the Borrower or any Subsidiary directly or indirectly resulting from or based upon (a) any violation of any Environmental Law, (b)&#160;the generation, use, handling, transportation, storage, treatment or disposal of any Hazardous Materials, (c) any exposure to any Hazardous Materials, (d)&#160;the Release or threatened Release of any Hazardous Materials into the environment or (e)&#160;any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect to any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Equity Interests</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means shares of capital stock, partnership interests, membership interests in a limited liability company, beneficial interests in a trust or other equity ownership interests in a Person, and any warrants, options or other rights entitling the holder thereof to purchase or acquire any such equity interest.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Equivalent Amount</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of any currency with respect to any amount of dollars at any date shall mean the equivalent in such currency of such amount of dollars, calculated on the basis of the Exchange Rate for such other currency at 11&#58;00 a.m., London time, on the date on or as of which such amount is to be determined.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">ERISA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Employee Retirement Income Security Act of 1974, as amended from time to time, and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">ERISA Affiliate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any trade or business (whether or not incorporated) that, together with the Borrower, is treated as a single employer under Section&#160;414(b) or (c)&#160;of the Code or Section 4001(14) of ERISA or, solely for purposes of Section&#160;302 of ERISA and Section&#160;412 of the Code, is treated as a single employer under Section&#160;414 of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">ERISA Event</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a)&#160;any &#8220;reportable event&#8221;, as defined in Section&#160;4043 of ERISA or the regulations issued thereunder with respect to a Plan (other than an event for which the 30 day notice period is waived)&#59; (b)&#160;the failure to satisfy the &#8220;minimum funding standard&#8221; (as defined in Section&#160;412 of the Code or Section&#160;302 of ERISA), whether or not waived&#59; (c)&#160;the filing pursuant to Section&#160;412(c) of the Code or Section&#160;302(c) of ERISA of an application for a waiver of the minimum funding standard with respect to any Plan&#59; (d)&#160;the incurrence by the Borrower or any of its ERISA Affiliates of any liability under Title&#160;IV of ERISA with respect to the termination of any Plan&#59; (e)&#160;the receipt by the Borrower or any ERISA Affiliate from the PBGC or a plan administrator of any notice relating to an intention to terminate any Plan or Plans or to appoint a trustee to administer any Plan&#59; (f)&#160;the incurrence by the Borrower or any of its ERISA Affiliates of any liability with respect to the withdrawal or partial withdrawal of the Borrower or any ERISA Affiliate from any Plan or Multiemployer Plan&#59; or (g)&#160;the receipt by the Borrower or any ERISA Affiliate of any notice, or the receipt by any Multiemployer Plan from the Borrower or any ERISA Affiliate of any notice, concerning the imposition upon the Borrower or any ERISA Affiliate of Withdrawal Liability or a determination that a Multiemployer Plan is, or is expected to be, insolvent, in critical status or in reorganization, within the meaning of Title&#160;IV of ERISA.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">EU Bail-In Legislation Schedule</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor Person), as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">EURIBOR Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in Euros and for any Interest Period, the EURIBOR Screen Rate two TARGET Days prior to the commencement of such Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">EURIBOR Screen Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the euro interbank offered rate administered by the European Money Markets Institute (or any other person which takes over the administration of that rate) for the relevant period displayed (before any correction, recalculation or republication by the administrator) on page EURIBOR01 of the Thomson Reuters screen (or any replacement Thomson Reuters page which displays that rate) or on the appropriate page of such other information service which publishes that rate from time to time in place of Thomson Reuters as published at approximately 11&#58;00 a.m. Local Time two TARGET Days prior to the commencement of such Interest Period.  If such page or service ceases to be available, the Administrative Agent may specify another page or service displaying the relevant rate after consultation with the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Euro</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#8364;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34; means the single currency of the Participating Member States.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Event of Default</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article&#160;VII</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Excluded Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i) any Subsidiary that is a &#8220;controlled foreign corporation&#8221; within the meaning of the Code (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">CFC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), (ii) any Subsidiary substantially all the assets of which consist of Equity Interests of one or more CFCs (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">CFC Holdco</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;),  (iii) any Subsidiary of a CFC and (iv) any Immaterial Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Excluded Swap Obligation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Guarantor, any Swap Obligation if, and to the extent that, all or a portion of the Guarantee of such Guarantor of, or the grant by such Guarantor of a security interest to secure, such Swap Obligation (or any Guarantee thereof) is or becomes illegal under the Commodity Exchange Act or any rule, regulation or order of the Commodity Futures Trading Commission (or the application or official interpretation of any thereof) by virtue of such Guarantor&#8217;s failure for any reason to constitute an ECP at the time the Guarantee of such Guarantor or the grant of such security interest becomes or would become effective with respect to such Swap Obligation.  If a Swap Obligation arises under a master agreement governing more than one swap, such exclusion shall apply only to the portion of such Swap Obligation that is attributable to swaps for which such Guarantee or security interest is or becomes illegal. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Excluded Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any of the following Taxes imposed on or with respect to a Recipient or required to be withheld or deducted from a payment to a Recipient, (a) Taxes imposed on or measured by net income (however denominated), franchise Taxes, and branch profits Taxes, in each case, (i) imposed as a result of such Recipient being organized under the laws of, or having its principal office or, in the case of any Lender, its applicable lending office located in, the jurisdiction imposing such Tax (or any political subdivision thereof) or (ii) that are Other Connection Taxes, (b) in the case of a Lender, U.S. federal withholding Taxes imposed on amounts payable to or for the account of such Lender with respect to an applicable interest in a Loan, Letter of Credit or Commitment pursuant to a law in effect on the date on which (i) such Lender acquires such interest in the Loan, Letter of Credit or Commitment (other than pursuant to an assignment request by the Borrower under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) or (ii) such Lender changes its lending office, except in each case to the extent that, pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, amounts with respect to such Taxes were payable either to such Lender&#8217;s assignor immediately before such Lender acquired the applicable interest in a Loan, Letter of Credit or Commitment or to such Lender immediately before it changed its lending office, (c) Taxes attributable to such Recipient&#8217;s failure to comply with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.17(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (d) any U.S. federal withholding Taxes imposed under FATCA.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">FATCA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Sections&#160;1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with), any current or future regulations or official interpretations thereof and any agreement entered into pursuant to Section 1471(b)(1) of the Code and any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities and implementing such Sections of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">FCA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.06</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Federal Funds Effective Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any day, the rate calculated by the NYFRB based on such day&#8217;s federal funds transactions by depositary institutions, as determined in such manner as  shall be set forth on the NYFRB&#8217;s Website  from time to time, and published on the next succeeding Business Day by the NYFRB as the effective federal funds rate&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if the Federal Funds Effective Rate as so determined would be less than zero percent, such rate shall be deemed to be zero percent for the purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Federal Reserve Board</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Board of Governors of the Federal Reserve System of the United&#160;States of America.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Financial Officer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the chief financial officer, vice president of finance, principal accounting officer, treasurer or controller of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Financial Statements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the financial statements to be furnished pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 5.01(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">First Amendment Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means May 11, 2020.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Flood Laws</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">has the meaning assigned to such term in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Floor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the benchmark rate floor, if any, provided in this Agreement initially (as of the execution of this Agreement, the modification, amendment or renewal of this Agreement or otherwise) with respect to the Adjusted Term SOFR Rate, Adjusted EURIBOR Rate, TIBOR Rate, STIBOR Rate, CDOR, AUD Rate, BKBM Rate or each Adjusted Daily Simple RFR, the Japanese Prime Rate or the Central Bank Rate, as applicable. For the avoidance of doubt the initial Floor for each of Adjusted Term SOFR Rate, Adjusted EURIBOR Rate, TIBOR Rate, each Adjusted Daily Simple RFR, the Japanese Prime Rate or the Central Bank Rate shall be zero.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Foreign Currency</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each Applicable Currency, other than dollars. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Foreign Currency LC Exposure</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, the sum of (a) the Dollar Equivalent of the aggregate undrawn and unexpired amount of all outstanding Foreign Currency Letters of Credit at such time plus (b) the aggregate principal Dollar Equivalent of all LC Disbursements in respect of Foreign Currency Letters of Credit that have not yet been reimbursed at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Foreign Currency Letter of Credit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Letter of Credit denominated in a Foreign Currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Foreign Currency Sublimit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means $50,000,000. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Foreign Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) if the Borrower is a U.S. Person, a Lender that is not a U.S. Person, and (b) if the Borrower is not a U.S. Person, a Lender that is resident or organized under the laws of a jurisdiction other than that in which the Borrower is resident for tax purposes.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">GAAP</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means generally accepted accounting principles in the United&#160;States of America.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Governmental Authority</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the government of the United&#160;States of America, any other nation or any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Governmental Authorizations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any and all permits, licenses, authorizations, certificates, registrations, accreditations and governmental or other approvals applied for, pending by, issued or given to any Loan Party or any of their Subsidiaries with or by any governmental or quasi-governmental authorities (federal, state, local or foreign) and all agreements with any governmental or quasi-governmental authorities (federal, state, local or foreign) entered into by any Loan Party or any of their Subsidiaries, that are in effect or applied for.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Guarantee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of or by any Person (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">guarantor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) means any obligation, contingent or otherwise, of the guarantor guaranteeing or having the economic effect of guaranteeing any Indebtedness of any other Person (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">primary obligor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in any manner, whether directly or indirectly, and including any obligation of the guarantor, direct or indirect, (a)&#160;to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or to purchase (or to advance or supply funds for the purchase of) any security for the payment thereof, (b)&#160;to purchase or lease property, securities or services for the purpose of assuring the owner of such Indebtedness of the payment thereof, (c)&#160;to maintain working capital, equity capital or any other financial statement condition or liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness or (d)&#160;as an account party in respect of any letter of credit or letter of guaranty issued to support such Indebtedness&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the term Guarantee shall not include endorsements for collection or deposit in the ordinary course of business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Guarantors</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all Loan Guarantors and all non-Loan Parties who have delivered an Obligation Guaranty, and the term &#8220;Guarantor&#8221; means each or any one of them individually.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Hazardous Materials</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;  means&#58;  (a) any substance, material, or waste that is included within the definitions of &#8220;hazardous substances,&#8221; &#8220;hazardous materials,&#8221; &#8220;hazardous waste,&#8221; &#8220;toxic substances,&#8221; &#8220;toxic materials,&#8221; &#8220;toxic waste,&#8221; or words of similar import in any Environmental Law, (b) those substances listed as hazardous substances by the United States Department of Transportation (or any successor agency) (49 C.F.R. Part 302 and amendments thereto) or by the Environmental Protection Agency (or any successor agency) (40 C.F.R. Part 302 and amendments thereto)&#59; and (c) any substance, material, or waste that is petroleum, petroleum related, or a petroleum by-product, asbestos or asbestos-containing material, polychlorinated biphenyls, flammable, explosive, radioactive, freon gas, radon, or a pesticide, herbicide, or any other agricultural chemical.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Immaterial Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any date, unless otherwise designated by Borrower in a written notice to the Administrative Agent, any Subsidiary that, together with such Subsidiary&#8217;s consolidated Subsidiaries, does not, as of the end of the most recently ended Reference Period are available to the Administrative Agent pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, have assets with a book value (or, if determined in good faith by Borrower to be greater, fair market value) in excess of 5.0% of Total Assets&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that the aggregate assets or revenues of all Immaterial Subsidiaries, determined in accordance with GAAP, as of the end of or for any Reference Period may not exceed 10.0% of Total Assets, respectively, of Borrower and its Subsidiaries on a consolidated basis (and Borrower will designate in writing to the Administrative Agent from time to time as necessary the Subsidiaries that will cease to be &#8220;Immaterial Subsidiaries&#8221; in order to comply with the foregoing limitation).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Impacted AUD Rate Interest Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the definition of &#8220;AUD Rate.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Impacted BKBM Rate Interest Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">has the meaning assigned to such term in the definition of &#8220;BKBM Rate.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Impacted CDOR Rate Interest Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the definition of &#8220;CDOR Rate.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Impacted STIBOR Rate Interest Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the definition of &#8220;STIBOR Rate.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Impacted TIBOR Rate Interest Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the definition of &#8220;TIBOR Rate.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Indebtedness</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of any Person means, without duplication, (a)&#160;all obligations of such Person for borrowed money or with respect to deposits or advances of any kind, (b)&#160;all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, (c)&#160;all obligations of such Person upon which interest charges are customarily paid, (d)&#160;all obligations of such Person under conditional sale or other title retention agreements relating to property acquired by such Person, (e)&#160;all obligations of such Person in respect of the deferred purchase price of property or services (excluding current accounts payable incurred in the ordinary course of business), (f)&#160;all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on property owned or acquired by such Person, whether or not the Indebtedness secured thereby has been assumed, (g)&#160;all Guarantees by such Person of Indebtedness of others, (h)&#160;all Finance Lease Obligations of such Person, (i)&#160;any earn-out obligation to the extent such obligation is a liability on the balance sheet of such Person in accordance with GAAP, (j) all obligations, contingent or otherwise, of such Person as an account party in respect of letters of credit and letters of guaranty and (k)&#160;all obligations, contingent or otherwise, of such Person in respect of bankers&#8217; acceptances.  The Indebtedness of any Person shall include the Indebtedness of any other entity (including any partnership in which such Person is a general partner) to the extent such Person is liable therefor as a result of such Person&#8217;s ownership interest in or other relationship with such entity, except to the extent the terms of such Indebtedness provide that such Person is not liable therefor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Indemnified Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a)&#160;Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of any Loan Party under any Loan Document and (b)&#160;to the extent not otherwise described in (a) hereof, Other Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Indemnitee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.03(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Ineligible Institution</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.04(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Intellectual Property</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, any and all of such Person&#8217;s (a) Patents, Trademarks and Copyrights, including any amendments, renewals and extensions thereof, (b) trade secrets and trade secret rights, including, without limitation, any rights to unpatented inventions, know-how, operating manuals, (c) source code, (d) design rights which may be available to such Person and (e) claims for damages by way of past, present and future infringement of any of the foregoing, with the right, but not the obligation, to sue for and collect such damages for said use or infringement of the Intellectual Property rights identified above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Interest Coverage Ratio</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any period, the ratio of (a) EBITDA to (b) cash Interest Expense in the four consecutive fiscal quarters ended on the last day of such period, all calculated for the Borrower and its Subsidiaries on a consolidated basis in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Interest Election Request</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a request by the Borrower to convert or continue a Revolving Borrowing in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.08</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Interest Expense</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with reference to any period, total interest expense (including that attributable to Finance Leases Obligations) of the Borrower and its Subsidiaries for such period with respect to all outstanding Indebtedness of the Borrower and its Subsidiaries (including all commissions, discounts and other fees and charges owed with respect to letters of credit and bankers&#8217; acceptances and net costs under Swap Agreements in respect of interest rates, to the extent such net costs are allocable to such period in accordance with GAAP), calculated for the Borrower and its Subsidiaries on a consolidated basis for such period in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Interest Payment Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a)&#160;with respect to any ABR&#160;Loan, the last day of each March, June, September and December, (b)&#160;with respect to any RFR Loan, (1) each date that is on the numerically corresponding day in each calendar month that is one month after the Borrowing of such Loan (or, if there is no such numerically corresponding day in such month, then the last day of such month) and (c) with respect to any Term Benchmark Loan, the last day of the Interest Period applicable to the Borrowing of which such Loan is a part and, in the case of a Term Benchmark Borrowing with an Interest Period of more than three months&#8217; duration, each day prior to the last day of such Interest Period that occurs at intervals of three months&#8217; duration after the first day of such Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Interest Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means with respect to any Term Benchmark Borrowing, the period commencing on the date of such Borrowing and ending on the numerically corresponding day in the calendar month that is one, three or six months thereafter (in each case, subject to the availability for the Benchmark applicable to the relevant Loan or Commitment for any Applicable Currency), as the Borrower may elect&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that (i)&#160;if any Interest Period would end on a day other than a Business Day, such Interest Period shall be extended to the next succeeding Business Day unless, in the case of a Term Benchmark Borrowing only, such next succeeding Business Day would fall in the next calendar month, in which case such Interest Period shall end on the next preceding Business Day, (ii)&#160;any Interest Period pertaining to a Term Benchmark Borrowing that commences on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the last calendar month of such Interest Period) shall end on the last Business Day of the last calendar month of such Interest Period and (iii) no tenor that has been removed from this definition pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be available for specification in such Borrowing Request or Interest Election Request.  For purposes hereof, the date of a Borrowing initially shall be the date on which such Borrowing is made and, in the case of a Revolving Borrowing, thereafter shall be the effective date of the most recent conversion or continuation of such Borrowing. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">IRS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the United&#160;States Internal Revenue Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Issuing Bank</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means JPMorgan in its capacity as the issuer of Letters of Credit hereunder, and its</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">successors in such capacity as provided in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.06(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any Issuing Bank may, in its discretion, arrange for one or more Letters of Credit to be issued by Affiliates of such Issuing Bank, in which case the term &#8220;Issuing Bank&#8221; shall include any such Affiliate with respect to Letters of Credit issued by such Affiliate.  Each reference herein to the &#8220;Issuing Bank&#8221; shall be deemed to be a reference to the relevant Issuing Bank.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Japanese Prime Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means for any Loan denominated in Yen the greater of (a) (i) the Japanese local bank prime rate plus (ii) the Japanese Prime Rate Adjustment and (b) the Floor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Japanese Prime Rate Adjustment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any day, for any Loan denominated in Yen, a rate equal to the difference (which may be a positive or negative value or zero) of (i) the average of the Adjusted TIBOR Rate for the five most recent Business Days preceding such day for which the TIBOR Screen Rate was available (excluding, from such averaging, the highest and the lowest Adjusted TIBOR Rate applicable during such period of five Business Days) minus (ii) the Japanese Prime Rate in effect on the last Business Day in such period. For purposes of this definition, the TIBOR Rate on any day shall be based on the TIBOR Screen </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Rate on such day at approximately the time referred to in the definition of such term for deposits in Yen for a maturity of one month.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">JPMorgan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means JPMorgan Chase Bank, National Association.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">LC Disbursement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a payment made by the Issuing Bank pursuant to a Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">LC Exposure</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, the sum of (a)&#160;the aggregate undrawn Dollar Equivalent of all outstanding Letters of Credit at such time plus (b)&#160;the aggregate Dollar Equivalent of all LC Disbursements that have not yet been reimbursed by or on behalf of the Borrower at such time.  The LC Exposure of any Lender at any time shall be its Applicable Percentage of the total LC Exposure at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Lender Parent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Lender, any Person as to which such Lender is, directly or indirectly, a subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Lender-Related Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.03(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Persons listed on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 2.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and any other Person that shall have become a party hereto pursuant to an Assignment and Assumption, other than any such Person that ceases to be a party hereto pursuant to an Assignment and Assumption.  Unless the context otherwise requires, the term &#8220;Lenders&#8221; includes the Issuing Bank.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Letter of Credit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any letter of credit issued pursuant to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Letter of Credit Commitment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to each Issuing Bank, the commitment of such Issuing Bank to issue Letters of Credit hereunder.  The initial amount of each Issuing Bank&#8217;s Letter of Credit Commitment is set forth on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 2.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or if an Issuing Bank has entered into an Assignment and Assumption, the amount set forth for such Issuing Bank as its Letter of Credit Commitment in the Register maintained by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Liabilities</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any losses, claims (including intraparty claims), demands, damages or liabilities of any kind.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Lien</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any asset, (a)&#160;any mortgage, deed of trust, lien, pledge, hypothecation, encumbrance, charge or security interest in, on or of such asset, (b)&#160;the interest of a vendor or a lessor under any conditional sale agreement, capital lease or title retention agreement (or any financing lease having substantially the same economic effect as any of the foregoing) relating to such asset and (c)&#160;in the case of securities, any purchase option, call or similar right of a third party with respect to such securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Liquidity</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to the Borrower at any date, the sum of unrestricted domestic cash, cash equivalents and other short-term domestic investments of the Borrower and its Subsidiaries on such date, determined in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Loan Documents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means this Agreement, including schedules and exhibits hereto, each Collateral Document, the Loan Guaranty and any promissory notes and any other agreement, instrument, document or certificate entered into in connection herewith by the Borrower or any Loan Party with or in favor of the Administrative Agent and&#47;or the Lenders, including any amendments, modifications or supplements thereto or waivers thereof, legal opinions issued in connection with the other Loan Documents, UCC filings, flood determinations, letter of credit applications and any agreements between the Borrower and the Issuing Bank regarding the Issuing Bank&#8217;s Letter of Credit Commitment or the respective rights and obligations between the Borrower and the Issuing Bank in connection with the issuance of Letters of Credit and any other documents prepared in connection with the other Loan Documents, if any, and each other written matter whether heretofore, now or hereafter executed </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">by or on behalf of any Loan Party, or any employee of any Loan Party, and delivered to the Administrative Agent or any Lender in connection with this Agreement or the transactions contemplated hereby.  Any reference in this Agreement or any other Loan Document to a Loan Document shall include all appendices, exhibits or schedules thereto, and all amendments, restatements, supplements or other modifications thereto, and shall refer to this Agreement or such Loan Document as the same may be in effect at any and all times such reference becomes operative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Loan Guarantor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each Loan Party, other than Excluded Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Loan Guaranty</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means that certain Guaranty (including any and all supplements thereto), dated as of the Original Effective Date, among the Loan Guarantors and the Administrative Agent, for the benefit of the Administrative Agent and the other Secured Parties, and any other guarantee entered into, after the date of this Agreement by any other Loan Party (as required by this Agreement or any other Loan Document) or any other Person for the benefit of the Administrative Agent and the other Secured Parties, as the same may be amended, restated, supplemented or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Loan Parties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Borrower and each Guarantor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Loans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the loans made by the Lenders to the Borrower pursuant to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Local Time</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i) New York City time in the case of a Loan, Borrowing or LC Disbursement denominated in dollars, (ii) Sydney, Australia time in the case of a Loan, Borrowing or LC Disbursement denominated in Australian Dollars, (iii) Toronto, Ontario time in the case of a Loan, Borrowing or LC Disbursement denominated in Canadian Dollars, (iv) Wellington, New Zealand time in the case of a Loan, Borrowing or LC Disbursement denominated in New Zealand Dollars, (v) Brussels time in the case of a Loan, Borrowing or LC Disbursement denominated in Euros, (vi) Tokyo time in the case of a Loan, Borrowing or LC Disbursement denominated in Yen and (vii) local time in the case of a Loan, Borrowing or LC Disbursement denominated in a Foreign Currency (it being understood that such local time shall mean London, England time unless otherwise notified by the Administrative Agent).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Long-Term Debt</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Indebtedness that, in accordance with GAAP, constitutes (or, when incurred, constituted) a long-term liability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Material Adverse Effect</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a material adverse effect on (a)&#160;the business, assets, operations, property or financial condition of the Borrower and its Subsidiaries taken as a whole or (b) the validity or enforceability of any of the Loan Documents or the rights and remedies of the Administrative Agent or Lenders thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Material Indebtedness</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Indebtedness (other than the Loans and Letters of Credit), or obligations in respect of one or more Swap Agreements, of any one or more of the Borrower and its Subsidiaries in an aggregate principal amount exceeding $25,000,000.  For purposes of determining Material Indebtedness, the &#8220;principal amount&#8221; of the obligations of the Borrower or any Subsidiary in respect of any Swap Agreement at any time shall be the maximum aggregate amount (giving effect to any netting agreements) that the Borrower or such Subsidiary would be required to pay if such Swap Agreement were terminated at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Maturity Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means October 13, 2026.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Maximum Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Moody&#8217;s</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Moody&#8217;s Investors Service, Inc.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Multiemployer Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a multiemployer plan as defined in Section&#160;4001(a)(3) of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Net Income</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any period, the consolidated net income (or loss) determined for the Borrower and its Subsidiaries, on a consolidated basis, in accordance with GAAP&#59; provided that there shall be excluded (a) subject to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.06</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof, the income (or deficit) of any Person accrued prior to the date it becomes a Subsidiary or is merged into or consolidated with the Borrower or any Subsidiary, (b) the income (or deficit) of any Person (other than a Subsidiary) in which the Borrower or any Subsidiary has an ownership interest, except to the extent that any such income is actually received by the Borrower or such Subsidiary in the form of dividends or similar distributions and (c) the undistributed earnings of any Subsidiary, to the extent that the declaration or payment of dividends or similar distributions by such Subsidiary is not at the time permitted by the terms of any contractual obligation (other than under any Loan Document) or requirement of law applicable to such Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Non-Consenting Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">has the meaning assigned to such term in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.02(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">NYFRB</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Federal Reserve Bank of New York.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">NYFRB Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any day, the greater of (a) the Federal Funds Effective Rate in effect on such day and (b) the Overnight Bank Funding Rate in effect on such day (or for any day that is not a Business Day, for the immediately preceding Business Day)&#59; provided that if none of such rates are published for any day that is a Business Day, the term &#8220;NYFRB Rate&#8221; means the rate for a federal funds transaction quoted at 11&#58;00 a.m. on such day received by the Administrative Agent from a federal funds broker of recognized standing selected by it&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if any of the aforesaid rates as so determined shall be less than zero, such rate shall be deemed to be zero for purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">NYFRB&#8217;s Website</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the website of the NYFRB at http&#58;&#47;&#47;www.newyorkfed.org, or any successor source.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Obligation Guaranty</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Guarantee of all or any portion of the Secured Obligations executed and delivered to the Administrative Agent for the benefit of the Secured Parties by a guarantor who is not a Loan Party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all unpaid principal of and accrued and unpaid interest on the Loans, all LC Exposure, all accrued and unpaid fees and all expenses, reimbursements, indemnities and other obligations and indebtedness (including interest and fees accruing during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding), obligations and liabilities of any of the Loan Parties to any of the Lenders, the Administrative Agent, the Issuing Bank or any indemnified party, individually or collectively, existing on the Restatement Effective Date or arising thereafter, direct or indirect, joint or several, absolute or contingent, matured or unmatured, liquidated or unliquidated, secured or unsecured, in each case arising by contract, operation of law or otherwise, arising or incurred under this Agreement or any of the other Loan Documents or in respect of any of the Loans made or reimbursement or other obligations incurred or any of the Letters of Credit or other instruments at any time evidencing any thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Original</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means June 17, 2016.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Other Connection Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Recipient, Taxes imposed as a result of a present or former connection between such Recipient and the jurisdiction imposing such Tax (other than connections arising from such Recipient having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan, Letter of Credit or Loan Document).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">24</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Other Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all present or future stamp, court or documentary, intangible, recording, filing or similar Taxes that arise from any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect to, any Loan Document, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment (other than an assignment made pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Overnight Bank Funding Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any day, the rate comprised of both overnight federal funds and overnight eurodollar transactions denominated in Dollars by U.S.-managed banking offices of depository institutions (as such composite rate shall be determined by the NYFRB as set forth on the NYFRB&#8217;s Website from time to time) and published on the next succeeding Business Day by the NYFRB as an overnight bank funding rate (from and after such date as the NYFRB shall commence to publish such composite rate).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Overnight Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any day, (a) with respect to any amount denominated in Dollars, the NYFRB Rate and (b) with respect to any amount denominated in an Applicable Currency, an overnight rate determined by the Administrative Agent or the Issuing Bank, as the case may be, in accordance with banking industry rules on interbank compensation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;9.04(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Participant Register</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;9.04(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Participating Member State</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any member state of the European Union that has the Euro as its lawful currency in accordance with legislation of the European Union relating to Economic and Monetary Union. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Patents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, all of such Person&#8217;s right, title, and interest in and to&#58;  (a) any and all patents and patent applications&#59; (b) all inventions and improvements described and claimed therein&#59; (c) all reissues, divisions, continuations, renewals, extensions, and continuations-in-part thereof&#59; (d) all income, royalties, damages, claims, and payments now or hereafter due or payable under and with respect thereto, including, without limitation, damages and payments for past and future infringements thereof&#59; (e) all rights to sue for past, present, and future infringements thereof&#59; and (f) all rights corresponding to any of the foregoing throughout the world.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Payment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.06(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Payment Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.06(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">PBGC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Pension Benefit Guaranty Corporation referred to and defined in ERISA and any successor entity performing similar functions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Permitted Bond Hedge Transaction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any call or capped call option (or substantively equivalent or similar derivative transaction) on the Borrower&#8217;s common stock purchased by the Borrower in connection with the issuance of any Convertible Notes&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the purchase price for such Permitted Bond Hedge Transaction does not exceed the net proceeds received by the Borrower from the sale of such Convertible Notes issued in connection with the Permitted Bond Hedge Transaction. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Permitted Encumbrances</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Liens imposed by law for Taxes that are not yet due or are being contested in compliance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;5.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;carriers&#8217;, warehousemen&#8217;s, mechanics&#8217;, materialmen&#8217;s, repairmen&#8217;s and other like Liens imposed by law, arising in the ordinary course of business and securing </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">obligations that are not overdue by more than thirty (30) days or are being contested in compliance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;5.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;pledges and deposits made in the ordinary course of business in compliance with workers&#8217; compensation, unemployment insurance and other social security laws or regulations&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;deposits to secure the performance of bids, trade contracts, leases, statutory obligations, surety and appeal bonds, performance bonds and other obligations of a like nature, in each case in the ordinary course of business, or cash collateral securing letters of credit or bank guarantees securing the performance of such obligations or securing obligations to vendors, and deposits to secure the performance of appeal bonds (or letters of credit securing such performance) in respect of judgments that do not constitute an Event of Default under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (k)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article&#160;VII</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;judgment liens in respect of judgments that do not constitute an Event of Default under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (k)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article&#160;VII</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;easements, zoning restrictions, rights-of-way and similar encumbrances on real property imposed by law or arising in the ordinary course of business that do not secure any monetary obligations and do not materially detract from the value of the affected property or interfere with the ordinary conduct of business of the Borrower or any Subsidiary&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;Liens in favor of a banking or other financial institution arising as a matter of law or in the ordinary course of business under customary general terms and conditions encumbering deposits or other funds maintained with a financial institution (including the right of set-off) and that are within the general parameters customary in the banking industry or arising pursuant to such banking institution&#8217;s general terms and conditions&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)&#160;&#160;&#160;&#160;Liens on specific items of inventory or other goods and proceeds thereof of any Person securing such Person&#8217;s obligations in respect of bankers&#8217; acceptances or letters of credit issued or created for the account of such Person to facilitate the purchase, shipment or storage of such inventory or other goods in the ordinary course of business&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;Liens encumbering reasonable customary initial deposits and margin deposits and similar Liens attaching to commodity trading accounts or other brokerage accounts incurred in the ordinary course of business and not for speculative purposes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Permitted Investments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;direct obligations of, or obligations the principal of and interest on which are unconditionally guaranteed by, the United&#160;States of America (or by any agency thereof to the extent such obligations are backed by the full faith and credit of the United&#160;States of America), in each case maturing within eighteen months from the date of acquisition thereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;investments in commercial paper maturing within 365 days from the date of acquisition thereof and investments in corporate obligations maturing within eighteen months, having, at such date of acquisition, a minimum S&#38;P rating of A1 or A2 or Moody&#8217;s rating of P1 or P2&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;investments in certificates of deposit, in individual increments of $250,000 or less from any individual commercial bank, banker&#8217;s acceptances and time deposits maturing within 180 days from the date of acquisition thereof issued or guaranteed by or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">26</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">placed with, and money market deposit accounts issued or offered by, any domestic office of any commercial bank organized under the laws of the United&#160;States of America or any State thereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;fully collateralized repurchase agreements with a term of not more than thirty (30) days for securities described in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above and entered into with a financial institution satisfying the criteria described in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;money market funds that (i)&#160;comply with the criteria set forth in SEC Rule 2a-7 under the Investment Company Act of 1940, (ii)&#160;are rated AAA by S&#38;P and Aaa by Moody&#8217;s and (iii)&#160;have portfolio assets of at least $100,000,000&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;investments in investment grade corporate bonds existing on the Restatement Effective Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;local currencies held by any foreign Subsidiary&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h) &#160;&#160;&#160;&#160;investments that are permitted by the Borrower&#8217;s investment policy as in effect on the date hereof&#59; and&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;investments of the type described in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> through </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above of foreign Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any natural person, corporation, limited liability company, trust, joint venture, association, company, partnership, Governmental Authority or other entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any employee pension benefit plan (other than a Multiemployer Plan) subject to the provisions of Title&#160;IV of ERISA or Section&#160;412 of the Code or Section&#160;302 of ERISA, and in respect of which the Borrower or any ERISA Affiliate is (or, if such plan were terminated, would under Section&#160;4069 of ERISA be deemed to be) an &#8220;employer&#8221; as defined in Section&#160;3(5) of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Plan Asset Regulations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means 29 CFR &#167; 2510.3-101 et seq., as modified by Section 3(42) of ERISA, as amended from time to time. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Prime Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the rate of interest last quoted by The Wall Street Journal as the &#8220;Prime Rate&#8221; in the U.S. or, if The Wall Street Journal ceases to quote such rate, the highest per annum interest rate published by the Federal Reserve Board in Federal Reserve Statistical Release H.15 (519) (Selected Interest Rates) as the &#8220;bank prime loan&#8221; rate or, if such rate is no longer quoted therein, any similar rate quoted therein (as determined by the Administrative Agent) or any similar release by the Federal Reserve Board (as determined by the Administrative Agent). Each change in the Prime Rate shall be effective from and including the date such change is publicly announced or quoted as being effective.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Projections</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.01(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">PTE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a prohibited transaction class exemption issued by the U.S. Department of Labor, as any such exemption may be amended from time to time. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">QFC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to the term &#8220;qualified financial contract&#8221; in, and shall be interpreted in accordance with, 12 U.S.C. 5390(c)(8)(D).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">QFC Credit Support</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.19</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Recipient</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) the Administrative Agent, (b) any Lender and (c) any Issuing Bank, as applicable.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">27</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Reference Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any period of four consecutive fiscal quarters of the Borrower for which financial statements have been or are required to have been delivered.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Reference Time</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; with respect to any setting of the then-current Benchmark means (1) if such Benchmark is the Term SOFR Rate, 5&#58;00 a.m. (Chicago time) on the day that is two U.S. Government Securities Business Days banking days preceding the date of such setting, (2) if such Benchmark is EURIBOR Rate, 11&#58;00 a.m. Local Time two TARGET Days preceding the date of such setting, (3) if such Benchmark is TIBOR Rate, 11&#58;00 a.m. Local Time two Business Days preceding the date of such setting, (4) if the RFR for such Benchmark is SONIA, then four (4) RFR Business Days prior to such setting, (5) if the RFR for such Benchmark is Daily Simple SOFR, then four (4) RFR Business Days prior to such setting or (6) if such Benchmark is none of the Term SOFR Rate, the EURIBOR Rate, TIBOR Rate or SONIA, the time determined by the Administrative Agent in its reasonable discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Register</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;9.04(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Regulation D</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Regulation D of the Federal Reserve Board, as in effect from time to time and all official rulings and interpretations thereunder or thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Regulation T</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Regulation T of the Federal Reserve Board, as in effect from time to time and all official rulings and interpretations thereunder or thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Regulation U</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Regulation U of the Federal Reserve Board, as in effect from time to time and all official rulings and interpretations thereunder or thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Regulation X</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Regulation X of the Federal Reserve Board, as in effect from time to time and all official rulings and interpretations thereunder or thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Related Parties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any specified Person, such Person&#8217;s Affiliates and the respective directors, officers, employees, agents and advisors of such Person and such Person&#8217;s Affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Release</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any releasing, spilling, leaking, pumping, pouring, emitting, emptying, discharging, injecting, escaping, leaching, migrating, disposing, or dumping of any substance into the environment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Relevant Governmental Body</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i) with respect to a Benchmark Replacement in respect of Loans denominated in Dollars, the Federal Reserve Board and&#47;or the NYFRB, or a committee officially endorsed or convened by the Federal Reserve Board and&#47;or the NYFRB or, in each case, any successor thereto, (ii) with respect to a Benchmark Replacement in respect of Loans denominated in Sterling, the Bank of England, or a committee officially endorsed or convened by the Bank of England or, in each case, any successor thereto, (iii) with respect to a Benchmark Replacement in respect of Loans denominated in Euros, the European Central Bank, or a committee officially endorsed or convened by the European Central Bank or, in each case, any successor thereto,  (iv) with respect to a Benchmark Replacement in respect of Loans denominated in Yen, the Bank of Japan, or a committee officially endorsed or convened by the Bank of Japan or, in each case, any successor thereto, and (v) with respect to a Benchmark Replacement in respect of Loan denominated in any other currency, (a) the central bank for the currency in which such Benchmark Replacement is denominated or any central bank or other supervisor which is responsible for supervising either (1) such Benchmark Replacement or (2) the administrator of such Benchmark Replacement or (b) any working group or committee officially endorsed or convened by (1) the central bank for the currency in which such Benchmark Replacement is denominated, (2) any central bank or other supervisor that is responsible for supervising either (A) such Benchmark Replacement or (B) the administrator of such Benchmark Replacement, (3) a group of those central banks or other supervisors or (4) the Financial Stability Board or any part thereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Relevant Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i) with respect to any Term Benchmark Borrowing denominated in Dollars, the Adjusted Term SOFR Rate, (ii) with respect to any Term Benchmark Borrowing denominated in Euros, the Adjusted EURIBOR Rate,  (iii) with respect to any Term Benchmark Borrowing denominated in Yen, the TIBOR Rate, as applicable or (iv) with respect to any Term Benchmark Borrowing denominated in Canadian Dollars, the CDOR, (v) with respect to any Term Benchmark Borrowing denominated in Swedish Kroner, the STIBOR Rate,  (vi) with respect to any Term Benchmark Borrowing denominated in British Pounds Sterling, the applicable Adjusted Daily Simple RFR, as applicable, (vii) with respect to any Term Benchmark Borrowing denominated in Australian Dollar, the applicable AUD Rate and (viii) with respect to any Term Benchmark Borrowing denominated in New Zealand Dollar, the BKBM Screen Rate. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Relevant Screen Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i) with respect to any Term Benchmark Borrowing denominated in Dollars, the Term SOFR Screen Rate, (ii) with respect to any Term Benchmark Borrowing denominated in Euros, the EURIBOR Screen Rate, (iii) with respect to any Term Benchmark Borrowing denominated in Yen, the TIBOR Screen Rate, as applicable, as applicable, (iv) with respect to any Term Benchmark Borrowing denominated in Canadian Dollars, the CDOR Screen Rate, (v) with respect to any Term Benchmark Borrowing denominated in Swedish Kroner, the STIBOR Screen Rate, (vi) with respect to any Term Benchmark Borrowing denominated in British Pounds Sterling, the applicable Daily Simple RFR, as applicable, (vii) with respect to any Term Benchmark Borrowing denominated in Australian Dollar, the applicable AUD Screen Rate and (viii) with respect to any Term Benchmark Borrowing denominated in New Zealand Dollar, the BKBM Screen Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Required Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, Lenders having Revolving Credit Exposures and unused Commitments representing greater than 50% of the sum of the total Revolving Credit Exposures and unused Commitments at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Requirement of Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, (a) the charter, articles or certificate of organization or incorporation and bylaws or operating, management or partnership agreement, or other organizational or governing documents of such Person and (b) any statute, law (including common law), treaty, rule, regulation, code, ordinance, order, decree, writ, judgment, injunction or determination of any arbitrator or court or other Governmental Authority (including Environmental Laws), in each case applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Resolution Authority</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an EEA Resolution Authority or, with respect to any UK Financial Institution, a UK Resolution Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Restatement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the date on which the conditions specified in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;4.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> are satisfied (or waived in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;9.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Restricted Payment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any dividend or other distribution (whether in cash, securities or other property) with respect to any Equity Interests in the Borrower or any Subsidiary, or any payment (whether in cash, securities or other property), including any sinking fund or similar deposit, on account of the purchase, redemption, retirement, acquisition, cancellation or termination of any such Equity Interests in the Borrower or any option, warrant or other right to acquire any such Equity Interests in the Borrower, but excluding any payment of principal of any of the Convertible Notes, any payment on account of the purchase, redemption, retirement, repayment, acquisition, cancellation or termination of Convertible Notes, and any settlement of the Convertible Notes on the conversion thereof, whether in cash, securities, other property or a combination thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Revaluation Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (a) with respect to any Loan denominated in any Applicable Currency, each of the following&#58; (i) the date of the Borrowing of such Loan and (ii) (A) with respect to any Term Benchmark Loan, each date of&#160;a conversion into or continuation of such Loan pursuant to the terms of this Agreement and (B) with respect to any RFR Loan, each date that is on the numerically corresponding day in each calendar month after the Borrowing of such Loan (or, if there is no such numerically corresponding day in such month, then the last </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">29</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">day of such month)&#59; (b) with respect&#160;to any Letter of Credit denominated in an Applicable Currency, each of the following&#58; (i) the date on which such Letter of Credit is issued, (ii) the first Business Day of each calendar month and (iii) the date of any&#160;amendment of such Letter of Credit that has the effect of increasing the face amount thereof&#59; and (c) any&#160;additional date as the Administrative Agent may determine at any time when an Event of Default exists.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Revolving Borrowing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Revolving Loans of the same Type and Applicable Currency, made, converted or continued on the same date and, in the case of Term Benchmark Loans, as to which a single Interest Period is in effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Revolving Credit Exposure</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Lender at any time, the sum of the outstanding principal amount of such Lender&#8217;s Revolving Loans, its LC Exposure at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Revolving Loan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Loan made pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">RFR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any RFR Loan denominated in (a) Sterling, SONIA or (b) Dollars, Daily Simple SOFR.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">RFR Administrator</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the SONIA Administrator or the SOFR Administrator.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">RFR Borrowing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as to any Borrowing, the RFR Loans comprising such Borrowing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">RFR Business Day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any Loan denominated in (a) Sterling, any day except for (i) a Saturday, (ii) a Sunday or (iii)&#160;a day on which banks are closed for general business in London and (b) Dollars, a U.S. Government Securities Business Day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">RFR Interest Day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in the definition of &#8220;Daily Simple RFR&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">RFR Loan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Loan that bears interest at a rate based on Adjusted Daily Simple RFR.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">S&#38;P</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Standard &#38; Poor&#8217;s Rating Services, a Standard &#38; Poor&#8217;s Financial Services LLC business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Sale and Leaseback Transaction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.09</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Sanctioned Country</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, a country, region or territory which is itself the subject or target of any Sanctions (at the time of this Agreement, the so-called Donetsk People&#8217;s Republic, the so-called Luhansk People&#8217;s Republic, the Crimea Region of Ukraine, Cuba, Iran, North Korea, and Syria).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Sanctioned Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, (a) any Person listed in any Sanctions-related list of designated Persons maintained by the Office of Foreign Assets Control of the U.S. Department of the Treasury, the U.S. Department of State, or by the United Nations Security Council, the European Union, any European Union member state, His Majesty&#8217;s Treasury of the United Kingdom, or other relevant sanctions authority, (b) any Person operating, organized or resident in a Sanctioned Country, (c) any Person owned or controlled by any such Person or Persons described in the foregoing </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or (d) any Person otherwise the subject of any Sanctions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Sanctions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by (a) the U.S. government, including those administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State, or (b) the United Nations Security Council, the European Union, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">any European Union member state, His Majesty&#8217;s Treasury of the United Kingdom, or other relevant sanctions authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">SEC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Securities and Exchange Commission of the United States of America.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Second Amendment Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means November 26, 2018.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Secured Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all Obligations, together with all (i) Banking Services Obligations and (ii) Swap Agreement Obligations owing to one or more Lenders or their respective Affiliates&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the definition of &#8220;Secured Obligations&#8221; shall not create any guarantee by any Guarantor of (or grant of security interest by any Guarantor to support, as applicable) any Excluded Swap Obligations of such Guarantor for purposes of determining any obligations of any Guarantor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Secured Parties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) the Lenders, (b) the Administrative Agent, (c) each Issuing Bank, (d) each provider of Banking Services, to the extent the Banking Services Obligations in respect thereof constitute Secured Obligations, (e) each counterparty to any Swap Agreement, to the extent the obligations thereunder constitute Secured Obligations, (f) the beneficiaries of each indemnification obligation undertaken by any Loan Party under any Loan Document and (g) the successors and assigns of each of the foregoing.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Security Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means that certain Pledge and Security Agreement (including any and all supplements thereto), dated as of the Original Effective Date among the Loan Parties and the Administrative Agent, for the benefit of the Administrative Agent and the other Secured Parties, and any other pledge or security agreement entered into, after the date of this Agreement by any other Loan Party (as required by this Agreement or any other Loan Document) or any other Person for the benefit of the Administrative Agent and the other Secured Parties, as the same may be amended, restated, supplemented or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Senior Secured Leverage Covenant Holiday</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.13(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Senior Secured Leverage Ratio</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, on any date, the ratio of (a) Total Indebtedness which is secured by a Lien of the Borrower and its Subsidiaries on such date </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Liquidity in excess of $50,000,000 to (b) EBITDA for the period of four consecutive fiscal quarters ended on or most recently prior to such date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">SOFR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a rate per annum equal to the secured overnight financing rate as administered by the SOFR Administrator.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">SOFR Administrator</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the NYFRB (or a successor administrator of the secured overnight financing rate).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">SOFR Administrator&#8217;s Website</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the NYFRB&#8217;s website, currently at http&#58;&#47;&#47;www.newyorkfed.org, or any successor source for the secured overnight financing rate identified as such by the SOFR Administrator from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">SOFR Determination Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in the definition of &#8220;Daily Simple SOFR&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">SOFR Rate Day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in the definition of &#8220;Daily Simple SOFR&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Solvent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as to any Person as of any date of determination, that on such date (a)&#160;the fair value of the property of such Person is greater than the total amount of liabilities, including contingent liabilities, of such Person, (b)&#160;the present fair saleable value of such Person is not less than the amount that will be required to pay the probable liability of such Person on </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">31</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">its debts, including contingent debts, as they become absolute and matured, (c)&#160;such Person does not intend to, and does not believe that it will, incur debts or liabilities, including contingent debts and liabilities, beyond such Person&#8217;s ability to pay such debts and liabilities as they mature and (d)&#160;such Person is not engaged in a business or a transaction, and is not about to engage in a business or a transaction, for which such Person&#8217;s property would constitute an unreasonably small capital.  The amount of any contingent liability at any time shall be computed as the amount that, in light of all of the facts and circumstances existing at such time, represents the amount that can reasonably be expected to become an actual or matured liability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">SONIA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Business Day, a rate per annum equal to the Sterling Overnight Index Average for such Business Day published by the SONIA Administrator on the SONIA Administrator&#8217;s Website on the immediately succeeding Business Day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">SONIA Administrator</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Bank of England (or any successor administrator of the Sterling Overnight Index Average).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">SONIA Administrator&#8217;s Website</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Bank of England&#8217;s website, currently at http&#58;&#47;&#47;www.bankofengland.co.uk, or any successor source for the Sterling Overnight Index Average identified as such by the SONIA Administrator from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Statutory Reserve Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a fraction (expressed as a decimal), the numerator of which is the number one and the denominator of which is the number one minus the aggregate of the maximum reserve percentage (including any marginal, special, emergency or supplemental reserves) expressed as a decimal established by the Federal Reserve Board to which the Administrative Agent is subject with respect to the Adjusted EURIBOR Rate, Adjusted TIBOR Rate, Adjusted CDOR, Adjusted STIBOR Rate, Adjusted AUD Rate or Adjusted BKBM Rate, as applicable, for eurocurrency funding (currently referred to as &#8220;Eurocurrency liabilities&#8221; in Regulation D) or any other reserve ratio or analogous requirement of any central banking or financial regulatory authority imposed in respect of the maintenance of the Commitments or the funding of the Loans.  Such reserve percentage shall include those imposed pursuant to Regulation D.  Term Benchmark Loans for which the associated Benchmark is adjusted by reference to the Statutory Reserve Rate (per the related definition of such Benchmark) shall be deemed to constitute eurocurrency funding and to be subject to such reserve requirements without benefit of or credit for proration, exemptions or offsets that may be available from time to time to any Lender under Regulation D or any comparable regulation.  The Statutory Reserve Rate shall be adjusted automatically on and as of the effective date of any change in any reserve percentage.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Sterling</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#163;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34; means the lawful currency of the United Kingdom.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">STIBOR Interpolated Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, with respect to any Term Benchmark Borrowing denominated in Swedish Kroner and for any Interest Period, the rate per annum (rounded to the same number of decimal places as the STIBOR Screen Rate) determined by the Administrative Agent (which determination shall be conclusive and binding absent manifest error) to be equal to the rate that results from interpolating on a linear basis between&#58; (a) the STIBOR Screen Rate for the longest period (for which the STIBOR Screen Rate is available for Swedish Kroner) that is shorter than the Impacted STIBOR Rate Interest Period&#59; and (b) the STIBOR Screen Rate for the shortest period (for which the STIBOR Screen Rate is available for Swedish Kroner) that exceeds the Impacted STIBOR Rate Interest Period, in each case, at such time&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if any STIBOR Interpolated Rate shall be less than zero, such rate shall be deemed to be zero for the purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">STIBOR Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in Swedish Kroner and for any Interest Period, the STIBOR Screen Rate at approximately 11&#58;00 a.m., Local Time, two Business Days prior to the commencement of such Interest Period&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if the STIBOR Screen Rate shall not be available at such time for such Interest </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">32</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Period (an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Impacted STIBOR Rate Interest Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) with respect to Swedish Kroner then the STIBOR Rate shall be the STIBOR Interpolated Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">STIBOR Screen Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Interest Period, the Stockholm interbank offered rate administered by the Swedish Bankers&#8217; Association ( or any other person that takes over the administration of that rate) for deposits in Swedish Kroner with a term equivalent to such Interest Period as displayed on the Reuters screen page that displays such rate (or, in the event such rate does not appear on such Reuters page, on any successor or substitute page on such screen that displays such rate, or on the appropriate page of such other information service that publishes such rate as shall be selected by the Administrative Agent from time to time in its reasonable discretion) as of 11&#58;00 a.m. London time two business days prior to the commencement of such Interest Period.  If the STIBOR Screen Rate shall be less than zero, the STIBOR Screen Rate shall be deemed to be zero for purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Subordinated Indebtedness</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of a Person means any Indebtedness of such Person, the payment of which is subordinated to payment of the Secured Obligations to the written satisfaction of the Administrative Agent. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">parent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) at any date, any corporation, limited liability company, partnership, association or other entity the accounts of which would be consolidated with those of the parent in the parent&#8217;s consolidated financial statements if such financial statements were prepared in accordance with GAAP as of such date, as well as any other corporation, limited liability company, partnership, association or other entity of which securities or other ownership interests representing more than 50% of the equity or more than 50% of the ordinary voting power or, in the case of a partnership, more than 50% of the general partnership interests are, as of such date, owned, controlled or held (excluding in all cases any &#8220;qualifying shares&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any direct or indirect subsidiary of the Borrower or of any other Loan Party, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Supported QFC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.19</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Swap Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any agreement with respect to any swap, forward, future or derivative transaction or option or similar agreement involving, or settled by reference to, one or more rates, currencies, commodities, equity or debt instruments or securities, or economic, financial or pricing indices or measures of economic, financial or pricing risk or value or any similar transaction or any combination of these transactions&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no phantom stock or similar plan providing for payments only on account of services provided by current or former directors, officers, employees or consultants of the Borrower or the Subsidiaries shall be a Swap Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Swap Agreement Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any and all obligations of the Loan Parties and their Subsidiaries, whether absolute or contingent and howsoever and whensoever created, arising, evidenced or acquired (including all renewals, extensions and modifications thereof and substitutions therefor), under (a) any Swap Agreement permitted hereunder with a Lender or an Affiliate of a Lender, and (b) any cancellations, buy backs, reversals, terminations or assignments of any Swap Agreement transaction permitted hereunder with a Lender or an Affiliate of a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Swap Obligation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Guarantor, any obligation to pay or perform under any agreement, contract or transaction that constitutes a &#8220;swap&#8221; within the meaning of Section 1a(47) of the Commodity Exchange Act or any rules or regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Swedish Kroner</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the lawful currency of Sweden. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Syndication Agent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, collectively, Bank of America, N.A. and Silicon Valley Bank.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), value added taxes, or any other goods and services, use or sales taxes, assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Term Benchmark</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; when used in reference to any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such Borrowing, are bearing interest at a rate determined by reference to the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, the Adjusted STIBOR Rate, the Adjusted CDOR, Adjusted AUD Rate, the Adjusted BKBM Rate or the Adjusted TIBOR Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Term SOFR Determination Day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it under the definition of Term SOFR Reference Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Term SOFR Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in Dollars and for any tenor comparable to the applicable Interest Period, the Term SOFR Reference Rate at approximately 5&#58;00 a.m., Chicago time, two U.S. Government Securities Business Days prior to the commencement of such tenor comparable to the applicable Interest Period, as such rate is published by the CME Term SOFR Administrator.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Term SOFR Reference Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;  means, for any day and time (such day, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Term SOFR Determination Day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), with respect to any Term Benchmark Borrowing denominated in Dollars and for any tenor comparable to the applicable Interest Period, the rate per annum published by the CME Term SOFR Administrator and identified by the Administrative Agent as the forward-looking term rate based on SOFR.  If by 5&#58;00 pm (New York City time) on such Term SOFR Determination Day, the &#8220;Term SOFR Reference Rate&#8221; for the applicable tenor has not been published by the CME Term SOFR Administrator and a Benchmark Replacement Date with respect to the Term SOFR Rate has not occurred, then, so long as such day is otherwise a U.S. Government Securities Business Day, the Term SOFR Reference Rate for such Term SOFR Determination Day will be the Term SOFR Reference Rate as published in respect of the first preceding U.S. Government Securities Business Day for which such Term SOFR Reference Rate was published by the CME Term SOFR Administrator, so long as such first preceding U.S. Government Securities Business Day is not more than five (5) U.S. Government Securities Business Days prior to such Term SOFR Determination Day. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">TIBOR Interpolated Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, with respect to any Term Benchmark Borrowing denominated in Yen and for any Interest Period, the rate per annum (rounded to the same number of decimal places as the TIBOR Screen Rate) determined by the Administrative Agent (which determination shall be conclusive and binding absent manifest error) to be equal to the rate that results from interpolating on a linear basis between&#58; (a) the TIBOR Screen Rate for the longest period (for which the TIBOR Screen Rate is available for Yen) that is shorter than the Impacted TIBOR Rate Interest Period&#59; and (b) the TIBOR Screen Rate for the shortest period (for which the TIBOR Screen Rate is available for Yen) that exceeds the Impacted TIBOR Rate Interest Period, in each case, at such time&#59; provided that, if any TIBOR Interpolated Rate shall be less than zero, such rate shall be deemed to be zero for the purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">TIBOR Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in Yen and for any Interest Period, the TIBOR Screen Rate two Business Days prior to the commencement of such Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">TIBOR Screen Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Tokyo interbank offered rate administered by the Ippan Shadan Hojin JBA TIBOR Administration (or any other person which takes over the administration of that rate) for the relevant currency and period displayed on page DTIBOR01 of the Reuters screen (or, in the event such rate does not appear on such Reuters page or screen, on any successor or substitute page on such screen that displays such rate, or on the appropriate page of such other information service that publishes such rate as selected by the Administrative Agent from time to time in its reasonable discretion) as published at </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">34</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">approximately 1&#58;00 p.m. Japan time two Business Days prior to the commencement of such Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Total Assets</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any date, the amount that would, in conformity with GAAP, be set forth opposite the caption &#8220;total assets&#8221; (or any like caption) on a consolidated balance sheet of the Borrower and its Subsidiaries on such date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Total Indebtedness</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any date, the aggregate principal amount of all Indebtedness of the type specified in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> through </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in the definition thereof determined for the Borrower and its Subsidiaries on a consolidated basis at such date, in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Total Leverage Ratio</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, on any date, the ratio of (a) Total Indebtedness, other than earn-out obligations which are not yet due and payable or are being contested in good faith and adequate reserves are maintained with respect thereto to the extent required by GAAP, on such date </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Liquidity in excess of $50,000,000 to (b) EBITDA for the period of four consecutive fiscal quarters ended on or most recently prior to such date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Total Revolving Credit Exposure</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, the sum of the outstanding principal amount of all Lenders&#8217; Revolving Loans and their LC Exposure at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Trademarks</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, all of such Person&#8217;s right, title, and interest in and to the following&#58;  (a) all trademarks (including service marks), trade names, trade dress, and trade styles and the registrations and applications for registration thereof and the goodwill of the business symbolized by the foregoing&#59; (b) all licenses of the foregoing, whether as licensee or licensor&#59; (c) all renewals of the foregoing&#59; (d) all income, royalties, damages, and payments now or hereafter due or payable with respect thereto, including, without limitation, damages, claims, and payments for past and future infringements thereof&#59; (e) all rights to sue for past, present, and future infringements of the foregoing, including the right to settle suits involving claims and demands for royalties owing&#59; and (f) all rights corresponding to any of the foregoing throughout the world.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Transaction Costs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all fees, costs and expenses incurred or paid by the Borrower or any Subsidiary in connection with the Transactions, this Agreement and the other Loan Documents and the transactions contemplated hereby and thereby.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Transactions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the execution, delivery and performance by the Borrower of this Agreement and the other Loan Documents, the borrowing of Loans and other credit extensions, the use of the proceeds thereof and the issuance of Letters of Credit hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Type</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, when used in reference to any Loan or Borrowing, refers to whether the rate of interest on such Loan, or on the Loans comprising such Borrowing, is determined by reference to the Adjusted Term SOFR Rate, the Adjusted CDOR, the Adjusted EURIBOR Rate, the Adjusted TIBOR Rate, the Adjusted AUD Rate, the Adjusted BKBM Rate, the Adjusted STIBOR Rate, the Alternate Base Rate or the Adjusted Daily Simple RFR.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">UK Financial Institutions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any BRRD Undertaking (as such term is defined under the PRA Rulebook (as amended from time to time) promulgated by the United Kingdom Prudential Regulation Authority) or any person falling within IFPRU 11.6 of the FCA Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct Authority, which includes certain credit institutions and investment firms, and certain affiliates of such credit institutions or investment firms.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">UK Resolution Authority</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Bank of England or any other public administrative authority having responsibility for the resolution of any UK Financial Institution.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">35</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Unadjusted Benchmark Replacement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the applicable Benchmark Replacement excluding the related Benchmark Replacement Adjustment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">U.S. Dollar Equivalent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any amount, at the time of determination thereof, (a) if such amount is expressed in dollars, such amount, (b) if such amount is expressed in a Foreign Currency, the equivalent of such amount in dollars determined by using the rate of exchange for the purchase of dollars with the Foreign Currency last provided (either by publication or otherwise provided to the Administrative Agent) by Reuters on the Business Day (New York City time) immediately preceding the date of determination or if such service ceases to be available or ceases to provide a rate of exchange for the purchase of dollars with the Applicable Currency, as provided by such other publicly available information service which provides that rate of exchange at such time in place of Reuters chosen by the Administrative Agent in its sole discretion (or if such service ceases to be available or ceases to provide such rate of exchange, the equivalent of such amount in dollars as determined by the Administrative Agent using any method of determination it deems appropriate in its sole discretion) and (c) if such amount is denominated in any other currency, the equivalent of such amount in dollars as determined by the Administrative Agent using any method of determination it deems appropriate in its sole discretion. &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">U.S.&#160;Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a &#8220;United&#160;States person&#8221; within the meaning of Section&#160;7701(a)(30) of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">U.S. Government Securities Business Day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any day except for (i) a Saturday, (ii) a Sunday or (iii) a day on which the Securities Industry and Financial Markets Association recommends that the fixed income departments of its members be closed for the entire day for purposes of trading in United States government securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">U.S.&#160;Tax Compliance Certificate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.17(f)(ii)(B)(3)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">USA Patriot Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the United and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Withdrawal Liability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means liability to a Multiemployer Plan as a result of a complete or partial withdrawal from such Multiemployer Plan, as such terms are defined in Part I of Subtitle E of Title&#160;IV of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Write-Down and Conversion Powers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom,  any powers of the applicable Resolution Authority under the Bail-In Legislation to cancel, reduce, modify or change the form of a liability of any UK Financial Institution  or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such contract or instrument is to have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability or any of the powers under that Bail-In Legislation that are related to or ancillary to any of those powers.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Yen</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Y</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; mean the lawful currency of Japan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 1.02.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Classification of Loans and Borrowings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For purposes of this Agreement, Loans may be classified and referred to by Type (e.g., a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Term Benchmark</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Loan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">RFR Loan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) or by class and Type (e.g., a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Term Benchmark Revolving Loan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">RFR Revolving Loan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  Borrowings also may be classified and referred to by Type (e.g., a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Term Benchmark</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Borrowing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or an </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;RFR Borrowing&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) or by class and Type (e.g., a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Term Benchmark</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Revolving Borrowing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 1.03.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Terms Generally</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The definitions of terms herein shall apply equally to the singular and plural forms of the terms defined.  Whenever the context may require, any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">36</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">pronoun shall include the corresponding masculine, feminine and neuter forms.  The words &#8220;include&#8221;, &#8220;includes&#8221; and &#8220;including&#8221; shall be deemed to be followed by the phrase &#8220;without limitation&#8221;.  The word &#8220;law&#8221; shall be construed as referring to all statutes, rules, regulations, codes and other laws (including official rulings and interpretations thereunder having the force of law or with which affected Persons customarily comply) and all judgments, orders and decrees of all Governmental Authorities. The word &#8220;will&#8221; shall be construed to have the same meaning and effect as the word &#8220;shall&#8221;.  Unless the context requires otherwise (a)&#160;any definition of or reference to any agreement, instrument or other document herein shall be construed as referring to such agreement, instrument or other document as from time to time amended, restated, supplemented or otherwise modified (subject to any restrictions on such amendments, restatements, supplements or modifications set forth herein), (b)&#160;any reference herein to any Person shall be construed to include such Person&#8217;s successors and assigns (subject to any restrictions on assignments set forth herein) and, in the case of any Governmental Authority, any other Governmental Authority that shall have succeeded to any or all functions thereof, (c)&#160;the words &#8220;herein&#8221;, &#8220;hereof&#8221; and &#8220;hereunder&#8221;, and words of similar import, shall be construed to refer to this Agreement in its entirety and not to any particular provision hereof, (d)&#160;all references herein to Articles, Sections, Exhibits and Schedules shall be construed to refer to Articles and Sections&#160;of, and Exhibits and Schedules to, this Agreement, (e)&#160;the words &#8220;asset&#8221; and &#8220;property&#8221; shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, securities, accounts and contract rights, (f) any reference in any definition to the phrase &#8220;at any time&#8221; or &#8220;for any period&#8221; shall refer to the same time or period for all calculations or determinations within such definition, and (g) any reference to any law, rule or regulations shall mean such law, rule or regulation as amended or restated from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 1.04.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Accounting Terms&#59; GAAP</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Except as otherwise expressly provided herein, all terms of an accounting or financial nature shall be construed in accordance with GAAP, as in effect from time to time&#59; provided that, if the Borrower notifies the Administrative Agent that the Borrower requests an amendment to any provision hereof to eliminate the effect of any change occurring after the date hereof in GAAP or in the application thereof on the operation of such provision (or if the Administrative Agent notifies the Borrower that the Required Lenders request an amendment to any provision hereof for such purpose), regardless of whether any such notice is given before or after such change in GAAP or in the application thereof, then such provision shall be interpreted on the basis of GAAP as in effect and applied immediately before such change shall have become effective until such notice shall have been withdrawn or such provision amended in accordance herewith.  Notwithstanding any other provision contained herein, all terms of an accounting or financial nature used herein shall be construed, and all computations of amounts and ratios referred to herein shall be made, without giving effect to (i) any election under Financial Accounting Standards Board Accounting Standards Codification 825 (or any other Financial Accounting Standard having a similar result or effect) to value any Indebtedness or other liabilities of the Borrower or any Subsidiary at &#8220;fair value&#8221;, as defined therein and (ii) any treatment of Indebtedness under Accounting Standards Codification 470-20 or 2015-03 (or any other Accounting Standards Codification or Financial Accounting Standard having a similar result or effect) to value any such Indebtedness in a reduced or bifurcated manner as described therein, and such Indebtedness shall at all times be valued at the full stated principal amount thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Notwithstanding anything to the contrary contained in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.04(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or in the definition of &#8220;Finance Lease Obligations,&#8221; any change in accounting for leases pursuant to GAAP resulting from the adoption of Financial Accounting Standards Board Accounting Standards Update No. 2016-02, Leases (Topic 842) (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">FAS 842</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), or other accounting change requiring leases that were not required to be capitalized on the date hereof to be capitalized, to the extent such adoption or change would require treating any lease (or similar arrangement conveying the right to use) as a capital lease where such lease (or similar arrangement) would not have been required to be so treated under GAAP as in effect on December 31, 2015, or (y) recognizing liabilities on the balance sheet with respect to operating leases, such lease shall not </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">37</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">be considered a capital lease, and all calculations and deliverables under this Agreement or any other Loan Document shall be made or delivered, as applicable, in accordance therewith and without giving effect to such adoption or change. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 1.05.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Rates&#59; Currency Equivalents .</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt"> The Administrative Agent or the Issuing Bank, as applicable, shall determine the Dollar Equivalent amounts of Term Benchmark Borrowings or RFR Borrowings or Letter of Credit extensions denominated in Applicable Currencies.  Such Dollar Equivalent shall become effective as of such Revaluation Date and shall be the Dollar Equivalent of such amounts until the next Revaluation Date to occur.  Except for purposes of financial statements delivered by the Borrower hereunder or calculating financial covenants hereunder or except as otherwise provided herein, the applicable amount of any Foreign Currency for purposes of the Loan Documents shall be such Dollar Equivalent amount as so determined by the Administrative Agent or the Issuing Bank, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt"> Wherever in this Agreement in connection with a Borrowing, conversion, continuation or prepayment of a Term Benchmark Loan or an RFR Loan or the issuance, amendment or extension of a Letter of Credit, an amount, such as a required minimum or multiple amount, is expressed in Dollars, but such Borrowing, Loan or Letter of Credit is denominated in an Applicable Currency, such amount shall be the Dollar Equivalent of such amount (rounded to the nearest unit of such Applicable Currency, with 0.5 of a unit being rounded upward), as determined by the Administrative Agent or the Issuing Bank, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 1.06.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Rates&#59; Benchmark Notification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The interest rate on a Loan denominated in dollars or an Applicable Currency may be derived from an interest rate benchmark that may be discontinued or is, or may in the future become, the subject of regulatory reform.  Upon the occurrence of a Benchmark Transition Event, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> provides a mechanism for determining an alternative rate of interest.  The Administrative Agent does not warrant or accept any responsibility for, and shall not have any liability with respect to, the administration, submission, performance or any other matter related to any interest rate used in this Agreement, or with respect to any alternative or successor rate thereto, or replacement rate thereof, including without limitation, whether the composition or characteristics of any such alternative, successor or replacement reference rate will be similar to, or produce the same value or economic equivalence of, the existing interest rate being replaced or have the same volume or liquidity as did any existing interest rate prior to its discontinuance or unavailability.  The Administrative Agent and its affiliates and&#47;or other related entities may engage in transactions that affect the calculation of any  interest rate used in this Agreement or any alternative, successor or alternative rate (including any Benchmark Replacement) and&#47;or any relevant adjustments thereto, in each case, in a manner adverse to the Borrowers.  The Administrative Agent may select information sources or services in its reasonable discretion to ascertain any interest rate used in this Agreement, any component thereof, or rates referenced in the definition thereof, in each case pursuant to the terms of this Agreement, and shall have no liability to the Borrowers, any Lender or any other person or entity for damages of any kind, including direct or indirect, special, punitive, incidental or consequential damages, costs, losses or expenses (whether in tort, contract or otherwise and whether at law or in equity), for any error or calculation of any such rate (or component thereof) provided by any such information source or service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 1.07.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Amounts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Unless otherwise specified herein, the amount of a Letter of Credit at any time shall be deemed to be the Dollar Equivalent of the stated amount of such Letter of Credit available to be drawn at such time&#59; provided that with respect to any Letter of Credit that, by its terms or the terms of any Letter of Credit Agreement related thereto, provides for one or more automatic increases in the available amount thereof, the amount of such Letter of Credit shall be deemed to be the Dollar Equivalent of the maximum amount of such Letter of Credit after giving effect to all such increases, whether or not such maximum amount is available to be drawn at such time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">38</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 1.08.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Pro Forma Adjustments for Acquisitions and Dispositions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To the extent the Borrower or any of its Subsidiaries makes any acquisition permitted pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or disposition of assets outside the ordinary course of business during the period of four fiscal quarters of the Borrower most recently ended for which financial statements have been delivered, the Senior Secured Leverage Ratio and Total Leverage Ratio shall be calculated after giving pro forma effect thereto (including pro forma adjustments arising out of events which are directly attributable to the acquisition or the disposition of assets, are factually supportable and are expected to have a continuing impact, in each case as determined on a basis consistent with Article 11 of Regulation S-X of the Securities Act of 1933, as amended, as interpreted by the SEC, and as certified by a Financial Officer), as if such acquisition or such disposition (and any related incurrence, repayment or assumption of Indebtedness) had occurred in the first day of such four-quarter period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 1.09.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Status of Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In the event that the Borrower or any other Loan Party shall at any time issue or have outstanding any Subordinated Indebtedness, the Borrower shall take or cause such other Loan Party to take all such actions as shall be necessary to cause the Secured Obligations to constitute senior indebtedness (however denominated) in respect of such Subordinated Indebtedness and to enable the Administrative Agent and the Lenders to have and exercise any payment blockage or other remedies available or potentially available to holders of senior indebtedness under the terms of such Subordinated Indebtedness.  Without limiting the foregoing, the Secured Obligations are hereby designated as &#8220;senior indebtedness&#8221; and as &#8220;designated senior indebtedness&#8221; and words of similar import under and in respect of any indenture or other agreement or instrument under which such Subordinated Indebtedness is outstanding and are further given all such other designations as shall be required under the terms of any such Subordinated Indebtedness in order that the Lenders may have and exercise any payment blockage or other remedies available or potentially available to holders of senior indebtedness under the terms of such Subordinated Indebtedness.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE II<br><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">The Credits</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.01.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Commitments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions set forth herein, each Lender agrees to make Revolving Loans to the Borrower in Dollars or in one or more Foreign Currencies from time to time during the Availability Period in an aggregate principal amount that will not result (after giving effect to any application of proceeds of such Borrowing pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) in (a)&#160;the Dollar Equivalent of any Lender&#8217;s Revolving Credit Exposure exceeding such Lender&#8217;s Commitment, (b)&#160;the sum of the Dollar Equivalent of the Total Revolving Credit Exposures exceeding the total Commitments or (c) the Dollar Equivalent of the total outstanding Revolving Loans denominated in Foreign Currencies to exceed the Foreign Currency Sublimit.  Within the foregoing limits and subject to the terms and conditions set forth herein, the Borrower may borrow, prepay and reborrow Revolving Loans. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.02.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loans and Borrowings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) Each Revolving Loan shall be made as part of a Borrowing consisting of Revolving Loans made by the Lenders ratably in accordance with their respective Commitments.  The failure of any Lender to make any Loan required to be made by it shall not relieve any other Lender of its obligations hereunder&#59; provided that the Commitments of the Lenders are several and no Lender shall be responsible for any other Lender&#8217;s failure to make Loans as required.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Subject to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, each Revolving Borrowing shall be comprised (A) in the case of Borrowings in Dollars, entirely of ABR&#160;Loans or Term Benchmark Loans and (B) in the case of Borrowings in any other Applicable Currency, entirely of Term Benchmark Loans or RFR Loans, as applicable in each case of the same Applicable Currency, as the Borrower may request in accordance herewith.  Each Lender at its option may make any Loan by causing any domestic or foreign branch or Affiliate of such Lender to make such Loan&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any exercise of such option shall not affect the obligation of the Borrower to repay such Loan in accordance with the terms of this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">39</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  At the commencement of each Interest Period for any Term Benchmark Revolving Borrowing, such Borrowing shall be in an aggregate Dollar Equivalent that is an integral multiple of the U.S. Dollar Equivalent of $1,000,000 and not less than the U.S. Dollar Equivalent of $5,000,000.  At the time that each ABR&#160;Revolving Borrowing and&#47;or RFR Borrowing is made, such Borrowing shall be in an aggregate Dollar Equivalent that is an integral multiple of the U.S. Dollar Equivalent of $100,000 and not less than $500,000&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that an ABR&#160;Revolving Borrowing may be in an aggregate Dollar Equivalent that is equal to the entire unused balance of the total Commitments or that is required to finance the reimbursement of an LC Disbursement as contemplated by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.06(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Borrowings of more than one Type may be outstanding at the same time&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that there shall not at any time be more than a total of ten (10) Term Benchmark Revolving Borrowings or RFR Borrowings outstanding. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Notwithstanding any other provision of this Agreement, the Borrower shall not be entitled to request, or to elect to convert or continue, any Borrowing if the Interest Period requested with respect thereto would end after the Maturity Date.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.03.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Requests for Revolving Borrowings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To request a Revolving Borrowing, the Borrower shall notify the Administrative Agent of such request by telephone (a)(i)(x)&#160;in the case of a Term Benchmark Borrowing denominated in Dollars, not later than 1&#58;00 p.m., New&#160;York City time, three (3) U.S. Government Securities Business Days before the date of the proposed Borrowing or (y) in the case of an RFR Borrowing denominated in Dollars, not later than 11&#58;00 a.m., New York City time, five (5) U.S. Government Securities Business Days before the date of the proposed Borrowing, (ii) in the case of a Term Benchmark Borrowing denominated in Euros or Yen, not later than 12&#58;00 p.m., New&#160;York City time, four (4) Business Days before the date of the proposed Borrowing and (iii) in the case of an RFR Borrowing denominated in Sterling, not later than 11&#58;00 a.m., New York City time, three (3) RFR Business Days before the date of the proposed Borrowing or (b)&#160;in the case of an ABR&#160;Borrowing, not later than 11&#58;00 a.m., New&#160;York City time, on the date of the proposed Borrowing&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any such notice of an ABR&#160;Revolving Borrowing to finance the reimbursement of an LC Disbursement as contemplated by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.06(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> may be given not later than 1&#58;00 p.m., New&#160;York City time, on the date of the proposed Borrowing.  Each such telephonic Borrowing Request shall be irrevocable and shall be confirmed promptly by hand delivery or telecopy (or transmit by electronic communication in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof) to the Administrative Agent of a written Borrowing Request in a form approved by the Administrative Agent and signed by the Borrower.  Each such telephonic and written Borrowing Request shall specify the following information in compliance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">the Applicable Currency and aggregate amount of the requested Borrowing&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the date of such Borrowing, which shall be a Business Day&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt">whether such Borrowing is to be an ABR&#160;Borrowing, a Term Benchmark Borrowing or an RFR Borrowing&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">in the case of a Term Benchmark Borrowing, the Applicable Currency and initial Interest Period to be applicable thereto, which shall be a period contemplated by the definition of the term &#8220;Interest Period&#8221;&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the location and number of the Borrower&#8217;s account to which funds are to be disbursed, which shall comply with the requirements of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.07</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If no election as to the currency of a Borrowing is specified, then the requested Revolving Borrowing shall be made in Dollars.  If no election as to the Type of Revolving Borrowing to be made in Dollars is specified, then the requested Revolving Borrowing shall be an ABR&#160;Borrowing.  If no Interest Period is specified with respect to any requested Term Benchmark Revolving Borrowing, then the Borrower shall be deemed to have selected an Interest Period of one month&#8217;s duration.  Promptly following receipt of a  Borrowing Request in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">accordance with this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Administrative Agent shall advise each Lender of the details thereof and of the amount of such Lender&#8217;s Loan to be made as part of the requested Borrowing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.04.  &#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Intentionally Omitted&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> .  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.05.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;Intentionally Omitted&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.06.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letters of Credit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions set forth herein, the Borrower may request the issuance of Letters of Credit denominated in Applicable Currencies as the applicant thereof for the support of its or its Subsidiaries&#8217; obligations, in a form reasonably acceptable to the Issuing Bank, at any time and from time to time during the Availability Period and the Issuing Bank shall, subject to the conditions precedent set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, issue such requested Letters of Credit pursuant to this Agreement.  In the event of any inconsistency between the terms and conditions of this Agreement and the terms and conditions of any form of letter of credit application or other agreement submitted by the Borrower to, or entered into by the Borrower with, the Issuing Bank relating to any Letter of Credit, the terms and conditions of this Agreement shall control.  Notwithstanding anything herein to the contrary, the Issuing Bank shall have no obligation hereunder to issue, and shall not issue, any Letter of Credit (i) the proceeds of which would be made available to any Person (A) to fund any activity or business of or with any Sanctioned Person, or in any country or territory that, at the time of such funding, is the subject of any Sanctions or (B) in any manner that would result in a violation of any Sanctions by any party to this Agreement, (ii) if any order, judgment or decree of any Governmental Authority or arbitrator shall by its terms purport to enjoin or restrain the Issuing Bank from issuing such Letter of Credit, or any Requirement of Law relating to the Issuing Bank or any request or directive (whether or not having the force of law) from any Governmental Authority with jurisdiction over the Issuing Bank shall prohibit, or request that the Issuing Bank refrain from, the issuance of letters of credit generally or such Letter of Credit in particular or shall impose upon the Issuing Bank with respect to such Letter of Credit any restriction, reserve or capital requirement (for which the Issuing Bank is not otherwise compensated hereunder) not in effect on the Restatement Effective Date, or shall impose upon the Issuing Bank any unreimbursed loss, cost or expense which was not applicable on the Restatement Effective Date and which the Issuing Bank in good faith deems material to it, or (iii) if the issuance of such Letter of Credit would violate one or more policies of the Issuing Bank applicable to letters of credit generally&#59; provided that, notwithstanding anything herein to the contrary, (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines, requirements or directives thereunder or issued in connection therewith or in the implementation thereof, and (y) all requests, rules, guidelines, requirements or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed not to be in effect on the Restatement Effective Date for purposes of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above, regardless of the date enacted, adopted, issued or implemented.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Issuance, Amendment, Renewal, Extension&#59; Certain Conditions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To request the issuance of a Letter of Credit (or the amendment, renewal or extension of an outstanding Letter of Credit), the Borrower shall hand deliver or telecopy (or transmit through Electronic System, if arrangements for doing so have been approved by the Issuing Bank) to the Issuing Bank and the Administrative Agent (reasonably in advance of the requested date of issuance, amendment, renewal or extension, but in any event no less than three (3) Business Days, or with respect to Letters of Credit to be issued in Swedish Kroner, such longer period as required by the Issuing Bank from time to time) a notice requesting the issuance of a Letter of Credit, or identifying the Letter of Credit to be amended, renewed or extended, and specifying the date of issuance, amendment, renewal or extension (which shall be a Business Day), the date on which such Letter of Credit is to expire (which shall comply with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), the amount of such Letter of Credit, the Applicable Currency, the name and address of the beneficiary thereof and such other information as shall be necessary to prepare, amend, renew or extend such Letter of Credit.  If requested by the Issuing Bank, the Borrower </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">41</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">also shall submit a letter of credit application on the Issuing Bank&#8217;s standard form in connection with any request for a Letter of Credit.  A Letter of Credit shall be issued, amended, renewed or extended only if (and upon issuance, amendment, renewal or extension of each Letter of Credit the Borrower shall be deemed to represent and warrant that), after giving effect to such issuance, amendment, renewal or extension (i)&#160;(x) the aggregate undrawn Dollar Equivalent of all outstanding Letters of Credit issued by the Issuing Bank at such time plus (y) the aggregate Dollar Equivalent of all LC Disbursements made the Issuing Bank that have not yet been reimbursed by or on behalf of the Borrower at such time shall not exceed its Letter of Credit Commitment, (ii) the Dollar Equivalent of any Lender&#8217;s Revolving Credit Exposure shall not exceed its Commitment and (iii)&#160;the sum of the Dollar Equivalent of the Total Revolving Credit Exposure shall not exceed the total Commitments.  The Borrower may, at any time and from time to time, reduce the Letter of Credit Commitment of any Issuing Bank&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Borrower shall not reduce the Letter of Credit Commitment of any Issuing Bank if, after giving effect of such reduction, the conditions set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> through </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above shall not be satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Letter of Credit shall expire (or be subject to termination by notice from the Issuing Bank to the beneficiary thereof) at or prior to the close of business on the earlier of (i)&#160;the date one year after the date of the issuance of such Letter of Credit (or, in the case of any renewal or extension thereof, one year after such renewal or extension) and (ii)&#160;the date that is five (5) Business Days prior to the Maturity Date.  Notwithstanding the foregoing, any Letter of Credit may, at the discretion of the Issuing Bank, expire no later than one year after the Maturity Date so long as the Borrower cash collateralizes an amount equal to 105% of the face amount of such Letter of Credit at least ten (10) Business Days prior to the Maturity Date in the manner described in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and otherwise on terms and conditions reasonably acceptable to the Issuing Bank and the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  By the issuance of a Letter of Credit (or an amendment to a Letter of Credit increasing the amount thereof) and without any further action on the part of the Issuing Bank or the Lenders, the Issuing Bank hereby grants to each Lender, and each Lender hereby acquires from the Issuing Bank, a participation in such Letter of Credit equal to such Lender&#8217;s Applicable Percentage of the aggregate amount available to be drawn under such Letter of Credit.  In consideration and in furtherance of the foregoing, each Lender hereby absolutely and unconditionally agrees to pay to the Administrative Agent, for the account of the Issuing Bank, such Lender&#8217;s Applicable Percentage of each LC Disbursement made by the Issuing Bank and not reimbursed by the Borrower on the date due as provided in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or of any reimbursement payment required to be refunded to the Borrower for any reason.  Each Lender acknowledges and agrees that its obligation to acquire participations pursuant to this paragraph&#160;in respect of Letters of Credit is absolute and unconditional and shall not be affected by any circumstance whatsoever, including any amendment, renewal or extension of any Letter of Credit or the occurrence and continuance of a Default or reduction or termination of the Commitments, and that each such payment shall be made without any offset, abatement, withholding or reduction whatsoever.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reimbursement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If the Issuing Bank shall make any LC Disbursement in respect of a Letter of Credit, the Borrower shall reimburse such LC Disbursement by paying to the Administrative Agent in dollars the Dollar Equivalent equal to such LC Disbursement, calculated as of the date the Issuing Bank made such LC Disbursement (or if the Issuing Bank shall so elect in its sole discretion by notice to the Borrower (given at the time such LC Disbursement is made), in such other Applicable Currency which was paid by the Issuing Bank pursuant to such LC Disbursement in an amount equal to such LC Disbursement) not later than 12&#58;00 noon, New&#160;York City time, on the date that such LC Disbursement is made, if the Borrower shall have received notice of such LC Disbursement prior to 10&#58;00 a.m., New&#160;York City time, on such date, or, if such notice has not been received by the Borrower prior to such time on such date, then not later than 12&#58;00 noon, New&#160;York City time, on&#160;the Business Day immediately following the day that the Borrower receives such notice&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Borrower may, subject to the conditions to borrowing set forth herein, request in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such payment be financed with (i) to the extent such LC Disbursement </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">42</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">was made in dollars, an ABR Revolving Borrowing in an amount equal to such LC Disbursement or (ii) to the extent that such LC Disbursement was made in a Foreign Currency, a Eurodollar Revolving Borrowing in such Foreign Currency in an amount equal to such LC Disbursement and, in each case, to the extent so financed, the Borrower&#8217;s obligation to make such payment shall be discharged and replaced by the resulting ABR&#160;Revolving Borrowing or Eurodollar Revolving Borrowing, as applicable.  If the Borrower fails to make such payment when due, the Administrative Agent shall notify each Lender of the applicable LC Disbursement, the payment then due from the Borrower in respect thereof and such Lender&#8217;s Applicable Percentage thereof.  Promptly following receipt of such notice, each Lender shall pay to the Administrative Agent its Applicable Percentage of the payment then due from the Borrower, in the same manner as provided in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.07</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to Loans made by such Lender (and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.07</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall apply, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">mutatis mutandis</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to the payment obligations of the Lenders), and the Administrative Agent shall promptly pay to the Issuing Bank the amounts so received by it from the Lenders.  Promptly following receipt by the Administrative Agent of any payment from the Borrower pursuant to this paragraph, the Administrative Agent shall distribute such payment to the Issuing Bank or, to the extent that Lenders have made payments pursuant to this paragraph&#160;to reimburse the Issuing Bank, then to such Lenders and the Issuing Bank as their interests may appear.  Any payment made by a Lender pursuant to this paragraph&#160;to reimburse the Issuing Bank for any LC Disbursement (other than the funding of ABR&#160;Revolving Loans as contemplated above) shall not constitute a Loan and shall not relieve the Borrower of its obligation to reimburse such LC Disbursement.  If the Borrower&#8217;s reimbursement of, or obligation to reimburse, any amounts in any Foreign Currency would subject the Administrative Agent, the Issuing Bank or any Lender to any stamp duty, ad valorem charge or similar tax that would not be payable if such reimbursement were made or required to be made in dollars, the Borrower shall, at its option, either (x) pay the amount of any such tax requested by the Administrative Agent, the Issuing Bank or the relevant Lender or (y) reimburse each LC Disbursement made in such Foreign Currency in dollars, in an amount equal to the Equivalent Amount, calculated using the applicable Exchange Rates, on the date such LC Disbursement is made, of such LC Disbursement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Obligations Absolute</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower&#8217;s obligation to reimburse LC Disbursements as provided in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be absolute, unconditional and irrevocable, and shall, subject to the limitations set forth in the immediately following sentence, be performed strictly in accordance with the terms of this Agreement under any and all circumstances whatsoever and irrespective of (i)&#160;any lack of validity or enforceability of any Letter of Credit or this Agreement, or any term or provision therein, (ii)&#160;any draft or other document presented under a Letter of Credit proving to be forged, fraudulent or invalid in any respect or any statement therein being untrue or inaccurate in any respect, (iii)&#160;payment by the Issuing Bank under a Letter of Credit against presentation of a draft or other document that does not comply with the terms of such Letter of Credit, or (iv)&#160;any other event or circumstance whatsoever, whether or not similar to any of the foregoing, that might, but for the provisions of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, constitute a legal or equitable discharge of, or provide a right of setoff against, the Borrower&#8217;s obligations hereunder.  Neither the Administrative Agent, the Lenders nor the Issuing Bank, nor any of their Related Parties, shall have any liability or responsibility by reason of or in connection with the issuance or transfer of any Letter of Credit or any payment or failure to make any payment thereunder (irrespective of any of the circumstances referred to in the preceding sentence), or any error, omission, interruption, loss or delay in transmission or delivery of any draft, notice or other communication under or relating to any Letter of Credit (including any document required to make a drawing thereunder), any error in interpretation of technical terms or any consequence arising from causes beyond the control of the Issuing Bank&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the foregoing shall not be construed to excuse the Issuing Bank from liability to the Borrower to the extent of any direct damages (as opposed to special, indirect, consequential or punitive damages, claims in respect of which are hereby waived by the Borrower to the extent permitted by applicable law) suffered by the Borrower that are caused by the Issuing Bank&#8217;s failure to exercise care when determining whether drafts and other documents presented under a Letter of Credit comply with the terms thereof.  The parties hereto expressly agree that, in the absence of gross negligence or willful misconduct on the part of the Issuing Bank (as finally determined by a court of competent jurisdiction), the Issuing Bank shall be deemed to have </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">43</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">exercised care in each such determination.  In furtherance of the foregoing and without limiting the generality thereof, the parties agree that, with respect to documents presented which appear on their face to be in substantial compliance with the terms of a Letter of Credit, the Issuing Bank may, in its sole discretion, either accept and make payment upon such documents without responsibility for further investigation, regardless of any notice or information to the contrary, or refuse to accept and make payment upon such documents if such documents are not in strict compliance with the terms of such Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Disbursement Procedures</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Issuing Bank shall, promptly following its receipt thereof, examine all documents purporting to represent a demand for payment under a Letter of Credit.  The Issuing Bank shall promptly notify the Administrative Agent and the Borrower by telephone (confirmed by telecopy or through Electronic Systems) of such demand for payment and whether the Issuing Bank has made or will make an LC Disbursement thereunder&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any failure to give or delay in giving such notice shall not relieve the Borrower of its obligation to reimburse the Issuing Bank and the Lenders with respect to any such LC Disbursement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interim Interest</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If the Issuing Bank shall make any LC Disbursement, then, unless the Borrower shall reimburse such LC Disbursement in full on the date such LC Disbursement is made, the unpaid amount thereof shall bear interest, for each day from and including the date such LC Disbursement is made to but excluding the date that the reimbursement is due and payable at the rate </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> then applicable to ABR&#160;Revolving Loans and such interest shall be due and payable on the date when such reimbursement is payable&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if the Borrower fails to reimburse such LC Disbursement when due pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.13(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall apply.  Interest accrued pursuant to this paragraph&#160;shall be for the account of the Issuing Bank, except that interest accrued on and after the date of payment by any Lender pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.06</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to reimburse the Issuing Bank shall be for the account of such Lender to the extent of such payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Replacement of the Issuing Bank</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (i) The Issuing Bank may be replaced at any time by written agreement among the Borrower, the Administrative Agent, the replaced Issuing Bank and the successor Issuing Bank.  The Administrative Agent shall notify the Lenders of any such replacement of the Issuing Bank.  At the time any such replacement shall become effective, the Borrower shall pay all unpaid fees accrued for the account of the replaced Issuing Bank pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.12(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  From and after the effective date of any such replacement, (x)&#160;the successor Issuing Bank shall have all the rights and obligations of the Issuing Bank under this Agreement with respect to Letters of Credit to be issued thereafter and (y)&#160;references herein to the term &#8220;Issuing Bank&#8221; shall be deemed to refer to such successor or to any previous Issuing Bank, or to such successor and all previous Issuing Banks, as the context shall require.  After the replacement of an Issuing Bank hereunder, the replaced Issuing Bank shall remain a party hereto and shall continue to have all the rights and obligations of an Issuing Bank under this Agreement with respect to Letters of Credit issued by it prior to such replacement, but shall not be required to issue additional Letters of Credit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Subject to the appointment and acceptance of a successor Issuing Bank, any Issuing Bank may resign as an Issuing Bank at any time upon thirty (30) days&#8217; prior written notice to the Administrative Agent, the Borrower and the Lenders, in which case, such Issuing Bank shall be replaced in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Collateralization</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If any Event of Default shall occur and be continuing, on the Business Day that the Borrower receives notice from the Administrative Agent or the Required Lenders (or, if the maturity of the Loans has been accelerated, Lenders with LC Exposure representing not less than 51% of the total LC Exposure) demanding the deposit of cash collateral pursuant to this paragraph, the Borrower shall deposit in an account with the Administrative Agent, in the name of the Administrative Agent and for the benefit of the Lenders, an amount in cash equal to 105% of the Dollar Equivalent of the LC Exposure as of such date plus any accrued and unpaid interest thereon&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) the portions of such amount </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">44</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">attributable to undrawn Foreign Currency Letters of Credit or LC Disbursements in a Foreign Currency that the Borrower is not late in reimbursing shall be deposited in the applicable Foreign Currencies in the actual amounts of such undrawn Letters of Credit and LC Disbursements and (ii) the obligation to deposit such cash collateral shall become effective immediately, and such deposit shall become immediately due and payable, without demand or other notice of any kind, upon the occurrence of any Event of Default with respect to the Borrower described in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article&#160;VII</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For the purposes of this paragraph, the Foreign Currency LC Exposure shall be calculated using the applicable Exchange Rate on the date notice demanding cash collateralization is delivered to the Borrower.  The Borrower also shall deposit cash collateral pursuant to this paragraph as and to the extent required by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Such deposit shall be held by the Administrative Agent as collateral for the payment of the LC Exposure under this Agreement.  The Administrative Agent shall have exclusive dominion and control, including the exclusive right of withdrawal, over such account.  Other than any interest earned on the investment of such deposits, which investments shall be made at the option and sole discretion of the Administrative Agent and at the Borrower&#8217;s risk and expense, such deposits shall not bear interest.  Interest or profits, if any, on such investments shall accumulate in such account.  Moneys in such account shall be applied by the Administrative Agent to reimburse the Issuing Bank for LC Disbursements for which it has not been reimbursed and, to the extent not so applied, shall be held for the satisfaction of the reimbursement obligations of the Borrower for the LC Exposure at such time or, if the maturity of the Loans has been accelerated (but subject to the consent of Lenders with LC Exposure representing not less than 51% of the total LC Exposure), be applied to satisfy other obligations of the Borrower under this Agreement.  If the Borrower is required to provide an amount of cash collateral hereunder as a result of the occurrence of an Event of Default, such amount (to the extent not applied as aforesaid) shall be returned to the Borrower within three (3) Business Days after all Events of Default have been cured or waived.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.07.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Funding of Borrowings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) Each Lender shall make each Loan to be made by it hereunder on the proposed date thereof solely by wire transfer of immediately available funds (i) in the case of Loans denominated in dollars, by 12&#58;00 noon, New&#160;York City time, to the account of the Administrative Agent most recently designated by it for such purpose by notice to the Lenders and (ii) in the case of each Loan denominated in a Foreign Currency, by 12&#58;00 noon, Local Time.  Except in respect of the provisions of this Agreement covering the reimbursement of Letters of Credit, the Administrative Agent will make such Loans available to the Borrower by promptly crediting the funds so received, in like funds, to (x) an account of the Borrower designated by the Borrower in the applicable Borrowing Request, in the case of Loans denominated in dollars made to the Borrower and (y) an account of the Borrower in the relevant jurisdiction and designated by the Borrower in the applicable Borrowing Request, in the case of Loans denominated in a Foreign Currency&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that ABR&#160;Revolving Loans made to finance the reimbursement of an LC Disbursement as provided in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.06(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be remitted by the Administrative Agent to the Issuing Bank.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Unless the Administrative Agent shall have received notice from a Lender prior to the proposed date of any Borrowing that such Lender will not make available to the Administrative Agent such Lender&#8217;s share of such Borrowing, the Administrative Agent may assume that such Lender has made such share available on such date in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.07</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and may, in reliance upon such assumption, make available to the Borrower a corresponding amount.  In such event, if a Lender has not in fact made its share of the applicable Borrowing available to the Administrative Agent, then the applicable Lender and the Borrower severally agree to pay to the Administrative Agent forthwith on demand such corresponding amount with interest thereon, for each day from and including the date such amount is made available to the Borrower to but excluding the date of payment to the Administrative Agent, at (i)&#160;in the case of such Lender, the greater of the applicable Overnight Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation or (ii)&#160;in the case of the Borrower, the interest rate applicable to ABR&#160;Loans, or in the case of Foreign Currencies, in accordance with such market practice, in each case, as applicable.  If such Lender pays such amount to the Administrative Agent, then such amount shall constitute such Lender&#8217;s Loan included in such Borrowing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">45</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.08.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Elections</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) Each Revolving Borrowing initially shall be of the Type and Applicable Currency specified in the applicable Borrowing Request and, in the case of a Term Benchmark Revolving Borrowing, shall have an initial Interest Period as specified in such Borrowing Request.  Thereafter, the Borrower may elect to convert such Borrowing to a different Type or to continue such Borrowing and, in the case of a Term Benchmark Revolving Borrowing, may elect Interest Periods therefor, all as provided in this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.08</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower may elect different options with respect to different portions of the affected Borrowing, in which case each such portion shall be allocated ratably among the Lenders holding the Loans comprising such Borrowing, and the Loans comprising each such portion shall be considered a separate Borrowing.  Notwithstanding anything in this Agreement to the contrary, the Borrower may not request that any Eurodollar Revolving Borrowing denominated in a Foreign Currency be converted into a different Type of Borrowing or Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  To make an election pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.08</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Borrower shall notify the Administrative Agent of such election by telephone by the time that a Borrowing Request would be required under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> if the Borrower were requesting a Revolving Borrowing of the Type resulting from such election to be made on the effective date of such election.  Each such telephonic Interest Election Request shall be irrevocable and shall be confirmed promptly by hand delivery or telecopy (or transmit by electronic communication in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof) to the Administrative Agent of a written Interest Election Request in a form approved by the Administrative Agent and signed by the Borrower&#59; provided, that any interest received from the Borrower by the Administrative Agent during the period beginning when the Administrative Agent funded the Borrowing until such Lender pays such amount shall be solely for the account of the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  Each telephonic and written Interest Election Request shall specify the following information in compliance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">the Applicable Currency and principal amount of Borrowing to which such Interest Election Request applies and, if different options are being elected with respect to different portions thereof, the portions thereof to be allocated to each resulting Borrowing (in which case the information to be specified pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses&#160;(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> below shall be specified for each resulting Borrowing)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the effective date of the election made pursuant to such Interest Election Request, which shall be a Business Day&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt">whether the resulting Borrowing is to be an ABR&#160;Borrowing (in the case of Borrowings denominated in Dollars) or a Term Benchmark Borrowing&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">if the resulting Borrowing is a Term Benchmark Borrowing, the Interest Period and Applicable Currency to be applicable thereto after giving effect to such election, which shall be a period contemplated by the definition of the term &#8220;Interest Period&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If any such Interest Election Request requests a Term Benchmark Borrowing but does not specify an Interest Period, then the Borrower shall be deemed to have selected an Interest Period of one month&#8217;s duration.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Promptly following receipt of an Interest Election Request, the Administrative Agent shall advise each Lender of the details thereof and of such Lender&#8217;s portion of each resulting Borrowing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  If the Borrower fails to deliver a timely Interest Election Request with respect to a Term Benchmark Revolving Borrowing in Dollars prior to the end of the Interest Period applicable thereto, then, unless such Borrowing is repaid as provided herein, at the end of such Interest Period such Borrowing shall be converted to an ABR Borrowing at the end of such Interest Period.  If the Borrower fails to deliver a timely and complete Interest Election Request </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">46</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">with respect to a Term Benchmark Borrowing in a Foreign Currency prior to the end of the Interest Period therefor, then, unless such Term Benchmark Borrowing is repaid as provided herein, such Borrower shall be deemed to have selected that such Term Benchmark Borrowing shall automatically be continued as a Term Benchmark Borrowing in its original Applicable Currency with an Interest Period of one month at the end of such Interest Period. Notwithstanding any contrary provision hereof, if an Event of Default has occurred and is continuing and the Administrative Agent, at the request of the Required Lenders, so notifies the Borrower, then, so long as such Event of Default is continuing (i)&#160;no outstanding Revolving Borrowing may be converted to or continued as a Term Benchmark Borrowing, (ii)&#160;unless repaid, (x) each Term Benchmark Borrowing denominated in Dollars shall be converted to an ABR&#160;Borrowing at the end of the Interest Period applicable thereto and (y) each Term Benchmark Borrowing and each RFR Borrowing, in each case, denominated in a Foreign Currency shall bear interest at the Central Bank Rate (or in the case of the Yen, the Japanese Prime Rate) for the applicable Applicable Currency </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Rate&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if the Administrative Agent determines (which determination shall be conclusive and binding absent manifest error) that the Central Bank Rate (or in the case of the Yen, the Japanese Prime Rate) for the applicable Applicable Currency cannot be determined, any outstanding affected Term Benchmark Loans denominated in any Applicable Currency other than Dollars shall either be (a) converted to an ABR Borrowing denominated in Dollars (in an amount equal to the U.S. Dollar Equivalent of such Applicable Currency) at the end of the Interest Period, as applicable, therefor or (b) prepaid at the end of the applicable Interest Period, as applicable, in full&#59; provided that if no election is made by the Borrower by the earlier of (x) the date that is three Business Days after receipt by such Borrower of such notice and (y) the last day of the current Interest Period for the applicable Term Benchmark Loan, such Borrower shall be deemed to have elected </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (A)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.09.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination and Reduction of Commitments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) Unless previously terminated, the Commitments shall terminate on the Maturity Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Borrower may at any time terminate the Commitments upon (i) the payment in full of all outstanding Revolving Loans and LC Disbursements, together with accrued and unpaid interest thereon, (ii) the cancellation and return of all outstanding Letters of Credit (or alternatively, with respect to each such Letter of Credit, the furnishing to the Administrative Agent of a cash deposit (or at the discretion of the Administrative Agent a backup standby letter of credit satisfactory to the Administrative Agent and the Issuing Bank) in a Dollar Equivalent equal to 105% of the LC Exposure as of such date), (iii) the payment in full of the accrued and unpaid fees, including applicable prepayment fee (if any), and (iv) the payment in full of all reimbursable expenses and other Obligations together with accrued and unpaid interest thereon.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  The Borrower may from time to time reduce the Commitments&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i)&#160;each reduction of the Commitments shall be in an amount that is an integral multiple of $1,000,000</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and not less than $5,000,000 and (ii)&#160;the Borrower shall not terminate or reduce the Commitments if, after giving effect to any concurrent prepayment of the Loans in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Dollar Equivalent of the sum of the Total Revolving Credit Exposures would exceed the total Commitments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Borrower shall notify the Administrative Agent of any election to terminate or reduce the Commitments under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.09</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;at least three (3) Business Days prior to the effective date of such termination or reduction, specifying such election and the effective date thereof.  Promptly following receipt of any notice, the Administrative Agent shall advise the Lenders of the contents thereof.  Each notice delivered by the Borrower pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.09 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">shall be irrevocable&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that a notice of termination of the Commitments delivered by the Borrower may state that such notice is conditioned upon the effectiveness of other credit facilities, in which case such notice may be revoked by the Borrower (by notice to the Administrative Agent on or prior to the specified effective date) if such condition is not satisfied.  Any termination or reduction of the Commitments shall be permanent.  Each reduction </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of the Commitments shall be made ratably among the Lenders in accordance with their respective Commitments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.10.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Repayment of Loans&#59; Evidence of Debt</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) The Borrower hereby unconditionally promises to pay to the Administrative Agent for the account of each Lender the then unpaid principal amount of each Revolving Loan on the Maturity Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Each Lender shall maintain in accordance with its usual practice an account or accounts evidencing the Indebtedness of the Borrower to such Lender resulting from each Loan made by such Lender, including the amounts of principal and interest payable and paid to such Lender from time to time hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  The Administrative Agent shall maintain accounts in which it shall record (i)&#160;the amount of each Loan made hereunder, the Applicable Currency and Type thereof and the Interest Period applicable thereto, (ii)&#160;the amount of any principal or interest due and payable or to become due and payable from the Borrower to each Lender hereunder and (iii)&#160;the amount of any sum received by the Administrative Agent hereunder for the account of the Lenders and each Lender&#8217;s share thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The entries made in the accounts maintained pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;shall be </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">prima facie</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> evidence of the existence and amounts of the obligations recorded therein&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the failure of any Lender or the Administrative Agent to maintain such accounts or any error therein shall not in any manner affect the obligation of the Borrower to repay the Loans in accordance with the terms of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Any Lender may request that Loans made by it be evidenced by a promissory note.  In such event, the Borrower shall prepare, execute and deliver to such Lender a promissory note payable to such Lender (or, if requested by such Lender, to such Lender and its registered assigns) and in a form approved by the Administrative Agent.  Thereafter, the Loans evidenced by such promissory note and interest thereon shall at all times (including after assignment pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;9.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) be represented by one or more promissory notes in such form.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.11.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Prepayment of Loans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) The Borrower shall have the right at any time and from time to time to prepay any Borrowing in whole or in part, subject to prior notice in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Borrower shall notify the Administrative  Agent by telephone (confirmed by telecopy or electronic mail) of any prepayment hereunder (i)(w) in the case of prepayment of a Term Benchmark Revolving Borrowing denominated in Dollars, not later than 11&#58;00 a.m., New&#160;York City time, three Business Days before the date of prepayment, (x) in the case of prepayment of a Term Benchmark Revolving Borrowing, not later than 12&#58;00 p.m., Local Time, three Business Days before the date of prepayment and (y) in the case of prepayment of an RFR Revolving Borrowing denominated in Sterling, not later than 11&#58;00 a.m., Local Time, five Business Days before the date of prepayment or (ii)&#160;in the case of prepayment of an ABR&#160;Revolving Borrowing, not later than 11&#58;00 a.m., New&#160;York City time, one Business Day before the date of prepayment.  Each such notice shall be irrevocable and shall specify the prepayment date and the principal amount of each Borrowing or portion thereof to be prepaid&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if a notice of prepayment is given in connection with a conditional notice of termination of the Commitments as contemplated by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.09</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then such notice of prepayment may be revoked if such notice of termination is revoked in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.09</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Promptly following receipt of any such notice relating to a Revolving Borrowing, the Administrative Agent shall advise the Lenders of the contents thereof.  Each partial prepayment of any Revolving Borrowing shall be in an amount that would be permitted in the case of an advance of a Revolving Borrowing of the same Type as provided in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each prepayment of a Revolving Borrowing shall be applied ratably to the Loans included in the prepaid Borrowing.  Prepayments shall be accompanied by accrued interest to the extent required by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">48</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  If at any time the sum of the aggregate principal Dollar Equivalent of all of the Revolving Credit Exposures (calculated, with respect to those Credit Events denominated in Foreign Currencies, as of the most recent Revaluation Date with respect to each such Credit Event) exceeds (A) the aggregate Commitments or (B) the sum of the aggregate principal Dollar Equivalent of all of the outstanding Revolving Credit Exposures denominated in a Foreign Currency, as of the most recent Revaluation Date with respect to each such Credit Event, exceeds the Foreign Currency Sublimit, the Borrower shall immediately repay Borrowings or cash collateralize LC Exposure in an account with the Administrative Agent pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as applicable, in an aggregate principal amount sufficient to cause (x) the aggregate Dollar Equivalent of all Revolving Credit Exposures (so calculated) to be less than or equal to the aggregate Commitments and (y) the Revolving Credit Exposures denominated in a Foreign Currency to be less than or equal to the Foreign Currency Sublimit, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.12.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) The Borrower agrees to pay to the Administrative Agent for the account of each Lender a commitment fee, which shall accrue at the Applicable Rate on the daily unused amount of the Commitment of such Lender during the period from and including the Restatement Effective Date to but excluding the date on which such Commitment terminates.  Accrued commitment fees shall be payable in arrears on the last day of March, June, September and December of each year and on the date on which the Commitments terminate, commencing on the first such date to occur after the date hereof.  All commitment fees shall be computed on the basis of a year of 360 days and shall be payable for the actual number of days elapsed (including the first day but excluding the last day).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Borrower agrees to pay (i)&#160;to the Administrative Agent for the account of each Lender a participation fee with respect to its participations in Letters of Credit, which shall accrue at the same Applicable Rate used to determine the interest rate applicable to Term Benchmark Revolving Loans on the average daily Dollar Equivalent of such Lender&#8217;s LC Exposure (excluding any portion thereof attributable to unreimbursed LC Disbursements) during the period from and including the Restatement Effective Date to but excluding the later of the date on which such Lender&#8217;s Commitment terminates and the date on which such Lender ceases to have any LC Exposure, and (ii)&#160;to the Issuing Bank a fronting fee, which shall accrue at the rate or rates </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> separately agreed upon between the Borrower and the Issuing Bank on the average daily Dollar Equivalent of the LC Exposure (excluding any portion thereof attributable to unreimbursed LC Disbursements) during the period from and including the Restatement Effective Date to but excluding the later of the date of termination of the Commitments and the date on which there ceases to be any LC Exposure, as well as the Issuing Bank&#8217;s standard fees with respect to the issuance, amendment, renewal or extension of any Letter of Credit or processing of drawings thereunder.  Participation fees and fronting fees accrued through and including the last day of March, June, September and December of each year shall be payable on the third (3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) Business Day following such last day, commencing on the first such date to occur after the Restatement Effective Date&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that all such fees shall be payable on the date on which the Commitments terminate and any such fees accruing after the date on which the Commitments terminate shall be payable on demand.  Any other fees payable to the Issuing Bank pursuant to this paragraph&#160;shall be payable within ten (10) days after demand.  All participation fees and fronting fees shall be computed on the basis of a year of 360 days and shall be payable for the actual number of days elapsed (including the first day but excluding the last day).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  The Borrower agrees to pay to the Administrative Agent, for its own account, fees payable in the amounts and at the times separately agreed upon between the Borrower and the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  All fees payable hereunder shall be paid on the dates due, in immediately available funds, to the Administrative Agent (or to the Issuing Bank, in the case of fees payable to it) for distribution, in the case of commitment fees and participation fees, to the Lenders.  Fees paid shall not be refundable under any circumstances.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">49</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.13.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) The Loans comprising each ABR&#160;Borrowing shall bear interest at the Alternate Base Rate plus the Applicable Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Loans comprising each Term Benchmark Borrowing shall bear interest in the case of a Term Benchmark Revolving Loan, at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, the Adjusted STIBOR Rate, the Adjusted CDOR, Adjusted AUD Rate, the Adjusted BKBM Rate or the Adjusted TIBOR Rate, as applicable, for the Interest Period in effect for such Borrowing plus the Applicable Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  Each RFR Loan shall bear interest at a rate per annum equal to the applicable Adjusted Daily Simple RFR plus the Applicable Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Notwithstanding the foregoing, if any principal of or interest on any Loan or any fee or other amount payable by the Borrower hereunder is not paid when due, whether at stated maturity, upon acceleration or otherwise, such overdue amount shall bear interest, after as well as before judgment, at a rate </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> equal to (i)&#160;in the case of overdue principal of any Loan, 2% plus the  rate otherwise applicable to such Loan as provided in the preceding paragraphs of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;or (ii)&#160;in the case of any other amount, 2% plus the rate applicable to ABR&#160;Loans as provided in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Accrued interest on each Loan shall be payable in arrears on each Interest Payment Date for such Loan and, in the case of Revolving Loans, upon termination of the Commitments&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i)&#160;interest accrued pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.13 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">shall be payable on demand, (ii)&#160;in the event of any repayment or prepayment of any Loan (other than a prepayment of an ABR&#160;Revolving Loan prior to the end of the Availability Period), accrued interest on the principal amount repaid or prepaid shall be payable on the date of such repayment or prepayment and (iii)&#160;in the event of any conversion of any Term Benchmark Revolving Loan prior to the end of the current Interest Period therefor, accrued interest on such Loan shall be payable on the effective date of such conversion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">  All interest hereunder shall be computed on the basis of a year of 360 days, except that (i) interest computed by reference to the Daily Simple RFR with respect to Sterling or the Alternate Base Rate at times when the Alternate Base Rate is based on the Prime Rate shall be computed on the basis of a year of 365 days (or 366 days in a leap year), and (ii) interest on Term Benchmark Borrowings denominated in a Foreign Currency (other than Canadian Dollars) shall be computed on the basis of a year of 365 days, and in each case shall be payable for the actual number of days elapsed (including the first day but excluding the last day).  All interest hereunder on any Loan shall be computed on a daily basis based upon the outstanding principal amount of such Loan as of the applicable date of determination.  The applicable Alternate Base Rate, Adjusted Term SOFR Rate, Term SOFR Rate, Daily Simple SOFR, Adjusted EURIBOR Rate, EURIBOR Rate, Adjusted STIBOR Rate, STIBOR Rate, Adjusted CDOR, CDOR, Adjusted AUD Rate, AUD Rate, Adjusted BKBM Rate, BKBM Rate, Adjusted TIBOR Rate, TIBOR Rate, Adjusted Daily Simple RFR or Adjusted Daily Simple RFR shall be determined by the Administrative Agent, and such determination shall be conclusive absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.14.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Rate of Interest</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Subject to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, if&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">if the Administrative Agent determines (which determination shall be conclusive absent manifest error) (A) prior to the commencement of any Interest Period for a Term Benchmark Borrowing, that adequate and reasonable means do not exist for ascertaining the Adjusted Term SOFR Rate, Term SOFR Rate, Adjusted EURIBOR Rate, EURIBOR Rate, Adjusted STIBOR Rate, STIBOR Rate, Adjusted CDOR, CDOR, Adjusted AUD Rate, AUD Rate, Adjusted BKBM Rate, BKBM Rate, Adjusted TIBOR Rate or TIBOR Rate (including because the Relevant Screen Rate is not available or published on a current basis), for the applicable Agreed Currency and such Interest </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">50</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Period or (B) at any time, that adequate and reasonable means do not exist for ascertaining the applicable Adjusted Daily Simple RFR or RFR for the applicable Agreed Currency, as applicable&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the Administrative Agent is advised by the Required Lenders that (A) prior to the commencement of any Interest Period for a Term Benchmark Borrowing, the Adjusted Term SOFR Rate, Term SOFR Rate, Adjusted EURIBOR Rate, EURIBOR Rate, Adjusted STIBOR Rate, STIBOR Rate, Adjusted CDOR, CDOR, Adjusted AUD Rate, AUD Rate, Adjusted BKBM Rate, BKBM Rate, Adjusted TIBOR Rate or TIBOR Rate for the applicable Agreed Currency and such Interest Period will not adequately and fairly reflect the cost to such Lenders (or Lender) of making or maintaining their Loans (or its Loan) included in such Borrowing for the applicable Agreed Currency and such Interest Period or (B) at any time, the applicable Adjusted Daily Simple RFR or RFR for the applicable Agreed Currency will not adequately and fairly reflect the cost to such Lenders (or Lender) of making or maintaining their Loans (or its Loan) included in such Borrowing for the applicable Agreed Currency, as applicable&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">then the Administrative Agent shall give notice thereof to the Borrower and the Lenders by telephone, telecopy or electronic mail as promptly as practicable thereafter and, until (x) the Administrative Agent notifies the Borrower and the Lenders that the circumstances giving rise to such notice no longer exist with respect to the relevant Benchmark and (y) the Borrower delivers a new Interest Election Request in accordance with the terms of Section 2.08 or a new Borrowing Request in accordance with the terms of Section 2.03, (A) for Loans denominated in Dollars, any Interest Election Request that requests the conversion of any Revolving Borrowing to, or continuation of any Revolving Borrowing as, a Term Benchmark Borrowing and any Borrowing Request that requests a Term Benchmark Revolving Borrowing shall instead be deemed to be an Interest Election Request or a Borrowing Request, as applicable, for (x) an RFR Borrowing denominated in Dollars so long as the Adjusted Daily Simple RFR for Dollar Borrowings is not also the subject of Section 2.14(a)(i) or (ii) above or (y) an ABR&#160;Borrowing if the Adjusted Daily Simple RFR for Dollar Borrowings also is the subject of Section 2.14(a)(i) or (ii) above and (B) for Loans denominated in a Foreign Currency, any Interest Election Request that requests the conversion of any Revolving Borrowing to, or continuation of any Revolving Borrowing as, a Term Benchmark Borrowing and any Borrowing Request that requests a Term Benchmark Borrowing or an RFR Borrowing, in each case, for the relevant Benchmark, shall be ineffective&#59; provided that&#160;if the circumstances giving rise to such notice affect only one Type of Borrowing, then all other Types of Borrowings shall be permitted.  Furthermore, if any Term Benchmark Loan or RFR Loan in any Agreed Currency is outstanding on the date of the Borrower&#8217;s receipt of the notice from the Administrative Agent referred to in this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to a Relevant Rate applicable to such Term Benchmark Loan or RFR Loan, then until (x) the Administrative Agent notifies the Borrower and the Lenders that the circumstances giving rise to such notice no longer exist with respect to the relevant Benchmark and (y) the Borrower delivers a new Interest Election Request in accordance with the terms of Section 2.08 or a new Borrowing Request in accordance with the terms of Section 2.03, (A) for Loans denominated in Dollars, any Term Benchmark Loan shall on the last day of the Interest Period applicable to such Loan, be converted by the Administrative Agent to, and shall constitute, (x) an RFR Borrowing denominated in Dollars so long as the Adjusted Daily Simple RFR for Dollar Borrowings is not also the subject of Section 2.14(a)(i) or (ii) above or (y) an ABR Loan if the Adjusted Daily Simple RFR for Dollar Borrowings also is the subject of Section 2.14(a)(i) or (ii) above, on such day, and (B) for Loans denominated in a Foreign Currency, (1) Term Benchmark Loan shall, on the last day of the Interest Period applicable to such Loan bear interest at the Central Bank Rate (or in the case of the Yen, the Japanese Prime Rate) for the applicable Applicable Currency </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Rate&#59; provided that, if the Administrative Agent determines (which determination shall be conclusive and binding absent manifest error) that the Central Bank Rate (or in the case of the Yen, the Japanese Prime Rate) for the applicable Applicable Currency cannot be determined, any outstanding affected Term Benchmark Loans denominated in any Foreign Currency shall, at the Borrower&#8217;s election prior to such day&#58; (A) be prepaid by the Borrower on such day or (B) solely for the purpose of calculating the interest rate applicable to such Term Benchmark Loan, such Term Benchmark Loan denominated in any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">51</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign Currency shall be deemed to be a Term Benchmark Loan denominated in Dollars and shall accrue interest at the same interest rate applicable to Term Benchmark Loans denominated in Dollars at such time or (2) if such RFR Loan is denominated in any Foreign Currency, then such Loan shall bear interest at the Central Bank Rate (or in the case of the Yen, the Japanese Prime Rate) for the applicable Applicable Currency </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Rate&#59; provided that, if the Administrative Agent determines (which determination shall be conclusive and binding absent manifest error) that the Central Bank Rate (or in the case of the Yen, the Japanese Prime Rate) for the applicable Applicable Currency cannot be determined, any outstanding affected RFR Loans denominated in any Foreign Currency, at the Borrower&#8217;s election, shall either (A) be converted into ABR Loans denominated in Dollars (in an amount equal to the Dollar Equivalent of such Applicable Currency) immediately or (B) be prepaid in full immediately.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Notwithstanding anything to the contrary herein or in any other Loan Document, if a Benchmark Transition Event and its related Benchmark Replacement Date have occurred prior to the Reference Time in respect of any setting of the then-current Benchmark, then (x) if a Benchmark Replacement is determined in accordance with clause (1) of the definition of &#8220;Benchmark Replacement&#8221; with respect to Dollars for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document in respect of such Benchmark setting and subsequent Benchmark settings without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document and (y) if a Benchmark Replacement is determined in accordance with clause (2) of the definition of &#8220;Benchmark Replacement&#8221; with respect to any Agreed Currency for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document in respect of any Benchmark setting at or after 5&#58;00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Benchmark Replacement is provided to the Lenders without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document so long as the Administrative Agent has not received, by such time, written notice of objection to such Benchmark Replacement from Lenders comprising the Required Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  Notwithstanding anything to the contrary herein or in any other Loan Document, the Administrative Agent will have the right to make Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this Agreement or any other Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Administrative Agent will promptly notify the Borrower and the Lenders of (i) any occurrence of a Benchmark Transition Event, (ii) the implementation of any Benchmark Replacement, (iii) the effectiveness of any Benchmark Replacement Conforming Changes, (iv) the removal or reinstatement of any tenor of a Benchmark pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> below and (v) the commencement or conclusion of any Benchmark Unavailability Period.  Any determination, decision or election that may be made by the Administrative Agent or, if applicable, any Lender (or group of Lenders) pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action or any selection, will be conclusive and binding absent manifest error and may be made in its or their sole discretion and without consent from any other party to this Agreement or any other Loan Document, except, in each case, as expressly required pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Notwithstanding anything to the contrary herein or in any other Loan Document, at any time (including in connection with the implementation of a Benchmark Replacement), (i) if the then-current Benchmark is a term rate (including the Term SOFR Rate, EURIBOR Rate or TIBOR Rate) and either (a) any tenor for such Benchmark is not displayed on a screen or other information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion or (b) the regulatory supervisor for the administrator of such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Benchmark has provided a public statement or publication of information announcing that any tenor for such Benchmark is or will be no longer representative, then the Administrative Agent may modify the definition of &#8220;Interest Period&#8221; for any Benchmark settings at or after such time to remove such unavailable or non-representative tenor and (ii) if a tenor that was removed pursuant to clause (i) above either (a) is subsequently displayed on a screen or information service for a Benchmark (including a Benchmark Replacement) or (b) is not, or is no longer, subject to an announcement that it is or will no longer be representative for a Benchmark (including a Benchmark Replacement), then the Administrative Agent may modify the definition of &#8220;Interest Period&#8221; for all Benchmark settings at or after such time to reinstate such previously removed tenor. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">  Upon the Borrower&#8217;s receipt of notice of the commencement of a Benchmark Unavailability Period, the Borrower may revoke any request for a Term Benchmark Borrowing or RFR Borrowing of, conversion to or continuation of Term Benchmark Loans to be made, converted or continued during any Benchmark Unavailability Period and, failing that, either (x) the Borrower will be deemed to have converted any request for (1) a Term Benchmark Borrowing denominated in Dollars into a request for a Borrowing of or conversion to (A) an RFR Borrowing denominated in Dollars so long as the Adjusted Daily Simple RFR for Dollar Borrowings is not the subject of a Benchmark Transition Event or (B) an ABR Borrowing if the Adjusted Daily Simple RFR for Dollar Borrowings is the subject of a Benchmark Transition Event or (y) any Term Benchmark Borrowing or RFR Borrowing denominated in a Foreign Currency shall be ineffective.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt"> During any Benchmark Unavailability Period or at any time that a tenor for the then-current Benchmark is not an Available Tenor, the component of ABR based upon the then-current Benchmark or such tenor for such Benchmark, as applicable, will not be used in any determination of ABR.  Furthermore, if any Term Benchmark Loan or RFR Loan in any Agreed Currency is outstanding on the date of the Borrower&#8217;s receipt of notice of the commencement of a Benchmark Unavailability Period with respect to a Relevant Rate applicable to such Term Benchmark Loan or RFR Loan, then until such time as a Benchmark Replacement for such Agreed Currency is implemented pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (A) for Loans denominated in Dollars, any Term Benchmark Loan shall on the last day of the Interest Period applicable to such Loan (or the next succeeding Business Day if such day is not a Business Day), be converted by the Administrative Agent to, and shall constitute, (x) an RFR Borrowing denominated in Dollars so long as the Adjusted Daily Simple RFR for Dollar Borrowings is not the subject of a Benchmark Transition Event or (y) an ABR Loan if the Adjusted Daily Simple RFR for Dollar Borrowings is the subject of a Benchmark Transition Event, on such day and (B) for Loans denominated in a Foreign Currency, (1) any Term Benchmark Loan shall, on the last day of the Interest Period applicable to such Loan bear interest at the Central Bank Rate (or in the case of the Yen, the Japanese Prime Rate) for the applicable Applicable Currency </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Rate&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if the Administrative Agent determines (which determination shall be conclusive and binding absent manifest error) that the Central Bank Rate (or in the case of the Yen, the Japanese Prime Rate) for the applicable Applicable Currency cannot be determined, any outstanding affected Term Benchmark Loans denominated in any Foreign Currency shall, at the Borrower&#8217;s election prior to such day&#58; (a) be prepaid by the Borrower on such day or (b) solely for the purpose of calculating the interest rate applicable to such Term Benchmark Loan, such Term Benchmark Loan denominated in any Applicable Currency other than Dollars shall be deemed to be a Term Benchmark Loan denominated in Dollars and shall accrue interest at the same interest rate applicable to Term Benchmark Loans denominated in Dollars at such time and (2) if such RFR Loan is denominated in any Applicable Currency other than Dollars, then such Loan shall bear interest at the Central Bank Rate (or in the case of the Yen, the Japanese Prime Rate) for the applicable Applicable Currency </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Rate&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if the Administrative Agent determines (which determination shall be conclusive and binding absent manifest error) that the Central Bank Rate (or in the case of the Yen, the Japanese Prime Rate) for the applicable Applicable Currency cannot be determined, any outstanding affected RFR Loans denominated in any Applicable Currency, at the Borrower&#8217;s election, shall either (a) be converted into ABR Loans denominated in Dollars (in an amount equal to the U.S. Dollar Equivalent of such Applicable Currency) immediately or (b) be prepaid in full immediately.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.15.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Increased Costs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) If any Change in Law shall&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">impose, modify or deem applicable any reserve, special deposit, liquidity or similar requirement (including any compulsory loan requirement, insurance charge or other assessment) against assets of, deposits with or for the account of, or credit extended by, any Lender (except any such reserve requirement reflected in the Adjusted EURIBOR Rate or Adjusted TIBOR Rate, as applicable) or the Issuing Bank&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">impose on any Lender or the Issuing Bank or the applicable offshore interbank market or the applicable Agreed Currency any other condition, cost or expense (other than Taxes) affecting this Agreement or Term Benchmark Loans made by such Lender or any Letter of Credit or participation therein&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">subject any Recipient to any Taxes (other than (A) Indemnified Taxes, (B) Taxes described in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> through </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the definition of Excluded Taxes and (C) Connection Income Taxes) on its loans, loan principal, letters of credit, commitments, or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and the result of any of the foregoing shall be to increase the cost to such Lender or such other Recipient of making, continuing, converting or maintaining any Term Benchmark Loan, or of maintaining its obligation to make any such Loan (including, without limitation, pursuant to any conversion of any Borrowing denominated in an Agreed Currency into a Borrowing denominated in any other Agreed Currency), or to increase the cost to such Lender, the Issuing Bank or such other Recipient of participating in, issuing or maintaining any Letter of Credit (including, without limitation, pursuant to any conversion of any Borrowing denominated in an Agreed Currency into a Borrowing denominated in any other Agreed Currency) or to reduce the amount of any sum received or receivable by such Lender, the Issuing Bank or such other Recipient hereunder, whether of principal, interest or otherwise (including, without limitation, pursuant to any conversion of any Borrowing denominated in an Agreed Currency into a Borrowing denominated in any other Agreed Currency), then the Borrower will pay to such Lender, the Issuing Bank or such other Recipient, as the case may be, such additional amount or amounts as will compensate such Lender, the Issuing Bank or such other Recipient, as the case may be, for such additional costs incurred or reduction suffered.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  If any Lender or the Issuing Bank determines that any Change in Law regarding capital or liquidity requirements has or would have the effect of reducing the rate of return on such Lender&#8217;s or the Issuing Bank&#8217;s capital or on the capital of such Lender&#8217;s or the Issuing Bank&#8217;s holding company, if any, as a consequence of this Agreement or the Loans made by, or participations in Letters of Credit held by, such Lender, or the Letters of Credit issued by the Issuing Bank, to a level below that which such Lender or the Issuing Bank or such Lender&#8217;s or the Issuing Bank&#8217;s holding company could have achieved but for such Change in Law (taking into consideration such Lender&#8217;s or the Issuing Bank&#8217;s policies and the policies of such Lender&#8217;s or the Issuing Bank&#8217;s holding company with respect to capital adequacy and liquidity and so long as it is generally the policy of such Lender to seek reimbursement for such amounts from similarly situated borrower), then from time to time the Borrower will pay to such Lender or the Issuing Bank, as the case may be, such additional amount or amounts as will compensate such Lender or the Issuing Bank or such Lender&#8217;s or the Issuing Bank&#8217;s holding company for any such reduction suffered.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  A certificate of a Lender or the Issuing Bank setting forth the amount or amounts necessary to compensate such Lender or the Issuing Bank or its holding company, as the case may be, as specified in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be delivered to the Borrower and shall be conclusive absent manifest error.  The Borrower shall pay such Lender or the Issuing Bank, as the case may be, the amount shown as due on any such certificate within ten (10) days after receipt thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Failure or delay on the part of any Lender or the Issuing Bank to demand compensation pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.15 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">shall not constitute a waiver of such Lender&#8217;s or the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Issuing Bank&#8217;s right to demand such compensation&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Borrower shall not be required to compensate a Lender or the Issuing Bank pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.15 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">for any increased costs or reductions incurred more than 180 days prior to the date that such Lender or the Issuing Bank, as the case may be, notifies the Borrower of the Change in Law giving rise to such increased costs or reductions and of such Lender&#8217;s or the Issuing Bank&#8217;s intention to claim compensation therefor&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if the Change in Law giving rise to such increased costs or reductions is retroactive, then the 180-day period referred to above shall be extended to include the period of retroactive effect thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.16.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Break Funding Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) With respect to Loans that are not RFR Loans, in the event of (i)&#160;the payment of any principal of any Term Benchmark Loan other than on the last day of an Interest Period applicable thereto (including as a result of an Event of Default or an optional or mandatory prepayment of Loans), (ii)&#160;the conversion of any Term Benchmark Loan other than on the last day of the Interest Period applicable thereto, (iii)&#160;the failure to borrow, convert, continue or prepay any Term Benchmark Loan on the date specified in any notice delivered pursuant hereto (regardless of whether such notice may be revoked under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.11(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and is revoked in accordance therewith), or (iv)&#160;the assignment of any Term Benchmark Loan other than on the last day of the Interest Period applicable thereto as a result of a request by the Borrower pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.19</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">9.02(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or (v) the failure by the Borrower to make any payment of any Loan or drawing under any Letter of Credit (or interest due thereof) denominated in a Foreign Currency on its scheduled due date or any payment thereof in a different currency, then, in any such event, the Borrower shall compensate each Lender for the loss, cost and expense attributable to such event. A certificate of any Lender setting forth any amount or amounts that such Lender is entitled to receive pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.16 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">shall be delivered to the Borrower and shall be conclusive absent manifest error.  The Borrower shall pay such Lender the amount shown as due on any such certificate within ten (10) days after receipt thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  With respect to RFR Loans, in the event of (i)&#160;the payment of any principal of any RFR Loan other than on the Interest Payment Date applicable thereto (including as a result of an Event of Default or an optional or mandatory prepayment of Loans), (ii)&#160;the failure to borrow or prepay any RFR Loan on the date specified in any notice delivered pursuant hereto (regardless of whether such notice may be revoked under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.10(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and is revoked in accordance therewith), (iii)&#160;the assignment of any RFR Loan other than on the Interest Payment Date applicable thereto as a result of a request by the Borrower pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.18</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or (iv) the failure by the Borrower to make any payment of any Loan or drawing under any Letter of Credit (or interest due thereof) denominated in an Applicable Currency on its scheduled due date or any payment thereof in a different currency, then, in any such event, the Borrower shall compensate each Lender for the loss, cost and expense attributable to such event.  A certificate of any Lender setting forth any amount or amounts that such Lender is entitled to receive pursuant to this Section&#160;shall be delivered to the Borrower and shall be conclusive absent manifest error.  The Borrower shall pay such Lender the amount shown as due on any such certificate within 10 days after receipt thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.17.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Payments Free of Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) Any and all payments by or on account of any obligation of the Borrower under any Loan Document shall be made without deduction or withholding for any Taxes, except as required by current and future applicable law.  If any applicable law (as determined in the good faith discretion of an applicable withholding agent) requires the deduction or withholding of any Tax from any such payment by a withholding agent, then the applicable withholding agent shall be entitled to make such deduction or withholding and shall timely pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with applicable law and, if such Tax is an Indemnified Tax, then the sum payable by the applicable Loan Party shall be increased as necessary so that after such deduction or withholding has been made (including such deductions and withholdings applicable to additional sums payable under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) the applicable Recipient receives an amount equal to the sum it would have received had no such deduction or withholding been made.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Payment of Other Taxes by the Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower shall timely pay to the relevant Governmental Authority in accordance with applicable law, or at the option of the Administrative Agent timely reimburse it for, Other Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Evidence of Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  As soon as practicable after any payment of Taxes by any Loan Party to a Governmental Authority pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Borrower shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnification by the Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower shall indemnify each Recipient, within ten (10) days after demand therefor, for the full amount of any Indemnified Taxes (including Indemnified Taxes imposed or asserted on or attributable to amounts payable under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) payable or paid by such Recipient or required to be withheld or deducted from a payment to such Recipient and any reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority.  A certificate as to the amount of such payment or liability delivered to the Borrower by a Lender (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of a Lender, shall be conclusive absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnification by the Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Lender shall severally indemnify the Administrative Agent, within ten (10) days after demand therefor, for (i) any Indemnified Taxes attributable to such Lender (but only to the extent that the Borrower has not already indemnified the Administrative Agent for such Indemnified Taxes and without limiting the obligation of the Borrower to do so), (ii) any Taxes attributable to such Lender&#8217;s failure to comply with the provisions of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.04(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> relating to the maintenance of a Participant Register and (iii) any Excluded Taxes attributable to such Lender, in each case, that are payable or paid by the Administrative Agent in connection with any Loan Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority.  A certificate as to the amount of such payment or liability delivered to any Lender by the Administrative Agent shall be conclusive absent manifest error.  Each Lender hereby authorizes the Administrative Agent to setoff and apply any and all amounts at any time owing to such Lender under any Loan Document or otherwise payable by the Administrative Agent to the Lender from any other source against any amount due to the Administrative Agent under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph (e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Status of Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (i)  Any Lender that is entitled to an exemption from or reduction of withholding Tax with respect to payments made under any Loan Document shall deliver to the Borrower and the Administrative Agent, at the time or times reasonably requested by the Borrower or the Administrative Agent, such properly completed and executed documentation reasonably requested by the Borrower or the Administrative Agent as will permit such payments to be made without withholding or at a reduced rate of withholding.  In addition, any Lender, if reasonably requested by the Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable law or reasonably requested by the Borrower or the Administrative Agent as will enable the Borrower or the Administrative Agent to determine whether or not such Lender is subject to backup withholding or information reporting requirements.  Notwithstanding anything to the contrary in the preceding two sentences, the completion, execution and submission of such documentation (other than such documentation set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.17(f)(ii)(A)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)(B)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)(D)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> below) shall not be required if in the Lender&#8217;s reasonable judgment such completion, execution or submission would subject such Lender to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Without limiting the generality of the foregoing, in the event that the Borrower is a U.S. Person,</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.35pt">any Lender that is a U.S. Person shall deliver to the Borrower and the Administrative Agent on or prior to the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), an executed IRS Form W-9 certifying that such Lender is exempt from U.S. federal backup withholding tax&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.35pt">any Foreign Lender shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), whichever of the following is applicable&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">in the case of a Foreign Lender claiming the benefits of an income tax treaty to which the United States is a party (x) with respect to payments of interest under any Loan Document, an executed IRS Form W-8BEN-E or IRS Form W-8BEN establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the &#8220;interest&#8221; article of such tax treaty and (y) with respect to any other applicable payments under any Loan Document, IRS Form W-8BEN-E or IRS Form W-8BEN establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the &#8220;business profits&#8221; or &#8220;other income&#8221; article of such tax treaty&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">in the case of a Foreign Lender claiming that its extension of credit will generate U.S. effectively connected income, an executed IRS Form W-8ECI&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under Section 881(c) of the Code, (x) a certificate substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C-1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to the effect that such Foreign Lender is not a &#8220;bank&#8221; within the meaning of Section 881(c)(3)(A) of the Code, a &#8220;10 percent shareholder&#8221; of the Borrower within the meaning of Section 881(c)(3)(B) of the Code, or a &#8220;controlled foreign corporation&#8221; described in Section 881(c)(3)(C) of the Code (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">U.S. Tax Compliance Certificate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and (y) executed IRS Form W-8BEN-E or  IRS Form W-8BEN&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">to the extent a Foreign Lender is not the beneficial owner, an executed IRS Form W-8IMY, accompanied by IRS Form W-8ECI, IRS Form W-8BEN-E, IRS Form W-8BEN, a U.S. Tax Compliance Certificate substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C-2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C-3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, IRS Form W-9, and&#47;or other certification documents from each beneficial owner, as applicable&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if the Foreign Lender is a partnership and one or more direct or indirect partners of such Foreign Lender are claiming the portfolio interest exemption, such Foreign Lender may provide a U.S. Tax Compliance Certificate substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C-4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> on behalf of each such direct and indirect partner&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:2.74pt">any Foreign Lender shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), executed originals of any other form prescribed by applicable law as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be prescribed by applicable law to permit the Borrower or the Administrative Agent to determine the withholding or deduction required to be made&#59; and</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:2.74pt">if a payment made to a Lender under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if such Lender were to fail </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), such Lender shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and the Administrative Agent to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender&#8217;s obligations under FATCA or to determine the amount to deduct and withhold from such payment.  Solely for purposes of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (D)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, &#8220;FATCA&#8221; shall include any amendments made to FATCA after the date of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Lender agrees that if any form or certification it previously delivered expires or becomes obsolete or inaccurate in any respect, it shall update such form or certification or promptly notify the Borrower and the Administrative Agent in writing of its legal inability to do so.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Treatment of Certain Refunds</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If any party determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes as to which it has been indemnified pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (including by the payment of additional amounts pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), it shall pay to the indemnifying party an amount equal to such refund (but only to the extent of indemnity payments made under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) of such indemnified party and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund).  Such indemnifying party, upon the request of such indemnified party, shall repay to such indemnified party the amount paid over pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph (g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) in the event that such indemnified party is required to repay such refund to such Governmental Authority.  Notwithstanding anything to the contrary in this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph (g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in no event will the indemnified party be required to pay any amount to an indemnifying party pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph (g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the payment of which would place the indemnified party in a less favorable net after-Tax position than the indemnified party would have been in if the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts giving rise to such refund had never been paid.  This </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph (g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not be construed to require any indemnified party to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to the indemnifying party or any other Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each party&#8217;s obligations under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall survive the resignation or replacement of the Administrative Agent or any assignment of rights by, or the replacement of, a Lender, the termination of the Commitments and the repayment, satisfaction or discharge of all obligations under any Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For purposes of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the term &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; includes any Issuing Bank and the term &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">applicable law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; includes FATCA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.18.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Payments Generally&#59; Pro Rata Treatment&#59; Sharing of Set-offs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) (i) Except with respect to principal of and interest on Loans denominated in a Foreign Currency, each Borrower shall make each payment required to be made by it hereunder (whether of principal, interest, fees or reimbursement of LC Disbursements, or of amounts payable under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.16</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or otherwise) in Dollars prior to (x) in the case of payments denominated in dollars, 12&#58;00 noon, New York City time and (y) in the case of payments denominated in a Foreign Currency, 12&#58;00 noon, New York City time, in each case on the date when due, and (ii) all payments with respect to principal and interest on Loans denominated in a Foreign Currency shall be made in such Applicable Currency not later than the Applicable Time specified by the Administrative Agent on the dates specified herein, in each case, in immediately available funds, without set-off or counterclaim.  Any amounts received after such time on any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">58</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">date may, in the discretion of the Administrative Agent, be deemed to have been received on the next succeeding Business Day for purposes of calculating interest thereon.  All such payments shall be made (i) subject to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in the same currency in which the applicable Credit Event was made (or where such currency has been converted to another Applicable Currency, in such Applicable Currency) and (ii) to the Administrative Agent at its offices at 383 Madison Avenue, New York, New York, except payments to be made directly to the Issuing Bank as expressly provided herein and except that payments pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections&#160;2.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.16</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">9.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be made directly to the Persons entitled thereto.  The Administrative Agent shall distribute any such payments denominated in the same currency received by it for the account of any other Person to the appropriate recipient promptly following receipt thereof.  If any payment hereunder shall be due on a day that is not a Business Day, the date for payment shall be extended to the next succeeding Business Day, and, in the case of any payment accruing interest, interest thereon shall be payable for the period of such extension.  Notwithstanding the foregoing provisions of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.18</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, if, after the making of any Credit Event in any Foreign Currency, currency control or exchange regulations are imposed in the country which issues such currency with the result that the type of currency in which the Credit Event was made (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Original Currency</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) no longer exists or the Borrower is not able to make payment to the Administrative Agent for the account of the Lenders in such Original Currency, then all payments to be made by the Borrower hereunder in such currency shall instead be made when due in dollars in an amount equal to the Dollar Equivalent (as of the date of repayment) of such payment due, it being the intention of the parties hereto that the Borrower take all risks of the imposition of any such currency control or exchange regulations.  Without limiting the generality of the foregoing, the Administrative Agent may require that any payments due under this Agreement be made in the United States.  If, for any reason, the Borrower is prohibited by any Law from making any required payment hereunder in an Applicable Currency, such Borrower shall make such payment in Dollars in the U.S. Dollar Equivalent of the Foreign Currency payment amount.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Any funds or proceeds of Collateral received by the Administrative Agent (i) not constituting either (A) a specific payment of principal, interest, fees or other sum payable under the Loan Documents (which shall be applied as specified by the Borrower), or (B) a mandatory prepayment (which shall be applied in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) or (ii) after an Event of Default has occurred and is continuing and the Administrative Agent so elects or the Required Lenders so direct, shall be applied ratably </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to pay any fees, indemnities, or expense reimbursements including amounts then due to the Administrative Agent and the Issuing Bank from the Borrower (other than in connection with Banking Services Obligations or Swap Agreement Obligations), </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to pay any fees or expense reimbursements then due to the Lenders from the Borrower (other than in connection with Banking Services Obligations or Swap Agreement Obligations), </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to pay interest then due and payable on the Loans ratably, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">fourth</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to prepay principal on the Loans and unreimbursed LC Disbursements and to pay any amounts owing with respect to Swap Agreement Obligations up to and including the amount most recently provided to the Administrative Agent pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.22</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, ratably, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">fifth</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to pay an amount to the Administrative Agent equal to one hundred five percent (105%) of the aggregate LC Exposure, to be held as cash collateral for such Obligations, and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">sixth</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to the payment of any amounts owing in respect of Banking Services Obligations up to and including the amount most recently provided to the Administrative Agent pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.22</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">seventh</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to the payment of any other Secured Obligation due to the Administrative Agent or any Lender from the Borrower or any other Loan Party. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Notwithstanding the foregoing, Secured Obligations arising under Banking Services Obligations or Swap Agreement Obligations shall be excluded from the application described above and paid in clause seventh if the Administrative Agent has not received written notice thereof, together with such supporting documentation as the Administrative Agent may have reasonably requested from the applicable provider of such Banking Services or Swap Agreements.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  If any Lender shall, by exercising any right of set off or counterclaim or otherwise, obtain payment in respect of any principal of or interest on any of its Revolving Loans </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or participations in LC Disbursements resulting in such Lender receiving payment of a greater proportion of the aggregate amount of its Revolving Loans and participations in LC Disbursements and accrued interest thereon than the proportion received by any other Lender, then the Lender receiving such greater proportion shall purchase (for cash at face value) participations in the Revolving Loans and participations in LC Disbursements of other Lenders to the extent necessary so that the benefit of all such payments shall be shared by the Lenders ratably in accordance with the aggregate amount of principal of and accrued interest on their respective Revolving Loans and participations in LC Disbursements&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i)&#160;if any such participations are purchased and all or any portion of the payment giving rise thereto is recovered,  such participations shall be rescinded and the purchase price restored to the extent of such recovery, without interest, and (ii)&#160;the provisions of this paragraph&#160;shall not be construed to apply to any payment made by the Borrower pursuant to and in accordance with the express terms of this Agreement or any payment obtained by a Lender as consideration for the assignment of or sale of a participation in any of its Loans or participations in LC Disbursements to any assignee or participant, other than to the Borrower or any Subsidiary or Affiliate thereof (as to which the provisions of this paragraph&#160;shall apply).  The Borrower consents to the foregoing and agrees, to the extent it may effectively do so under applicable law, that any Lender acquiring a participation pursuant to the foregoing arrangements may exercise against the Borrower rights of set-off and counterclaim with respect to such participation as fully as if such Lender were a direct creditor of the Borrower in the amount of such participation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Unless the Administrative Agent shall have received notice from the Borrower prior to the date on which any payment is due to the Administrative Agent for the account of the Lenders or the Issuing Bank hereunder that the Borrower will not make such payment, the Administrative Agent may assume that the Borrower has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the Lenders or the Issuing Bank, as the case may be, the amount due.  In such event, if the Borrower has not in fact made such payment, then each of the Lenders or the Issuing Bank, as the case may be, severally agrees to repay to the Administrative Agent forthwith on demand the amount so distributed to such Lender or Issuing Bank with interest thereon, for each day from and including the date such amount is distributed to it to but excluding the date of payment to the Administrative Agent, at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  If any Lender shall fail to make any payment required to be made by it pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.06(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.07(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.18(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">9.03(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then the Administrative Agent may, in its discretion  and notwithstanding any contrary provision hereof, (i) apply any amounts thereafter received by the Administrative Agent for the account of such Lender to satisfy such Lender&#8217;s obligations under such Sections until all such unsatisfied obligations are fully paid, and&#47;or (ii) hold such amounts in a segregated account over which the Administrative Agent shall have exclusive control as cash collateral for, and application to, any future funding obligations of such Lender under any such Section, in the case of each of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above, in any order as determined by the Administrative Agent at the applicable Overnight Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.19.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Mitigation Obligations&#59; Replacement of Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) If any Lender requests compensation under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or if the Borrower is required to pay any Indemnified Taxes or additional amounts to any Lender or any Governmental Authority for the account of any Lender pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then such Lender shall use reasonable efforts to designate a different lending office for funding or booking its Loans hereunder or to assign its rights and obligations hereunder to another of its offices, branches or affiliates, if, in the judgment of such Lender, such designation or assignment (i)&#160;would eliminate or reduce amounts payable pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections&#160;2.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as the case may be, in the future and (ii)&#160;would not subject such Lender to any unreimbursed cost or expense and would not otherwise be disadvantageous to such Lender.  The Borrower hereby agrees to pay all reasonable costs and expenses incurred by any Lender in connection with any such designation or assignment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">60</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  If any Lender (i) requests compensation under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (ii) if the Borrower is required to pay any Indemnified Taxes or additional amounts to any Lender or any Governmental Authority for the account of any Lender pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (iii) if any Lender becomes Defaulting Lender or (iv) if any Lender has failed to consent to any amendment, consent or waiver that has been approved by the Required Lenders but requires the approval of all the Lenders or all affected Lenders, then the Borrower may, at its sole expense and effort, upon notice to such Lender and the Administrative Agent, require such Lender to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;9.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), all its interests, rights (other than its existing rights to payments pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) and obligations under this Agreement to an assignee that shall assume such obligations (which assignee may be another Lender, if a Lender accepts such assignment)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i)&#160;the Borrower shall have received the prior written consent of the Administrative Agent (and if a Commitment is being assigned, the Issuing Bank), which consent shall not unreasonably be withheld, (ii)&#160;such Lender shall have received payment of an amount equal to the outstanding principal of its Loans and participations in LC Disbursements, accrued interest thereon, accrued fees and all other amounts payable to it hereunder, from the assignee (to the extent of such outstanding principal and accrued interest and fees) or the Borrower (in the case of all other amounts) and (iii)&#160;in the case of any such assignment resulting from a claim for compensation under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or payments required to be made pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, such assignment will result in a reduction in such compensation or payments.  A Lender shall not be required to make any such assignment and delegation if, prior thereto, as a result of a waiver by such Lender or otherwise, the circumstances entitling the Borrower to require such assignment and delegation cease to apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.20.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Defaulting Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding any provision of this Agreement to the contrary, if any Lender becomes a Defaulting Lender, then the following provisions shall apply for so long as such Lender is a Defaulting Lender&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  fees shall cease to accrue on the Commitment of such Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.12(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  such Defaulting Lender shall not have the right to vote on any issue on which voting is required (other than to the extent expressly provided in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.02(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) and the Commitment and Revolving Credit Exposure of such Defaulting Lender shall not be included in determining whether the Required Lenders have taken or may take any action hereunder (including any consent to any amendment, waiver or other modification pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, except as otherwise provided in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not apply to the vote of a Defaulting Lender in the case of an amendment, waiver or other modification requiring the consent of such Lender or each Lender affected thereby&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  if any LC Exposure exists at the time such Lender becomes a Defaulting Lender then&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">all or any part of the LC Exposure of such Defaulting Lender shall be reallocated among the non-Defaulting Lenders in accordance with their respective Applicable Percentages but only (x) to the extent that such reallocation does not, as to any non-Defaulting Lender, cause such non-Defaulting Lender&#8217;s Revolving Credit Exposure to exceed its Commitment and (y) if the conditions set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> are satisfied at such time&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">if the reallocation described in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above cannot, or can only partially, be effected, the Borrower shall within one (1) Business Day following notice by the Administrative Agent cash collateralize for the benefit of the Issuing Bank only the Borrower&#8217;s obligations corresponding to such Defaulting Lender&#8217;s LC Exposure (after giving effect to any partial reallocation pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above) in accordance with the procedures set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for so long as such LC Exposure is outstanding&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt">if the Borrower cash collateralizes any portion of such Defaulting Lender&#8217;s LC Exposure pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above, the Borrower shall not be required to pay any fees to such Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.12(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to such Defaulting Lender&#8217;s LC Exposure during the period such Defaulting Lender&#8217;s LC Exposure is cash collateralized&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">if the LC Exposure of the non-Defaulting Lenders is reallocated pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above, then the fees payable to the Lenders pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.12(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.12(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be adjusted in accordance with such non-Defaulting Lenders&#8217; Applicable Percentages&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">if all or any portion of such Defaulting Lender&#8217;s LC Exposure is neither reallocated nor cash collateralized pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above, then, without prejudice to any rights or remedies of the Issuing Bank or any other Lender hereunder, all commitment fees that otherwise would have been payable to such Defaulting Lender (solely with respect to the portion of such Defaulting Lender&#8217;s Commitment that was utilized by such LC Exposure) and letter of credit fees payable under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.12(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to such Defaulting Lender&#8217;s LC Exposure shall be payable to the Issuing Bank until and to the extent that such LC Exposure is reallocated and&#47;or cash collateralized&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  so long as any Lender is a Defaulting Lender, the Issuing Bank shall not be required to issue, amend or increase any Letter of Credit, unless it is satisfied that the related exposure and the Defaulting Lender&#8217;s then outstanding LC Exposure will be 100% covered by the Commitments of the non-Defaulting Lenders and&#47;or cash collateral will be provided by the Borrower in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.20(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and LC Exposure related to any newly issued or increased Letter of Credit shall be allocated among non-Defaulting Lenders in a manner consistent with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.20(d)(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (and Defaulting Lenders shall not participate therein).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If (i) a Bankruptcy Event or a Bail-In Action with respect to a Lender Parent shall occur following the date hereof and for so long as such event shall continue or (ii) the Issuing Bank has a good faith belief that any Lender has defaulted in fulfilling its obligations under one or more other agreements in which such Lender commits to extend credit, the Issuing Bank shall not be required to issue, amend or increase any Letter of Credit, unless the Issuing Bank shall have entered into arrangements with the Borrower or such Lender, satisfactory to the Issuing Bank to defease any risk to it in respect of such Lender hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event that the Administrative Agent, the Borrower, and the Issuing Bank each agrees that a Defaulting Lender has adequately remedied all matters that caused such Lender to be a Defaulting Lender, then the LC Exposure of the Lenders shall be readjusted to reflect the inclusion of such Lender&#8217;s Commitment and on such date such Lender shall purchase at par such of the Loans of the other Lenders as the Administrative Agent shall determine may be necessary in order for such Lender to hold such Loans in accordance with its Applicable Percentage.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.21.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Increase in Commitments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Request for Increase</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Provided there exists no Default, upon notice to the Administrative Agent (which shall promptly notify the Lenders), the Borrower may from time to time request an increase in the Commitments by an amount (for all such increases) not exceeding $300,000,000&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) any such increase shall be in a minimum amount of $25,000,000 and (ii) the Borrower may make a maximum of three such increases.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Increasing and Additional Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower may, in consultation with the Administrative Agent, designate any Lender party to this Agreement (with the consent of such Lender, which may be given or withheld in its sole discretion) or another Person (which may be, but need not be, an existing Lender) which is not an Ineligible Institution and which such Person shall be subject to the consent of the Administrative Agent and the Issuing Bank (such consents </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">62</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">not to be unreasonably withheld) if such Person is not a Lender, an Affiliate of a Lender or an Approved Fund and which at the time agrees in its sole discretion to (i) in the case of any such designated Lender that is an existing Lender, increase its Commitment, and (ii) in the case of any other such Person (an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), become a party to this Agreement pursuant to a customary joinder agreement in form and substance reasonably satisfactory to the Administrative Agent and its counsel.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date and Allocations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If the Commitments are increased in accordance with this Section, the Borrower shall determine the effective date (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Increase Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and the final allocation of such increase in consultation with the Administrative Agent.  The Administrative Agent shall promptly notify the Lenders of the final allocation of such increase and the Increase Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Conditions to Effectiveness of Increase</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  As a condition precedent to such increase, the Borrower shall deliver to the Administrative Agent a certificate of each Loan Party dated as of the Increase Effective Date (in sufficient copies for each Lender) signed by a Financial Officer of such Loan Party (x) certifying and attaching the resolutions adopted by such Loan Party approving or consenting to such increase, and (y) in the case of the Borrower, certifying that, before and after giving effect to such increase, the representations and warranties contained in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article V</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and the other Loan Documents are true and correct in all material respects on and as of the Increase Effective Date, except to the extent that such representations and warranties specifically refer to an earlier date, in which case they are true and correct in all material respects as of such earlier date.  The Borrower shall prepay any Revolving Loans outstanding on the Increase Effective Date (and pay any additional amounts required pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.16</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) to the extent necessary to keep the outstanding Revolving Loans ratable with any revised Applicable Percentages arising from any nonratable increase in the Commitments under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.21</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Conflicting Provisions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.21 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">shall supersede any provisions in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.18 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">9.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to the contrary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.22.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Returned Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If, after receipt of any payment which is applied to the payment of all or any part of the Obligations (including a payment effected through exercise of a right of setoff), the Administrative Agent or any Lender is for any reason compelled to surrender such payment or proceeds to any Person because such payment or application of proceeds is invalidated, declared fraudulent, set aside, determined to be void or voidable as a preference, impermissible setoff, or a diversion of trust funds, or for any other reason (including pursuant to any settlement entered into by the Administrative Agent or such Lender in its discretion), then the Obligations or part thereof intended to be satisfied shall be revived and continued and this Agreement shall continue in full force as if such payment or proceeds had not been received by the Administrative Agent or such Lender.  The provisions of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.22</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be and remain effective notwithstanding any contrary action which may have been taken by the Administrative Agent or any Lender in reliance upon such payment or application of proceeds.  The provisions of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.22</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall survive the termination of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2.23.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Banking Services and Swap Agreements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Lender or Affiliate thereof providing Banking Services for, or having Swap Agreements with, any Loan Party or any Subsidiary thereof shall deliver to the Administrative Agent, promptly after entering into such Banking Services or Swap Agreements, written notice setting forth the aggregate amount of all Banking Services Obligations and Swap Agreement Obligations of such Loan Party or Subsidiary thereof  to such Lender or Affiliate (whether matured or unmatured, absolute or contingent).  In furtherance of that requirement, each such Lender or Affiliate thereof shall furnish the Administrative Agent, from time to time after a significant change therein or upon a request therefor, a summary of the amounts due or to become due in respect of such Banking Services Obligations and Swap Agreement Obligations.  The most recent information provided to the Administrative Agent shall be used in determining which tier of the waterfall, contained in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.18(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, such Banking Services Obligations and&#47;or Swap Agreement Obligations will be placed. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">63</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE III<br><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Representations and Warranties</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Borrower represents and warrants to the Administrative Agent and the Lenders that&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.01.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Organization&#59; Powers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each of the Loan Parties and their Subsidiaries is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization, has all requisite power and authority to carry on its business as now conducted and, except where the failure to do so, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect, is qualified to do business in, and is in good standing in, every jurisdiction where such qualification is required.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.02.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Authorization&#59; Enforceability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Transactions are within the Borrower&#8217;s and each other Loan Party&#8217;s corporate powers and have been duly authorized by all necessary corporate and, if required, stockholder action.  This Agreement has been duly executed and delivered by the Borrower and constitutes a legal, valid and binding obligation of the Borrower, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors&#8217; rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.03.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governmental Approvals&#59; No Conflicts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Transactions (a)&#160;do not require any consent or approval of, registration or filing with, or any other action by, any Governmental Authority, except such as have been obtained or made and are in full force and effect, and except for filings necessary to perfect Liens created pursuant to the Loan Documents, (b)&#160;will not violate any Requirement of Law applicable to any Loan Party or any Subsidiary, (c)&#160;will not violate or result in a default under any indenture, material agreement or other material instrument binding upon any Loan Party or any of their Subsidiaries or their assets, or give rise to a right thereunder to require any payment to be made by any Loan Party or any of their Subsidiaries, and (d)&#160;will not result in the creation or imposition of any Lien on any asset of any Loan Party or any of their Subsidiaries, except Liens created pursuant to the Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.04.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Condition&#59; No Material Adverse Change</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) The Borrower has heretofore furnished to the Lenders its consolidated balance sheet and statements of income, stockholders equity and cash flows (i)&#160;as of and for the fiscal year ended December 31, 2020, audited by Ernst &#38; Young LLP, independent public accountants, and (ii)&#160;as of and for the fiscal quarter and the portion of the fiscal year ended June 30, 2021, certified by its chief financial officer.  Such financial statements present fairly, in all material respects, the financial position and results of operations and cash flows of the Borrower and its consolidated Subsidiaries as of such dates and for such periods in accordance with GAAP, subject to year-end audit adjustments and the absence of footnotes in the case of the statements referred to in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Since December 31, 2020, there has been no event, development or circumstance that has had or would reasonably be expected to have a Material Adverse Effect. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.05.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Properties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) Each of the Loan Parties and its Subsidiaries has good title to, or valid leasehold interests in, all its real and personal property material to its business, except for minor defects in title that do not interfere with its ability to conduct its business as currently conducted or to utilize such properties for their intended purposes or except where the failure to do so would not reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  As of the Restatement Effective Date, the Loan Parties do not have any interest in, or title to, any United States federally registered Intellectual Property except as set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3.05</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each of the Loan Parties and its Subsidiaries owns, or is licensed to use, all Trademarks, Copyrights, Patents and other Intellectual Property free and clear of all Liens (other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">64</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">than Liens permitted under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), and the use thereof by the Loan Parties and their Subsidiaries does not infringe upon the rights of any other Person, except for any such infringements that, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.06.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Litigation and Environmental Matters</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) There are no actions, suits or proceedings by or before any arbitrator or Governmental Authority pending against or, to the knowledge of the Borrower, threatened against or affecting any Loan Party or any of their Subsidiaries that would reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect (other than the Disclosed Matters) or (ii)&#160;that involve any Loan Document or the Transactions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Except for the Disclosed Matters, (i) as of the Restatement Effective Date, no Loan Party or any Subsidiary has received notice of any claim with respect to any Environmental Liability or knows of any basis for any Environmental Liability and (ii) except with respect to any other matters that, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect, no Loan Party nor any of their Subsidiaries (A)&#160;has failed to comply with any Environmental Law or to obtain, maintain or comply with any permit, license or other approval required under any Environmental Law, (B)&#160;has become subject to any Environmental Liability, (C)&#160;has received notice of any claim with respect to any Environmental Liability or (D)&#160;knows of any basis for any Environmental Liability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  Since the date of this Agreement, there has been no change in the status of the Disclosed Matters that, individually or in the aggregate, has resulted in, or would reasonably be expected to result in Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.07.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Laws and Agreements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Loan Party and its Subsidiaries is in compliance with (i) all Requirements of Law applicable to it or its property and (ii) all indentures, agreements and other instruments binding upon it or its property, except where the failure to do so, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect.  No Default has occurred and is continuing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.08.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Investment Company Status</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  No Loan Party nor any of their Subsidiaries is an &#8220;investment company&#8221; as defined in, or subject to regulation under, the Investment Company Act of 1940.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.09.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Loan Party and its Subsidiaries has timely filed or caused to be filed all Tax returns and reports required to have been filed and has paid or caused to be paid all Taxes required to have been paid by it, except (a)&#160;Taxes that are being contested in good faith by appropriate proceedings and for which such Loan Party or such Subsidiary, as applicable, has set aside on its books adequate reserves or (b)&#160;to the extent that the failure to do so would not reasonably be expected to result in a Material Adverse Effect.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.10.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  No ERISA Event has occurred or is reasonably expected to occur that, when taken together with all other such ERISA Events for which liability is reasonably expected to occur, would reasonably be expected to result in a Material Adverse Effect.  The present value of all accumulated benefit obligations under each Plan (based on the assumptions used for purposes of Statement of Financial Accounting Standards No.&#160;87) did not, as of the date of the most recent financial statements reflecting such amounts, exceed the fair market value of the assets of such Plan by an amount that would reasonably be expected to result in a Material Adverse Effect, and the present value of all accumulated benefit obligations of all underfunded Plans (based on the assumptions used for purposes of Statement of Financial Accounting Standards No.&#160;87 or subsequent recodification thereof, as applicable) did not, as of the date of the most recent financial statements reflecting such amounts, exceed the fair market value of the assets of all such underfunded Plans by an amount that would reasonably be expected to result in a Material Adverse Effect.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.11.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Disclosure</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) None of the reports, financial statements, certificates or other written information furnished by or on behalf of the Borrower to the Administrative Agent or any Lender in connection with the negotiation of this Agreement or delivered hereunder (as modified or supplemented by other information so furnished) contains any material misstatement of fact or omits to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading in any material respect&#59; provided that, with respect to projected financial information, the Borrower represents only that such information was prepared in good faith based upon assumptions believed by it to be reasonable at the time (it being recognized that such projections are not to be viewed as facts and are subject to significant uncertainties and contingencies, which are beyond the Borrower&#8217;s control, that no assurance can be given that any particular financial projections will be realized, that actual results may differ from projected results and that such differences may be material).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  As of the Restatement Effective Date, to the best knowledge of the Borrower, the information included in the Beneficial Ownership Certification provided on or prior to the Restatement Effective Date to any Lender in connection with this Agreement is true and correct in all respects.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.12.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Laws and Sanctions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Loan Parties have implemented and maintain in effect policies and procedures designed to ensure compliance by the Loan Parties, their Subsidiaries and their respective directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions, and the Loan Parties, their Subsidiaries and their respective officers and directors and to the knowledge of any Loan Party its employees and agents, are in compliance with Anti-Corruption Laws and applicable Sanctions in all material respects.  None of (a) any Loan Party, any Subsidiary or any of their respective directors, officers or employees, or (b)  to the knowledge of any Loan Party, any agent of any Loan Party or any of their Subsidiaries that will act in any capacity in connection with or benefit from the credit facility established hereby, is a Sanctioned Person.  No Transaction will violate any Anti-Corruption Law or applicable Sanctions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.13.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affected Financial Institutions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  No Loan Party is an Affected Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.14.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Capitalization and Subsidiaries</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> sets forth as of the Restatement Effective Date (a) a correct and complete list of the name and relationship to the Borrower of each Subsidiary, (b) a true and complete listing of each class of each Loan Parties&#8217; (other than the Borrower) authorized Equity Interests, of which all of such issued Equity Interests are validly issued, outstanding, fully paid and non-assessable, and owned beneficially and of record by the Persons identified on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and (c) the type of entity of each Loan Party and each of their Subsidiaries.  All of the issued and outstanding Equity Interests owned by any Loan Party have been (to the extent such concepts are relevant with respect to such ownership interests) duly authorized and issued and are fully paid and non-assessable.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.15.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Employment Matters</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  As of the Restatement Effective Date, there are no strikes, lockouts or slowdowns against any Loan Party or any Subsidiary pending or, to the knowledge of any Loan Party, threatened.  The hours worked by and payments made to employees of the Loan Parties and their Subsidiaries have not been in violation in any material respect of the Fair Labor Standards Act or any other applicable federal, state, local or foreign law dealing with such matters.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.16.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Federal Reserve Regulations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  No part of the proceeds of any Loan or Letter of Credit has been used or will be used, whether directly or indirectly, for any purpose that entails a violation of any of the Regulations of the Federal Reserve Board, including Regulations T, U and X.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.17.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The proceeds of the Loans and the Letters of Credit will be used as set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.08</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">66</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.18. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Security Interest in Collateral.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The provisions of this Agreement and the other Loan Documents create legal and valid Liens on all the Collateral in favor of the Administrative Agent, for the benefit of the Secured Parties, and such Liens constitute perfected and continuing Liens on the Collateral, securing the Secured Obligations, enforceable against the applicable Loan Party and all third parties, and having priority over all other Liens on the Collateral except in the case of (a) Permitted Encumbrances, to the extent any such Permitted Encumbrances would have priority over the Liens in favor of the Administrative Agent pursuant to any applicable law or agreement and (b) Liens perfected only by possession (including possession of any certificate of title), to the extent the Administrative Agent has not obtained or does not maintain possession of such Collateral.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.19.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan Assets&#59; Prohibited Transactions.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  None of the Loan Parties or any of their Subsidiaries is an entity deemed to hold &#8220;plan assets&#8221; (within the meaning of the Plan Asset Regulations), and neither the execution, delivery nor performance of the transactions contemplated under this Agreement, including the making of any Loan and the issuance of any Letter of Credit hereunder, will give rise to a non-exempt prohibited transaction under Section 406 of ERISA or Section 4975 of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3.20.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Solvency</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower and its Subsidiaries taken as a whole are Solvent as of the Restatement Effective Date.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE IV<br><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Conditions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 4.01.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restatement Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The obligations of the Lenders to make Loans and of the Issuing Bank to issue Letters of Credit hereunder shall not become effective until the date on which each of the following conditions is satisfied (or waived in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;9.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Agreement and Loan Documents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent (or its counsel) shall have received (i) from each party hereto either (A) a counterpart of this Agreement signed on behalf of such party or (B) written evidence satisfactory to the Administrative Agent (which may include fax or other electronic transmission of a signed signature page of this Agreement) that such party has signed a counterpart of this Agreement and (ii) duly executed copies of the Loan Documents to be executed on the Restatement Effective Date, including any promissory notes requested by a Lender pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> payable to the order of each such requesting Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lien Searches</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent shall have received the results of a recent Lien search in the jurisdiction of organization of each Loan Party and each jurisdiction where assets of the Loan Parties are located, and such search shall reveal no Liens on any of the assets of the Loan Parties except for Liens permitted by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or discharged on or prior to the Restatement Effective Date pursuant to a pay-off letter or other documentation satisfactory to the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Filings, Registrations and Recordings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each document (including any Uniform Commercial Code financing statement) required by the Collateral Documents or under law or reasonably requested by the Administrative Agent to be filed, registered or recorded in order to create in favor of the Administrative Agent, for the benefit of the Secured Parties, a perfected Lien on the Collateral described therein, prior and superior in right to any other Person (other than with respect to Liens expressly permitted by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), shall be in proper form for filing, registration or recordation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Pledged Equity Interests&#59; Stock Powers&#59; Pledged Notes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent shall have received (i) the certificates representing the Equity Interests required to be pledged pursuant to the Security Agreement on the Restatement Effective Date, together with an undated stock power for each such certificate executed in blank by a duly authorized officer </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">67</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of the pledgor thereof and (ii) each promissory note (if any) pledged to the Administrative Agent pursuant to the Security Agreement endorsed (without recourse) in blank (or accompanied by an executed transfer form in blank) by the pledgor thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Closing Certificates&#59; Certified Certificate of Incorporation&#59; Good Standing Certificates</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent shall have received (i) a certificate of each Loan Party, dated the Restatement Effective Date and executed by its secretary or assistant secretary, which shall (A) certify the resolutions of its Board of Directors, members or other body authorizing the execution, delivery and performance of the Loan Documents to which it is a party, (B) identify by name and title and bear specimen signatures of the officers of such Loan Party authorized to sign the Loan Documents to which it is a party and, in the case of the Borrower, its Financial Officers, and (C) contain appropriate attachments, including the charter, articles or certificate of organization or incorporation of each Loan Party certified by the relevant authority of the jurisdiction of organization of such Loan Party and a true and correct copy of its bylaws or operating, management or partnership agreement, or other organizational or governing documents, and (ii) a good standing certificate for each Loan Party from its jurisdiction of organization.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Default Certificate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent shall have received a certificate confirming compliance with the conditions set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraphs (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;4.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> dated the Restatement Effective Date and signed by the president, a vice president or a Financial Officer of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Legal Opinion.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The Administrative Agent shall have received a favorable written opinion (addressed to the Administrative Agent and the Lenders and dated the Restatement Effective Date) of Fenwick &#38; West LLP, counsel for the Loan Parties, and covering such other matters relating to the Loan Parties, this Agreement or the Transactions as the Required Lenders shall reasonably request.  Each Loan Party hereby requests such counsel to deliver such opinion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent shall have received insurance certificates and endorsements for all insurance of the Borrower and the other Loan Parties as the Administrative Agent shall request naming the Administrative Agent, on behalf of the Lenders, as additional insured or lenders loss payee (or similar designation), as applicable, in form, scope and substance satisfactory to the Administrative Agent, and otherwise in compliance with the terms of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.05</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Security Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent and Lead Arrangers shall have received all fees and other amounts due and payable on or prior to the Restatement Effective Date, including, to the extent invoiced on or prior to the Restatement Effective Date, reimbursement or payment of all out-of-pocket expenses required to be reimbursed or paid by the Borrower hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USA PATRIOT Act, Etc.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  (i) The Administrative Agent shall have received, (x) at least five (5) days prior to the Restatement Effective Date, all documentation and other information regarding the Borrower requested in connection with applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including the USA PATRIOT Act, to the extent requested in writing of the Borrower at least ten (10) days prior to the Restatement Effective Date, and (y) a properly completed and signed IRS Form W-8 or W-9, as applicable, for each Loan Party, and (ii) to the extent the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation, at least five (5) days prior to the Restatement Effective Date, any Lender that has requested, in a written notice to the Borrower at least (10) days prior to the Restatement Effective Date, a Beneficial Ownership Certification in relation to the Borrower shall have received such Beneficial Ownership Certification (provided that, upon the execution and delivery by such Lender of its signature page to this Agreement, the condition set forth in this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be deemed to be satisfied).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Administrative Agent shall notify the Borrower and the Lenders of the Restatement Effective Date, and such notice shall be conclusive and binding.  Notwithstanding the foregoing, the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">68</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">obligations of the Lenders to make Loans and of the Issuing Bank to issue Letters of Credit hereunder shall not become effective unless each of the foregoing conditions is satisfied (or waived pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;9.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) at or prior to 3&#58;00 p.m., New&#160;York City time, on October 13, 2021 (and, in the event such conditions are not so satisfied or waived, the Commitments shall terminate at such time).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 4.02.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Each Credit Event</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The obligation of each Lender to make a Loan on the occasion of any Borrowing (other than a Borrowing consisting solely of a conversion of Loans of one Type to another Type or a continuation of a Term Benchmark Loan or RFR Loan following the expiration of the applicable Interest Period), and of the Issuing Bank to issue, amend, renew or extend any Letter of Credit, is subject to the satisfaction of the following conditions&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The representations and warranties of the Loan Parties set forth in the Loan Documents shall be true and correct in all material respects (without duplication of any materiality qualifiers set forth therein) on and as of the date of such Borrowing or the date of issuance, amendment, renewal or extension of such Letter of Credit, as applicable (unless such representation and warranty relates to an earlier date, then such representation and warranty shall be true and correct in all material respects (without duplication of any materiality qualifiers set forth therein) as of such earlier date).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  At the time of and immediately after giving effect to such Borrowing or the issuance, amendment, renewal or extension of such Letter of Credit, as applicable, no Default shall have occurred and be continuing.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Borrowing and each issuance, amendment, renewal or extension of a Letter of Credit shall be deemed to constitute a representation and warranty by the Borrower on the date thereof as to the matters specified in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraphs (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the failure to satisfy the conditions precedent set forth in paragraphs (a) or (b) of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, unless otherwise directed by the Required Lenders, the Administrative Agent may, but shall have no obligation to, continue to make Loans and an Issuing Bank may, but shall have no obligation to, issue, amend, renew or extend, or cause to be issued, amended, renewed or extended, any Letter of Credit for the ratable account and risk of Lenders from time to time if the Administrative Agent believes that making such Loans or issuing, amending, renewing or extending, or causing the issuance, amendment, renewal or extension of, any such Letter of Credit is in the best interests of the Lenders.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE V<br><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affirmative Covenants</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Until the Commitments have expired or been terminated and the principal of and interest on each Loan and all fees payable hereunder shall have been paid in full and all Letters of Credit shall have expired or terminated , in each case, without any pending draw, and all LC Disbursements shall have been reimbursed, the Borrower covenants and agrees with the Lenders that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 5.01.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Statements&#59; Ratings Change and Other Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will furnish to the Administrative Agent and each Lender&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  within ninety (90) days after the end of each fiscal year of the Borrower, its audited consolidated balance sheet and related statements of operations, stockholders&#8217; equity and cash flows as of the end of and for such year, setting forth in each case in comparative form the figures for the previous fiscal year, all audited by Ernst &#38; Young LLP or other independent public accountants of recognized national standing (without a &#8220;going concern&#8221; or like qualification commentary or exception and without any qualification or exception as to the scope of such audit) to the effect that such consolidated financial statements present fairly in all </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">69</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">material respects the financial condition and results of operations of the Borrower and its consolidated Subsidiaries on a consolidated basis in accordance with GAAP consistently applied, accompanied by any management letter prepared by said accountants&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  within forty-five (45) days after the end of each of the first three fiscal quarters of each fiscal year of the Borrower, its consolidated balance sheet and related statements of operations and cash flows as of the end of and for such fiscal quarter and the then elapsed portion of the fiscal year, setting forth in each case in comparative form the figures for the corresponding period or periods of (or, in the case of the balance sheet, as of the end of) the previous fiscal year, all certified by one of its Financial Officers as presenting fairly in all material respects the financial condition and results of operations of the Borrower and its consolidated Subsidiaries on a consolidated basis in accordance with GAAP consistently applied, subject to normal year-end audit adjustments and the absence of footnotes&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  concurrently with any delivery of financial statements under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above, a certificate of a Financial Officer of the Borrower (i)&#160;certifying as to whether a Default has occurred and, if a Default has occurred, specifying the details thereof and any action taken or proposed to be taken with respect thereto, (ii)&#160;setting forth reasonably detailed calculations demonstrating compliance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;6.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (iii)&#160;stating whether any change in GAAP or in the application thereof has occurred since the date of the audited financial statements referred to in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;3.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and, if any such change has occurred, specifying the effect of such change on the financial statements accompanying such certificate&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  as soon as available, but in any event no later than 100 days following the end of, each fiscal year of the Borrower, a copy of the Borrower&#8217;s plan and forecast, in a form consistent with the Borrower&#8217;s past practice (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Projections</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  promptly after the same become publicly available, copies of all periodic and other reports, proxy statements and other materials filed by the Borrower or any Subsidiary with the SEC, or any Governmental Authority succeeding to any or all of the functions of said Commission, or with any national securities exchange, or distributed by the Borrower to its shareholders generally, as the case may be&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">  promptly following any request therefor, such other information regarding the operations, business affairs and financial condition of the Borrower or any of its Subsidiaries, or compliance with the terms of this Agreement, as the Administrative Agent or any Lender may reasonably request&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  promptly following any request therefor, such information and documentation reasonably requested by the Administrative Agent or any Lender, and reasonably available to the Borrower, for purposes of compliance with applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including the Patriot Act and the Beneficial Ownership Regulation.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Information required to be delivered pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.01(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">5.01(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">5.01(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be deemed to have been delivered if such information, or one or more annual, quarterly or current reports containing such information, shall have been posted by the Administrative Agent on the Platform, on the website of the SEC at http&#58;&#47;&#47;www.sec.gov or on the website of the Borrower.  Information required to be delivered pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> may also be delivered by electronic communications pursuant to procedures approved by the Administrative Agent. Each Lender shall be solely responsible for timely accessing posted documents and maintaining its copies of such documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 5.02.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notices of Material Events</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will furnish to the Administrative Agent and each Lender prompt written notice of a Financial Officer of the Borrower becoming aware of the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  the occurrence of any Default&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">70</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  the filing or commencement of any action, suit or proceeding by or before any arbitrator or Governmental Authority against or affecting any Loan Party or any Affiliate thereof that, if adversely determined, could reasonably be expected to result in a Material Adverse Effect&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  the occurrence of any ERISA Event that, alone or together with any other ERISA Events that have occurred, could reasonably be expected to result in liability of the Loan Parties and their Subsidiaries in an aggregate amount that could reasonably be expected to result in a Material Adverse Effect&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  any other development that results in, or would reasonably be expected to result in, a Material Adverse Effect&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  any change in the credit ratings from a credit rating agency, or the placement by a credit rating agency of the Borrower on a &#8220;CreditWatch&#8221; or &#8220;WatchList&#8221; or any similar list, in each case with negative implications, or the cessation by a credit rating agency of, or its intent to cease, rating the Borrower&#8217;s debt&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt"> any change in the information provided in the Beneficial Ownership Certification delivered to such Lender that would result in a change to the list of beneficial owners identified in such certification.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each notice delivered under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be accompanied by a statement of a Financial Officer or other executive officer of the Borrower setting forth the details of the event or development requiring such notice and any action taken or proposed to be taken with respect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 5.03.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Existence&#59; Conduct of Business</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will, and will cause each of its Subsidiaries to, do or cause to be done all things necessary to preserve, renew and keep in full force and effect its legal existence and the rights, Governmental Authorizations, privileges and franchises material to the conduct of its business except where the failure to do so would not reasonably be expected to have a Material Adverse Effect&#59; provided that the foregoing shall not prohibit any merger, consolidation, Division, liquidation or dissolution permitted under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;6.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 5.04.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Payment of Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will, and will cause each of its Subsidiaries to, pay its obligations, including Tax liabilities, that, if not paid, could result in a Material Adverse Effect before the same shall become delinquent or in default, except where (a)&#160;the validity or amount thereof is being contested in good faith by appropriate proceedings, (b)&#160;to the extent required by GAAP, the Borrower or such Subsidiary has set aside on its books adequate reserves with respect thereto in accordance with GAAP and (c)&#160;the failure to make payment pending such contest would not reasonably be expected to result in a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 5.05.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maintenance of Properties&#59; Insurance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will, and will cause each of its Subsidiaries to, (a)&#160;except as otherwise permitted pursuant to this Agreement keep and maintain all property material to the conduct of its business in good working order and condition, ordinary wear and tear excepted, and (b)&#160;maintain, with financially sound and reputable insurance companies, insurance in such amounts and against such risks as are customarily maintained by companies engaged in the same or similar businesses operating in the same or similar locations.  The Borrower will furnish to the Lenders, upon request of the Administrative Agent, but no less frequently than annually, information in reasonable detail as to the insurance so maintained.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 5.06.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Books and Records&#59; Inspection Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will, and will cause each of its Subsidiaries to, keep proper books of record and account in which full, true and correct entries in all material respects are made of all dealings and transactions in relation to its business and activities.  The Borrower will, and will cause each of its Subsidiaries to, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">71</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">permit any representatives designated by the Administrative Agent, upon reasonable prior notice, to visit and inspect its properties, to examine and make extracts from its books and records, and to discuss its affairs, finances and condition with its officers and independent accountants (at which the Borrower shall have the right to be present), all at such reasonable times and as often as reasonably requested (and, if requested, any Lender may accompany the Agent on such inspection, which shall be at such Lender&#8217;s sole expense unless an Event of Default has occurred and is continuing)&#59; provided, however, that unless an Event of Default has occurred and is continuing, any such inspection shall be limited to once in any calendar year.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 5.07.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Laws</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will, and will cause each of its Subsidiaries to, comply with all laws, rules, regulations and orders of any Governmental Authority applicable to it or its property, except where the failure to do so, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect.  The Borrower will maintain in effect and enforce policies and procedures designed to ensure compliance by the Borrower, its Subsidiaries and their respective directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 5.08.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Proceeds and Letters of Credit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The proceeds of the Loans and the Letters of Credit will be used only for general corporate purposes of the Borrower and its Subsidiaries including working capital, capital expenditures, acquisitions, dividends and share repurchases permitted hereunder.  No part of the proceeds of any Loan will be used, whether directly or indirectly, for any purpose that entails a violation of any of the regulations of the Federal Reserve Board, including Regulations T, U and X.  The Borrower will not request any Borrowing or Letter of Credit, and the Borrower shall not use, and shall procure that its Subsidiaries and its or their respective directors, officers, employees and agents shall not use, the proceeds of any Borrowing or Letter of Credit (A) in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any Anti-Corruption Laws, (B) for the purpose of funding, financing or facilitating any activities, business or transaction of or with any Sanctioned Person, or in any Sanctioned Country, to the extent such activities, business or transaction would be prohibited by Sanctions if conducted by a corporation incorporated in the United States or in a European Union member state, or (C)  in any manner that would result in the violation of  any Sanctions applicable to any party hereto. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 5.09.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Accuracy of Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will ensure that any written information, including financial statements or other documents, furnished to the Administrative Agent or the Lenders in connection with this Agreement or any amendment or modification hereof or waiver hereunder contains no material misstatement of fact or omits to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not materially misleading, and the furnishing of such information shall be deemed to be a representation and warranty by the Borrower on the date thereof as to the matters specified in this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.09</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, with respect to projected financial information, the Borrower will cause such projections to be prepared in good faith based upon assumptions believed to be reasonable at the time (it being recognized that such projections are not to be viewed as facts and are subject to significant uncertainties and contingencies, which are beyond the Borrower&#8217;s control, that no assurance can be given that any particular financial projections will be realized, that actual results may differ from projected results and that such differences may be material).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 5.10.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Collateral&#59; Further Assurances</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) Subject to applicable law and the Collateral Documents, the Borrower shall cause (x) each Division Successor and (y) each wholly-owned domestic Subsidiary (other than any Excluded Subsidiary), in each case, formed or acquired after the date of this Agreement in accordance with the terms of this Agreement to become a Loan Party by executing one or more joinder agreements (or similar documents) as requested by Administrative Agent.  Upon execution and delivery thereof, each such Person (i) shall become a Loan Guarantor and thereupon shall have all of the rights, benefits, duties, and obligations in such capacity under the Loan Documents and (ii) will grant </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">72</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Liens to the Administrative Agent, for the benefit of the Administrative Agent and the Secured Parties, in any property of such Loan Party which constitutes Collateral.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Without limiting the foregoing, the Borrower will, and will cause each Loan Party to, execute and deliver, or cause to be executed and delivered, to the Administrative Agent such documents, agreements and instruments, and will take or cause to be taken such further actions (including the filing and recording of financing statements and other documents and such other actions or deliveries of the type required by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as applicable, including, without limitation, issuance of legal opinions), which may be required by law or which the Administrative Agent may, from time to time, reasonably request to carry out the terms and conditions of this Agreement and the other Loan Documents and to ensure perfection and priority of the Liens created or intended to be created by the Collateral Documents, all at the expense of the Borrower.  The Borrower will cause (i) 100% of the issued and outstanding Equity Interests of each of its domestic Subsidiaries (other than Excluded Subsidiaries) and (ii) 65% of all issued and outstanding voting Equity Interests and 100% of the issued and outstanding nonvoting Equity Interests (which, for the avoidance of doubt, is not convertible into voting Equity Interests) of each of its directly-owned foreign Subsidiaries and CFC Holdcos, in each case of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above, to be subject at all times to a first priority, perfected Lien in favor of the Administrative Agent pursuant to terms in the Loan Documents or as Administrative Agent may reasonably request (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this shall not be construed to constitute consent by the Administrative Agent or any of the Lenders to the establishment of any foreign Subsidiaries or the consummation of any other transaction not expressly permitted by the terms of this Agreement).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  If any assets which constitute or are required to constitute Collateral are acquired by any Loan Party after the Restatement Effective Date (other than assets constituting Collateral under the Security Agreement that become subject to the Lien in favor of the Administrative Agent upon acquisition thereof), the Borrower, on behalf of the Loan Parties, will notify the Administrative Agent thereof and cause such assets to be subjected to a Lien securing the Secured Obligations in connection with and at the time of acquisition thereof and will take, and cause each Loan Party to take, such actions as shall be necessary or reasonably requested by the Administrative Agent to grant and perfect such Liens, including actions described in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.10(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, all at the expense of the Loan Parties. Administrative Agent may determine in its sole discretion whether or not to take any steps with respect to obtaining a security interest in or pledge or perfection of any Collateral if it determines that the cost thereof exceeds the practical benefit to the Secured Parties of the security afforded thereby.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Each Loan Party agrees that each action required by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.10(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be completed not less than sixty (60) days after the formation or acquisition of a Subsidiary, or redesignation of a Subsidiary to not be an Immaterial Subsidiary as provided in Section 5.10(f) (or such longer period of time as designated by the Administrative Agent in its reasonable discretion).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The parties hereto agree that if a Borrower who caused any Equity Interests in its domestic or foreign Subsidiaries to be subject to a first priority, perfected Lien in favor of the Administrative Agent per </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above and that Subsidiary subsequently is transferred in a manner permitted hereunder such that it is no longer a direct subsidiary of the Borrower, the Parties agree that the Lien on the Equity Interests of such Subsidiary shall be released upon consummation of the transfer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt"> Immaterial Subsidiaries.  Notwithstanding anything in this Agreement to the contrary, if the Total Assets of all Immaterial Subsidiaries constitute, in the aggregate, more than 10.0% of the Total Assets of Borrower and its Subsidiaries (determined as of the last day of the most recent fiscal quarter of Borrower for which financial statements are available to the Administrative Agent pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), Borrower shall redesignate one or more of such Subsidiaries to not be Immaterial Subsidiaries within 10 Business Days after delivery of the compliance certificate for such fiscal quarter such that after giving effect thereto the Total Assets </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">73</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of all Immaterial Subsidiaries constitute, in the aggregate, no more than 10.0% of the Total Assets of Borrower and its Subsidiaries on a consolidated basis.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 5.11.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a)  The Borrower will, and will cause each of its Subsidiaries to, take all actions necessary to maintain and pursue each application, to obtain the relevant registration and to maintain the registration of each of its Patents, Trademarks and Copyrights (now or hereafter existing), including the filing of applications for renewal, affidavits of use, affidavits of noncontestability and opposition and interference and cancellation proceedings, unless the Borrower shall determine that such Patent, Trademark or Copyright is not material to the conduct of its business or operations or such failures to take such actions could not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Borrower will, and will cause each of its Subsidiaries to promptly sue, or pursue such other enforcement action as is reasonably deemed appropriate by Borrower, for any known infringement, misappropriation or dilution and to recover any and all damages for such infringement, misappropriation or dilution to protect such Patent, Trademark or Copyright, unless the Borrower shall determine that such Patent, Trademark or Copyright is not material to the conduct of its business or operations or such infringement, misappropriation or dilution could not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.  In the event that the Borrower or such Subsidiary institutes suit because any of its Patents, Trademarks or Copyrights is infringed upon, or misappropriated or diluted by a third party, such Person shall comply with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Security Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 5.12.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Post-Closing Matters</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.   Within forty-five (45) days (or such longer period as the Administrative Agent may agree to in its sole discretion) after the Restatement Effective Date, the Company shall deliver to the Administrative Agent stock certificates and related stock powers representing the Equity Interest of such Subsidiaries as are required to be delivered pursuant to the Security Agreement. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VI<br><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Negative Covenants</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Until the Commitments have expired or terminated and the principal of and interest on each Loan and all fees  payable hereunder have been paid in full and all Letters of Credit have expired or terminated, in each case, without any pending draw, and all LC Disbursements shall have been reimbursed, the Borrower covenants and agrees with the Lenders that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6.01.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indebtedness</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will not, and will not permit any of its Subsidiaries to, create, incur, assume or permit to exist any Indebtedness, except&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  (i) Indebtedness created hereunder or (ii) any other Secured Obligations&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Indebtedness existing on the date hereof and set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 6.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and extensions, amendments, refinancings, renewals and replacements of any such Indebtedness that do not increase the outstanding principal amount thereof or shorten the final maturity or weighted average life to maturity thereof&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  Indebtedness of the Borrower to any Subsidiary and of any Subsidiary to the Borrower or any other Subsidiary, provided that (i) Indebtedness of any Subsidiary that is not a Loan Party to the Borrower or any other Loan Party shall be subject to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (ii) Indebtedness of any Loan Party to any Subsidiary that is not a Loan Party shall be subordinated to the Secured Obligations on terms reasonably satisfactory to the Administrative Agent&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Guarantees by the Borrower of Indebtedness of any Subsidiary and by any Subsidiary of Indebtedness of the Borrower or any other Subsidiary, provided that (i) the Indebtedness so Guaranteed is permitted by this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (ii) Guarantees by the Borrower </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">74</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or any other Loan Party of Indebtedness of any Subsidiary that is not a Loan Party shall be subject to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (iii) Guarantees permitted under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be subordinated to the Secured Obligations on the same terms as the Indebtedness so Guaranteed is subordinated to the Secured Obligations&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Indebtedness of the Borrower or any Subsidiary incurred to finance the acquisition, construction or improvement of any fixed or capital assets, including Finance Leases Obligations and any Indebtedness assumed in connection with the acquisition of any such assets or secured by a Lien on any such assets prior to the acquisition thereof, and extensions, renewals and replacements of any such Indebtedness that do not increase the outstanding principal amount thereof&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i)&#160;such Indebtedness is incurred prior to or within one hundred eighty (180) days after such acquisition or the completion of such construction or improvement and (ii)&#160;the aggregate principal amount of Indebtedness permitted by this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;shall not exceed the greater of $250,000,000 and 10% of the total consolidated assets of the Borrower and its Subsidiaries at any time outstanding&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">  Indebtedness of the Borrower or any Subsidiary as an account party in respect of trade letters of credit&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Indebtedness which may be deemed to exist pursuant to any Guarantees, performance, statutory or similar obligations (including in connection with workers&#8217; compensation) or obligations in respect of letters of credit, surety bonds, bank guarantees or similar instruments related thereto, or to obligations to vendors, incurred in the ordinary course of business, such obligations or pursuant to any appeal obligation, appeal bond or letter of credit in respect of judgments that do not constitute an Event of Default under clause (k) of Article VII&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Indebtedness of any Person that becomes a Subsidiary of the Borrower in connection with an acquisition permitted hereunder&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such Indebtedness exists at the time such Person becomes a Subsidiary of the Borrower and is not incurred in contemplation of or in connection with such Person becoming a Subsidiary of the Borrower, (ii) immediately before and after such Person becomes a Subsidiary of the Borrower, no Default or Event of Default shall have occurred and be continuing and (iii) the aggregate outstanding principal amount of Indebtedness permitted by this clause shall not to exceed $50,000,000&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">  other unsecured Indebtedness of the Borrower or any of its Subsidiaries (including, without limitation, any Indebtedness assumed in connection with an acquisition permitted hereunder), so long as, after giving effect thereto as of the last day of the most recently ended fiscal quarter for which financial statements are available the Borrower is in pro forma compliance with each of the covenants contained in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and no Default or Event of Default shall have occurred and be continuing. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6.02.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Liens</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will not, and will not permit any of its Subsidiaries to, create, incur, assume or permit to exist any Lien on any property or asset (including trademarks, trade names, copyrights, patents and other Intellectual Property) now owned or hereafter acquired by it, or assign or sell any income or revenues (including accounts receivable) or rights in respect of any thereof, except&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Permitted Encumbrances&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  any Lien on any property or asset of the Borrower or any Subsidiary existing on the date hereof and set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 6.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i)&#160;such Lien shall not apply to any other property or asset of the Borrower or any Subsidiary and (ii)&#160;such Lien shall secure only those obligations which it secures on the date hereof and extensions, renewals and replacements thereof that do not increase the outstanding principal amount thereof&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  any Lien existing on any property or asset prior to the acquisition thereof by the Borrower or any Subsidiary or existing on any property or asset of any Person that becomes a Subsidiary after the date hereof prior to the time such Person becomes a Subsidiary&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">75</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that (i)&#160;such Lien is not created in contemplation of or in connection with such acquisition or such Person becoming a Subsidiary, as the case may be, (ii)&#160;such Lien shall not apply to any other property or assets of the Borrower or any Subsidiary and (iii)&#160;such Lien shall secure only those obligations which it secures on the date of such acquisition or the date such Person becomes a Subsidiary, as the case may be and extensions, renewals and replacements thereof that do not increase the outstanding principal amount thereof&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Liens on fixed or capital assets acquired, constructed or improved by the Borrower or any Subsidiary&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i)&#160;such security interests secure Indebtedness permitted by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;6.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (ii)&#160;such security interests and the Indebtedness secured thereby are incurred prior to or within one hundred eighty (180) days after such acquisition or the completion of such construction or improvement, (iii)&#160;the Indebtedness secured thereby does not exceed 80% of the cost of acquiring, constructing or improving such fixed or capital assets and (iv)&#160;such security interests shall not apply to any other property or assets of the Borrower or any Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Liens of a collecting bank arising in the ordinary course of business under Section 4-208 of the UCC in effect in the relevant jurisdiction covering only the items being collected upon&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">  Liens granted by a Subsidiary that is not a Loan Party in favor of the Borrower or another Loan Party in respect of Indebtedness owed by such Subsidiary&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Liens, if any, in favor of the Issuing Bank to cash collateralize LC Exposure or otherwise secure the obligations of a Defaulting Lender to fund risk participations hereunder&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  financing statements filed under the UCC of any jurisdiction for notice purposes in connection with any operating lease in respect of the amounts covered by such lease.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6.03.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fundamental Changes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) The Borrower will not, and will not permit any of its Subsidiaries to, merge into or consolidate with any other Person, or permit any other Person to merge into or consolidate with it, consummate a Division as the Dividing Person or sell, transfer, lease or otherwise dispose of (in one transaction or in a series of transactions) all or any substantial part of its assets, or all or substantially all of the stock of any of its Subsidiaries (in each case, whether now owned or hereafter acquired), or liquidate or dissolve, except that, if at the time thereof and immediately after giving effect thereto no Default shall have occurred and be continuing (i) any Subsidiary may merge into the Borrower in a transaction in which the Borrower is the surviving corporation, (ii) any Subsidiary may merge into any Loan Party in a transaction in which the surviving entity is a Loan Party or any Subsidiary that is not a Loan Party may merge into any other Subsidiary that is not a Loan Party, (iii) any Subsidiary (x) that is a Loan Party may sell, transfer, lease or otherwise dispose of its assets to the Borrower or to another Loan Party and (y) that is not a Loan Party may sell, transfer, lease or otherwise dispose of its assets to the Borrower, to any other Subsidiary or to any other Person&#59; provided that in the case of any such sale, transfer, lease or other disposition to a Person that is not the Borrower or a Subsidiary, (A) such transaction shall be for fair market value, (B) after giving effect to such transaction as of the last day of the most recently ended fiscal quarter for which financial statements are available, the Borrower is in pro forma compliance with each of the covenants contained in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (C) no Default or Event of Default shall have occurred and be continuing and (D) the assets which are subject to such transaction are not material to the business of the Borrower and is Subsidiaries taken as a whole, (iv) any Subsidiary may merge into or consolidate with the Borrower or another Loan Party and any Subsidiary that is not a Loan Party may merge into or consolidate with other Subsidiary that is not a Loan Party or to any other Person&#59; provided that in the case of any such merger into or consolidation with a Person that is not the Borrower or a Subsidiary, (x) such merger or consolidation shall be for fair market value, (y) after giving effect to such merger or consolidation as of the last day of the most recently ended fiscal quarter for which financial statements are available, the Borrower is in pro forma compliance with each of the covenants </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">76</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">contained in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (z) no Default or Event of Default shall have occurred and be continuing and (aa) such Subsidiary and its assets are not material to the business of the Borrower and is Subsidiaries taken as a whole, (v) any Subsidiary may liquidate or dissolve if the Borrower determines in good faith that such liquidation or dissolution is in the best interests of the Borrower and is not materially disadvantageous to the Lenders&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any such merger involving a Person that is not a wholly-owned Subsidiary immediately prior to such merger shall not be permitted unless also permitted by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;6.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (vi) any Subsidiary that is a limited liability company may consummate a Division as the Dividing Person if, immediately upon the consummation of the Division, the assets of the applicable Dividing Person are held by one or more Subsidiaries at such time so long as, in the case of a Division pursuant to which the Dividing Person is a Guarantor, any such Subsidiaries which hold such assets upon the consummation of such Division are Guarantors or become Guarantors concurrently with such Division. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Borrower will not, and will not permit any of its Subsidiaries to, engage to any material extent in any business other than businesses of the type conducted by the Borrower and its Subsidiaries on the Restatement Effective Date and any other businesses reasonably related or otherwise complimentary or similar thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6.04.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Investments, Loans, Advances, Guarantees and Acquisitions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will not, and will not permit any of its Subsidiaries to, purchase, hold or acquire (including pursuant to any merger, or as a Division Successor pursuant to the Division of, with any Person that was not a wholly owned Subsidiary prior to such merger or Division) any capital stock, evidences of indebtedness or other securities (including any option, warrant or other right to acquire any of the foregoing) of, make or permit to exist any loans or advances to, Guarantee any obligations of, or make or permit to exist any investment or any other interest in, any other Person, or purchase or otherwise acquire (in one transaction or a series of transactions) any assets of any other Person constituting a business unit, except&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  cash or Permitted Investments&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  investments (other than investments permitted under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) existing on the Restatement Effective Date and set forth on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 6.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and any investment that replaces, refinances or refunds any investment made pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; provided that the amount of any such investment may be increased (x) as required by the terms of such investment as in existence on the date hereof or (y) as otherwise permitted hereunder&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  investments by the Borrower existing on the date hereof in the capital stock of its Subsidiaries&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  (i) loans or advances made by the Borrower to any Loan Party and made by any Loan Party to the Borrower or any other Loan Party, (ii) loans or advances made by any Subsidiary that is not a Loan Party to the Borrower or any Loan Party or to any non-Loan Party, (iii) loans or advances made by the Borrower or any Loan Party to any foreign Subsidiary, provided that the aggregate amount of such loans or advances under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not exceed $50,000,000 for the fiscal year ending December 31, 2019 and each fiscal year ending thereafter&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Guarantees constituting Indebtedness permitted by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;6.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">  other acquisitions, investments, loans or advancements made by the Loan Parties, so long as, after giving effect thereto (i) pro forma Senior Secured Leverage Ratio is less than or equal to (x) 2.00 to 1.00 or (y) if a Senior Secured Leverage Covenant Holiday is then in effect, 2.50 to 1.00, (ii) the Borrower is in pro forma compliance with each of the other covenants contained in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and (iii) no Default or Event of Default shall have occurred and be continuing&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">77</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  other acquisitions, investments, loans or advancements made by the Loan Parties, so long as, after giving effect thereto (i) the Borrower shall have not less than $350,000,000 in the aggregate of (x) Borrowing Availability and (y) unrestricted domestic cash and (ii) no Default or Event of Default shall have occurred and be continuing&#59;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  acquisitions or investments made by foreign Subsidiaries that are not Loan Parties in an aggregate amount not to exceed in any fiscal year the greater of (x) $200,000,000 in the aggregate, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">net of any returns</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> on such investment to such foreign Subsidiary and (y) 5% of the total consolidated assets of the Borrower and its Subsidiaries at any time outstanding&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">  notes payable, or stock or other securities issued by an account debtor to the Borrower or any Subsidiary pursuant to negotiated agreements with respect to settlement of such account debtor&#8217;s accounts in the ordinary course of business, consistent with past practices&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">  investments in the form of Swap Agreements permitted by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.05</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  investments of any Person existing at the time such Person becomes a Subsidiary of the Borrower or consolidates or merges with the Borrower or any of the Subsidiaries so long as such investments were not made in contemplation of such Person becoming a Subsidiary or of such merger&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">  investments constituting deposits described in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the definition of the term &#8220;Permitted Encumbrances&#8221;&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.52pt">  advances or extensions of credit to officers, directors and employees of the Borrower or any Subsidiaries made in the ordinary course of business and consistent with past practices for travel, entertainment, relocation and similar purposes up to a maximum of $10,000,000 in the aggregate at any one time outstanding&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  investments consisting of extensions of credit in the nature of accounts or notes receivable arising from the grant of trade credit in the ordinary course of business, and investments received in satisfaction or partial satisfaction thereof from financially troubled account debtors to the extent reasonably necessary in order to prevent or limit loss&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  investments in the form of Indebtedness of, or equity interests in, foreign Subsidiaries that are not Loan Parties representing consideration for licenses to any rights to Intellectual Property outside of the United States so long as the Loan Party licensing such Intellectual Property retains ownership of such Intellectual Property, provided that the Borrower determine in good faith that any such license has been effected for fair value.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6.05.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swap Agreements.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The Borrower will not, and will not permit any of its Subsidiaries to, enter into any Swap Agreement, except (a) Swap Agreements entered into to hedge or mitigate risks to which the Borrower or any Subsidiary has actual exposure (other than those in respect of Equity Interests of the Borrower or any of its Subsidiaries), (b) Swap Agreements entered into in order to effectively cap, collar or exchange interest rates (from fixed to floating rates, from one floating rate to another floating rate or otherwise) with respect to any interest-bearing liability or investment of the Borrower or any Subsidiary, (c) the 2018 Call Spread and (d) any Permitted Bond Hedge Transaction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6.06.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Payments&#59; Certain Payments of Indebtedness</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Borrower will not, and will not permit any of its Subsidiaries to, declare or make, or agree to pay or make, directly or indirectly, any Restricted Payment, except (i) the Borrower may declare and pay dividends with respect to its Equity Interests payable solely in additional shares of its common stock, (ii) Subsidiaries of the Borrower may declare and pay dividends ratably with respect to their Equity Interests, (iii) the Borrower may make Restricted </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">78</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Payments pursuant to and in accordance with stock option plans or other benefit plans for management, directors or employees of the Borrower and its Subsidiaries, (iv) the Borrower may make other Restricted Payments not to exceed $50,000,000  in the aggregate during any four consecutive fiscal quarters so long as after giving effect thereto (x) the Borrower shall have not less than $25,000,000 of Liquidity and (y) no Default or Event of Default shall have occurred and be continuing, (v) the Borrower may make any other Restricted Payments so long as after giving effect thereto (w) the pro forma Total Leverage Ratio is less than or equal to 1.75 to 1.00, (x) the Borrower is in pro forma compliance with each of the covenants contained in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (y) the Borrower shall have not less than $25,000,000 of Liquidity and (z) no Default or Event of Default shall have occurred and be continuing, (vi) the Borrower may make any other Restricted Payments so long as after giving effect thereto (x) the Borrower shall have not less than $350,000,000 of Liquidity, (y) the Borrower is in pro forma compliance with each of the covenants contained in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and (z) no Default or Event of Default shall have occurred and be continuing and (vii) the Borrower may (x) enter into Permitted Bond Hedge Transactions and (y) make payments in connection with any Permitted Bond Hedge Transaction (I) by delivery of shares of the Borrower&#8217;s common stock upon settlement thereof or (II) payment of an early termination amount thereof in common stock upon any early termination thereof&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.06</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not prohibit the repurchase of Equity Interests pursuant to any accelerated stock repurchase or similar agreement so long as any payment made by the Borrower with respect to such repurchase is permitted under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.06(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (without regard to this proviso) at the time of such payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Borrower will not, nor will it permit any Subsidiary to, pay or make, directly or indirectly, any cash payment of principal of any of the Convertible Notes, or any cash payment on account of the purchase, redemption, settlement on conversion, retirement, acquisition, cancellation or termination of any such Indebtedness, unless (i) the Borrower is in pro forma compliance with each of the covenants contained in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (ii) the Borrower shall have not less than $100,000,000 of Liquidity on a pro forma basis, (iii) no Default or Event of Default shall have occurred and be continuing, in each case of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, on the date of such payment and giving effect thereto and (iv) in the case of redemption, the Borrower shall deliver to the Administrative Agent a certificate of a Financial Officer to effect that the Borrower is in compliance with the conditions set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.06(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that for the avoidance of doubt, this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.06(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not restrict (w) the repayment of the principal amount of Convertible Notes at the stated maturity thereof, (x) the payment of interest (including any additional interest payable upon specified events) on the Convertible Notes, (y) the settlement of conversion of Convertible Notes for securities, other property (excluding cash other than cash in lieu of any fractional share) or a combination thereof or (z) the redemption or repurchase of Convertible Notes using the net cash proceeds of any new issuance of Convertible Notes</font><font style="color:#1f497d;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or other unsecured Indebtedness permitted hereunder&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.06(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not apply in the case of any settlement on conversion for cash.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6.07.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Transactions with Affiliates</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will not, and will not permit any of its Subsidiaries to, sell, lease or otherwise transfer any property or assets to, or purchase, lease or otherwise acquire any property or assets from, or otherwise engage in any other transactions with, any of its Affiliates, except (a)&#160;in the ordinary course of business at prices and on terms and conditions not less favorable to the Borrower or such Subsidiary than could be obtained on an arm&#8217;s-length basis from unrelated third parties, (b)&#160;transactions between or among the Borrower and its wholly-owned Subsidiaries not involving any other Affiliate, excluding any transfer or other disposition of Intellectual Property rights of any Loan Party or any of their United States Subsidiaries which are material to the ongoing business of the Loan Parties and their Subsidiaries, taken as a whole, provided that licenses of such Intellectual Property shall be permitted so long as the Loan Party or United States Subsidiary licensing such Intellectual Property retains ownership thereof, and (c)&#160;any Restricted Payment permitted by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;6.06</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6.08.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restrictive Agreements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will not, and will not permit any of its Subsidiaries to, directly or indirectly, enter into, incur or permit to exist any agreement or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">79</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">other arrangement that prohibits, restricts or imposes any condition upon (a)&#160;the ability of any Loan Party or any of their Subsidiaries to create, incur or permit to exist any Lien of the Administrative Agent or any Secured Party upon any of its property or assets, or (b)&#160;the ability of any Subsidiary of a Loan Party to pay dividends or other distributions with respect to any shares of its capital stock or to make or repay loans or advances to the Borrower or any other Loan Party or to Guarantee Indebtedness of the Borrower or any other Loan Party&#59; provided that (i)&#160;the foregoing shall not apply to restrictions and conditions imposed by any Requirement of Law or by any Loan Document, (ii)&#160;the foregoing shall not apply to restrictions and conditions existing on the date hereof identified on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 6.08</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (but shall apply to any extension or renewal of, or any amendment or modification expanding the scope of, any such restriction or condition), (iii)&#160;the foregoing shall not apply to customary restrictions and conditions contained in agreements relating to the sale of a Subsidiary pending such sale, provided that such restrictions and conditions apply only to the Subsidiary that is to be sold and such sale is permitted hereunder, (iv)&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the foregoing shall not apply to restrictions or conditions imposed by any agreement relating to secured Indebtedness permitted by this Agreement if such restrictions or conditions apply only to the property or assets securing such Indebtedness and (v)&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the foregoing shall not apply to customary provisions in leases restricting the assignment thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6.09.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sale and Leaseback Transactions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will not, and will not permit any of its Subsidiaries to, enter into any arrangement, directly or indirectly, whereby it shall sell or transfer any property, real or personal, used or useful in its business, whether now owned or hereafter acquired, and thereafter rent or lease such property or other property that it intends to use for substantially the same purpose or purposes as the property sold or transferred (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Sale and Leaseback Transaction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  For the avoidance of doubt, customary &#8220;build to suit&#8221; transactions do not constitute a Sale and Leaseback Transaction hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6.10.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment of Material Documents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will not, and will not permit any of its Subsidiaries to, amend, modify or waive any of its rights under (a) any agreement relating to any Subordinated Indebtedness, or (b) its charter, articles or certificate of organization or incorporation and bylaws or operating, management or partnership agreement, or other organizational or governing documents, to the extent any such amendment, modification or waiver would be adverse to the Administrative Agent or the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6.11.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fiscal Year</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will not, and will not permit any of its Subsidiaries to, change its fiscal year to end on any date other than December 31 of each year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6.12.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Laws and Sanctions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will not, and will not permit any of its Subsidiaries to, fail to maintain in effect and enforce policies and procedures designed to ensure compliance by the Borrower, its Subsidiaries and their respective directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6.13.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Covenants</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Minimum Interest Coverage Ratio</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will not permit the Interest Coverage Ratio, for any period of four consecutive fiscal quarters ending on the last day of any fiscal quarter (commencing with the fiscal quarter ending December 31, 2021) to be less than 4.00 to 1.00.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maximum Senior Secured Leverage Ratio</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower will not permit the Senior Secured Leverage Ratio, on the last day of any fiscal quarter (commencing with the fiscal quarter ending December 31, 2021) to be greater than 2.00 to 1.00. Notwithstanding the foregoing, in the event that the Borrower and&#47;or one or more of its Subsidiaries makes an acquisition which is permitted hereunder with a total purchase price greater than $150,000,000 during the fiscal quarter then most recently ended, the maximum Senior Secured Leverage Ratio may be increased at the election of the Borrower to 2.50 to 1.00 for such fiscal quarter and for each of the three (3) subsequent fiscal quarters (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Senior Secured Leverage Covenant Holiday</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Borrower shall not be permitted to elect an additional Senior </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">80</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Secured Leverage Covenant Holiday until the Senior Secured Leverage Ratio has returned, after the Senior Secured Leverage Covenant Holiday, to a ratio of less than or equal to 2.00 to 1.00 for a period of four (4) full fiscal quarters.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VII<br><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Events of Default</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If any of the following events (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Events of Default</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) shall occur&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  the Borrower shall fail to pay any principal of any Loan or any reimbursement obligation in respect of any LC Disbursement when and as the same shall become due and payable, whether at the due date thereof or at a date fixed for prepayment thereof or otherwise&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  the Borrower shall fail to pay any interest on any Loan or any fee or any other amount (other than an amount referred to in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Article) payable under this Agreement or any other Loan Document, when and as the same shall become due and payable, and such failure shall continue unremedied for a period of three (3) Business Days&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  any representation or warranty made or deemed made by or on behalf of the Borrower or any Subsidiary in or in connection with this Agreement, any other Loan Document, or any amendment or modification hereof or thereof or waiver hereunder or thereunder, or in any report, certificate, financial statement or other document furnished pursuant to or in connection with this Agreement, any other Loan Document, or any amendment or modification hereof or thereof or waiver hereunder or thereunder, shall prove to have been incorrect in any material respect when made or deemed made&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  the Borrower shall fail to observe or perform any covenant, condition or agreement contained in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;5.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">5.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (with respect to the Borrower&#8217;s existence), </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">5.08</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">5.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article&#160;VI</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  the Borrower or any other Loan Party shall fail to observe or perform any covenant, condition or agreement contained in this Agreement (other than those specified in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Article) or any other Loan Document, and such failure shall continue unremedied for a period of thirty</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(30) days after notice thereof from the Administrative Agent to the Borrower (which notice will be given at the request of any Lender)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">  any Loan Party or any of their Subsidiaries shall fail to make a principal payment in respect of any Material Indebtedness, when and as the same shall become due and payable (other than earn-out obligations to the extent such obligations are being contested in good faith and adequate reserves are maintained with respect thereto to the extent required by GAAP), after giving effect to any applicable grace or cure period&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  any event or condition occurs that results in any Material Indebtedness becoming due prior to its scheduled maturity or that enables or permits (with or without the giving of notice, the lapse of time or both) the holder or holders of any Material Indebtedness or any trustee or agent on its or their behalf to cause any Material Indebtedness to become due, or to require the prepayment, repurchase, redemption or defeasance thereof, prior to its scheduled maturity&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not apply to (i) secured Indebtedness that becomes due as a result of the voluntary sale or transfer of the property or assets securing such Indebtedness, (ii) any event or condition that gives a holder the right to convert any Convertible Note (other than an event of default under the Convertible Notes), (iii) any conversion of the Convertible Notes (and the settlement thereof, whether in securities, other property (excluding cash) or a combination thereof) or (iv) any purchase, redemption, retirement, settlement on conversion for cash, acquisition, cancellation or termination of any Convertible Notes that is permitted by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.06(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">81</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  an involuntary proceeding shall be commenced or an involuntary petition shall be filed seeking (i)&#160;liquidation, reorganization or other relief in respect of any Loan Party or any of their Subsidiaries or their debts, or of a substantial part of its assets, under any  federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect or (ii)&#160;the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for any Loan Party or any of their Subsidiaries or for a substantial part of its assets, and, in any such case, such proceeding or petition shall continue undismissed for sixty (60) days or an order or decree approving or ordering any of the foregoing shall be entered&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">  any Loan Party or any of their Subsidiaries shall (i)&#160;voluntarily commence any proceeding or file any petition seeking liquidation, reorganization or other relief under any federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect, (ii)&#160;consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding or petition described in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Article, (iii)&#160;apply for or consent to the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for any Loan Party or any of their Subsidiaries or for a substantial part of their assets, (iv)&#160;file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v)&#160;make a general assignment for the benefit of creditors or (vi)&#160;take any action for the purpose of effecting any of the foregoing&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">  any Loan Party or any of their Subsidiaries shall become unable, admit in writing its inability or fail generally to pay its debts as they become due&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  one or more judgments for the payment of money in an aggregate amount in excess of $25,000,000 (except to the extent covered by insurance) shall be rendered against any Loan Party, any of their Subsidiaries or any combination thereof and the same shall remain undischarged for a period of thirty (30) consecutive days during which execution shall not be effectively stayed, or any action shall be legally taken by a judgment creditor to attach or levy upon any assets of any Loan Party or any of their Subsidiaries to enforce any such judgment&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">  an ERISA Event shall have occurred that, in the opinion of the Required Lenders, when taken together with all other ERISA Events that have occurred, could reasonably be expected to result in liability of any Loan Party or any of their Subsidiaries in an aggregate amount that could reasonably be expected to result in a Material Adverse Effect&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.52pt">  a Change in Control shall occur&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  except for expiration, termination or release in accordance with its terms, (i) the Loan Guaranty or any Obligation Guaranty shall fail to remain in full force or effect or (ii) any action shall be taken to discontinue or to assert the invalidity or unenforceability of the Loan Guaranty or any Obligation Guaranty, or any Guarantor shall deny in writing to the Administrative Agent that it has any further liability under the Loan Guaranty or any Obligation Guaranty to which it is a party&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  except as permitted by the terms of any Loan Document, (i) any Collateral Document shall for any reason fail to create a valid security interest in any Collateral purported to be covered thereby, or (ii) any Lien securing any Secured Obligation shall cease to be a perfected, first priority Lien&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  except for expiration, termination or release in accordance with its terms, any Collateral Document shall fail to remain in full force or effect or any action shall be taken by any Loan Party or any of their Subsidiaries to discontinue or to assert the invalidity or unenforceability of any Collateral Document&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  any material provision of any Loan Document for any reason ceases to be valid, binding and enforceable (except solely as a result of applicable law) in accordance with its terms (or any Loan Party shall challenge the enforceability of any Loan Document or shall assert in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">82</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">writing that any material provision of any of the Loan Documents has ceased to be or otherwise is not valid, binding and enforceable in accordance with its terms)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">then, and in every such event (other than an event with respect to the Borrower described in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;of this Article), and at any time thereafter during the continuance of such event, the Administrative Agent may, and at the request of the Required Lenders shall, by notice to the Borrower, take either or both of the following actions, at the same or different times&#58;  (i)&#160;terminate the Commitments (including the Letter of Credit Commitments), and thereupon the Commitments shall terminate immediately, (ii)&#160;declare the Loans then outstanding to be due and payable in whole (or in part, in which case any principal not so declared to be due and payable may thereafter be declared to be due and payable), and thereupon the principal of the Loans so declared to be due and payable, together with accrued interest thereon and all fees and other obligations of the Borrower accrued hereunder, shall become  due and payable immediately, without presentment, demand, protest or other notice of any kind, all of which are hereby waived by the Borrower, and (iii) require cash collateral for the LC Exposure in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; and in case of any event with respect to the Borrower described in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;of this Article, the Commitments shall automatically terminate and the principal of the Loans then outstanding and cash collateral for the LC Exposure, together with accrued interest thereon and all fees and other obligations of the Borrower accrued hereunder, shall automatically become due and payable, without presentment, demand, protest or other notice of any kind, all of which are hereby waived by the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In addition to any other rights and remedies granted to the Administrative Agent and the Lenders in the Loan Documents, the Administrative Agent on behalf of the Lenders may exercise all rights and remedies of a secured party under the New York Uniform Commercial Code or any other applicable law.  Without limiting the generality of the foregoing, the Administrative Agent, without demand of performance or other demand, presentment, protest, advertisement or notice of any kind (except any notice required by law referred to below) to or upon any Loan Party or any other Person (all and each of which demands, defenses, advertisements and notices are hereby waived by the Borrower on behalf of itself and its Subsidiaries), may in such circumstances forthwith collect, receive, appropriate and realize upon the Collateral, or any part thereof, or consent to the use by any Loan Party of any cash collateral arising in respect of the Collateral on such terms as the Administrative Agent deems reasonable, and&#47;or may forthwith sell, lease, assign give an option or options to purchase or otherwise dispose of and deliver, or acquire by credit bid on behalf of the Lenders, the Collateral or any part thereof (or contract to do any of the foregoing), in one or more parcels at public or private sale or sales, at any exchange, broker&#8217;s board or office of the Administrative Agent or any Lender or elsewhere, upon such terms and conditions as it may deem advisable and at such prices as it may deem best, for cash or on credit or for future delivery, all without assumption of any credit risk.  The Administrative Agent or any Lender shall have the right upon any such public sale or sales, and, to the extent permitted by law, upon any such private sale or sales, to purchase the whole or any part of the Collateral so sold, free of any right or equity of redemption in any Loan Party, which right or equity is hereby waived and released by the Borrower on behalf of itself and its Subsidiaries.  The Borrower further agrees on behalf of itself and its Subsidiaries, at the Administrative Agent&#8217;s request, to assemble the Collateral and make it available to the Administrative Agent at places which the Administrative Agent shall reasonably select, whether at the premises of the Borrower, another Loan Party or elsewhere.  The Administrative Agent shall apply the net proceeds of any action taken by it pursuant to this Article 7, after deducting all reasonable costs and expenses of every kind incurred in connection therewith or incidental to the care or safekeeping of any of the Collateral or in any other way relating to the Collateral or the rights of the Administrative Agent and the Lenders hereunder, including reasonable attorneys&#8217; fees and disbursements, to the payment in whole or in part of the obligations of the Loan Parties under the Loan Documents, in such order as the Administrative Agent may elect, and only after such application and after the payment by the Administrative Agent of any other amount required by any provision of law, including Section 9-615(a)(3) of the New York Uniform Commercial Code, need the Administrative Agent account for the surplus, if any, to any Loan Party.  To the extent permitted by applicable law, the Borrower on behalf of itself and its Subsidiaries waives all Liabilities it may acquire against the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">83</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Administrative Agent or any Lender arising out of the exercise by them of any rights hereunder.  If any notice of a proposed sale or other disposition of Collateral shall be required by law, such notice shall be deemed reasonable and proper if given at least 10 days before such sale or other disposition.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VIII<br><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">The Administrative Agent&#59; Credit Bidding</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 8.01.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">The Administrative Agent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Each Lender, on behalf of itself and any of its Affiliates that are Secured Parties and each Issuing Bank hereby irrevocably appoints the entity named as Administrative Agent in the heading of this Agreement and its successors and assigns to serve as the administrative agent and collateral agent under the Loan Documents and each Lender and each Issuing Bank authorizes the Administrative Agent to take such actions as agent on its behalf and to exercise such powers under this Agreement and the other Loan Documents as are delegated to the Administrative Agent under such agreements and to exercise such powers as are reasonably incidental thereto. In addition, to the extent required under the laws of any jurisdiction other than within the United States, each Lender and each Issuing Bank hereby grants to the Administrative Agent any required powers of attorney to execute and enforce any Collateral Document governed by the laws of such jurisdiction on such Lender&#8217;s or such Issuing Bank&#8217;s behalf.  Without limiting the foregoing, each Lender and each Issuing Bank hereby authorizes the Administrative Agent to execute and deliver, and to perform its obligations under, each of the Loan Documents to which the Administrative Agent is a party, and to exercise all rights, powers and remedies that the Administrative Agent may have under such Loan Documents</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  As to any matters not expressly provided for herein and in the other Loan Documents (including enforcement or collection), the Administrative Agent shall not be required to exercise any discretion or take any action, but shall be required to act or to refrain from acting (and shall be fully protected in so acting or refraining from acting) upon the written instructions of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary, pursuant to the terms in the Loan Documents), and, unless and until revoked in writing, such instructions shall be binding upon each Lender and each Issuing Bank&#59; provided, however, that the Administrative Agent shall not be required to take any action that (i) the Administrative Agent in good faith believes exposes it to liability unless the Administrative Agent receives an indemnification and is exculpated in a manner satisfactory to it from the Lenders and the Issuing Banks with respect to such action or (ii) is contrary to this Agreement or any other Loan Document or applicable law, including any action that may be in violation of the automatic stay under any requirement of law relating to bankruptcy, insolvency or reorganization or relief of debtors or that may effect a forfeiture, modification or termination of property of a Defaulting Lender in violation of any requirement of law relating to bankruptcy, insolvency or reorganization or relief of debtors&#59; provided, further, that the Administrative Agent may seek clarification or direction from the Required Lenders prior to the exercise of any such instructed action and may refrain from acting until such clarification or direction has been provided. Except as expressly set forth in the Loan Documents, the Administrative Agent shall not have any duty to disclose, and shall not be liable for the failure to disclose, any information relating to the Borrower, any other Loan Party, any Subsidiary or any Affiliate of any of the foregoing that is communicated to or obtained by the Person serving as Administrative Agent or any of its Affiliates in any capacity. Nothing in this Agreement shall require the Administrative Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of any of its rights or powers if it shall have reasonable grounds for believing that repayment of such funds or adequate indemnity against such risk or liability is not reasonably assured to it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  In performing its functions and duties hereunder and under the other Loan Documents, the Administrative Agent is acting solely on behalf of the Lenders and the Issuing Banks (except in limited circumstances expressly provided for herein relating to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">84</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">maintenance of the Register), and its duties are entirely mechanical and administrative in nature.  Without limiting the generality of the foregoing&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">the Administrative Agent does not assume and shall not be deemed to have assumed any obligation or duty or any other relationship as the agent, fiduciary or trustee of or for any Lender, Issuing Bank, any other Secured Party or holder of any other obligation other than as expressly set forth herein and in the other Loan Documents, regardless of whether a Default or an Event of Default has occurred and is continuing (and it is understood and agreed that the use of the term &#8220;agent&#8221; (or any similar term) herein or in any other Loan Document with reference to the Administrative Agent is not intended to connote any fiduciary duty or other implied (or express) obligations arising under agency doctrine of any applicable law, and that such term is used as a matter of market custom and is intended to create or reflect only an administrative relationship between contracting parties)&#59; additionally, each Lender agrees that it will not assert any claim against the Administrative Agent based on an alleged breach of fiduciary duty by the Administrative Agent in connection with this Agreement and&#47;or the transactions contemplated hereby&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">where the Administrative Agent is required or deemed to act as a trustee in respect of any Collateral over which a security interest has been created pursuant to a Loan Document expressed to be governed by the laws of the United States of America , or is required or deemed to hold any Collateral &#8220;on trust&#8221; pursuant to the foregoing, the obligations and liabilities of the Administrative Agent to the Secured Parties in its capacity as trustee shall be excluded to the fullest extent permitted by applicable law&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt">to the extent that English law is applicable to the duties of the Administrative Agent under any of the Loan Documents, Section 1 of the Trustee Act 2000 of the United Kingdom shall not apply to the duties of the Administrative Agent in relation to the trusts constituted by that Loan Document&#59; where there are inconsistencies between the Trustee Act 1925 or the Trustee Act 2000 of the United Kingdom and the provisions of this Agreement or such Loan Document, the provisions of this Agreement shall, to the extent permitted by applicable law, prevail and, in the case of any inconsistency with the Trustee Act 2000 of the United Kingdom, the provisions of this Agreement shall constitute a restriction or exclusion for the purposes of that Act&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">nothing in this Agreement or any Loan Document shall require the Administrative Agent to account to any Lender for any sum or the profit element of any sum received by the Administrative Agent for its own account&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Administrative Agent may perform any of its duties and exercise its rights and powers hereunder or under any other Loan Document by or through any one or more sub-agents appointed by the Administrative Agent. The Administrative Agent and any such sub-agent may perform any of their respective duties and exercise their respective rights and powers through their respective Related Parties. The exculpatory provisions of this Article shall apply to any such sub-agent and to the Related Parties of the Administrative Agent and any such sub-agent, and shall apply to their respective activities pursuant to this Agreement. The Administrative Agent shall not be responsible for the negligence or misconduct of any sub-agent except to the extent that a court of competent jurisdiction determines in a final and non-appealable judgment that the Administrative Agent acted with gross negligence or willful misconduct in the selection of such sub-agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  None of any Syndication Agent, or any Arranger shall have obligations or duties whatsoever in such capacity under this Agreement or any other Loan Document and shall incur no liability hereunder or thereunder in such capacity, but all such persons shall have the benefit of the indemnities provided for hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">  In case of the pendency of any proceeding with respect to any Loan Party under any federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">85</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in effect, the Administrative Agent (irrespective of whether the principal of any Loan or any reimbursement obligation in respect of any LC Disbursement shall then be due and payable as herein expressed or by declaration or otherwise and irrespective of whether the Administrative Agent shall have made any demand on the Borrower) shall be entitled and empowered (but not obligated) by intervention in such proceeding or otherwise&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">to file and prove a claim for the whole amount of the principal and interest owing and unpaid in respect of the Loans, LC Disbursements and all other Obligations that are owing and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Lenders, the Issuing Banks and the Administrative Agent (including any claim under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">9.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) allowed in such judicial proceeding&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">to collect and receive any monies or other property payable or deliverable on any such claims and to distribute the same&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such proceeding is hereby authorized by each Lender, each Issuing Bank and each other Secured Party to make such payments to the Administrative Agent and, in the event that the Administrative Agent shall consent to the making of such payments directly to the Lenders, the Issuing Banks or the other Secured Parties, to pay to the Administrative Agent any amount due to it, in its capacity as the Administrative Agent, under the Loan Documents (including under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">).  Nothing contained herein shall be deemed to authorize the Administrative Agent to authorize or consent to or accept or adopt on behalf of any Lender or Issuing Bank any plan of reorganization, arrangement, adjustment or composition affecting the Obligations or the rights of any Lender or Issuing Bank or to authorize the Administrative Agent to vote in respect of the claim of any Lender or Issuing Bank in any such proceeding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The provisions of this Article are solely for the benefit of the Administrative Agent, the Lenders and the Issuing Banks, and, except solely to the extent of the Borrower&#8217;s rights to consent pursuant to and subject to the conditions set forth in this Article, none of the Borrower or any Subsidiary, or any of their respective Affiliates, shall have any rights as a third party beneficiary under any such provisions. Each Secured Party, whether or not a party hereto, will be deemed, by its acceptance of the benefits of the Collateral and of the Guarantees of the Secured Obligations provided under the Loan Documents, to have agreed to the provisions of this Article.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 8.02.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent&#8217;s Reliance, Limitation of Liability, Etc</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Neither the Administrative Agent nor any of its Related Parties shall be (i) liable for any action taken or omitted to be taken by such party, the Administrative Agent or any of its Related Parties under or in connection with this Agreement or the other Loan Documents (x) with the consent of or at the request of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary, or as the Administrative Agent shall believe in good faith to be necessary, under the circumstances as provided in the Loan Documents) or (y) in the absence of its own gross negligence or willful misconduct (such absence to be presumed unless otherwise determined by a court of competent jurisdiction by a final and non-appealable judgment) or (ii) responsible in any manner to any of the Lenders for any recitals, statements, representations or warranties made by any Loan Party or any officer thereof contained in this Agreement or any other Loan Document or in any certificate, report, statement or other document referred to or provided for in, or received by the Administrative Agent under or in connection with, this Agreement or any other Loan Document or for the value, validity, effectiveness, genuineness, enforceability or sufficiency of this Agreement or any other Loan Document (including, for the avoidance of doubt, in connection with the Administrative Agent&#8217;s reliance on any Electronic Signature transmitted by telecopy, emailed pdf. or any other electronic means that reproduces an image of an actual executed signature page) or for any failure of any Loan Party to perform its obligations hereunder or thereunder.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Administrative Agent shall be deemed not to have knowledge of any Default unless and until written notice thereof (stating that it is a &#8220;notice of default&#8221;) is given to the Administrative Agent by the Borrower, a Lender or an Issuing Bank, and the Administrative Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with any Loan Document, (ii) the contents of any certificate, report or other document delivered thereunder or in connection therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth in any Loan Document or the occurrence of any Default, (iv) the sufficiency, validity, enforceability, effectiveness or genuineness of any Loan Document or any other agreement, instrument or document, (v) the satisfaction of any condition set forth in Article IV or elsewhere in any Loan Document, other than to confirm receipt of items (which on their face purport to be such items) expressly required to be delivered to the Administrative Agent or satisfaction of any condition that expressly refers to the matters described therein being acceptable or satisfactory to the Administrative Agent, or (vi) the creation, perfection or priority of Liens on the Collateral. Notwithstanding anything herein to the contrary, the Administrative Agent shall not be liable for, or be responsible for any Liabilities, costs or expenses suffered by the Borrower, any other Loan Party, any Subsidiary, any Lender or any Issuing Bank as a result of, any determination of the Revolving Credit Exposure, any of the component amounts thereof or any portion thereof attributable to each Lender or Issuing Bank, or any exchange rate or Dollar Equivalent, except to the extent that a court of competent jurisdiction determines in a final and non-appealable judgment that the Administrative Agent acted with gross negligence or willful misconduct in making such determination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  Without limiting the foregoing, the Administrative Agent (i) may treat the payee of any promissory note as its holder until such promissory note has been assigned in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (ii) may rely on the Register to the extent set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.04(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (iii) may consult with legal counsel (including counsel to the Borrower), independent public accountants and other experts selected by it, and shall not be liable for any action taken or omitted to be taken in good faith by it in accordance with the advice of such counsel, accountants or experts, (iv) makes no warranty or representation to any Lender or Issuing Bank and shall not be responsible to any Lender or Issuing Bank for any statements, warranties or representations made by or on behalf of any Loan Party in connection with this Agreement or any other Loan Document, (v) in determining compliance with any condition hereunder to the making of a Loan, or the issuance of a Letter of Credit, that by its terms must be fulfilled to the satisfaction of a Lender or an Issuing Bank, may presume that such condition is satisfactory to such Lender or Issuing Bank unless the Administrative Agent shall have received notice to the contrary from such Lender or Issuing Bank sufficiently in advance of the making of such Loan or the issuance of such Letter of Credit and (vi) shall be entitled to rely on, and shall incur no liability under or in respect of this Agreement or any other Loan Document by acting upon, any notice, consent, certificate or other instrument or writing (which writing may be a fax, any electronic message, Internet or intranet website posting or other distribution) or any statement made to it orally or by telephone and believed by it to be genuine and signed or sent or otherwise authenticated by the proper party or parties (whether or not such Person in fact meets the requirements set forth in the Loan Documents for being the maker thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 8.03.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Posting of Communications</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Borrower agrees that the Administrative Agent may, but shall not be obligated to, make any Communications available to the Lenders and the Issuing Banks by posting the Communications on IntraLinks&#8482;, DebtDomain, SyndTrak, ClearPar or any other electronic system chosen by the Administrative Agent to be its electronic transmission system (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Approved Electronic Platform</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Although the Approved Electronic Platform and its primary web portal are secured with generally-applicable security procedures and policies implemented or modified by the Administrative Agent from time to time (including, as of the Restatement Effective Date, a user ID&#47;password authorization system) and the Approved Electronic Platform is secured through a per-deal authorization method whereby each user may access the Approved </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Electronic Platform only on a deal-by-deal basis, each of the Lenders, each of the Issuing Banks and the Borrower acknowledges and agrees that the distribution of material through an electronic medium is not necessarily secure, that the Administrative Agent is not responsible for approving or vetting the representatives or contacts of any Lender that are added to the Approved Electronic Platform, and that there may be confidentiality and other risks associated with such distribution. Each of the Lenders, each of the Issuing Banks and the Borrower hereby approves distribution of the Communications through the Approved Electronic Platform and understands and assumes the risks of such distribution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  THE APPROVED ELECTRONIC PLATFORM AND THE COMMUNICATIONS ARE PROVIDED &#8220;AS IS&#8221; AND &#8220;AS AVAILABLE&#8221;. THE APPLICABLE PARTIES (AS DEFINED BELOW) DO NOT WARRANT THE ACCURACY OR COMPLETENESS OF THE COMMUNICATIONS, OR THE ADEQUACY OF THE APPROVED ELECTRONIC PLATFORM AND EXPRESSLY DISCLAIM LIABILITY FOR ERRORS OR OMISSIONS IN THE APPROVED ELECTRONIC PLATFORM AND THE COMMUNICATIONS. NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS, IS MADE BY THE APPLICABLE PARTIES IN CONNECTION WITH THE COMMUNICATIONS OR THE APPROVED ELECTRONIC PLATFORM. IN NO EVENT SHALL THE ADMINISTRATIVE AGENT, ANY ARRANGER, ANY SYNDICATION AGENT OR ANY OF THEIR RESPECTIVE RELATED PARTIES (COLLECTIVELY, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">APPLICABLE PARTIES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) HAVE ANY LIABILITY TO ANY LOAN PARTY, ANY LENDER, ANY ISSUING BANK OR ANY OTHER PERSON OR ENTITY FOR DAMAGES OF ANY KIND, INCLUDING DIRECT OR INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES, LOSSES OR EXPENSES (WHETHER IN TORT, CONTRACT OR OTHERWISE) ARISING OUT OF ANY LOAN PARTY&#8217;S OR THE ADMINISTRATIVE AGENT&#8217;S TRANSMISSION OF COMMUNICATIONS THROUGH THE INTERNET OR THE APPROVED ELECTRONIC PLATFORM.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Communications</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, collectively, any notice, demand, communication, information, document or other material provided by or on behalf of any Loan Party pursuant to any Loan Document or the transactions contemplated therein which is distributed by the Administrative Agent, any Lender or any Issuing Bank by means of electronic communications pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, including through an Approved Electronic Platform.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Each Lender and each Issuing Bank agrees that notice to it (as provided in the next sentence) specifying that Communications have been posted to the Approved Electronic Platform shall constitute effective delivery of the Communications to such Lender for purposes of the Loan Documents.  Each Lender and Issuing Bank agrees (i) to notify the Administrative Agent in writing (which could be in the form of electronic communication) from time to time of such Lender&#8217;s or Issuing Bank&#8217;s (as applicable) email address to which the foregoing notice may be sent by electronic transmission and (ii) that the foregoing notice may be sent to such email address.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Each of the Lenders, each of the Issuing Banks and the Borrower agrees that the Administrative Agent may, but (except as may be required by applicable law) shall not be obligated to, store the Communications on the Approved Electronic Platform in accordance with the Administrative Agent&#8217;s generally applicable document retention procedures and policies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">  Nothing herein shall prejudice the right of the Administrative Agent, any Lender or any Issuing Bank to give any notice or other communication pursuant to any Loan Document in any other manner specified in such Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 8.04.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">The Administrative Agent Individually</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. With respect to its Commitment, Loans and Letters of Credit, the Person serving as the Administrative Agent shall have and may exercise the same rights and powers hereunder and is subject to the same obligations and liabilities as and to the extent set forth herein for any other Lender or Issuing Bank, as the case may be.  The terms &#8220;Issuing Banks&#8221;, &#8220;Lenders&#8221;, &#8220;Required Lenders&#8221; and any similar terms shall, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">88</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">unless the context clearly otherwise indicates, include the Administrative Agent in its individual capacity as a Lender, Issuing Bank or as one of the Required Lenders, as applicable. The Person serving as the Administrative Agent and its Affiliates may accept deposits from, lend money to, own securities of, act as the financial advisor or in any other advisory capacity for and generally engage in any kind of banking, trust or other business with, any Loan Party, any Subsidiary or any Affiliate of any of the foregoing as if such Person was not acting as the Administrative Agent and without any duty to account therefor to the Lenders or the Issuing Banks.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 8.05.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Successor Administrative Agent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Administrative Agent may resign at any time by giving 30 days&#8217; prior written notice thereof to the Lenders, the Issuing Banks and the Borrower, whether or not a successor Administrative Agent has been appointed. Upon any such resignation, the Required Lenders shall have the right to appoint a successor Administrative Agent.  If no successor Administrative Agent shall have been so appointed by the Required Lenders, and shall have accepted such appointment, within thirty (30) days after the retiring Administrative Agent&#8217;s giving of notice of resignation, then the retiring Administrative Agent may, on behalf of the Lenders and the Issuing Banks, appoint a successor Administrative Agent, which shall be a bank with an office in New York, New York or an Affiliate of any such bank.  In either case, such appointment shall be subject to the prior written approval of the Borrower (which approval may not be unreasonably withheld and shall not be required while an Event of Default has occurred and is continuing).  Upon the acceptance of any appointment as Administrative Agent by a successor Administrative Agent, such successor Administrative Agent shall succeed to, and become vested with, all the rights, powers, privileges and duties of the retiring Administrative Agent. Upon the acceptance of appointment as Administrative Agent by a successor Administrative Agent, the retiring Administrative Agent shall be discharged from its duties and obligations under this Agreement and the other Loan Documents. Prior to any retiring Administrative Agent&#8217;s resignation hereunder as Administrative Agent, the retiring Administrative Agent shall take such action as may be reasonably necessary to assign to the successor Administrative Agent its rights as Administrative Agent under the Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Notwithstanding </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.05</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in the event no successor Administrative Agent shall have been so appointed and shall have accepted such appointment within thirty (30) days after the retiring Administrative Agent gives notice of its intent to resign, the retiring Administrative Agent may give notice of the effectiveness of its resignation to the Lenders, the Issuing Banks and the Borrower, whereupon, on the date of effectiveness of such resignation stated in such notice, (i) the retiring Administrative Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents&#59; provided that, solely for purposes of maintaining any security interest granted to the Administrative Agent under any Collateral Document for the benefit of the Secured Parties, the retiring Administrative Agent shall continue to be vested with such security interest as collateral agent for the benefit of the Secured Parties, and continue to be entitled to the rights set forth in such Collateral Document and Loan Document, and, in the case of any Collateral in the possession of the Administrative Agent, shall continue to hold such Collateral, in each case until such time as a successor Administrative Agent is appointed and accepts such appointment in accordance with this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.05</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (it being understood and agreed that the retiring Administrative Agent shall have no duty or obligation to take any further action under any Security Document, including any action required to maintain the perfection of any such security interest),  and (ii) the Required Lenders shall succeed to and become vested with all the rights, powers, privileges and duties of the retiring Administrative Agent&#59; provided that (A) all payments required to be made hereunder or under any other Loan Document to the Administrative Agent for the account of any Person other than the Administrative Agent shall be made directly to such Person and (B) all notices and other communications required or contemplated to be given or made to the Administrative Agent shall directly be given or made to each Lender and each Issuing Bank.  Following the effectiveness of the Administrative Agent&#8217;s resignation from its capacity as such, the provisions of this Article, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.17(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as well as any exculpatory, reimbursement and indemnification provisions set forth in any other Loan Document, shall continue in effect for the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">89</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">benefit of such retiring Administrative Agent, its sub-agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while the retiring Administrative Agent was acting as Administrative Agent and in respect of the matters referred to in the proviso under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 8.06.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgements of Lenders and Issuing Banks</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Each Lender represents that it is engaged in making, acquiring or holding commercial loans in the ordinary course of its business and that it has, independently and without reliance upon the Administrative Agent, any Arranger, any Syndication Agent, or any other Lender, or any of the Related Parties of any of the foregoing, and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement as a Lender, and to make, acquire or hold Loans hereunder.  Each Lender also acknowledges that it will, independently and without reliance upon the Administrative Agent, any Arranger, any Syndication Agent, or any other Lender, or any of the Related Parties of any of the foregoing, and based on such documents and information (which may contain material, non-public information within the meaning of the United States securities laws concerning the Borrower and its Affiliates) as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement, any other Loan Document or any related agreement or any document furnished hereunder or thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Each Lender, by delivering its signature page to this Agreement on the Restatement Effective Date, or delivering its signature page to an Assignment and Assumption or any other Loan Document pursuant to which it shall become a Lender hereunder, shall be deemed to have acknowledged receipt of, and consented to and approved, each Loan Document and each other document required to be delivered to, or be approved by or satisfactory to, the Administrative Agent or the Lenders on the Restatement Effective Date or the effective date of any such Assignment and Assumption or any other Loan document pursuant to which it shall have become a Lender hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  (i) Each Lender  hereby agrees that (x) if the Administrative Agent notifies such Lender that the Administrative Agent has determined in its sole discretion that any funds received by such Lender from the Administrative Agent or any of its Affiliates (whether as a payment, prepayment or repayment of principal, interest, fees or otherwise&#59; individually and collectively, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Payment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) were erroneously transmitted to such Lender (whether or not known to such Lender), and demands the return of such Payment (or a portion thereof), such Lender shall promptly, but in no event later than one Business Day thereafter, return to the Administrative Agent the amount of any such Payment (or portion thereof) as to which such a demand was made in same day funds, together with interest thereon in respect of each day from and including the date such Payment (or portion thereof) was received by such Lender to the date such amount is repaid to the Administrative Agent at the greater of the NYFRB Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation from time to time in effect, and (y) to the extent permitted by applicable law, such Lender shall not assert, and hereby waives, as to the Administrative Agent, any claim, counterclaim, defense or right of set-off or recoupment with respect to any demand, claim or counterclaim by the Administrative Agent for the return of any Payments received, including without limitation any defense based on &#8220;discharge for value&#8221; or any similar doctrine.  A notice of the Administrative Agent to any Lender under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.06(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be conclusive, absent manifest error.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Each Lender hereby further agrees that if it receives a Payment from the Administrative Agent or any of its Affiliates (x) that is in a different amount than, or on a different date from, that specified in a notice of payment sent by the Administrative Agent (or any of its Affiliates) with respect to such Payment (a &#8220;Payment Notice&#8221;) or (y) that was not preceded or accompanied by a Payment Notice, it shall be on notice, in each such case, that an error has been made with respect to such Payment.  Each Lender agrees that, in each such case, or if it otherwise becomes aware a Payment (or portion thereof) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">90</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">may have been sent in error, such Lender shall promptly notify the Administrative Agent of such occurrence and, upon demand from the Administrative Agent, it shall promptly, but in no event later than one Business Day thereafter, return to the Administrative Agent the amount of any such Payment (or portion thereof) as to which such a demand was made in same day funds, together with interest thereon in respect of each day from and including the date such Payment (or portion thereof) was received by such Lender to the date such amount is repaid to the Administrative Agent at the greater of the NYFRB Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation from time to time in effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt">Each Borrower and each other Loan Party hereby agrees that (x) in the event an erroneous Payment (or portion thereof) are not recovered from any Lender that has received such Payment (or portion thereof) for any reason, the Administrative Agent shall be subrogated to all the rights of such Lender with respect to such amount and (y) an erroneous Payment shall not pay, prepay, repay, discharge or otherwise satisfy any Obligations owed by any Borrower or any other Loan Party.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">Each party&#8217;s obligations under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.06(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall survive the resignation or replacement of the Administrative Agent or any transfer of rights or obligations by, or the replacement of, a Lender, the termination of the Commitments or the repayment, satisfaction or discharge of all Obligations under any Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Each Lender hereby agrees that (i) it has requested a copy of each Report prepared by or on behalf of the Administrative Agent&#59; (ii) the Administrative Agent (A) makes no representation or warranty, express or implied, as to the completeness or accuracy of any Report or any of the information contained therein or any inaccuracy or omission contained in or relating to a Report and (B) shall not be liable for any information contained in any Report&#59; (iii) the Reports are not comprehensive audits or examinations, and that any Person performing any field examination will inspect only specific information regarding the Loan Parties and will rely significantly upon the Loan Parties&#8217; books and records, as well as on representations of the Loan Parties&#8217; personnel and that the Administrative Agent undertakes no obligation to update, correct or supplement the Reports&#59; (iv) it will keep all Reports confidential and strictly for its internal use, not share the Report with any Loan Party or any other Person except as otherwise permitted pursuant to this Agreement&#59; and (v) without limiting the generality of any other indemnification provision contained in this Agreement, (A) it will hold the Administrative Agent and any such other Person preparing a Report harmless from any action the indemnifying Lender may take or conclusion the indemnifying Lender may reach or draw from any Report in connection with any extension of credit that the indemnifying Lender has made or may make to the Borrower, or the indemnifying Lender&#8217;s participation in, or the indemnifying Lender&#8217;s purchase of, a Loan or Loans&#59; and (B) it will pay and protect, and indemnify, defend, and hold the Administrative Agent and any such other Person preparing a Report harmless from and against, the claims, actions, proceedings, damages, costs, expenses, and other amounts (including reasonable attorneys&#8217; fees) incurred by the Administrative Agent or any such other Person as the direct or indirect result of any third parties who might obtain all or part of any Report through the indemnifying Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 8.07.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Collateral Matters</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Except with respect to the exercise of setoff rights in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.08</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or with respect to a Secured Party&#8217;s right to file a proof of claim in an insolvency proceeding, no Secured Party shall have any right individually to realize upon any of the Collateral or to enforce any Guarantee of the Secured Obligations, it being understood and agreed that all powers, rights and remedies under the Loan Documents may be exercised solely by the Administrative Agent on behalf of the Secured Parties in accordance with the terms thereof.  In its capacity, the Administrative Agent is a &#8220;representative&#8221; of the Secured Parties within the meaning of the term &#8220;secured party&#8221; as defined in the UCC.  In the event that any Collateral is hereafter pledged by any Person as collateral security for the Secured Obligations, the Administrative Agent is hereby authorized, and hereby granted a power of attorney, to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">91</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">execute and deliver on behalf of the Secured Parties any Loan Documents necessary or appropriate to grant and perfect a Lien on such Collateral in favor of the Administrative Agent on behalf of the Secured Parties.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  In furtherance of the foregoing and not in limitation thereof, no arrangements in respect of Banking Services, the obligations under which constitute Secured Obligations, and no Swap Agreement, the obligations under which constitute Secured Obligations, will create (or be deemed to create) in favor of any Secured Party that is a party thereto any rights in connection with the management or release of any Collateral or of the obligations of any Loan Party under any Loan Document.  By accepting the benefits of the Collateral, each Secured Party that is a party to any such arrangement in respect of Banking Services or Swap Agreement, as applicable, shall be deemed to have appointed the Administrative Agent to serve as administrative agent and collateral agent under the Loan Documents and agreed to be bound by the Loan Documents as a Secured Party thereunder, subject to the limitations set forth in this paragraph. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  The Secured Parties irrevocably authorize the Administrative Agent, at its option and in its discretion, to subordinate any Lien on any property granted to or held by the Administrative Agent under any Loan Document to the holder of any Lien on such property that is permitted by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.02(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall not be responsible for or have a duty to ascertain or inquire into any representation or warranty regarding the existence, value or collectability of the Collateral, the existence, priority or perfection of the Administrative Agent&#8217;s Lien thereon or any certificate prepared by any Loan Party in connection therewith, nor shall the Administrative Agent be responsible or liable to the Lenders or any other Secured Party for any failure to monitor or maintain any portion of the Collateral.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 8.08.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Bidding</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Secured Parties hereby irrevocably authorize the Administrative Agent, at the direction of the Required Lenders, to credit bid all or any portion of the Obligations (including by accepting some or all of the Collateral in satisfaction of some or all of the Obligations pursuant to a deed in lieu of foreclosure or otherwise) and in such manner purchase (either directly or through one or more acquisition vehicles) all or any portion of the Collateral (a) at any sale thereof conducted under the provisions of the Bankruptcy Code, including under Sections 363, 1123 or 1129 of the Bankruptcy Code, or any similar laws in any other jurisdictions to which a Loan Party is subject, or (b) at any other sale, foreclosure or acceptance of collateral in lieu of debt conducted by (or with the consent or at the direction of) the Administrative Agent (whether by judicial action or otherwise) in accordance with any applicable law.  In connection with any such credit bid and purchase, the Obligations owed to the Secured Parties shall be entitled to be, and shall be, credit bid by the Administrative Agent at the direction of the Required Lenders on a ratable basis (with Obligations with respect to contingent or unliquidated claims receiving contingent interests in the acquired assets on a ratable basis that shall vest upon the liquidation of such claims in an amount proportional to the liquidated portion of the contingent claim amount used in allocating the contingent interests) for  the asset or assets so purchased (or for the equity interests or debt instruments of the acquisition vehicle or vehicles that are issued in connection with such purchase).  In connection with any such bid (i) the Administrative Agent shall be authorized to form one or more acquisition vehicles and to assign any successful credit bid to such acquisition vehicle or vehicles (ii) each of the Secured Parties&#8217; ratable interests in the Obligations which were credit bid shall be deemed without any further action under this Agreement to be assigned to such vehicle or vehicles for the purpose of closing such sale, (iii) the Administrative shall be authorized to adopt documents providing for the governance of the acquisition vehicle or vehicles (provided that any actions by the Administrative Agent with respect to such acquisition vehicle or vehicles, including any disposition of the assets or equity interests thereof, shall be governed, directly or indirectly, by, and the governing documents shall provide for, control by the vote of the Required Lenders or their permitted assignees under the terms of this Agreement or the governing documents of the applicable acquisition vehicle or vehicles, as the case may be, irrespective of the termination of this Agreement and without giving effect to the limitations on actions by the Required Lenders contained in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement), (iv) the Administrative Agent on behalf of such acquisition vehicle or vehicles shall be authorized to issue to each of the Secured Parties, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">92</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ratably on account of the relevant Obligations which were credit bid, interests, whether as equity, partnership interests, limited partnership interests or membership interests, in any such acquisition vehicle  and&#47;or debt instruments issued by such acquisition vehicle, all without the need for any Secured Party or acquisition vehicle to take any further action, and (v) to the extent that Obligations that are assigned to an acquisition vehicle are not used to acquire Collateral for any reason, such Obligations shall automatically be reassigned to the Secured Parties pro rata with their original interest in such Obligations and the equity interests and&#47;or debt instruments issued by any acquisition vehicle on account of such Obligations shall automatically be cancelled, without the need for any Secured Party or any acquisition vehicle to take any further action.  Notwithstanding that the ratable portion of the Obligations of each Secured Party are deemed assigned to the acquisition vehicle or vehicles as set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above, each Secured Party shall execute such documents and provide such information regarding the Secured Party (and&#47;or any designee of the Secured Party which will receive interests in or debt instruments issued by such acquisition vehicle) as the Administrative Agent may reasonably request in connection with the formation of any acquisition vehicle, the formulation or submission of any credit bid or the consummation of the transactions contemplated by such credit bid.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 8.09.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Certain ERISA Matters</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Each Lender (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and each Arranger and their respective Affiliates, and not, for the avoidance of doubt, to or for the benefit of the Borrower or any other Loan Party, that at least one of the following is and will be true&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">such Lender is not using &#8220;plan assets&#8221; (within the meaning of the Plan Asset Regulations) of one or more Benefit Plans in connection with the Loans, the Letters of Credit or the Commitments,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the transaction exemption set forth in one or more PTEs, such as PTE 84-14 (a class exemption for certain transactions determined by independent qualified professional asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance company general accounts), PTE 90-1 (a class exemption for certain transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96-23 (a class exemption for certain transactions determined by in-house asset managers), is applicable with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement, </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt">(A) such Lender is an investment fund managed by a &#8220;Qualified Professional Asset Manager&#8221; (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender to enter into, participate in, administer and perform the Loans, the Letters of Credit, the Commitments and this Agreement, (C) the entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE 84-14 and (D) to the best knowledge of such Lender, the requirements of subsection (a) of Part I of PTE 84-14 are satisfied with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement, or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">such other representation, warranty and covenant as may be agreed in writing between the Administrative Agent, in its sole discretion, and such Lender.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">93</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  In addition, unless </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">sub-clause (i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in the immediately preceding </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> is true with respect to a Lender or such Lender has not provided another representation, warranty and covenant as provided in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">sub-clause (iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in the immediately preceding </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, such Lender further (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent, and each Arranger and their respective Affiliates, and not, for the avoidance of doubt, to or for the benefit of the Borrower or any other Loan Party, that none of the Administrative Agent, or any Arranger, any Syndication Agent, or any of their respective Affiliates is a fiduciary with respect to the Collateral or the assets of such Lender (including in connection with the reservation or exercise of any rights by the Administrative Agent under this Agreement, any Loan Document or any documents related to hereto or thereto).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  The Administrative Agent, each Arranger and each Syndication Agent hereby informs the Lenders that each such Person is not undertaking to provide investment advice or to give advice in a fiduciary capacity, in connection with the transactions contemplated hereby, and that such Person has a financial interest in the transactions contemplated hereby in that such Person or an Affiliate thereof (i) may receive interest or other payments with respect to the Loans, the Letters of Credit, the Commitments, this Agreement and any other Loan Documents (ii) may recognize a gain if it extended the Loans, the Letters of Credit or the Commitments for an amount less than the amount being paid for an interest in the Loans, the Letters of Credit or the Commitments by such Lender or (iii) may receive fees or other payments in connection with the transactions contemplated hereby, the Loan Documents or otherwise, including structuring fees, commitment fees, arrangement fees, facility fees, upfront fees, underwriting fees, ticking fees, agency fees, administrative agent or collateral agent fees, utilization fees, minimum usage fees, letter of credit fees, fronting fees, deal-away or alternate transaction fees, amendment fees, processing fees, term out premiums, banker&#8217;s acceptance fees, breakage or other early termination fees or fees similar to the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 8.10.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Flood Laws.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  JPMorgan Chase has adopted internal policies and procedures that address requirements placed on federally regulated lenders under the National Flood Insurance Reform Act of 1994 and related legislation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Flood Laws</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  JPMorgan Chase, as administrative agent or collateral agent on a syndicated facility, will post on the applicable electronic platform (or otherwise distribute to each Lender in the syndicate) documents that it receives in connection with the Flood Laws.  However, JPMorgan Chase reminds each Lender and Participant in the facility that, pursuant to the Flood Laws, each federally regulated Lender (whether acting as a Lender or Participant in the facility) is responsible for assuring its own compliance with the flood insurance requirements.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE IX<br><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Miscellaneous</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.01.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) Except in the case of notices and other communications expressly permitted to be given by telephone or Electronic System (and subject to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> below), all notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by telecopy, as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;if to the Borrower or any other Loan Party, to&#58; </font></div><div style="margin-bottom:5pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DexCom, Inc.<br>6340 Sequence Drive<br>San Diego, CA  92121<br>Attention&#58;  Jereme Sylvain <br>Telephone No.&#58;<br>Email&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">94</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;if to the Administrative Agent or Issuing Bank, to&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">JPMorgan Chase Bank, N.A.<br>131 S Dearborn St, Floor 04<br>Chicago, IL, 60603-5506<br>Attention&#58; Loan and Agency Servicing<br>Email&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Agency Withholding Tax Inquiries&#58;<br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Email&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Agency Compliance&#47;Financials&#47;Intralinks&#58;<br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Email&#58;</font></div><div style="margin-bottom:5pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">With a copy to&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">JPMorgan Chase Bank, N.A. <br>2029 Century Park East, Suite 3800&#124;<br>Los Angeles, CA 90067  <br>Attention&#58; Ling Li<br>Fax No.&#58;<br>Email&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Mayer Brown LLP<br>1221 Avenue of the Americas <br>New York, New York 10020<br>Attention&#58; Adam Wolk<br>Telephone No.&#58;<br>Fax No.&#58;<br>Email&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;if to any other Lender, to it at its address (or telecopy number) set forth in its Administrative Questionnaire.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notices sent by hand or overnight courier service, or mailed by certified or registered mail, shall be deemed to have been given when received&#59; notices sent by facsimile shall be deemed to have been given when sent (except that, if not given during normal business hours for the recipient, shall be deemed to have been given at the opening of business on the next Business Day for the recipient).  Notices delivered through Electronic Systems, to the extent provided in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> below, shall be effective as provided in said </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Notices and other communications to the Lenders and the Issuing Bank hereunder may be delivered or furnished by using Electronic Systems or Approved Electronic Platforms, as applicable, or pursuant to procedures approved by the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the foregoing shall not apply to notices pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article&#160;II </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">unless otherwise agreed by the Administrative Agent and the applicable Lender.  The Administrative Agent or the Borrower may, in its discretion, agree to accept notices and other communications to it hereunder by using Electronic Systems or Approved Electronic Platforms, as applicable, pursuant to procedures approved by it&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that approval of such procedures may be limited to particular notices or communications.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unless the Administrative Agent otherwise prescribes, (i)&#160;notices and other communications sent to an e-mail address shall be deemed received upon the sender&#8217;s receipt of an acknowledgement from the intended recipient (such as by the &#8220;return receipt requested&#8221; function, as available, return e-mail or other written acknowledgement), and (ii)&#160;notices or communications posted to an Internet or intranet website shall be deemed received upon the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">95</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">deemed receipt by the intended recipient, at its e-mail address as described in the foregoing </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause&#160;(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, of notification that such notice or communication is available and identifying the website address therefor&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, for both </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above, if such notice, email or other communication is not sent during the normal business hours of the recipient, such notice or communication shall be deemed to have been sent at the opening of business on the next Business Day for the recipient.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  Any party hereto may change its address or telecopy number for notices and other communications hereunder by notice to the other parties hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.02.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Waivers&#59; Amendments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) No failure or delay by the Administrative Agent, the Issuing Bank or any Lender in exercising any right or power hereunder or under any other Loan Document shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the exercise of any other right or power.  The rights and remedies of the Administrative Agent, the Issuing Bank and the Lenders hereunder and under any other Loan Document are cumulative and are not exclusive of any rights or remedies that they would otherwise have.  No waiver of any provision of any Loan Document or consent to any departure by the Borrower therefrom shall in any event be effective unless the same shall be permitted by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.02</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and then such waiver or consent shall be effective only in the specific instance and for the purpose for which given.  Without limiting the generality of the foregoing, the making of a Loan or issuance of a Letter of Credit shall not be construed as a waiver of any Default, regardless of whether the Administrative Agent, any Lender or the Issuing Bank may have had notice or knowledge of such Default at the time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Subject to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.02(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> below, neither this Agreement nor any other Loan Document nor any provision hereof or thereof may be waived, amended or modified except (i) in the case of this Agreement, pursuant to an agreement or agreements in writing entered into by the  Borrower and the Required Lenders or (ii) in the case of any other Loan Document, pursuant to an agreement or agreements in writing entered into by the Administrative Agent and the Loan Party or Loan Parties that are parties thereto, with the consent of the Required Lenders&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no such agreement shall (A)&#160;increase the Commitment of any Lender without the written consent of such Lender, (B)&#160;reduce or forgive the principal amount of any Loan or LC Disbursement or reduce or the rate of interest thereon (other than to reduce the default rate accruing under and in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), or reduce or forgive any interest or fees or other amount payable hereunder, without the written consent of each Lender (including any such Lender that is a Defaulting Lender) affected thereby, (iii)&#160;postpone the scheduled date of payment of the principal amount of any Loan or LC Disbursement, or any interest thereon, or any fees or other amount payable hereunder, or reduce the amount of, waive or excuse any such payment, or postpone the scheduled date of expiration of any Commitment, without the written consent of each Lender affected thereby, (iv)&#160;change </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.18(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;in any manner or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.08</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in a manner that would alter the pro rata sharing by the Lenders required thereby, in each case, without the written consent of each Lender, (v)&#160;change any of the provisions of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.02(b) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or the definition of &#8220;Required Lenders&#8221; or any other provision hereof specifying the number or percentage of Lenders required to waive, amend or modify any rights hereunder or make any determination or grant any consent hereunder, without the  written consent of each Lender, (vi) waive or amend </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the definition of &#8220;Ineligible Institution&#8221;, without the  written consent of each Lender, (vii) except as provided in any Collateral Document, release all or substantially all of the Collateral without the written consent of each Lender, (viii) release any Guarantor from its obligation under its Loan Guaranty or Obligation Guaranty (except as otherwise permitted herein or in the other Loan Documents), without the written consent of each Lender or (ix) subordinate any of the Obligations (or any Lien securing any of the Obligations) to any other Indebtedness (or any Lien securing any other Indebtedness) of the Loan Parties (except as otherwise permitted herein or in the other Loan Documents), without the written consent of each Lender&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no such agreement shall amend, modify or otherwise affect the rights or duties of the Administrative Agent or the Issuing Bank hereunder without the prior written </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">96</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">consent of the Administrative Agent or the Issuing Bank, as the case may be&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no such agreement shall amend or modify the provisions of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.07</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or any letter of credit application and any bilateral agreement between the Borrower and the Issuing Bank regarding the Issuing Bank&#8217;s Letter of Credit Commitment or the respective rights and obligations between the Borrower and the Issuing Bank in connection with the issuance of Letters of Credit without the prior written consent of the Administrative Agent and the Issuing Bank, respectively. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  The Lenders and the Issuing Bank hereby irrevocably authorize the Administrative Agent, at its option and in its sole discretion, to release any Liens granted to the Administrative Agent by the Loan Parties on any Collateral (i) upon the Payment in Full of all Secured Obligations, and the cash collateralization of all unliquidated obligations in a manner satisfactory to each affected Lender, (ii) constituting property being sold or disposed of if the Loan Party disposing of such property certifies to the Administrative Agent that the sale or disposition is made in compliance with the terms of this Agreement (and the Administrative Agent may rely conclusively on any such certificate, without further inquiry), and to the extent that the property being sold or disposed of constitutes 100% of the Equity Interests of a Subsidiary, the Administrative Agent is authorized to release any Loan Guaranty or Obligation Guaranty provided by such Subsidiary, (iii) constituting property leased to a Loan Party under a lease which has expired or been terminated in a transaction permitted under this Agreement, (iv) as required to effect any sale or other disposition of such Collateral in connection with any exercise of remedies of the Administrative Agent and the Lenders pursuant to Article VII or (v) as required pursuant to the terms of the Security Agreement or any other Loan Document.  Any such release shall not in any manner discharge, affect, or impair the Obligations or any Liens (other than those expressly being released) upon (or obligations of the Loan Parties in respect of) all interests retained by the Loan Parties, including the proceeds of any sale, all of which shall continue to constitute part of the Collateral. Any execution and delivery by the Administrative Agent of documents in connection with any such release shall be without recourse to or warranty by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  If, in connection with any proposed amendment, waiver or consent requiring the consent of &#8220;each Lender&#8221; or &#8220;each Lender affected thereby,&#8221; the consent of the Required Lenders is obtained, but the consent of other necessary Lenders is not obtained (any such Lender whose consent is necessary but has not been obtained being referred to herein as a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Non-Consenting Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), then the Borrower may elect to replace a Non-Consenting Lender as a Lender party to this Agreement, provided that, concurrently with such replacement, (i) another bank or other entity which is reasonably satisfactory to the Borrower, the Administrative Agent and the Issuing Bank shall agree, as of such date, to purchase for cash the Loans and other Obligations due to the Non-Consenting Lender pursuant to an Assignment and Assumption and to become a Lender for all purposes under this Agreement and to assume all obligations of the Non-Consenting Lender to be terminated as of such date and to comply with the requirements of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and (ii) the Borrower shall pay to such Non-Consenting Lender in same day funds on the day of such replacement (1) all interest, fees and other amounts then accrued but unpaid to such Non-Consenting Lender by the Borrower hereunder to and including the date of termination, including without limitation payments due to such Non-Consenting Lender under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and (2) an amount, if any, equal to the payment which would have been due to such Lender on the day of such replacement under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.16</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> had the Loans of such Non-Consenting Lender been prepaid on such date rather than sold to the replacement Lender.  Each party hereto agrees that an assignment required pursuant to this paragraph may be effected pursuant to an Assignment and Assumption executed by the Borrower, the Administrative Agent and the assignee (or, to the extent applicable, an agreement incorporating an Assignment and Assumption by reference pursuant to an Approved Electronic Platform as to which the Administrative Agent and such parties are participants), and (b) the Lender required to make such assignment need not be a party thereto in order for such assignment to be effective and shall be deemed to have consented to an be bound by the terms thereof&#59; provided that, following the effectiveness of any such assignment, the other parties to such assignment agree to execute and deliver such documents necessary to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">97</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">evidence such assignment as reasonably requested by the applicable Lender, provided that any such documents shall be without recourse to or warranty by the parties thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.03.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Expenses&#59; Limitation of Liability&#59; Indemnity, Etc.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Expenses</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower shall pay (i)&#160;all reasonable and documented out of pocket expenses incurred by the Administrative Agent and its Affiliates, including the reasonable fees, charges and disbursements of counsel for the Administrative Agent (which shall be limited, in the case of legal fees and expenses, to the reasonable and documented fees, disbursements and other charges of one primary counsel and one local counsel in each applicable jurisdiction) and the Lead Arrangers in connection with the syndication and distribution (including, without limitation, via the internet or through an Electronic System or Approved Electronic Platform) the credit facilities provided for herein, the preparation and administration of this Agreement and the other Loan Documents or any amendments, modifications or waivers of the provisions hereof or thereof (whether or not the transactions contemplated hereby or thereby shall be consummated), (ii)&#160;all reasonable and documented out-of-pocket expenses incurred by any Issuing Bank in connection with the issuance, amendment, renewal or extension of any Letter of Credit or any demand for payment thereunder and (iii)&#160;all reasonable and documented out-of-pocket expenses incurred by the Administrative Agent, any Issuing Bank or any Lender (which shall be limited, in the case of legal fees and expenses, to the reasonable and documented fees, disbursements and other charges of one primary counsel and one local counsel in each applicable jurisdiction for the Administrative Agent and not more than one outside counsel and one local counsel in each applicable jurisdiction for all of the other Lenders and, solely in the case of an actual or reasonably perceived conflict of interest, one additional counsel for each affected Lender) in connection with the enforcement or protection of its rights in connection with this Agreement and the other Loan Documents, including its rights under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.03(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or in connection with the Loans made or Letters of Credit issued hereunder, including all such out-of-pocket expenses incurred during  any workout, restructuring or negotiations in respect of such Loans or Letters of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Limitation of Liability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To the extent permitted by applicable law (i) the Borrower and any Loan Party shall not assert, and the Borrower and each Loan Party hereby waives, any claim against the Administrative Agent, any Arranger and any Lender, and any Related Party of any of the foregoing Persons (each such Person being called a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Lender-Related Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) for any Liabilities arising from the use by others of information or other materials (including, without limitation, any personal data) obtained through telecommunications, electronic or other information transmission systems (including the Internet), and (ii) no party hereto shall assert, and each such party hereby waives, any Liabilities against any other party hereto, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Agreement, any other Loan Document, or any agreement or instrument contemplated hereby or thereby, the Transactions, any Loan or Letter of Credit or the use of the proceeds thereof&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, nothing in this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.03(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall relieve the Borrower and each Loan Party of any obligation it may have to indemnify an Indemnitee, as provided in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.03(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, against any special, indirect, consequential or punitive damages asserted against such Indemnitee by a third party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Indemnity</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower shall indemnify the Administrative Agent, each Arranger, each Issuing Bank and each Lender, and each Related Party of any of the foregoing Persons (each such Person being called an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Indemnitee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) against, and hold each Indemnitee harmless from, any and all Liabilities and related expenses (which shall be limited, in the case of legal fees and expenses, to the reasonable and documented fees, disbursements and other charges of one primary counsel and one local counsel in each applicable jurisdiction for the Administrative Agent, and not more than one outside counsel, and one local counsel in each applicable jurisdiction for all of the other Indemnitees and, solely in the case of an actual or reasonably perceived conflict of interest, one additional counsel for each affected Indemnitee) incurred by or asserted against any Indemnitee arising out of, in connection with, or as a result of (i)&#160;the execution or delivery of this Agreement, any other Loan Document, or any agreement or instrument contemplated hereby or thereby, (ii) the performance by the parties hereto of their respective obligations hereunder or thereunder or the consummation of the Transactions or any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">other transactions contemplated hereby, (iii)&#160;any Loan or Letter of Credit or the use of the proceeds therefrom (including any refusal by an Issuing Bank to honor a demand for payment under a Letter of Credit if the documents presented in connection with such demand do not strictly comply with the terms of such Letter of Credit), (iv)&#160;any actual or alleged presence or release of Hazardous Materials on or from any property owned or operated by the Borrower or any of its Subsidiaries, or any Environmental Liability related in any way to the Borrower or any of its Subsidiaries, or (v)&#160;any actual or prospective  Proceeding relating to any of the foregoing, whether or not such Proceeding is brought by the Borrower or any other Loan Party or its or their respective equity holders, Affiliates, creditors or any other third Person and whether based on contract, tort or any other theory and regardless of whether any Indemnitee is a party thereto&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such indemnity shall not, as to any Indemnitee, be available to the extent that such Liabilities or related expenses are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted primarily from the gross negligence or willful misconduct of such Indemnitee.  This </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.03(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not apply with respect to Taxes other than any Taxes that represent losses, claims or damages arising from any non-Tax claim..</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Lender Reimbursement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Lender severally agrees to pay any amount required to be paid by the Borrower under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraphs (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (b) or (c) of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to the Administrative Agent, each Issuing Bank and each Related Party of any of the foregoing Persons (each, an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Agent-Related Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (to the extent not reimbursed by the Borrower and without limiting the obligation of the Borrower to do so), ratably according to their respective Applicable Percentage in effect on the date on which such payment is sought under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (or, if such payment is sought after the date upon which the Commitments shall have terminated and the Loans shall have been paid in full, ratably in accordance with such Applicable Percentage immediately prior to such date), and agrees to indemnify and hold each Agent-Related Person harmless from and against any and all Liabilities and related expenses, including the fees, charges and disbursements of any kind whatsoever that may at any time (whether before or after the payment of the Loans) be imposed on, incurred by or asserted against such Agent-Related Person in any way relating to or arising out of the Commitments, this Agreement, any of the other Loan Documents or any documents contemplated by or referred to herein or therein or the transactions contemplated hereby or thereby or any action taken or omitted by such Agent-Related Person under or in connection with any of the foregoing&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the unreimbursed expense or Liability or related expense, as the case may be, was incurred by or asserted against such Agent-Related Person in its capacity as such&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no Lender shall be liable for the payment of any portion of such Liabilities, costs, expenses or disbursements that are found by a final and nonappealable decision of a court of competent jurisdiction to have resulted primarily from such Agent-Related Party&#8217;s gross negligence or willful misconduct.&#160; The agreements in this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;shall survive the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder..</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  All amounts due under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;shall be payable promptly after written demand therefor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.04.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted hereby (including any Affiliate of the Issuing Bank that issues any Letter of Credit), except that (i)&#160;the Borrower may not assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of each Lender (and any attempted assignment or transfer by the Borrower without such consent shall be null and void) and (ii)&#160;no Lender may assign or otherwise transfer its rights or obligations hereunder except in accordance with this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Nothing in this Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby (including any Affiliate of the Issuing Bank that issues any Letter of Credit), Participants (to the extent provided in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) and, to the extent expressly contemplated hereby, the Related Parties of each of the Administrative Agent, the Issuing Bank and the Lenders) any legal or equitable right, remedy or claim under or by reason of this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">99</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  (i)  Subject to the conditions set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(b)(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;below, any Lender may assign to one or more Persons (other than an Ineligible Institution) all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitment, participations in Letters of Credit and the Loans at the time owing to it) with the prior written consent (such consent not to be unreasonably withheld) of&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.35pt">the Borrower, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, the Borrower shall be deemed to have consented to an assignment unless it shall have objected thereto by written notice to the Administrative Agent within ten (10) Business Days after having received notice thereof&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no consent of the Borrower shall be required for an assignment to a Lender, an Affiliate of a Lender, an Approved Fund or, if an Event of Default has occurred and is continuing, any other assignee&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.35pt">the Administrative Agent, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no consent of the Administrative Agent shall be required for an assignment of any Commitment to an assignee that is a Lender (other than a Defaulting Lender) with a Commitment immediately prior to giving effect to such assignment&#59; and</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:2.74pt">the Issuing Bank. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Assignments shall be subject to the following additional conditions&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.35pt">except in the case of an assignment to a Lender or an Affiliate of a Lender or an assignment of the entire remaining amount of the assigning Lender&#8217;s Commitment or Loans, the amount of the Commitment or Loans of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent) shall not be less than $5,000,000 unless each of the Borrower and the Administrative Agent agree to a lesser amount, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no such consent of the Borrower shall be required if an Event of Default has occurred and is continuing&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.35pt">each partial assignment shall be made as an assignment of a proportionate part of all the assigning Lender&#8217;s rights and obligations under this Agreement, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this clause shall not be construed to prohibit the assignment of a proportionate part of all the assigning Lender&#8217;s rights and obligations in respect of its Commitments or Loans&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:2.74pt">the parties to each assignment shall execute and deliver to the Administrative Agent (x) an Assignment and Assumption or (y) to the extent applicable, an agreement incorporating an Assignment and Assumption by reference pursuant to an Approved Electronic Platform as to which the Administrative Agent and the parties to the Assignment and Assumption are participants, together with a processing and recordation fee of $3,500&#59; and</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:2.74pt">the assignee, if it shall not be a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire in which the assignee designates one or more credit contacts to whom all syndicate-level information (which may contain material non-public information about the Borrower, the Loan Parties and their Related Parties or their respective securities) will be made available and who may receive such information in accordance with the assignee&#8217;s compliance procedures and applicable laws, including federal and state securities laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For the purposes of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;9.04(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the term &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Approved Fund</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Ineligible Institution</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; have the following meanings&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Approved Fund</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Person (other than a natural person) that is engaged in making, purchasing, holding or investing in bank loans and similar extensions of credit in the ordinary course of its business and that is administered or managed by (a)&#160;a Lender, (b)&#160;an </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Affiliate of a Lender or (c)&#160;an entity or an Affiliate of an entity that administers or manages a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Ineligible Institution</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) a natural person, (b) a Defaulting Lender or its  Lender Parent, (c) a company, investment vehicle or trust for, or owned and operated for the primary benefit of, a natural person or relative(s) thereof&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, such company, investment vehicle or trust shall not constitute an Ineligible Institution if it (x) has not been established for the primary purpose of acquiring any Loans or Commitments, (y) is managed by a professional advisor, who is not such natural person or a relative thereof, having significant experience in the business of making or purchasing commercial loans, and (z) has assets greater than $25,000,000 and a significant part of its activities consist of making or purchasing commercial loans and similar extensions of credit in the ordinary course of its business, or (d) the Borrower or any of its Affiliates. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt">Subject to acceptance and recording thereof pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(b)(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, from and after the effective date specified in each Assignment and Assumption the assignee thereunder shall be a party hereto and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender&#8217;s rights and obligations under this Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections&#160;2.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.16</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">9.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">).  Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;9.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">The Administrative Agent, acting for this purpose as a non-fiduciary agent of the Borrower, shall maintain at one of its offices a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitment of, and principal amount (and stated interest) of the Loans and LC Disbursements owing to, each Lender pursuant to the terms hereof from time to time (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Register</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The entries in the Register shall be conclusive, and the Borrower, the Administrative Agent, the Issuing Bank and the Lenders shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary.  The Register shall be available for inspection by the Borrower, the Issuing Bank and any Lender, at any reasonable time and from time to time upon reasonable prior notice.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Upon its receipt of (x) a duly completed Assignment and Assumption executed by an assigning Lender and an assignee or (y) to the extent applicable, an agreement incorporating an Assignment and Assumption by reference pursuant to an Approved Electronic Platform as to which the Administrative Agent and the parties to the Assignment and Assumption are participants, the assignee&#8217;s completed Administrative Questionnaire (unless the assignee shall already be a Lender hereunder), the processing and recordation fee referred to in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.04 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and any written consent to such assignment required by </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Administrative Agent shall accept such Assignment and Assumption and record the information contained therein in the Register&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if either the assigning Lender or the assignee shall have failed to make any payment required to be made by it pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.06(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.07(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.18(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">9.03(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Administrative Agent shall have no obligation to accept such Assignment and Assumption and record the information therein in the Register unless and until such payment shall have been made in full, together with all accrued interest thereon.  No assignment shall be effective for purposes of this Agreement unless it has been recorded in the Register as provided in this paragraph.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">101</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  Any Lender may, without the consent of, or notice to, the Borrower, the Administrative Agent or the Issuing Bank, sell participations to one or more banks or other entities (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), other than an Ineligible Institution, in all or a portion of such Lender&#8217;s rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans owing to it)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (A)&#160;such Lender&#8217;s obligations under this Agreement shall remain unchanged&#59; (B)&#160;such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations&#59; and (C)&#160;the Borrower, the Administrative Agent, the Issuing Bank and the other Lenders shall continue to deal solely and directly with such Lender in connection with such Lender&#8217;s rights and obligations under this Agreement.  Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such agreement or instrument may provide that such Lender will not, without the consent of the Participant, agree to any amendment, modification or waiver described in the first proviso to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;9.02(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that affects such Participant.  The Borrower agrees that each Participant shall be entitled to the benefits of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections&#160;2.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.16</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (subject to the requirements and limitations therein, including the requirements under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.17(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (it being understood that the documentation required under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.17(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be delivered to the participating Lender and the information and documentation required under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.17(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> will be delivered to the Borrower and the Administrative Agent)) to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Section&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Participant (A) agrees to be subject to the provisions of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> as if it were an assignee under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.04</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; and (B) shall not be entitled to receive any greater payment under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, with respect to any participation, than its participating Lender would have been entitled to receive, except to the extent such entitlement to receive a greater payment results from a Change in Law that occurs after the Participant acquired the applicable participation.  Each Lender that sells a participation agrees, at the Borrower&#8217;s request and expense, to use reasonable efforts to cooperate with the Borrower to effectuate the provisions of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.19(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to any Participant.  To the extent permitted by law, each Participant also shall be entitled to the benefits of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;9.08</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> as though it were a Lender&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Participant agrees to be subject to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.18(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> as though it were a Lender.  Each Lender that sells a participation shall, acting solely for this purpose as a non-fiduciary agent of the Borrower, maintain a register on which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant&#8217;s interest in the Loans or other obligations under the Loan Documents (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Participant Register</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant&#8217;s interest in any Commitments, Loans, Letters of Credit or its other obligations under any Loan Document) to any Person except to the extent that such disclosure is necessary to establish that such Commitment, Loan, Letter of Credit or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations.  The entries in the Participant Register shall be conclusive absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary.  For the avoidance of doubt, the Administrative Agent (in its capacity as Administrative Agent) shall have no responsibility for maintaining a Participant Register.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Any Lender may at any time pledge or assign a security interest in all or any portion of its rights under this Agreement to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank, and this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.04 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">shall not apply to any such pledge or assignment of a security interest&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no such pledge or assignment of a security interest shall release a Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.05.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  All covenants, agreements, representations and warranties made by the Borrower herein and in the certificates or other instruments  delivered in connection with or pursuant to this Agreement and the other Loan Documents shall be considered to have been relied upon by the other parties hereto and shall survive the execution and delivery of this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">102</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Agreement and the making of any Loans and issuance of any Letters of Credit, regardless of any investigation made by any such other party or on its behalf and notwithstanding that the Administrative Agent, the Issuing Bank or any Lender may have had notice or knowledge of any Default or incorrect representation or warranty at the time any credit is extended hereunder, and shall continue in full force and effect as long as the principal of or any accrued interest on any Loan or any fee or any other amount payable under this Agreement is outstanding and unpaid or any Letter of Credit is outstanding and so long as the Commitments have not expired or terminated.  The provisions of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections&#160;2.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.16</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">9.03</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article&#160;VIII</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall survive and remain in full force and effect regardless of the consummation of the transactions contemplated hereby, the repayment of the Loans, the expiration or termination of the Letters of Credit and the Commitments or the termination of this Agreement or any provision hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.06.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Counterparts&#59; Integration&#59; Effectiveness&#59; Electronic Execution</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) This Agreement may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract.  This Agreement, the other Loan Documents and any separate letter agreements with respect to (i) fees payable to the Administrative Agent and (ii) the reductions of the Letter of Credit Commitment of any Issuing Bank constitute the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof.  Except as provided in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;4.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, this Agreement shall become effective when it shall have been executed by the Administrative Agent and when the Administrative Agent shall have received counterparts hereof which, when taken together, bear the signatures of each of the other parties hereto, and thereafter shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Delivery of an executed counterpart of a signature page of (x) this Agreement, (y) any other Loan Document and&#47;or (z) any document, amendment, approval, consent, information, notice (including, for the avoidance of doubt, any notice delivered pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), certificate, request, statement, disclosure or authorization related to this Agreement, any other Loan Document and&#47;or the transactions contemplated hereby and&#47;or thereby (each an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Ancillary Document</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) that is an Electronic Signature transmitted by telecopy, emailed pdf. or any other electronic means that reproduces an image of an actual executed signature page shall be effective as delivery of a manually executed counterpart of this Agreement, such other Loan Document or such Ancillary Document, as applicable.  The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; &#8220;delivery,&#8221; and words of like import in or relating to this Agreement, any other Loan Document and&#47;or any Ancillary Document shall be deemed to include Electronic Signatures, deliveries or the keeping of records in any electronic form (including deliveries by telecopy, emailed pdf. or any other electronic means that reproduces an image of an actual executed signature page), each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that nothing herein shall require the Administrative Agent to accept Electronic Signatures in any form or format without its prior written consent and pursuant to procedures approved by it&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, without limiting the foregoing, (i) to the extent the Administrative Agent has agreed to accept any Electronic Signature, the Administrative Agent and each of the Lenders shall be entitled to rely on such Electronic Signature purportedly given by or on behalf of the Borrower or any other Loan Party without further verification thereof and without any obligation to review the appearance or form of any such Electronic signature and (ii) upon the request of the Administrative Agent or any Lender, any Electronic Signature  shall be promptly followed by a manually executed counterpart.  Without limiting the generality of the foregoing, the Borrower and each Loan Party hereby (A) agrees that, for all purposes, including without limitation, in connection with any workout, restructuring, enforcement of remedies, bankruptcy proceedings or litigation among the Administrative Agent, the Lenders, the Borrower and the Loan Parties, Electronic Signatures transmitted by telecopy, emailed pdf. or any other electronic means that reproduces an image of an actual executed signature page and&#47;or any electronic images of this Agreement,  any other Loan Document and&#47;or any Ancillary Document shall have the same legal effect, validity and enforceability as any paper original, (B) the Administrative Agent and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">103</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">each of the Lenders may, at its option, create one or more copies of this Agreement, any other Loan Document and&#47;or any Ancillary Document in the form of an imaged electronic record in any format, which shall be deemed created in the ordinary course of such Person&#8217;s business, and destroy the original paper document (and all such electronic records shall be considered an original for all purposes and shall have the same legal effect, validity and enforceability as a paper record), (C) waives any argument, defense or right to contest the legal effect, validity or enforceability of this Agreement, any other Loan Document and&#47;or any Ancillary Document based solely on the lack of paper original copies of this Agreement, such other Loan Document and&#47;or such Ancillary Document, respectively, including with respect to any signature pages thereto and (D) waives any claim against any Lender-Related Person for any Liabilities arising solely from the Administrative Agent&#8217;s and&#47;or any Lender&#8217;s reliance on or use of Electronic Signatures and&#47;or transmissions by telecopy, emailed pdf. or any other electronic means that reproduces an image of an actual executed signature page, including any Liabilities arising as a result of the failure of the Borrower and&#47;or any Loan Party to use any available security measures in connection with the execution, delivery or transmission of any Electronic Signature.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.07.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any provision of any Loan Document held to be invalid, illegal or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the remaining provisions thereof&#59; and the invalidity of a particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.08.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Right of Setoff</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If an Event of Default shall have occurred and be continuing, each Lender and each of its Affiliates is hereby authorized at any time and from time to time, to the fullest extent permitted by law, to set off and apply any and all deposits (general or special, time or demand, provisional or final) at any time held and other obligations at any time owing by such Lender or Affiliate to or for the credit or the account of the Borrower against any of and all the obligations of the Borrower now or hereafter existing under this Agreement held by such Lender, irrespective of whether or not such Lender shall have made any demand under this Agreement and although such obligations may be unmatured.  The rights of each Lender under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.08 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">are in addition to other rights and remedies (including other rights of setoff) which such Lender may have.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.09.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law&#59; Jurisdiction&#59; Consent to Service of Process</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (a) (a)&#160;&#160;&#160;&#160;The Loan Documents (other than those containing a contrary express choice of law provision) shall be governed by and construed in accordance with the internal laws of the State of New York, but giving effect to federal laws applicable to national banks.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Each party hereto irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of the Supreme Court of the State of New&#160;York sitting in the  Borough of Manhattan, and of the United&#160;States District Court for the Southern District of New York sitting in the Borough of Manhattan, and any appellate court from any thereof, in any action or proceeding arising out of or relating to any Loan Documents, the transactions relating hereto or thereto, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may (and any such claims, cross-claims or third party claims brought against the Administrative Agent or any of its Related Parties may only) be heard and determined in such New&#160;York State or, to the extent permitted by law, in such federal court.  Each of the parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.  Nothing in this Agreement  or any other Loan Document shall affect any right that the Administrative Agent, the Issuing Bank or any Lender may otherwise have to bring any action or proceeding relating to this Agreement against the Borrower or its properties in the courts of any jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  Each party hereto irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement or any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">104</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">other Loan Document in any court referred to in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph&#160;(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.09</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Each party to this Agreement irrevocably consents to service of process in the manner provided for notices in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;9.01</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Nothing in this Agreement or any other Loan Document will affect the right of any party to this Agreement to serve process in any other manner permitted by law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.10.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">WAIVER OF JURY TRIAL</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY).  EACH PARTY HERETO (A)&#160;CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B)&#160;ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SECTION 9.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.11.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Article&#160;and Section&#160;headings and the Table of Contents used herein are for convenience of reference only, are not part of this Agreement and shall not affect the construction of, or be taken into consideration in interpreting, this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.12.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each of the Administrative Agent, the Issuing Bank and the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (a)&#160;to its and its Affiliates&#8217; directors, officers, employees and agents, including accountants, legal counsel and other advisors (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential), (b)&#160;to the extent requested by any Governmental Authority (including any self-regulatory authority, such as the National Association of Insurance Commissioners), (c)&#160;to the extent required by any Requirement of Law or by any subpoena or similar legal process, (d)&#160;to any other party to this Agreement, (e)&#160;in connection with the exercise of any remedies hereunder or under any other Loan Document or any suit, action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder, (f)&#160;subject to an agreement containing provisions substantially the same as those of this Section 9.12, to (i)&#160;any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights or obligations under this Agreement or (ii) any actual or prospective counterparty (or its advisors) to any swap or derivative transaction relating to the Borrower and its obligations, (g)&#160;with the consent of the Borrower, (h) on a confidential basis to (i) any rating agency in connection with rating the Borrower or its Subsidiaries or the credit facilities provided for herein or (ii) the CUSIP Service Bureau or any similar agency in connection with the issuance and monitoring of identification numbers with respect to the credit facilities provided for herein or (i)&#160;to the extent such Information (i)&#160;becomes publicly available other than as a result of a breach of this Section 9.12 or (ii)&#160;becomes available to the Administrative Agent, the Issuing Bank or any Lender on a non-confidential basis from a source other than the Borrower.  For the purposes of this Section 9.12, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all information received from the Borrower relating to the Borrower or its business, other than any such information that is available to the Administrative Agent, the Issuing Bank or any Lender on a non-confidential basis prior to disclosure by the Borrower and other than information pertaining to this Agreement routinely provided by arrangers to data service providers, including league table providers, that serve the lending industry&#59; provided that, in the case of information received from the Borrower after the date hereof, such information is clearly identified at the time of delivery as confidential.  Any Person required to maintain the confidentiality of Information as provided in this Section 9.12 shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">105</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">to maintain the confidentiality of such Information as such Person would accord to its own confidential information.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.13.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Material Non-Public Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  EACH LENDER ACKNOWLEDGES THAT INFORMATION AS DEFINED IN </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SECTION&#160;9.12(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> FURNISHED TO IT PURSUANT TO THIS AGREEMENT MAY INCLUDE MATERIAL NON-PUBLIC INFORMATION CONCERNING THE BORROWER AND ITS RELATED PARTIES OR THEIR RESPECTIVE SECURITIES, AND CONFIRMS THAT IT HAS DEVELOPED COMPLIANCE PROCEDURES REGARDING THE USE OF MATERIAL NON-PUBLIC INFORMATION AND THAT IT WILL HANDLE SUCH MATERIAL NON-PUBLIC INFORMATION IN ACCORDANCE WITH THOSE PROCEDURES AND APPLICABLE LAW, INCLUDING FEDERAL AND STATE SECURITIES LAWS.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  ALL INFORMATION, INCLUDING REQUESTS FOR WAIVERS AND AMENDMENTS, FURNISHED BY THE BORROWER OR THE ADMINISTRATIVE AGENT PURSUANT TO, OR IN THE COURSE OF ADMINISTERING, THIS AGREEMENT WILL BE SYNDICATE-LEVEL INFORMATION, WHICH MAY CONTAIN MATERIAL NON-PUBLIC INFORMATION ABOUT THE BORROWER, THE LOAN PARTIES AND THEIR RELATED PARTIES OR THEIR RESPECTIVE SECURITIES.  ACCORDINGLY, EACH LENDER REPRESENTS TO THE BORROWER AND THE ADMINISTRATIVE AGENT THAT IT HAS IDENTIFIED IN ITS ADMINISTRATIVE QUESTIONNAIRE A CREDIT CONTACT WHO MAY RECEIVE INFORMATION THAT MAY CONTAIN MATERIAL NON-PUBLIC INFORMATION IN ACCORDANCE WITH ITS COMPLIANCE PROCEDURES AND APPLICABLE LAW.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.14.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Rate Limitation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything herein to the contrary, if at any time the interest rate applicable to any Loan, together with all fees, charges and other amounts which are treated as interest on such Loan under applicable law (collectively the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Charges</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), shall exceed the maximum lawful rate (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Maximum Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) which may be contracted for, charged, taken, received or reserved by the Lender holding such Loan in accordance with applicable law, the rate of interest payable in respect of such Loan hereunder, together with all Charges payable in respect thereof, shall be limited to the Maximum Rate and, to the extent lawful, the interest and Charges that would have been payable in respect of such Loan but were not payable as a result of the operation of this Section 9.14 shall be cumulated and the interest and Charges payable to such Lender in respect of other Loans or periods shall be increased (but not above the Maximum Rate therefor) until such cumulated amount, together with interest thereon at the Overnight Rate to the date of repayment, shall have been received by such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.15.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USA PATRIOT Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Lender that is subject to the requirements of the USA PATRIOT Act of 2001 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Patriot Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) hereby notifies the Borrower that pursuant to the requirements of the Patriot Act, it is required to obtain, verify and record information that identifies the Borrower, which information includes the name and address of the Borrower and other information that will allow such Lender to identify the Borrower in accordance with the Patriot Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.16.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement and Consent to Bail-In of Affected Financial Institutions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any Affected Financial Institution arising under any Loan Document may be subject to the Write-Down and Conversion Powers of the applicable Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by&#58;&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  the application of any Write-Down and Conversion Powers by an the applicable Resolution Authority to any such liabilities arising hereunder which may be payable to it by any party hereto that is an Affected Financial Institution&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">106</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  the effects of any Bail-In Action on any such liability, including, if applicable&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">a reduction in full or in part or cancellation of any such liability&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such Affected Financial Institution, its parent entity, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Agreement or any other Loan Document&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt">the variation of the terms of such liability in connection with the exercise of the Write-Down   and Conversion Powers of the applicable Resolution Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.17.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Fiduciary Duty, etc</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Borrower acknowledges and agrees, and acknowledges its Subsidiaries&#8217; understanding, that no Credit Party will have any obligations except those obligations expressly set forth herein and in the other Loan Documents and each Credit Party is acting solely in the capacity of an arm&#8217;s length contractual counterparty to the Borrower with respect to the Loan Documents and the transactions contemplated herein and therein and not as a financial advisor or a fiduciary to, or an agent of, the Borrower or any other person.  The Borrower agrees that it will not assert any claim against any Credit Party based on an alleged breach of fiduciary duty by such Credit Party in connection with this Agreement and the transactions contemplated hereby.  Additionally, the Borrower acknowledges and agrees that no Credit Party is advising the Borrower as to any legal, tax, investment, accounting, regulatory or any other matters in any jurisdiction.  The Borrower shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated herein or in the other Loan Documents, and the Credit Parties shall have no responsibility or liability to the Borrower with respect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Borrower further acknowledges and agrees, and acknowledges its Subsidiaries&#8217; understanding, that each Credit Party, together with its Affiliates, is a full service securities or banking firm engaged in securities trading and brokerage activities as well as providing investment banking and other financial services.  In the ordinary course of business, any Credit Party may provide investment banking and other financial services to, and&#47;or acquire, hold or sell, for its own accounts and the accounts of customers, equity, debt and other securities and financial instruments (including bank loans and other obligations) of, the Borrower and other companies with which the Borrower may have commercial or other relationships.  With respect to any securities and&#47;or financial instruments so held by any Credit Party or any of its customers, all rights in respect of such securities and financial instruments, including any voting rights, will be exercised by the holder of the rights, in its sole discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  In addition, the Borrower acknowledges and agrees, and acknowledges its Subsidiaries&#8217; understanding, that each Credit Party and its affiliates may be providing debt financing, equity capital or other services (including financial advisory services) to other companies in respect of which the Borrower may have conflicting interests regarding the transactions described herein and otherwise.  No Credit Party will use confidential information obtained from the Borrower by virtue of the transactions contemplated by the Loan Documents or its other relationships with the Borrower in connection with the performance by such Credit Party of services for other companies, and no Credit Party will furnish any such information to other companies.  The Borrower also acknowledges that no Credit Party has any obligation to use in connection with the transactions contemplated by the Loan Documents, or to furnish to the Borrower, confidential information obtained from other companies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.18.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment and Restatement&#59; Reaffirmation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The parties hereto agree that, on the Restatement Effective Date, the following transactions shall be deemed to occur automatically, without further action by any party hereto&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">107</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Existing Credit Agreement shall be deemed to be amended and restated in its entirety in the form of and pursuant to this Agreement and the terms of this Agreement shall replace and supersede the Existing Credit Agreement (which shall hereafter have no further effect upon the parties thereto other than with respect to any action, event, representation, warranty or covenant occurring, made or applying prior to the Restatement Effective Date).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  All &#8220;Revolving Loans&#8221; outstanding under the Existing Credit Agreement shall be deemed to be Revolving Loans under this Agreement.  All other &#8220;Obligations&#8221; existing under the Existing Credit Agreement shall be deemed to be outstanding under this Agreement and, in each case (i) are in all respects enforceable with only the terms thereof being modified as provided by this Agreement and (ii) shall in all respects be continuing after the Restatement Effective Date and shall be deemed to be Obligations governed by this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">  All references to the Existing Credit Agreement or the &#8220;Credit Agreement&#8221; in the existing Loan Documents executed in connection with the Original Credit Agreement (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Existing Loan Documents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), whether on the Existing Credit Agreement&#8217;s &#8220;Restatement Effective Date&#8221; or at any time thereafter but prior to the Restatement Effective Date, shall be deemed to include references to this Agreement, as amended, restated, supplemented or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  The Borrower hereby acknowledges and agrees that each of the Existing Loan Documents that are not superseded by corresponding Loan Documents executed and delivered in connection with this Agreement to which the Borrower is a party remains in full force and effect.  The Borrower hereby (i) ratifies and reaffirms all of its repayment and performance obligations, including obligations to indemnify, contingent or otherwise, under each of such Existing Loan Documents to which it is a party, (ii) ratifies and reaffirms its grant of liens on, or security interests in, its properties pursuant to such Existing Loan Documents to which it is a party as security for the Secured Obligations under or with respect to this Agreement, (iii) confirms and agrees that such liens and security interests secure all of the Secured Obligations, in each case as if each reference in such Existing Loan Documents to the obligations secured thereby are construed to mean and refer to such Secured Obligations under this Agreement.  To the extent the Borrower guaranteed any of the Secured Obligations as defined in the Existing Credit Agreement pursuant to any of such Existing Loan Documents as security for such Secured Obligations, the Borrower, hereby ratifies and reaffirms such guaranty and agrees that such guaranty secures all of the Secured Obligations under this Agreement and remain in full force and effect after giving effect to this Agreement.  The execution, delivery and effectiveness of this Agreement shall not operate as a waiver of any right, power or remedy of the Administrative Agent or the Lenders under the Existing Credit Agreement or any Existing Loan Document, nor constitute a waiver of any provision of the Existing Credit Agreement or any other Existing Loan Document, except as specifically set forth therein or in a corresponding Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">  Each party to this Agreement acknowledges and agrees that this Agreement and the documents executed and delivered in connection herewith do not constitute a novation, payment and reborrowing or termination of any of the Obligations under the Existing Credit Agreement as in effect prior to the Restatement Effective Date or a novation or payment and reborrowing of any amount owing under the Existing Credit Agreement as in effect prior to the Restatement Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9.19.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement Regarding Any Supported QFCs </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To the extent that the Loan Documents provide support, through a guarantee or otherwise, for Swap Agreements or any other agreement or instrument that is a QFC (such support &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">QFC Credit Support</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and each such QFC a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Supported QFC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the parties acknowledge and agree as follows with respect to the resolution power of the Federal Deposit Insurance Corporation under the Federal Deposit Insurance Act and Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act (together with the regulations promulgated thereunder, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">U.S. Special Resolution Regimes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in respect of such Supported QFC and QFC Credit Support (with the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">108</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">provisions below applicable notwithstanding that the Loan Documents and any Supported QFC may in fact be stated to be governed by the laws of the State of New York and&#47;or of the United States or any other state of the United States)&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event a Covered Entity that is party to a Supported QFC (each, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Covered Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer of such Supported QFC and the benefit of such QFC Credit Support (and any interest and obligation in or under such Supported QFC and such QFC Credit Support, and any rights in property securing such Supported QFC or such QFC Credit Support) from such Covered Party will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if the Supported QFC and such QFC Credit Support (and any such interest, obligation and rights in property) were governed by the laws of the United States or a state of the United States.  In the event a Covered Party or a BHC Act Affiliate of a Covered Party becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under the Loan Documents that might otherwise apply to such Supported QFC or any QFC Credit Support that may be exercised against such Covered Party are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if the Supported QFC and the Loan Documents were governed by the laws of the United States or a state of the United States.  Without limitation of the foregoing, it is understood and agreed that rights and remedies of the parties with respect to a Defaulting Lender shall in no event affect the rights of any Covered Party with respect to a Supported QFC or any QFC Credit Support.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">109</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_287"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SCHEDULE 2.01</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Commitment Schedule </font></div><div><font><br></font></div><div style="padding-left:3.78pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.397%"><tr><td style="width:1.0%"></td><td style="width:36.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.451%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Lender</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Commitment</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Letter of Credit Commitment</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">JPMorgan Chase Bank, National Association</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.85pt;padding-right:10.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$60,000,000.00</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:20.55pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$25,000,000</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Bank of America N.A.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.85pt;padding-right:10.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$55,000,000.00</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:20.55pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">--</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Silicon Valley Bank</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.85pt;padding-right:10.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$40,000,000.00</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:20.55pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">--</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">UniCredit Bank AG, New York Branch</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.85pt;padding-right:10.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$22,500,000.00</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:20.55pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">--</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Santander Bank, N.A.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.85pt;padding-right:10.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$22,500,000.00</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:20.55pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">--</font></div></td></tr><tr style="height:16pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="padding-left:4.85pt;padding-right:10.1pt;text-align:right"><font><br></font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="padding-left:2.75pt;padding-right:20.55pt;text-align:right"><font><br></font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Total</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.85pt;padding-right:10.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$200,000,000.00</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:20.55pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$25,000,000</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sched. 2.01</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_290"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:22pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXHIBIT A<br>ASSIGNMENT AND ASSUMPTION</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exh. A - 1</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_293"></div><hr style="page-break-after:always"><div style="min-height:64.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ANNEX 1 TO EXHIBIT A</font></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DEXCOM, INC.<br>STANDARD TERMS AND CONDITIONS FOR<br>ASSIGNMENT AND ASSUMPTION</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Annex 1 &#8211; 1</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_296"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXHIBIT B<br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;RESERVED&#93;</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ex. B - 1</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_299"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXHIBIT C-1<br>FORM OF <br>U.S. TAX COMPLIANCE CERTIFICATE</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ex. C-1 &#8211; 1</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_302"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXHIBIT C-2<br>FORM OF <br>U.S. TAX COMPLIANCE CERTIFICATE</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ex. C-2 &#8211; 1</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_305"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXHIBIT C-3<br>FORM OF <br>U.S. TAX COMPLIANCE CERTIFICATE</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ex. C-3 &#8211; 1</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div><div id="i6f60c3db2b834874baac87815ad2054f_308"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXHIBIT C-4<br>FORM OF <br>U.S. TAX COMPLIANCE CERTIFICATE</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ex. C-4 &#8211; 1</font></div><div style="margin-bottom:12pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.07
<SEQUENCE>7
<FILENAME>dxcm6302023ex1007-byramhea.htm
<DESCRIPTION>EX-10.07
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie0953157f73542c3afe7e84f78d47aef_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 10.07</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY &#91;******&#93;, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.</font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">AMENDMENT NUMBER FIFTEEN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">TO THE AMENDED AND RESTATED NON-EXCLUSIVE DISTRIBUTION AGREEMENT</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This AMENDMENT NUMBER FIFTEEN TO THE AMENDED AND RESTATED NON-EXCLUSIVE DISTRIBUTION AGREEMENT (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is made effective as of June 15, 2023 (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) by and between DexCom, Inc. (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DexCom</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and Byram Healthcare (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#8220;Distributor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Capitalized terms used herein but not defined shall have the meaning ascribed to them in the Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RECITALS</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, DexCom and Distributor previously entered into that certain Amended and Restated Non-Exclusive Distribution Agreement entered into by the Parties as of February 1, 2016 (as the same has been and may be amended from time to time, the &#8220;Agreement&#8221;)&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, DexCom and Distributor desire to further amend the Agreement, as more fully described herein.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW THEREFORE, DexCom and Distributor agree as follows&#58;</font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">Definitions and Interpretation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Section 1.1.10 of the Agreement is hereby added in its entirety&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1.10 </font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;Commercial&#8221; shall mean a sale to a Customer whose medical benefit is not paid in whole or in part by any Federal Health Care Program, as that term is defined by 42 U.S.C. &#167; 1320a-7b(f).</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">Exhibit 6, &#91;******&#93; Rebate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt;text-decoration:underline">Exhibit 6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto is hereby appended to the Agreement and made a part hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">No Further Modification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except to the extent set forth in this Amendment, all other terms and conditions of the Agreement shall remain unmodified and in full force and effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Remainder of Page Intentionally Blank&#59; <br>Signature Page Follows</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the parties have executed this Amendment effective as of the Amendment Effective Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.428%"><tr><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">DexCom, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Distributor</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Christophe Cantenot</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Neel Vadhan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Christophe Cantenot</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Neel Vadhan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VP, Finance and Corporate Controller</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VP, Purchasing</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">6&#47;22&#47;2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">6&#47;22&#47;2023</font></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><div id="ie0953157f73542c3afe7e84f78d47aef_71"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">EXHIBIT 6</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">&#91;******&#93; Rebate</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#91;******&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.01
<SEQUENCE>8
<FILENAME>dxcm6302023exhibit3101.htm
<DESCRIPTION>EX-31.01
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie8c1a6bcdc1f4deab101e76a82e84cf0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.01</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Kevin R. Sayer, certify that&#58;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form 10-Q of DexCom, Inc.&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.364%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 27, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; KEVIN R. SAYER</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin R. Sayer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board of Directors, President and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.02
<SEQUENCE>9
<FILENAME>dxcm6302023exhibit3102.htm
<DESCRIPTION>EX-31.02
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i2604408b95fe4b218cdc011a4367b028_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.02</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jereme M. Sylvain, certify that&#58;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form 10-Q of DexCom, Inc.&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.364%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 27, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JEREME M. SYLVAIN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jereme M. Sylvain</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.01
<SEQUENCE>10
<FILENAME>dxcm6302023exhibit3201.htm
<DESCRIPTION>EX-32.01
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic52c6e96aec34c6b8e7763defbfe4634_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.01</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned, Kevin R. Sayer, President and Chief Executive Officer of DexCom, Inc. (the &#8220;Company&#8221;), pursuant to 18 U.S.C. &#167;1350, hereby certifies that&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) the quarterly Report on Form 10-Q for the period ended June&#160;30, 2023 of the Company (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; July&#160;27, 2023</font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.637%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; KEVIN R. SAYER</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin R. Sayer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board of Directors, President and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.02
<SEQUENCE>11
<FILENAME>dxcm6302023exhibit3202.htm
<DESCRIPTION>EX-32.02
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ida7e13ae494948ee947d56f30c8cd321_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.02</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned, Jereme M. Sylvain, Executive Vice President and Chief Financial Officer of DexCom, Inc. (the &#8220;Company&#8221;), pursuant to 18 U.S.C. &#167;1350, hereby certifies that&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) the quarterly Report on Form 10-Q for the period ended June&#160;30, 2023 of the Company (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; July&#160;27, 2023</font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.637%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JEREME M. SYLVAIN</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jereme M. Sylvain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Executive Vice President and Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>dxcm-20230630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:3f233038-1297-4d40-b9d2-42700d6fe8fe,g:c1345a4d-d54c-45d2-818f-78cac7edf10e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dxcm="http://www.dexcom.com/20230630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.dexcom.com/20230630">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20230630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20230630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20230630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20230630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.dexcom.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsUnaudited" roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited">
        <link:definition>0000002 - Statement - Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsUnauditedParenthetical" roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>0000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperationsUnaudited" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited">
        <link:definition>0000004 - Statement - Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeUnaudited" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited">
        <link:definition>0000005 - Statement - Consolidated Statements of Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityUnaudited" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited">
        <link:definition>0000006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>0000007 - Statement - Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPolicies" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies">
        <link:definition>0000008 - Disclosure - Organization and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DevelopmentandOtherAgreements" roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreements">
        <link:definition>0000009 - Disclosure - Development and Other Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.dexcom.com/role/FairValueMeasurements">
        <link:definition>0000010 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetails">
        <link:definition>0000011 - Disclosure - Balance Sheet Details</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.dexcom.com/role/Debt">
        <link:definition>0000012 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.dexcom.com/role/Contingencies">
        <link:definition>0000013 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.dexcom.com/role/IncomeTaxes">
        <link:definition>0000014 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.dexcom.com/role/StockholdersEquity">
        <link:definition>0000015 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformation" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformation">
        <link:definition>0000016 - Disclosure - Business Segment and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesPolicies" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies">
        <link:definition>9954701 - Disclosure - Organization and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesTables" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables">
        <link:definition>9954702 - Disclosure - Organization and Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.dexcom.com/role/FairValueMeasurementsTables">
        <link:definition>9954703 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsTables" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsTables">
        <link:definition>9954704 - Disclosure - Balance Sheet Details (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.dexcom.com/role/DebtTables">
        <link:definition>9954705 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.dexcom.com/role/StockholdersEquityTables">
        <link:definition>9954706 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformationTables" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables">
        <link:definition>9954707 - Disclosure - Business Segment and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>9954708 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails">
        <link:definition>9954709 - Disclosure - Organization and Significant Accounting Policies - Earnings Per Share, Basic and Diluted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails">
        <link:definition>9954710 - Disclosure - Organization and Significant Accounting Policies - Anti-dilutive Securities Excluded from Calculation of Net Income (Loss) per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DevelopmentandOtherAgreementsDetails" roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails">
        <link:definition>9954711 - Disclosure - Development and Other Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsSummaryDetails" roleURI="http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails">
        <link:definition>9954712 - Disclosure - Fair Value Measurements - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>9954713 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails" roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails">
        <link:definition>9954714 - Disclosure - Fair Value Measurements - Fair Value of Convertible Senior Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsShortTermMarketableSecuritiesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails">
        <link:definition>9954715 - Disclosure - Balance Sheet Details - Short-Term Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsNarrativeDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails">
        <link:definition>9954716 - Disclosure - Balance Sheet Details - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsInventoryDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails">
        <link:definition>9954717 - Disclosure - Balance Sheet Details - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails">
        <link:definition>9954718 - Disclosure - Balance Sheet Details - Prepaid and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsPropertyandEquipmentDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails">
        <link:definition>9954719 - Disclosure - Balance Sheet Details - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsOtherAssetsDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsOtherAssetsDetails">
        <link:definition>9954720 - Disclosure - Balance Sheet Details - Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails">
        <link:definition>9954721 - Disclosure - Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails">
        <link:definition>9954722 - Disclosure - Balance Sheet Details - Accrued Payroll and Related Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsOtherLongTermLiabilitiesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails">
        <link:definition>9954723 - Disclosure - Balance Sheet Details - Other Long-Term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSeniorConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails">
        <link:definition>9954724 - Disclosure - Debt - Senior Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtConversionValueofConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails">
        <link:definition>9954725 - Disclosure - Debt - Conversion Value of Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails">
        <link:definition>9954726 - Disclosure - Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.dexcom.com/role/DebtNarrativeDetails">
        <link:definition>9954727 - Disclosure - Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" roleURI="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails">
        <link:definition>9954728 - Disclosure - Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesDetails">
        <link:definition>9954729 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityShareBasedCompensationExpenseDetails" roleURI="http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails">
        <link:definition>9954730 - Disclosure - Stockholders' Equity - Share-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.dexcom.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>9954731 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformationNarrativeDetails" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails">
        <link:definition>9954732 - Disclosure - Business Segment and Geographic Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformationSummaryDetails" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails">
        <link:definition>9954733 - Disclosure - Business Segment and Geographic Information - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dxcm_SellingGeneralAndAdministrativeMember" abstract="true" name="SellingGeneralAndAdministrativeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_ShareRepurchaseProgramMember" abstract="true" name="ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_PrepaidInventoryCurrent" abstract="false" name="PrepaidInventoryCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_StevenRAltmanMember" abstract="true" name="StevenRAltmanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_FederalReserveBankOfNewYorkRateNYFRBMember" abstract="true" name="FederalReserveBankOfNewYorkRateNYFRBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_ConvertibleNotesDue2023Member" abstract="true" name="ConvertibleNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_OtherLongTermAssets" abstract="false" name="OtherLongTermAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_CollaborativeArrangementUpfrontFee" abstract="false" name="CollaborativeArrangementUpfrontFee" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_OtherTaxLiabilitiesNoncurrent" abstract="false" name="OtherTaxLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" abstract="false" name="PrepaidAndOtherCurrentAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" abstract="false" name="DebtSecuritiesAvailableForSaleAndEquitySecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DeferredCompensationPlanAssetsCurrent" abstract="false" name="DeferredCompensationPlanAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DebtInstrumentConversionTermAxis" abstract="true" name="DebtInstrumentConversionTermAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_SharesReceivedFromExerciseOfNoteHedge" abstract="false" name="SharesReceivedFromExerciseOfNoteHedge" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_CollaborativeArrangementMilestonePaymentsMember" abstract="true" name="CollaborativeArrangementMilestonePaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_CollaborativeArrangementInitialPaymentMember" abstract="true" name="CollaborativeArrangementInitialPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_FairValueDisclosuresSeniorConvertibleNotesTable" abstract="true" name="FairValueDisclosuresSeniorConvertibleNotesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_ConvertibleNotesDue2025Member" abstract="true" name="ConvertibleNotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_DebtInstrumentConversionTermOneMember" abstract="true" name="DebtInstrumentConversionTermOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_ConvertibleNotesDue2028Member" abstract="true" name="ConvertibleNotesDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_AccruedWagesBonusesAndTaxesCurrent" abstract="false" name="AccruedWagesBonusesAndTaxesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" abstract="false" name="DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DonaldMAbbeyMember" abstract="true" name="DonaldMAbbeyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_VerilyLifeSciencesMember" abstract="true" name="VerilyLifeSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent" abstract="false" name="EstimatedAnnualEffectiveIncomeTaxRatePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone" abstract="false" name="StockIssuedDuringPeriodValueAchievementOfMilestone" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_CollaborativeArrangementApprovalMilestoneMember" abstract="true" name="CollaborativeArrangementApprovalMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_BridgettePHellerMember" abstract="true" name="BridgettePHellerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" abstract="false" name="StockIssuedDuringPeriodSharesAchievementOfMilestone" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" abstract="false" name="NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dxcm_RestrictedAndPerformanceStockUnitsMember" abstract="true" name="RestrictedAndPerformanceStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_DebtInstrumentCovenantRepurchasePricePercentage" abstract="false" name="DebtInstrumentCovenantRepurchasePricePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_AccruedTaxAuditAndLegalFees" abstract="false" name="AccruedTaxAuditAndLegalFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_RevenuePercentage" abstract="false" name="RevenuePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="dxcm_CashInterestExpenseAbstract" abstract="true" name="CashInterestExpenseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" abstract="false" name="DebtInstrumentCapCallTransactionCapPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" abstract="false" name="DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" abstract="false" name="ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" abstract="false" name="DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" abstract="true" name="OrganizationAndSummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_LongTermDeposits" abstract="false" name="LongTermDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_PaymentsForPurchasesOfCappedCallTransactions" abstract="false" name="PaymentsForPurchasesOfCappedCallTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_PaymentsUnderCollaborationAgreementsAxis" abstract="true" name="PaymentsUnderCollaborationAgreementsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_SharesReceivedFromBenefitOfNoteHedgeValue" abstract="false" name="SharesReceivedFromBenefitOfNoteHedgeValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_NonCashInterestExpenseAbstract" abstract="true" name="NonCashInterestExpenseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_PaymentsUnderCollaborationAgreementsDomain" abstract="true" name="PaymentsUnderCollaborationAgreementsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" abstract="false" name="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" abstract="false" name="TreasuryStockValueBenefitReceivedFromNoteHedge" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DebtInstrumentConversionTermTwoMember" abstract="true" name="DebtInstrumentConversionTermTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_DebtInstrumentConversionTermDomain" abstract="true" name="DebtInstrumentConversionTermDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_ContractPaymentTermsNumberofDays" abstract="false" name="ContractPaymentTermsNumberofDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" abstract="false" name="DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="dxcm_PharmacyRebates" abstract="false" name="PharmacyRebates" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_CollaborativeResearchAndDevelopmentFee" abstract="false" name="CollaborativeResearchAndDevelopmentFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" abstract="false" name="IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_FairValueDisclosuresLineItems" abstract="true" name="FairValueDisclosuresLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" abstract="false" name="PotentialFutureCommonStockIssuableSharesNewIssues" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_SimpleRiskFreeRateRFRMember" abstract="true" name="SimpleRiskFreeRateRFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_FairValueAssetsLevel3TransfersAmount" abstract="false" name="FairValueAssetsLevel3TransfersAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>dxcm-20230630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:3f233038-1297-4d40-b9d2-42700d6fe8fe,g:c1345a4d-d54c-45d2-818f-78cac7edf10e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="dxcm-20230630.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_65109ccb-6fd0-4fb3-ad49-303fcfd124c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e97b644a-61b6-4aa7-8572-cbf9a4163aff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_65109ccb-6fd0-4fb3-ad49-303fcfd124c4" xlink:to="loc_us-gaap_LiabilitiesCurrent_e97b644a-61b6-4aa7-8572-cbf9a4163aff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_94daf788-bd7e-45af-9ebf-1f7523f5ba98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_65109ccb-6fd0-4fb3-ad49-303fcfd124c4" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_94daf788-bd7e-45af-9ebf-1f7523f5ba98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_075b54d9-f272-4f05-9340-ea15f8658dff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_65109ccb-6fd0-4fb3-ad49-303fcfd124c4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_075b54d9-f272-4f05-9340-ea15f8658dff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d8052a91-c2b3-4447-b169-026fec800a87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_65109ccb-6fd0-4fb3-ad49-303fcfd124c4" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d8052a91-c2b3-4447-b169-026fec800a87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_05110620-b96d-45a3-a915-0a6f7cde6db8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_ae937c99-d093-4e1d-b0c2-56c207a07a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_05110620-b96d-45a3-a915-0a6f7cde6db8" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_ae937c99-d093-4e1d-b0c2-56c207a07a8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_14fc66d2-fbe6-459b-b9e8-ad08a6cf0ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_05110620-b96d-45a3-a915-0a6f7cde6db8" xlink:to="loc_us-gaap_TreasuryStockCommonValue_14fc66d2-fbe6-459b-b9e8-ad08a6cf0ee3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_62119544-5889-4633-95e3-ad3eb7dcf077" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_05110620-b96d-45a3-a915-0a6f7cde6db8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_62119544-5889-4633-95e3-ad3eb7dcf077" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_8c97f2ba-a6a0-438c-9d51-9a7612b16580" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_05110620-b96d-45a3-a915-0a6f7cde6db8" xlink:to="loc_us-gaap_CommonStockValueOutstanding_8c97f2ba-a6a0-438c-9d51-9a7612b16580" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fce29541-bea8-43f5-9cb9-0d945702b3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_05110620-b96d-45a3-a915-0a6f7cde6db8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fce29541-bea8-43f5-9cb9-0d945702b3bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fba4c2bc-8b4c-44ab-8933-67adcbb93295" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_05110620-b96d-45a3-a915-0a6f7cde6db8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fba4c2bc-8b4c-44ab-8933-67adcbb93295" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_efeda491-b453-42d2-b538-00922286379a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ad76ffd8-1a23-439f-b478-3d2cc89d4817" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_efeda491-b453-42d2-b538-00922286379a" xlink:to="loc_us-gaap_AssetsCurrent_ad76ffd8-1a23-439f-b478-3d2cc89d4817" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_943a5cf5-450a-437c-9a85-e3350af02091" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_efeda491-b453-42d2-b538-00922286379a" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_943a5cf5-450a-437c-9a85-e3350af02091" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_67a6d80d-220b-45b6-9417-9b87048e8b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_efeda491-b453-42d2-b538-00922286379a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_67a6d80d-220b-45b6-9417-9b87048e8b4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_bf704ef7-3b1e-4e20-852d-18ff1072724b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_efeda491-b453-42d2-b538-00922286379a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_bf704ef7-3b1e-4e20-852d-18ff1072724b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e0d72417-7edb-440b-9ba3-5b1667f70859" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_efeda491-b453-42d2-b538-00922286379a" xlink:to="loc_us-gaap_Goodwill_e0d72417-7edb-440b-9ba3-5b1667f70859" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7d4ec6e3-b657-4566-b7c0-fff3ee8a296c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_efeda491-b453-42d2-b538-00922286379a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7d4ec6e3-b657-4566-b7c0-fff3ee8a296c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ae7736f0-ceb4-42ff-9896-e4d0770c4d26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_efeda491-b453-42d2-b538-00922286379a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ae7736f0-ceb4-42ff-9896-e4d0770c4d26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_191128f4-8ce3-4c4d-bded-449a64e20dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_7451b113-f87d-40db-b57e-9883e954b5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_191128f4-8ce3-4c4d-bded-449a64e20dd8" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_7451b113-f87d-40db-b57e-9883e954b5d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_dd3e2fb9-e2cb-4010-99f0-c47d16387d00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_191128f4-8ce3-4c4d-bded-449a64e20dd8" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_dd3e2fb9-e2cb-4010-99f0-c47d16387d00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_bdb63026-3523-4e8d-a334-2f3fb77001cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_191128f4-8ce3-4c4d-bded-449a64e20dd8" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_bdb63026-3523-4e8d-a334-2f3fb77001cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8c0523c5-fbd5-420a-a75c-27a2484f5b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_191128f4-8ce3-4c4d-bded-449a64e20dd8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8c0523c5-fbd5-420a-a75c-27a2484f5b6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a6e0d552-2eb6-4258-9eac-63bfceb5aeda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_191128f4-8ce3-4c4d-bded-449a64e20dd8" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a6e0d552-2eb6-4258-9eac-63bfceb5aeda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_eff72ae0-316e-4f82-aa72-fc68775da3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_cb43899c-3ccf-4e54-b520-dca47e90be79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_eff72ae0-316e-4f82-aa72-fc68775da3f7" xlink:to="loc_us-gaap_Liabilities_cb43899c-3ccf-4e54-b520-dca47e90be79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_affcd0a7-f7db-41f5-8361-d3cea5b447cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_eff72ae0-316e-4f82-aa72-fc68775da3f7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_affcd0a7-f7db-41f5-8361-d3cea5b447cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_fd8f1b5e-de66-423b-8777-640f65ab519b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_eff72ae0-316e-4f82-aa72-fc68775da3f7" xlink:to="loc_us-gaap_CommitmentsAndContingencies_fd8f1b5e-de66-423b-8777-640f65ab519b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8c05f676-e6d8-4403-ba04-930c06419705" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6713b521-4e1a-44d7-9292-c444b90936db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8c05f676-e6d8-4403-ba04-930c06419705" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6713b521-4e1a-44d7-9292-c444b90936db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_15911261-e76b-43ed-92ae-de811a35dafc" xlink:href="dxcm-20230630.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8c05f676-e6d8-4403-ba04-930c06419705" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_15911261-e76b-43ed-92ae-de811a35dafc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_bee8882e-3b01-4ecc-ab46-4c5b73117409" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8c05f676-e6d8-4403-ba04-930c06419705" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_bee8882e-3b01-4ecc-ab46-4c5b73117409" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_546533a0-60be-42c6-bd74-97bf6f621c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8c05f676-e6d8-4403-ba04-930c06419705" xlink:to="loc_us-gaap_InventoryNet_546533a0-60be-42c6-bd74-97bf6f621c8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b87d39f2-56c1-4137-a328-013e3d4bc1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8c05f676-e6d8-4403-ba04-930c06419705" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b87d39f2-56c1-4137-a328-013e3d4bc1f2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="dxcm-20230630.xsd#ConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_11131913-fb3c-4575-9c99-e2ef28789bac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3a87ca43-aeb4-4fdb-b324-69db30f5ac6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_11131913-fb3c-4575-9c99-e2ef28789bac" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3a87ca43-aeb4-4fdb-b324-69db30f5ac6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_8cbb8f0e-ad9c-4fe8-8f00-9cdf74e9eb19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_11131913-fb3c-4575-9c99-e2ef28789bac" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_8cbb8f0e-ad9c-4fe8-8f00-9cdf74e9eb19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6adfa030-4b0c-45e7-93c7-c3bc5e5d7a37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_11131913-fb3c-4575-9c99-e2ef28789bac" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6adfa030-4b0c-45e7-93c7-c3bc5e5d7a37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8d5c4415-2e2d-4789-99f9-d85b5f80bcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_5ad67dd2-bb54-45d3-9fa2-fd5bb3bea4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8d5c4415-2e2d-4789-99f9-d85b5f80bcfa" xlink:to="loc_us-gaap_GrossProfit_5ad67dd2-bb54-45d3-9fa2-fd5bb3bea4a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_c3b4073d-40c0-40e6-a8dd-9eb110e0b9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8d5c4415-2e2d-4789-99f9-d85b5f80bcfa" xlink:to="loc_us-gaap_OperatingExpenses_c3b4073d-40c0-40e6-a8dd-9eb110e0b9a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d4fae6ac-1556-4e0c-a295-618431283b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_44ab991d-9bab-46db-8637-b508895c1936" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d4fae6ac-1556-4e0c-a295-618431283b3d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_44ab991d-9bab-46db-8637-b508895c1936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b0151fea-165b-4f58-9c89-6a4360982cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d4fae6ac-1556-4e0c-a295-618431283b3d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b0151fea-165b-4f58-9c89-6a4360982cf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_04d6a9d6-d786-47d2-b8d7-06eb18fa5385" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_68a5182e-fe17-473e-abdb-05c08bf76cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_04d6a9d6-d786-47d2-b8d7-06eb18fa5385" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_68a5182e-fe17-473e-abdb-05c08bf76cd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9a8111e2-c64a-414b-baa6-a6be0aca8783" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_04d6a9d6-d786-47d2-b8d7-06eb18fa5385" xlink:to="loc_us-gaap_OperatingIncomeLoss_9a8111e2-c64a-414b-baa6-a6be0aca8783" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_01cf8a7f-a006-4a3c-9426-a5d448ddd4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_04d6a9d6-d786-47d2-b8d7-06eb18fa5385" xlink:to="loc_us-gaap_InterestExpense_01cf8a7f-a006-4a3c-9426-a5d448ddd4e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_4a93ba4d-9a95-4568-935d-fc92a79af57b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_04d6a9d6-d786-47d2-b8d7-06eb18fa5385" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_4a93ba4d-9a95-4568-935d-fc92a79af57b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_08c673ff-8d3a-40eb-a809-7a0bb780c552" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_55952243-b15e-4621-a242-1747a58fe92c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_08c673ff-8d3a-40eb-a809-7a0bb780c552" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_55952243-b15e-4621-a242-1747a58fe92c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c7e71d80-decd-4c28-800d-8b3d7d5672d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_08c673ff-8d3a-40eb-a809-7a0bb780c552" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c7e71d80-decd-4c28-800d-8b3d7d5672d9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="dxcm-20230630.xsd#ConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3100a2e4-0d00-43cc-94b2-1e9855847650" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_e0e63b10-79d2-4345-a626-49a80fb0e376" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3100a2e4-0d00-43cc-94b2-1e9855847650" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_e0e63b10-79d2-4345-a626-49a80fb0e376" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_56ec5611-e375-4fb0-9f62-ba23f36f3790" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3100a2e4-0d00-43cc-94b2-1e9855847650" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_56ec5611-e375-4fb0-9f62-ba23f36f3790" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_000002d8-de98-4716-8a70-a1dca6bb15d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6bca4b91-c565-4f04-8181-cf555b90ab88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_000002d8-de98-4716-8a70-a1dca6bb15d5" xlink:to="loc_us-gaap_NetIncomeLoss_6bca4b91-c565-4f04-8181-cf555b90ab88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a6825a68-6efb-4616-935b-af1f1464b26e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_000002d8-de98-4716-8a70-a1dca6bb15d5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a6825a68-6efb-4616-935b-af1f1464b26e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="dxcm-20230630.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f0e20604-5a94-4995-bd4c-0b7444ef2aea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_5a9b07fe-1180-4a26-8d45-aa3a953a731f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f0e20604-5a94-4995-bd4c-0b7444ef2aea" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_5a9b07fe-1180-4a26-8d45-aa3a953a731f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_e0d4f300-082d-4211-8ea8-ae256c89983c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f0e20604-5a94-4995-bd4c-0b7444ef2aea" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_e0d4f300-082d-4211-8ea8-ae256c89983c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d75dc947-423a-4532-9aeb-b17319cbe8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f0e20604-5a94-4995-bd4c-0b7444ef2aea" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d75dc947-423a-4532-9aeb-b17319cbe8dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7e29e212-bf1f-40bd-bd93-e84b09805623" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f0e20604-5a94-4995-bd4c-0b7444ef2aea" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7e29e212-bf1f-40bd-bd93-e84b09805623" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c4d89de8-0d56-48ed-9938-f5015f926286" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f0e20604-5a94-4995-bd4c-0b7444ef2aea" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c4d89de8-0d56-48ed-9938-f5015f926286" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78fa2c9c-f8ba-4c04-b505-1c0f7247c033" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b27a7e04-589e-459a-a0c7-fec90e27bec4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78fa2c9c-f8ba-4c04-b505-1c0f7247c033" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b27a7e04-589e-459a-a0c7-fec90e27bec4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b75c58f0-607e-404b-af1f-6df882520968" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78fa2c9c-f8ba-4c04-b505-1c0f7247c033" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b75c58f0-607e-404b-af1f-6df882520968" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_078134f3-857b-459e-b0ac-c57efb0adb55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaidInKindInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78fa2c9c-f8ba-4c04-b505-1c0f7247c033" xlink:to="loc_us-gaap_PaidInKindInterest_078134f3-857b-459e-b0ac-c57efb0adb55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f017977f-a37a-4b62-abe0-cbd8438bfca6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78fa2c9c-f8ba-4c04-b505-1c0f7247c033" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f017977f-a37a-4b62-abe0-cbd8438bfca6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_44bc8b6e-172c-4ccf-972a-4508e83032c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78fa2c9c-f8ba-4c04-b505-1c0f7247c033" xlink:to="loc_us-gaap_ShareBasedCompensation_44bc8b6e-172c-4ccf-972a-4508e83032c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_f034e46d-b64a-46ab-9cc3-7b016da68381" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78fa2c9c-f8ba-4c04-b505-1c0f7247c033" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_f034e46d-b64a-46ab-9cc3-7b016da68381" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_72651723-ae81-43a9-bf79-1a4910f677c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78fa2c9c-f8ba-4c04-b505-1c0f7247c033" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_72651723-ae81-43a9-bf79-1a4910f677c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_57c6f194-ab0a-4c8b-a299-1a1a06931ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78fa2c9c-f8ba-4c04-b505-1c0f7247c033" xlink:to="loc_us-gaap_NetIncomeLoss_57c6f194-ab0a-4c8b-a299-1a1a06931ba6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4033f1e2-937c-4130-a3d7-4b0b76e8004b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78fa2c9c-f8ba-4c04-b505-1c0f7247c033" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4033f1e2-937c-4130-a3d7-4b0b76e8004b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_86e3cdef-a108-47b1-a9cd-580d22bcff41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78fa2c9c-f8ba-4c04-b505-1c0f7247c033" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_86e3cdef-a108-47b1-a9cd-580d22bcff41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_cde95719-b40a-4d6d-aede-cb7dada63079" xlink:href="dxcm-20230630.xsd#dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78fa2c9c-f8ba-4c04-b505-1c0f7247c033" xlink:to="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_cde95719-b40a-4d6d-aede-cb7dada63079" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_bc3cc42a-5abc-4d51-84d5-5ddb4587b972" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78fa2c9c-f8ba-4c04-b505-1c0f7247c033" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_bc3cc42a-5abc-4d51-84d5-5ddb4587b972" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_9575e533-4caa-4d14-bc9b-772a58bb8a44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78fa2c9c-f8ba-4c04-b505-1c0f7247c033" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_9575e533-4caa-4d14-bc9b-772a58bb8a44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_00f9ca20-051c-45a1-9d2e-3d36aa25c639" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78fa2c9c-f8ba-4c04-b505-1c0f7247c033" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_00f9ca20-051c-45a1-9d2e-3d36aa25c639" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d9cae0f6-903a-4ee4-b178-fb01a0271dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_74a50bdc-449f-4366-947d-2a15974506f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d9cae0f6-903a-4ee4-b178-fb01a0271dd4" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_74a50bdc-449f-4366-947d-2a15974506f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_529c9ac8-12c5-46e8-a0e9-fb433d7db9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d9cae0f6-903a-4ee4-b178-fb01a0271dd4" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_529c9ac8-12c5-46e8-a0e9-fb433d7db9a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_2785f56b-1860-4356-8d93-cde4260bc010" xlink:href="dxcm-20230630.xsd#dxcm_PaymentsForPurchasesOfCappedCallTransactions"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d9cae0f6-903a-4ee4-b178-fb01a0271dd4" xlink:to="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_2785f56b-1860-4356-8d93-cde4260bc010" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d96d89f3-6f0d-4942-9030-64c0e96c7dba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d9cae0f6-903a-4ee4-b178-fb01a0271dd4" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d96d89f3-6f0d-4942-9030-64c0e96c7dba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_15445da8-40b3-4a94-8b7a-35dd62f23a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d9cae0f6-903a-4ee4-b178-fb01a0271dd4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_15445da8-40b3-4a94-8b7a-35dd62f23a9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_336fa82b-f2c4-41d5-904e-39e13a569d97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5d65f114-17ce-4b46-97b9-a53f24c7b0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_336fa82b-f2c4-41d5-904e-39e13a569d97" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5d65f114-17ce-4b46-97b9-a53f24c7b0ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_8d793944-18ba-4c09-989b-c7a489b3c040" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_336fa82b-f2c4-41d5-904e-39e13a569d97" xlink:to="loc_us-gaap_RestrictedCash_8d793944-18ba-4c09-989b-c7a489b3c040" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_36b51193-dd91-4962-8734-e5b0e98a45f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c8f67b06-d783-4983-a494-b586f2c9c042" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_36b51193-dd91-4962-8734-e5b0e98a45f5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c8f67b06-d783-4983-a494-b586f2c9c042" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c63ca6a8-5ad0-42e6-887f-3106a685b603" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_36b51193-dd91-4962-8734-e5b0e98a45f5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c63ca6a8-5ad0-42e6-887f-3106a685b603" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d3f5db3d-1612-4751-ae67-8aabaa8dd657" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_36b51193-dd91-4962-8734-e5b0e98a45f5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d3f5db3d-1612-4751-ae67-8aabaa8dd657" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_82a50361-be13-4432-97bf-31e6be0d6809" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_36b51193-dd91-4962-8734-e5b0e98a45f5" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_82a50361-be13-4432-97bf-31e6be0d6809" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a2508769-dae4-4e57-91e5-a957761946ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_aa2ece2b-4e9f-4835-a250-20740204b0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a2508769-dae4-4e57-91e5-a957761946ee" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_aa2ece2b-4e9f-4835-a250-20740204b0c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3199cc94-b114-43cc-b835-91a5bec3251f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a2508769-dae4-4e57-91e5-a957761946ee" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3199cc94-b114-43cc-b835-91a5bec3251f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_bcaa71b8-6677-4a4e-8294-fd20fd402403" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_72dafe84-db5c-4f42-9d94-d623212c649f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_bcaa71b8-6677-4a4e-8294-fd20fd402403" xlink:to="loc_us-gaap_NetIncomeLoss_72dafe84-db5c-4f42-9d94-d623212c649f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_91d63817-46ef-4f1c-a0e6-236e4ee349bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_bcaa71b8-6677-4a4e-8294-fd20fd402403" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_91d63817-46ef-4f1c-a0e6-236e4ee349bf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#FairValueMeasurementsSummaryDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c1eb2d73-dfcc-4116-b9ed-58da50260279" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_a79cdf9b-d91c-4aa5-a72d-f9810d5c3055" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_c1eb2d73-dfcc-4116-b9ed-58da50260279" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_a79cdf9b-d91c-4aa5-a72d-f9810d5c3055" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_91d576cc-69c6-4025-8e86-c3778f2e3d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_c1eb2d73-dfcc-4116-b9ed-58da50260279" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_91d576cc-69c6-4025-8e86-c3778f2e3d1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_3733a41f-8563-436a-998f-0e5557683628" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_c1eb2d73-dfcc-4116-b9ed-58da50260279" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_3733a41f-8563-436a-998f-0e5557683628" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsShortTermMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_95903f85-8a1d-4ad5-a85c-d8b06fd08f71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b03356f1-afe0-4a08-80d3-dc97340404ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_95903f85-8a1d-4ad5-a85c-d8b06fd08f71" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b03356f1-afe0-4a08-80d3-dc97340404ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_020b42ee-657f-448b-8799-3d78b8320032" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_95903f85-8a1d-4ad5-a85c-d8b06fd08f71" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_020b42ee-657f-448b-8799-3d78b8320032" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_845c8f55-e685-4911-afba-45f95bbea031" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_95903f85-8a1d-4ad5-a85c-d8b06fd08f71" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_845c8f55-e685-4911-afba-45f95bbea031" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3d1a6182-126e-4c25-a1f8-83c512dd22d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_6b687a67-e22c-4aa1-98c2-84e4cbf3ec17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3d1a6182-126e-4c25-a1f8-83c512dd22d0" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_6b687a67-e22c-4aa1-98c2-84e4cbf3ec17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ed8fb270-4570-46d8-91d8-0c930164c477" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3d1a6182-126e-4c25-a1f8-83c512dd22d0" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ed8fb270-4570-46d8-91d8-0c930164c477" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d8eba7a9-90fb-42b5-a6b0-cb10ede6605f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3d1a6182-126e-4c25-a1f8-83c512dd22d0" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d8eba7a9-90fb-42b5-a6b0-cb10ede6605f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0e05f20b-ba68-4f08-b148-1904056578ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_b20d00fd-8260-4111-a28a-b1ea9416e6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0e05f20b-ba68-4f08-b148-1904056578ca" xlink:to="loc_us-gaap_IncomeTaxesReceivable_b20d00fd-8260-4111-a28a-b1ea9416e6c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_d1c73283-1652-41eb-9702-5da7621a92ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0e05f20b-ba68-4f08-b148-1904056578ca" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_d1c73283-1652-41eb-9702-5da7621a92ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_d739b346-8ebf-4afa-89d9-7ffe283b88e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0e05f20b-ba68-4f08-b148-1904056578ca" xlink:to="loc_us-gaap_OtherAssetsCurrent_d739b346-8ebf-4afa-89d9-7ffe283b88e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PrepaidInventoryCurrent_bab0d1ce-58fa-4989-8ef3-ee6d529d6739" xlink:href="dxcm-20230630.xsd#dxcm_PrepaidInventoryCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0e05f20b-ba68-4f08-b148-1904056578ca" xlink:to="loc_dxcm_PrepaidInventoryCurrent_bab0d1ce-58fa-4989-8ef3-ee6d529d6739" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredCompensationPlanAssetsCurrent_2d4ae4d8-576c-4eb4-83b4-62638a6ff4a5" xlink:href="dxcm-20230630.xsd#dxcm_DeferredCompensationPlanAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0e05f20b-ba68-4f08-b148-1904056578ca" xlink:to="loc_dxcm_DeferredCompensationPlanAssetsCurrent_2d4ae4d8-576c-4eb4-83b4-62638a6ff4a5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_8edd222f-648f-42e3-aa95-7d5d2b8e2673" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_5d3d2d8f-4858-47c5-8b36-6dd6c973ea07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_8edd222f-648f-42e3-aa95-7d5d2b8e2673" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_5d3d2d8f-4858-47c5-8b36-6dd6c973ea07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_04b2b445-f17e-4ff1-ae48-8a9af9050934" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_8edd222f-648f-42e3-aa95-7d5d2b8e2673" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_04b2b445-f17e-4ff1-ae48-8a9af9050934" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsOtherAssetsDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsOtherAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7d9268c0-22b1-46e9-8e1f-13e2402f3792" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherLongTermAssets_21f05029-0b91-4217-8fae-c11c259694cf" xlink:href="dxcm-20230630.xsd#dxcm_OtherLongTermAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_7d9268c0-22b1-46e9-8e1f-13e2402f3792" xlink:to="loc_dxcm_OtherLongTermAssets_21f05029-0b91-4217-8fae-c11c259694cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LongTermDeposits_db0a1087-b00a-468b-9646-8256d876582a" xlink:href="dxcm-20230630.xsd#dxcm_LongTermDeposits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_7d9268c0-22b1-46e9-8e1f-13e2402f3792" xlink:to="loc_dxcm_LongTermDeposits_db0a1087-b00a-468b-9646-8256d876582a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_4af2a9bd-048e-409d-ba50-8a764e71bdc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_7d9268c0-22b1-46e9-8e1f-13e2402f3792" xlink:to="loc_us-gaap_LongTermInvestments_4af2a9bd-048e-409d-ba50-8a764e71bdc3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_041609e9-391e-4630-af3b-18bf8370de6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_841be0a3-6897-4e09-8d09-1c49a77461b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_041609e9-391e-4630-af3b-18bf8370de6d" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_841be0a3-6897-4e09-8d09-1c49a77461b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedTaxAuditAndLegalFees_d1a0d39c-7d09-4d27-b21b-9462428bc1a3" xlink:href="dxcm-20230630.xsd#dxcm_AccruedTaxAuditAndLegalFees"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_041609e9-391e-4630-af3b-18bf8370de6d" xlink:to="loc_dxcm_AccruedTaxAuditAndLegalFees_d1a0d39c-7d09-4d27-b21b-9462428bc1a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PharmacyRebates_141460be-7f24-40d1-b305-1e8c599a9fa7" xlink:href="dxcm-20230630.xsd#dxcm_PharmacyRebates"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_041609e9-391e-4630-af3b-18bf8370de6d" xlink:to="loc_dxcm_PharmacyRebates_141460be-7f24-40d1-b305-1e8c599a9fa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_37d040c7-659f-4ba6-adaf-aa923e7d232d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_041609e9-391e-4630-af3b-18bf8370de6d" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_37d040c7-659f-4ba6-adaf-aa923e7d232d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_bc81a40b-1e91-44bb-9181-9a5e7dcee08d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_041609e9-391e-4630-af3b-18bf8370de6d" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_bc81a40b-1e91-44bb-9181-9a5e7dcee08d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent_f68a1e50-cbe6-4c40-a23d-4e96b736e2af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_041609e9-391e-4630-af3b-18bf8370de6d" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrent_f68a1e50-cbe6-4c40-a23d-4e96b736e2af" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_43ecddb3-f62f-4141-825f-cc26b8523017" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent_f2f1cd29-5edb-4836-9fda-ce60cd094402" xlink:href="dxcm-20230630.xsd#dxcm_AccruedWagesBonusesAndTaxesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_43ecddb3-f62f-4141-825f-cc26b8523017" xlink:to="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent_f2f1cd29-5edb-4836-9fda-ce60cd094402" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_d08bc066-6d91-4b2e-8f98-d8a239a0f34d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_43ecddb3-f62f-4141-825f-cc26b8523017" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_d08bc066-6d91-4b2e-8f98-d8a239a0f34d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsOtherLongTermLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_0bf4ecc5-393e-48e6-b44c-7ae28a4ac3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_54401011-3e45-4c67-8a00-15739c58d59a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_0bf4ecc5-393e-48e6-b44c-7ae28a4ac3d2" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_54401011-3e45-4c67-8a00-15739c58d59a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherTaxLiabilitiesNoncurrent_1680321e-66ee-4264-8894-114b880d82f1" xlink:href="dxcm-20230630.xsd#dxcm_OtherTaxLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_0bf4ecc5-393e-48e6-b44c-7ae28a4ac3d2" xlink:to="loc_dxcm_OtherTaxLiabilitiesNoncurrent_1680321e-66ee-4264-8894-114b880d82f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_fdaefe7e-bf0a-4ffb-9498-e6886d087b10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_0bf4ecc5-393e-48e6-b44c-7ae28a4ac3d2" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_fdaefe7e-bf0a-4ffb-9498-e6886d087b10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_00725c34-524b-4616-abe8-fc5fd24ceae8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_0bf4ecc5-393e-48e6-b44c-7ae28a4ac3d2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_00725c34-524b-4616-abe8-fc5fd24ceae8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0c78e0bd-0ddb-45dc-9a92-062f70754146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_0bf4ecc5-393e-48e6-b44c-7ae28a4ac3d2" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0c78e0bd-0ddb-45dc-9a92-062f70754146" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#DebtSeniorConvertibleNotesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_1e68ca49-26b0-498a-873b-6902985f4474" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_00b8439f-3c03-403d-86cb-dad7d867c214" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleNotesPayable_1e68ca49-26b0-498a-873b-6902985f4474" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_00b8439f-3c03-403d-86cb-dad7d867c214" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_3ae8f704-5ff1-4cef-99ad-122b4804656a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleNotesPayable_1e68ca49-26b0-498a-873b-6902985f4474" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_3ae8f704-5ff1-4cef-99ad-122b4804656a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_a6345a7d-1335-427a-bb18-993177418f22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_07ac5bd4-82c6-4e6d-a288-0021db7b002d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_a6345a7d-1335-427a-bb18-993177418f22" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_07ac5bd4-82c6-4e6d-a288-0021db7b002d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_670c0449-4f78-42bd-92fb-d26567639169" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_a6345a7d-1335-427a-bb18-993177418f22" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_670c0449-4f78-42bd-92fb-d26567639169" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>dxcm-20230630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:3f233038-1297-4d40-b9d2-42700d6fe8fe,g:c1345a4d-d54c-45d2-818f-78cac7edf10e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="dxcm-20230630.xsd#ConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended" id="i4e7420f800254e6cba7f27f40a02f6d6_ConsolidatedStatementsofStockholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b6dcd6cc-5d1d-4835-b36d-57db2cd17315" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b6dcd6cc-5d1d-4835-b36d-57db2cd17315" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6407ca40-c032-43c2-982c-e802da677dde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6407ca40-c032-43c2-982c-e802da677dde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_02c62a25-7009-4007-9886-8c1c8a52e429" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_StockholdersEquity_02c62a25-7009-4007-9886-8c1c8a52e429" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_ab4aae71-82df-4c7b-bd75-b888cea30aca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_ab4aae71-82df-4c7b-bd75-b888cea30aca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f8912b7d-a0b3-4500-9ccb-02204417b77e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f8912b7d-a0b3-4500-9ccb-02204417b77e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a9f4520d-bf0a-41d1-b241-5c3239ff94e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a9f4520d-bf0a-41d1-b241-5c3239ff94e0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_6a52bfde-617c-49d2-be54-c5c454c796cf" xlink:href="dxcm-20230630.xsd#dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_6a52bfde-617c-49d2-be54-c5c454c796cf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone_9b55eb8e-f5e1-4983-8860-6f6f63f259bd" xlink:href="dxcm-20230630.xsd#dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone_9b55eb8e-f5e1-4983-8860-6f6f63f259bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_698e05b5-f966-423e-8034-0384ea8daccd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_698e05b5-f966-423e-8034-0384ea8daccd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_abd9277c-8647-4b39-9808-d42e2433f112" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_abd9277c-8647-4b39-9808-d42e2433f112" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_cf04b5dd-abd0-49ca-aff9-a03bfa09e1aa" xlink:href="dxcm-20230630.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_cf04b5dd-abd0-49ca-aff9-a03bfa09e1aa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_f567b839-3e7f-4651-b643-05130a64706d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_f567b839-3e7f-4651-b643-05130a64706d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_21273522-bb7c-45e6-bb5f-26b92dfccd62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_21273522-bb7c-45e6-bb5f-26b92dfccd62" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge_062bd11f-5ec5-4e2f-8a51-8ee268adecd4" xlink:href="dxcm-20230630.xsd#dxcm_SharesReceivedFromExerciseOfNoteHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge_062bd11f-5ec5-4e2f-8a51-8ee268adecd4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue_a6a61d17-e4d8-49f7-a712-6f4c5d2f5f2d" xlink:href="dxcm-20230630.xsd#dxcm_SharesReceivedFromBenefitOfNoteHedgeValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue_a6a61d17-e4d8-49f7-a712-6f4c5d2f5f2d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d2d7d2fd-41fb-499a-8fa2-4553a81397b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d2d7d2fd-41fb-499a-8fa2-4553a81397b2" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3cf739ef-6f66-400f-bf0c-0ea2a6b390a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_NetIncomeLoss_3cf739ef-6f66-400f-bf0c-0ea2a6b390a7" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2a21c106-a769-480b-9e4b-20c24d64dbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2a21c106-a769-480b-9e4b-20c24d64dbb8" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a059dea5-7bfa-4b90-97bf-e277cc0faf80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_967aee47-705b-4650-9c2e-dd40eeeb7ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f5162a71-2575-4520-81f8-5357befdb831" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b6dcd6cc-5d1d-4835-b36d-57db2cd17315" xlink:to="loc_us-gaap_StatementTable_f5162a71-2575-4520-81f8-5357befdb831" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9a5ed516-bc48-43a2-92bc-5fcc1248da74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f5162a71-2575-4520-81f8-5357befdb831" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9a5ed516-bc48-43a2-92bc-5fcc1248da74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9a5ed516-bc48-43a2-92bc-5fcc1248da74_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9a5ed516-bc48-43a2-92bc-5fcc1248da74" xlink:to="loc_us-gaap_EquityComponentDomain_9a5ed516-bc48-43a2-92bc-5fcc1248da74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c9390a4b-4370-4fc2-ad96-27a371e4597c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9a5ed516-bc48-43a2-92bc-5fcc1248da74" xlink:to="loc_us-gaap_EquityComponentDomain_c9390a4b-4370-4fc2-ad96-27a371e4597c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_72c5f11e-2531-47e0-b6f8-0a03ae031094" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c9390a4b-4370-4fc2-ad96-27a371e4597c" xlink:to="loc_us-gaap_CommonStockMember_72c5f11e-2531-47e0-b6f8-0a03ae031094" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9596fe7c-f9d2-48aa-8bcb-4646f6341c88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c9390a4b-4370-4fc2-ad96-27a371e4597c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9596fe7c-f9d2-48aa-8bcb-4646f6341c88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2ddc020c-b653-4445-b2ec-28d3e23fffbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c9390a4b-4370-4fc2-ad96-27a371e4597c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2ddc020c-b653-4445-b2ec-28d3e23fffbd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a2af26e5-6991-4e3f-b006-96177c9b2b11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c9390a4b-4370-4fc2-ad96-27a371e4597c" xlink:to="loc_us-gaap_RetainedEarningsMember_a2af26e5-6991-4e3f-b006-96177c9b2b11" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_3440c192-598a-4931-ac27-175a0ece2d36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c9390a4b-4370-4fc2-ad96-27a371e4597c" xlink:to="loc_us-gaap_TreasuryStockCommonMember_3440c192-598a-4931-ac27-175a0ece2d36" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#OrganizationandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i67b46d9d20fa407a959a9c93fd59fa03_OrganizationandSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_8a61dea3-f6ce-4945-9e29-61733aaea023" xlink:href="dxcm-20230630.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_9c7fda2e-264d-47ac-88f1-1b16fe99d856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_8a61dea3-f6ce-4945-9e29-61733aaea023" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_9c7fda2e-264d-47ac-88f1-1b16fe99d856" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0fca3060-7dd0-4bc8-8408-70648aed6c20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_8a61dea3-f6ce-4945-9e29-61733aaea023" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0fca3060-7dd0-4bc8-8408-70648aed6c20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ContractPaymentTermsNumberofDays_9f6cf492-bb4d-4c4b-bfb0-f42dad137f8f" xlink:href="dxcm-20230630.xsd#dxcm_ContractPaymentTermsNumberofDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_8a61dea3-f6ce-4945-9e29-61733aaea023" xlink:to="loc_dxcm_ContractPaymentTermsNumberofDays_9f6cf492-bb4d-4c4b-bfb0-f42dad137f8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_dba470f9-ff51-411e-be6b-4ccec5196656" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_8a61dea3-f6ce-4945-9e29-61733aaea023" xlink:to="loc_us-gaap_UnbilledContractsReceivable_dba470f9-ff51-411e-be6b-4ccec5196656" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ef4c616a-4699-4958-a200-d7de3d353377" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_8a61dea3-f6ce-4945-9e29-61733aaea023" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ef4c616a-4699-4958-a200-d7de3d353377" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_a035aea9-089b-4d5c-b70a-f00a4a64c468" xlink:href="dxcm-20230630.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_8a61dea3-f6ce-4945-9e29-61733aaea023" xlink:to="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_a035aea9-089b-4d5c-b70a-f00a4a64c468" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6503bb58-2064-47f2-83f3-d4f57ec66618" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_a035aea9-089b-4d5c-b70a-f00a4a64c468" xlink:to="loc_srt_RangeAxis_6503bb58-2064-47f2-83f3-d4f57ec66618" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6503bb58-2064-47f2-83f3-d4f57ec66618_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6503bb58-2064-47f2-83f3-d4f57ec66618" xlink:to="loc_srt_RangeMember_6503bb58-2064-47f2-83f3-d4f57ec66618_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4d332a2d-dcac-48e5-ab0e-26a6fec6888f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6503bb58-2064-47f2-83f3-d4f57ec66618" xlink:to="loc_srt_RangeMember_4d332a2d-dcac-48e5-ab0e-26a6fec6888f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_975ad60a-5d2a-45ce-a47b-50df04ecaeba" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4d332a2d-dcac-48e5-ab0e-26a6fec6888f" xlink:to="loc_srt_MinimumMember_975ad60a-5d2a-45ce-a47b-50df04ecaeba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_45a7cdbb-f813-4ecf-92f3-2ab9e63564c4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4d332a2d-dcac-48e5-ab0e-26a6fec6888f" xlink:to="loc_srt_MaximumMember_45a7cdbb-f813-4ecf-92f3-2ab9e63564c4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails" xlink:type="extended" id="ibbb6e2e0c3404bec85feaf62ea456983_OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1211c4cd-24c6-4fbe-8d55-702f47e149c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:to="loc_us-gaap_NetIncomeLoss_1211c4cd-24c6-4fbe-8d55-702f47e149c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_b53620a7-92a7-4b37-a6d3-5235b7221602" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_b53620a7-92a7-4b37-a6d3-5235b7221602" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_06c74aaf-ea61-47ac-9733-930289b8f007" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_06c74aaf-ea61-47ac-9733-930289b8f007" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ec750fc0-0006-402d-be5d-21cbb00beaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:to="loc_us-gaap_EarningsPerShareAbstract_ec750fc0-0006-402d-be5d-21cbb00beaf4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4fd22752-48c1-4362-b6af-74d805ad43b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec750fc0-0006-402d-be5d-21cbb00beaf4" xlink:to="loc_us-gaap_EarningsPerShareBasic_4fd22752-48c1-4362-b6af-74d805ad43b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_db3cf4b7-61fa-4ed5-b296-82f4b1107c50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec750fc0-0006-402d-be5d-21cbb00beaf4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_db3cf4b7-61fa-4ed5-b296-82f4b1107c50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a11e7922-6ef4-4ad9-a040-97aa0434e70f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a11e7922-6ef4-4ad9-a040-97aa0434e70f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4d42c1df-b637-45c6-9111-cf3b0a4b5029" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4d42c1df-b637-45c6-9111-cf3b0a4b5029" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_167f8087-e2ee-47f5-bbeb-6c3873ae255b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_167f8087-e2ee-47f5-bbeb-6c3873ae255b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53916042-4bd7-4cd6-8425-f7153225c529" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53916042-4bd7-4cd6-8425-f7153225c529" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e02c3a58-f493-46ef-a979-1a5ccdb03134" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53916042-4bd7-4cd6-8425-f7153225c529" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e02c3a58-f493-46ef-a979-1a5ccdb03134" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e02c3a58-f493-46ef-a979-1a5ccdb03134_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e02c3a58-f493-46ef-a979-1a5ccdb03134" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e02c3a58-f493-46ef-a979-1a5ccdb03134_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ec335272-8d95-4c10-b189-d7702a0995a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e02c3a58-f493-46ef-a979-1a5ccdb03134" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ec335272-8d95-4c10-b189-d7702a0995a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_14c068fa-2248-4a7c-aabf-7eab6c5dfa07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ec335272-8d95-4c10-b189-d7702a0995a4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_14c068fa-2248-4a7c-aabf-7eab6c5dfa07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_7700d827-9e45-4ce1-88fd-13f366f5881d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ec335272-8d95-4c10-b189-d7702a0995a4" xlink:to="loc_us-gaap_WarrantMember_7700d827-9e45-4ce1-88fd-13f366f5881d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_a3dc99b2-7a2a-455c-80a1-b26fb6714d76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ec335272-8d95-4c10-b189-d7702a0995a4" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_a3dc99b2-7a2a-455c-80a1-b26fb6714d76" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails" xlink:type="extended" id="ibf720c864c1545b68ce3285d44ef2b1c_OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c07a39bf-2886-4946-951c-a01235d8613d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bea8e188-92b3-40a4-8910-7daa8210f65c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c07a39bf-2886-4946-951c-a01235d8613d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bea8e188-92b3-40a4-8910-7daa8210f65c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_df4d6e2b-72e8-4756-8f01-ee600d7c2272" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c07a39bf-2886-4946-951c-a01235d8613d" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_df4d6e2b-72e8-4756-8f01-ee600d7c2272" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e9c05010-72d5-44ab-b532-ef54e784006a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_df4d6e2b-72e8-4756-8f01-ee600d7c2272" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e9c05010-72d5-44ab-b532-ef54e784006a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e9c05010-72d5-44ab-b532-ef54e784006a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e9c05010-72d5-44ab-b532-ef54e784006a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e9c05010-72d5-44ab-b532-ef54e784006a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f9aa2e2a-3ed0-4875-9d43-659c64aad6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e9c05010-72d5-44ab-b532-ef54e784006a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f9aa2e2a-3ed0-4875-9d43-659c64aad6c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RestrictedAndPerformanceStockUnitsMember_2208a1e8-0dd6-4850-8dff-aae75e7dface" xlink:href="dxcm-20230630.xsd#dxcm_RestrictedAndPerformanceStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f9aa2e2a-3ed0-4875-9d43-659c64aad6c3" xlink:to="loc_dxcm_RestrictedAndPerformanceStockUnitsMember_2208a1e8-0dd6-4850-8dff-aae75e7dface" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_0e2c9b4f-bd5b-47dd-966b-00333f993ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f9aa2e2a-3ed0-4875-9d43-659c64aad6c3" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_0e2c9b4f-bd5b-47dd-966b-00333f993ea8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#DevelopmentandOtherAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails" xlink:type="extended" id="i2ebf0ab78d104817bd36418795f19f76_DevelopmentandOtherAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_7817b93d-1e25-4e11-af8e-6c80474d7a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:to="loc_us-gaap_SharePrice_7817b93d-1e25-4e11-af8e-6c80474d7a2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementUpfrontFee_143cb671-3bd1-41c6-838a-7829c166ceee" xlink:href="dxcm-20230630.xsd#dxcm_CollaborativeArrangementUpfrontFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:to="loc_dxcm_CollaborativeArrangementUpfrontFee_143cb671-3bd1-41c6-838a-7829c166ceee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cb7e5426-b1d4-48f7-bf2f-0bb64c018b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cb7e5426-b1d4-48f7-bf2f-0bb64c018b4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee_aaf4995c-1a3c-49d9-b7da-7e6724498b4d" xlink:href="dxcm-20230630.xsd#dxcm_CollaborativeResearchAndDevelopmentFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:to="loc_dxcm_CollaborativeResearchAndDevelopmentFee_aaf4995c-1a3c-49d9-b7da-7e6724498b4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_de99aa5d-a4e3-4ea5-adbe-ffb16dbb74fb" xlink:href="dxcm-20230630.xsd#dxcm_PotentialFutureCommonStockIssuableSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:to="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_de99aa5d-a4e3-4ea5-adbe-ffb16dbb74fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_beaaef06-06bb-4652-858b-7c670240031e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_beaaef06-06bb-4652-858b-7c670240031e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_20b4c6ba-6f69-4c66-9e9c-1ae7f108c21c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_20b4c6ba-6f69-4c66-9e9c-1ae7f108c21c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_174c47f0-4da3-44b1-be8a-9bb20e412079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:to="loc_us-gaap_OtherCommitmentsTable_174c47f0-4da3-44b1-be8a-9bb20e412079" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_91efd945-d19c-4474-88ec-503587b3bd18" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_174c47f0-4da3-44b1-be8a-9bb20e412079" xlink:to="loc_srt_CounterpartyNameAxis_91efd945-d19c-4474-88ec-503587b3bd18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_91efd945-d19c-4474-88ec-503587b3bd18_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_91efd945-d19c-4474-88ec-503587b3bd18" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_91efd945-d19c-4474-88ec-503587b3bd18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_31dee363-f552-4c21-95a1-0d23b2b84d9a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_91efd945-d19c-4474-88ec-503587b3bd18" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_31dee363-f552-4c21-95a1-0d23b2b84d9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyLifeSciencesMember_5f324c3e-830b-48c1-9e87-fc7bd12d7a50" xlink:href="dxcm-20230630.xsd#dxcm_VerilyLifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_31dee363-f552-4c21-95a1-0d23b2b84d9a" xlink:to="loc_dxcm_VerilyLifeSciencesMember_5f324c3e-830b-48c1-9e87-fc7bd12d7a50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_476353c7-36a3-4296-8735-2dfd6a12b535" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_174c47f0-4da3-44b1-be8a-9bb20e412079" xlink:to="loc_us-gaap_TypeOfArrangementAxis_476353c7-36a3-4296-8735-2dfd6a12b535" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_476353c7-36a3-4296-8735-2dfd6a12b535_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_476353c7-36a3-4296-8735-2dfd6a12b535" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_476353c7-36a3-4296-8735-2dfd6a12b535_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a462ce7c-208e-4e1c-bbda-1edb08a746f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_476353c7-36a3-4296-8735-2dfd6a12b535" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a462ce7c-208e-4e1c-bbda-1edb08a746f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_38167e41-cde2-431a-8724-6687be8e3287" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a462ce7c-208e-4e1c-bbda-1edb08a746f4" xlink:to="loc_us-gaap_CollaborativeArrangementMember_38167e41-cde2-431a-8724-6687be8e3287" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_de216382-6563-4ea9-8882-7e8374ea751c" xlink:href="dxcm-20230630.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_174c47f0-4da3-44b1-be8a-9bb20e412079" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_de216382-6563-4ea9-8882-7e8374ea751c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_de216382-6563-4ea9-8882-7e8374ea751c_default" xlink:href="dxcm-20230630.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_de216382-6563-4ea9-8882-7e8374ea751c" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_de216382-6563-4ea9-8882-7e8374ea751c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_46ee2abc-c8a0-483f-8dd7-00fea9c925c6" xlink:href="dxcm-20230630.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_de216382-6563-4ea9-8882-7e8374ea751c" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_46ee2abc-c8a0-483f-8dd7-00fea9c925c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementInitialPaymentMember_36a2d350-7c21-475c-af32-0cc287c8766e" xlink:href="dxcm-20230630.xsd#dxcm_CollaborativeArrangementInitialPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_46ee2abc-c8a0-483f-8dd7-00fea9c925c6" xlink:to="loc_dxcm_CollaborativeArrangementInitialPaymentMember_36a2d350-7c21-475c-af32-0cc287c8766e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_088ca57a-ba0d-43a1-969b-45ec4dd1ee65" xlink:href="dxcm-20230630.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_46ee2abc-c8a0-483f-8dd7-00fea9c925c6" xlink:to="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_088ca57a-ba0d-43a1-969b-45ec4dd1ee65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementApprovalMilestoneMember_3e8e5aea-0ee6-4a46-9e32-a1012549afbb" xlink:href="dxcm-20230630.xsd#dxcm_CollaborativeArrangementApprovalMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_46ee2abc-c8a0-483f-8dd7-00fea9c925c6" xlink:to="loc_dxcm_CollaborativeArrangementApprovalMilestoneMember_3e8e5aea-0ee6-4a46-9e32-a1012549afbb" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#FairValueMeasurementsSummaryDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails" xlink:type="extended" id="if7963c14b90b4efa8a854d95b4515a7c_FairValueMeasurementsSummaryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f18bdcd8-d920-4188-8417-98b10110ed1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_4e5fd0b1-518a-4dc0-88c7-2a3f8a4da4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f18bdcd8-d920-4188-8417-98b10110ed1b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_4e5fd0b1-518a-4dc0-88c7-2a3f8a4da4f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_f035e21b-47b8-4640-a6b9-8aa8f98ea218" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_4e5fd0b1-518a-4dc0-88c7-2a3f8a4da4f4" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_f035e21b-47b8-4640-a6b9-8aa8f98ea218" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ccfec73e-d94b-4860-9b36-5ffb9d75c4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_4e5fd0b1-518a-4dc0-88c7-2a3f8a4da4f4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ccfec73e-d94b-4860-9b36-5ffb9d75c4fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_d035ef9e-7181-4b48-81b9-5a0c4dfc57c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_4e5fd0b1-518a-4dc0-88c7-2a3f8a4da4f4" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_d035ef9e-7181-4b48-81b9-5a0c4dfc57c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e9fbb773-9293-457d-954c-2f8f114504b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_4e5fd0b1-518a-4dc0-88c7-2a3f8a4da4f4" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_e9fbb773-9293-457d-954c-2f8f114504b5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c68e48e-8663-411b-966c-da5b9d75bd81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f18bdcd8-d920-4188-8417-98b10110ed1b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c68e48e-8663-411b-966c-da5b9d75bd81" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_60bda168-b622-4373-8dce-8019a274ede9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c68e48e-8663-411b-966c-da5b9d75bd81" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_60bda168-b622-4373-8dce-8019a274ede9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_60bda168-b622-4373-8dce-8019a274ede9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_60bda168-b622-4373-8dce-8019a274ede9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_60bda168-b622-4373-8dce-8019a274ede9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00f3da31-bbbe-4ad1-9ecf-8fd74f821eff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_60bda168-b622-4373-8dce-8019a274ede9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00f3da31-bbbe-4ad1-9ecf-8fd74f821eff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3d7ed2dc-2425-4f9f-b340-f987ec916d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00f3da31-bbbe-4ad1-9ecf-8fd74f821eff" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3d7ed2dc-2425-4f9f-b340-f987ec916d2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_08f022c2-1135-4df4-8917-04c56119cc08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00f3da31-bbbe-4ad1-9ecf-8fd74f821eff" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_08f022c2-1135-4df4-8917-04c56119cc08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_10e30433-57c1-4093-9f87-612cc863e7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00f3da31-bbbe-4ad1-9ecf-8fd74f821eff" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_10e30433-57c1-4093-9f87-612cc863e7f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3d494930-d9f5-4318-a807-f5ede4f6b7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c68e48e-8663-411b-966c-da5b9d75bd81" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3d494930-d9f5-4318-a807-f5ede4f6b7e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3d494930-d9f5-4318-a807-f5ede4f6b7e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3d494930-d9f5-4318-a807-f5ede4f6b7e6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3d494930-d9f5-4318-a807-f5ede4f6b7e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c63c8ec8-ed49-4e03-878a-b698fc68d584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3d494930-d9f5-4318-a807-f5ede4f6b7e6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c63c8ec8-ed49-4e03-878a-b698fc68d584" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_2d02ef54-8d74-4c57-86a5-9828bb843e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c63c8ec8-ed49-4e03-878a-b698fc68d584" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_2d02ef54-8d74-4c57-86a5-9828bb843e5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_c4991788-6144-44ab-ac7c-71a3cc72ed16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c63c8ec8-ed49-4e03-878a-b698fc68d584" xlink:to="loc_us-gaap_CommercialPaperMember_c4991788-6144-44ab-ac7c-71a3cc72ed16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_7b1533f1-4ca2-4889-82f7-47f36cf60ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c63c8ec8-ed49-4e03-878a-b698fc68d584" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_7b1533f1-4ca2-4889-82f7-47f36cf60ecb" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="ieb72efd71a674445a7fa0ff24172f382_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b5a4194-19bc-495e-bfb1-2002545c6337" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueAssetsLevel3TransfersAmount_758d6b75-ed60-487b-8419-11f7bf57ea1b" xlink:href="dxcm-20230630.xsd#dxcm_FairValueAssetsLevel3TransfersAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b5a4194-19bc-495e-bfb1-2002545c6337" xlink:to="loc_dxcm_FairValueAssetsLevel3TransfersAmount_758d6b75-ed60-487b-8419-11f7bf57ea1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_eed875c7-3092-4e25-b78a-3056120a1476" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b5a4194-19bc-495e-bfb1-2002545c6337" xlink:to="loc_us-gaap_DerivativeNotionalAmount_eed875c7-3092-4e25-b78a-3056120a1476" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_c9422450-28f6-45e4-bf9c-ba67e50e43aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b5a4194-19bc-495e-bfb1-2002545c6337" xlink:to="loc_us-gaap_LongTermInvestments_c9422450-28f6-45e4-bf9c-ba67e50e43aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a32912c2-24e3-40ba-bcef-7f28bf30ed83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b5a4194-19bc-495e-bfb1-2002545c6337" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a32912c2-24e3-40ba-bcef-7f28bf30ed83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d698938b-4627-4ab6-8748-c659c7448628" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b5a4194-19bc-495e-bfb1-2002545c6337" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d698938b-4627-4ab6-8748-c659c7448628" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3f563668-079c-46b9-a002-0324c3ab5079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d698938b-4627-4ab6-8748-c659c7448628" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3f563668-079c-46b9-a002-0324c3ab5079" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3f563668-079c-46b9-a002-0324c3ab5079_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3f563668-079c-46b9-a002-0324c3ab5079" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3f563668-079c-46b9-a002-0324c3ab5079_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4092ab90-daa5-4ec1-bbb6-1ae95104b1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3f563668-079c-46b9-a002-0324c3ab5079" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4092ab90-daa5-4ec1-bbb6-1ae95104b1f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_4293593f-2932-4262-b5bc-70adffdb2f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_4092ab90-daa5-4ec1-bbb6-1ae95104b1f8" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_4293593f-2932-4262-b5bc-70adffdb2f5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4ae0d8d4-cb2a-436b-8fe3-4911d7c208bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d698938b-4627-4ab6-8748-c659c7448628" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4ae0d8d4-cb2a-436b-8fe3-4911d7c208bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4ae0d8d4-cb2a-436b-8fe3-4911d7c208bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4ae0d8d4-cb2a-436b-8fe3-4911d7c208bd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4ae0d8d4-cb2a-436b-8fe3-4911d7c208bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0f835632-89ef-4277-afaa-7ae09e8fcc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4ae0d8d4-cb2a-436b-8fe3-4911d7c208bd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0f835632-89ef-4277-afaa-7ae09e8fcc5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_bccdbf5e-51ca-4b14-8be6-75c4e7517eae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0f835632-89ef-4277-afaa-7ae09e8fcc5c" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_bccdbf5e-51ca-4b14-8be6-75c4e7517eae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d6823696-da73-49c1-aae7-56ddc527a452" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d698938b-4627-4ab6-8748-c659c7448628" xlink:to="loc_us-gaap_HedgingDesignationAxis_d6823696-da73-49c1-aae7-56ddc527a452" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d6823696-da73-49c1-aae7-56ddc527a452_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d6823696-da73-49c1-aae7-56ddc527a452" xlink:to="loc_us-gaap_HedgingDesignationDomain_d6823696-da73-49c1-aae7-56ddc527a452_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_135634b0-9c90-423c-8ae5-79639a3a50dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d6823696-da73-49c1-aae7-56ddc527a452" xlink:to="loc_us-gaap_HedgingDesignationDomain_135634b0-9c90-423c-8ae5-79639a3a50dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_17e5900b-fb8c-40a9-bf65-b2eac5a14734" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_135634b0-9c90-423c-8ae5-79639a3a50dc" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_17e5900b-fb8c-40a9-bf65-b2eac5a14734" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails" xlink:type="extended" id="i11ce3636fa2d4dc2a4f480c4a7ba7590_FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueDisclosuresLineItems_46bc7725-4e6f-48dd-af20-fe8feb006470" xlink:href="dxcm-20230630.xsd#dxcm_FairValueDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_90be7c65-82fd-49cf-9e93-c36756cf8e87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_FairValueDisclosuresLineItems_46bc7725-4e6f-48dd-af20-fe8feb006470" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_90be7c65-82fd-49cf-9e93-c36756cf8e87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_d2760cf1-f55a-48f6-9668-f133dd92f28e" xlink:href="dxcm-20230630.xsd#dxcm_FairValueDisclosuresSeniorConvertibleNotesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dxcm_FairValueDisclosuresLineItems_46bc7725-4e6f-48dd-af20-fe8feb006470" xlink:to="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_d2760cf1-f55a-48f6-9668-f133dd92f28e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4dfc0451-b089-4a65-820b-7aeac8c4a03c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_d2760cf1-f55a-48f6-9668-f133dd92f28e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4dfc0451-b089-4a65-820b-7aeac8c4a03c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4dfc0451-b089-4a65-820b-7aeac8c4a03c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4dfc0451-b089-4a65-820b-7aeac8c4a03c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4dfc0451-b089-4a65-820b-7aeac8c4a03c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6e7762df-c062-48d9-af3d-09eedcb71d34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4dfc0451-b089-4a65-820b-7aeac8c4a03c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6e7762df-c062-48d9-af3d-09eedcb71d34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_8ab5f187-f696-4426-b4f8-fab85d146d67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6e7762df-c062-48d9-af3d-09eedcb71d34" xlink:to="loc_us-gaap_SeniorNotesMember_8ab5f187-f696-4426-b4f8-fab85d146d67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ffa1bf27-ef0b-47f6-b16b-24f943b58291" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_d2760cf1-f55a-48f6-9668-f133dd92f28e" xlink:to="loc_us-gaap_DebtInstrumentAxis_ffa1bf27-ef0b-47f6-b16b-24f943b58291" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ffa1bf27-ef0b-47f6-b16b-24f943b58291_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ffa1bf27-ef0b-47f6-b16b-24f943b58291" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ffa1bf27-ef0b-47f6-b16b-24f943b58291_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a7191140-8fbc-468f-b5fe-453f6930ba95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ffa1bf27-ef0b-47f6-b16b-24f943b58291" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a7191140-8fbc-468f-b5fe-453f6930ba95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_729ca587-03ca-4fe9-955e-b6987ddb0f6a" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a7191140-8fbc-468f-b5fe-453f6930ba95" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_729ca587-03ca-4fe9-955e-b6987ddb0f6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_d16f1417-c69f-4f79-982f-4e6876119136" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a7191140-8fbc-468f-b5fe-453f6930ba95" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_d16f1417-c69f-4f79-982f-4e6876119136" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_9ec5c478-28ea-42f9-9e4e-5df1ae241a02" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a7191140-8fbc-468f-b5fe-453f6930ba95" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_9ec5c478-28ea-42f9-9e4e-5df1ae241a02" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsShortTermMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails" xlink:type="extended" id="ide01b314b6d54d73b8d48b46d690ee9d_BalanceSheetDetailsShortTermMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_5576908c-a7c5-4f6d-92ff-e18268b950f7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_51bbeda4-4a80-4d49-80f0-50c12836f7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_5576908c-a7c5-4f6d-92ff-e18268b950f7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_51bbeda4-4a80-4d49-80f0-50c12836f7a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7db04e0b-38cf-4b47-96a7-33d477252531" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_51bbeda4-4a80-4d49-80f0-50c12836f7a5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7db04e0b-38cf-4b47-96a7-33d477252531" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_12b7ce7d-6f77-4aed-9d01-bb54199348ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_51bbeda4-4a80-4d49-80f0-50c12836f7a5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_12b7ce7d-6f77-4aed-9d01-bb54199348ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_69aa1cf5-90ff-42f3-a68c-d932803e77f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_51bbeda4-4a80-4d49-80f0-50c12836f7a5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_69aa1cf5-90ff-42f3-a68c-d932803e77f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2ee4c314-282b-454a-a805-53a00b161e14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_51bbeda4-4a80-4d49-80f0-50c12836f7a5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2ee4c314-282b-454a-a805-53a00b161e14" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_c9b9d2af-9e89-4c73-96db-4238d09dcffa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_5576908c-a7c5-4f6d-92ff-e18268b950f7" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_c9b9d2af-9e89-4c73-96db-4238d09dcffa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e9df98b4-bf22-4742-b718-2d37313be8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_c9b9d2af-9e89-4c73-96db-4238d09dcffa" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e9df98b4-bf22-4742-b718-2d37313be8c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9df98b4-bf22-4742-b718-2d37313be8c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e9df98b4-bf22-4742-b718-2d37313be8c3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9df98b4-bf22-4742-b718-2d37313be8c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f37e5a5d-e749-4778-affb-bb8fb96116f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e9df98b4-bf22-4742-b718-2d37313be8c3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f37e5a5d-e749-4778-affb-bb8fb96116f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1b6f73c1-94ae-4273-a365-1d7506c818fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f37e5a5d-e749-4778-affb-bb8fb96116f3" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1b6f73c1-94ae-4273-a365-1d7506c818fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_5e9a4497-85b0-4c2d-8654-f2f2d71006b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f37e5a5d-e749-4778-affb-bb8fb96116f3" xlink:to="loc_us-gaap_CommercialPaperMember_5e9a4497-85b0-4c2d-8654-f2f2d71006b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_f83cc146-6884-4a22-951f-da5e62802e72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f37e5a5d-e749-4778-affb-bb8fb96116f3" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_f83cc146-6884-4a22-951f-da5e62802e72" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="extended" id="i1aeaf0ee47254b0890094332031929a0_BalanceSheetDetailsPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_006ce00a-4bb5-4ad4-886b-69f78c566585" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_2f568806-aa9b-497e-8055-ef14f73f34fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_006ce00a-4bb5-4ad4-886b-69f78c566585" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_2f568806-aa9b-497e-8055-ef14f73f34fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_a230b270-e67a-438f-b4fa-43e47a810b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_006ce00a-4bb5-4ad4-886b-69f78c566585" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_a230b270-e67a-438f-b4fa-43e47a810b8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_43b7dfd9-b0e7-48dc-a3c5-7931c0b49e03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_006ce00a-4bb5-4ad4-886b-69f78c566585" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_43b7dfd9-b0e7-48dc-a3c5-7931c0b49e03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_115627e2-2c4d-4e86-b1a4-16aaffd9e576" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_006ce00a-4bb5-4ad4-886b-69f78c566585" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_115627e2-2c4d-4e86-b1a4-16aaffd9e576" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eb5ac491-678a-4450-abc4-d4686d862fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_006ce00a-4bb5-4ad4-886b-69f78c566585" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eb5ac491-678a-4450-abc4-d4686d862fc0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3393fd5c-7322-4c98-ae0a-9ed9b2fefd50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eb5ac491-678a-4450-abc4-d4686d862fc0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3393fd5c-7322-4c98-ae0a-9ed9b2fefd50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3393fd5c-7322-4c98-ae0a-9ed9b2fefd50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3393fd5c-7322-4c98-ae0a-9ed9b2fefd50" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3393fd5c-7322-4c98-ae0a-9ed9b2fefd50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3393fd5c-7322-4c98-ae0a-9ed9b2fefd50" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_0cc7fc06-406d-47f0-bcfa-a33abc53dd55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_0cc7fc06-406d-47f0-bcfa-a33abc53dd55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_7e126b79-9992-42e2-9c83-e9443d1c35b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:to="loc_us-gaap_BuildingMember_7e126b79-9992-42e2-9c83-e9443d1c35b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_26c5f63e-b579-4597-9f99-8919505f9287" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_26c5f63e-b579-4597-9f99-8919505f9287" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_5e77b594-03fe-43ea-b202-d9d066020c22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:to="loc_us-gaap_ComputerEquipmentMember_5e77b594-03fe-43ea-b202-d9d066020c22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_ea6b9bb9-3ceb-462f-8ee2-77e60c56fd04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:to="loc_us-gaap_EquipmentMember_ea6b9bb9-3ceb-462f-8ee2-77e60c56fd04" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_f5bad1e8-d77c-4ec5-8fd7-dfc312efc4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_f5bad1e8-d77c-4ec5-8fd7-dfc312efc4ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_0683020a-d610-4099-9508-d85b1fd77ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:to="loc_us-gaap_ConstructionInProgressMember_0683020a-d610-4099-9508-d85b1fd77ef2" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#DebtSeniorConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="extended" id="i465fbdc442b84fac8962a3cc201ff261_DebtSeniorConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_27567132-d9e3-4bf8-8e06-901b22b11f62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_7738cf1c-a213-4f71-8426-3965b7ebe0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27567132-d9e3-4bf8-8e06-901b22b11f62" xlink:to="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_7738cf1c-a213-4f71-8426-3965b7ebe0b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_19e13aa3-7e85-4ae5-8743-bf185990c079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_7738cf1c-a213-4f71-8426-3965b7ebe0b8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_19e13aa3-7e85-4ae5-8743-bf185990c079" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_08e56a51-8552-49bd-be62-dafcb916622a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_7738cf1c-a213-4f71-8426-3965b7ebe0b8" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_08e56a51-8552-49bd-be62-dafcb916622a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_902d35cf-5c71-476d-9782-4201796884fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_7738cf1c-a213-4f71-8426-3965b7ebe0b8" xlink:to="loc_us-gaap_ConvertibleNotesPayable_902d35cf-5c71-476d-9782-4201796884fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_bb6127ee-d916-4895-9e98-ca579ff7a716" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27567132-d9e3-4bf8-8e06-901b22b11f62" xlink:to="loc_us-gaap_DebtInstrumentTable_bb6127ee-d916-4895-9e98-ca579ff7a716" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8094b7b9-e0e5-4816-8174-7f67a3cafb85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bb6127ee-d916-4895-9e98-ca579ff7a716" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8094b7b9-e0e5-4816-8174-7f67a3cafb85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8094b7b9-e0e5-4816-8174-7f67a3cafb85_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8094b7b9-e0e5-4816-8174-7f67a3cafb85" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8094b7b9-e0e5-4816-8174-7f67a3cafb85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1034c874-57fd-4eed-8f48-c5c06019b1f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8094b7b9-e0e5-4816-8174-7f67a3cafb85" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1034c874-57fd-4eed-8f48-c5c06019b1f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_fec68da4-a1e2-406e-94de-374f5b2016b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1034c874-57fd-4eed-8f48-c5c06019b1f5" xlink:to="loc_us-gaap_SeniorNotesMember_fec68da4-a1e2-406e-94de-374f5b2016b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6de29721-0372-4ffb-a8e9-3fbed17f20d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bb6127ee-d916-4895-9e98-ca579ff7a716" xlink:to="loc_us-gaap_DebtInstrumentAxis_6de29721-0372-4ffb-a8e9-3fbed17f20d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6de29721-0372-4ffb-a8e9-3fbed17f20d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6de29721-0372-4ffb-a8e9-3fbed17f20d1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6de29721-0372-4ffb-a8e9-3fbed17f20d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f323b912-e3d1-420b-b9e9-f83e040f0bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6de29721-0372-4ffb-a8e9-3fbed17f20d1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f323b912-e3d1-420b-b9e9-f83e040f0bb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_01300ae5-4e6c-4709-9412-47eee3db733c" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f323b912-e3d1-420b-b9e9-f83e040f0bb1" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_01300ae5-4e6c-4709-9412-47eee3db733c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_1e17912e-26ef-4478-8042-f0522fd167bb" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f323b912-e3d1-420b-b9e9-f83e040f0bb1" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_1e17912e-26ef-4478-8042-f0522fd167bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_a15481d4-cba2-420c-aa23-08f014db7ffe" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f323b912-e3d1-420b-b9e9-f83e040f0bb1" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_a15481d4-cba2-420c-aa23-08f014db7ffe" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#DebtConversionValueofConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails" xlink:type="extended" id="i4ec6b41ee0514f19bbb22a7f50690a22_DebtConversionValueofConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bf2591aa-4c36-450f-872a-303d05b7089a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_e3e227fe-10de-450d-a5c4-ead93961fc81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bf2591aa-4c36-450f-872a-303d05b7089a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_e3e227fe-10de-450d-a5c4-ead93961fc81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c666aa78-a4d8-43d2-b6a8-54f8ffab7474" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bf2591aa-4c36-450f-872a-303d05b7089a" xlink:to="loc_us-gaap_DebtInstrumentTable_c666aa78-a4d8-43d2-b6a8-54f8ffab7474" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b002e57c-5416-469a-ba1c-13f193d05e64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c666aa78-a4d8-43d2-b6a8-54f8ffab7474" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b002e57c-5416-469a-ba1c-13f193d05e64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b002e57c-5416-469a-ba1c-13f193d05e64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b002e57c-5416-469a-ba1c-13f193d05e64" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b002e57c-5416-469a-ba1c-13f193d05e64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b0ca412b-a311-4a04-b411-292f0dd1decb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b002e57c-5416-469a-ba1c-13f193d05e64" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b0ca412b-a311-4a04-b411-292f0dd1decb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_9dab8ff9-e2c7-4f1d-9871-36fef3d0860a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b0ca412b-a311-4a04-b411-292f0dd1decb" xlink:to="loc_us-gaap_SeniorNotesMember_9dab8ff9-e2c7-4f1d-9871-36fef3d0860a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8ec7c85e-0967-44db-9026-f4ceeec2a2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c666aa78-a4d8-43d2-b6a8-54f8ffab7474" xlink:to="loc_us-gaap_DebtInstrumentAxis_8ec7c85e-0967-44db-9026-f4ceeec2a2cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8ec7c85e-0967-44db-9026-f4ceeec2a2cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8ec7c85e-0967-44db-9026-f4ceeec2a2cc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8ec7c85e-0967-44db-9026-f4ceeec2a2cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7bc9cacd-70c8-4077-aff2-48b0cd4f8f31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8ec7c85e-0967-44db-9026-f4ceeec2a2cc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7bc9cacd-70c8-4077-aff2-48b0cd4f8f31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_bbd9164f-1da0-45f7-82d1-5275fe10a770" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7bc9cacd-70c8-4077-aff2-48b0cd4f8f31" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_bbd9164f-1da0-45f7-82d1-5275fe10a770" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_914e9a4a-d0bb-444f-90e6-dc6d8d0417d3" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7bc9cacd-70c8-4077-aff2-48b0cd4f8f31" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_914e9a4a-d0bb-444f-90e6-dc6d8d0417d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_f5598f95-0776-4107-aba5-fda0d7dba139" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7bc9cacd-70c8-4077-aff2-48b0cd4f8f31" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_f5598f95-0776-4107-aba5-fda0d7dba139" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="extended" id="i4cb6af6de95142aebf4693c85fd3606d_DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ba1d8e51-ca34-409e-81ae-e361413e53a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CashInterestExpenseAbstract_1b14f72c-2d82-41ee-8f42-c35666d732bf" xlink:href="dxcm-20230630.xsd#dxcm_CashInterestExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ba1d8e51-ca34-409e-81ae-e361413e53a1" xlink:to="loc_dxcm_CashInterestExpenseAbstract_1b14f72c-2d82-41ee-8f42-c35666d732bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_1b735ff5-0a90-4268-8afc-be1651961fea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_CashInterestExpenseAbstract_1b14f72c-2d82-41ee-8f42-c35666d732bf" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_1b735ff5-0a90-4268-8afc-be1651961fea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NonCashInterestExpenseAbstract_9615d5c4-5c3b-4b31-ae1e-dee721694126" xlink:href="dxcm-20230630.xsd#dxcm_NonCashInterestExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ba1d8e51-ca34-409e-81ae-e361413e53a1" xlink:to="loc_dxcm_NonCashInterestExpenseAbstract_9615d5c4-5c3b-4b31-ae1e-dee721694126" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_b8d6841a-5c88-460f-a710-5e16cc47fdd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_9615d5c4-5c3b-4b31-ae1e-dee721694126" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_b8d6841a-5c88-460f-a710-5e16cc47fdd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_d83c4155-6095-43e4-9d35-84a2b04b9d73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_9615d5c4-5c3b-4b31-ae1e-dee721694126" xlink:to="loc_us-gaap_InterestExpenseDebt_d83c4155-6095-43e4-9d35-84a2b04b9d73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f74bbff0-a6c4-4fcf-835c-efd0b587c6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ba1d8e51-ca34-409e-81ae-e361413e53a1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f74bbff0-a6c4-4fcf-835c-efd0b587c6f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4be693ad-68f1-4ae3-8883-4ec2c679cc99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ba1d8e51-ca34-409e-81ae-e361413e53a1" xlink:to="loc_us-gaap_DebtInstrumentTable_4be693ad-68f1-4ae3-8883-4ec2c679cc99" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9a332b50-7166-47af-9407-2b942052951e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4be693ad-68f1-4ae3-8883-4ec2c679cc99" xlink:to="loc_us-gaap_DebtInstrumentAxis_9a332b50-7166-47af-9407-2b942052951e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9a332b50-7166-47af-9407-2b942052951e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9a332b50-7166-47af-9407-2b942052951e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9a332b50-7166-47af-9407-2b942052951e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cc86c44f-125a-4eed-82b5-2d17b0d055ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9a332b50-7166-47af-9407-2b942052951e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cc86c44f-125a-4eed-82b5-2d17b0d055ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_6832380f-9589-4374-80e4-3768ded62e64" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc86c44f-125a-4eed-82b5-2d17b0d055ad" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_6832380f-9589-4374-80e4-3768ded62e64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_e35d64e6-8092-4968-a89c-edca455db420" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc86c44f-125a-4eed-82b5-2d17b0d055ad" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_e35d64e6-8092-4968-a89c-edca455db420" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_45a16637-14b2-412a-b381-1f368288ace9" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc86c44f-125a-4eed-82b5-2d17b0d055ad" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_45a16637-14b2-412a-b381-1f368288ace9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="extended" id="ie9813934be864599b9386ebe6b1a0386_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2fc73eb9-ab40-4f1a-82a6-b1dd1f368a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2fc73eb9-ab40-4f1a-82a6-b1dd1f368a3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_43e22687-d8c7-4ef1-a7e3-2f36c1c6cb81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_43e22687-d8c7-4ef1-a7e3-2f36c1c6cb81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_a71829fa-fa0c-432a-8f22-a90451aa16ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_a71829fa-fa0c-432a-8f22-a90451aa16ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_691166e8-da79-4a00-a570-0e2f2b6d89fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_691166e8-da79-4a00-a570-0e2f2b6d89fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled_44111715-a19a-42b8-9679-e16765ada75a" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled_44111715-a19a-42b8-9679-e16765ada75a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_75851cf7-0c97-40ae-9836-efe7c409f1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_75851cf7-0c97-40ae-9836-efe7c409f1c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge_8fea39cf-333d-4ce2-b403-3ed04bf098c3" xlink:href="dxcm-20230630.xsd#dxcm_SharesReceivedFromExerciseOfNoteHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge_8fea39cf-333d-4ce2-b403-3ed04bf098c3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_464189d2-7745-449c-9378-b3d02002da33" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentCovenantRepurchasePricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_464189d2-7745-449c-9378-b3d02002da33" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_b73382c9-ac36-40be-ba36-314cf89ccf78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_b73382c9-ac36-40be-ba36-314cf89ccf78" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_2cac3fec-68b1-42fe-9c0d-cc97f1b66925" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_2cac3fec-68b1-42fe-9c0d-cc97f1b66925" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_14da542a-2849-4753-a6ac-71bcc958f841" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_14da542a-2849-4753-a6ac-71bcc958f841" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_cc6b88d0-3885-46ec-8519-2bd678706f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_cc6b88d0-3885-46ec-8519-2bd678706f1b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_fe399dd8-87da-4591-a036-c49d8bb3c4f1" xlink:href="dxcm-20230630.xsd#dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_fe399dd8-87da-4591-a036-c49d8bb3c4f1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_c8ebf9a5-aef8-4a31-8cac-ffff58fccd5f" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_c8ebf9a5-aef8-4a31-8cac-ffff58fccd5f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_be39dc3c-5926-445f-9a2e-d10aedecdfc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_be39dc3c-5926-445f-9a2e-d10aedecdfc0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_b4f92690-0daa-404d-a7e7-0fe95f363e04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_b4f92690-0daa-404d-a7e7-0fe95f363e04" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_ddd2a6a8-4ef0-4767-a8ca-8d0f3ae70ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_ddd2a6a8-4ef0-4767-a8ca-8d0f3ae70ce7" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_874c0aab-f6e5-4b72-a8e8-54ecfd332d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_874c0aab-f6e5-4b72-a8e8-54ecfd332d7f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_ca31a796-3d2e-4b99-8fa0-873918785526" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_ca31a796-3d2e-4b99-8fa0-873918785526" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_290770e9-4a4b-4d56-974a-9bec9d0bf71f" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentCapCallTransactionCapPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_290770e9-4a4b-4d56-974a-9bec9d0bf71f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_8e83a62b-c1a6-49ba-8293-0bfb1fb6abc0" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_8e83a62b-c1a6-49ba-8293-0bfb1fb6abc0" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_44a3b2da-4a13-42ec-85b4-8c1313b78e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_SharePrice_44a3b2da-4a13-42ec-85b4-8c1313b78e4e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_d9fa17f2-da4d-4c1d-91d3-b0f333939eaa" xlink:href="dxcm-20230630.xsd#dxcm_PaymentsForPurchasesOfCappedCallTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_d9fa17f2-da4d-4c1d-91d3-b0f333939eaa" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_ac78da30-1707-4f5c-84af-2d71fe4f58ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentTerm_ac78da30-1707-4f5c-84af-2d71fe4f58ff" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_568d527e-a7a5-40cd-ba72-2bea267bab33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_568d527e-a7a5-40cd-ba72-2bea267bab33" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_5ddda8f7-f26c-4fdd-91d1-8e60f0ef4384" xlink:href="dxcm-20230630.xsd#dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_5ddda8f7-f26c-4fdd-91d1-8e60f0ef4384" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d5cc4a5c-0d30-431d-bb31-c56234005c55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d5cc4a5c-0d30-431d-bb31-c56234005c55" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_e0ac1985-04c6-47c1-a6d6-845518b71f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_e0ac1985-04c6-47c1-a6d6-845518b71f0d" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositAssets_f00bc459-83f5-45c0-baef-de97bb9b1243" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DepositAssets_f00bc459-83f5-45c0-baef-de97bb9b1243" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ff497bac-ceea-48d2-895d-32836e98193f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ff497bac-ceea-48d2-895d-32836e98193f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ff497bac-ceea-48d2-895d-32836e98193f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ff497bac-ceea-48d2-895d-32836e98193f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ff497bac-ceea-48d2-895d-32836e98193f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_608d8386-ce79-4a6d-bf89-78b68b71f3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ff497bac-ceea-48d2-895d-32836e98193f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_608d8386-ce79-4a6d-bf89-78b68b71f3a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_f5a533b5-9959-4000-bb1e-9ac85ba120f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_608d8386-ce79-4a6d-bf89-78b68b71f3a3" xlink:to="loc_us-gaap_SeniorNotesMember_f5a533b5-9959-4000-bb1e-9ac85ba120f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_76fdd905-fdce-46d0-a12b-53f541c81e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_608d8386-ce79-4a6d-bf89-78b68b71f3a3" xlink:to="loc_us-gaap_LineOfCreditMember_76fdd905-fdce-46d0-a12b-53f541c81e1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1fa841d5-2bd6-4971-9da4-6ba3b9820f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_us-gaap_DebtInstrumentAxis_1fa841d5-2bd6-4971-9da4-6ba3b9820f1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1fa841d5-2bd6-4971-9da4-6ba3b9820f1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1fa841d5-2bd6-4971-9da4-6ba3b9820f1f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1fa841d5-2bd6-4971-9da4-6ba3b9820f1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7be6641e-c5b2-4c48-af94-0ce61e3a4465" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1fa841d5-2bd6-4971-9da4-6ba3b9820f1f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7be6641e-c5b2-4c48-af94-0ce61e3a4465" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_0be81327-1830-4eec-8fda-978a557e1a46" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7be6641e-c5b2-4c48-af94-0ce61e3a4465" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_0be81327-1830-4eec-8fda-978a557e1a46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_5f6ab56a-1cd5-4d8d-9db1-ef9b0d1eb246" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7be6641e-c5b2-4c48-af94-0ce61e3a4465" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_5f6ab56a-1cd5-4d8d-9db1-ef9b0d1eb246" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_bc23d839-c2f5-4863-9aed-644d0bef2b1d" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7be6641e-c5b2-4c48-af94-0ce61e3a4465" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_bc23d839-c2f5-4863-9aed-644d0bef2b1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_bc91c015-3e64-41b1-8123-e47c3901ecd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_bc91c015-3e64-41b1-8123-e47c3901ecd5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bc91c015-3e64-41b1-8123-e47c3901ecd5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_bc91c015-3e64-41b1-8123-e47c3901ecd5" xlink:to="loc_us-gaap_EquityComponentDomain_bc91c015-3e64-41b1-8123-e47c3901ecd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a868c340-5078-4886-847b-d1fdba4bd23c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_bc91c015-3e64-41b1-8123-e47c3901ecd5" xlink:to="loc_us-gaap_EquityComponentDomain_a868c340-5078-4886-847b-d1fdba4bd23c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_969150e6-e383-419a-a357-a9a350eb7197" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a868c340-5078-4886-847b-d1fdba4bd23c" xlink:to="loc_us-gaap_CommonStockMember_969150e6-e383-419a-a357-a9a350eb7197" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_bcc69b10-c0c5-4b09-a222-19f3074b24f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_bcc69b10-c0c5-4b09-a222-19f3074b24f8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bcc69b10-c0c5-4b09-a222-19f3074b24f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bcc69b10-c0c5-4b09-a222-19f3074b24f8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bcc69b10-c0c5-4b09-a222-19f3074b24f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_98c88504-3767-4b34-9b11-87b4d5e7e116" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bcc69b10-c0c5-4b09-a222-19f3074b24f8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_98c88504-3767-4b34-9b11-87b4d5e7e116" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a6fa1e03-432a-4523-b5fc-bd5cb28cea73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_98c88504-3767-4b34-9b11-87b4d5e7e116" xlink:to="loc_us-gaap_SubsequentEventMember_a6fa1e03-432a-4523-b5fc-bd5cb28cea73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermAxis_e989589f-7842-4d82-b65c-53c2e32f692c" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConversionTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_dxcm_DebtInstrumentConversionTermAxis_e989589f-7842-4d82-b65c-53c2e32f692c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain_e989589f-7842-4d82-b65c-53c2e32f692c_default" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConversionTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis_e989589f-7842-4d82-b65c-53c2e32f692c" xlink:to="loc_dxcm_DebtInstrumentConversionTermDomain_e989589f-7842-4d82-b65c-53c2e32f692c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain_b017c515-469c-4842-b0d6-517380e744a7" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConversionTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis_e989589f-7842-4d82-b65c-53c2e32f692c" xlink:to="loc_dxcm_DebtInstrumentConversionTermDomain_b017c515-469c-4842-b0d6-517380e744a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermOneMember_9f7bef41-8113-4f0b-9ca3-35022bf936ab" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConversionTermOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_b017c515-469c-4842-b0d6-517380e744a7" xlink:to="loc_dxcm_DebtInstrumentConversionTermOneMember_9f7bef41-8113-4f0b-9ca3-35022bf936ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermTwoMember_7c4a4424-0c55-467d-bb9c-48f2088052cd" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConversionTermTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_b017c515-469c-4842-b0d6-517380e744a7" xlink:to="loc_dxcm_DebtInstrumentConversionTermTwoMember_7c4a4424-0c55-467d-bb9c-48f2088052cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a094f9c3-8c0a-4486-9786-0eabf6d17d49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_us-gaap_HedgingDesignationAxis_a094f9c3-8c0a-4486-9786-0eabf6d17d49" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a094f9c3-8c0a-4486-9786-0eabf6d17d49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_a094f9c3-8c0a-4486-9786-0eabf6d17d49" xlink:to="loc_us-gaap_HedgingDesignationDomain_a094f9c3-8c0a-4486-9786-0eabf6d17d49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_df615568-31d1-45a3-be54-e02dbf35567f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_a094f9c3-8c0a-4486-9786-0eabf6d17d49" xlink:to="loc_us-gaap_HedgingDesignationDomain_df615568-31d1-45a3-be54-e02dbf35567f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fda034f8-2b15-4fa1-8841-25cc1dafcde9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_df615568-31d1-45a3-be54-e02dbf35567f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fda034f8-2b15-4fa1-8841-25cc1dafcde9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e0a1e9cb-9277-49c3-a969-563d0ba8ea55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_us-gaap_VariableRateAxis_e0a1e9cb-9277-49c3-a969-563d0ba8ea55" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e0a1e9cb-9277-49c3-a969-563d0ba8ea55_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_e0a1e9cb-9277-49c3-a969-563d0ba8ea55" xlink:to="loc_us-gaap_VariableRateDomain_e0a1e9cb-9277-49c3-a969-563d0ba8ea55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_fde3275f-f561-4ebb-b047-9d91c06a0efe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_e0a1e9cb-9277-49c3-a969-563d0ba8ea55" xlink:to="loc_us-gaap_VariableRateDomain_fde3275f-f561-4ebb-b047-9d91c06a0efe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember_520d01b4-73e6-41e2-b53a-420274d6cf2d" xlink:href="dxcm-20230630.xsd#dxcm_FederalReserveBankOfNewYorkRateNYFRBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_fde3275f-f561-4ebb-b047-9d91c06a0efe" xlink:to="loc_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember_520d01b4-73e6-41e2-b53a-420274d6cf2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_6578a57c-2d5b-439d-b6b0-a3e4827dc276" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_fde3275f-f561-4ebb-b047-9d91c06a0efe" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_6578a57c-2d5b-439d-b6b0-a3e4827dc276" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SimpleRiskFreeRateRFRMember_fcd28a4c-8fde-4ca4-864d-3374e0df3fd6" xlink:href="dxcm-20230630.xsd#dxcm_SimpleRiskFreeRateRFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_fde3275f-f561-4ebb-b047-9d91c06a0efe" xlink:to="loc_dxcm_SimpleRiskFreeRateRFRMember_fcd28a4c-8fde-4ca4-864d-3374e0df3fd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e7d63e32-189f-446d-af68-464bcbe7c566" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_srt_RangeAxis_e7d63e32-189f-446d-af68-464bcbe7c566" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e7d63e32-189f-446d-af68-464bcbe7c566_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e7d63e32-189f-446d-af68-464bcbe7c566" xlink:to="loc_srt_RangeMember_e7d63e32-189f-446d-af68-464bcbe7c566_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ee15c905-6f23-4aba-9cc5-15283f2ae364" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e7d63e32-189f-446d-af68-464bcbe7c566" xlink:to="loc_srt_RangeMember_ee15c905-6f23-4aba-9cc5-15283f2ae364" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_eac11dd7-665c-4ebb-a72b-ca56e2e402bd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ee15c905-6f23-4aba-9cc5-15283f2ae364" xlink:to="loc_srt_MinimumMember_eac11dd7-665c-4ebb-a72b-ca56e2e402bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f723f26d-7dc7-4300-ad9a-ff328ad8326e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ee15c905-6f23-4aba-9cc5-15283f2ae364" xlink:to="loc_srt_MaximumMember_f723f26d-7dc7-4300-ad9a-ff328ad8326e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="extended" id="i233a2070d671458dbb9677459b0407eb_DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_06cefefb-d58e-4b5e-a7dd-e0e09838aaa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f2a6056a-ff1a-46d5-914d-99c620642174" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_06cefefb-d58e-4b5e-a7dd-e0e09838aaa0" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f2a6056a-ff1a-46d5-914d-99c620642174" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_65b059b5-47fb-480a-a83a-82c6b262a53c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_06cefefb-d58e-4b5e-a7dd-e0e09838aaa0" xlink:to="loc_us-gaap_LineOfCredit_65b059b5-47fb-480a-a83a-82c6b262a53c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_25ff3cbb-7e49-44d3-9efa-8555d8cedec5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_06cefefb-d58e-4b5e-a7dd-e0e09838aaa0" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_25ff3cbb-7e49-44d3-9efa-8555d8cedec5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d7338c42-0209-4c21-8d7f-28b0ea59a89f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_06cefefb-d58e-4b5e-a7dd-e0e09838aaa0" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d7338c42-0209-4c21-8d7f-28b0ea59a89f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_696a828d-fc89-49bd-901f-5323dc540ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_06cefefb-d58e-4b5e-a7dd-e0e09838aaa0" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_696a828d-fc89-49bd-901f-5323dc540ee2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_dd519162-b3eb-4ade-92d5-4100f7bd354f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_696a828d-fc89-49bd-901f-5323dc540ee2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_dd519162-b3eb-4ade-92d5-4100f7bd354f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dd519162-b3eb-4ade-92d5-4100f7bd354f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dd519162-b3eb-4ade-92d5-4100f7bd354f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dd519162-b3eb-4ade-92d5-4100f7bd354f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fd67ccb0-6cf7-4d12-b1ca-c567c79e5723" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dd519162-b3eb-4ade-92d5-4100f7bd354f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fd67ccb0-6cf7-4d12-b1ca-c567c79e5723" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_034ddddb-43ad-4fb7-9746-241305286239" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fd67ccb0-6cf7-4d12-b1ca-c567c79e5723" xlink:to="loc_us-gaap_LineOfCreditMember_034ddddb-43ad-4fb7-9746-241305286239" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7f0810da-59c6-4685-aab3-784d374618eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_696a828d-fc89-49bd-901f-5323dc540ee2" xlink:to="loc_us-gaap_CreditFacilityAxis_7f0810da-59c6-4685-aab3-784d374618eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7f0810da-59c6-4685-aab3-784d374618eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_7f0810da-59c6-4685-aab3-784d374618eb" xlink:to="loc_us-gaap_CreditFacilityDomain_7f0810da-59c6-4685-aab3-784d374618eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0430804f-d931-4939-960f-d709d41d962c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_7f0810da-59c6-4685-aab3-784d374618eb" xlink:to="loc_us-gaap_CreditFacilityDomain_0430804f-d931-4939-960f-d709d41d962c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_a272141b-d117-41bb-a28c-e763a0d7daa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0430804f-d931-4939-960f-d709d41d962c" xlink:to="loc_us-gaap_LetterOfCreditMember_a272141b-d117-41bb-a28c-e763a0d7daa8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#StockholdersEquityShareBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails" xlink:type="extended" id="i70ab0f6689814724a03a6bf8a3ce3398_StockholdersEquityShareBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6622efdd-31b3-4575-9675-0e62deb5956a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3bbd19ac-018b-4958-b153-d488d7af8da1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6622efdd-31b3-4575-9675-0e62deb5956a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3bbd19ac-018b-4958-b153-d488d7af8da1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f209fa7b-6eb7-4903-802b-27f2eb102bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6622efdd-31b3-4575-9675-0e62deb5956a" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f209fa7b-6eb7-4903-802b-27f2eb102bf8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_645f1962-1108-4944-ba1e-af3751dc00e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f209fa7b-6eb7-4903-802b-27f2eb102bf8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_645f1962-1108-4944-ba1e-af3751dc00e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_645f1962-1108-4944-ba1e-af3751dc00e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_645f1962-1108-4944-ba1e-af3751dc00e7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_645f1962-1108-4944-ba1e-af3751dc00e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_08c67ea5-af3d-41ef-95e3-8af372828e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_645f1962-1108-4944-ba1e-af3751dc00e7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_08c67ea5-af3d-41ef-95e3-8af372828e9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_93844b7d-e1c6-48c4-a04b-39a3414bc9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_08c67ea5-af3d-41ef-95e3-8af372828e9c" xlink:to="loc_us-gaap_CostOfSalesMember_93844b7d-e1c6-48c4-a04b-39a3414bc9b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_cef8c5e0-e371-4147-94dc-65209aa0f737" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_08c67ea5-af3d-41ef-95e3-8af372828e9c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_cef8c5e0-e371-4147-94dc-65209aa0f737" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SellingGeneralAndAdministrativeMember_f04ee6e6-d117-4598-8cd6-58a45754e4d5" xlink:href="dxcm-20230630.xsd#dxcm_SellingGeneralAndAdministrativeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_08c67ea5-af3d-41ef-95e3-8af372828e9c" xlink:to="loc_dxcm_SellingGeneralAndAdministrativeMember_f04ee6e6-d117-4598-8cd6-58a45754e4d5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" id="i16c543ae0a4c4d64bbaf2b0d7aab6b42_StockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_06e4c279-8da0-4eda-8c6a-be9af0e8a7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_06e4c279-8da0-4eda-8c6a-be9af0e8a7ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_f6ec801a-f463-43fc-a714-0970aec7748f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_f6ec801a-f463-43fc-a714-0970aec7748f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_27a3f923-e037-4600-9031-be855ac58a25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_27a3f923-e037-4600-9031-be855ac58a25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_19b61bf6-a9dc-4809-89e2-7ec73736c258" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_19b61bf6-a9dc-4809-89e2-7ec73736c258" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6dbaff5f-4776-4ff3-a0ce-122589645b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6dbaff5f-4776-4ff3-a0ce-122589645b0d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_6daa3a77-e244-43ca-8358-ab2167c4679a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_6daa3a77-e244-43ca-8358-ab2167c4679a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_dd6cb5f9-487d-4694-bdd5-398b695870cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_dd6cb5f9-487d-4694-bdd5-398b695870cb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e5fad49-a85d-4f37-bf4d-de4fb3be74ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e5fad49-a85d-4f37-bf4d-de4fb3be74ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f6efd6db-f2fc-4f43-9eed-986bc4ebef21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e5fad49-a85d-4f37-bf4d-de4fb3be74ef" xlink:to="loc_us-gaap_AwardTypeAxis_f6efd6db-f2fc-4f43-9eed-986bc4ebef21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f6efd6db-f2fc-4f43-9eed-986bc4ebef21_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f6efd6db-f2fc-4f43-9eed-986bc4ebef21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f6efd6db-f2fc-4f43-9eed-986bc4ebef21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4f68a657-b164-4355-80df-961b241cede5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f6efd6db-f2fc-4f43-9eed-986bc4ebef21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4f68a657-b164-4355-80df-961b241cede5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e55cdabb-ea29-4f27-828b-3b0c33f15a29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4f68a657-b164-4355-80df-961b241cede5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e55cdabb-ea29-4f27-828b-3b0c33f15a29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_220a2b9c-9196-47bd-8f8a-891a30bdebe4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4f68a657-b164-4355-80df-961b241cede5" xlink:to="loc_us-gaap_PerformanceSharesMember_220a2b9c-9196-47bd-8f8a-891a30bdebe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_811cbc1b-80ec-45f7-980a-ced76fc0ba69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e5fad49-a85d-4f37-bf4d-de4fb3be74ef" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_811cbc1b-80ec-45f7-980a-ced76fc0ba69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_811cbc1b-80ec-45f7-980a-ced76fc0ba69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_811cbc1b-80ec-45f7-980a-ced76fc0ba69" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_811cbc1b-80ec-45f7-980a-ced76fc0ba69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_92b77ec4-eb0a-45a9-9972-efc469f0f95a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_811cbc1b-80ec-45f7-980a-ced76fc0ba69" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_92b77ec4-eb0a-45a9-9972-efc469f0f95a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareRepurchaseProgramMember_11a46757-ad64-4cfa-ba36-dcd98061214f" xlink:href="dxcm-20230630.xsd#dxcm_ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_92b77ec4-eb0a-45a9-9972-efc469f0f95a" xlink:to="loc_dxcm_ShareRepurchaseProgramMember_11a46757-ad64-4cfa-ba36-dcd98061214f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BusinessSegmentandGeographicInformationSummaryDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails" xlink:type="extended" id="ic67c1ab4496140c2803a3368a31e20e7_BusinessSegmentandGeographicInformationSummaryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_d8e5ac04-65ef-4f7b-8ec3-0bf19c5821b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_11da7a6e-8a5d-46aa-9a2d-ed5d6c52dcd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d8e5ac04-65ef-4f7b-8ec3-0bf19c5821b2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_11da7a6e-8a5d-46aa-9a2d-ed5d6c52dcd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RevenuePercentage_3e60100c-2039-410b-9508-978223f3ebea" xlink:href="dxcm-20230630.xsd#dxcm_RevenuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d8e5ac04-65ef-4f7b-8ec3-0bf19c5821b2" xlink:to="loc_dxcm_RevenuePercentage_3e60100c-2039-410b-9508-978223f3ebea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_2c8e8df6-6de3-4fb8-87ea-19fd7163e5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d8e5ac04-65ef-4f7b-8ec3-0bf19c5821b2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_2c8e8df6-6de3-4fb8-87ea-19fd7163e5c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e72ab46b-f039-4803-b7bf-8d3e7312d2c0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2c8e8df6-6de3-4fb8-87ea-19fd7163e5c5" xlink:to="loc_srt_StatementGeographicalAxis_e72ab46b-f039-4803-b7bf-8d3e7312d2c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e72ab46b-f039-4803-b7bf-8d3e7312d2c0_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e72ab46b-f039-4803-b7bf-8d3e7312d2c0" xlink:to="loc_srt_SegmentGeographicalDomain_e72ab46b-f039-4803-b7bf-8d3e7312d2c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_16150ab8-3a41-450a-9e96-d68e9cae653d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e72ab46b-f039-4803-b7bf-8d3e7312d2c0" xlink:to="loc_srt_SegmentGeographicalDomain_16150ab8-3a41-450a-9e96-d68e9cae653d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b1d0454d-97eb-4b26-a784-3a286b9a6415" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_16150ab8-3a41-450a-9e96-d68e9cae653d" xlink:to="loc_country_US_b1d0454d-97eb-4b26-a784-3a286b9a6415" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_94817241-e59a-41b2-a1fb-d98930c46ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_16150ab8-3a41-450a-9e96-d68e9cae653d" xlink:to="loc_us-gaap_NonUsMember_94817241-e59a-41b2-a1fb-d98930c46ed3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_1e98b476-a698-4c36-b7b4-78487c329046" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2c8e8df6-6de3-4fb8-87ea-19fd7163e5c5" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_1e98b476-a698-4c36-b7b4-78487c329046" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_1e98b476-a698-4c36-b7b4-78487c329046_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_1e98b476-a698-4c36-b7b4-78487c329046" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_1e98b476-a698-4c36-b7b4-78487c329046_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9432b0e4-c9c2-4c37-b2dc-8cb780d624e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_1e98b476-a698-4c36-b7b4-78487c329046" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9432b0e4-c9c2-4c37-b2dc-8cb780d624e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_630901a8-4aa3-4bb2-baa2-bd3e961dea14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9432b0e4-c9c2-4c37-b2dc-8cb780d624e8" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_630901a8-4aa3-4bb2-baa2-bd3e961dea14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_d86fa41a-ca5e-4ded-bf18-8e0035effb04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9432b0e4-c9c2-4c37-b2dc-8cb780d624e8" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_d86fa41a-ca5e-4ded-bf18-8e0035effb04" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_PerformanceSharesMember" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#IndividualsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DonaldMAbbeyMember_e6867d31-3981-43ca-9834-41fa31a1f9c8" xlink:href="dxcm-20230630.xsd#dxcm_DonaldMAbbeyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_dxcm_DonaldMAbbeyMember_e6867d31-3981-43ca-9834-41fa31a1f9c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StevenRAltmanMember_b6caff3a-5fbe-4861-bb34-2b2df5682d7a" xlink:href="dxcm-20230630.xsd#dxcm_StevenRAltmanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_dxcm_StevenRAltmanMember_b6caff3a-5fbe-4861-bb34-2b2df5682d7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_BridgettePHellerMember_04b2acb5-5c5e-4990-8596-ec51d406f0c1" xlink:href="dxcm-20230630.xsd#dxcm_BridgettePHellerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_dxcm_BridgettePHellerMember_04b2acb5-5c5e-4990-8596-ec51d406f0c1" xlink:type="arc" order="4"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>dxcm-20230630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:3f233038-1297-4d40-b9d2-42700d6fe8fe,g:c1345a4d-d54c-45d2-818f-78cac7edf10e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions_50e5ac6b-e308-44e9-ace0-b2e39f455dad_negatedTerseLabel_en-US" xlink:label="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of capped call transactions</link:label>
    <link:label id="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions_7d6a56e7-56f2-492e-8482-a601be9c3f4a_terseLabel_en-US" xlink:label="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of capped call transactions</link:label>
    <link:label id="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions_label_en-US" xlink:label="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Purchases Of Capped Call Transactions</link:label>
    <link:label id="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions_documentation_en-US" xlink:label="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Purchases Of Capped Call Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:href="dxcm-20230630.xsd#dxcm_PaymentsForPurchasesOfCappedCallTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:to="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_f7b98da6-8f21-46b1-8ad3-d1b925b15cec_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_0385dbd3-860d-497e-acfe-ad281bcfc6db_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dcc926e7-224f-4df8-9a6b-ff4fc814d519_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity of revolving credit agreement</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d60cb79e-cde1-4802-a9ee-306c87a10d79_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit sub-facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_bbf9a399-e3c0-4f8f-b2bc-ec5a828f52cb_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_704196d7-b2a4-4539-bfe6-b09d079f2072_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_48218fd0-0fcb-42d7-8f08-1a85451a7149_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_39f5a211-d7e5-42e2-b737-4ef97e7ce731_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_ec0e815b-fec2-4fb2-bc07-42de54c52fc2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_70ea17ed-af86-4adb-a5c6-b8761c364f77_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent_32f88b46-f0f7-4994-84a8-14c8c4df6fc3_terseLabel_en-US" xlink:label="lab_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual effective tax rate (as a percent)</link:label>
    <link:label id="lab_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent_label_en-US" xlink:label="lab_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Annual Effective Income Tax Rate, Percent</link:label>
    <link:label id="lab_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent_documentation_en-US" xlink:label="lab_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Annual Effective Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent" xlink:href="dxcm-20230630.xsd#dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent" xlink:to="lab_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_51d807e6-efc4-4c26-8958-4e1f2babcb40_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_303b716c-a53a-4220-8d53-3a05095d78da_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_c248b48e-14a4-49e0-b3f6-a1970f93b04d_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance stock units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_a487bac2-f474-49af-b55f-210eaf18aabd_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_ffeb4de6-a359-43b8-aac1-d9c2ae0f12ef_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer software and hardware</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_a2528d7e-374f-4d26-a2a0-b26f3aa1fff1_terseLabel_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs (shares)</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_label_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Achievement Of Milestone</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_documentation_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Achievement Of Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:href="dxcm-20230630.xsd#dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:to="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_5c818ac6-c2f4-4232-8be1-9192b215187c_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_2d9c87de-ceff-4eba-90a6-f2d29b23a104_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_3c3769b5-d50f-48d7-83c6-48a28b6cd94f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_FairValueDisclosuresLineItems_ad6bafbd-977e-4e2d-9080-c0ff625fef85_terseLabel_en-US" xlink:label="lab_dxcm_FairValueDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Line Items]</link:label>
    <link:label id="lab_dxcm_FairValueDisclosuresLineItems_label_en-US" xlink:label="lab_dxcm_FairValueDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Line Items]</link:label>
    <link:label id="lab_dxcm_FairValueDisclosuresLineItems_documentation_en-US" xlink:label="lab_dxcm_FairValueDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Fair Value Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueDisclosuresLineItems" xlink:href="dxcm-20230630.xsd#dxcm_FairValueDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FairValueDisclosuresLineItems" xlink:to="lab_dxcm_FairValueDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_0bb43c63-e693-471c-972f-259820f59216_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_d6f1ec95-946b-4c12-9372-73feca6c0720_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_45926145-fabc-4fc9-907f-42f486343220_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_47663230-736a-497a-874e-135818391aac_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_ad62bdb2-bf4a-4c3d-9478-1f28bb6327bc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_eb0f4dfb-6eef-4a83-ade2-cbe2326d4185_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Long-Term Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets and Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_f07dff2b-4e80-4eaf-a613-0bfa53292d87_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued upon conversion of senior notes (shares)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:to="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_8eed1ef7-2589-4b3b-a730-8d02ef218aca_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_b117cde8-e945-4541-bfb4-c40f7552ae59_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue_3c75f879-162b-4b1c-9572-4f5fed132f47_terseLabel_en-US" xlink:label="lab_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit of note hedge upon conversions of 2023 Notes</link:label>
    <link:label id="lab_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue_label_en-US" xlink:label="lab_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Received From Benefit Of Note Hedge, Value</link:label>
    <link:label id="lab_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue_documentation_en-US" xlink:label="lab_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Received From Benefit Of Note Hedge, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue" xlink:href="dxcm-20230630.xsd#dxcm_SharesReceivedFromBenefitOfNoteHedgeValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue" xlink:to="lab_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_ca817ab5-b1b4-44bb-8287-bc99f8aaf3a5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_6eba344e-a482-4659-a7d9-bbb6d6bc5df9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9d2adcba-8413-4a98-b408-94b6058b3f0d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_89856a15-d18e-4e23-8f22-b3a6244fb3f2_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment losses</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_9342c6bd-21e5-4d0a-b392-173b21daeb1b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_69fbdd88-ab32-49c3-bb17-27759dc187c5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_75b514ee-d435-4032-902d-322d7732c174_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_b68b6417-0cd9-4882-baf1-4351587f978b_terseLabel_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and land improvements</link:label>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and Land Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAndLandImprovementsMember" xlink:to="lab_us-gaap_LandAndLandImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_e75b2d5d-14b6-41a9-9e6c-2141f66555dd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_ce9c4f72-a272-4608-8d65-a21797ac72a5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_bfae0f35-01e0-4f67-8bdd-d6a96f78175d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_24a59d1a-e4e5-46ed-99db-b4fdc1007a6f_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued employee benefits</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermTwoMember_0c186cd5-b91b-4b06-85be-aac6125bfd0b_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term two</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermTwoMember_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term Two [Member]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermTwoMember_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermTwoMember" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConversionTermTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermTwoMember" xlink:to="lab_dxcm_DebtInstrumentConversionTermTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_20b48f19-8720-41ab-ada2-6f623ff3b13b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_590f3b78-1f0c-42c5-a253-c1d3147e5af3_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding letters of credit</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_StevenRAltmanMember_label_en-US" xlink:label="lab_dxcm_StevenRAltmanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Steven R. Altman [Member]</link:label>
    <link:label id="lab_dxcm_StevenRAltmanMember_documentation_en-US" xlink:label="lab_dxcm_StevenRAltmanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Steven R. Altman</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StevenRAltmanMember" xlink:href="dxcm-20230630.xsd#dxcm_StevenRAltmanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_StevenRAltmanMember" xlink:to="lab_dxcm_StevenRAltmanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_54281c63-5723-434a-8ee4-8da5b0d812f5_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_82bb6317-74a2-4d26-a7ec-3022f48825b5_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_48517471-a48d-4e77-9bbe-5c45611cc0d9_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_ab77d05f-42dc-45be-ad2b-d21c09213b84_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_2aa0f852-f98f-4d8a-89f4-0dffb70e289c_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_b4d83fcc-2030-4118-abc7-02c56989c579_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_f258019a-9d4c-4fe9-9597-f24fcab24711_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent_e287407f-7a99-4cd1-81e4-8ddd65b5211c_terseLabel_en-US" xlink:label="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued wages, bonus and taxes</link:label>
    <link:label id="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent_label_en-US" xlink:label="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Wages, Bonuses and Taxes, Current</link:label>
    <link:label id="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent_documentation_en-US" xlink:label="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Wages, Bonuses and Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:href="dxcm-20230630.xsd#dxcm_AccruedWagesBonusesAndTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:to="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_04dc0a00-926c-40c4-8f48-531f240e2b10_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7c151c6b-4ae1-47c6-b09f-eb6dd9a08272_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermAxis_151f2598-e7cc-4cab-b474-8f92c2681481_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term [Axis]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermAxis_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term [Axis]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermAxis_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermAxis" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConversionTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis" xlink:to="lab_dxcm_DebtInstrumentConversionTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3531f9fe-9e19-4f04-99a6-3ebecae8b769_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_7ed97494-59af-43d4-9a09-85905ec167d4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c42c756d-3d52-4f9b-b559-df1429c83bf4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_d1a91838-dffd-4ed0-871b-baa3b59b6a6d_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:to="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_fcb50048-e2f3-40c6-8a84-d89e9d38f22b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Basic and Diluted Net Income per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_764b4d67-4f0d-4faf-8f7b-d350b9071bae_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_7c667e8d-f401-468b-a2cb-fef0f98a4c51_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_8ac4ad25-c4f1-4937-a6ca-f4c524f0f65e_negatedLabel_en-US" xlink:label="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets and liabilities, net</link:label>
    <link:label id="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_label_en-US" xlink:label="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Assets and Liabilities, Net</link:label>
    <link:label id="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_documentation_en-US" xlink:label="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:href="dxcm-20230630.xsd#dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:to="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_c916e06e-8c51-415a-89a2-659a687f3070_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_ac362e8b-b6b3-4164-81ea-45bd521c03a9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_da488bc3-44e8-4080-bfdb-43c62a4d937e_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes</link:label>
    <link:label id="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_a869ada0-1b8f-4382-b712-c1fbdfb79da6_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_cf614ec3-7f23-4a38-b64b-1eaeba82bb1f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_fefa5720-b316-4bf2-b960-a76181549f52_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8fa54776-5704-4d83-8da4-59fcd733fb5b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of warrants or rights (USD per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ce40728f-1d06-4e5b-8d80-33611f544a38_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_cde4eee3-7ef9-420c-834c-725c1677a7d6_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_40ab0914-e9aa-4bfd-b487-11fa162962a5_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_4af1a853-8057-47b4-8fd9-4a3e793788ae_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_5b9d1bf6-5589-4578-aecb-cdf5f2ca49e2_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock_f44ffc5b-5a49-43c9-9658-ec6c47595f7d_terseLabel_en-US" xlink:label="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Payroll and Related Expenses</link:label>
    <link:label id="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock_label_en-US" xlink:label="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Payroll and Related Expenses [Table Text Block]</link:label>
    <link:label id="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock_documentation_en-US" xlink:label="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Payroll and Related Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:href="dxcm-20230630.xsd#dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:to="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_14841bf8-4f65-4cab-9b26-42c8a29a46f8_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount of derivative instrument</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToParentDiluted_ed9a54ce-0628-4c8d-8155-25678d36e1a4_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income - diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToParentDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:to="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2aeb5999-886e-4ff7-9aa7-2e464f28037f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable debt securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_37b578d4-95d5-47ff-a3d4-e4df6b192a42_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_18d86e38-d14d-4c35-83b4-d29a865a67a1_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_28b52b9e-1df2-4c0f-92a0-3bcd7701c613_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_07afdbfc-3f99-4ef4-ad50-2a454e1a0fc4_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units and performance stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_145e18f9-0c42-40b0-912d-acc99e200f45_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_af295315-7a84-4b0b-9501-000c8f0c7716_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_SellingGeneralAndAdministrativeMember_a2722ad5-ec43-4d95-8782-b19b0fc6a296_terseLabel_en-US" xlink:label="lab_dxcm_SellingGeneralAndAdministrativeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_dxcm_SellingGeneralAndAdministrativeMember_label_en-US" xlink:label="lab_dxcm_SellingGeneralAndAdministrativeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling General And Administrative [Member]</link:label>
    <link:label id="lab_dxcm_SellingGeneralAndAdministrativeMember_documentation_en-US" xlink:label="lab_dxcm_SellingGeneralAndAdministrativeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The allocation of expenses to selling, general and administrative</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SellingGeneralAndAdministrativeMember" xlink:href="dxcm-20230630.xsd#dxcm_SellingGeneralAndAdministrativeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SellingGeneralAndAdministrativeMember" xlink:to="lab_dxcm_SellingGeneralAndAdministrativeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_a7c4c8e5-9cdc-4d32-ae6c-139e203f08c2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_b06020c6-8122-4dfe-afe1-702c33101ab1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_b4e6220d-5206-4725-b268-373d63baa3d4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_826bb81d-1e93-4fab-9fd6-9111df578135_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_52d59d94-5633-4198-b06b-fde5574edc63_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under equity incentive plans (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_ce3279ff-19b9-44b6-84d9-9c82abf6a516_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government agencies</link:label>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Corporations and Agencies Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_7b847fdc-b18b-4af3-9d78-f16351976940_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_d8746939-ec4b-414e-8e67-230eaa7ea061_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of conversion price (as a percent)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_label_en-US" xlink:label="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock</link:label>
    <link:label id="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:to="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet_7fa0a7ab-3696-4b24-b457-8989cada583c_terseLabel_en-US" xlink:label="lab_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease liabilities</link:label>
    <link:label id="lab_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet_label_en-US" xlink:label="lab_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability, Net</link:label>
    <link:label id="lab_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet_documentation_en-US" xlink:label="lab_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" xlink:href="dxcm-20230630.xsd#dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" xlink:to="lab_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_c87f3430-2e33-48a3-a376-0e0e314880e1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_563aa02a-9901-4f4d-b5b3-fdac628fc35f_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Outstanding Anti-dilutive Securities Excluded from Diluted Net Income per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_3b8f3ada-06b2-463e-8d72-06b1a63471c8_totalLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest expense recognized on senior notes</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_76a3d695-84c2-4631-948b-c64fb039ad95_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_SimpleRiskFreeRateRFRMember_512bac4c-72f6-4eef-8ea6-8f620b9128e8_terseLabel_en-US" xlink:label="lab_dxcm_SimpleRiskFreeRateRFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simple Risk Free Rate (RFR)</link:label>
    <link:label id="lab_dxcm_SimpleRiskFreeRateRFRMember_label_en-US" xlink:label="lab_dxcm_SimpleRiskFreeRateRFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simple Risk Free Rate (RFR) [Member]</link:label>
    <link:label id="lab_dxcm_SimpleRiskFreeRateRFRMember_documentation_en-US" xlink:label="lab_dxcm_SimpleRiskFreeRateRFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simple Risk Free Rate (RFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SimpleRiskFreeRateRFRMember" xlink:href="dxcm-20230630.xsd#dxcm_SimpleRiskFreeRateRFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SimpleRiskFreeRateRFRMember" xlink:to="lab_dxcm_SimpleRiskFreeRateRFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_bbb2800b-8a90-4d27-8118-a8160a33d13a_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ab660cdc-42e0-4d3d-94d7-9ece9e34f320_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_64a96303-ecbd-48fd-a450-61d5db345c29_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e8466206-19fa-4cb0-b6b9-946bdbbb0557_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_8b58b39d-6998-4890-b6b6-ba573bf2a3cd_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_545394e0-f2d5-414f-88f9-ce8098bfb8f0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivables</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_1c7b2c97-cdcd-4fa6-94b4-bf220188341f_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_112bec61-9318-4c1a-a36a-af73ba8d02e6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized estimated compensation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_f6c2e022-0d7c-4e5e-9854-25012bde33dc_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77a1e346-97a4-4ce5-8c7b-1bc4d4e27fe3_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeArrangementApprovalMilestoneMember_d1bc0fb1-d2f7-42cf-907e-e1aff80aaf31_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementApprovalMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approval Milestone</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementApprovalMilestoneMember_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementApprovalMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Approval Milestone [Member]</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementApprovalMilestoneMember_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementApprovalMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Approval Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementApprovalMilestoneMember" xlink:href="dxcm-20230630.xsd#dxcm_CollaborativeArrangementApprovalMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementApprovalMilestoneMember" xlink:to="lab_dxcm_CollaborativeArrangementApprovalMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_6df0f7e4-ebdf-440d-ac13-3e550ef76e1c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Details</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_b1f52a83-e53b-407d-b678-29f418d2e30d_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_ec8f1d38-f6fe-4b08-ba4f-99935edbf725_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_00c7be2c-bbfb-46a9-bde4-ac012f18b0aa_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes</link:label>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:to="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_bea438cc-1ad1-4fb9-9290-b7394b0fa6a0_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_941902b9-5cd8-465a-95e0-4d7cef965831_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of property and equipment included in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Fixed Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_6a2f1ad2-57b7-428d-bc64-70d2a97422fc_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_79934afb-86e3-4778-aded-d764b669b084_terseLabel_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes</link:label>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_label_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on Convertible Debt, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:to="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_abd65409-0f17-4eb9-bf36-52cae1456ade_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity component of 2025 Notes issuance, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_73cd9de1-986a-4795-9650-97a7e84da04d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, available-for-sale:</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_251c9f7d-73ef-4791-8e04-000a2423b25d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_c999bb6b-3acc-4383-87ac-f3eaf8e1f74d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_411f78fa-166d-4cc6-8657-069919ded48f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OtherLongTermAssets_63b3fa4c-0432-48a6-84d6-eda2bfa9c0a4_terseLabel_en-US" xlink:label="lab_dxcm_OtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_dxcm_OtherLongTermAssets_label_en-US" xlink:label="lab_dxcm_OtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long -Term Assets</link:label>
    <link:label id="lab_dxcm_OtherLongTermAssets_documentation_en-US" xlink:label="lab_dxcm_OtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long -Term Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherLongTermAssets" xlink:href="dxcm-20230630.xsd#dxcm_OtherLongTermAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OtherLongTermAssets" xlink:to="lab_dxcm_OtherLongTermAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_a031a402-2fe4-4558-a7b2-87fc2915d8ea_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_e1d16e2a-9b38-4c8c-a71a-653f73dbe466_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_d8856c76-3cc0-4442-bccf-30bd97b32685_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_752be611-fa3f-44d2-ae1a-d93388744077_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for Employee Stock Purchase Plan (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled_e81bbf7c-808e-4e01-8076-5f4bffed52c4_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument convertible principal amount exercised</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Principal Amount Exercised, Not Settled</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Principal Amount Exercised, Not Settled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" xlink:to="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_b2a0bed6-9947-4a5b-b1f2-f3cc087abece_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale and maturity of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_72beca16-82e2-4aca-bef5-f8ab32a2718e_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValueOutstanding_3e565f11-90c2-4afd-b61d-cb4f70a640a6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at June&#160;30, 2023 and December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_PreferredStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValueOutstanding" xlink:to="lab_us-gaap_PreferredStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_112b1167-a528-4d99-a6d5-1c66af22b918_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_60fa7e20-890a-41e3-992a-2636af4761ee_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_3aeb2643-1cba-455a-91e5-3d56d5fe7b98_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_c2c5f5d6-9a8e-4505-930f-89944ae3a819_terseLabel_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Domain]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_label_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Domain]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_documentation_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:href="dxcm-20230630.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:to="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a9e989d1-403b-4759-89ef-468ffd7aa0be_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Guidance</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_e31ff9fe-9895-459e-adba-1395f4676de7_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_7c581c08-518a-4ee2-975e-12aa0b790f3e_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_38734088-78c0-4353-aff3-9ba737128998_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7d124857-d559-4428-9d9f-19a5339828bf_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b1bdeb2e-e2ba-4e1b-a549-4c540250c271_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ea93f71b-f8fa-4454-aaa8-af6a99bbd4da_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_6b55bd37-0ae2-4c1e-8896-b560b9671214_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_1b50f57d-59b6-46a4-8e72-937c943ab561_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_5937ff04-4674-40d7-8c7c-c6dfc4eb7894_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 8.5 million shares at June&#160;30, 2023 and 6.9 million shares at December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_6cfd2a8f-4c21-477b-9451-39407f15e431_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_8897781e-10ad-49c8-b5d1-63fda6d25b48_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_ff890a99-2e27-4e43-85b8-80f8f4ce71c3_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3f722330-6ad4-4201-9994-7ffad0206465_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PharmacyRebates_9e3e59e1-483c-47a1-b3d8-ca4585d149fc_terseLabel_en-US" xlink:label="lab_dxcm_PharmacyRebates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued rebates</link:label>
    <link:label id="lab_dxcm_PharmacyRebates_label_en-US" xlink:label="lab_dxcm_PharmacyRebates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Rebates</link:label>
    <link:label id="lab_dxcm_PharmacyRebates_documentation_en-US" xlink:label="lab_dxcm_PharmacyRebates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Rebates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PharmacyRebates" xlink:href="dxcm-20230630.xsd#dxcm_PharmacyRebates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PharmacyRebates" xlink:to="lab_dxcm_PharmacyRebates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_9ecf82bc-cba8-480a-adbb-f1486040ce15_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and Other Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_95f0ed96-ca26-49f8-9199-7d378a9e09a5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_595d8244-b709-42e1-b2b2-414a9c061d56_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_4cbdd8dd-31e4-4208-b4bc-99185df49cca_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_229821b1-9f0e-446a-9660-10aae05ca37e_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_114a817b-4f44-46e6-9fce-52e95ba11c9e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_b05946b9-ad6d-43f9-bb6b-6550c163dd65_terseLabel_en-US" xlink:label="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Initial purchasers</link:label>
    <link:label id="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_label_en-US" xlink:label="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Initial Purchasers For Convertible Note Hedge Transactions</link:label>
    <link:label id="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_documentation_en-US" xlink:label="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Initial Purchasers For Convertible Note Hedge Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:href="dxcm-20230630.xsd#dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:to="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_53c99b06-bba1-4794-a61e-9d2febd7b932_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_6ea9789b-3fbc-4f10-9a6b-b85f6ec91619_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_62d5a786-0deb-486c-acf6-b0427a386932_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_3b24aaa8-c404-44dc-b9c5-acf5bd699afc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from equity investments</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_34536d04-07f0-4016-b9e4-1a09182df616_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d938b758-53b0-4216-b746-7ba984b5adbc_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_58169817-7335-4479-99ca-998808138653_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash income and expenses</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_fce09fb5-4745-4c7e-aef0-c9c987f6a860_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized (gain) loss on equity investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_5167f0e3-8cc9-4e88-9e2a-66b73ab6036b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_6bd47077-a7db-4078-97e8-08e07517da5c_terseLabel_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:href="dxcm-20230630.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_ff4bdf2b-7237-46d3-b4a9-2bb1355b74eb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_99d43ff9-5845-4a75-9287-0014303f7663_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Availability and Outstanding Borrowings on Credit Agreement</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_03807031-26db-4fb1-8049-927482b4e5f9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b5e2be10-f056-4ea0-9d04-7fa72632e3a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_b02635e5-c7d0-4c0b-9c84-68ad9aada3b7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_3d4323a6-46c6-4136-a866-5898b95953d9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d53e5c62-05d4-4236-ae46-2d1a9e6c9674_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with acquisition, shares (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3210bfcc-48e0-4a0b-98b4-2961727f5179_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_3d8dd86c-9883-4f44-9486-7135b45f26a6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_cb877216-6d4e-4bed-b74a-1cbfef71f637_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_d07e6c70-727b-4f0f-bd77-0396cb009461_terseLabel_en-US" xlink:label="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential future common stock issuable (shares)</link:label>
    <link:label id="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_label_en-US" xlink:label="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Future Common Stock Issuable, Shares, New Issues</link:label>
    <link:label id="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_documentation_en-US" xlink:label="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Future Common Stock Issuable, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:href="dxcm-20230630.xsd#dxcm_PotentialFutureCommonStockIssuableSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:to="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositAssets_183b9a74-f3ce-4d2b-9e06-fe57068f36b7_terseLabel_en-US" xlink:label="lab_us-gaap_DepositAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit assets</link:label>
    <link:label id="lab_us-gaap_DepositAssets_label_en-US" xlink:label="lab_us-gaap_DepositAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositAssets" xlink:to="lab_us-gaap_DepositAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_f0739974-d2a7-4287-b48a-5fab6859c2f6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued for conversions of 2023 Notes</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeResearchAndDevelopmentFee_d9c3b12e-cc7e-4046-a374-a43e05930b2e_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative research and development fee</link:label>
    <link:label id="lab_dxcm_CollaborativeResearchAndDevelopmentFee_label_en-US" xlink:label="lab_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Research And Development Fee</link:label>
    <link:label id="lab_dxcm_CollaborativeResearchAndDevelopmentFee_documentation_en-US" xlink:label="lab_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Research and Development Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:href="dxcm-20230630.xsd#dxcm_CollaborativeResearchAndDevelopmentFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:to="lab_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d9c9df7b-11c3-473b-b343-48291d89d3d1_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_05860d55-7fbc-478b-b104-f67ae9111743_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_2a5e9068-9f12-47bd-afc0-fa4dbf31c86b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_d604d747-6652-4d73-a663-4c9e7cfed8ed_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_985bccbb-03d9-4809-9f3a-1c1ec4b6e2bb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock counterparties to acquire with warrants purchased (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_2ce21f0f-c83b-48a8-b691-24ce08c0165d_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_336d08a4-981c-4d63-9bfc-4d97516d9034_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual coupon interest</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_1c4645b7-a2fc-447c-a50d-a23b10a45766_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CashInterestExpenseAbstract_ab6b6225-e919-46ae-9502-cfdc700a35e6_terseLabel_en-US" xlink:label="lab_dxcm_CashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash interest expense:</link:label>
    <link:label id="lab_dxcm_CashInterestExpenseAbstract_label_en-US" xlink:label="lab_dxcm_CashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Interest Expense [Abstract]</link:label>
    <link:label id="lab_dxcm_CashInterestExpenseAbstract_documentation_en-US" xlink:label="lab_dxcm_CashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Interest Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CashInterestExpenseAbstract" xlink:href="dxcm-20230630.xsd#dxcm_CashInterestExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CashInterestExpenseAbstract" xlink:to="lab_dxcm_CashInterestExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_9fd9383d-1192-472c-a7c7-6a05e873820f_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_f791f653-ab6c-499a-94ef-29b47847cf18_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_0b9f319e-602a-429d-8c9d-af641ea9e83f_totalLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayable" xlink:to="lab_us-gaap_ConvertibleNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_8f5a45df-9e99-4840-b3fd-03f4d81dc5f3_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of cash, cash equivalents and restricted cash, end of period:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_6a1de547-2df1-4621-a63e-354ec76bfb3c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_852c45b0-aa00-43da-852e-bd80b2542b0a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_1966931d-6545-41de-b6d5-30ed29850fc5_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_dfbe52c3-b0e9-4430-903d-6897f4d8f8f3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_RestrictedAndPerformanceStockUnitsMember_b8b0f627-3146-42db-81a7-ac933dc20e73_terseLabel_en-US" xlink:label="lab_dxcm_RestrictedAndPerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units and performance stock units</link:label>
    <link:label id="lab_dxcm_RestrictedAndPerformanceStockUnitsMember_label_en-US" xlink:label="lab_dxcm_RestrictedAndPerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted And Performance Stock Units [Member]</link:label>
    <link:label id="lab_dxcm_RestrictedAndPerformanceStockUnitsMember_documentation_en-US" xlink:label="lab_dxcm_RestrictedAndPerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted And Performance Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RestrictedAndPerformanceStockUnitsMember" xlink:href="dxcm-20230630.xsd#dxcm_RestrictedAndPerformanceStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RestrictedAndPerformanceStockUnitsMember" xlink:to="lab_dxcm_RestrictedAndPerformanceStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dca4380-a336-4f8d-a19c-4766c0a016fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_5263d1ce-4016-455c-8c09-61c0b153dae3_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d5c78a71-81eb-45d3-800a-fa28e3a67a85_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_e32463b6-c840-4b51-8505-93dc3f3bc7dd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Balances</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_da7e4a4a-397b-4ce6-9c55-d706ac0a0b35_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_4df446cf-620f-41f7-9cfc-5a54badf3215_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_864555b1-c173-499d-b981-1abc4f5d119a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_d1148335-5c8c-4241-b460-54e6a5ee6b7a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_ff7cf95f-eb56-4f40-88ba-25fdfc5614a0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_38104513-e684-4521-9b06-afcdb926e899_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ContractPaymentTermsNumberofDays_fef0962e-7657-499a-a039-56a5c7049a9f_terseLabel_en-US" xlink:label="lab_dxcm_ContractPaymentTermsNumberofDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract payment term</link:label>
    <link:label id="lab_dxcm_ContractPaymentTermsNumberofDays_label_en-US" xlink:label="lab_dxcm_ContractPaymentTermsNumberofDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Payment Terms, Number of Days</link:label>
    <link:label id="lab_dxcm_ContractPaymentTermsNumberofDays_documentation_en-US" xlink:label="lab_dxcm_ContractPaymentTermsNumberofDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Payment Terms, Number of Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ContractPaymentTermsNumberofDays" xlink:href="dxcm-20230630.xsd#dxcm_ContractPaymentTermsNumberofDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ContractPaymentTermsNumberofDays" xlink:to="lab_dxcm_ContractPaymentTermsNumberofDays" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_d4ee98e2-4b59-4e34-9ed9-fbe04077b555_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_bdbaf987-b12f-4830-87c6-0ca79c9a7bbf_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DonaldMAbbeyMember_label_en-US" xlink:label="lab_dxcm_DonaldMAbbeyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Donald M. Abbey [Member]</link:label>
    <link:label id="lab_dxcm_DonaldMAbbeyMember_documentation_en-US" xlink:label="lab_dxcm_DonaldMAbbeyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Donald M. Abbey</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DonaldMAbbeyMember" xlink:href="dxcm-20230630.xsd#dxcm_DonaldMAbbeyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DonaldMAbbeyMember" xlink:to="lab_dxcm_DonaldMAbbeyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_b779f574-41ba-45fb-9d0b-2290bd701e7c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Fair Values of Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_c46005ef-4346-4f0c-8927-7acb93aeee3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_38d82f71-51e2-4df4-82e5-dac096f5ce01_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_374b4523-8b5c-4b05-8738-bd9afdb1c726_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_3d5c48c4-e965-4e90-b6a3-b7e53fa368f7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_d46bcabe-fcd6-42ac-8993-b7a6e1b56520_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_d155cf5b-d9dc-428d-b02c-a2c1c9226fc6_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_bcd15cba-f9ba-40fa-83f0-7226bdd9b851_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price of convertible notes (USD per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_fb9381c4-ae5f-4a16-a2fc-bca6a085f9ff_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_8cc94f18-7442-4434-94e9-5dda0d97bc6a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableCurrent_bd92607c-e217-4c79-a450-a0fc44650f34_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableCurrent" xlink:to="lab_us-gaap_ConvertibleNotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_97b78557-8426-4d1a-a7fb-4b9fb7784900_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of applicable conversion price (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_49d16d09-e39f-44e8-8ea3-8b1a3746026a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_da74422a-a2d1-4a4f-8c35-b47e84b74aea_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_6bf25301-599b-49db-93d0-c6c621dde321_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_29744fb6-526b-456b-8360-3a5518abe7b7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeArrangementInitialPaymentMember_852d913f-bd4d-4b18-8b35-2ceea34bfc1d_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Payment</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementInitialPaymentMember_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Initial Payment [Member]</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementInitialPaymentMember_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Initial Payment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:href="dxcm-20230630.xsd#dxcm_CollaborativeArrangementInitialPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:to="lab_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DeferredCompensationPlanAssetsCurrent_d0162fe1-aff7-4931-957c-2b55bb359518_terseLabel_en-US" xlink:label="lab_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan assets</link:label>
    <link:label id="lab_dxcm_DeferredCompensationPlanAssetsCurrent_label_en-US" xlink:label="lab_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets, Current</link:label>
    <link:label id="lab_dxcm_DeferredCompensationPlanAssetsCurrent_documentation_en-US" xlink:label="lab_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:href="dxcm-20230630.xsd#dxcm_DeferredCompensationPlanAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:to="lab_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_045cf1c8-e5c7-4108-9b6b-8ac6a4b28396_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_45fb06d4-9307-4fcc-a892-76904db4abd6_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a17b9aa4-3d3b-4213-a48e-7f77ba1b4b32_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_c4e86c00-6427-4153-9f97-104c89fe3256_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_b00ad3af-cb11-45b5-a2e0-071df1ed1917_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_f9c2eb43-b295-433e-aa4b-418641153377_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_413cc527-50f4-4465-b099-373a1e735583_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_767b78a8-c46d-4cf0-bacd-2481fe2fe41d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1991edf4-3138-4137-88e7-3a6ad01d6fde_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_bddeab7c-4976-4f5c-9881-a49e826289be_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_6f934e1e-7d72-447e-b9de-08ddfac0e70f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_b04ce5be-a196-4769-9420-e52294188e62_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, long-term</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_7e6f905b-16d3-4c17-88d4-b8bbdadecdba_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, long-term</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_1289da5d-6c69-47a9-9da6-aefa9e3d94d2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_fac9bbf6-c014-47bb-975c-47a744c86163_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_412c73d1-4036-4257-a4bc-d8f645b862aa_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_6c3e27db-3281-4203-9f57-7d98d44411a9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per common share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_46b7f3ec-5cb5-4062-9980-1fecb1aa36db_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7462e6f9-25a6-41c7-8bc9-1c06b05ea191_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_a089b516-bd7f-4aee-aff8-848b9be53970_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Deferred Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_d134247e-6eeb-4d70-a9b5-72ec71e9181e_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_9ad281e1-3aef-4a1c-a772-83676c1685d1_negatedTerseLabel_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of capped call transactions, net of tax</link:label>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_label_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid-In Capital, Purchase Of Capped Call Transactions, Net Of Tax</link:label>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_documentation_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid-In Capital, Purchase Of Capped Call Transactions, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:href="dxcm-20230630.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:to="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermOneMember_f5418989-ddee-4cca-84ad-7decfb9a038c_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term one</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermOneMember_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term One [Member]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermOneMember_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermOneMember" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConversionTermOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermOneMember" xlink:to="lab_dxcm_DebtInstrumentConversionTermOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_d83d6e0e-36ec-4c48-91e5-25caae928ee5_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_754946a5-41d0-4dc0-b6ca-9bcac7403637_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_c83346a0-48fe-446b-813a-98c910e4119f_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holder's repurchase price percentage in event of fundamental change (as a percent)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_label_en-US" xlink:label="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Repurchase Price, Percentage</link:label>
    <link:label id="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Repurchase Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentCovenantRepurchasePricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:to="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_f4865ee3-c8aa-4562-8422-8b6b1edf3495_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_7a23b7b4-74a1-486f-a7f8-0a689ba98470_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing transactions:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_ad04c5c2-e3e4-4584-8366-3e82df6d91e9_terseLabel_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term marketable securities</link:label>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_label_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale and Equity Securities</link:label>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_documentation_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale and Equity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:href="dxcm-20230630.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:to="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_a36f7dcd-27da-4893-abfd-747a20d8bd7e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_449a956b-a040-44d2-a681-6ee55275af6f_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_4402f401-bbaf-458e-9f66-3b3de44f8052_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_dfe22943-7cf4-4099-b45a-4501566d9461_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_b7fd96b6-1f11-486f-9b08-4c64714bed50_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_d355162d-3208-47cd-9d58-2c8fa08f8dc6_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_b613067c-f14a-4080-ae52-ac13a4f8737d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable trade</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_85314733-d518-468f-a8c0-0664e343a1b8_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock premium (Percentage)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Capped Calls Initial Cap Price, Premium Percentage</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Capped Calls Initial Cap Price, Premium Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:to="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_2da40a96-9f57-4f9c-afa5-1c37b03a06cb_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_594ff2ca-fd3e-4641-86a4-2322c4f03288_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_393167a8-a780-41e1-9d36-b5f53e0b1614_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OtherTaxLiabilitiesNoncurrent_bee7afaa-458f-4948-9dbd-e37af391e13b_terseLabel_en-US" xlink:label="lab_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other tax liabilities</link:label>
    <link:label id="lab_dxcm_OtherTaxLiabilitiesNoncurrent_label_en-US" xlink:label="lab_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tax Liabilities, Noncurrent</link:label>
    <link:label id="lab_dxcm_OtherTaxLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tax Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:href="dxcm-20230630.xsd#dxcm_OtherTaxLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:to="lab_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_52a334e3-7552-4cab-ab34-7120ce3b468d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_NonCashInterestExpenseAbstract_2ce9ee8b-29ee-4004-bfa5-93aae0f4bb7b_terseLabel_en-US" xlink:label="lab_dxcm_NonCashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense:</link:label>
    <link:label id="lab_dxcm_NonCashInterestExpenseAbstract_label_en-US" xlink:label="lab_dxcm_NonCashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Interest Expense [Abstract]</link:label>
    <link:label id="lab_dxcm_NonCashInterestExpenseAbstract_documentation_en-US" xlink:label="lab_dxcm_NonCashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Interest Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NonCashInterestExpenseAbstract" xlink:href="dxcm-20230630.xsd#dxcm_NonCashInterestExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract" xlink:to="lab_dxcm_NonCashInterestExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_d9ec8c0e-f885-407d-bd6b-db567731f5bc_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities current</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_7697207e-234d-41c1-b25b-6a2d9aaf191f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember_261d0a12-4125-435c-80db-ef2d9f164824_terseLabel_en-US" xlink:label="lab_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Reserve Bank Of New York Rate (NYFRB)</link:label>
    <link:label id="lab_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember_label_en-US" xlink:label="lab_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Reserve Bank Of New York Rate (NYFRB) [Member]</link:label>
    <link:label id="lab_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember_documentation_en-US" xlink:label="lab_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Reserve Bank Of New York Rate (NYFRB)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember" xlink:href="dxcm-20230630.xsd#dxcm_FederalReserveBankOfNewYorkRateNYFRBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember" xlink:to="lab_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_4bd2b58e-3617-4826-a24a-b43388428cce_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_c304d234-93e1-4419-a239-75bc33ae6244_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ConvertibleNotesDue2025Member_20971840-27f2-4958-a30e-44cd3aa26c7b_terseLabel_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes due 2025</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2025Member_label_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2025 [Member]</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2025Member_documentation_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ConvertibleNotesDue2025Member" xlink:to="lab_dxcm_ConvertibleNotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_4625c3a2-4007-4f4d-ae44-aa491693b650_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_2dd4e547-d0a9-4f2e-b768-201e86d7af6b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on convertible notes (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_2a8b8205-08d5-4359-8f4f-7a93b79e0bc5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_7f02cd65-9fdd-4e7d-956b-9a403bac200f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_824a4312-d001-4cd6-b6f4-c36805d84466_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_6a555afd-bbfc-4693-b4e5-99e9a9696731_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_6be2905c-b008-4c3e-9479-0a646bad3fe0_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_FairValueAssetsLevel3TransfersAmount_12ddd3c4-160f-4e4e-8d91-528e57cc0cf1_terseLabel_en-US" xlink:label="lab_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers into or out of Level 3 securities</link:label>
    <link:label id="lab_dxcm_FairValueAssetsLevel3TransfersAmount_label_en-US" xlink:label="lab_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets, Level 3 Transfers, Amount</link:label>
    <link:label id="lab_dxcm_FairValueAssetsLevel3TransfersAmount_documentation_en-US" xlink:label="lab_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets, Level 3 Transfers, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:href="dxcm-20230630.xsd#dxcm_FairValueAssetsLevel3TransfersAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:to="lab_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fafe4761-5219-48db-892f-d2c908f02219_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_618718a1-860c-4c68-87a5-4a87da55bdc3_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Milestone Payments [Member]</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Milestone Payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:href="dxcm-20230630.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:to="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0005ccdc-b22b-4683-9f22-318776b7d266_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_48d553d8-4e67-4f07-9c4f-dbe6ac2a1699_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled accounts receivable</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable" xlink:to="lab_us-gaap_UnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e77c9e49-fd37-44d5-bd84-ec5feb1fa59b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_f0273138-84ec-438d-9181-6d829dad60a0_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_117380ff-098e-4c0b-924b-15fb380c403f_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1e6238bc-fad1-419f-a745-1184f9e90b34_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversions of 2023 Notes (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_684e52c6-ac42-4ab9-aad5-8b1ba41ece4d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and conversions of notes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_20870b3a-fde3-4b87-98d3-fda64fabeb44_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_74251863-b7c5-4bec-a688-8c416492dea2_terseLabel_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Axis]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_label_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Axis]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_documentation_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:href="dxcm-20230630.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:to="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_e559d517-d7d3-496c-a211-296bf9a9d708_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_1901667d-350e-48e4-996f-513aedef6ead_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_337908bf-94ba-4156-991c-ac4c1cbd8ed1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PrepaidInventoryCurrent_b4b6f633-1d30-4ab8-af8e-f908046fba42_terseLabel_en-US" xlink:label="lab_dxcm_PrepaidInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid inventory</link:label>
    <link:label id="lab_dxcm_PrepaidInventoryCurrent_label_en-US" xlink:label="lab_dxcm_PrepaidInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Inventory, Current</link:label>
    <link:label id="lab_dxcm_PrepaidInventoryCurrent_documentation_en-US" xlink:label="lab_dxcm_PrepaidInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PrepaidInventoryCurrent" xlink:href="dxcm-20230630.xsd#dxcm_PrepaidInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PrepaidInventoryCurrent" xlink:to="lab_dxcm_PrepaidInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78e30dbf-b96d-49ab-91c5-abe739fa12b7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_c37f36ea-9857-4334-b124-518f0b547b9c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_e9112c35-9c51-4a6f-99ce-81223bc96b94_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total available balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f51bb4b8-6f17-4c30-a670-e00728691a7b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_cf48a444-fa59-40b0-a755-2ce964fb8115_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_03d6f4b6-cfe5-4c59-a18f-945044b3de27_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_93f46a10-fd5d-4512-b0a6-7ea0d6fc2dc4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaidInKindInterest_8e1a6a17-6271-4b2e-8d45-6a66ff2c25c8_terseLabel_en-US" xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_us-gaap_PaidInKindInterest_label_en-US" xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid-in-Kind Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaidInKindInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaidInKindInterest" xlink:to="lab_us-gaap_PaidInKindInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_47c67948-666d-4acf-9bd3-465062236bf0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common&#160;Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_cf9b6c07-8a19-4c2d-bdc4-24954b4ae9df_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_1b2fc543-d1b2-4759-b767-586a823437ab_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_224a3120-3997-4a37-b035-2d732d248084_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_67dceb03-2408-4532-a403-3920e27408bb_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_0fa6353b-90b5-4169-8079-422e3f526754_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_426cc077-d4af-4691-b0fc-09e044d8949a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_ce1a6eed-56ab-4ff1-bb5d-1d5df5e9d58c_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_71ec22bd-84a9-47ca-be86-dc0698f6ba1b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_32d5a061-1d3e-4ad2-8e70-9d44a2890481_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_670d4960-3de5-4ab5-82be-531385c5f4e8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2d0cc731-2070-4a2c-ae6d-8f816ccef34c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_BridgettePHellerMember_label_en-US" xlink:label="lab_dxcm_BridgettePHellerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bridgette P. Heller [Member]</link:label>
    <link:label id="lab_dxcm_BridgettePHellerMember_documentation_en-US" xlink:label="lab_dxcm_BridgettePHellerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bridgette P. Heller</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_BridgettePHellerMember" xlink:href="dxcm-20230630.xsd#dxcm_BridgettePHellerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_BridgettePHellerMember" xlink:to="lab_dxcm_BridgettePHellerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0ee9a8ad-ad87-4bfd-9e83-209784bd3c69_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_3aee794a-b968-4b85-a22c-252fa2cc1f14_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_235d4eb3-75fe-4d44-b1ec-2c384ac037c7_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued warranty</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_f947068f-8a7d-46af-a389-d888bda59cdd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hierarchy for Financial Assets</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_fb3659d2-edcc-4cfa-ba6b-efbbd2ac67af_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_c09071c1-fb0c-41e9-ae5b-f268f228997f_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_788cefcd-d798-4848-9f3b-6db862c3adeb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_1fded0f8-8230-4c4f-b9ec-44abf14a31d4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ebb86c63-451b-46c4-b76b-24522ebb6643_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_af213e36-f41c-4e20-a5db-bb7d089ab63d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_231e9083-f6a0-461d-849b-2ded1732c082_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_1cd73f3c-6963-482b-91e3-9414e8223b85_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_370c1d67-69e9-453c-b505-1fea4a78ac19_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_6afc337e-0c8f-4cdb-a530-fedfdfce2227_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_02c21879-d4b5-48f5-a51b-1469935c8a62_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_447aedfe-e983-43dc-8af5-a4c553edeec1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_d992716e-4bff-481e-8d02-35e9b7d990c6_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Converted Value of Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:to="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AccruedTaxAuditAndLegalFees_b1d68e8a-1810-4b9c-b6e5-43211db3570a_terseLabel_en-US" xlink:label="lab_dxcm_AccruedTaxAuditAndLegalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued tax, audit, and legal fees</link:label>
    <link:label id="lab_dxcm_AccruedTaxAuditAndLegalFees_label_en-US" xlink:label="lab_dxcm_AccruedTaxAuditAndLegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Tax Audit And Legal Fees</link:label>
    <link:label id="lab_dxcm_AccruedTaxAuditAndLegalFees_documentation_en-US" xlink:label="lab_dxcm_AccruedTaxAuditAndLegalFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of accrued current tax, audit and legal fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedTaxAuditAndLegalFees" xlink:href="dxcm-20230630.xsd#dxcm_AccruedTaxAuditAndLegalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AccruedTaxAuditAndLegalFees" xlink:to="lab_dxcm_AccruedTaxAuditAndLegalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d3ac88f7-216a-41b9-960d-494c3a44cef5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_f7e45007-9918-40b7-aff6-13df2139c10e_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_513a509d-ff5c-449b-9615-68c5a268c03c_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_0c1a334c-45ad-4be7-8107-739021357cbc_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributor</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f2d45b9b-cd02-49a4-9180-7a16b24509fb_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_5230508c-17f5-46be-bbd8-dcaec4a9c57d_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of outstanding senior convertible notes:</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_8938cb64-693f-44ba-a7a8-e25d6b1740bc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_27b2f6b9-3265-422a-8508-d2e1bc75f7b0_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d612939e-7721-4f0b-85cc-da20a13943af_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Market Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_eca09619-59d0-4a1c-b8ad-38c9fa38ebe4_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0e7f0be0-0a16-418e-ae32-1e0235224b19_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_51e50ab4-d4d5-4205-a0d2-94568780f65f_terseLabel_en-US" xlink:label="lab_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Table]</link:label>
    <link:label id="lab_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_label_en-US" xlink:label="lab_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures, Senior Convertible Notes [Table]</link:label>
    <link:label id="lab_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_documentation_en-US" xlink:label="lab_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures, Senior Convertible Notes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable" xlink:href="dxcm-20230630.xsd#dxcm_FairValueDisclosuresSeniorConvertibleNotesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable" xlink:to="lab_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_b53f033a-c755-42d3-9e6d-40c69494867f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_6daf65a3-662d-45f8-9895-15e93dab366b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:to="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ShareRepurchaseProgramMember_ff15b2b0-c4a3-49a1-b541-f9f82b2f16d3_terseLabel_en-US" xlink:label="lab_dxcm_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program</link:label>
    <link:label id="lab_dxcm_ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_dxcm_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:label id="lab_dxcm_ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_dxcm_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareRepurchaseProgramMember" xlink:href="dxcm-20230630.xsd#dxcm_ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ShareRepurchaseProgramMember" xlink:to="lab_dxcm_ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5221bc10-d8eb-4bc6-b815-a6d182a0cb50_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ConvertibleNotesDue2023Member_945a27a9-a583-4c2d-98e1-69c1daa85546_terseLabel_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes due 2023</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2023Member_label_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2023 [Member]</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2023Member_documentation_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ConvertibleNotesDue2023Member" xlink:to="lab_dxcm_ConvertibleNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_f8b8fcda-73cb-4edc-bbb6-a4351935d4a6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_LongTermDeposits_21c0eae1-40c5-4953-85f1-d5f1d2192a0b_terseLabel_en-US" xlink:label="lab_dxcm_LongTermDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deposits</link:label>
    <link:label id="lab_dxcm_LongTermDeposits_label_en-US" xlink:label="lab_dxcm_LongTermDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long -Term Deposits</link:label>
    <link:label id="lab_dxcm_LongTermDeposits_documentation_en-US" xlink:label="lab_dxcm_LongTermDeposits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long -Term Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LongTermDeposits" xlink:href="dxcm-20230630.xsd#dxcm_LongTermDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LongTermDeposits" xlink:to="lab_dxcm_LongTermDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_a1939ed2-a969-4722-b21f-98436d8b8965_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value, 800.0 million shares authorized; 394.6 million and 386.1 million shares issued and outstanding, respectively, at June&#160;30, 2023; and 393.2 million and 386.3 million shares issued and outstanding, respectively, at December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding" xlink:to="lab_us-gaap_CommonStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_d9e2d76f-f5f2-4399-9dbd-133ace34631e_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock split ratio</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_757e0fb3-c854-438d-a272-2b0c2cc45b67_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total vest date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_5e81b32f-b7c1-478c-8d87-5804fd938420_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_2f62866d-7288-4441-b60e-0a038b62d1db_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_13ea0703-8581-4451-bd2d-6e15624899cf_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_64d93bb3-1334-4eff-978b-d2a3f4b9dcd4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_eb245ba9-e569-4c77-ade7-d2dde070e39d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8dda386b-61fb-4735-a497-b5144942f0eb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_545cc054-9d83-46d0-982a-1acd43bb2422_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7bad99db-d804-4f7a-91f2-54086701da59_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_333e69e8-b84b-46ff-8366-913fc6a2b8dc_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing stock price (USD per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_7cba5940-8a30-4275-b830-cabff0d2ae10_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b629f34d-40d4-4a47-9a98-4f137235c0ff_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeArrangementUpfrontFee_509140d5-59e8-4ecf-acba-5d1c3696bee2_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial payment on collaborative agreement</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementUpfrontFee_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Upfront Fee</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementUpfrontFee_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Upfront Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementUpfrontFee" xlink:href="dxcm-20230630.xsd#dxcm_CollaborativeArrangementUpfrontFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementUpfrontFee" xlink:to="lab_dxcm_CollaborativeArrangementUpfrontFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrent_ee49b245-025b-4c71-8186-144d3ec00150_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityCurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_56d2cf8e-dde6-4192-b115-6fbc07aac49b_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_845bd5c4-25fd-4bc2-a3c3-cf68c64a45db_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_8ef09ae9-b28e-43c6-b47f-088cfb232e9a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_b5b0a3cf-c06f-4bbe-9dbf-f311399cee3b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3c2c98fc-f631-4bbf-81c3-fb49fde87dd8_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_fa040477-b7b9-4078-8f8e-7d6b7618914f_terseLabel_en-US" xlink:label="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to increase revolving line of credit</link:label>
    <link:label id="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_label_en-US" xlink:label="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Option To Increase, Amount</link:label>
    <link:label id="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_documentation_en-US" xlink:label="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Option to Increase, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:href="dxcm-20230630.xsd#dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:to="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_ae12671b-55c6-47ab-9711-34b82fbd3009_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_fcee2eb2-9b8b-4f2a-886f-ce35eac7103a_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-based milestones</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_52510a50-f52b-4ead-aba8-c5d70a7ce2d9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_bb10ddb5-97a0-47e4-b866-1165b555f43d_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_ca5d0d69-ef96-4ea0-98a5-56ee421d94c3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_a38711aa-bd81-451c-a065-7418c9359df1_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as hedging instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_RevenuePercentage_76cff29f-dfb8-4343-ae4d-04d0c260a970_terseLabel_en-US" xlink:label="lab_dxcm_RevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of revenue (as a percent)</link:label>
    <link:label id="lab_dxcm_RevenuePercentage_label_en-US" xlink:label="lab_dxcm_RevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Percentage</link:label>
    <link:label id="lab_dxcm_RevenuePercentage_documentation_en-US" xlink:label="lab_dxcm_RevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RevenuePercentage" xlink:href="dxcm-20230630.xsd#dxcm_RevenuePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RevenuePercentage" xlink:to="lab_dxcm_RevenuePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_9789e150-6476-4345-b272-cefb9d710c93_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_1c7416a7-2101-42ca-8cdf-317fd4c04884_totalLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ec1cbc67-9e77-407a-9c53-a1c0c7b04df7_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_56d7c839-4215-4ec7-ba1a-dc8d18ac635d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_49b2916e-1981-4663-9773-1fc3e13afb1c_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_273cbbed-3b93-4de0-877d-09aee79a6f5f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_11695e18-204d-42de-864d-01a8f1c726a8_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_0589bc07-acb0-4df8-8047-c1ca6ee4be1e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_bff47e44-39dd-46aa-9392-c757d23cb49e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone_ef568306-f8cd-4a66-869d-8a911002f8ae_terseLabel_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone_label_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Achievement Of Milestone</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone_documentation_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Achievement Of Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone" xlink:href="dxcm-20230630.xsd#dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone" xlink:to="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_2c93684f-0f52-4c04-abf7-1aff9e02e59b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total by which the notes&#8217; if-converted value exceeds their principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, If-converted Value in Excess of Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:to="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6e656a42-985f-4654-b3a9-76554c22a6a9_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_2d4fb28a-d2d3-445d-a008-a207f08d6c1e_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_72c885f8-3c2d-4daa-9512-dd962c088551_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_90f14067-e959-4104-be0a-3b407d53468e_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_74781754-da19-4d68-bcce-116216502e34_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_9c4085f3-d640-4f4a-8613-ff5e5b03438f_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock_4eea10b0-de8c-4be4-b897-fae2756969cc_terseLabel_en-US" xlink:label="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Prepaid and Other Current Assets</link:label>
    <link:label id="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid And Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock_documentation_en-US" xlink:label="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid And Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:href="dxcm-20230630.xsd#dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:to="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_43cd4c14-209c-49d1-b66c-6d60d512edc4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_2afe3922-f15d-4abb-be22-6a1145e26c77_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_58e3500d-abcf-4ebe-9b97-a6be7228a6bc_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute diluted net income per share (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_39f7a246-cc14-44f9-963c-5978ca162b8f_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2f96450f-0d4b-41d5-9288-b8eb4dcf9152_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_481041de-1e2b-4aad-bc93-0a543e230c42_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cfa93342-bb05-4b55-ba26-899085905808_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_8bed1f2b-ebf9-46e9-9bc7-ce571e1b48f2_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_19941aa8-6dfb-4f8f-8889-88fa15faf953_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_VerilyLifeSciencesMember_b12119b6-4804-47b1-9b3e-d678c079422e_terseLabel_en-US" xlink:label="lab_dxcm_VerilyLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Verily Life Sciences</link:label>
    <link:label id="lab_dxcm_VerilyLifeSciencesMember_label_en-US" xlink:label="lab_dxcm_VerilyLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Verily Life Sciences [Member]</link:label>
    <link:label id="lab_dxcm_VerilyLifeSciencesMember_documentation_en-US" xlink:label="lab_dxcm_VerilyLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Verily Life Sciences [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyLifeSciencesMember" xlink:href="dxcm-20230630.xsd#dxcm_VerilyLifeSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_VerilyLifeSciencesMember" xlink:to="lab_dxcm_VerilyLifeSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_85a98eb4-4b8f-4d5b-906d-e86c444bb1e5_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_d46e86df-effe-4999-bb61-f63cb225e42d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_335b5750-4867-4ba4-9466-aaaa03f42aa6_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_9e8b5dae-5719-42d5-ada5-04233116977a_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_b8e33f10-99a3-4802-8dc4-106ad08d1d0b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_c7c6bde6-f0b4-4cce-8f54-03a8c06b69a2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of senior convertible notes, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_336df929-79d2-48f0-9812-38c4556f8340_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_32614013-a67c-40ec-a353-75558dab6134_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_6b382476-8e73-41f2-a469-fca2d9c8bb85_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_4234612a-6134-42e9-a81d-6112ff695081_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_574718fd-bd8d-49b8-b4ce-dc89efaf0079_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_b837da16-c94d-495d-913c-e92d2359a7d3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_75eec7a4-7786-4a50-a21a-100eb5a43bd4_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_5384c089-278b-4c4c-bc7a-de8d8ac21de9_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_f2d71ada-6d88-43ba-95b1-03b7cd60cc74_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_29755ec0-afdb-48f3-b947-a7729f3048f9_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segment and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_68b3296c-610b-4c36-8c6c-33193e8f8fbe_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5640bbf8-5b15-43b3-abb7-4aebb745cda2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_481af50a-3032-4388-b988-bf1bfdd7217c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermDomain_0e2c2d96-0efd-4293-a33e-8b54e1255300_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term [Domain]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermDomain_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term [Domain]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermDomain_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Debt Instrument Conversion Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConversionTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain" xlink:to="lab_dxcm_DebtInstrumentConversionTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_56601a29-5f45-469b-88e1-f6f6a9d3f426_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_749eac05-2263-42e6-bd93-a7881acc2005_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e58f3818-a7ab-457c-a144-325734c0ecf9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute basic net income per share (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_db836a6c-77bc-43ba-990a-81d503486a62_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_e52b85ff-0a98-4654-ab4e-6bd2247183bb_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_ddf530ab-14a4-47e7-87e4-f80b456db177_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_82e2a1a8-e732-4f66-a19a-736e1653d03d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_c06c2157-0100-4cb2-87d4-21bcdd9bd45d_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped call, cap price (in dollars per share)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_label_en-US" xlink:label="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Cap Call Transaction, Cap Price Per Share</link:label>
    <link:label id="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Cap Call Transaction, Cap Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentCapCallTransactionCapPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:to="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b321428e-dc6f-47f7-af85-45cc684a8738_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused capacity fee (as a percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_cbff7b3a-f013-466b-878c-ffa914bec92f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_7fe2a687-f5ec-400b-9107-736a5d2320c2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversions of 2023 Notes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_97f9a378-0891-43a1-8ffe-e6c46a6bdd5e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ConvertibleNotesDue2028Member_51464122-5642-4665-9948-4ac140713e31_terseLabel_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes due 2028</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2028Member_label_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2028 [Member]</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2028Member_documentation_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ConvertibleNotesDue2028Member" xlink:to="lab_dxcm_ConvertibleNotesDue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_ace7d101-11e4-45e3-8f86-b06ffa560228_terseLabel_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:href="dxcm-20230630.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_0b77a8ba-3771-4319-9b3e-246dba56ad02_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding borrowings</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_43ea02e6-203c-48c8-b6b5-4e49cce14aed_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_953564d1-f3db-429c-b602-2011126e2a23_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Marketable Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_3eb41b1a-7a04-45f4-9b73-1a309ac3c70e_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge_c17fbcc3-590e-4d82-82eb-1621104ff531_negatedTerseLabel_en-US" xlink:label="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit of note hedge upon conversions of 2023 Notes (shares)</link:label>
    <link:label id="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge_29ad93a9-76d9-4bbd-819f-e4d2b9d4e298_verboseLabel_en-US" xlink:label="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares received from Note Hedge</link:label>
    <link:label id="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge_label_en-US" xlink:label="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Received From Exercise Of Note Hedge</link:label>
    <link:label id="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge_documentation_en-US" xlink:label="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Received From Exercise Of Note Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge" xlink:href="dxcm-20230630.xsd#dxcm_SharesReceivedFromExerciseOfNoteHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge" xlink:to="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge_048059cd-b213-4729-bb12-9ee716ec1aa3_terseLabel_en-US" xlink:label="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares received under note hedge upon conversion of 2023 Notes</link:label>
    <link:label id="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge_label_en-US" xlink:label="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Benefit Received From Note Hedge</link:label>
    <link:label id="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge_documentation_en-US" xlink:label="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Benefit Received From Note Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:href="dxcm-20230630.xsd#dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:to="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>dxcm-20230630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:3f233038-1297-4d40-b9d2-42700d6fe8fe,g:c1345a4d-d54c-45d2-818f-78cac7edf10e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.dexcom.com/role/Cover" xlink:type="simple" xlink:href="dxcm-20230630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_877daec9-d1e3-4aac-83ab-0fc35e61ea5a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_DocumentType_877daec9-d1e3-4aac-83ab-0fc35e61ea5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_787d154d-224d-4902-93bc-d001ed1c1bb2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_DocumentQuarterlyReport_787d154d-224d-4902-93bc-d001ed1c1bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d0f7bbe6-3099-40ee-b797-ce442a0e6354" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_DocumentPeriodEndDate_d0f7bbe6-3099-40ee-b797-ce442a0e6354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_931e77b7-80e4-4ba4-a3cc-50f9a71c41bb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_DocumentTransitionReport_931e77b7-80e4-4ba4-a3cc-50f9a71c41bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4e727b02-f38e-42ea-98ad-8b02deeff8a1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_EntityFileNumber_4e727b02-f38e-42ea-98ad-8b02deeff8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_cb078dc7-d227-41e2-b8c3-c8ebf65ea57f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_EntityRegistrantName_cb078dc7-d227-41e2-b8c3-c8ebf65ea57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f4745619-f090-4651-a57e-4361189edc54" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f4745619-f090-4651-a57e-4361189edc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_955cd05b-7b1d-4e8e-8b28-854ea3db271a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_EntityTaxIdentificationNumber_955cd05b-7b1d-4e8e-8b28-854ea3db271a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_a549de5d-ee64-4947-b841-e09015863ec7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_EntityAddressAddressLine1_a549de5d-ee64-4947-b841-e09015863ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c50a3dba-78c3-4121-8df6-985d8ef4e970" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_EntityAddressCityOrTown_c50a3dba-78c3-4121-8df6-985d8ef4e970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b5ca6129-e190-4474-90d6-ab5ae2f738ae" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_EntityAddressStateOrProvince_b5ca6129-e190-4474-90d6-ab5ae2f738ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d5d2cff6-8434-458a-870e-e36a56f8fd2c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_EntityAddressPostalZipCode_d5d2cff6-8434-458a-870e-e36a56f8fd2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b8d5d090-6f98-4ad1-8b16-7a24a710026c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_CityAreaCode_b8d5d090-6f98-4ad1-8b16-7a24a710026c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ce87fcbd-de06-4c97-a45c-2ae45b85b613" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_LocalPhoneNumber_ce87fcbd-de06-4c97-a45c-2ae45b85b613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1867aaf6-cac5-4fb0-ab64-70109ec1df0c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_Security12bTitle_1867aaf6-cac5-4fb0-ab64-70109ec1df0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_01a1d88f-9615-460e-a412-8ef02559e1c9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_TradingSymbol_01a1d88f-9615-460e-a412-8ef02559e1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_9fdbc1af-f300-4e54-9e3b-98b89b413900" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_SecurityExchangeName_9fdbc1af-f300-4e54-9e3b-98b89b413900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_1f34b919-d5b7-4138-8c74-60784505ce13" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_EntityCurrentReportingStatus_1f34b919-d5b7-4138-8c74-60784505ce13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_5b183de6-44b3-461b-992b-7a9d44d310c1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_EntityInteractiveDataCurrent_5b183de6-44b3-461b-992b-7a9d44d310c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_5bf71536-eb6b-49a7-9b69-4c20b36fb60f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_EntityFilerCategory_5bf71536-eb6b-49a7-9b69-4c20b36fb60f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_899fb3a0-e529-4963-9480-0d71c65b6a30" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_EntitySmallBusiness_899fb3a0-e529-4963-9480-0d71c65b6a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_a32fee22-da52-4ae0-a5a1-7e5436b2f37b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_EntityEmergingGrowthCompany_a32fee22-da52-4ae0-a5a1-7e5436b2f37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_1449cfb9-368d-4863-aed1-c139f0bc1c4e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_EntityShellCompany_1449cfb9-368d-4863-aed1-c139f0bc1c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_3095b485-f98d-4458-8610-4c9e1efcae8b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_3095b485-f98d-4458-8610-4c9e1efcae8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_adff20a2-fd7b-4e4d-8711-ca23030a09aa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_AmendmentFlag_adff20a2-fd7b-4e4d-8711-ca23030a09aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f424738d-c25b-4826-94fb-6e0591501d78" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_DocumentFiscalYearFocus_f424738d-c25b-4826-94fb-6e0591501d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_fae4ba2a-f931-48ae-affc-0d5971c43a9d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_DocumentFiscalPeriodFocus_fae4ba2a-f931-48ae-affc-0d5971c43a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e02f3e60-eddf-4fbf-af24-4ad76eaf6fe8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_EntityCentralIndexKey_e02f3e60-eddf-4fbf-af24-4ad76eaf6fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_677c0cf8-1e0e-4df2-ab4f-6302d7864726" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_17be545b-9270-471f-92f4-7701793538af" xlink:to="loc_dei_CurrentFiscalYearEndDate_677c0cf8-1e0e-4df2-ab4f-6302d7864726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="dxcm-20230630.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e7fa2b69-f01e-4bf6-ac8e-41d3e9622166" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_f0444ca7-3cc8-4ffc-bfb8-67aa54ab3c00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e7fa2b69-f01e-4bf6-ac8e-41d3e9622166" xlink:to="loc_us-gaap_AssetsAbstract_f0444ca7-3cc8-4ffc-bfb8-67aa54ab3c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_ef8a4b79-f0fd-4b76-83cf-e9a2750e28fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f0444ca7-3cc8-4ffc-bfb8-67aa54ab3c00" xlink:to="loc_us-gaap_AssetsCurrentAbstract_ef8a4b79-f0fd-4b76-83cf-e9a2750e28fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_213fb99a-16f2-4bd2-b4ed-d349abfe2c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef8a4b79-f0fd-4b76-83cf-e9a2750e28fe" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_213fb99a-16f2-4bd2-b4ed-d349abfe2c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_6480e0df-8cef-47f6-8fb8-2ec99794f8b5" xlink:href="dxcm-20230630.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef8a4b79-f0fd-4b76-83cf-e9a2750e28fe" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_6480e0df-8cef-47f6-8fb8-2ec99794f8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4c13557d-2c4f-4b1f-8de9-3e25afec7112" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef8a4b79-f0fd-4b76-83cf-e9a2750e28fe" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4c13557d-2c4f-4b1f-8de9-3e25afec7112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_288ff66f-d97a-4191-8468-74ae045b10d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef8a4b79-f0fd-4b76-83cf-e9a2750e28fe" xlink:to="loc_us-gaap_InventoryNet_288ff66f-d97a-4191-8468-74ae045b10d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_789629d7-26dd-46d7-b8df-73b21bc6b94d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef8a4b79-f0fd-4b76-83cf-e9a2750e28fe" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_789629d7-26dd-46d7-b8df-73b21bc6b94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_918566b5-070f-4468-95bb-ec05a0bea238" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef8a4b79-f0fd-4b76-83cf-e9a2750e28fe" xlink:to="loc_us-gaap_AssetsCurrent_918566b5-070f-4468-95bb-ec05a0bea238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_dd80426a-56b1-408c-ba82-cbdcec00648a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f0444ca7-3cc8-4ffc-bfb8-67aa54ab3c00" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_dd80426a-56b1-408c-ba82-cbdcec00648a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_497fa8b5-ebe3-4906-883c-facb3d52c786" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f0444ca7-3cc8-4ffc-bfb8-67aa54ab3c00" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_497fa8b5-ebe3-4906-883c-facb3d52c786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fa936985-d477-4699-86c3-82c70fef91c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f0444ca7-3cc8-4ffc-bfb8-67aa54ab3c00" xlink:to="loc_us-gaap_Goodwill_fa936985-d477-4699-86c3-82c70fef91c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6c9b84a7-2b99-4654-95a0-881656e26dea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f0444ca7-3cc8-4ffc-bfb8-67aa54ab3c00" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6c9b84a7-2b99-4654-95a0-881656e26dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_84984027-3d53-4651-80f6-0696aae5498a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f0444ca7-3cc8-4ffc-bfb8-67aa54ab3c00" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_84984027-3d53-4651-80f6-0696aae5498a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_50f95365-4ca4-40fd-b25a-a0696018ff00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f0444ca7-3cc8-4ffc-bfb8-67aa54ab3c00" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_50f95365-4ca4-40fd-b25a-a0696018ff00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9b1a9b59-5f3c-424c-87be-f3cd74912a08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f0444ca7-3cc8-4ffc-bfb8-67aa54ab3c00" xlink:to="loc_us-gaap_Assets_9b1a9b59-5f3c-424c-87be-f3cd74912a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab8771ce-2708-4cca-8094-790eaef1ddd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e7fa2b69-f01e-4bf6-ac8e-41d3e9622166" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab8771ce-2708-4cca-8094-790eaef1ddd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_e6cc7303-18c4-4048-af19-4b721d97450c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab8771ce-2708-4cca-8094-790eaef1ddd9" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_e6cc7303-18c4-4048-af19-4b721d97450c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_b977e5f0-b0e1-4109-a6d1-95dbc51295d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e6cc7303-18c4-4048-af19-4b721d97450c" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_b977e5f0-b0e1-4109-a6d1-95dbc51295d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e24db833-1c74-4bf7-88a5-b88919e0e90a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e6cc7303-18c4-4048-af19-4b721d97450c" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e24db833-1c74-4bf7-88a5-b88919e0e90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_160ddfe4-e63a-4708-8c1d-b40332d03a39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e6cc7303-18c4-4048-af19-4b721d97450c" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_160ddfe4-e63a-4708-8c1d-b40332d03a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_4ccc02ec-e249-4ce3-8fa1-3635b93d4335" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e6cc7303-18c4-4048-af19-4b721d97450c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_4ccc02ec-e249-4ce3-8fa1-3635b93d4335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_219689fc-89dd-415f-8a84-d026b7e4f068" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e6cc7303-18c4-4048-af19-4b721d97450c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_219689fc-89dd-415f-8a84-d026b7e4f068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7326ed57-786b-4411-bf00-4f00f4f9905f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e6cc7303-18c4-4048-af19-4b721d97450c" xlink:to="loc_us-gaap_LiabilitiesCurrent_7326ed57-786b-4411-bf00-4f00f4f9905f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_02c33042-3095-4861-87ba-de32fc88a769" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab8771ce-2708-4cca-8094-790eaef1ddd9" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_02c33042-3095-4861-87ba-de32fc88a769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d329274e-5ed7-471d-9122-fd6b04804114" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab8771ce-2708-4cca-8094-790eaef1ddd9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d329274e-5ed7-471d-9122-fd6b04804114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7a439bee-bb04-41f5-9ec7-e0b16ed34c84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab8771ce-2708-4cca-8094-790eaef1ddd9" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7a439bee-bb04-41f5-9ec7-e0b16ed34c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e7949df6-a534-4ef3-aebc-808cd367414f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab8771ce-2708-4cca-8094-790eaef1ddd9" xlink:to="loc_us-gaap_Liabilities_e7949df6-a534-4ef3-aebc-808cd367414f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d93be801-8bf6-4a59-8cdb-6c71143a74c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab8771ce-2708-4cca-8094-790eaef1ddd9" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d93be801-8bf6-4a59-8cdb-6c71143a74c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_c67d4154-453d-46fd-bba8-559e6210152e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab8771ce-2708-4cca-8094-790eaef1ddd9" xlink:to="loc_us-gaap_StockholdersEquityAbstract_c67d4154-453d-46fd-bba8-559e6210152e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_883a70a7-c652-46dc-84fd-48069c5699e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c67d4154-453d-46fd-bba8-559e6210152e" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_883a70a7-c652-46dc-84fd-48069c5699e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_8d89eae5-ee29-4051-9aa2-39d35e35f12e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c67d4154-453d-46fd-bba8-559e6210152e" xlink:to="loc_us-gaap_CommonStockValueOutstanding_8d89eae5-ee29-4051-9aa2-39d35e35f12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0df5f46b-a00c-458a-9483-d820cbd4d321" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c67d4154-453d-46fd-bba8-559e6210152e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0df5f46b-a00c-458a-9483-d820cbd4d321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_21036779-fa1f-4d1e-b406-8a6b231c9d53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c67d4154-453d-46fd-bba8-559e6210152e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_21036779-fa1f-4d1e-b406-8a6b231c9d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d1e6bef3-e0ce-4994-91df-156b5ad2b0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c67d4154-453d-46fd-bba8-559e6210152e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d1e6bef3-e0ce-4994-91df-156b5ad2b0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_c85b3731-14db-4aee-92df-4c4ee9009446" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c67d4154-453d-46fd-bba8-559e6210152e" xlink:to="loc_us-gaap_TreasuryStockCommonValue_c85b3731-14db-4aee-92df-4c4ee9009446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f032b4f9-9476-4ce0-93f1-e394e3a9a5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c67d4154-453d-46fd-bba8-559e6210152e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f032b4f9-9476-4ce0-93f1-e394e3a9a5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9f5ad65c-1c78-42f1-8cb6-8407ec707b73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab8771ce-2708-4cca-8094-790eaef1ddd9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_9f5ad65c-1c78-42f1-8cb6-8407ec707b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="dxcm-20230630.xsd#ConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ba504976-dc9f-4b20-a45b-29d7a3bb79c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8d32680e-e074-49aa-a54d-55b5902f8f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba504976-dc9f-4b20-a45b-29d7a3bb79c5" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8d32680e-e074-49aa-a54d-55b5902f8f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_25a7679a-44c9-49ea-a36b-58372bf72a88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba504976-dc9f-4b20-a45b-29d7a3bb79c5" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_25a7679a-44c9-49ea-a36b-58372bf72a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_2ab2acbf-50ce-471c-87de-8ebfdb5ed576" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba504976-dc9f-4b20-a45b-29d7a3bb79c5" xlink:to="loc_us-gaap_PreferredStockSharesIssued_2ab2acbf-50ce-471c-87de-8ebfdb5ed576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_f25f88cb-ca95-4a8d-b717-32a4024c9da9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba504976-dc9f-4b20-a45b-29d7a3bb79c5" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_f25f88cb-ca95-4a8d-b717-32a4024c9da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019ea9ab-93c2-45ae-8052-b10980a3f266" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba504976-dc9f-4b20-a45b-29d7a3bb79c5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019ea9ab-93c2-45ae-8052-b10980a3f266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_345b80d0-a8cf-4641-9663-70186c9038f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba504976-dc9f-4b20-a45b-29d7a3bb79c5" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_345b80d0-a8cf-4641-9663-70186c9038f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_3f9aebe8-df3c-4552-931c-76273460a1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba504976-dc9f-4b20-a45b-29d7a3bb79c5" xlink:to="loc_us-gaap_CommonStockSharesIssued_3f9aebe8-df3c-4552-931c-76273460a1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e9d93b9a-d615-4f4a-9a61-483a3b8daaba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba504976-dc9f-4b20-a45b-29d7a3bb79c5" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e9d93b9a-d615-4f4a-9a61-483a3b8daaba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_f159f6ab-ce99-40c7-949f-1b8f0eadcc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba504976-dc9f-4b20-a45b-29d7a3bb79c5" xlink:to="loc_us-gaap_TreasuryStockCommonShares_f159f6ab-ce99-40c7-949f-1b8f0eadcc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="dxcm-20230630.xsd#ConsolidatedStatementsofOperationsUnaudited"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_d086dc1d-2a14-41ff-87aa-8724ab1de7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_83a62f81-0fbd-4218-9741-32ff31c6200f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d086dc1d-2a14-41ff-87aa-8724ab1de7f7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_83a62f81-0fbd-4218-9741-32ff31c6200f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_48e97cff-05da-439c-b368-e61c75503def" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d086dc1d-2a14-41ff-87aa-8724ab1de7f7" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_48e97cff-05da-439c-b368-e61c75503def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0fe6bbe6-1bb7-4e86-84e7-385ffbdca3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d086dc1d-2a14-41ff-87aa-8724ab1de7f7" xlink:to="loc_us-gaap_GrossProfit_0fe6bbe6-1bb7-4e86-84e7-385ffbdca3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_a1a37c1e-d32e-481e-bc94-36de1341482e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d086dc1d-2a14-41ff-87aa-8724ab1de7f7" xlink:to="loc_us-gaap_OperatingExpensesAbstract_a1a37c1e-d32e-481e-bc94-36de1341482e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f2070659-67e1-46fd-bf40-c3c9001b629c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a1a37c1e-d32e-481e-bc94-36de1341482e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f2070659-67e1-46fd-bf40-c3c9001b629c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_36b6c2b4-7a9d-454b-9f2b-3476d9f82511" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a1a37c1e-d32e-481e-bc94-36de1341482e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_36b6c2b4-7a9d-454b-9f2b-3476d9f82511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_68fa1885-8a95-4a57-848d-e42798d346e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a1a37c1e-d32e-481e-bc94-36de1341482e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_68fa1885-8a95-4a57-848d-e42798d346e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_93fa0161-4b89-4729-a0f4-8fc7fa0a1fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a1a37c1e-d32e-481e-bc94-36de1341482e" xlink:to="loc_us-gaap_OperatingExpenses_93fa0161-4b89-4729-a0f4-8fc7fa0a1fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f5c5ef82-db76-49a2-99be-10e4c5c95409" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d086dc1d-2a14-41ff-87aa-8724ab1de7f7" xlink:to="loc_us-gaap_OperatingIncomeLoss_f5c5ef82-db76-49a2-99be-10e4c5c95409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c3449914-4604-41ef-9df3-8e542cb25143" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d086dc1d-2a14-41ff-87aa-8724ab1de7f7" xlink:to="loc_us-gaap_InterestExpense_c3449914-4604-41ef-9df3-8e542cb25143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_dd429017-c5d9-4e46-849f-949b0bd37f27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d086dc1d-2a14-41ff-87aa-8724ab1de7f7" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_dd429017-c5d9-4e46-849f-949b0bd37f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_02804b6a-0b93-411d-8c2e-ccd43b707f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d086dc1d-2a14-41ff-87aa-8724ab1de7f7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_02804b6a-0b93-411d-8c2e-ccd43b707f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0230a239-ac5c-47cd-9f8c-d97a2af2eb88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d086dc1d-2a14-41ff-87aa-8724ab1de7f7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0230a239-ac5c-47cd-9f8c-d97a2af2eb88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4781e99f-f389-466d-9f3f-9962750e9943" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d086dc1d-2a14-41ff-87aa-8724ab1de7f7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4781e99f-f389-466d-9f3f-9962750e9943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9c8ee925-0a3b-4aa9-964f-440e83e87602" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d086dc1d-2a14-41ff-87aa-8724ab1de7f7" xlink:to="loc_us-gaap_NetIncomeLoss_9c8ee925-0a3b-4aa9-964f-440e83e87602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ed7cd231-6661-4b19-812a-103ae78554a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d086dc1d-2a14-41ff-87aa-8724ab1de7f7" xlink:to="loc_us-gaap_EarningsPerShareBasic_ed7cd231-6661-4b19-812a-103ae78554a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6a6af5dc-7f7e-4179-b5f1-2e44307bb72b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d086dc1d-2a14-41ff-87aa-8724ab1de7f7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6a6af5dc-7f7e-4179-b5f1-2e44307bb72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_72434df2-0ac0-4a14-a91b-ea7cba3899e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d086dc1d-2a14-41ff-87aa-8724ab1de7f7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_72434df2-0ac0-4a14-a91b-ea7cba3899e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5b6c3432-1908-4d1c-9a5a-b776f7b8565e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d086dc1d-2a14-41ff-87aa-8724ab1de7f7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5b6c3432-1908-4d1c-9a5a-b776f7b8565e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="dxcm-20230630.xsd#ConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5923c3d7-f043-47a7-a781-45497e978cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5446c089-3494-4af1-bbd4-0c9ca89b008c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5923c3d7-f043-47a7-a781-45497e978cbe" xlink:to="loc_us-gaap_NetIncomeLoss_5446c089-3494-4af1-bbd4-0c9ca89b008c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ec61178b-a728-4ab6-a3d8-0fe0e7439f92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5923c3d7-f043-47a7-a781-45497e978cbe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ec61178b-a728-4ab6-a3d8-0fe0e7439f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_52b1bf79-fd1a-4d7e-bd3e-622a40eef1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ec61178b-a728-4ab6-a3d8-0fe0e7439f92" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_52b1bf79-fd1a-4d7e-bd3e-622a40eef1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2775a6e8-7b99-490c-a123-90ff6a8d62e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ec61178b-a728-4ab6-a3d8-0fe0e7439f92" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2775a6e8-7b99-490c-a123-90ff6a8d62e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_748153e0-328a-4b4e-ba0f-6a2eaaff7eda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ec61178b-a728-4ab6-a3d8-0fe0e7439f92" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_748153e0-328a-4b4e-ba0f-6a2eaaff7eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a6725173-923f-4b8e-8b62-aad2aecff8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5923c3d7-f043-47a7-a781-45497e978cbe" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_a6725173-923f-4b8e-8b62-aad2aecff8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="dxcm-20230630.xsd#ConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_95c7f6c0-7cd4-4c20-8d45-6c2cfd68bb59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f5162a71-2575-4520-81f8-5357befdb831" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_95c7f6c0-7cd4-4c20-8d45-6c2cfd68bb59" xlink:to="loc_us-gaap_StatementTable_f5162a71-2575-4520-81f8-5357befdb831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9a5ed516-bc48-43a2-92bc-5fcc1248da74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f5162a71-2575-4520-81f8-5357befdb831" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9a5ed516-bc48-43a2-92bc-5fcc1248da74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c9390a4b-4370-4fc2-ad96-27a371e4597c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9a5ed516-bc48-43a2-92bc-5fcc1248da74" xlink:to="loc_us-gaap_EquityComponentDomain_c9390a4b-4370-4fc2-ad96-27a371e4597c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_72c5f11e-2531-47e0-b6f8-0a03ae031094" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c9390a4b-4370-4fc2-ad96-27a371e4597c" xlink:to="loc_us-gaap_CommonStockMember_72c5f11e-2531-47e0-b6f8-0a03ae031094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9596fe7c-f9d2-48aa-8bcb-4646f6341c88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c9390a4b-4370-4fc2-ad96-27a371e4597c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9596fe7c-f9d2-48aa-8bcb-4646f6341c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2ddc020c-b653-4445-b2ec-28d3e23fffbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c9390a4b-4370-4fc2-ad96-27a371e4597c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2ddc020c-b653-4445-b2ec-28d3e23fffbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a2af26e5-6991-4e3f-b006-96177c9b2b11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c9390a4b-4370-4fc2-ad96-27a371e4597c" xlink:to="loc_us-gaap_RetainedEarningsMember_a2af26e5-6991-4e3f-b006-96177c9b2b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_3440c192-598a-4931-ac27-175a0ece2d36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c9390a4b-4370-4fc2-ad96-27a371e4597c" xlink:to="loc_us-gaap_TreasuryStockCommonMember_3440c192-598a-4931-ac27-175a0ece2d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b6dcd6cc-5d1d-4835-b36d-57db2cd17315" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f5162a71-2575-4520-81f8-5357befdb831" xlink:to="loc_us-gaap_StatementLineItems_b6dcd6cc-5d1d-4835-b36d-57db2cd17315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b6dcd6cc-5d1d-4835-b36d-57db2cd17315" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6407ca40-c032-43c2-982c-e802da677dde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6407ca40-c032-43c2-982c-e802da677dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_02c62a25-7009-4007-9886-8c1c8a52e429" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_StockholdersEquity_02c62a25-7009-4007-9886-8c1c8a52e429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_ab4aae71-82df-4c7b-bd75-b888cea30aca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_ab4aae71-82df-4c7b-bd75-b888cea30aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f8912b7d-a0b3-4500-9ccb-02204417b77e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f8912b7d-a0b3-4500-9ccb-02204417b77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a9f4520d-bf0a-41d1-b241-5c3239ff94e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a9f4520d-bf0a-41d1-b241-5c3239ff94e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_6a52bfde-617c-49d2-be54-c5c454c796cf" xlink:href="dxcm-20230630.xsd#dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_6a52bfde-617c-49d2-be54-c5c454c796cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone_9b55eb8e-f5e1-4983-8860-6f6f63f259bd" xlink:href="dxcm-20230630.xsd#dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone_9b55eb8e-f5e1-4983-8860-6f6f63f259bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_698e05b5-f966-423e-8034-0384ea8daccd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_698e05b5-f966-423e-8034-0384ea8daccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_abd9277c-8647-4b39-9808-d42e2433f112" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_abd9277c-8647-4b39-9808-d42e2433f112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_cf04b5dd-abd0-49ca-aff9-a03bfa09e1aa" xlink:href="dxcm-20230630.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_cf04b5dd-abd0-49ca-aff9-a03bfa09e1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_f567b839-3e7f-4651-b643-05130a64706d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_f567b839-3e7f-4651-b643-05130a64706d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_21273522-bb7c-45e6-bb5f-26b92dfccd62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_21273522-bb7c-45e6-bb5f-26b92dfccd62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge_062bd11f-5ec5-4e2f-8a51-8ee268adecd4" xlink:href="dxcm-20230630.xsd#dxcm_SharesReceivedFromExerciseOfNoteHedge"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge_062bd11f-5ec5-4e2f-8a51-8ee268adecd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue_a6a61d17-e4d8-49f7-a712-6f4c5d2f5f2d" xlink:href="dxcm-20230630.xsd#dxcm_SharesReceivedFromBenefitOfNoteHedgeValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue_a6a61d17-e4d8-49f7-a712-6f4c5d2f5f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d2d7d2fd-41fb-499a-8fa2-4553a81397b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d2d7d2fd-41fb-499a-8fa2-4553a81397b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3cf739ef-6f66-400f-bf0c-0ea2a6b390a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_NetIncomeLoss_3cf739ef-6f66-400f-bf0c-0ea2a6b390a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2a21c106-a769-480b-9e4b-20c24d64dbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2a21c106-a769-480b-9e4b-20c24d64dbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a059dea5-7bfa-4b90-97bf-e277cc0faf80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a059dea5-7bfa-4b90-97bf-e277cc0faf80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_967aee47-705b-4650-9c2e-dd40eeeb7ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c67f3488-82bc-48f3-b836-8cb262b3b71a" xlink:to="loc_us-gaap_StockholdersEquity_967aee47-705b-4650-9c2e-dd40eeeb7ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="dxcm-20230630.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_8aa582e5-9b24-49b4-ba41-086c15a4ccd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b9833f5-e69d-41a5-9b71-676e9ab5afc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8aa582e5-9b24-49b4-ba41-086c15a4ccd2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b9833f5-e69d-41a5-9b71-676e9ab5afc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_89ef2f8e-84f0-4588-afbf-e717ca11c35f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b9833f5-e69d-41a5-9b71-676e9ab5afc4" xlink:to="loc_us-gaap_NetIncomeLoss_89ef2f8e-84f0-4588-afbf-e717ca11c35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43061fe7-9049-4fb7-beda-761b51b2bc88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b9833f5-e69d-41a5-9b71-676e9ab5afc4" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43061fe7-9049-4fb7-beda-761b51b2bc88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_941329ed-3daa-4e65-bb84-33a719502ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43061fe7-9049-4fb7-beda-761b51b2bc88" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_941329ed-3daa-4e65-bb84-33a719502ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a6bfb5e0-5e3c-42e2-a3fa-4d37d62533b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43061fe7-9049-4fb7-beda-761b51b2bc88" xlink:to="loc_us-gaap_ShareBasedCompensation_a6bfb5e0-5e3c-42e2-a3fa-4d37d62533b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_a83908f5-93b2-415a-aeac-2238f75c85a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaidInKindInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43061fe7-9049-4fb7-beda-761b51b2bc88" xlink:to="loc_us-gaap_PaidInKindInterest_a83908f5-93b2-415a-aeac-2238f75c85a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_ce38dadd-6187-4239-8e0e-57b6bb68cd95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43061fe7-9049-4fb7-beda-761b51b2bc88" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_ce38dadd-6187-4239-8e0e-57b6bb68cd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_491e7179-8638-40b1-b661-12c526f69fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43061fe7-9049-4fb7-beda-761b51b2bc88" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_491e7179-8638-40b1-b661-12c526f69fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_2cfd10aa-ed19-408a-a028-2c1f5376fc09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43061fe7-9049-4fb7-beda-761b51b2bc88" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_2cfd10aa-ed19-408a-a028-2c1f5376fc09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_dfca53e8-2c2d-42aa-b714-81cd3e0ab434" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b9833f5-e69d-41a5-9b71-676e9ab5afc4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_dfca53e8-2c2d-42aa-b714-81cd3e0ab434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_396289bc-b092-4a59-8363-b264a298575a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_dfca53e8-2c2d-42aa-b714-81cd3e0ab434" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_396289bc-b092-4a59-8363-b264a298575a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_46d93be6-94d8-4808-85d0-68fda77393a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_dfca53e8-2c2d-42aa-b714-81cd3e0ab434" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_46d93be6-94d8-4808-85d0-68fda77393a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d4fc9a28-c322-4a8e-ade9-a1d33b10d2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_dfca53e8-2c2d-42aa-b714-81cd3e0ab434" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d4fc9a28-c322-4a8e-ade9-a1d33b10d2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_4bb78416-d345-4037-8ad9-77e76226e832" xlink:href="dxcm-20230630.xsd#dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_dfca53e8-2c2d-42aa-b714-81cd3e0ab434" xlink:to="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_4bb78416-d345-4037-8ad9-77e76226e832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_eae0e5bb-d6c8-42be-b57b-628ab8c44ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_dfca53e8-2c2d-42aa-b714-81cd3e0ab434" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_eae0e5bb-d6c8-42be-b57b-628ab8c44ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0076155d-6890-4327-8548-47a199149c39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_dfca53e8-2c2d-42aa-b714-81cd3e0ab434" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0076155d-6890-4327-8548-47a199149c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_c40c46b7-6814-4f99-9070-c1e06fbee639" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_dfca53e8-2c2d-42aa-b714-81cd3e0ab434" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_c40c46b7-6814-4f99-9070-c1e06fbee639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_47401969-d150-462c-8251-f0ddc1085202" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b9833f5-e69d-41a5-9b71-676e9ab5afc4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_47401969-d150-462c-8251-f0ddc1085202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6136b1cc-898b-419c-b786-60bdc3905ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8aa582e5-9b24-49b4-ba41-086c15a4ccd2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6136b1cc-898b-419c-b786-60bdc3905ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_fbf7114c-193e-4918-bd5e-a38afef038d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6136b1cc-898b-419c-b786-60bdc3905ae2" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_fbf7114c-193e-4918-bd5e-a38afef038d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_a419adae-085a-4e6a-918f-2e543627b6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6136b1cc-898b-419c-b786-60bdc3905ae2" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_a419adae-085a-4e6a-918f-2e543627b6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0ce9e616-1b69-4eb0-a7b8-a1bd34877caa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6136b1cc-898b-419c-b786-60bdc3905ae2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0ce9e616-1b69-4eb0-a7b8-a1bd34877caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_83b5ee5d-f355-435a-98aa-06938dcc49ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6136b1cc-898b-419c-b786-60bdc3905ae2" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_83b5ee5d-f355-435a-98aa-06938dcc49ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_afe54131-d02b-468b-8703-de9cf528fd50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6136b1cc-898b-419c-b786-60bdc3905ae2" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_afe54131-d02b-468b-8703-de9cf528fd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_01b72437-23ca-4a07-a13c-880363ab7ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6136b1cc-898b-419c-b786-60bdc3905ae2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_01b72437-23ca-4a07-a13c-880363ab7ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c76cb2a-f83d-4d28-9f9e-07cc732f3954" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8aa582e5-9b24-49b4-ba41-086c15a4ccd2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c76cb2a-f83d-4d28-9f9e-07cc732f3954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e5a0771d-9f1e-46f2-bcb0-6cb27a1047f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c76cb2a-f83d-4d28-9f9e-07cc732f3954" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e5a0771d-9f1e-46f2-bcb0-6cb27a1047f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d63c3b4b-aef9-4a04-82e8-0c5e04834ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c76cb2a-f83d-4d28-9f9e-07cc732f3954" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d63c3b4b-aef9-4a04-82e8-0c5e04834ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_76bad3ed-e392-42e8-bf47-a5000c404238" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c76cb2a-f83d-4d28-9f9e-07cc732f3954" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_76bad3ed-e392-42e8-bf47-a5000c404238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_d5b60a17-8fd8-4b23-aa8a-b0cf61df0f1d" xlink:href="dxcm-20230630.xsd#dxcm_PaymentsForPurchasesOfCappedCallTransactions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c76cb2a-f83d-4d28-9f9e-07cc732f3954" xlink:to="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_d5b60a17-8fd8-4b23-aa8a-b0cf61df0f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_9f17dca0-5af1-4ac6-bafb-1623f957643f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c76cb2a-f83d-4d28-9f9e-07cc732f3954" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_9f17dca0-5af1-4ac6-bafb-1623f957643f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_659ec564-74a0-49c9-908f-7e4f8034c1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c76cb2a-f83d-4d28-9f9e-07cc732f3954" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_659ec564-74a0-49c9-908f-7e4f8034c1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_915de316-53a2-44c0-8ad9-041ba3468734" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8aa582e5-9b24-49b4-ba41-086c15a4ccd2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_915de316-53a2-44c0-8ad9-041ba3468734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_425a010b-5e35-48f1-92ba-8b4bd51fe841" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8aa582e5-9b24-49b4-ba41-086c15a4ccd2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_425a010b-5e35-48f1-92ba-8b4bd51fe841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_219831a8-20c8-49dc-a023-bc3a684cebb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8aa582e5-9b24-49b4-ba41-086c15a4ccd2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_219831a8-20c8-49dc-a023-bc3a684cebb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_db5e6a0d-a520-4aa4-b939-9ff2b19e627f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8aa582e5-9b24-49b4-ba41-086c15a4ccd2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_db5e6a0d-a520-4aa4-b939-9ff2b19e627f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_77d42751-3567-47f9-a7f7-52cf8ab85d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8aa582e5-9b24-49b4-ba41-086c15a4ccd2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_77d42751-3567-47f9-a7f7-52cf8ab85d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6a3acaee-0add-463a-b9c6-333644cc2b09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_77d42751-3567-47f9-a7f7-52cf8ab85d6b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6a3acaee-0add-463a-b9c6-333644cc2b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_001c4d7b-3079-4324-bb6c-7f7600c6c1db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_77d42751-3567-47f9-a7f7-52cf8ab85d6b" xlink:to="loc_us-gaap_RestrictedCash_001c4d7b-3079-4324-bb6c-7f7600c6c1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_78742339-86c9-4284-8321-db8e69ef8120" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_77d42751-3567-47f9-a7f7-52cf8ab85d6b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_78742339-86c9-4284-8321-db8e69ef8120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_4296a695-b965-4590-9e4d-b93a9107f551" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8aa582e5-9b24-49b4-ba41-086c15a4ccd2" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_4296a695-b965-4590-9e4d-b93a9107f551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_99f8d1a6-9a7b-4cb3-8867-5f13fa74f1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4296a695-b965-4590-9e4d-b93a9107f551" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_99f8d1a6-9a7b-4cb3-8867-5f13fa74f1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge_d2dc068a-93d4-4892-9b43-1a35edb8d89e" xlink:href="dxcm-20230630.xsd#dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4296a695-b965-4590-9e4d-b93a9107f551" xlink:to="loc_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge_d2dc068a-93d4-4892-9b43-1a35edb8d89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_a58dfa24-20fd-4593-9b0d-34c1da8118f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4296a695-b965-4590-9e4d-b93a9107f551" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_a58dfa24-20fd-4593-9b0d-34c1da8118f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet_fdffc556-ca70-40ba-96d3-a124cc2c84b6" xlink:href="dxcm-20230630.xsd#dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4296a695-b965-4590-9e4d-b93a9107f551" xlink:to="loc_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet_fdffc556-ca70-40ba-96d3-a124cc2c84b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_380490bf-42e0-445c-8fe1-879819e3e13a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4296a695-b965-4590-9e4d-b93a9107f551" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_380490bf-42e0-445c-8fe1-879819e3e13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies" xlink:type="simple" xlink:href="dxcm-20230630.xsd#OrganizationandSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7f92fc7-bcd9-471d-ad34-bb0c135aa0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_36dda2f0-e1fc-41d6-a818-1fde95ab9669" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7f92fc7-bcd9-471d-ad34-bb0c135aa0d0" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_36dda2f0-e1fc-41d6-a818-1fde95ab9669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreements" xlink:type="simple" xlink:href="dxcm-20230630.xsd#DevelopmentandOtherAgreements"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DevelopmentandOtherAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9d554c75-9ec2-48cd-826d-941ed7cced41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_132c705f-2a87-4d86-af41-498ec6a6aa34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9d554c75-9ec2-48cd-826d-941ed7cced41" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_132c705f-2a87-4d86-af41-498ec6a6aa34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="dxcm-20230630.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_37584602-9d0a-44b1-8668-bd155833beff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_92eee276-c3fe-4e9e-a65f-7dfe57062719" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_37584602-9d0a-44b1-8668-bd155833beff" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_92eee276-c3fe-4e9e-a65f-7dfe57062719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f0ea9a8d-2fd1-46de-9eec-7cd588242c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_6f5358bf-3261-474e-a85a-34bb92b2340f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f0ea9a8d-2fd1-46de-9eec-7cd588242c4f" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_6f5358bf-3261-474e-a85a-34bb92b2340f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/Debt" xlink:type="simple" xlink:href="dxcm-20230630.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3d22f798-3f4d-4743-b634-8a71d56da89c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_00810a3c-c991-4700-8bdf-1b233b45d92d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3d22f798-3f4d-4743-b634-8a71d56da89c" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_00810a3c-c991-4700-8bdf-1b233b45d92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/Contingencies" xlink:type="simple" xlink:href="dxcm-20230630.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9aa881cf-e537-4384-8c48-288f4a870be6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_29179f37-f43f-45d9-9713-a4d94e79ced2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9aa881cf-e537-4384-8c48-288f4a870be6" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_29179f37-f43f-45d9-9713-a4d94e79ced2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxes" xlink:type="simple" xlink:href="dxcm-20230630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_411c3754-8876-4209-958a-36979f41de29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f411e06a-3504-4fd2-928d-dc064f41ff18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_411c3754-8876-4209-958a-36979f41de29" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f411e06a-3504-4fd2-928d-dc064f41ff18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/StockholdersEquity" xlink:type="simple" xlink:href="dxcm-20230630.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_907af641-14ac-4752-9f73-6f44df39bcce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3a82bc0c-a1f3-42c6-a796-5b63242b18a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_907af641-14ac-4752-9f73-6f44df39bcce" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3a82bc0c-a1f3-42c6-a796-5b63242b18a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformation" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BusinessSegmentandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5cc89a98-be84-4319-9640-5ed68ee9725a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_f0fac517-45dd-4de2-8abf-7e71a1086506" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5cc89a98-be84-4319-9640-5ed68ee9725a" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_f0fac517-45dd-4de2-8abf-7e71a1086506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="dxcm-20230630.xsd#OrganizationandSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ebe96e7b-51ff-4814-916c-e63cfb97f13d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d5a821d7-de36-4295-9e8a-986aefdde024" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ebe96e7b-51ff-4814-916c-e63cfb97f13d" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d5a821d7-de36-4295-9e8a-986aefdde024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_5c0699af-a640-4182-afbf-6bd66d769769" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ebe96e7b-51ff-4814-916c-e63cfb97f13d" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_5c0699af-a640-4182-afbf-6bd66d769769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_6a787eed-64c1-4554-97df-5300a3dd4ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ebe96e7b-51ff-4814-916c-e63cfb97f13d" xlink:to="loc_us-gaap_UseOfEstimates_6a787eed-64c1-4554-97df-5300a3dd4ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_55189a28-2f0f-4334-8a5c-5b99dc89ef29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ebe96e7b-51ff-4814-916c-e63cfb97f13d" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_55189a28-2f0f-4334-8a5c-5b99dc89ef29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_620f63ed-9fce-413d-a477-737dde6568ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ebe96e7b-51ff-4814-916c-e63cfb97f13d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_620f63ed-9fce-413d-a477-737dde6568ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_8f1c20bc-8be6-4bd6-983d-1fc5b3481afa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ebe96e7b-51ff-4814-916c-e63cfb97f13d" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_8f1c20bc-8be6-4bd6-983d-1fc5b3481afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_49314c7a-83b6-4edd-84d5-7caf91dcd8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ebe96e7b-51ff-4814-916c-e63cfb97f13d" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_49314c7a-83b6-4edd-84d5-7caf91dcd8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="dxcm-20230630.xsd#OrganizationandSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0fdbe812-6d72-428f-b3cd-e3b254a592f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_710ccc58-e1d6-469f-94c9-2abac6bda0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0fdbe812-6d72-428f-b3cd-e3b254a592f4" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_710ccc58-e1d6-469f-94c9-2abac6bda0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_2751363c-935b-4f3d-baa0-bea6af8586f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0fdbe812-6d72-428f-b3cd-e3b254a592f4" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_2751363c-935b-4f3d-baa0-bea6af8586f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="dxcm-20230630.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6d742cd7-6eeb-4499-a3f3-495175de9236" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_1378e986-75b1-4c12-89d6-85216b2bd9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6d742cd7-6eeb-4499-a3f3-495175de9236" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_1378e986-75b1-4c12-89d6-85216b2bd9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_5b611421-f157-4066-82e3-5a059c17ba26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6d742cd7-6eeb-4499-a3f3-495175de9236" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_5b611421-f157-4066-82e3-5a059c17ba26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsTables" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_68f48be8-0772-4940-8a01-4ecd64b05dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_058ebe43-9d1c-4cf4-a9b4-07570f58a57b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_68f48be8-0772-4940-8a01-4ecd64b05dd4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_058ebe43-9d1c-4cf4-a9b4-07570f58a57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_063fb722-1fe5-4960-a711-f83f2434df28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_68f48be8-0772-4940-8a01-4ecd64b05dd4" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_063fb722-1fe5-4960-a711-f83f2434df28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock_ebb3596f-b7b4-47ad-bcd8-7c0ad5817407" xlink:href="dxcm-20230630.xsd#dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_68f48be8-0772-4940-8a01-4ecd64b05dd4" xlink:to="loc_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock_ebb3596f-b7b4-47ad-bcd8-7c0ad5817407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_d0dfe323-6fda-4c02-b072-bec8e4874d05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_68f48be8-0772-4940-8a01-4ecd64b05dd4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_d0dfe323-6fda-4c02-b072-bec8e4874d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_cf7f3c6e-3d17-4604-ad46-03b90eb25a45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_68f48be8-0772-4940-8a01-4ecd64b05dd4" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_cf7f3c6e-3d17-4604-ad46-03b90eb25a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_b95acf7f-6a25-44bf-ab23-747a891e39a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_c81c1410-8e88-40fd-863e-f1fa9a37447e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_68f48be8-0772-4940-8a01-4ecd64b05dd4" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_c81c1410-8e88-40fd-863e-f1fa9a37447e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock_97d48a06-a9f0-4e9e-ade1-75f223163339" xlink:href="dxcm-20230630.xsd#dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_68f48be8-0772-4940-8a01-4ecd64b05dd4" xlink:to="loc_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock_97d48a06-a9f0-4e9e-ade1-75f223163339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_3916c7aa-bb66-4123-8686-0bcf6ed4790e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_68f48be8-0772-4940-8a01-4ecd64b05dd4" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_3916c7aa-bb66-4123-8686-0bcf6ed4790e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtTables" xlink:type="simple" xlink:href="dxcm-20230630.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ba4cfcc6-e345-4262-81d4-bfb8940bce52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_6f9bcb62-bbd1-493e-8f86-b6e6c9baa53e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ba4cfcc6-e345-4262-81d4-bfb8940bce52" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_6f9bcb62-bbd1-493e-8f86-b6e6c9baa53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock_fd1c876b-b99f-41f3-9328-976540e99faa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ba4cfcc6-e345-4262-81d4-bfb8940bce52" xlink:to="loc_us-gaap_ConvertibleDebtTableTextBlock_fd1c876b-b99f-41f3-9328-976540e99faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_ed3481c9-f9e0-4c57-a745-1115edadd7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ba4cfcc6-e345-4262-81d4-bfb8940bce52" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_ed3481c9-f9e0-4c57-a745-1115edadd7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_1b753f1e-3cf7-43f4-aebe-11dfb327a6f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ba4cfcc6-e345-4262-81d4-bfb8940bce52" xlink:to="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_1b753f1e-3cf7-43f4-aebe-11dfb327a6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="dxcm-20230630.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ded2375b-4c44-47db-8958-8bd90304ed9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_800573d7-d762-437a-af68-6c61a1ed3f64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ded2375b-4c44-47db-8958-8bd90304ed9c" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_800573d7-d762-437a-af68-6c61a1ed3f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BusinessSegmentandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ba6116a4-67ae-4dd1-9b41-3c3b2c551bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_a59f23af-bfea-41df-b627-cf5e20e94321" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ba6116a4-67ae-4dd1-9b41-3c3b2c551bc2" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_a59f23af-bfea-41df-b627-cf5e20e94321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_a2f6ebab-10a8-43ee-9469-7854568db8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ba6116a4-67ae-4dd1-9b41-3c3b2c551bc2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_a2f6ebab-10a8-43ee-9469-7854568db8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#OrganizationandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_54f8b326-c1a5-4b76-9f7d-81ad501f7e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_a035aea9-089b-4d5c-b70a-f00a4a64c468" xlink:href="dxcm-20230630.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_54f8b326-c1a5-4b76-9f7d-81ad501f7e8f" xlink:to="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_a035aea9-089b-4d5c-b70a-f00a4a64c468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6503bb58-2064-47f2-83f3-d4f57ec66618" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_a035aea9-089b-4d5c-b70a-f00a4a64c468" xlink:to="loc_srt_RangeAxis_6503bb58-2064-47f2-83f3-d4f57ec66618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4d332a2d-dcac-48e5-ab0e-26a6fec6888f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6503bb58-2064-47f2-83f3-d4f57ec66618" xlink:to="loc_srt_RangeMember_4d332a2d-dcac-48e5-ab0e-26a6fec6888f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_975ad60a-5d2a-45ce-a47b-50df04ecaeba" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4d332a2d-dcac-48e5-ab0e-26a6fec6888f" xlink:to="loc_srt_MinimumMember_975ad60a-5d2a-45ce-a47b-50df04ecaeba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_45a7cdbb-f813-4ecf-92f3-2ab9e63564c4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4d332a2d-dcac-48e5-ab0e-26a6fec6888f" xlink:to="loc_srt_MaximumMember_45a7cdbb-f813-4ecf-92f3-2ab9e63564c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_8a61dea3-f6ce-4945-9e29-61733aaea023" xlink:href="dxcm-20230630.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_a035aea9-089b-4d5c-b70a-f00a4a64c468" xlink:to="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_8a61dea3-f6ce-4945-9e29-61733aaea023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_9c7fda2e-264d-47ac-88f1-1b16fe99d856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_8a61dea3-f6ce-4945-9e29-61733aaea023" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_9c7fda2e-264d-47ac-88f1-1b16fe99d856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0fca3060-7dd0-4bc8-8408-70648aed6c20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_8a61dea3-f6ce-4945-9e29-61733aaea023" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0fca3060-7dd0-4bc8-8408-70648aed6c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ContractPaymentTermsNumberofDays_9f6cf492-bb4d-4c4b-bfb0-f42dad137f8f" xlink:href="dxcm-20230630.xsd#dxcm_ContractPaymentTermsNumberofDays"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_8a61dea3-f6ce-4945-9e29-61733aaea023" xlink:to="loc_dxcm_ContractPaymentTermsNumberofDays_9f6cf492-bb4d-4c4b-bfb0-f42dad137f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_dba470f9-ff51-411e-be6b-4ccec5196656" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_8a61dea3-f6ce-4945-9e29-61733aaea023" xlink:to="loc_us-gaap_UnbilledContractsReceivable_dba470f9-ff51-411e-be6b-4ccec5196656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ef4c616a-4699-4958-a200-d7de3d353377" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_8a61dea3-f6ce-4945-9e29-61733aaea023" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ef4c616a-4699-4958-a200-d7de3d353377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_475626cf-374d-47a3-8b7d-7cec27746da9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53916042-4bd7-4cd6-8425-f7153225c529" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_475626cf-374d-47a3-8b7d-7cec27746da9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53916042-4bd7-4cd6-8425-f7153225c529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e02c3a58-f493-46ef-a979-1a5ccdb03134" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53916042-4bd7-4cd6-8425-f7153225c529" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e02c3a58-f493-46ef-a979-1a5ccdb03134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ec335272-8d95-4c10-b189-d7702a0995a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e02c3a58-f493-46ef-a979-1a5ccdb03134" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ec335272-8d95-4c10-b189-d7702a0995a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_14c068fa-2248-4a7c-aabf-7eab6c5dfa07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ec335272-8d95-4c10-b189-d7702a0995a4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_14c068fa-2248-4a7c-aabf-7eab6c5dfa07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_7700d827-9e45-4ce1-88fd-13f366f5881d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ec335272-8d95-4c10-b189-d7702a0995a4" xlink:to="loc_us-gaap_WarrantMember_7700d827-9e45-4ce1-88fd-13f366f5881d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_a3dc99b2-7a2a-455c-80a1-b26fb6714d76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ec335272-8d95-4c10-b189-d7702a0995a4" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_a3dc99b2-7a2a-455c-80a1-b26fb6714d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53916042-4bd7-4cd6-8425-f7153225c529" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1211c4cd-24c6-4fbe-8d55-702f47e149c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:to="loc_us-gaap_NetIncomeLoss_1211c4cd-24c6-4fbe-8d55-702f47e149c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_b53620a7-92a7-4b37-a6d3-5235b7221602" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_b53620a7-92a7-4b37-a6d3-5235b7221602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_06c74aaf-ea61-47ac-9733-930289b8f007" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_06c74aaf-ea61-47ac-9733-930289b8f007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ec750fc0-0006-402d-be5d-21cbb00beaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:to="loc_us-gaap_EarningsPerShareAbstract_ec750fc0-0006-402d-be5d-21cbb00beaf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4fd22752-48c1-4362-b6af-74d805ad43b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec750fc0-0006-402d-be5d-21cbb00beaf4" xlink:to="loc_us-gaap_EarningsPerShareBasic_4fd22752-48c1-4362-b6af-74d805ad43b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_db3cf4b7-61fa-4ed5-b296-82f4b1107c50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec750fc0-0006-402d-be5d-21cbb00beaf4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_db3cf4b7-61fa-4ed5-b296-82f4b1107c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a11e7922-6ef4-4ad9-a040-97aa0434e70f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a11e7922-6ef4-4ad9-a040-97aa0434e70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4d42c1df-b637-45c6-9111-cf3b0a4b5029" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4d42c1df-b637-45c6-9111-cf3b0a4b5029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_167f8087-e2ee-47f5-bbeb-6c3873ae255b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf73449e-d8e3-4412-a317-bec2e318407e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_167f8087-e2ee-47f5-bbeb-6c3873ae255b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_883d02c8-9bd0-403e-bb32-76aa8d4b68c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_df4d6e2b-72e8-4756-8f01-ee600d7c2272" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_883d02c8-9bd0-403e-bb32-76aa8d4b68c8" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_df4d6e2b-72e8-4756-8f01-ee600d7c2272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e9c05010-72d5-44ab-b532-ef54e784006a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_df4d6e2b-72e8-4756-8f01-ee600d7c2272" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e9c05010-72d5-44ab-b532-ef54e784006a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f9aa2e2a-3ed0-4875-9d43-659c64aad6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e9c05010-72d5-44ab-b532-ef54e784006a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f9aa2e2a-3ed0-4875-9d43-659c64aad6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RestrictedAndPerformanceStockUnitsMember_2208a1e8-0dd6-4850-8dff-aae75e7dface" xlink:href="dxcm-20230630.xsd#dxcm_RestrictedAndPerformanceStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f9aa2e2a-3ed0-4875-9d43-659c64aad6c3" xlink:to="loc_dxcm_RestrictedAndPerformanceStockUnitsMember_2208a1e8-0dd6-4850-8dff-aae75e7dface" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_0e2c9b4f-bd5b-47dd-966b-00333f993ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f9aa2e2a-3ed0-4875-9d43-659c64aad6c3" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_0e2c9b4f-bd5b-47dd-966b-00333f993ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c07a39bf-2886-4946-951c-a01235d8613d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_df4d6e2b-72e8-4756-8f01-ee600d7c2272" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c07a39bf-2886-4946-951c-a01235d8613d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bea8e188-92b3-40a4-8910-7daa8210f65c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c07a39bf-2886-4946-951c-a01235d8613d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bea8e188-92b3-40a4-8910-7daa8210f65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#DevelopmentandOtherAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_743cb7f3-38a1-4177-8815-288a2f47e090" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_174c47f0-4da3-44b1-be8a-9bb20e412079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_743cb7f3-38a1-4177-8815-288a2f47e090" xlink:to="loc_us-gaap_OtherCommitmentsTable_174c47f0-4da3-44b1-be8a-9bb20e412079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_91efd945-d19c-4474-88ec-503587b3bd18" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_174c47f0-4da3-44b1-be8a-9bb20e412079" xlink:to="loc_srt_CounterpartyNameAxis_91efd945-d19c-4474-88ec-503587b3bd18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_31dee363-f552-4c21-95a1-0d23b2b84d9a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_91efd945-d19c-4474-88ec-503587b3bd18" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_31dee363-f552-4c21-95a1-0d23b2b84d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyLifeSciencesMember_5f324c3e-830b-48c1-9e87-fc7bd12d7a50" xlink:href="dxcm-20230630.xsd#dxcm_VerilyLifeSciencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_31dee363-f552-4c21-95a1-0d23b2b84d9a" xlink:to="loc_dxcm_VerilyLifeSciencesMember_5f324c3e-830b-48c1-9e87-fc7bd12d7a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_476353c7-36a3-4296-8735-2dfd6a12b535" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_174c47f0-4da3-44b1-be8a-9bb20e412079" xlink:to="loc_us-gaap_TypeOfArrangementAxis_476353c7-36a3-4296-8735-2dfd6a12b535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a462ce7c-208e-4e1c-bbda-1edb08a746f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_476353c7-36a3-4296-8735-2dfd6a12b535" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a462ce7c-208e-4e1c-bbda-1edb08a746f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_38167e41-cde2-431a-8724-6687be8e3287" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a462ce7c-208e-4e1c-bbda-1edb08a746f4" xlink:to="loc_us-gaap_CollaborativeArrangementMember_38167e41-cde2-431a-8724-6687be8e3287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_de216382-6563-4ea9-8882-7e8374ea751c" xlink:href="dxcm-20230630.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_174c47f0-4da3-44b1-be8a-9bb20e412079" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_de216382-6563-4ea9-8882-7e8374ea751c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_46ee2abc-c8a0-483f-8dd7-00fea9c925c6" xlink:href="dxcm-20230630.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_de216382-6563-4ea9-8882-7e8374ea751c" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_46ee2abc-c8a0-483f-8dd7-00fea9c925c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementInitialPaymentMember_36a2d350-7c21-475c-af32-0cc287c8766e" xlink:href="dxcm-20230630.xsd#dxcm_CollaborativeArrangementInitialPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_46ee2abc-c8a0-483f-8dd7-00fea9c925c6" xlink:to="loc_dxcm_CollaborativeArrangementInitialPaymentMember_36a2d350-7c21-475c-af32-0cc287c8766e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_088ca57a-ba0d-43a1-969b-45ec4dd1ee65" xlink:href="dxcm-20230630.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_46ee2abc-c8a0-483f-8dd7-00fea9c925c6" xlink:to="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_088ca57a-ba0d-43a1-969b-45ec4dd1ee65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementApprovalMilestoneMember_3e8e5aea-0ee6-4a46-9e32-a1012549afbb" xlink:href="dxcm-20230630.xsd#dxcm_CollaborativeArrangementApprovalMilestoneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_46ee2abc-c8a0-483f-8dd7-00fea9c925c6" xlink:to="loc_dxcm_CollaborativeArrangementApprovalMilestoneMember_3e8e5aea-0ee6-4a46-9e32-a1012549afbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_174c47f0-4da3-44b1-be8a-9bb20e412079" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_7817b93d-1e25-4e11-af8e-6c80474d7a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:to="loc_us-gaap_SharePrice_7817b93d-1e25-4e11-af8e-6c80474d7a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementUpfrontFee_143cb671-3bd1-41c6-838a-7829c166ceee" xlink:href="dxcm-20230630.xsd#dxcm_CollaborativeArrangementUpfrontFee"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:to="loc_dxcm_CollaborativeArrangementUpfrontFee_143cb671-3bd1-41c6-838a-7829c166ceee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cb7e5426-b1d4-48f7-bf2f-0bb64c018b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cb7e5426-b1d4-48f7-bf2f-0bb64c018b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee_aaf4995c-1a3c-49d9-b7da-7e6724498b4d" xlink:href="dxcm-20230630.xsd#dxcm_CollaborativeResearchAndDevelopmentFee"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:to="loc_dxcm_CollaborativeResearchAndDevelopmentFee_aaf4995c-1a3c-49d9-b7da-7e6724498b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_de99aa5d-a4e3-4ea5-adbe-ffb16dbb74fb" xlink:href="dxcm-20230630.xsd#dxcm_PotentialFutureCommonStockIssuableSharesNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:to="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_de99aa5d-a4e3-4ea5-adbe-ffb16dbb74fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_beaaef06-06bb-4652-858b-7c670240031e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_beaaef06-06bb-4652-858b-7c670240031e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_20b4c6ba-6f69-4c66-9e9c-1ae7f108c21c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cc7ed19c-3991-4fe5-b83f-bddd7708e5f6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_20b4c6ba-6f69-4c66-9e9c-1ae7f108c21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#FairValueMeasurementsSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_49a63e82-213f-42aa-8fe1-557e2718da3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c68e48e-8663-411b-966c-da5b9d75bd81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_49a63e82-213f-42aa-8fe1-557e2718da3b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c68e48e-8663-411b-966c-da5b9d75bd81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_60bda168-b622-4373-8dce-8019a274ede9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c68e48e-8663-411b-966c-da5b9d75bd81" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_60bda168-b622-4373-8dce-8019a274ede9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00f3da31-bbbe-4ad1-9ecf-8fd74f821eff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_60bda168-b622-4373-8dce-8019a274ede9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00f3da31-bbbe-4ad1-9ecf-8fd74f821eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3d7ed2dc-2425-4f9f-b340-f987ec916d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00f3da31-bbbe-4ad1-9ecf-8fd74f821eff" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3d7ed2dc-2425-4f9f-b340-f987ec916d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_08f022c2-1135-4df4-8917-04c56119cc08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00f3da31-bbbe-4ad1-9ecf-8fd74f821eff" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_08f022c2-1135-4df4-8917-04c56119cc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_10e30433-57c1-4093-9f87-612cc863e7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00f3da31-bbbe-4ad1-9ecf-8fd74f821eff" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_10e30433-57c1-4093-9f87-612cc863e7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3d494930-d9f5-4318-a807-f5ede4f6b7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c68e48e-8663-411b-966c-da5b9d75bd81" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3d494930-d9f5-4318-a807-f5ede4f6b7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c63c8ec8-ed49-4e03-878a-b698fc68d584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3d494930-d9f5-4318-a807-f5ede4f6b7e6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c63c8ec8-ed49-4e03-878a-b698fc68d584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_2d02ef54-8d74-4c57-86a5-9828bb843e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c63c8ec8-ed49-4e03-878a-b698fc68d584" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_2d02ef54-8d74-4c57-86a5-9828bb843e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_c4991788-6144-44ab-ac7c-71a3cc72ed16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c63c8ec8-ed49-4e03-878a-b698fc68d584" xlink:to="loc_us-gaap_CommercialPaperMember_c4991788-6144-44ab-ac7c-71a3cc72ed16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_7b1533f1-4ca2-4889-82f7-47f36cf60ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c63c8ec8-ed49-4e03-878a-b698fc68d584" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_7b1533f1-4ca2-4889-82f7-47f36cf60ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f18bdcd8-d920-4188-8417-98b10110ed1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c68e48e-8663-411b-966c-da5b9d75bd81" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f18bdcd8-d920-4188-8417-98b10110ed1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_4e5fd0b1-518a-4dc0-88c7-2a3f8a4da4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f18bdcd8-d920-4188-8417-98b10110ed1b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_4e5fd0b1-518a-4dc0-88c7-2a3f8a4da4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_f035e21b-47b8-4640-a6b9-8aa8f98ea218" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_4e5fd0b1-518a-4dc0-88c7-2a3f8a4da4f4" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_f035e21b-47b8-4640-a6b9-8aa8f98ea218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ccfec73e-d94b-4860-9b36-5ffb9d75c4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_4e5fd0b1-518a-4dc0-88c7-2a3f8a4da4f4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ccfec73e-d94b-4860-9b36-5ffb9d75c4fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_d035ef9e-7181-4b48-81b9-5a0c4dfc57c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_4e5fd0b1-518a-4dc0-88c7-2a3f8a4da4f4" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_d035ef9e-7181-4b48-81b9-5a0c4dfc57c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e9fbb773-9293-457d-954c-2f8f114504b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_4e5fd0b1-518a-4dc0-88c7-2a3f8a4da4f4" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_e9fbb773-9293-457d-954c-2f8f114504b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bc3c7452-9b15-46d7-8035-bcc34250753f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d698938b-4627-4ab6-8748-c659c7448628" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bc3c7452-9b15-46d7-8035-bcc34250753f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d698938b-4627-4ab6-8748-c659c7448628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3f563668-079c-46b9-a002-0324c3ab5079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d698938b-4627-4ab6-8748-c659c7448628" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3f563668-079c-46b9-a002-0324c3ab5079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4092ab90-daa5-4ec1-bbb6-1ae95104b1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3f563668-079c-46b9-a002-0324c3ab5079" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4092ab90-daa5-4ec1-bbb6-1ae95104b1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_4293593f-2932-4262-b5bc-70adffdb2f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_4092ab90-daa5-4ec1-bbb6-1ae95104b1f8" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_4293593f-2932-4262-b5bc-70adffdb2f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4ae0d8d4-cb2a-436b-8fe3-4911d7c208bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d698938b-4627-4ab6-8748-c659c7448628" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4ae0d8d4-cb2a-436b-8fe3-4911d7c208bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0f835632-89ef-4277-afaa-7ae09e8fcc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4ae0d8d4-cb2a-436b-8fe3-4911d7c208bd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0f835632-89ef-4277-afaa-7ae09e8fcc5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_bccdbf5e-51ca-4b14-8be6-75c4e7517eae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0f835632-89ef-4277-afaa-7ae09e8fcc5c" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_bccdbf5e-51ca-4b14-8be6-75c4e7517eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d6823696-da73-49c1-aae7-56ddc527a452" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d698938b-4627-4ab6-8748-c659c7448628" xlink:to="loc_us-gaap_HedgingDesignationAxis_d6823696-da73-49c1-aae7-56ddc527a452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_135634b0-9c90-423c-8ae5-79639a3a50dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d6823696-da73-49c1-aae7-56ddc527a452" xlink:to="loc_us-gaap_HedgingDesignationDomain_135634b0-9c90-423c-8ae5-79639a3a50dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_17e5900b-fb8c-40a9-bf65-b2eac5a14734" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_135634b0-9c90-423c-8ae5-79639a3a50dc" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_17e5900b-fb8c-40a9-bf65-b2eac5a14734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b5a4194-19bc-495e-bfb1-2002545c6337" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d698938b-4627-4ab6-8748-c659c7448628" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b5a4194-19bc-495e-bfb1-2002545c6337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueAssetsLevel3TransfersAmount_758d6b75-ed60-487b-8419-11f7bf57ea1b" xlink:href="dxcm-20230630.xsd#dxcm_FairValueAssetsLevel3TransfersAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b5a4194-19bc-495e-bfb1-2002545c6337" xlink:to="loc_dxcm_FairValueAssetsLevel3TransfersAmount_758d6b75-ed60-487b-8419-11f7bf57ea1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_eed875c7-3092-4e25-b78a-3056120a1476" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b5a4194-19bc-495e-bfb1-2002545c6337" xlink:to="loc_us-gaap_DerivativeNotionalAmount_eed875c7-3092-4e25-b78a-3056120a1476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_c9422450-28f6-45e4-bf9c-ba67e50e43aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b5a4194-19bc-495e-bfb1-2002545c6337" xlink:to="loc_us-gaap_LongTermInvestments_c9422450-28f6-45e4-bf9c-ba67e50e43aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a32912c2-24e3-40ba-bcef-7f28bf30ed83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b5a4194-19bc-495e-bfb1-2002545c6337" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a32912c2-24e3-40ba-bcef-7f28bf30ed83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_996b6d3a-aba3-45fe-b463-f7d445c7b160" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_d2760cf1-f55a-48f6-9668-f133dd92f28e" xlink:href="dxcm-20230630.xsd#dxcm_FairValueDisclosuresSeniorConvertibleNotesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_996b6d3a-aba3-45fe-b463-f7d445c7b160" xlink:to="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_d2760cf1-f55a-48f6-9668-f133dd92f28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4dfc0451-b089-4a65-820b-7aeac8c4a03c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_d2760cf1-f55a-48f6-9668-f133dd92f28e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4dfc0451-b089-4a65-820b-7aeac8c4a03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6e7762df-c062-48d9-af3d-09eedcb71d34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4dfc0451-b089-4a65-820b-7aeac8c4a03c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6e7762df-c062-48d9-af3d-09eedcb71d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_8ab5f187-f696-4426-b4f8-fab85d146d67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6e7762df-c062-48d9-af3d-09eedcb71d34" xlink:to="loc_us-gaap_SeniorNotesMember_8ab5f187-f696-4426-b4f8-fab85d146d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ffa1bf27-ef0b-47f6-b16b-24f943b58291" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_d2760cf1-f55a-48f6-9668-f133dd92f28e" xlink:to="loc_us-gaap_DebtInstrumentAxis_ffa1bf27-ef0b-47f6-b16b-24f943b58291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a7191140-8fbc-468f-b5fe-453f6930ba95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ffa1bf27-ef0b-47f6-b16b-24f943b58291" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a7191140-8fbc-468f-b5fe-453f6930ba95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_729ca587-03ca-4fe9-955e-b6987ddb0f6a" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a7191140-8fbc-468f-b5fe-453f6930ba95" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_729ca587-03ca-4fe9-955e-b6987ddb0f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_d16f1417-c69f-4f79-982f-4e6876119136" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a7191140-8fbc-468f-b5fe-453f6930ba95" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_d16f1417-c69f-4f79-982f-4e6876119136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_9ec5c478-28ea-42f9-9e4e-5df1ae241a02" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a7191140-8fbc-468f-b5fe-453f6930ba95" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_9ec5c478-28ea-42f9-9e4e-5df1ae241a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueDisclosuresLineItems_46bc7725-4e6f-48dd-af20-fe8feb006470" xlink:href="dxcm-20230630.xsd#dxcm_FairValueDisclosuresLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_d2760cf1-f55a-48f6-9668-f133dd92f28e" xlink:to="loc_dxcm_FairValueDisclosuresLineItems_46bc7725-4e6f-48dd-af20-fe8feb006470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_90be7c65-82fd-49cf-9e93-c36756cf8e87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FairValueDisclosuresLineItems_46bc7725-4e6f-48dd-af20-fe8feb006470" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_90be7c65-82fd-49cf-9e93-c36756cf8e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsShortTermMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ac6a939-a7be-4038-b5eb-150941bfe985" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_c9b9d2af-9e89-4c73-96db-4238d09dcffa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ac6a939-a7be-4038-b5eb-150941bfe985" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_c9b9d2af-9e89-4c73-96db-4238d09dcffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e9df98b4-bf22-4742-b718-2d37313be8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_c9b9d2af-9e89-4c73-96db-4238d09dcffa" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e9df98b4-bf22-4742-b718-2d37313be8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f37e5a5d-e749-4778-affb-bb8fb96116f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e9df98b4-bf22-4742-b718-2d37313be8c3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f37e5a5d-e749-4778-affb-bb8fb96116f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1b6f73c1-94ae-4273-a365-1d7506c818fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f37e5a5d-e749-4778-affb-bb8fb96116f3" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1b6f73c1-94ae-4273-a365-1d7506c818fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_5e9a4497-85b0-4c2d-8654-f2f2d71006b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f37e5a5d-e749-4778-affb-bb8fb96116f3" xlink:to="loc_us-gaap_CommercialPaperMember_5e9a4497-85b0-4c2d-8654-f2f2d71006b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_f83cc146-6884-4a22-951f-da5e62802e72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f37e5a5d-e749-4778-affb-bb8fb96116f3" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_f83cc146-6884-4a22-951f-da5e62802e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_5576908c-a7c5-4f6d-92ff-e18268b950f7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_c9b9d2af-9e89-4c73-96db-4238d09dcffa" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_5576908c-a7c5-4f6d-92ff-e18268b950f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_51bbeda4-4a80-4d49-80f0-50c12836f7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_5576908c-a7c5-4f6d-92ff-e18268b950f7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_51bbeda4-4a80-4d49-80f0-50c12836f7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7db04e0b-38cf-4b47-96a7-33d477252531" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_51bbeda4-4a80-4d49-80f0-50c12836f7a5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7db04e0b-38cf-4b47-96a7-33d477252531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_12b7ce7d-6f77-4aed-9d01-bb54199348ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_51bbeda4-4a80-4d49-80f0-50c12836f7a5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_12b7ce7d-6f77-4aed-9d01-bb54199348ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_69aa1cf5-90ff-42f3-a68c-d932803e77f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_51bbeda4-4a80-4d49-80f0-50c12836f7a5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_69aa1cf5-90ff-42f3-a68c-d932803e77f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2ee4c314-282b-454a-a805-53a00b161e14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_51bbeda4-4a80-4d49-80f0-50c12836f7a5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2ee4c314-282b-454a-a805-53a00b161e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d53b2514-900a-480c-982d-281ffe8a0be4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_2bd48061-5d87-4ab8-9f8b-c234bea9dd86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d53b2514-900a-480c-982d-281ffe8a0be4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_2bd48061-5d87-4ab8-9f8b-c234bea9dd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1a56a2f1-28f2-4766-bcc0-e4b0d39b9c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d53b2514-900a-480c-982d-281ffe8a0be4" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1a56a2f1-28f2-4766-bcc0-e4b0d39b9c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_89de04d8-9210-4159-a8ee-92a46d8732fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_9177d75d-6ab4-4fa5-9963-1138f9dc74ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_89de04d8-9210-4159-a8ee-92a46d8732fd" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_9177d75d-6ab4-4fa5-9963-1138f9dc74ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9cf8d09d-771d-457f-8de6-d9e74356f76d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_89de04d8-9210-4159-a8ee-92a46d8732fd" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9cf8d09d-771d-457f-8de6-d9e74356f76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2087df35-6206-4abe-bd61-2e82e450205a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_89de04d8-9210-4159-a8ee-92a46d8732fd" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2087df35-6206-4abe-bd61-2e82e450205a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c74e0b35-b41b-49a3-840f-bba933848064" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_89de04d8-9210-4159-a8ee-92a46d8732fd" xlink:to="loc_us-gaap_InventoryNet_c74e0b35-b41b-49a3-840f-bba933848064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_872c6538-8f80-40c8-bab0-32a84f2a2f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_f071b253-2309-45b8-a8ec-78e3436ca4da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_872c6538-8f80-40c8-bab0-32a84f2a2f3b" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_f071b253-2309-45b8-a8ec-78e3436ca4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PrepaidInventoryCurrent_a7b32e50-cb0f-48de-9a2c-70e7eaa62edd" xlink:href="dxcm-20230630.xsd#dxcm_PrepaidInventoryCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_872c6538-8f80-40c8-bab0-32a84f2a2f3b" xlink:to="loc_dxcm_PrepaidInventoryCurrent_a7b32e50-cb0f-48de-9a2c-70e7eaa62edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredCompensationPlanAssetsCurrent_f050fa92-cf0b-4a72-9e2a-8be1802a2a36" xlink:href="dxcm-20230630.xsd#dxcm_DeferredCompensationPlanAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_872c6538-8f80-40c8-bab0-32a84f2a2f3b" xlink:to="loc_dxcm_DeferredCompensationPlanAssetsCurrent_f050fa92-cf0b-4a72-9e2a-8be1802a2a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_004e8ccf-15d5-441d-a621-8e7b41e0b1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_872c6538-8f80-40c8-bab0-32a84f2a2f3b" xlink:to="loc_us-gaap_IncomeTaxesReceivable_004e8ccf-15d5-441d-a621-8e7b41e0b1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_4d930d6e-c27c-427b-9710-07ee66a5b10c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_872c6538-8f80-40c8-bab0-32a84f2a2f3b" xlink:to="loc_us-gaap_OtherAssetsCurrent_4d930d6e-c27c-427b-9710-07ee66a5b10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fd7081bd-a7ea-492c-a3fc-eb0f12445f98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_872c6538-8f80-40c8-bab0-32a84f2a2f3b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fd7081bd-a7ea-492c-a3fc-eb0f12445f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e2766bc-3dc8-4aab-8e80-8b9ce6d3cdde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eb5ac491-678a-4450-abc4-d4686d862fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e2766bc-3dc8-4aab-8e80-8b9ce6d3cdde" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eb5ac491-678a-4450-abc4-d4686d862fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3393fd5c-7322-4c98-ae0a-9ed9b2fefd50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eb5ac491-678a-4450-abc4-d4686d862fc0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3393fd5c-7322-4c98-ae0a-9ed9b2fefd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3393fd5c-7322-4c98-ae0a-9ed9b2fefd50" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_0cc7fc06-406d-47f0-bcfa-a33abc53dd55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_0cc7fc06-406d-47f0-bcfa-a33abc53dd55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_7e126b79-9992-42e2-9c83-e9443d1c35b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:to="loc_us-gaap_BuildingMember_7e126b79-9992-42e2-9c83-e9443d1c35b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_26c5f63e-b579-4597-9f99-8919505f9287" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_26c5f63e-b579-4597-9f99-8919505f9287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_5e77b594-03fe-43ea-b202-d9d066020c22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:to="loc_us-gaap_ComputerEquipmentMember_5e77b594-03fe-43ea-b202-d9d066020c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_ea6b9bb9-3ceb-462f-8ee2-77e60c56fd04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:to="loc_us-gaap_EquipmentMember_ea6b9bb9-3ceb-462f-8ee2-77e60c56fd04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_f5bad1e8-d77c-4ec5-8fd7-dfc312efc4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_f5bad1e8-d77c-4ec5-8fd7-dfc312efc4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_0683020a-d610-4099-9508-d85b1fd77ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_07951321-a95f-475d-b886-61d7370e80c1" xlink:to="loc_us-gaap_ConstructionInProgressMember_0683020a-d610-4099-9508-d85b1fd77ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_006ce00a-4bb5-4ad4-886b-69f78c566585" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eb5ac491-678a-4450-abc4-d4686d862fc0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_006ce00a-4bb5-4ad4-886b-69f78c566585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_2f568806-aa9b-497e-8055-ef14f73f34fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_006ce00a-4bb5-4ad4-886b-69f78c566585" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_2f568806-aa9b-497e-8055-ef14f73f34fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_a230b270-e67a-438f-b4fa-43e47a810b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_006ce00a-4bb5-4ad4-886b-69f78c566585" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_a230b270-e67a-438f-b4fa-43e47a810b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_43b7dfd9-b0e7-48dc-a3c5-7931c0b49e03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_006ce00a-4bb5-4ad4-886b-69f78c566585" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_43b7dfd9-b0e7-48dc-a3c5-7931c0b49e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_115627e2-2c4d-4e86-b1a4-16aaffd9e576" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_006ce00a-4bb5-4ad4-886b-69f78c566585" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_115627e2-2c4d-4e86-b1a4-16aaffd9e576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsOtherAssetsDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsOtherAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_136bc9ef-5f20-4fcd-9774-19317137ca4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_2af8b3aa-c1f8-4b80-aba5-16b64a0af60e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_136bc9ef-5f20-4fcd-9774-19317137ca4d" xlink:to="loc_us-gaap_LongTermInvestments_2af8b3aa-c1f8-4b80-aba5-16b64a0af60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LongTermDeposits_d4e15d09-64f7-4102-be14-cfa3f0d64bf7" xlink:href="dxcm-20230630.xsd#dxcm_LongTermDeposits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_136bc9ef-5f20-4fcd-9774-19317137ca4d" xlink:to="loc_dxcm_LongTermDeposits_d4e15d09-64f7-4102-be14-cfa3f0d64bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherLongTermAssets_ba641c9f-2e5d-4722-91c2-af146ae41b6e" xlink:href="dxcm-20230630.xsd#dxcm_OtherLongTermAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_136bc9ef-5f20-4fcd-9774-19317137ca4d" xlink:to="loc_dxcm_OtherLongTermAssets_ba641c9f-2e5d-4722-91c2-af146ae41b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e700be33-ab10-41ad-b96b-5da389babb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_136bc9ef-5f20-4fcd-9774-19317137ca4d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e700be33-ab10-41ad-b96b-5da389babb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_74703c0b-cf28-4a30-aa30-8e5b9eb9cebb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_a8de3661-98d6-4c18-8cc5-39ec97eeee61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_74703c0b-cf28-4a30-aa30-8e5b9eb9cebb" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_a8de3661-98d6-4c18-8cc5-39ec97eeee61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_185aa59f-f88d-4bbb-97f8-363caef45ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_a8de3661-98d6-4c18-8cc5-39ec97eeee61" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_185aa59f-f88d-4bbb-97f8-363caef45ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedTaxAuditAndLegalFees_53507f21-112d-4174-872a-ca79656de006" xlink:href="dxcm-20230630.xsd#dxcm_AccruedTaxAuditAndLegalFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_a8de3661-98d6-4c18-8cc5-39ec97eeee61" xlink:to="loc_dxcm_AccruedTaxAuditAndLegalFees_53507f21-112d-4174-872a-ca79656de006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PharmacyRebates_0dd33015-91e7-4f4c-ae81-199d87947915" xlink:href="dxcm-20230630.xsd#dxcm_PharmacyRebates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_a8de3661-98d6-4c18-8cc5-39ec97eeee61" xlink:to="loc_dxcm_PharmacyRebates_0dd33015-91e7-4f4c-ae81-199d87947915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_c0f43b01-6c39-4866-8b69-4465c71bf980" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_a8de3661-98d6-4c18-8cc5-39ec97eeee61" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_c0f43b01-6c39-4866-8b69-4465c71bf980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent_ec2220c3-5b71-46f7-9147-0d040ed9ae07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_a8de3661-98d6-4c18-8cc5-39ec97eeee61" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrent_ec2220c3-5b71-46f7-9147-0d040ed9ae07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_518f42b8-1850-438b-96d8-331982570ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_a8de3661-98d6-4c18-8cc5-39ec97eeee61" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_518f42b8-1850-438b-96d8-331982570ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_b3fa82aa-f285-44ed-a803-23e49bfd455c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_a8de3661-98d6-4c18-8cc5-39ec97eeee61" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_b3fa82aa-f285-44ed-a803-23e49bfd455c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_46a93c71-f564-433e-bdc7-be14e326c860" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_22ba6b0b-8d97-4c46-96e8-fa92dee6014e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_46a93c71-f564-433e-bdc7-be14e326c860" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_22ba6b0b-8d97-4c46-96e8-fa92dee6014e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent_514e3c1a-98af-49fa-b1ea-67cf693befde" xlink:href="dxcm-20230630.xsd#dxcm_AccruedWagesBonusesAndTaxesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_22ba6b0b-8d97-4c46-96e8-fa92dee6014e" xlink:to="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent_514e3c1a-98af-49fa-b1ea-67cf693befde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_d38fc303-37f0-4e80-b9ec-382878c96d73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_22ba6b0b-8d97-4c46-96e8-fa92dee6014e" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_d38fc303-37f0-4e80-b9ec-382878c96d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_28166455-6654-42f9-9262-4bd3f2efd59e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_22ba6b0b-8d97-4c46-96e8-fa92dee6014e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_28166455-6654-42f9-9262-4bd3f2efd59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BalanceSheetDetailsOtherLongTermLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_369a8284-3604-49d7-83a8-0f5d96ac0f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5902de44-4745-4ef4-834b-d32145d8af0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_369a8284-3604-49d7-83a8-0f5d96ac0f3c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5902de44-4745-4ef4-834b-d32145d8af0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_35130353-84f4-4bf1-9527-5af9840f3a58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_369a8284-3604-49d7-83a8-0f5d96ac0f3c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_35130353-84f4-4bf1-9527-5af9840f3a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0c7f6828-4cba-4b94-b872-8193d3f11cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_369a8284-3604-49d7-83a8-0f5d96ac0f3c" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0c7f6828-4cba-4b94-b872-8193d3f11cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherTaxLiabilitiesNoncurrent_92a709c7-d43d-444c-ae0a-914579a907c6" xlink:href="dxcm-20230630.xsd#dxcm_OtherTaxLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_369a8284-3604-49d7-83a8-0f5d96ac0f3c" xlink:to="loc_dxcm_OtherTaxLiabilitiesNoncurrent_92a709c7-d43d-444c-ae0a-914579a907c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_7485ff84-720b-4af1-b0b2-7bce853ade9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_369a8284-3604-49d7-83a8-0f5d96ac0f3c" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_7485ff84-720b-4af1-b0b2-7bce853ade9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f228c52a-d7ad-4002-98f9-ecc9a350ec15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_369a8284-3604-49d7-83a8-0f5d96ac0f3c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f228c52a-d7ad-4002-98f9-ecc9a350ec15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#DebtSeniorConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_72b4be03-65de-484f-875a-7a91628ff9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_bb6127ee-d916-4895-9e98-ca579ff7a716" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_72b4be03-65de-484f-875a-7a91628ff9cf" xlink:to="loc_us-gaap_DebtInstrumentTable_bb6127ee-d916-4895-9e98-ca579ff7a716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8094b7b9-e0e5-4816-8174-7f67a3cafb85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bb6127ee-d916-4895-9e98-ca579ff7a716" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8094b7b9-e0e5-4816-8174-7f67a3cafb85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1034c874-57fd-4eed-8f48-c5c06019b1f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8094b7b9-e0e5-4816-8174-7f67a3cafb85" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1034c874-57fd-4eed-8f48-c5c06019b1f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_fec68da4-a1e2-406e-94de-374f5b2016b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1034c874-57fd-4eed-8f48-c5c06019b1f5" xlink:to="loc_us-gaap_SeniorNotesMember_fec68da4-a1e2-406e-94de-374f5b2016b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6de29721-0372-4ffb-a8e9-3fbed17f20d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bb6127ee-d916-4895-9e98-ca579ff7a716" xlink:to="loc_us-gaap_DebtInstrumentAxis_6de29721-0372-4ffb-a8e9-3fbed17f20d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f323b912-e3d1-420b-b9e9-f83e040f0bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6de29721-0372-4ffb-a8e9-3fbed17f20d1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f323b912-e3d1-420b-b9e9-f83e040f0bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_01300ae5-4e6c-4709-9412-47eee3db733c" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f323b912-e3d1-420b-b9e9-f83e040f0bb1" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_01300ae5-4e6c-4709-9412-47eee3db733c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_1e17912e-26ef-4478-8042-f0522fd167bb" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f323b912-e3d1-420b-b9e9-f83e040f0bb1" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_1e17912e-26ef-4478-8042-f0522fd167bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_a15481d4-cba2-420c-aa23-08f014db7ffe" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f323b912-e3d1-420b-b9e9-f83e040f0bb1" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_a15481d4-cba2-420c-aa23-08f014db7ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_27567132-d9e3-4bf8-8e06-901b22b11f62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bb6127ee-d916-4895-9e98-ca579ff7a716" xlink:to="loc_us-gaap_DebtInstrumentLineItems_27567132-d9e3-4bf8-8e06-901b22b11f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_7738cf1c-a213-4f71-8426-3965b7ebe0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27567132-d9e3-4bf8-8e06-901b22b11f62" xlink:to="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_7738cf1c-a213-4f71-8426-3965b7ebe0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_19e13aa3-7e85-4ae5-8743-bf185990c079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_7738cf1c-a213-4f71-8426-3965b7ebe0b8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_19e13aa3-7e85-4ae5-8743-bf185990c079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_08e56a51-8552-49bd-be62-dafcb916622a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_7738cf1c-a213-4f71-8426-3965b7ebe0b8" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_08e56a51-8552-49bd-be62-dafcb916622a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_902d35cf-5c71-476d-9782-4201796884fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_7738cf1c-a213-4f71-8426-3965b7ebe0b8" xlink:to="loc_us-gaap_ConvertibleNotesPayable_902d35cf-5c71-476d-9782-4201796884fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#DebtConversionValueofConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cc3ff07b-38c1-46c6-925c-afb5ad3173c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c666aa78-a4d8-43d2-b6a8-54f8ffab7474" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cc3ff07b-38c1-46c6-925c-afb5ad3173c1" xlink:to="loc_us-gaap_DebtInstrumentTable_c666aa78-a4d8-43d2-b6a8-54f8ffab7474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b002e57c-5416-469a-ba1c-13f193d05e64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c666aa78-a4d8-43d2-b6a8-54f8ffab7474" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b002e57c-5416-469a-ba1c-13f193d05e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b0ca412b-a311-4a04-b411-292f0dd1decb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b002e57c-5416-469a-ba1c-13f193d05e64" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b0ca412b-a311-4a04-b411-292f0dd1decb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_9dab8ff9-e2c7-4f1d-9871-36fef3d0860a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b0ca412b-a311-4a04-b411-292f0dd1decb" xlink:to="loc_us-gaap_SeniorNotesMember_9dab8ff9-e2c7-4f1d-9871-36fef3d0860a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8ec7c85e-0967-44db-9026-f4ceeec2a2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c666aa78-a4d8-43d2-b6a8-54f8ffab7474" xlink:to="loc_us-gaap_DebtInstrumentAxis_8ec7c85e-0967-44db-9026-f4ceeec2a2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7bc9cacd-70c8-4077-aff2-48b0cd4f8f31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8ec7c85e-0967-44db-9026-f4ceeec2a2cc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7bc9cacd-70c8-4077-aff2-48b0cd4f8f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_bbd9164f-1da0-45f7-82d1-5275fe10a770" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7bc9cacd-70c8-4077-aff2-48b0cd4f8f31" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_bbd9164f-1da0-45f7-82d1-5275fe10a770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_914e9a4a-d0bb-444f-90e6-dc6d8d0417d3" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7bc9cacd-70c8-4077-aff2-48b0cd4f8f31" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_914e9a4a-d0bb-444f-90e6-dc6d8d0417d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_f5598f95-0776-4107-aba5-fda0d7dba139" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7bc9cacd-70c8-4077-aff2-48b0cd4f8f31" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_f5598f95-0776-4107-aba5-fda0d7dba139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bf2591aa-4c36-450f-872a-303d05b7089a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c666aa78-a4d8-43d2-b6a8-54f8ffab7474" xlink:to="loc_us-gaap_DebtInstrumentLineItems_bf2591aa-4c36-450f-872a-303d05b7089a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_e3e227fe-10de-450d-a5c4-ead93961fc81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bf2591aa-4c36-450f-872a-303d05b7089a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_e3e227fe-10de-450d-a5c4-ead93961fc81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e09a0426-69a4-4589-8b7f-a488736a8be6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4be693ad-68f1-4ae3-8883-4ec2c679cc99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e09a0426-69a4-4589-8b7f-a488736a8be6" xlink:to="loc_us-gaap_DebtInstrumentTable_4be693ad-68f1-4ae3-8883-4ec2c679cc99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9a332b50-7166-47af-9407-2b942052951e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4be693ad-68f1-4ae3-8883-4ec2c679cc99" xlink:to="loc_us-gaap_DebtInstrumentAxis_9a332b50-7166-47af-9407-2b942052951e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cc86c44f-125a-4eed-82b5-2d17b0d055ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9a332b50-7166-47af-9407-2b942052951e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cc86c44f-125a-4eed-82b5-2d17b0d055ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_6832380f-9589-4374-80e4-3768ded62e64" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc86c44f-125a-4eed-82b5-2d17b0d055ad" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_6832380f-9589-4374-80e4-3768ded62e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_e35d64e6-8092-4968-a89c-edca455db420" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc86c44f-125a-4eed-82b5-2d17b0d055ad" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_e35d64e6-8092-4968-a89c-edca455db420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_45a16637-14b2-412a-b381-1f368288ace9" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc86c44f-125a-4eed-82b5-2d17b0d055ad" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_45a16637-14b2-412a-b381-1f368288ace9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ba1d8e51-ca34-409e-81ae-e361413e53a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4be693ad-68f1-4ae3-8883-4ec2c679cc99" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ba1d8e51-ca34-409e-81ae-e361413e53a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CashInterestExpenseAbstract_1b14f72c-2d82-41ee-8f42-c35666d732bf" xlink:href="dxcm-20230630.xsd#dxcm_CashInterestExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ba1d8e51-ca34-409e-81ae-e361413e53a1" xlink:to="loc_dxcm_CashInterestExpenseAbstract_1b14f72c-2d82-41ee-8f42-c35666d732bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_1b735ff5-0a90-4268-8afc-be1651961fea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_CashInterestExpenseAbstract_1b14f72c-2d82-41ee-8f42-c35666d732bf" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_1b735ff5-0a90-4268-8afc-be1651961fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NonCashInterestExpenseAbstract_9615d5c4-5c3b-4b31-ae1e-dee721694126" xlink:href="dxcm-20230630.xsd#dxcm_NonCashInterestExpenseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ba1d8e51-ca34-409e-81ae-e361413e53a1" xlink:to="loc_dxcm_NonCashInterestExpenseAbstract_9615d5c4-5c3b-4b31-ae1e-dee721694126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_b8d6841a-5c88-460f-a710-5e16cc47fdd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_9615d5c4-5c3b-4b31-ae1e-dee721694126" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_b8d6841a-5c88-460f-a710-5e16cc47fdd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_d83c4155-6095-43e4-9d35-84a2b04b9d73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_9615d5c4-5c3b-4b31-ae1e-dee721694126" xlink:to="loc_us-gaap_InterestExpenseDebt_d83c4155-6095-43e4-9d35-84a2b04b9d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f74bbff0-a6c4-4fcf-835c-efd0b587c6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ba1d8e51-ca34-409e-81ae-e361413e53a1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f74bbff0-a6c4-4fcf-835c-efd0b587c6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_60b0644e-d28a-435b-b0a0-aeec02659f13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_60b0644e-d28a-435b-b0a0-aeec02659f13" xlink:to="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ff497bac-ceea-48d2-895d-32836e98193f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ff497bac-ceea-48d2-895d-32836e98193f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_608d8386-ce79-4a6d-bf89-78b68b71f3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ff497bac-ceea-48d2-895d-32836e98193f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_608d8386-ce79-4a6d-bf89-78b68b71f3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_f5a533b5-9959-4000-bb1e-9ac85ba120f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_608d8386-ce79-4a6d-bf89-78b68b71f3a3" xlink:to="loc_us-gaap_SeniorNotesMember_f5a533b5-9959-4000-bb1e-9ac85ba120f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_76fdd905-fdce-46d0-a12b-53f541c81e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_608d8386-ce79-4a6d-bf89-78b68b71f3a3" xlink:to="loc_us-gaap_LineOfCreditMember_76fdd905-fdce-46d0-a12b-53f541c81e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1fa841d5-2bd6-4971-9da4-6ba3b9820f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_us-gaap_DebtInstrumentAxis_1fa841d5-2bd6-4971-9da4-6ba3b9820f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7be6641e-c5b2-4c48-af94-0ce61e3a4465" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1fa841d5-2bd6-4971-9da4-6ba3b9820f1f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7be6641e-c5b2-4c48-af94-0ce61e3a4465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_0be81327-1830-4eec-8fda-978a557e1a46" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7be6641e-c5b2-4c48-af94-0ce61e3a4465" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_0be81327-1830-4eec-8fda-978a557e1a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_5f6ab56a-1cd5-4d8d-9db1-ef9b0d1eb246" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7be6641e-c5b2-4c48-af94-0ce61e3a4465" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_5f6ab56a-1cd5-4d8d-9db1-ef9b0d1eb246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_bc23d839-c2f5-4863-9aed-644d0bef2b1d" xlink:href="dxcm-20230630.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7be6641e-c5b2-4c48-af94-0ce61e3a4465" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_bc23d839-c2f5-4863-9aed-644d0bef2b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_bc91c015-3e64-41b1-8123-e47c3901ecd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_bc91c015-3e64-41b1-8123-e47c3901ecd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a868c340-5078-4886-847b-d1fdba4bd23c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_bc91c015-3e64-41b1-8123-e47c3901ecd5" xlink:to="loc_us-gaap_EquityComponentDomain_a868c340-5078-4886-847b-d1fdba4bd23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_969150e6-e383-419a-a357-a9a350eb7197" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a868c340-5078-4886-847b-d1fdba4bd23c" xlink:to="loc_us-gaap_CommonStockMember_969150e6-e383-419a-a357-a9a350eb7197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_bcc69b10-c0c5-4b09-a222-19f3074b24f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_bcc69b10-c0c5-4b09-a222-19f3074b24f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_98c88504-3767-4b34-9b11-87b4d5e7e116" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bcc69b10-c0c5-4b09-a222-19f3074b24f8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_98c88504-3767-4b34-9b11-87b4d5e7e116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a6fa1e03-432a-4523-b5fc-bd5cb28cea73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_98c88504-3767-4b34-9b11-87b4d5e7e116" xlink:to="loc_us-gaap_SubsequentEventMember_a6fa1e03-432a-4523-b5fc-bd5cb28cea73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermAxis_e989589f-7842-4d82-b65c-53c2e32f692c" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConversionTermAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_dxcm_DebtInstrumentConversionTermAxis_e989589f-7842-4d82-b65c-53c2e32f692c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain_b017c515-469c-4842-b0d6-517380e744a7" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConversionTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis_e989589f-7842-4d82-b65c-53c2e32f692c" xlink:to="loc_dxcm_DebtInstrumentConversionTermDomain_b017c515-469c-4842-b0d6-517380e744a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermOneMember_9f7bef41-8113-4f0b-9ca3-35022bf936ab" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConversionTermOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_b017c515-469c-4842-b0d6-517380e744a7" xlink:to="loc_dxcm_DebtInstrumentConversionTermOneMember_9f7bef41-8113-4f0b-9ca3-35022bf936ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermTwoMember_7c4a4424-0c55-467d-bb9c-48f2088052cd" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConversionTermTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_b017c515-469c-4842-b0d6-517380e744a7" xlink:to="loc_dxcm_DebtInstrumentConversionTermTwoMember_7c4a4424-0c55-467d-bb9c-48f2088052cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a094f9c3-8c0a-4486-9786-0eabf6d17d49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_us-gaap_HedgingDesignationAxis_a094f9c3-8c0a-4486-9786-0eabf6d17d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_df615568-31d1-45a3-be54-e02dbf35567f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_a094f9c3-8c0a-4486-9786-0eabf6d17d49" xlink:to="loc_us-gaap_HedgingDesignationDomain_df615568-31d1-45a3-be54-e02dbf35567f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fda034f8-2b15-4fa1-8841-25cc1dafcde9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_df615568-31d1-45a3-be54-e02dbf35567f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fda034f8-2b15-4fa1-8841-25cc1dafcde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e0a1e9cb-9277-49c3-a969-563d0ba8ea55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_us-gaap_VariableRateAxis_e0a1e9cb-9277-49c3-a969-563d0ba8ea55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_fde3275f-f561-4ebb-b047-9d91c06a0efe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_e0a1e9cb-9277-49c3-a969-563d0ba8ea55" xlink:to="loc_us-gaap_VariableRateDomain_fde3275f-f561-4ebb-b047-9d91c06a0efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember_520d01b4-73e6-41e2-b53a-420274d6cf2d" xlink:href="dxcm-20230630.xsd#dxcm_FederalReserveBankOfNewYorkRateNYFRBMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_fde3275f-f561-4ebb-b047-9d91c06a0efe" xlink:to="loc_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember_520d01b4-73e6-41e2-b53a-420274d6cf2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_6578a57c-2d5b-439d-b6b0-a3e4827dc276" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_fde3275f-f561-4ebb-b047-9d91c06a0efe" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_6578a57c-2d5b-439d-b6b0-a3e4827dc276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SimpleRiskFreeRateRFRMember_fcd28a4c-8fde-4ca4-864d-3374e0df3fd6" xlink:href="dxcm-20230630.xsd#dxcm_SimpleRiskFreeRateRFRMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_fde3275f-f561-4ebb-b047-9d91c06a0efe" xlink:to="loc_dxcm_SimpleRiskFreeRateRFRMember_fcd28a4c-8fde-4ca4-864d-3374e0df3fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e7d63e32-189f-446d-af68-464bcbe7c566" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_srt_RangeAxis_e7d63e32-189f-446d-af68-464bcbe7c566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ee15c905-6f23-4aba-9cc5-15283f2ae364" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e7d63e32-189f-446d-af68-464bcbe7c566" xlink:to="loc_srt_RangeMember_ee15c905-6f23-4aba-9cc5-15283f2ae364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_eac11dd7-665c-4ebb-a72b-ca56e2e402bd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ee15c905-6f23-4aba-9cc5-15283f2ae364" xlink:to="loc_srt_MinimumMember_eac11dd7-665c-4ebb-a72b-ca56e2e402bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f723f26d-7dc7-4300-ad9a-ff328ad8326e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ee15c905-6f23-4aba-9cc5-15283f2ae364" xlink:to="loc_srt_MaximumMember_f723f26d-7dc7-4300-ad9a-ff328ad8326e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f5e2ddac-a588-4f56-9e49-2e5c5133eeed" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2fc73eb9-ab40-4f1a-82a6-b1dd1f368a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2fc73eb9-ab40-4f1a-82a6-b1dd1f368a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_43e22687-d8c7-4ef1-a7e3-2f36c1c6cb81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_43e22687-d8c7-4ef1-a7e3-2f36c1c6cb81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_a71829fa-fa0c-432a-8f22-a90451aa16ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_a71829fa-fa0c-432a-8f22-a90451aa16ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_691166e8-da79-4a00-a570-0e2f2b6d89fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_691166e8-da79-4a00-a570-0e2f2b6d89fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled_44111715-a19a-42b8-9679-e16765ada75a" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled_44111715-a19a-42b8-9679-e16765ada75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_75851cf7-0c97-40ae-9836-efe7c409f1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_75851cf7-0c97-40ae-9836-efe7c409f1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge_8fea39cf-333d-4ce2-b403-3ed04bf098c3" xlink:href="dxcm-20230630.xsd#dxcm_SharesReceivedFromExerciseOfNoteHedge"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge_8fea39cf-333d-4ce2-b403-3ed04bf098c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_464189d2-7745-449c-9378-b3d02002da33" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentCovenantRepurchasePricePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_464189d2-7745-449c-9378-b3d02002da33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_b73382c9-ac36-40be-ba36-314cf89ccf78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_b73382c9-ac36-40be-ba36-314cf89ccf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_2cac3fec-68b1-42fe-9c0d-cc97f1b66925" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_2cac3fec-68b1-42fe-9c0d-cc97f1b66925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_14da542a-2849-4753-a6ac-71bcc958f841" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_14da542a-2849-4753-a6ac-71bcc958f841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_cc6b88d0-3885-46ec-8519-2bd678706f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_cc6b88d0-3885-46ec-8519-2bd678706f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_fe399dd8-87da-4591-a036-c49d8bb3c4f1" xlink:href="dxcm-20230630.xsd#dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_fe399dd8-87da-4591-a036-c49d8bb3c4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_c8ebf9a5-aef8-4a31-8cac-ffff58fccd5f" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_c8ebf9a5-aef8-4a31-8cac-ffff58fccd5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_be39dc3c-5926-445f-9a2e-d10aedecdfc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_be39dc3c-5926-445f-9a2e-d10aedecdfc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_b4f92690-0daa-404d-a7e7-0fe95f363e04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_b4f92690-0daa-404d-a7e7-0fe95f363e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_ddd2a6a8-4ef0-4767-a8ca-8d0f3ae70ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_ddd2a6a8-4ef0-4767-a8ca-8d0f3ae70ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_874c0aab-f6e5-4b72-a8e8-54ecfd332d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_874c0aab-f6e5-4b72-a8e8-54ecfd332d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_ca31a796-3d2e-4b99-8fa0-873918785526" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_ca31a796-3d2e-4b99-8fa0-873918785526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_290770e9-4a4b-4d56-974a-9bec9d0bf71f" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentCapCallTransactionCapPricePerShare"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_290770e9-4a4b-4d56-974a-9bec9d0bf71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_8e83a62b-c1a6-49ba-8293-0bfb1fb6abc0" xlink:href="dxcm-20230630.xsd#dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_8e83a62b-c1a6-49ba-8293-0bfb1fb6abc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_44a3b2da-4a13-42ec-85b4-8c1313b78e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_SharePrice_44a3b2da-4a13-42ec-85b4-8c1313b78e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_d9fa17f2-da4d-4c1d-91d3-b0f333939eaa" xlink:href="dxcm-20230630.xsd#dxcm_PaymentsForPurchasesOfCappedCallTransactions"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_d9fa17f2-da4d-4c1d-91d3-b0f333939eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_ac78da30-1707-4f5c-84af-2d71fe4f58ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentTerm_ac78da30-1707-4f5c-84af-2d71fe4f58ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_568d527e-a7a5-40cd-ba72-2bea267bab33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_568d527e-a7a5-40cd-ba72-2bea267bab33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_5ddda8f7-f26c-4fdd-91d1-8e60f0ef4384" xlink:href="dxcm-20230630.xsd#dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_5ddda8f7-f26c-4fdd-91d1-8e60f0ef4384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d5cc4a5c-0d30-431d-bb31-c56234005c55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d5cc4a5c-0d30-431d-bb31-c56234005c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_e0ac1985-04c6-47c1-a6d6-845518b71f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_e0ac1985-04c6-47c1-a6d6-845518b71f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositAssets_f00bc459-83f5-45c0-baef-de97bb9b1243" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositAssets"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1a9cf548-72b5-43ff-ae62-97465f6da41a" xlink:to="loc_us-gaap_DepositAssets_f00bc459-83f5-45c0-baef-de97bb9b1243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2c8efa78-53cf-45fd-b918-66c063ac8eab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_696a828d-fc89-49bd-901f-5323dc540ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2c8efa78-53cf-45fd-b918-66c063ac8eab" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_696a828d-fc89-49bd-901f-5323dc540ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_dd519162-b3eb-4ade-92d5-4100f7bd354f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_696a828d-fc89-49bd-901f-5323dc540ee2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_dd519162-b3eb-4ade-92d5-4100f7bd354f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fd67ccb0-6cf7-4d12-b1ca-c567c79e5723" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dd519162-b3eb-4ade-92d5-4100f7bd354f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fd67ccb0-6cf7-4d12-b1ca-c567c79e5723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_034ddddb-43ad-4fb7-9746-241305286239" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fd67ccb0-6cf7-4d12-b1ca-c567c79e5723" xlink:to="loc_us-gaap_LineOfCreditMember_034ddddb-43ad-4fb7-9746-241305286239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7f0810da-59c6-4685-aab3-784d374618eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_696a828d-fc89-49bd-901f-5323dc540ee2" xlink:to="loc_us-gaap_CreditFacilityAxis_7f0810da-59c6-4685-aab3-784d374618eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0430804f-d931-4939-960f-d709d41d962c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_7f0810da-59c6-4685-aab3-784d374618eb" xlink:to="loc_us-gaap_CreditFacilityDomain_0430804f-d931-4939-960f-d709d41d962c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_a272141b-d117-41bb-a28c-e763a0d7daa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0430804f-d931-4939-960f-d709d41d962c" xlink:to="loc_us-gaap_LetterOfCreditMember_a272141b-d117-41bb-a28c-e763a0d7daa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_06cefefb-d58e-4b5e-a7dd-e0e09838aaa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_696a828d-fc89-49bd-901f-5323dc540ee2" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_06cefefb-d58e-4b5e-a7dd-e0e09838aaa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f2a6056a-ff1a-46d5-914d-99c620642174" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_06cefefb-d58e-4b5e-a7dd-e0e09838aaa0" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f2a6056a-ff1a-46d5-914d-99c620642174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_65b059b5-47fb-480a-a83a-82c6b262a53c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_06cefefb-d58e-4b5e-a7dd-e0e09838aaa0" xlink:to="loc_us-gaap_LineOfCredit_65b059b5-47fb-480a-a83a-82c6b262a53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_25ff3cbb-7e49-44d3-9efa-8555d8cedec5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_06cefefb-d58e-4b5e-a7dd-e0e09838aaa0" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_25ff3cbb-7e49-44d3-9efa-8555d8cedec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d7338c42-0209-4c21-8d7f-28b0ea59a89f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_06cefefb-d58e-4b5e-a7dd-e0e09838aaa0" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d7338c42-0209-4c21-8d7f-28b0ea59a89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9adec9a0-3129-4920-aa45-3ad955ee11af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent_f8b4c6af-7335-419d-bf9f-e74d6c608987" xlink:href="dxcm-20230630.xsd#dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9adec9a0-3129-4920-aa45-3ad955ee11af" xlink:to="loc_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent_f8b4c6af-7335-419d-bf9f-e74d6c608987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1158777e-6587-4c07-b65c-6023b6571fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9adec9a0-3129-4920-aa45-3ad955ee11af" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1158777e-6587-4c07-b65c-6023b6571fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#StockholdersEquityShareBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8597ce25-5a4c-4b6c-9ab3-7e589ce2fbc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f209fa7b-6eb7-4903-802b-27f2eb102bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8597ce25-5a4c-4b6c-9ab3-7e589ce2fbc2" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f209fa7b-6eb7-4903-802b-27f2eb102bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_645f1962-1108-4944-ba1e-af3751dc00e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f209fa7b-6eb7-4903-802b-27f2eb102bf8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_645f1962-1108-4944-ba1e-af3751dc00e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_08c67ea5-af3d-41ef-95e3-8af372828e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_645f1962-1108-4944-ba1e-af3751dc00e7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_08c67ea5-af3d-41ef-95e3-8af372828e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_93844b7d-e1c6-48c4-a04b-39a3414bc9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_08c67ea5-af3d-41ef-95e3-8af372828e9c" xlink:to="loc_us-gaap_CostOfSalesMember_93844b7d-e1c6-48c4-a04b-39a3414bc9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_cef8c5e0-e371-4147-94dc-65209aa0f737" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_08c67ea5-af3d-41ef-95e3-8af372828e9c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_cef8c5e0-e371-4147-94dc-65209aa0f737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SellingGeneralAndAdministrativeMember_f04ee6e6-d117-4598-8cd6-58a45754e4d5" xlink:href="dxcm-20230630.xsd#dxcm_SellingGeneralAndAdministrativeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_08c67ea5-af3d-41ef-95e3-8af372828e9c" xlink:to="loc_dxcm_SellingGeneralAndAdministrativeMember_f04ee6e6-d117-4598-8cd6-58a45754e4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6622efdd-31b3-4575-9675-0e62deb5956a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f209fa7b-6eb7-4903-802b-27f2eb102bf8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6622efdd-31b3-4575-9675-0e62deb5956a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3bbd19ac-018b-4958-b153-d488d7af8da1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6622efdd-31b3-4575-9675-0e62deb5956a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3bbd19ac-018b-4958-b153-d488d7af8da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_72c036d4-3595-4bcf-8058-2c94b0fe8a58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e5fad49-a85d-4f37-bf4d-de4fb3be74ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_72c036d4-3595-4bcf-8058-2c94b0fe8a58" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e5fad49-a85d-4f37-bf4d-de4fb3be74ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f6efd6db-f2fc-4f43-9eed-986bc4ebef21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e5fad49-a85d-4f37-bf4d-de4fb3be74ef" xlink:to="loc_us-gaap_AwardTypeAxis_f6efd6db-f2fc-4f43-9eed-986bc4ebef21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4f68a657-b164-4355-80df-961b241cede5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f6efd6db-f2fc-4f43-9eed-986bc4ebef21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4f68a657-b164-4355-80df-961b241cede5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e55cdabb-ea29-4f27-828b-3b0c33f15a29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4f68a657-b164-4355-80df-961b241cede5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e55cdabb-ea29-4f27-828b-3b0c33f15a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_220a2b9c-9196-47bd-8f8a-891a30bdebe4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4f68a657-b164-4355-80df-961b241cede5" xlink:to="loc_us-gaap_PerformanceSharesMember_220a2b9c-9196-47bd-8f8a-891a30bdebe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_811cbc1b-80ec-45f7-980a-ced76fc0ba69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e5fad49-a85d-4f37-bf4d-de4fb3be74ef" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_811cbc1b-80ec-45f7-980a-ced76fc0ba69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_92b77ec4-eb0a-45a9-9972-efc469f0f95a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_811cbc1b-80ec-45f7-980a-ced76fc0ba69" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_92b77ec4-eb0a-45a9-9972-efc469f0f95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareRepurchaseProgramMember_11a46757-ad64-4cfa-ba36-dcd98061214f" xlink:href="dxcm-20230630.xsd#dxcm_ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_92b77ec4-eb0a-45a9-9972-efc469f0f95a" xlink:to="loc_dxcm_ShareRepurchaseProgramMember_11a46757-ad64-4cfa-ba36-dcd98061214f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e5fad49-a85d-4f37-bf4d-de4fb3be74ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_06e4c279-8da0-4eda-8c6a-be9af0e8a7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_06e4c279-8da0-4eda-8c6a-be9af0e8a7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_f6ec801a-f463-43fc-a714-0970aec7748f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_f6ec801a-f463-43fc-a714-0970aec7748f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_27a3f923-e037-4600-9031-be855ac58a25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_27a3f923-e037-4600-9031-be855ac58a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_19b61bf6-a9dc-4809-89e2-7ec73736c258" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_19b61bf6-a9dc-4809-89e2-7ec73736c258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6dbaff5f-4776-4ff3-a0ce-122589645b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6dbaff5f-4776-4ff3-a0ce-122589645b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_6daa3a77-e244-43ca-8358-ab2167c4679a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_6daa3a77-e244-43ca-8358-ab2167c4679a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_dd6cb5f9-487d-4694-bdd5-398b695870cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5ed8ae6-0bc0-4471-9491-c482b5d771ff" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_dd6cb5f9-487d-4694-bdd5-398b695870cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BusinessSegmentandGeographicInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5ccbbce9-525a-49c0-bb29-f33548302efa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_a935824a-0c4c-4568-ac7d-a826f3ba1a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5ccbbce9-525a-49c0-bb29-f33548302efa" xlink:to="loc_us-gaap_NumberOfReportableSegments_a935824a-0c4c-4568-ac7d-a826f3ba1a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails" xlink:type="simple" xlink:href="dxcm-20230630.xsd#BusinessSegmentandGeographicInformationSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7ec68e55-860c-447f-9edc-477347f2333e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_2c8e8df6-6de3-4fb8-87ea-19fd7163e5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7ec68e55-860c-447f-9edc-477347f2333e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_2c8e8df6-6de3-4fb8-87ea-19fd7163e5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e72ab46b-f039-4803-b7bf-8d3e7312d2c0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2c8e8df6-6de3-4fb8-87ea-19fd7163e5c5" xlink:to="loc_srt_StatementGeographicalAxis_e72ab46b-f039-4803-b7bf-8d3e7312d2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_16150ab8-3a41-450a-9e96-d68e9cae653d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e72ab46b-f039-4803-b7bf-8d3e7312d2c0" xlink:to="loc_srt_SegmentGeographicalDomain_16150ab8-3a41-450a-9e96-d68e9cae653d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b1d0454d-97eb-4b26-a784-3a286b9a6415" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_16150ab8-3a41-450a-9e96-d68e9cae653d" xlink:to="loc_country_US_b1d0454d-97eb-4b26-a784-3a286b9a6415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_94817241-e59a-41b2-a1fb-d98930c46ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_16150ab8-3a41-450a-9e96-d68e9cae653d" xlink:to="loc_us-gaap_NonUsMember_94817241-e59a-41b2-a1fb-d98930c46ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_1e98b476-a698-4c36-b7b4-78487c329046" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2c8e8df6-6de3-4fb8-87ea-19fd7163e5c5" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_1e98b476-a698-4c36-b7b4-78487c329046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9432b0e4-c9c2-4c37-b2dc-8cb780d624e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_1e98b476-a698-4c36-b7b4-78487c329046" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9432b0e4-c9c2-4c37-b2dc-8cb780d624e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_630901a8-4aa3-4bb2-baa2-bd3e961dea14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9432b0e4-c9c2-4c37-b2dc-8cb780d624e8" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_630901a8-4aa3-4bb2-baa2-bd3e961dea14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_d86fa41a-ca5e-4ded-bf18-8e0035effb04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9432b0e4-c9c2-4c37-b2dc-8cb780d624e8" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_d86fa41a-ca5e-4ded-bf18-8e0035effb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_d8e5ac04-65ef-4f7b-8ec3-0bf19c5821b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2c8e8df6-6de3-4fb8-87ea-19fd7163e5c5" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_d8e5ac04-65ef-4f7b-8ec3-0bf19c5821b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_11da7a6e-8a5d-46aa-9a2d-ed5d6c52dcd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d8e5ac04-65ef-4f7b-8ec3-0bf19c5821b2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_11da7a6e-8a5d-46aa-9a2d-ed5d6c52dcd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RevenuePercentage_3e60100c-2039-410b-9508-978223f3ebea" xlink:href="dxcm-20230630.xsd#dxcm_RevenuePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d8e5ac04-65ef-4f7b-8ec3-0bf19c5821b2" xlink:to="loc_dxcm_RevenuePercentage_3e60100c-2039-410b-9508-978223f3ebea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_PerformanceSharesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DonaldMAbbeyMember" xlink:href="dxcm-20230630.xsd#dxcm_DonaldMAbbeyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_dxcm_DonaldMAbbeyMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StevenRAltmanMember" xlink:href="dxcm-20230630.xsd#dxcm_StevenRAltmanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_dxcm_StevenRAltmanMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_BridgettePHellerMember" xlink:href="dxcm-20230630.xsd#dxcm_BridgettePHellerMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_dxcm_BridgettePHellerMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>dxcm-20230630_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dxcm-20230630_g1.jpg
M_]C_X  02D9)1@ ! @$$L 2P  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
MGJZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H
M4JC$J3>IJ:H<JH^K JMUJ^FL7*S0K42MN*XMKJ&O%J^+L "P=;#JL6"QUK)+
MLL*S.+.NM"6TG+43M8JV ;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]
M%;V/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_
MR#W(O,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'3
M1-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N W 7<BMT0W9;>'-ZB
MWRG?K^ VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJ
MY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[
M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____[@ .061O8F4 9
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MQ\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#   !$0(1 #\
M_?R@",T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M[R<E]TKK\#KO^&GO%W_00_\ )>V_^-5O_:57^;\(_P"1V_ZP8G^?_P DA_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M5?YOPC_D'^L&)_G_ /)(?_(A_P -/>+O^@A_Y+VW_P :H_M*K_-^$?\ (/\
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M()[Z>+IU-I+7I>S^YZGMT<SHUK<LXZNR3:3O>VSL_334]&KK/3"@ H * "@
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M ,DA_P#(A_PT]XN_Z"'_ )+VW_QJC^TJO\WX1_R#_6#$_P __DD/_D30TO\
M:K\5:?,LDEU'<(N<Q201!&R".3$L;\9R-K#D#.1D&HYI53O>_DTOT29I3XCQ
M,'=R4O)QC;_R51?XG7?\-G^(/^?:P_[]S?\ Q^NC^V*G:/W/_P"2.S_6JO\
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ME0RDCC<.HX7G7:/_ )-_P$>-+BUVTIZVTO.ZOZ<JO]Z]3B?^&S_$'_/M8?\
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M_P#DD/\ Y$X'_A:WB#_H*W__ (%S?_%US?6JG\TO_ G_ )GG?VC7_P"?D_\
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M^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\
M_/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X
M_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\
MD'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_
M^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\
M_/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X
M_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\
MD'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_
M^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\
M_/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X
M_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\
MD'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_
M^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M18BKLU%-6M%6^=W=I^C7EJ>!ZIJMQK<S7%U+)/,^-TDCL[M@ #+,23@  9/
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M 4 % !0 4 % !0 4 % !0 4 % !0 4 5[N[CL(WFF=8XXU+.[$*JJHR68G@
M#DD\ <TF[:LF4E%7>B2NV]%8^9?'?[66A>%U9+$MJ%P&9=L>4B!5@#F9EP01
MN*-$LJMMZJ&#5X]?-(4_A]Y^6B^__*Y\KC.)*-#2'ON[VT6C[M?<TG?\3Y-\
M8_M8>(?$VZ.V>.QA;S%Q"N9"C\ -*^XAU'1XA$<DM@';M\2MFE2>WNK7;?[W
M^:L?'XKB2O6TC:"U^%:V?F[ZKNK=^UOG35-5N-;F:XNI9)YGQNDD=G=L  99
MB2<  #)X  Z"O*E)S=V[ON]3YFI4E4?-)MM]6VWVW9GU!F% !0 4 % !0 4
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MLX)4-M8=4<!@2C ,N>0#7MTZL:BO%W1]A0Q$,1'F@U)=T_*]GV>NSU1OUJ=
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!P/Q,^(-O\ #'3)=2N!
MOV86.(,JM+(QPJ*3^+,0&*HKL%;;@\N)KJA%R?R7=_U^!YV/QL<%3=26MME=
M*[>RU^][Z)NSL?G#K7[6/BG5) \,\-JH4 QPP(5)R3N)F$K9.<<,%P!\N<D_
M*3S2K+9I>B7ZW/S*KQ)B)NZ:CIM&*MZ^]S/\3(_X:>\7?]!#_P E[;_XU6?]
MI5?YOPC_ )&/^L&)_G_\DA_\B'_#3WB[_H(?^2]M_P#&J/[2J_S?A'_(/]8,
M3_/_ .20_P#D0_X:>\7?]!#_ ,E[;_XU1_:57^;\(_Y!_K!B?Y__ "2'_P B
M'_#3WB[_ *"'_DO;?_&J/[2J_P WX1_R#_6#$_S_ /DD/_D0_P"&GO%W_00_
M\E[;_P"-4?VE5_F_"/\ D'^L&)_G_P#)(?\ R(?\-/>+O^@A_P"2]M_\:H_M
M*K_-^$?\@_U@Q/\ /_Y)#_Y$/^&GO%W_ $$/_)>V_P#C5']I5?YOPC_D'^L&
M)_G_ /)(?_(GT'X!_;-6XD\K7;98U9N)[8,50$J!OB=F; ^9F=&9L841$\UZ
ME#.+Z37S7^3_ *\CZ/!<57=JT;:_%&]EMNFV^[;3?9(^V= U^U\46L5[92K-
M;S+NCD7H1T/!Y!!R&4@,K J0""*^AIU%45UJF?=T:T:\5.#NFM&OZ^]=-F:]
M:&P4 % !0!P/C3XHZ-\/=HU.[C@=\;8_F>0@[L-Y<89]GRL-^-N1MSD@5RUL
M3"C\3M^+^Y7?0\[%YA2PG\225^FK?76R3=M-[6/D;QI^VG]U=$L_0M)=_P#
MLJ(XG_W2',G]Y?+Z-7AULX_D7SE_DG^OR/C<7Q7_ ,^H^KG\]+1?IK?Y=3Y<
M\3_&_P 1^,(_)O-0F,>UU9(]L*NK@!E<0J@<$#&'W  D#&XY\:IC:E31R?RT
MW]+7/D\1F]?$*TINUFK*T4T][\J5_F>55Q'D!0 4 % !0 4 % !0 4 % !0
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M?7=[O?79=;'SW7EGS84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MB]0>AX/!!&0RD%64E2""16E.HZ;NM&C:C6E0DIP=FGHU_7WKKLS]UZ_2#^@
MH * "@ H * "@ H * "@ H * "@ H X'X@_$S3/AC;BXU*79OW"*-06DE95R
M511^ +,512RAG7<,\M?$QH*\GZ+J_P"ON/.QN/IX*/-4=KWLMV[*^B_5V6JN
MU<^%_''[8^IZHTD>D0QVD)X260"6?AR=V#^Z7<N 4*R;<MB0G:5^<K9O*6D%
M9=WJ]_N_/U/@<7Q14G=4DHKHW[TM]^RNNEG;74^3M:\07GB2037UQ-<R!0H>
M:1I&"@DA07).,DG'3))[UXDZCGK)M^KO^9\=5KRK.\VY.UKR;;M\S'K,Q"@
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M^V?_ ,B_;?\ 7_'_ .B9Z\/./X:_Q+\I'QO%7\"/_7Q?^DS/S)KX\_*PH *
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M3K6C5]R7?>+V6^ZUOOHEO(^N:]P^R"@ H * "@ H * "@ H * "@ H * "@
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MYI-MOJVV^V[,^H,PH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M_3YVN[NW4\YKD/,"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MN]3\IJ5)5'S2;;?5MM]MV9]09A0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M+%8Y&0%B !G YP ,]A7YS6AR2<5T;7W.Q^"8NDJ-24%M&<DK[V3:.8K$Y H
M* "@ H * "@ H * +%I=R6$B30NT<D;!D=25964Y#*1R"#R".0>::=M45&3B
M[K1IW36CN%W=R7\CS3.TDDC%G=B69F8Y+,3R23R2>2>:&[ZL)2<G=ZMN[;U=
MRO2)"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#8T#7[KPO
M=17ME*T-Q"VZ.1>H/0\'@@C(92"K*2I!!(K2G4=-W6C1M1K2H24X.S3T:_K[
MUUV9^R/PM^)5K\5=-74+96C.XQS1-R8Y5 ++NP PPP*L.JD9"MN1?O<-B%B(
M\R]&O,_;<NQ\<=3YXZ:V:?1Z:>>^C_)Z'HU=9Z8Y: '4 % 'GWQ6_P"1?U7_
M *\+O_T2]<N*_AR_PR_)GG9C_ J?]>Y_^DL_$VOST_"@H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^NOA
M)^U;?>$MMKK/F7MH-Y\W.^Z4GD#<[@2)G(PY# -P^U%C/NX3-)4])^\M==Y?
MB]?ZUZ'V66<1SH>[5O..NN\_O;U7KKKO9)'Z/:!K]KXHM8KVRE6:WF7='(O0
MCH>#R"#D,I 96!4@$$5]73J*HKK5,_3J-:->*G!W36C7]?>NFS->M#8* "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H R-?U^U\+VLM[>RK#;PKNDD;
MH!T' Y))P%4 LS$* 20*SJ5%35WHD8UJT:$7.;LDM6_Z^Y==D?F%\=_VB)OB
MEBRL1);Z8NUF1\"29Q@YDVE@$4_<0$@D>8Q+;%C^/QV8/$>['2/XOU_R^?I^
M4YQGCQON0O&&FCW;\[-Z+HOF^EOF2O'/E0H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@"Q:7<EA(DT+M')&P9'4E65E.
M0RD<@@\@CD'FFG;5%1DXNZT:=TUH[GZN?L[_ !H_X6E8F&\>,:G;<2*O!ECX
M G"X &2=KA,A6 .$61$'VV7XSZQ&S^);^:[_ .?Z7/U[(\U^NPM)KGCOYK3W
MK?@[;/M=(^BZ]4^F"@ H * "@ H * "@ H * /@C]L?X;?ZGQ!;)Z07>U?\
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M]Y^/XW'U,;+FJ.]KV6R5W?1?J[O17;L<#7*><% !0 4 % !0 4 % !0 4 %
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M_$#Q*=.EI&]G+K)>G1?BU:]M4?'M>"?%A0 4 % !0 4 % !0 4 % !0 4 %
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MJWX77FGSX4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M5C.6,:*W;YGJUHKI+SN]=].7;8_/"OE3\V"@ H * "@ H * "@ H * "@ H
M^F_V5OAW_P )GK@O)1FVT[;,W/68D^0O#*PPRF3(#+^[V,,.*]C+,/[6=WM'
M7Y].OS^1]5P[@?K%;F?PT[2_[>^SU3W5^JTL]S]5*^T/UP* "@ H * "@ H
M* "@ H \Y^*7Q*M?A5IK:A<JTAW".&)>#)*P)5=V"%&%)9CT4' 9MJ-R8G$+
M#QYGZ)>9YF8X^.!I\\M=;)+J]=/+;5_F]#\A?''CB^^(E])?W\F^5^%4<)&@
MSMCC7)VH,G Y))+,6=F8_"UJTJTN:6_]:'XSB\7/%S<YN[?W)=EY?\.]3D*P
M.(* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@#8T#0+KQ1=165E$TUQ,VV.->I/4\G@ #)9B0JJ"Q( )K2G3=1V6
MK9M1HRKR4(*[;T2_K[WTW9^W'A30_P#A&-/M;#?YGV:WBAWXV[O+0)NVY.,X
MSC)QTR:_0Z4/9Q4>R2^Y6/WC#4?8PC"]^6,8WVV27GV-^M3H"@ H * "@ H
M* "@ H KW=W'81O-,ZQQQJ6=V(5551DLQ/  '))X YI-VU9,I**N]$E=MZ*Q
M^7?[07[04GQ)D;3]/9H]+C;D\JURRGAW'41@\QQGG.)'&_:L7QN/Q_M_=C\/
MY_\  [+YOR_)\ZSIXQ\D-*:?HY/N_+LOF];)?+E>,?)A0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'UU^S'\
M<?\ A"[@:3J<^W39<^2S\K!,S \MD;(GRV_@JKD/\@,KGW<MQOLGR2?NO;R?
MZ+]>VI]EP_F_U>7LZC]Q[7Z2OWZ)]>B>NFK/TUKZ\_5 H * "@ H * "@ H
M* "@ H * "@ H _.']M719(-4L;XE?+FM6A49.X-#(SL2,8P1,NW!)R&R!@9
M^3SF%I*7=6^YW_4_,N*Z352$^CA;SO%MO_TI?B?%U?/GPP4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % '[L>']:C\26=O?0AA'<PQS(& #!9%#@, 2,X/."1GN:_2*<^=*2ZI/[]3
M^@*%55HJ:VE%-7WLU<V5K0V'4 % 'GWQ6_Y%_5?^O"[_ /1+URXK^'+_  R_
M)GG9C_ J?]>Y_P#I+/Q-K\]/PH* "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ]=^"_Q4F^%&II=9D>
MTD^6ZA0C]XF#@@-P70G>GW2>4WJKL:[L'BGAY7Z/=?UV_P"!U/9RK,7@:BEJ
MXO2275?/JMUMVNDV?KWH&OVOBBUBO;*59K>9=T<B]".AX/((.0RD!E8%2 01
M7W5.HJBNM4S]GHUHUXJ<'=-:-?U]ZZ;,UZT-@H * "@ H * "@ H * "@ H
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MA6,Q3Q5251_:>W9;);+9)*_4Y"L#B"@ H * "@ H * "@ H * "@ H _7O\
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MM_+_ )7WVTLD_O"OI3]!"@ H * "@ H * "@ H * "@ H * /@C]N#_F$_\
M;Y_[0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 =O:?#37+^-)H=-OI(Y%#(ZVTK*RL,AE(7!!'((X(Y
MKH6&F]5&7_@+_P COC@*TE=0FTU=-0DU;[CT7_AF'Q=_T#__ "8MO_CM=?\
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MA18XXU"HB@*JJHP%4#@ #@ < <5](E;1'W\8J*LM$E9):*Q8IE!0 4 % !0
M4 % 'RK\>?V<K?Q["U]I4<<&IIN9E4*B7.268/T E))*RG[Q.V0[2KQ^+CLO
M59<T=)?=?_@^?W^7R.<Y%'%+GII*:N^B4NNOGV?79]U^85W:26$CPS(T<D;%
M71@5964X*L#R"#P0>0>*^.:MHS\IE%Q=GHT[-/1W*](D* "@ H * "@ H *
M"@ H _2[]D'XAMX@TV72KF9I+BS8&$.5S]F8 *J<[V$; @Y&$5XD#8VJOUV4
MXCGBXMZQV]/^!^&A^I<,8[VM-TY.[@]+V^#1675V?W72\C[!KWC[0* "@ H
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M[M:^2_X/Y>J9\3Q%FOL8^Q@US23YNMHM;=KM/U2Z:IGYLU\D?EX4 % !0 4
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M * "@ H * "@ H * /T7_9R_9R_L#R]:UJ/_ $KA[:V<?ZGN)) ?^6O=$/\
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M7P]0Q%[+DD^L=%M;X=K=7:S?<^3?%W['VNZ*Q;3WAOX]RA0&$,N"N2S)(=@
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M=QW\:30NLD<BAD=2&5E89#*1P01R".".:_0$[ZH_<8R4E=:IJZ:U5BQ3*"@
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M5?\ KPN__1+URXK^'+_#+\F>=F/\"I_U[G_Z2S\3:_/3\*"@ H * "@ H *
M"@ H * "@ H * /KK]C#_D8+G_KPD_\ 1T%>[D_\1_X7^<3[+A7^/+_KV_\
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MT7AW*8N*KSU=WRKHK-J[\[K3MOO:WWA7TI^@A0 4 % !0 4 % !0 4 % !0
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M<&OL<JK^TARO[/Y/;\ONL?JW#.-=>DX/>FTK_P!UWMU>UFNB2L?65>V?8!0
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MR6_^7S/D^),9["CR+>H[:-K16;_1-=;^I^65?&'Y*% !0 4 % !0 4 % !0
M4 % !0 4 ?L'\!OA6OPKTE8I!F\N-LMTQ"95RHQ$&7.4CY ^9@6+N,!]H^[P
M.%^KPMU>KV^[Y?YG[3DV7?4:=G\4K.6V]MM.B]7K=K<]LKT3W0H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#PO]H+XI
M-\+M':6W91?7#>5; A6P>KR;"1D(O0X91(T892K$5YN/Q/L(76[T7^?]=;'@
M9UF/U*E>/Q2=H[/U=F^B]=6KJS/R$KX4_& H * "@ H * "@ H * "@ H *
M/KK]D?X;?\)+J;:M<)FVL,>7N7*O<,/EQE2I\M<N<%71S"PX->[E6'YY<[VC
MMZ_=TW\G8^RX:P'MJGM9+W8;><GMNK:+7>Z?*S]-:^O/U0* "@ H * "@ H
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M,?R1^ZY=_ I_]>X?^DH] 6NH]$=0 4 >??%;_D7]5_Z\+O\ ]$O7+BOX<O\
M#+\F>=F/\"I_U[G_ .DL_$VOST_"@H * "@ H * "@ H * "@ H * "@#ZZ_
M8P_Y&"Y_Z\)/_1T%>[D_\1_X7^<3[+A7^/+_ *]O_P!*@?IK7UY^J!0 4 %
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M5+?RI+[];_C^!^2\38AU*_+TA%+?2[7,W;INE\D?+E>,?)A0 4 % !0 4 %
M!0 4 % !0 4 ?3?[*WP[_P"$SUP7DHS;:=MF;GK,2?(7AE8893)D!E_=[&&'
M%>QEF']K.[VCK\^G7Y_(^JX=P/UBMS/X:=I?]O?9ZI[J_5:6>Y^JE?:'ZX%
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MHKYON_Z_ _<\!@HX*FJ<=;;NR5V]WI]RWT25W8[ZNH]$* "@ H * "@ H *
M"@ H * "@ H _*O]K#P=_P (SXA>YC7;#?1K,-L>Q!(/DE4$<.Y*B5SP<RC(
MR=S?%YI1Y*E^DE?:VNS_ ,WZGY'Q)A?8U^9;32EM97V?J]+OUU[GS)7CGRH4
M % !0 4 % !0 4 % !0 4 % 'ZN?LL>.V\8>'T@F93/8-]G(W+N,04&%B@ V
MC;^[4G.\Q,VXMN ^URRO[2G9[QT^73_+Y'Z]P[C/K%%)[TWR[J]K>Z[*UM-/
M.S=SZ3KUSZ@* "@ H * "@ H * "@ H ^"/VX/\ F$_]OG_M"OF<Z^S_ -O?
M^VGYYQ;_ ,N_^XG_ +8? ]?,GYX% !0 4 % !0 4 % !0 4 % !0!^Q?[/FB
MR:#X6TV&4J6:$S J21MG=ID'('(5P&[!L@$C!/WN AR4HI]K_>[_ *G[7DE)
MTL/!/^6^G:3<E^#U/9*[SVPH * "@ H * "@ H * "@#X(_;@_YA/_;Y_P"T
M*^9SK[/_ &]_[:?GG%O_ "[_ .XG_MA\#U\R?G@4 % !0 4 % !0 4 % !0
M4 % '[%_L^:+)H/A;3892I9H3,"I)&V=VF0<@<A7 ;L&R 2,$_>X"')2BGVO
M][O^I^UY)2=+#P3_ );Z=I-R7X/4]DKO/;"@ H * "@ H * "@ H * "@#\$
M*_,S^>0H * "@ H * "@ H * "@ H * /VQ^%/\ R+^E?]>%I_Z)2OT+"_PX
M_P"&/Y(_=<N_@4_^O</_ $E'H"UU'HCJ "@#S[XK?\B_JO\ UX7?_HEZY<5_
M#E_AE^3/.S'^!4_Z]S_])9^)M?GI^%!0 4 % !0 4 % !0 4 % !0 4 % 'U
MU^QA_P C!<_]>$G_ *.@KW<G_B/_  O\XGV7"O\ 'E_U[?\ Z5 _36OKS]4"
M@ H * "@ H * "@ H * "@#\E/VD_AI'\.=:/V8,+2\4SQCRPJ1L7;?"A4!2
M$X(  *(Z*0>&;X?,<-[&>FTM5IIOM_72Q^.Y]@%A*ON_#-<RTLD[N\5;33\$
MTO-_/=>6?-A0 4 % !0 4 % !0 4 % !0 4 ?;/[&'C'[%?7>D2-A+B,31!I
M,#S(N'5(SP7=&W,5P=L/((&5^AR>M:3AW5UKU7EZ?D?=\*XKEG*D_M+F6O5;
MV7=IW?E'[OT6KZL_2PH * "@ H * "@ H * "@#\Z?VV-<^T:AI]ALQY-O)-
MOS][SWV;=N.-ODYSDYW8P-O/RF<SO*,>R;^]V_0_-.+*UYPA;:+E?_$[?^V?
MB?$U?/'P@4 % !0 4 % !0 4 % !0 4 % 'W1^Q/X:\RXU#4V60;(X[>-L?N
MV\QO,D&<<NOEQ< _*'Y!W*1])DU/64O)+RUU?Y(^_P"$Z%Y3J:Z)17;5W?S5
ME]_FC]!Z^H/T<* "@ H * "@ H * "@ H * "@ H * /S2_;-T!K'6K:]6)4
MCN;4*9!M!DEB=@^X#YB51HAN8<KM4$[2!\CG%.TT^Z_%/_)H_+>*J/+5C.UE
M*&^FKBW?\''7Y=#X]KP3XL* "@ H * "@ H * "@ H _>#2M4AUNWBNK=M\,
M\:21M@C<CJ&4X(!&00<$ CN :_2HR4TFMFKKYG]!4ZBJ14HZJ233\FKK<OU1
MH% !0 4 % !0 4 % !0 4 % &1K^@6OBBUELKV)9K>9=LD;=".HY'((."K A
ME8!@00#6=2FJBL]4S&M1C7BX35TUJG_7W/INC\F_C=\$;KX1W6Y=TVG3,1!.
M1R#U\J7' D S@\+(H+* 0Z)\3C<$\.^\7L_T?G^?Y?C^;93+ 2[P;]V7Z/S_
M #W75+PNO-/GPH * "@ H * "@ H * "@ H _3W]EWXS2>/+5]+U"1I-0M5W
M*[*<R6XVJ&9\G=(K-M8G:64HWSMYC#['+,9[9<LOB7XK_/\ K74_5N'LU>*C
M[.;O.*NG;>.BU?=-V>U]-W=GUE7MGV 4 % !0 4 4-5U2'1+>6ZN&V0P1O)(
MV"=J(I9C@ DX )P 2>P)J924$V]DKOY&=2HJ<7*6BBFV_)*[V/Q\^-'Q4F^*
M^IO=9D2TC^6UA<C]VF!DD+P'<C>_WB.$WLJ*:^#QF*>(E?HME_7?_@=#\6S7
M,7CJCEJHK2*?1?+J]WOVNTD>15PGC!0 4 % !0 4 % !0 4 % !0!Z=\*_A7
M??%B^%K:C9$F&N+AAE(D/<]-SG!"(""Q!Y5%=U[,+A98B5EMU?;^NB/5R[+I
MXZ?+'1+XI=$O\^RZ^EVOUS\#^!['X=V,=A81[(DY9CR\CG&Z21L#<YP,G@
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MW_EW_P!Q/_;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%/_ "+^E?\
M7A:?^B4K]"PO\./^&/Y(_=<N_@4_^O</_24=]74>B% !0 4 % !0 4 % !0
M4 % 'X(5^9G\\A0 4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_ $2E
M?H6%_AQ_PQ_)'[KEW\"G_P!>X?\ I*/0%KJ/1'4 % 'GWQ6_Y%_5?^O"[_\
M1+URXK^'+_#+\F>=F/\  J?]>Y_^DL_$VOST_"@H * "@ H * "@ H * "@
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MQ^%/_(OZ5_UX6G_HE*_0L+_#C_AC^2/W7+OX%/\ Z]P_])1WU=1Z(4 % !0
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MDK:(_>XQ459:)*R2T5BQ3*"@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * /DW]L77VTSP_':I*JM=72*\?R[GBC5I#@'G
M"N(BS+C!*J3AL'Q,WJ<M.W=K3R6OYV/C^**W)144_BFKK2[23?X-+5>7<_,*
MOCC\I"@ H * "@ H * "@ H * "@ H ^V?V)]#^T:AJ%_OQY-O'#LQ][SWW[
MMV>-ODXQ@YW9R-O/T.30O*4NR2^]W_0^[X3HWG.=]HJ-O\3O_P"V?B?HM7U9
M^EA0 4 % !0 4 % !0 4 % !0 4 % !0!Y5\<=%CU[PUJ<,I8*MK),"I .Z
M><@Y!X+( W<KD @X(XL;#GIR3[-_=K^AY&;TE5P]1/\ D;T[Q]Y?BM3\9:^
M/Q * "@ H * "@ H * "@ H * "@"Q:7<EA(DT+M')&P9'4E65E.0RD<@@\@
MCD'FFG;5%1DXNZT:=TUH[G[D>%-<_P"$GT^UO]GE_:;>*;9G=M\Q ^W=@9QG
M&<#/7 K]&I3]I%2[I/[U<_?,-6]M",[6YHQE;?=)^7<WZU.@* "@ H * "@
MH * "@#X(_;@_P"83_V^?^T*^9SK[/\ V]_[:?GG%O\ R[_[B?\ MA\#U\R?
MG@4 % !0 4 % !0 4 % !0 4 % '[8_"G_D7]*_Z\+3_ -$I7Z%A?X<?\,?R
M1^ZY=_ I_P#7N'_I*.^KJ/1"@ H * "@ H * "@ H * /@C]N#_F$_\ ;Y_[
M0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0 4 % !0 4 % !0 4
M ?MC\*?^1?TK_KPM/_1*5^A87^''_#'\D?NN7?P*?_7N'_I*.^KJ/1"@ H *
M "@ H * "@ H * "@#\$*_,S^>0H * "@ H * "@ H * "@ H * /VQ^%/\
MR+^E?]>%I_Z)2OT+"_PX_P"&/Y(_=<N_@4_^O</_ $E'H"UU'HCJ "@#S[XK
M?\B_JO\ UX7?_HEZY<5_#E_AE^3/.S'^!4_Z]S_])9^)M?GI^%!0 4 % !0
M4 % !0 4 % !0 4 % 'UU^QA_P C!<_]>$G_ *.@KW<G_B/_  O\XGV7"O\
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M%G=B69F8Y+,3R23R2>2>:_-F[ZL_G^4G)W>K;NV]7<KTB0H * "@ H * "@
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M?:T:,:,>6.W]:GZ]A,)#"04(*R7WM]WY_P##+0ZZMSM"@ H * "@ H * "@
MH * "@ H _/C]MCQ+YEQI^F*T@V1R7$BY_=MYC>7&<9Y=?+EY(^4/P3N8#Y?
M.:FL8^3?EKHOR9^<<65[RA3UT3D^VKLOFK/[_-GPO7S9\ % !0 4 % !0 4
M% !0 4 % !0!])_LG:+)JGBF"9"H6UAGFD!)R5*&$!< Y.Z53S@;0QSG /KY
M7#FJI]DW^%OU/J.&Z3GB$U]F,F_2W+^<D?JY7VI^O!0 4 % !0 4 % !0 4
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M\,?R1^ZY=_ I_P#7N'_I*.^KJ/1"@ H * "@ H * "@ H * /@C]N#_F$_\
M;Y_[0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0 4 % !0 4 %
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M9)?>[_H?=\)T;SG.^T5&W^)W_P#;/Q/T6KZL_2PH * "@ H * "@ H * "@
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MP:K_ -?]W_Z.>OSW%?Q)?XI?FS\*S'^/4_Z^3_\ 2F<#7*><% !0 4 % !0
M4 % !0 4 % !0!^@_P"Q'JDTMOJ=JS9ACDMY$7 X>59%<YQDY$2#!) V\ $G
M/U&32;4ET33^^_\ DC]'X2J-QJ1Z)Q:7FU)/_P!)1]T5](??A0 4 % !0 4
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MC\*?^1?TK_KPM/\ T2E?H6%_AQ_PQ_)'[KEW\"G_ ->X?^DH] 6NH]$=0 4
M>??%;_D7]5_Z\+O_ -$O7+BOX<O\,OR9YV8_P*G_ %[G_P"DL_$VOST_"@H
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MT+"_PX_X8_DC]UR[^!3_ .O</_24=]74>B% !0 4 % !0 4 % !0 4 % !0
M4 % !0!D:_H%KXHM9;*]B6:WF7;)&W0CJ.1R"#@JP(96 8$$ UG4IJHK/5,Q
MK48UXN$U=-:I_P!?<^FZ/R;^-WP1NOA'=;EW3:=,Q$$Y'(/7RI<<"0#.#PLB
M@LH!#HGQ.-P3P[[Q>S_1^?Y_E^/YME,L!+O!OW9?H_/\]UU2\+KS3Y\* "@
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MH?"/_+S_ +A_^WGWO7TQ^AA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0!^%_BO7/^$GU"ZO\ 9Y?VFXEFV9W;?,<O
MMW8&<9QG SUP*_.*L_:2<N[;^]W/P+$UO;3E.UN:4I6WW;?EW,"LCF"@ H *
M "@ H * "@ H * "@ H _;'X4_\ (OZ5_P!>%I_Z)2OT+"_PX_X8_DC]UR[^
M!3_Z]P_])1WU=1Z(4 % !0 4 % !0 4 % !0 4 % !0 4 % 'XG?%;_D8-5_
MZ_[O_P!'/7Y[BOXDO\4OS9^%9C_'J?\ 7R?_ *4S@:Y3S@H * "@ H * "@
MH * "@ H * /JK]CS5(=/\2-'(VU[BSECB&"=SAHY2. 0/DC=LG XQG) /M9
M3)*IKUBTOO3_ "1]=PO44*]G]J$DO6\9?E%GZBU]D?K 4 % !0 4 % !0 4
M% 'P1^W!_P PG_M\_P#:%?,YU]G_ +>_]M/SSBW_ )=_]Q/_ &P^!Z^9/SP*
M "@ H * "@ H * "@ H * "@#]L?A3_R+^E?]>%I_P"B4K]"PO\ #C_AC^2/
MW7+OX%/_ *]P_P#24=]74>B% !0 4 % !0 4 % !0 4 ?!'[<'_,)_[?/_:%
M?,YU]G_M[_VT_/.+?^7?_<3_ -L/@>OF3\\"@ H * "@ H * "@ H * "@ H
M _;'X4_\B_I7_7A:?^B4K]"PO\./^&/Y(_=<N_@4_P#KW#_TE'?5U'HA0 4
M% !0 4 % !0 4 % !0!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % '[8_"G_
M )%_2O\ KPM/_1*5^A87^''_  Q_)'[KEW\"G_U[A_Z2CT!:ZCT1U !0!Y]\
M5O\ D7]5_P"O"[_]$O7+BOX<O\,OR9YV8_P*G_7N?_I+/Q-K\]/PH* "@ H
M* "@ H * "@ H * "@ H ^NOV,/^1@N?^O"3_P!'05[N3_Q'_A?YQ/LN%?X\
MO^O;_P#2H'Z:U]>?J@4 % !0 4 % !0 4 % !0 4 % 'YL_MIZ7-%K%G=,N(
M9+/RT;(Y>*5V<8SD8$J') !W<$D''R6<1:FGT<;?<W_FC\PXKIM58RZ.%D_-
M2;?_ *4CXVKP#X@* "@ H * "@ H * "@ H * "@#U7X':U)H/B73)H@I9KJ
M.$A@2-LY\ESP1R%<E>P;!((R#VX*?)4BUW2^_3]3U\HJNEB*;7\Z6O:7NO\
M!Z'[-5]^?MX4 % !0 4 % !0 4 ?!'[<'_,)_P"WS_VA7S.=?9_[>_\ ;3\\
MXM_Y=_\ <3_VP^!Z^9/SP* "@ H * "@ H * "@ H * "@ H _>^OTP_H8*
M"@ H * "@ H * "@ H * *&J:K;Z)"UQ=2QP0IC=)(ZHBY( RS$ 9) &3R2!
MU-3*2@KMV7=Z&=2I&FN:322ZMI+MNSPOQ=^T]X:\)L8Q<->2!E!2U42  KNW
M"0E8F X!VNS!CC;PVWS:N94Z?6_^'7\=%^)\_B>(,/0TYN9WV@K]+WNVHOY/
M]3YL\8_MGWU[NCTBTCMT/F*)9CYLF#Q&ZH-J(XY8JWG+D@<@'=Y%;.)/X%;?
M5ZOR\E^)\QBN*IRTI14=]9>\_)VT2?D^9?K\B^)?%-]XPN&NM0GDN)FS\SMG
M +%MJCHB L2$4!5SP *\.I5E4=Y.[/C:^(GB)<TVY/NWYWLNRUV6B,"LCF"@
M H * "@ H * "@ H * "@#]L?A3_ ,B_I7_7A:?^B4K]"PO\./\ AC^2/W7+
MOX%/_KW#_P!)1WU=1Z(4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!D:_H%K
MXHM9;*]B6:WF7;)&W0CJ.1R"#@JP(96 8$$ UG4IJHK/5,QK48UXN$U=-:I_
MU]SZ;H_)OXW?!&Z^$=UN7=-ITS$03D<@]?*EQP) ,X/"R*"R@$.B?$XW!/#O
MO%[/]'Y_G^7X_FV4RP$N\&_=E^C\_P ]UU2\+KS3Y\* "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * /=/@C\$;KXN76YMT.G0L!/.!R3U\J+/!D(
MQD\K&I#,"2B/Z6"P3Q#[16[_ $7G^7Y_093E,L?+M!/WI?HO/\MWT3_630-
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M/Q/.S&I[.C.5[6A*SO;6S2U[WM;S/Q.K\]/PH* "@ H * "@ H * "@ H *
M"@ H _;'X4_\B_I7_7A:?^B4K]"PO\./^&/Y(_=<N_@4_P#KW#_TE'?5U'HA
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?CK^T'HL>@^*=2AB+%6F$Q+$$[IT
M69QP!P&<A>X7 ))R3\'CX<E627>_WI/]3\4SNDJ6(FE_-?7O)*3_ !>AXU7G
MGB!0 4 % !0 4 % !0 4 % !0 4 >R_L^:U'H/BG39I0Q5IC" H!.Z=&A0\D
M<!G!;N%R0"< ^A@)\E6+?>WWJWZGMY)55+$0;_FMIWDG%?B]3]BJ^\/VL* "
M@ H * "@ H * "@#X(_;@_YA/_;Y_P"T*^9SK[/_ &]_[:?GG%O_ "[_ .XG
M_MA\#U\R?G@4 % !0 4 % !0 4 % !0 4 % '[8_"G_D7]*_Z\+3_P!$I7Z%
MA?X<?\,?R1^ZY=_ I_\ 7N'_ *2COJZCT0H * "@ H * "@ H * "@#X(_;@
M_P"83_V^?^T*^9SK[/\ V]_[:?GG%O\ R[_[B?\ MA\#U\R?G@4 % !0 4 %
M !0 4 % !0 4 % '[8_"G_D7]*_Z\+3_ -$I7Z%A?X<?\,?R1^ZY=_ I_P#7
MN'_I*.^KJ/1"@ H * "@ H * "@ H * "@#\$*_,S^>0H * "@ H * "@ H
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M)_[?/_:%?,YU]G_M[_VT_/.+?^7?_<3_ -L/@>OF3\\"@ H * "@ H * "@
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MGAWWB]G^C\_S_+\?S;*98"7>#?NR_1^?Y[KJEX77FGSX4 % !0 4 % !0 4
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M;_Q/\HGZIPK_  )?]?'_ .DP/KFO</L@H * "@ H * "@ H * "@ H * "@
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M 4 % !0!^]]?IA_0P4 % !0 4 % !0 4 ?!'[<'_ #"?^WS_ -H5\SG7V?\
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MZ)-OOLC]#OV??V:6\*2+JNN1J;Q&S;V^5=82#Q*Y4E6D[Q@$K&,/DR8\KZG
M9=[/WI[]%O;S]>W;UV_2LER'V#]I67O)^['1I>;M=-]NV^^WVC7T!]P% !0
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MJJC 50.  . !P!Q7V25M$?K$8J*LM$E9):*Q8IE!0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % !0!^FW[&'
M_(OW/_7_ "?^B8*^PR?^&_\ $_RB?JG"O\"7_7Q_^DP/KFO</L@H * "@ H
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M]$I7Z%A?X<?\,?R1^ZY=_ I_]>X?^DH[ZNH]$* "@ H * "@ H * "@ H *
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M_P#2F?LO#_\ NT/^W_\ TN1[Y7IGT(4 % !0 4 % !0 4 % !0 4 % !0 4
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M?_<3_P!L/@>OF3\\"@ H * "@ H * "@ H * "@ H * /WOK],/Z&"@ H *
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M_7_'_P"B9Z\/./X:_P 2_*1\;Q5_ C_U\7_I,S\R:^//RL* "@ H * "@ H
M* "@ H * "@ H _;'X4_\B_I7_7A:?\ HE*_0L+_  X_X8_DC]UR[^!3_P"O
M</\ TE'?5U'HA0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?F5^V?_ ,C!;?\
M7A'_ .CIZ^0SC^(O\*_.1^5\5?QX_P#7M?\ I4SY%KPCXT* "@ H * "@ H
M* "@ H * "@ H _;'X4_\B_I7_7A:?\ HE*_0L+_  X_X8_DC]UR[^!3_P"O
M</\ TE'?5U'HA0 4 % !0 4 % !0!\$?MP?\PG_M\_\ :%?,YU]G_M[_ -M/
MSSBW_EW_ -Q/_;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%/\ R+^E
M?]>%I_Z)2OT+"_PX_P"&/Y(_=<N_@4_^O</_ $E'?5U'HA0 4 % !0 4 % !
M0 4 % 'P1^W!_P PG_M\_P#:%?,YU]G_ +>_]M/SSBW_ )=_]Q/_ &P^!Z^9
M/SP* "@ H * "@ H * "@ H * "@#]L?A3_R+^E?]>%I_P"B4K]"PO\ #C_A
MC^2/W7+OX%/_ *]P_P#24=]74>B% !0 4 % !0 4 % !0 4 % 'X(5^9G\\A
M0 4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_1*5^A87^''_#'\D?NN
M7?P*?_7N'_I*/0%KJ/1'4 % 'GWQ6_Y%_5?^O"[_ /1+URXK^'+_  R_)GG9
MC_ J?]>Y_P#I+/Q-K\]/PH* "@ H * "@ H * "@ H * "@ H ^NOV,/^1@N
M?^O"3_T=!7NY/_$?^%_G$^RX5_CR_P"O;_\ 2H'Z:U]>?J@4 % !0 4 % !0
M 4 % !0 4 % 'P1^W!_S"?\ M\_]H5\SG7V?^WO_ &T_/.+?^7?_ '$_]L/@
M>OF3\\"@ H * "@ H * "@ H * "@ H * /WOK],/Z&"@ H * "@ H * "@#
MX(_;@_YA/_;Y_P"T*^9SK[/_ &]_[:?GG%O_ "[_ .XG_MA\#U\R?G@4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M\*?^1?TK_KPM/_1*5^A87^''_#'\D?NN7?P*?_7N'_I*.^KJ/1"@ H * "@
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M "@ H * "@ H * "@#\$*_,S^>0H * "@ H * "@ H * "@ H * /VQ^%/\
MR+^E?]>%I_Z)2OT+"_PX_P"&/Y(_=<N_@4_^O</_ $E'H"UU'HCJ "@#S[XK
M?\B_JO\ UX7?_HEZY<5_#E_AE^3/.S'^!4_Z]S_])9^)M?GI^%!0 4 % !0
M4 % !0 4 % !0 4 % 'UU^QA_P C!<_]>$G_ *.@KW<G_B/_  O\XGV7"O\
M'E_U[?\ Z5 _36OKS]4"@ H * "@ H * "@ H * "@ H ^"/VX/^83_V^?\
MM"OF<Z^S_P!O?^VGYYQ;_P N_P#N)_[8? ]?,GYX% !0 4 % !0 4 % !0 4
M % !0 4 ?O?7Z8?T,% !0 4 % !0 4 % 'P1^W!_S"?^WS_VA7S.=?9_[>_]
MM/SSBW_EW_W$_P#;#X'KYD_/ H * "@ H * "@ H * "@ H * "@ H * "@
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M 4 % !0 4 % !0 4 % !0!R/CCQQ8_#NQDO[^39$G"J.7D<YVQQKD;G.#@<
M %F*HK,,*U:-&/-+;^M#BQ>+AA(.<W9+[V^R\_\ AWH?D9\5/BI??%B^-U='
M9$F5M[=3E(D/8=-SG +N0"Q X5%1%^&Q6*EB)7>W1=OZZL_&\QS&>.GS2T2^
M&/1+_/N^OI9+S&N,\H* "@ H * "@ H * "@ H * +%I=R6$B30NT<D;!D=2
M5964Y#*1R"#R".0>::=M45&3B[K1IW36CN?J+^S[^T%'\28UT_4&6/5(UX/"
MK<JHY=!T$@',D8XQF1!LW+%]E@,?[?W9?%^?_![KYKR_6,ESI8Q<D]*B7HI+
MNO/NOFM+I?45>R?6!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % !0!^V/PI_Y%_2O^O"T_\ 1*5^
MA87^''_#'\D?NN7?P*?_ %[A_P"DH[ZNH]$* "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H \#_:>_Y%'4/^W?_P!*8J\S
M,OX4OE_Z4CY[B#_=I_\ ;G_I<3\C*^&/QH* "@ H * "@ H * "@ H * "@
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M -H5\SG7V?\ M[_VT_/.+?\ EW_W$_\ ;#X'KYD_/ H * "@ H * "@ H *
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M'P/7S)^>!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M[<;N,YP,>A# TX;17SU_.Y[=')L/2O:$=?YO?_\ 2KV^1Z[7<>R% !0 4 %
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MY%_2O^O"T_\ 1*5^A87^''_#'\D?NN7?P*?_ %[A_P"DH[ZNH]$* "@ H *
M"@ H * "@ H * "@ H * "@#X(_;@_YA/_;Y_P"T*^9SK[/_ &]_[:?GG%O_
M "[_ .XG_MA\#U\R?G@4 % !0 4 % !0 4 % !0 4 % !0!^V/PI_P"1?TK_
M *\+3_T2E?H6%_AQ_P ,?R1^ZY=_ I_]>X?^DH[ZNH]$* "@ H * "@ H *
M/@C]N#_F$_\ ;Y_[0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0
M 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_1*5^A87^''_#'\D?NN7?P*?_7N
M'_I*.^KJ/1"@ H * "@ H * "@ H * /@C]N#_F$_P#;Y_[0KYG.OL_]O?\
MMI^><6_\N_\ N)_[8? ]?,GYX% !0 4 % !0 4 % !0 4 % !0!^V/PI_P"1
M?TK_ *\+3_T2E?H6%_AQ_P ,?R1^ZY=_ I_]>X?^DH[ZNH]$* "@ H * "@
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MZT-@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@#D?''CBQ^'=C)?W\FR).%4<O(YSMCC7(W.<' X
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M/#I+[,I)^M^;\I(^DZ]<^H"@ H * "@ H * "@ H * "@ H * "@ H * "@
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M*^9SK[/_ &]_[:?GG%O_ "[_ .XG_MA\#U\R?G@4 % !0 4 % !0 4 % !0
M4 % '[8_"G_D7]*_Z\+3_P!$I7Z%A?X<?\,?R1^ZY=_ I_\ 7N'_ *2COJZC
MT0H * "@ H * "@ H * "@ H _!"OS,_GD* "@ H * "@ H * "@ H * "@#
M]L?A3_R+^E?]>%I_Z)2OT+"_PX_X8_DC]UR[^!3_ .O</_24>@+74>B.H *
M//OBM_R+^J_]>%W_ .B7KEQ7\.7^&7Y,\[,?X%3_ *]S_P#26?B;7YZ?A04
M% !0 4 % !0 4 % !0 4 % !0!]=?L8?\C!<_P#7A)_Z.@KW<G_B/_"_SB?9
M<*_QY?\ 7M_^E0/TUKZ\_5 H * "@ H * "@ H * "@ H * /@C]N#_F$_\
M;Y_[0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0 4 % !0 4 %
M!0 4 =O\-+2._P!<TV&9%DCDOK971@&5E:5058'@@C@@\$<5T897G%/^:/YH
M[\!%2K03U3J033U5N9'[<5^B'[N% !0 4 % !0 4 % 'P1^W!_S"?^WS_P!H
M5\SG7V?^WO\ VT_/.+?^7?\ W$_]L/@>OF3\\"@ H * "@ H * "@ H * "@
M H * /VB^#GA:'PAH-C;QP?9Y&MXI)T*E7,[HIE,F[YM^[@AON@!  JA1^@8
M2DJ<$K6T3?JUJ?N.5X=8>C"*7*W&+DK6?,TKWOK>_P!VVR/3:[#U0H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@#D?''CBQ^'=C)?W\FR).%4<O(YSMCC
M7(W.<' X  +,516885JT:,>:6W]:'%B\7#"0<YNR7WM]EY_\.]#\C/BI\5+[
MXL7QNKH[(DRMO;J<I$A[#IN<X!=R 6('"HJ(OPV*Q4L1*[VZ+M_75GXWF.8S
MQT^:6B7PQZ)?Y]WU]+)>8UQGE!0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 ?HO^SE^T;_;_EZ+K4G^E<);7+G_ %W81R$_\M>R.?\ 6_=/[W!E^KR_
M,.?W)[]'W\GY_GZ[_I>19[[6U*J_>VC)]?)^?9]?7?[8KZ$^["@ H * "@ H
M * "@ H * "@ H * "@ H * "@#\$*_,S^>0H * "@ H * "@ H * "@ H *
M "@#]%_V)]<^T:?J%ALQY-Q'-OS][STV;=N.-ODYSDYW8P-O/U>33O&4>S3^
M]6_0_2^$ZUX3A;:2E?\ Q*W_ +9^)]L5]"?=A0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % ' _%;_D7]5_Z\+O\ ]$O7
M+BOX<O\ #+\F>=F/\"I_U[G_ .DL_$ZOST_"@H * "@ H * "@ H * "@ H
M* "@#]L?A3_R+^E?]>%I_P"B4K]"PO\ #C_AC^2/W7+OX%/_ *]P_P#24=]7
M4>B% !0 4 % !0 4 % !0 4 % !0 4 % !0!^87[9-W'<>(H51U9H[&)9 ""
M48R2N%8#H=K*V#SM93T(KX[-W>HO**_-L_*>*9)UU;I3BGY/FD_R:9\FUXA\
M>% !0 4 % !0 4 % !0 4 % !0!ZK\#M%DU[Q+ID,14,MU',2Q(&V ^<XX!Y
M*H0O8M@$@9([<%#GJ12[I_=K^AZ^44G5Q%-+^=/7M'WG^"T/V:K[\_;PH *
M"@ H * "@ H * /@C]N#_F$_]OG_ +0KYG.OL_\ ;W_MI^><6_\ +O\ [B?^
MV'P/7S)^>!0 4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_ $2E?H6%
M_AQ_PQ_)'[KEW\"G_P!>X?\ I*.^KJ/1"@ H * "@ H * "@ H * /@C]N#_
M )A/_;Y_[0KYG.OL_P#;W_MI^><6_P#+O_N)_P"V'P/7S)^>!0 4 % !0 4
M% !0 4 % !0 4 ?MC\*?^1?TK_KPM/\ T2E?H6%_AQ_PQ_)'[KEW\"G_ ->X
M?^DH[ZNH]$* "@ H * "@ H * "@ H * /P0K\S/YY"@ H * "@ H * "@ H
M * "@ H _;'X4_\ (OZ5_P!>%I_Z)2OT+"_PX_X8_DC]UR[^!3_Z]P_])1Z
MM=1Z(Z@ H \^^*W_ "+^J_\ 7A=_^B7KEQ7\.7^&7Y,\[,?X%3_KW/\ ])9^
M)M?GI^%!0 4 % !0 4 % !0 4 % !0 4 % 'UU^QA_R,%S_UX2?^CH*]W)_X
MC_PO\XGV7"O\>7_7M_\ I4#]-:^O/U0* "@ H * "@ H * "@ H * "@#X(_
M;@_YA/\ V^?^T*^9SK[/_;W_ +:?GG%O_+O_ +B?^V'P/7S)^>!0 4 % !0
M4 % !0 4 % !0 4 ?3?[)&A_VMXGCFW[?LEO--C&=^X"#;G(V_ZW=GG[N,<Y
M'L95#FJ7[)O]/U/JN&J/M,0G?X(REZ_9_P#;K_(_52OM#]<"@ H * "@ H *
M "@#XG_;8T/[1I^GW^_'DW$D.S'WO/3?NW9XV^3C&#G=G(V\_/9S"\8R[-K[
MU?\ 0^$XLHWA"=]I.-O\2O\ ^V?B?G17RA^:!0 4 % !0 4 % !0 4 % !0
M4 % '[WU^F']#!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M3_ _1ZOK#]-"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M#-)3Q%W]F$FO72/Y29^IE?9GZT% !0 4 % !0 4 % !0!\$?MP?\PG_M\_\
M:%?,YU]G_M[_ -M/SSBW_EW_ -Q/_;#X'KYD_/ H * "@ H * "@ H * "@
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MR2268L[,Q^&K5I5I<TM_ZT/QO%XN>+FYS=V_N2[+R_X=ZG(5@<04 % !0 4
M% !0 4 % !0![I\-?V>=:^*%JU[:^3#;AMJ27#.@E(R&\L*CDA2,%B N[*@D
MJX7TL/@)UU=62\[Z_<F?08#)*N-CSQLE?1R;5^]K)[=_ET=N)^(/PSU/X8W
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M\K'[GEDE*A3MK^[@M.ZBD_N:LST:NL],* "@ H * "@ H * "@ H * "@ H
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MA'[J% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % 'YI?MD^$5TC6+?4D"A;Z$A_F8L98-JEB#P!L:)5VGDJQ*@\M\CF
M]+EFI?S+\5_P+'Y;Q3AO9U547VXZ[WO&RO\ <TM.S^?Q[7@GQ84 % !0 4 %
M !0 4 % !0 4 % 'Z+_L3ZY]HT_4+#9CR;B.;?G[WGILV[<<;?)SG)SNQ@;>
M?J\FG>,H]FG]ZM^A^E\)UKPG"VTE*_\ B5O_ &S\3[8KZ$^["@ H * "@ H
M* "@ H * "@ H * "@ H _"CQ!K4GB2\N+Z8*)+F:29PH(4-(Q<A023C)XR2
M<=S7YO4GSMR?5M_?J?S_ %ZKK2<WO*3;MM=NYCUF8A0 4 % !0 4 % !0 4
M% !0 4 ?JY^R=HL>E^%H)D+%KJ:>:0$C 8.80%P!@;8E/.3N+'., ?:Y7#EI
M)]VW^-OT/U[ANDH8=-?:E)OUOR_E%'TG7KGU 4 % !0 4 % !0 4 % 'P1^W
M!_S"?^WS_P!H5\SG7V?^WO\ VT_/.+?^7?\ W$_]L/@>OF3\\"@ H * "@ H
M * "@ H * "@ H _;'X4_P#(OZ5_UX6G_HE*_0L+_#C_ (8_DC]UR[^!3_Z]
MP_\ 24=]74>B% !0 4 % !0 4 % !0 4 ?!'[<'_ #"?^WS_ -H5\SG7V?\
MM[_VT_/.+?\ EW_W$_\ ;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%
M/_(OZ5_UX6G_ *)2OT+"_P ./^&/Y(_=<N_@4_\ KW#_ -)1WU=1Z(4 % !0
M 4 % !0 4 % !0 4 ?@A7YF?SR% !0 4 % !0 4 % !0 4 % !0!^V/PI_Y%
M_2O^O"T_]$I7Z%A?X<?\,?R1^ZY=_ I_]>X?^DH] 6NH]$=0 4 >??%;_D7]
M5_Z\+O\ ]$O7+BOX<O\ #+\F>=F/\"I_U[G_ .DL_$VOST_"@H * "@ H *
M"@ H * "@ H * "@#ZZ_8P_Y&"Y_Z\)/_1T%>[D_\1_X7^<3[+A7^/+_ *]O
M_P!*@?IK7UY^J!0 4 % !0 4 % !0 4 % !0!@>*]<_X1C3[J_V>9]FMY9MF
M=N[RT+[=V#C.,9P<=<&LJL_9Q<NR;^Y7.?$UO8PE.U^6,I6VV3?GV/POK\X/
MP$* "@ H * "@ H * "@ H * "@ H _=#PIH?_",:?:V&_S/LUO%#OQMW>6@
M3=MR<9QG&3CIDU^CTH>SBH]DE]RL?OV&H^QA&%[\L8QOMLDO/L;]:G0% !0
M4 % !0 4 % !0!^*WQ=T!O#/B#4;4Q+"JW4K1QKM"K%(WF1;0O &QE(48VCY
M2 00/S[%T_9U)+;5Z>3U7X'X9F='V-:<;6]]V2M:S=UMY-:=#SFN0\P* "@
MH * "@ H * "@ H * "@#]5/V2-<_M;PQ'#LV_9+B:'.<[]Q$^[&!M_UNW'/
MW<YYP/M,JGS4[=FU^OZGZYPU6]IATK?!*4?7[7_MUOD?3=>P?5!0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M5Z1(4 % !0 4 % !0 4 % !0!]L_LY?M&_V!Y>BZU)_HO"6URY_U/81R$_\
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M%&$[W;BKNUO>6CZ+JGY=M#OJZCT0H * "@ H * "@ H * "@ H * "@ H *
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M_(OZ5_UX6G_HE*_0L+_#C_AC^2/W7+OX%/\ Z]P_])1WU=1Z(4 % !0 4 %
M!0 4 % !0!\$?MP?\PG_ +?/_:%?,YU]G_M[_P!M/SSBW_EW_P!Q/_;#X'KY
MD_/ H * "@ H * "@ H * "@ H * /VQ^%/_ "+^E?\ 7A:?^B4K]"PO\./^
M&/Y(_=<N_@4_^O</_24=]74>B% !0 4 % !0 4 % !0 4 % 'X(5^9G\\A0
M4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_ $2E?H6%_AQ_PQ_)'[KE
MW\"G_P!>X?\ I*/0%KJ/1'4 % 'GWQ6_Y%_5?^O"[_\ 1+URXK^'+_#+\F>=
MF/\  J?]>Y_^DL_$VOST_"@H * "@ H * "@ H * "@ H * "@#ZZ_8P_P"1
M@N?^O"3_ -'05[N3_P 1_P"%_G$^RX5_CR_Z]O\ ]*@?IK7UY^J!0 4 % !0
M 4 % !0 4 % !0!^=/[9_C'[;?6FD1ME+>,S2A9,CS)>$5XQP'1%W*6R=LW
M .6^4SBM>2AV5WKU?EZ?F?FG%6*YIQI+[*YGKU>UUW25UY2^_P")J^>/A H
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M)_[?/_:%?,YU]G_M[_VT_/.+?^7?_<3_ -L/@>OF3\\"@ H * "@ H * "@
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MP2-V<8&!7Y]B:WMIN7=_@M%WZ(_#,PQ?UNK*IMS/3T2275ZV2OYG URGG!0
M4 % !0 4 % !0 4 % !0!8M+22_D2&%&DDD8*B*"S,S' 50.22> !R3Q32OH
MBHQ<G9:MNR2U=S]H?A1X!C^&FCV^G+M,BKNG=<?/,_+MG:I8 _*A8;A&J*>E
M?H&%H>P@H_?Z]>WR\C]QRW!+!THPZI7D^\GOT5^ROK9(]&KK/3"@ H * "@
MH * "@ H * *]W:1W\;PS(LD<BE71@&5E88*L#P01P0>".*35]&3**DK/5-6
M:>JL?B?\2/"+>!-8O--(8+!,PCW,K,8C\T3,5XRR%6. ,$X*J<@?GF(I>RFX
M]G^'3\#\*Q^&^JU94_Y9.U[-VW3T[IIG$5SG % !0 4 % !0 4 % !0 4 %
M!0!^JG[)_C'_ (2;P\EM(VZ:QD:$[I-[F,_/$Q!Y1 &,2#D8B.#@;5^TRNMS
MT[=8NV]]-U_DO0_7.&\5[:ARO>#<=[NVZ]%K9>FG9?3=>P?5!0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0!YE\5/BI8_">Q-U='?*^5M[=3AY7'8==J#(+N00H(X9V1&X\5BHX>
M-WOT7?\ KJSRLQS&&!AS2U;^&/5O_+N^GK9/\==?U^Z\474M[>RM-<3-NDD;
MJ3T' X  P%4 *J@*   *^#J5'4=WJV?BE:M*O)SF[MO5O^ON739&/69B% !0
M 4 % !0 4 % !0 4 % 'Z'_LD_"!M+C/B"^1EEE4I:1NB\1,%)G!.6!?E$/R
M?N]Q^=)5(^JRK"<O[R6[V]._]=/4_2>&LLY%[>:U:M%-+9V][OKLMM+[IH^X
M*^B/O0H * "@ H * "@#RKXO_"VU^*NFO;2JOVJ-7:TF)VF.4CC+ ,?+8@"1
M<'*\@;U1EXL7AEB(V>_1^?\ EW/(S/+HXZFXOXDGRO:S^YZ/JOU2/QUU72YM
M$N);6X79-!(\<BY!VNC%6&02#@@C()![$BO@Y1<&T]T[/Y'XI4ING)QEHXMI
MKS3L]C/J#,* "@ H * "@ H * "@ H * /JK]G+X\S> KB/2KYM^F3R!59F
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MA7S.=?9_[>_]M/SSBW_EW_W$_P#;#X'KYD_/ H * "@ H * "@ H * "@ H
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M!!%?=4ZBJ*ZU3/V>C6C7BIP=TUHU_7WKILS7K0V"@ H * "@ H * "@ H *
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MN9^B7D?B&8X^6.J<\M-+)+HM=//?5_DM#SFN0\P* "@ H * "@ H * "@ H
M* /5?@S\-6^*FL1V!9D@"M+<2+MW+$F =H8]68J@(#;2V\JRJ17;@\/]8GR]
M-WZ?UH>OE6 ^O55#96;DU:]EZ]VTNMKWL['[)6EI'81I#"BQQQJ%1% 5551@
M*H'  '  X XK[Y*VB/VV,5%66B2LDM%8L4R@H * "@ H * "@ H ^+OVLOA
MNMVIU^R11<6R_P"EA48O-%\H5_ER,Q#)8D#]UDEP(E4_/YIA.9>T6ZW\U_P/
MRZZ'P_$F6>TC[:"UBO>LG=K17T[=?+=Z)'YPU\F?F(4 % !0 4 % !0 4 %
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MW!_S"?\ M\_]H5\SG7V?^WO_ &T_/.+?^7?_ '$_]L/@>OF3\\"@ H * "@
MH * "@ H * "@ H _;'X4_\ (OZ5_P!>%I_Z)2OT+"_PX_X8_DC]UR[^!3_Z
M]P_])1WU=1Z(4 % !0 4 % !0 4 % !0 4 ?@A7YF?SR% !0 4 % !0 4 %
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MO)>?Y>NWPF>Y[[*]*D_>VE)=/)>?=]/7;\Z*^4/S0* "@ H * "@ H * "@
MH * "@#8T#0+KQ1=165E$TUQ,VV.->I/4\G@ #)9B0JJ"Q( )K2G3=1V6K9M
M1HRKR4(*[;T2_K[WTW9^U/@+P?#X!TRVTR [DMXPI;D;W)+2/@LQ&YRS;<D+
MG:. *_0:%)48J*Z+_A_Q/W/!X586G&FOLK?N]V]WNVW;H==6YVA0 4 % !0
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MGH^OW[=#]2P.;T<9I%VE_++277Y/17T;LM['KM=Q[(4 % !0 4 % !0 4 %
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M?^B4K]"PO\./^&/Y(_=<N_@4_P#KW#_TE'?5U'HA0 4 % !0 4 % !0 4 %
M!0!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % '[8_"G_ )%_2O\ KPM/_1*5
M^A87^''_  Q_)'[KEW\"G_U[A_Z2CT!:ZCT1U !0!Y]\5O\ D7]5_P"O"[_]
M$O7+BOX<O\,OR9YV8_P*G_7N?_I+/Q-K\]/PH* "@ H * "@ H * "@ H *
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M# '#*K9 ^!K4G2DXO='XGBL-+"S=.6\7TU6UT_FG?\SF*Q.0* "@ H * "@
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MU=RO2)"@ H * "@ H * "@ H * "@#8T#0+KQ1=165E$TUQ,VV.->I/4\G@
M#)9B0JJ"Q( )K2G3=1V6K9M1HRKR4(*[;T2_K[WTW9^U/@+P?#X!TRVTR [D
MMXPI;D;W)+2/@LQ&YRS;<D+G:. *_0:%)48J*Z+_ (?\3]SP>%6%IQIK[*W[
MO=O=[MMVZ'75N=H4 % !0 4 % !0 4 % !0 4 % 'P1^W!_S"?\ M\_]H5\S
MG7V?^WO_ &T_/.+?^7?_ '$_]L/@>OF3\\"@ H * "@ H * "@ H * "@ H
M_;'X4_\ (OZ5_P!>%I_Z)2OT+"_PX_X8_DC]UR[^!3_Z]P_])1WU=1Z(4 %
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MO_\ P+F_^+H^M5/YI?\ @3_S#^T:_P#S\G_X'+_,/^%K>(/^@K?_ /@7-_\
M%T?6JG\TO_ G_F']HU_^?D__  .7^8?\+6\0?]!6_P#_  +F_P#BZ/K53^:7
M_@3_ ,P_M&O_ ,_)_P#@<O\ ,X&N4\X* "@ H * "@ H * "@ H * "@ H *
M "@#ZC_9]_9]D^),BZAJ"M'I<;<#E6N64X*(>HC!XDD'.<QH=^YHO9P& ]O[
MTOA_/_@=W\EY?69+DKQCYYZ4T_1R?9>7=_):W:_4ROLS]:"@ H * "@ H *
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M/B#+/K4.>"O."V25VKZKOINOFDKL_+*OC#\E"@ H * "@ H * "@ H * "@
MH _3W]E#XI-XPTUM+NF7[58*BQ\*I>V "IP#EC&1L=@H 4Q9+.S$_8Y7B?:1
MY7O&UO3_ ('^1^K<.9C]8I^SE\5-*VRO#9==;;-V[;MGUE7MGV 4 % !0 4
M% !0 4 % !0!0U72X=;MY;6X7?#/&\<BY(W(ZE6&001D$C((([$&IE%333V:
ML_F9U*:J1<9:J2::\FK/8_)/XW?!&Z^$=UN7=-ITS$03D<@]?*EQP) ,X/"R
M*"R@$.B?#XW!/#OO%[/]'Y_G^7X[FV4RP$N\&_=E^C\_SW75+PNO-/GPH *
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MY%_2O^O"T_\ 1*5^A87^''_#'\D?NN7?P*?_ %[A_P"DH[ZNH]$* "@ H *
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MHB@*JJHP%4#@ #@ < <5]<E;1'ZE&*BK+1)626BL6*904 % !0 4 % !0 4
M% !0 4 % !0 4 % !0!R/CCP/8_$2QDL+^/?$_*L.'C<9VR1M@[7&3@\@@E6
M#(S*<*U&-:/++;^M3BQ>$ABX.$U=/[T^Z\_^&>A^-OCCP/??#N^DL+^/9*G*
ML.4D0YVR1M@;D.#@\$$%6"NK*/@:U&5&7++?^M3\3Q>$GA)N$U9K[FNZ\O\
MAGJ<A6!Q!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M'Y#GF5?4IWBGR2V\GK[M_P 5?==[-GSG7E'S(4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^B_[.7[.7]@>7
MK6M1_P"E</;6SC_4]Q)(#_RU[HA_U7WC^]P(OJ\OR_D]^>_1=O-^?Y>NWZ7D
M61>RM5JKWMXQ?3S?GV73UV^V*^A/NPH * "@ H * "@ H * "@ H * "@ H
M^"/VX/\ F$_]OG_M"OF<Z^S_ -O?^VGYYQ;_ ,N_^XG_ +8? ]?,GYX% !0
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M ->%W_Z)>N7%?PY?X9?DSSLQ_@5/^O<__26?B;7YZ?A04 % !0 4 % !0 4
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M5G:_39^:NG\O0YBL3D"@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MMT??^NJ/Q3,<NG@9\LM4_AET:_S[KIZ6;\QKC/*"@ H * "@ H * "@ H *
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M,OR9YV8_P*G_ %[G_P"DL_$VOST_"@H * "@ H * "@ H * "@ H * "@ H
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M0PPP&&4@J>#C<J,O)B,-'$*TODUN>9C\NIXZ/+/H]&M&O31[]5^J1^8?Q4^
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M^AAHT%:*]7U?]?<?J>"P%/!1Y::M>UWNW96U?Z*RU=DKG?5U'HA0 4 % !0
M4 % !0 4 % 'P_\ MF^.UM+6VT2)F$DS"XFPS*/*3<L:L,;7#/EL;OE:%25Y
M4CYW.*]DH+KJ_3I^/Y'P7%6,Y8QHK=OF>K6BNDO.[UWTY=MC\\*^5/S8* "@
M H * "@ H * "@ H * "@#])OV1_A6WART;7+D8FO8PL"$.K)!NR2V< ^:51
MUX.$5&5R)&4?6Y5A>1<[WDM-]O\ @_EZGZAPUEWL8^VEO-6BM5:-_P!;)K39
M)IZGV37OGVP4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\3_MC_  [_ +2M
M(==A'[RUQ#<<]87;]VW+ ?)(VW"J6;S<D[8Z^>S?#\R4UTT?ITZ]_P _(^$X
MHP//%5EO'W9?X6].O1NVBN[]D?G17RA^:!0 4 % !0 4 % !0 4 % !0!H:5
MJDVB7$5U;MLF@D22-L [71@RG!!!P0#@@@]P15QDX--;IW7R-*=1TY*4='%I
MI^:=UN?M#\,_B#;_ !.TR+4K<;-^5DB+*S12*<,C$?@RDA2R,C%5W8'W^&KJ
MO%27S79_U^!^XX#&QQM-5(Z7W5T[-;K3[UMHT[*YWU=1Z(4 % !0 4 % !0
M4 % !0 4 <CXX\#V/Q$L9+"_CWQ/RK#AXW&=LD;8.UQDX/(()5@R,RG"M1C6
MCRRV_K4XL7A(8N#A-73^]/NO/_AGH?E'\6O@CJ7PCD4W&V:TE9EBN(P=I()P
MK@_<D*C=MRRD9VN^Q]OQ6*P4L/OJGLU_6C/R',LIJ8!^]K%MVDMO1]G;6WW-
MV9XU7GGB!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MP/URLHOX5[TO\*^:>KLM-5>_0_8JTM(["-(846..-0J(H"JJJ,!5 X  X '
M'%?>I6T1^UQBHJRT25DEHK%BF4% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M 4-5TN'6[>6UN%WPSQO'(N2-R.I5AD$$9!(R"".Q!J914TT]FK/YF=2FJD7&
M6JDFFO)JSV/Q&\:>&)/!FI76G2[BUM,\89D*%U!^1]I)P'7#KR058$$C!/YW
M6I^RDXOHVNWS/PC%X=X>I*#^S)K56NNCMYK5',5B<@4 % !0 4 % !0 4 %
M!0 4 ?9/[''CAM+U.;2)),0W<9DB0[S^_B&3MP=J[H]Y<D#=Y<8W9 5O?RBM
MRR<'M)76^Z_X'Y(^WX7Q?)4=)O2:NEK\2_!75[][+4_2:OK3]/"@ H * "@
MH * "@ H * "@ H KW=I'?QO#,BR1R*5=& 965A@JP/!!'!!X(XI-7T9,HJ2
ML]4U9IZJQ\(?%O\ 9$^]=^&_]@&Q=OP9HYI'_P!UBDA_OD2?<CKYK%Y3UI^7
MN_\ !;_/[^A^?9GPS]JAY>XW][4I/\'YZ[(^%]4TJXT29K>ZBD@F3&Z.1&1U
MR 1E6 (R"",CD$'H:^<E%P=FK/L]#X"I3E3?+)--=&FGWV9GU!F% !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '3^$?!M_X[NA9Z; T\
MY5FV@@ *O5F9B%4=!EB 6*J/F8 [4J,JKM%79UX;"SQ4N2FKNU^FR\W9+Y^A
M^A_PD_92L?"6VZUGR[V[&\>5C?:J#P#M= 9'QDY<!06X3<BR'ZK"97&GK/WG
MKIO'\5K_ %IU/TG+.'(4/>JVG+73>'W-:OUTUVNDSZYKW#[(* "@ H * "@
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M?^B4K]"PO\./^&/Y(_=<N_@4_P#KW#_TE'?5U'HA0 4 % !0 4 % !0 4 %
M!0!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % '[8_"G_ )%_2O\ KPM/_1*5
M^A87^''_  Q_)'[KEW\"G_U[A_Z2CT!:ZCT1U !0!Y]\5O\ D7]5_P"O"[_]
M$O7+BOX<O\,OR9YV8_P*G_7N?_I+/Q-K\]/PH* "@ H * "@ H * "@ H *
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MVOV5EOH>FUV'JA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 9&OZ!:^*+66RO8EFMYEVR1MT(ZCD<@@X*L"&5@&!! -9U*
M:J*SU3,:U&->+A-736J?]?<^FZ/B;Q]^QDMQ)YNA7*QJS<P7)8J@)8G9*BLV
M!\JJCJS8RQE)XKYZOD]]8/Y/_-?UYGPF-X5N[T96U^&5[+?9I-]DDT^[9\;^
M+OAOK'@1B-2LYH%#*OF%<Q%F7<%65<QL<9.%8D88'E2!X%7#SI?$FO/I]^Q\
M3B<!5PO\2+6MKVTNU?=73^3.(KG. * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@#0TO2KC6YEM[6*2>9\[8XT9W; ).%4$G !)P. ">@JXQ<W9*[[+4
MTITY5'RQ3;?1)M]]D?47A']C[7=:8-J#PV$>Y@P+":7 7(94C.P@GY>9%888
M[3@!O8I93.7Q6C^+_#3\3ZS#<,5JGQM05^_,]M[1T_\ )E_G]D^ ?V=/#_P]
MD\^&%KFX#;DFN2LC)@J1L4*J*5*[E<+Y@)(WX.*]^AE].CJE=]WK_P #Y[GV
M^"R.CA'=+F=]'*S:VVT26VCM?S/=*](]\* "@ H * "@ H * "@ H * "@ H
M R/$&M1^&[.XOI@QCMH9)G"@%BL:ER%!(&<#C) SW%9U)\B<GT3?W:F->JJ,
M7-[1BV[;V2N?A?=W<E_(\TSM))(Q9W8EF9F.2S$\DD\DGDGFOSAN^K/P&4G)
MW>K;NV]7<KTB0H * "@ H * "@ H * "@ H _7/]G+X;?\*ZT./SDVWEWB>X
MRN&7</W<1RJN-B_>1L[96EP<&ON<OP_L8:[O5_HMEM^=S]ER+ ?5**NO>G[T
MN_DMD]%T>S;/?*],^A"@ H * "@ H * "@ H * "@ H * "@ H * "@ H _.
M']LGP(NEW]OK,*MMO%,<YVL5$L04(2Y) +I\JH O$+-\Q+$?)YO0Y9*:^UH_
M5?\  _(_,N*<'R355?;5I:.UTE;7S733X6^Y\75\^?#!0 4 % !0 4 % !0
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MP_\ 24=]74>B% !0 4 % !0 4 % !0 4 ?!'[<'_ #"?^WS_ -H5\SG7V?\
MM[_VT_/.+?\ EW_W$_\ ;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%
M/_(OZ5_UX6G_ *)2OT+"_P ./^&/Y(_=<N_@4_\ KW#_ -)1WU=1Z(4 % !0
M 4 % !0 4 % !0 4 ?@A7YF?SR% !0 4 % !0 4 % !0 4 % !0!^V/PI_Y%
M_2O^O"T_]$I7Z%A?X<?\,?R1^ZY=_ I_]>X?^DH] 6NH]$=0 4 >??%;_D7]
M5_Z\+O\ ]$O7+BOX<O\ #+\F>=F/\"I_U[G_ .DL_$VOST_"@H * "@ H *
M"@ H * "@ H * -_0_"FH>)]_P!@M;BY\O&_R8GDV[L[=VP'&<'&>N#Z5K"E
M*I\*;MV3?Y'31PTZU^2,I6WY8M[^B?8W_P#A5/B#_H%7_P#X"3?_ !%:_5:G
M\LO_  %_Y'1_9U?_ )]S_P# )?Y!_P *I\0?] J__P# 2;_XBCZK4_EE_P"
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M_P"&8?%W_0/_ /)BV_\ CM5_9M7^7\8_YFO^K^)_D_\ )X?_ "0?\,P^+O\
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MG;'&BHBY))PJ@ 9)).!R23U->G&*@K)679:'T5.G&FN6*22Z))+OLB_5&@4
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M(8UC4L0 6(0 9P ,]< #M7K0IJ&D4EZ*WY'U%*A&BK02BKWM%)*_R->M#8*
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M_P#_  $F_P#B*/JM3^67_@+_ ,@_LZO_ ,^Y_P#@$O\ (/\ A5/B#_H%7_\
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M7_\ X"3?_$4?5:G\LO\ P%_Y!_9U?_GW/_P"7^0?\*I\0?\ 0*O_ /P$F_\
MB*/JM3^67_@+_P @_LZO_P ^Y_\ @$O\@_X53X@_Z!5__P" DW_Q%'U6I_++
M_P !?^0?V=7_ .?<_P#P"7^0?\*I\0?] J__ / 2;_XBCZK4_EE_X"_\@_LZ
MO_S[G_X!+_(/^%4^(/\ H%7_ /X"3?\ Q%'U6I_++_P%_P"0?V=7_P"?<_\
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MZMSM"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M!_PQAX?_ .?F_P#^_D/_ ,8H_L>GWE]Z_P#D0_U5H?S3^^/_ ,@'_#&'A_\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M'_\ GYO_ /OY#_\ &*/['I]Y?>O_ )$/]5:'\T_OC_\ (!_PQAX?_P"?F_\
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M  QAX?\ ^?F__P"_D/\ \8H_L>GWE]Z_^1#_ %5H?S3^^/\ \@'_  QAX?\
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M=]74>B% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 .6
M@!U !0 F* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H
M ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4
M &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &*
M #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #%
M !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B
M@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q
M0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8
MH ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,
M4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &
M* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #
M% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !
MB@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@
MQ0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0
M8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H
M,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4
M&* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &*
*#% !C% "T ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>dxcm-20230630_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dxcm-20230630_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMMJ$MLQFBU"38=\3*W&X\9P:_?FOQ*_X)/\ _*>_XG_]AGQI_P"E[T"/7O\
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M;G[.G[&GC/XQ>"K?4/!WB#1---QH%S=>*9ITOKL$!+0Q7#L'\PG8-F&!8-G
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M"_!6Q;_@J5_P7QUOXL7B_;_ OPJO3<63'YH7M],D\BR53T(FO2;G:>JF3CT
ML?HI^VS_ ,%)O@'^P+\+]'\;?'F/4%US7X-VD^#-)$<]_/(%4R#)98UCC+!6
ME+!<GY=Q(%?-WP-_X.0/V7OB!\0M.\#_ !D^$7BGX=6NL,BZ?X@U26.YLE#G
M"R3%0CQQD\>8JNHZL0H+#Y"_X+$Z[\0_%G_!;C0?#MA\.8/&MQHK>&[;POX.
MU.8);:L"$N1:,7(79+/+(C9(!R0:](_X*(^#O^"M/_!1/X6:/\./'?\ P2\T
M_0+G0=86^TO7M,\16DES GE/');KOGXC?<A9>F8D/\(H'9'Z,?M\_MU> _V
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M]L=M;Q(7DD8]@JJ2?I7YO>,/^#FGX!6VOZC!\+?V8O''B;1=-8^;K;SPVBE
M2/-\O$A1#C(WE3CJ%.0/NC]L7XA_ ?X4_LR>,OB!^TWHMMJ?@73M)+:_I=U9
M)<K?(SJD=N(GPKO)*T:*&(&YER1U'YU?LI?M>?ME_%[X:ZIX8_X)+_\ !+GP
M9X+^'=_J]P)]=\5ZL'M9IV"I+*5:2 2,%"J43SE3&W! Q0"/M[_@G]_P4B^
M?_!17P/JGB;X00ZGINIZ!-#%X@\.ZW"BW-F90QBD#1LR21OY<@5@<_(=RJ<
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MJ;XS_9\^*MRFGZMJ&CZKX8M3=L$,FI6U]#)Y63W=+>;;_>(4#)(H$C[G\?\
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M:OX4\,Z;-<>,+.[N_%=Z;9'?4;C[5/$T<Q(^=8U01!#P G3).?A+]BO1]+^
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M_:3T!7BOO"7Q(U[2Y[JWX>..[N'FCD)'0)+9@ ]C-[U[-^P_\2+_ /X*:_\
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MSR/[6SB;.['[WROLWE]?DSM[XK[E_P""BW[1/Q>L_P!@/X&_L'^");B?XO\
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M_ ?XNV\R6MQ(MSI>J6@'VC2[U PCN8B>,@,RE3PR.RGKFO6** /Q@;_@CO\
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M \>>$VF.@ZCJ",;6[@EVF2UN#&"ZJ61&60*Q0AOE(<U]?T4!=GY%^.?V!/\
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MNA^-_"EQ-<>%M5OD8V\BRJHFM9]@++')Y<9WJ&*-&" 064_6%% 7/R9\(_\
M!-;_ (+8?&SX/C]D[]IO]J+2M'^%VEV @6QM;VWN;W5(X5S;VOGQP"5H=ZH"
M9Y/E4 [)-H6OHK_@B;_P3W^//_!/OX:^.?"?QWN] FNO$6N6MWIYT#49+A!'
M'"R-O+QI@Y(P #7VY10%PK\_/^"HO_!$'3?VQ?B)_P -+?LX>/K7P7\2#Y3:
MB+WS$LM4EB $5P9(09+:X4*H\Q5<,$7*A@7/Z!T4"V/QTUG]A/\ X.,_'&@?
M\*B\3?M.2#0G7[/-?O\ $!4\V+&T^9-#']JD4CJ&R2,Y!S7TQ_P2H_X(GZ5^
MP%XWE^/'Q)^+#>)O'-QI<MC';Z3 T.FV$4I4R8+_ +RX<[  [", $_(3AA]Y
MT4#N?G?\'O\ @ES^TKX%_P""S6L?M[:W?>&#X'OM8U:Z@B@U21K_ &7-A+!'
MF(Q!0=[C/S\#)YZ5]E?M9?LQ_#K]L3X >(OV>?BC'*-+U^U55N[;'G65PCB2
M&XC)XWI(JM@\, 5.0Q%>C44"/R!\!_\ !-#_ (+H_L2V6J?!G]CK]I/0KKP1
MJ5U))%-%>VT?E[^#((;Z!VM)".6^SNW(!W$C-?2__!)S_@D%<_L.>(=7_:#^
M/GCJV\6_%+Q#!)#->6LDDMOIL4KB2;9+, \\\K %YF53C*@89F?[GHH'<_+;
MXD?\$HO^"B7[)O[6>N_M0_\ !-/XU:5>V7B,S+<^'O%=]F>W@ED$K6C?:%>*
M>%' */O210 .<%F/AM_P29_;W_:X_;#\-?M:?\%/?B/X:6V\)O:FQ\.>'3&\
MMS';3-/#:XA18HH#*[,[EWD8,R\9#+^I-% 7/S[_ ."FW_!*/]HCXX?M%Z)^
MVS^Q1\:HM \>:,]M-+H^MWTB6S7%NH2*YMFVR(CE J/$Z>7(!DGE@WCGQE_X
M)W_\%K/^"C,OA[X:_ML_$SP+X<\&:)J:WLLFG+;R2-+L:,SI%:H3+*$=P%>2
M-/G/2OUGHH"YS/P9^%'A3X$_"3PU\&/ T4J:/X5T.VTO3?/?=(T4$:QJSD ;
MG.W+' R237E?_!3G]FSXA_M>?L.>./V=_A3-IT>O^(ETX:>^K7+0VX\C4K6Y
M?>ZJQ'[N%\84Y.!QG->]44"/S^\ ?\$K/C%%_P $8M9_X)_^/KOP]_PFLUQ=
M7VE75K?R/91W0U 7=OF4Q!E!"[&(0X#MUI?^",7_  2M^,7[ VB?$K6/CG=^
M'KCQ!XNM[2RTEM#OY+A(+6)9F?<SQH07DE3(P>(@:_0"B@=S\\O^",/_  2O
M^/W[#2?%32_VD+GPW<V/CK2M/LK5/#VJRSL4B^UB8.6BCV96=<$9[],5XG\"
MO^"6'_!7W_@G?\9?%-I^PY\2/!-_X7\4F."35M<N(@KP1,YMY;BWEC+)/&))
M!^Z\Q?G;[P.!^O-% 7/RN^!7_!'']NWX*?\ !2'P=^VAXQ^,/ACQ\4U0:CXW
MUB[O);2ZEGN8)8+Q88?**LD:2GR^4#!5&V,?*/0?V@O^"7/[2WQ._P""Q'AG
M]NOPW?>&%\$Z1K&B75U%<ZK(M\4M(8TEVQ"(J3E3CYQGVK]$** N<!^U1IWP
M2UG]G/QGHO[2&HP6?@6^T">V\3WEPQ5;>UD78TFX E&4L&# ?*P![5^2O[)?
M_!.']MKPWXG\2V'_  3 _P""G7@'4?A]J-XB:QJNA^)9#<VZ,&\MKFS2"58;
MG8&"LKJ6V\.HX'[)?$#P%X1^*7@;6/AKX_T.'4]#U[39K#5M/GSLN+>5"DB$
M@@C*L>001U!!K\U=6_X-K;/PIXJU#5OV:_V]O&7@33M0)62Q.BFYF,621&\]
MO=VOF*,G&Y/UYH!'S%^PK\![7X&_\'!>B_!CP[XYO?%B^%]7U1=4\27SAIKR
MZ&@W#7<TA!;:3<O(,%F()"EF()/V=^U3_P $N/VEOC+_ ,%<_!/[;WA&^\,+
MX,\/ZQX?NK^*\U21+TI92(TVR(1%2<*=OSC/M7JO_!.?_@CQ\"O^">_B/4/B
M?8>,=4\9^.-2LWM)?$>KP)"EM [!I%@@4ML9RJ[G9W8@8!4%@WUW0#>I^=__
M  5V_P""7/[2O[<'[47P[^,/P8OO#$6D^%M'AMM376]4D@F+K>O.=BI$X8;&
M'4CFOI;_ (*<_LV_$/\ :\_8<\<_L[_"F?3H]?\ $2Z<-/?5KEH;<>1J5K<O
MO=58CY(7QA3DX'&<U[U10%SYH_X)+?LD_%/]B?\ 8WTWX#_&.XTF76[36[^[
ME?1;MIX/+FEW)AV1#G'48KZ7HHH$?*?_  5^\&?M=_&/]EMOV>/V0?AW-JVH
M>.M133O%&KC5+:UBTO2<@S;C-(K-YIVQD(&/E^<,9*YZ3Q!_P3Y\#I_P3=O?
M^">_@;4DL+)_!+:3::K)#PU__K?MDJKUWW7[UP/[S =J^B** /QDO/\ @G'_
M ,%7OCS^S_\ #3_@FS\4_@AX>\,> OA[XLGO[CXD)XDMK@7,#R7!5EA24R.4
M2ZG"+Y:ELQA_+PS']D="T:P\.:)9^'M*C*6MA:QV]LA.2L:*%49^@%6J* "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\
MP+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8H
MH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A
M!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$
M'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^
M;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GY
MO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "
MVK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+
M:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'
M_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!]
M(_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'T
MC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W
M_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;
MW_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MB
MB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C
M_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_
M^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_
MY^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_
M )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P
M+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\
MP+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8H
MH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A
M!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$
M'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^
M;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GY
MO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "
MVK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+
M:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'
M_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!]
M(_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'T
MC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W
M_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;
MW_P+:M#3=.@TJU%I;O(RAB<RN6//N:L44 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 454U_6K#PWH5[XBU1V6VL+22YN65<D1HI9B!WX!K\Q]
M:_:]_;]_:=\;^%OBM\(]2L- TRY\4:G8^"O#MJP/VF:WLO/DCN 01<$Q,JC?
MA?,;*JF-P^<S_B;"</\ LXSA*I.H](P5W:\4WT6\DEW;27=>#G7$&&R3V<9P
ME.<]HQ5W:Z3?_DR2[MI>GZAT5X#\.?VLOB7IG[%^K_M$?M#_  :U+PYXA\-6
M5P=0T.YLY+3[=)&JF*2-906C20NJG.=K!^H%?-4'[8'_  5#U+X%2_ML64'@
ME? L=PT@T V0,C6ZW'D-(!GS"@<%2?-#\%@N.:Y\;QAEF"A3ER5)N<'4M&#;
MC!;RFG:R3T?7R,<7Q1E^$A!\DY.4/:6C%MQ@MY23M9+9]3]$Z*^;/&O[0?[5
M7QI_92\$?&_]BOX=V%YK?B&99-7TO5;BWV6L*I*DH5IY8@V)T"@@Y*\[1SCY
MR^-7[:__  5@_9XCTIOB_P##[PEI4FN79MM(MHDM+N>[E&,A(K>[D<@;E&=N
M,LHSE@#&8\9Y=EL%5G1JRIN,9>TC3;A:237O:+JOGH1C^*\#@(*I*E5E3:C+
MGC!N%I6M[VBZKYZ'Z045Y-J7[2&E?L^_LZ:#\3/VO->LM"UN?2H3JEC;)N>:
M_,>Y[>")"Q=@<C )4=2P'-> ?L _M_\ Q<_:Y_:[\7>%]::*R\'0^&KG4-!T
M0V<0FMMEU:11EY0-SL4D<L,E<OQP!7=B.)LJPN-P^#G)^UK6M'[4;J]YJ_N]
MN]]D[.W97X@RW#XNAA9M^TJVM'JKJ]Y*_N]N]]EN?;%%%?*'[67[3G[7,_[1
MEA^RM^R+X"MH+^2P%UJ/BK7K%C;*2GF%8W<>7M1"NYL.2S[ H*_-VYKFN'RC
M#*M5C*5VHJ,5S2E)[)+OZM(Z\RS*AE>'56HI2NU%**O)M[)+_ACZOHKY&_8I
M_;1^/7B?]H?Q#^Q[^U9H.FKXLT6V>>VU;2(PB3! C%'53M.Z.19%=0O (*Y(
MKZYI91F^$SK"?6*%TDW%J2M*,HNSBUT:%EF9X;-L-[:C=6;BTU9QDMTUW045
M^9&H_P#!57]IWPC^U=?>#O$^OZ8_@O2OB))IFHH-&B5DL%O7C(\T#(81(Q![
ME2?6OIO_ (*?_M;_ !"_98^&?AO_ (5#=V\7B7Q'KQ@MOM-FLX-M'&3+M1N"
MV]X!_P "->%AN.<DQ67XK&1YE'#M*2:5]7965];O1:K4\:AQAE&(P.(Q4>91
MH.TDTKZNRMKK=Z+5'TY17S'_ ,$MOVG_ (M_M3_!_P 0^,?C!JMI=WVG>)39
MVKVEBD"B+[/$^"$&"=SMS7TY7T&4YGA\YRZGC:"?)-75]'O;75_F>YEN84,U
MP,,71ORS5U??MKN%%%%>B=P4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P"]>^]WW9^.?B/X8_\ "QT_:BO[>W\RZ\,>*EUFV '(":I=12G\(9I6_P"
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+_P9#_,^B:*^=O\ AZ_^P%_T7O\ \M;5?_D6C_AZ_P#L!?\ 1>__ "UM5_\
MD6C_ %HX9_Z#J/\ X-A_\D'^L7#_ /T&4O\ P9#_ #/HFBOG;_AZ_P#L!?\
M1>__ "UM5_\ D6C_ (>O_L!?]%[_ /+6U7_Y%H_UHX9_Z#J/_@V'_P D'^L7
M#_\ T&4O_!D/\SZ)HKYV_P"'K_[ 7_1>_P#RUM5_^1:/^'K_ .P%_P!%[_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O!/^"H'_)B'Q!_
MZ\;3_P!+K>O>Z\$_X*@?\F(?$'_KQM/_ $NMZ\7B3_DG<9_UZJ?^D,\G/_\
MD18K_KW/_P!)9^*U%%%?QB?RB%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% ']"_AG_D7-/_Z\8O\ T 5=JEX9
M_P"1<T__ *\8O_0!5VO[EI_PUZ']@T_@7H%%%%66%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_2&>3G__ "(L5_U[G_Z2S\5J***_C$_E$**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /Z%_#/_(N:?_UXQ?\
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M_H4+W_OI:/\ A)=7_P"A0O?^^EKZH^D-BBL?_A)=7_Z%"]_[Z6C_ (275_\
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M^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\
MX275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_
M *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?
M_H4+W_OI:/\ A)=7_P"A0O?^^EH V*\$_P""H'_)B'Q!_P"O&T_]+K>O8_\
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M_EK:K_\ (M'_  ]?_8"_Z+W_ .6MJO\ \BU^,E%'_$8>)O\ GS1_\!G_ /+
M_P"(I<0?\^J7_@,__DS]F_\ AZ_^P%_T7O\ \M;5?_D6C_AZ_P#L!?\ 1>__
M "UM5_\ D6OQDHH_XC#Q-_SYH_\ @,__ )8'_$4N(/\ GU2_\!G_ /)G[-_\
M/7_V O\ HO?_ ):VJ_\ R+1_P]?_ & O^B]_^6MJO_R+7XR44?\ $8>)O^?-
M'_P&?_RP/^(I<0?\^J7_ (#/_P"3/V;_ .'K_P"P%_T7O_RUM5_^1:/^'K_[
M 7_1>_\ RUM5_P#D6OQDHH_XC#Q-_P ^:/\ X#/_ .6!_P 12X@_Y]4O_ 9_
M_)G[-_\ #U_]@+_HO?\ Y:VJ_P#R+1_P]?\ V O^B]_^6MJO_P BU^,E%'_$
M8>)O^?-'_P !G_\ + _XBEQ!_P ^J7_@,_\ Y,_9O_AZ_P#L!?\ 1>__ "UM
M5_\ D6C_ (>O_L!?]%[_ /+6U7_Y%K\9**/^(P\3?\^:/_@,_P#Y8'_$4N(/
M^?5+_P !G_\ )G[-_P##U_\ 8"_Z+W_Y:VJ__(M'_#U_]@+_ *+W_P"6MJO_
M ,BU^,E%'_$8>)O^?-'_ ,!G_P#+ _XBEQ!_SZI?^ S_ /DS]F_^'K_[ 7_1
M>_\ RUM5_P#D6C_AZ_\ L!?]%[_\M;5?_D6OQDHH_P"(P\3?\^:/_@,__E@?
M\12X@_Y]4O\ P&?_ ,F?LW_P]?\ V O^B]_^6MJO_P BT?\ #U_]@+_HO?\
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M *\;3_TNMZ][KP3_ (*@?\F(?$'_ *\;3_TNMZ\7B3_DG<9_UZJ?^D,\G/\
M_D18K_KW/_TEGXK4445_&)_*(4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 ?T+^&?^1<T_P#Z\8O_ $ 5=JEX
M9_Y%S3_^O&+_ - %7:_N6G_#7H?V#3^!>@4445984444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7\]'B;_D8]0_Z_I?_ $,U_0O7\]'B;_D8]0_Z_I?_ $,U^'>-
M'\/ ^M3_ -L/Q_Q8^#!^M3_VPI4445^$'XV%%%% !1110 4444 ?1'_!/G]B
M?3?VL_%.M^(/B%XDFT;P5X2M5N->O;<JLLI8.RQ(S J@VQNS.0=H4#&6!'IW
MCG]GW_@FE\:?@=XJ\7?LR?$RY\+>(?"4;O!;^+=8$$>KE59U54N6R?,",J%"
MI5L;DYP?3?\ @D2O@C_AB'XKMXVM)+C33J-]_;T%LY666Q_LV/>BE2""5\T
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M\.I?%'Q.\<6 MO"%K;"-ETBRDSBX<N0N3M\PCG.(DP,O6W_P4&^"/QS\7?\
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M:+N_F?'?[4G['_[/FE_%GX=6'[+?QEL=5T/XCZA:6::=)JL5S=Z1)/)"J.Z
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M\+_^2AG_ ->Y?^E0/I:BBBOZ4/WT**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "O!/^"H'_)B'Q!_Z\;3_P!+
MK>O>Z\$_X*@?\F(?$'_KQM/_ $NMZ\7B3_DG<9_UZJ?^D,\G/_\ D18K_KW/
M_P!)9^*U%%%?QB?RB%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ_5/"#_DJ*G_ %ZE_P"E0/T?PO\ ^2AG_P!>Y?\ I4#Z6HHHK^E#]]"BBB@
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MSM)W8[5E67P+^*E_\'+SX_P>%L>$;'5%TZ?5YKZ",-=-M(BCC=Q)*<,"2BL
M,DD;6QG4R_'TJ\Z,Z,E.*O*+BTTDKMM6NDEK=Z6(G@<;2K2I3I24HJ[3BTTE
MJVU:Z5M;LY*BBBN,Y0HHHH **** "BBB@ HHHH _H7\,_P#(N:?_ ->,7_H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7\]'B;_ )&/4/\ K^E_]#-?T+U_/1XF_P"1CU#_ *_I?_0S7X=XT?P\#ZU/
M_;#\?\6/@P?K4_\ ;"E1117X0?C84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5^QW_!(O_DQ#PI_U_:G_ .ETU?CC
M7['?\$B_^3$/"G_7]J?_ *735^J>$'_)45/^O4O_ $J!^C^%_P#R4,_^O<O_
M $J!]+4445_2A^^A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5X)_P %0/\ DQ#X@_\ 7C:?^EUO7O=>"?\
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MHK\(/QL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *_8[_ ()%_P#)B'A3_K^U/_TNFK\<:_8[_@D7_P F(>%/^O[4
M_P#TNFK]4\(/^2HJ?]>I?^E0/T?PO_Y*&?\ U[E_Z5 ^EJ***_I0_?0HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *\$_X*@?\F(?$'_KQM/_ $NMZ][KP3_@J!_R8A\0?^O&T_\ 2ZWKQ>)/
M^2=QG_7JI_Z0SR<__P"1%BO^O<__ $EGXK4445_&)_*(4444 %%%% !1110
M4444 %%%% $&HZ=8:O82Z9J=HD]O.A26*1<JRGL:^=_BI\"-=\(Z['_PC-G/
M?:??3A+38NYXG/2-OZ-T/>OH^BOJN%N+LSX5Q,IX?WH2^*#V?9^37==-#Z3A
MSB?,.&\0YT/>A+>+V?9^37?MH<)\&O@U8?#JP&IZFJ3ZQ.G[V4<K I_@3^I[
M_2N[HHKQ<TS3'9SCIXO%SYIR_#LDNB71'DYEF6,S;&2Q6*ES3E^'DNR71!11
M17GG"%%%% !1110 4444 %%%% !1110!_0OX9_Y%S3_^O&+_ - %7:I>&?\
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MHH **** "BBB@ HHHH _H7\,_P#(N:?_ ->,7_H J[5+PS_R+FG_ /7C%_Z
M*NU_<M/^&O0_L&G\"] HHHJRPHHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ IES<P6<#75U*$C09=VZ 4^D=$D4I(@93U##(- &=_PF/AC_
M *#4'_?5'_"8^&/^@U!_WU5S^SM/_P"?&'_OT*/[.T__ )\8?^_0H I_\)CX
M8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\
MPF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*
M *?_  F/AC_H-0?]]4?\)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.T_\ Y\8?
M^_0H I_\)CX8_P"@U!_WU1_PF/AC_H-0?]]5<_L[3_\ GQA_[]"C^SM/_P"?
M&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\ ?57/[.T__GQA_P"_0H_L[3_^
M?&'_ +]"@"G_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?57/[.T_P#Y\8?^_0H_
ML[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5?S]>)"&\17[ \&]EQ_P!]FOZ$?[.T
M_P#Y\8?^_0K^>[Q+QXCU#'_/[+_Z&:_#O&C^'@?6I_[8?C_BQ\&#]:G_ +84
MJ***_"#\;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "OV _X)+^(]#T[]AGPM:7NIQ1R+>ZEN1CR,WLQK\?Z_8G_@
MD?9VDW["?A626UC9C>ZGEF0$_P#']-7ZIX0?\E14_P"O4O\ TJ!^C^%__)0S
M_P"O<O\ TJ!]$_\ "8^&/^@U!_WU1_PF/AC_ *#4'_?57/[.T_\ Y\8?^_0H
M_L[3_P#GQA_[]"OZ4/WTI_\ "8^&/^@U!_WU1_PF/AC_ *#4'_?57/[.T_\
MY\8?^_0H_L[3_P#GQA_[]"@"G_PF/AC_ *#4'_?5'_"8^&/^@U!_WU5S^SM/
M_P"?&'_OT*/[.T__ )\8?^_0H I_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L
M[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]
M]5<_L[3_ /GQA_[]"C^SM/\ ^?&'_OT* *?_  F/AC_H-0?]]4?\)CX8_P"@
MU!_WU5S^SM/_ .?&'_OT*/[.T_\ Y\8?^_0H I_\)CX8_P"@U!_WU1_PF/AC
M_H-0?]]5<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/A
MC_H-0?\ ?57/[.T__GQA_P"_0H_L[3_^?&'_ +]"@"G_ ,)CX8_Z#4'_ 'U1
M_P )CX8_Z#4'_?57/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'
M_?5'_"8^&/\ H-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\
MH-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC
M_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"
M8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H
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M=_P2+_Y,0\*?]?VI_P#I=-7ZIX0?\E14_P"O4O\ TJ!^C^%__)0S_P"O<O\
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MX:]#^P:?P+T"BBBK+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M?T+^&?\ D7-/_P"O&+_T 5=JEX9_Y%S3_P#KQB_] %7:_N6G_#7H?V#3^!>@
M4445984444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7\]'B;_ )&/4/\ K^E_]#-?
MT+U_/1XF_P"1CU#_ *_I?_0S7X=XT?P\#ZU/_;#\?\6/@P?K4_\ ;"E1117X
M0?C84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5^QW_!(O_DQ#PI_U_:G_ .ETU?CC7['?\$B_^3$/"G_7]J?_ *73
M5^J>$'_)45/^O4O_ $J!^C^%_P#R4,_^O<O_ $J!]+4445_2A^^A1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5X)_P %0/\ DQ#X@_\ 7C:?^EUO7O=>"?\ !4#_ ),0^(/_ %XVG_I=;UXO
M$G_).XS_ *]5/_2&>3G_ /R(L5_U[G_Z2S\5J***_C$_E$**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /Z%_#
M/_(N:?\ ]>,7_H J[5+PS_R+FG_]>,7_ * *NU_<M/\ AKT/[!I_ O0****L
ML**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ,GJ?_)A_J!PE_T#?^3U/_DS\[?^'!W_ %==_P"6+_\ =U'_  X._P"KKO\
MRQ?_ +NK]$J*/^(:\$_] O\ Y/4_^3#_ % X2_Z!O_)ZG_R9^=O_  X._P"K
MKO\ RQ?_ +NH_P"'!W_5UW_EB_\ W=7Z)44?\0UX)_Z!?_)ZG_R8?Z@<)?\
M0-_Y/4_^3/SM_P"'!W_5UW_EB_\ W=1_PX._ZNN_\L7_ .[J_1*BC_B&O!/_
M $"_^3U/_DP_U X2_P"@;_R>I_\ )GYV_P##@[_JZ[_RQ?\ [NH_X<'?]77?
M^6+_ /=U?HE11_Q#7@G_ *!?_)ZG_P F'^H'"7_0-_Y/4_\ DS\[?^'!W_5U
MW_EB_P#W=1_PX._ZNN_\L7_[NK]$J*/^(:\$_P#0+_Y/4_\ DP_U X2_Z!O_
M ">I_P#)GYV_\.#O^KKO_+%_^[J/^'!W_5UW_EB__=U?HE11_P 0UX)_Z!?_
M ">I_P#)A_J!PE_T#?\ D]3_ .3/SM_X<'?]77?^6+_]W4?\.#O^KKO_ "Q?
M_NZOT2HH_P"(:\$_] O_ )/4_P#DP_U X2_Z!O\ R>I_\F?G;_PX._ZNN_\
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M?_)GYV_\.#O^KKO_ "Q?_NZC_AP=_P!77?\ EB__ '=7Z)44?\0UX)_Z!?\
MR>I_\F'^H'"7_0-_Y/4_^3/SM_X<'?\ 5UW_ )8O_P!W4?\ #@[_ *NN_P#+
M%_\ NZOT2HH_XAKP3_T"_P#D]3_Y,/\ 4#A+_H&_\GJ?_)GYV_\ #@[_ *NN
M_P#+%_\ NZC_ (<'?]77?^6+_P#=U?HE11_Q#7@G_H%_\GJ?_)A_J!PE_P!
MW_D]3_Y,_.W_ (<'?]77?^6+_P#=U'_#@[_JZ[_RQ?\ [NK]$J*/^(:\$_\
M0+_Y/4_^3#_4#A+_ *!O_)ZG_P F?G;_ ,.#O^KKO_+%_P#NZC_AP=_U==_Y
M8O\ ]W5^B5%'_$->"?\ H%_\GJ?_ "8?Z@<)?] W_D]3_P"3/SM_X<'?]77?
M^6+_ /=U'_#@[_JZ[_RQ?_NZOT2HH_XAKP3_ - O_D]3_P"3#_4#A+_H&_\
M)ZG_ ,F?G;_PX._ZNN_\L7_[NH_X<'?]77?^6+_]W5^B5%'_ !#7@G_H%_\
M)ZG_ ,F'^H'"7_0-_P"3U/\ Y,_.W_AP=_U==_Y8O_W=1_PX._ZNN_\ +%_^
M[J_1*BC_ (AKP3_T"_\ D]3_ .3#_4#A+_H&_P#)ZG_R9^=O_#@[_JZ[_P L
M7_[NH_X<'?\ 5UW_ )8O_P!W5^B5%'_$->"?^@7_ ,GJ?_)A_J!PE_T#?^3U
M/_DR#3+/^SM-M]/\S?Y$"1[\8W;0!G';I4]%%?<I)*R/L$DE9!1113&%%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *H^*%U5O#6HKH)(OC8S"R(/
M278=G_CV*O44 ?DA_P &LS^'X[3XV6MT$7Q +O1#.LW$WV<"]'&><"3=N]RN
M>U?3/_!;GX@_!_QM_P $K?BC=Z;XQT764MM2T_3[>33M0BN/)U2+5;8-!E&.
MV9-L@=.&"JX(ZUY%^T5_P2)_:\^ 7[5^J_MG?\$JOBSI>A7WB"::;6_!VK2K
M%'NF<2311^8CPS6[R#?Y4FSRFP4;A=GR#\3?^"'7_!4SQMI7BSXH:E\,O".D
MM=72ZG=^!O#WB1$&HW"AAOM[=&>'> \K -(I^=P@RVTA6[N?IG_P0?CUV/\
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M(DC1*PD0=)6AQ(1A2?V5T^_L]5L(-4T^=9;>YA66"5>CHP!4CZ@@U^5_B?\
MX)N?\%6/^"CGQ/\ !ME_P4J\8^%=!\!>"[@RSV7AN>$W&I[B@E9$M\J)950*
M9'91&"2D>25/ZI6MK;6-K'96<"Q0PQA(HT7"HH&  .P H!DE%%% @HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHKC/VC_%GB#P%^SSX\\<^$[_[)JNB^
M#-4O],NO*23R;B&TEDC?:X*MAE!PP(.,$$5EB*T</0G5EM%-NWDKF5:K&A1E
M4EM%-_=J=G17XR?\/7_V_?\ HO?_ ):VE?\ R+1_P]?_ &_?^B]_^6MI7_R+
M7Y;_ ,1AX9_Y\UO_  &'_P L/SK_ (BEP_\ \^JO_@,/_DS]FZ*_&3_AZ_\
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M$\]0NX[*#]JGPVKRL%5I_/B0'W=XPJCW) KW?0M>T/Q3HUKXC\,ZS::CI]]
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*FB*ND_"R'3+BS&HQFY:_ALO(-HL6=YF,J[50#)R".#F@#>\"?\ !2KPL?\
M@G7I?[>?Q;\)?V;_ &G]JAM_#6D3F:2ZNTOY[2&WB9P"6<PAB2/E&X\A:YOQ
M/^V7_P %$/@YX%_X:'^.?[&7AJ#P#;Q)=:YH^@>*GFU_1K)C\T\J.HBE,:D%
MD7!&#N* ,5^4/%'@W7?$/_!!;X*^*]/.J+IOA+XCR:OXCFT9L7-M8C5=6@>>
M,X.'1YXR"00"<G@5[/\ &OX*?LU^&/V9]4^-'CC_ (*O_'/Q#X*U#17!L+/X
ME6ET^M13(5-G' \0$KR!BAC; &6W[0&( /O;P)XW\,?$OP3I'Q$\%:HE[I&N
MZ;!?Z9=Q@@302H'1L'D95AP>1T-:U>9?L9>#_"G@+]E;P'X5\"P^(X]%M_#D
M#Z5'XNBB34DMY!YB+<+%\BR!7 *CI@#J#7IM !1110 4444 8_C_ ,?^"OA7
MX*U/XC?$;Q/9Z-H6C6;W6J:I?S!(K>)1DLQ/Y #DD@ $D"OY]_\ @K?_ ,%;
M_&O[?GC5_AS\.9[S1OA3HUX6TO2W)27695) O+H#\XXCP@.3EB2/UZ_X*X?L
M&^-?V_/V87^'/PY^(UYHVNZ->'4M+TM[LII^LRJN!;W0'YQN>$<Y(()(_G)\
M?^ /&OPK\:ZG\.?B-X9O-&US1KQ[75-+OX3'+;RJ<%6!_,$<$$$$@@T%1L?7
MG_!)#_@K?XU_8#\:I\.?B-/>:S\*=9O VJ:6A+RZ-*QP;RU!_.2(<.!D88 G
M^@CP!X_\%?%3P5IGQ&^'/B>SUG0M9LTNM+U2PF#Q7$3#(92/R(/((((!!%?R
M=^ / 'C7XJ>-=,^'/PY\,WFLZYK-XEKI>EV$)DEN)6. J@?F2>  22 ":_HV
M_P""1_[!OC7]@/\ 9A3X<_$;XC7FLZ[K-X-2U32TNR^GZ-*RX-O:@_G(XX=Q
MD   D"5CZFKYW_X*H_M$>)?V9/V(O%_Q!\#W[VFNW:0Z5HUY$<-;37,@C:93
MV=(C(ZGLRK7T17S[_P %0_V;_$O[4W[%?BWX9^![0W&OPI#J>AVJGFXN+:02
M&$?[4D8D1>@W.N>*"2U^QI^Q1\#_ -D?X&Z5I0\':0^OMI27/B_Q3J5M&]S>
M7;('G=YI 66)6+;5SM51ZEF/-^(?V3_@'>?MA^"OVK/@7\6O#/@O6],^T6GB
MG2M#2W9/%4$P54AD2.5%60$M^\VNQ/E\$QJ1!^S;^W3^RG^V+^SFWP^^+_CO
M1='UR\\/2:+\0O!7B75!IUTDC0F"[C =D=HVR^'0Y4, 2K@@?)'[0WP>_P""
M=_A']K7X#^ ?V"M#TS4?%]O\6=+O/$\?A+5[S5EM].AN8W=I)#++$FPJ7;!W
M*J,6P!0!]0_M ?\ !0+]H#PI^UKK/[&G[.W[.%GXP\4Q^'[34M&N+K6/LUND
M;KOGENBQ54C0;54!@6:11G/!O?$;]N_X^>"#X ^ &E?LX66K?'KQII$FH:AX
M.M_$"C3- M4=U-U<70!RA\ML*IZJR[R0GF8OPPAB;_@M[\2IS&"Z_!6P56QR
M ;FTR/T'Y5E^./$_A_\ 9Z_X+267Q"^+^I0Z7H/Q$^$)T3PSKFHR".U34(KN
M*1[8RMA48K%W(R9XQU;% '8>$OVW/VAOA+\=O"WP(_;I^".@^'%\>7)L_!_C
M/P;K$EUID]]P%LYDE421.Q955CU9E 4C<RS>/_VQOVE_B#^TAXO_ &;OV,/@
MUX6U>X^'D-D?%_B+QOKLMK;+/=(9([>"*%3(YVJV9#QN5A@ *7X/_@J5XX\)
M?&CXE? ?]E[X7:]9ZQXSN/B_INO36^EW"SR:;I]JDHFGEV$^6N)=_.,B%R,[
M:I_%WX._L?\ [5G[97CG3?"'Q?\ '?P7^-7A&.UAU77-*UB+3?[<A:(&*XCC
M\PFYC6-8@64Q-AH]V1B@#VKX%_MF>.=:\ ?$G5OVG_@3J7@36OA/;RW/B06Q
M>ZL-0M4MY+C[18SE5$OR1,2@)*Y3+?-@>7Z'^VY_P44\9_!U/VK_  1^Q]X-
MOOA_/I[ZI9>'D\7S/K]SIZY/F+LC,1<H"PC"E^P4M@'"_96_:0^+/AOQE\>/
MV<OVA?B0OQT\%?#3PDM])XIT;1X6N;N&2!C/ITB*^R>4Q^:-K.S;HI%+G.U>
M"\-?L^?"3PM^SQ-^UG_P3S_X*)^*/ACH(TB75T\'>(]<@OM-LYE4R-936SR$
M12!LQG?Y[;CQO!&0#]#/A7X_M_BI\-M"^)%KH&I:4FMZ7#>?V9K%HT%U:%T#
M&&6-N5=22I[9'&1@U\@_\%BO^$?_ .$W_9K_ .$L^Q_V5_PN_3O[3_M'9]G^
MS^;%YGF[_EV;<[MW&,YXKWS]@/XW_$+]H_\ 8_\  WQJ^*FC1V.O:YIDCW\<
M,)C2;R[B6))U4_=$J1I* ./WG'&*^?\ _@LIX6\/^.?%O[.'@GQ9I<=]I6L?
M&O3['4[*4D+<6\LD4<D9P0<,K$'!SS0!Z_\ $6Y_X)>VO@C4Y/B#)\%%T8V;
MB_W#2R3'CD*(_G+_ -T)\^[&WG%?+'["O[1OCK]CS_@D1XV_:(LO"D^LZ+H?
MQ G;P!I>M7+PB72;B]LK8?, 2%$TMRW Y<-ZU]4Z;_P2O_X)ZZ3?1ZA:_LJ>
M&7DB8,JW*33(3[I)(RL/8@BN._X+*:-H_AW_ ()<^/\ 0?#^DVUA8V<6B0V=
ME9P+%%!&NKV(5$10 J@   # % %KX4?MN?M&ZCIFO?M"?M _LZ6'@?X*6WA.
M?7M#\13:XDVJS0*8S DMJK$B2>-RZIA=IPI8DC//>'?VRO\ @I#\2_AVG[1_
MPO\ V)O#,G@6YM3?Z3X?U3Q9(GB#5+#&Y)XU5/*0NGS*A!8@C;ORI;J/^"@O
MPW\3_$G_ ()8>*_!'@+3I9[X>"M-NH+2U0EY(K66UN9$51RQ,4+@*.3T'6NH
M_9R_;#_9IU']CGPS\8V^*^@:?H>E>$K0:JL^HQH^G2PVZ+);/'G<)%92H0#+
M?+M#!ER > _M]_M6ZU^U'_P2LU/XS_L]^&+&X\*:_IC0^,WU?4C!?Z&\=W;I
MY*1*K"9_,W*V64;"K#(85+JOQ@\4_ ?]BCX3ZG\=_P!D3X;ZA!?>-?#.B>&=
M,6=;V&.WDLG:'4B)(,172$/@ <>8Q#<G/D?@;P]KUC_P0L^-'CK5=%GT^R\;
M>+[W7] M+A-K)8RWUC''@=E+0N1V(((X(->M?\%%?^3$_P!G/_LH_@O_ -(9
MJ ,G]K#Q/^U)8_\ !7OX:3^ ?A;X6U"_L_"6K)X-M]0\1R01ZC:-;R^?+<,(
MCY#J3(%4!@VU>1GC]!X3*T*-.@5RHWJIR <<@5\8?M2>*_"_@7_@K[\"/$GC
M7Q'8Z1IW_"":[$=0U.[2" .8IP%+N0H))  )Y) ZFOM".1)4$L3AE8 JRG((
M]: /R*_;5\->(M(_X*-?';]J#P-!))KGP:O_  3XG@BC8@SVBV5G%<PG_9*.
MK-_LQMZFOT*_:\_:?TKX5?L1>(?VC/ VH&X>_P#"\4G@^6$9:XNKY4CLF11R
MWSS1O@=E->$_"3P1H'Q+_P""K'[6/PY\56OGZ9K_ ($T'3M1A_OP3:3;1N/^
M^6->/_LH:_XQ^._C#X0?\$XO'<4TT_P'\<ZQJ?Q 9XR$FMM(E":3CL\32W*Q
M[<X*Q*>>* .K_P"".GP93]FG]JOX[?!_4)_W_A[PYX57596?<#=M9/+<L#_=
M\YY"/;%>L^$OVP_V_/VE=)OOB9^RA^RUX2MO!4.HW%KH]W\0]?GMK_6EA<HT
ML<$: 0 LK*!(3@@\\'',?L\>*[CP'_P4-_;)\<VFCR:C+HNB:+?1:?"?GN6A
MTV201+P>6*[1QWKF_P!FZ;XG?MF_L^)^UE^TC_P4TUWP;H^H374E]X9^'^IV
M>AV^@Q1S.@@DN&#2;MJ!\O\ -M=?F;AB >T_"G_@HEJ'Q,_8H^(O[2=W\*#H
MWBKX8_VK9>)/"-W?[XTU&QA$C1K,JY,;;E&<94[A\VW<<C]F+]N7]K#]H"XT
M3XS:[^S#I'ACX*WNAS7>J>,-2\1J+NW,%J[S7"P9WM;^?&\:90$H!(6 .*^:
M/V,-2\-ZG_P3!_:ZNO".J7U[IDVO>))M-N]4F:2ZGMGT^,Q23,_S-(R@%F/)
M;)-?5GPF^'FO?$[_ (([:-\,?!<>-4\0? 1+'3HU.WS+B?2MJJ3VW.V"?]HT
M <UX!_;C_;M_:"\-W/Q]_9Q_8]T&^^&L=Q-_8UOXA\3M:ZWX@MXG*M-;HJF*
M(L58*KYR1@,W6HO!?_!1&Q_:1_X)^_&#]I?Q1\ =+N=,\(:YJ.EQ>#_$!$T6
MIVL,-K*@NT=&57(N,,F&4%.IK0_X)U_ME?LT>'?V#O"=CXX^+.@>&;_P'H(T
MKQ7H^M:C';7=A<6NZ-]\#D2$OMW*%4EBVT98%1\X?L^^+--\??\ !(?]JSQU
MHUD]M9ZU\3/$=_:6[IM:**:WTZ15([$!@,>U 'TM\9_^"@LW[-'P(^ GC+PQ
M\!X;^U^)=AI]O;^%M <1-8^;8PR06EF@4*?GD2%%(4 8XXQ67XQ_;Q_;1_9O
M\7>%->_:^_9:\,Z+X"\7>(K?1QJ?ACQ2;R[T.>?/EBY!&V7 #$E %.QL-G:K
M>=_&]$D\"_\ !/\ 6101_P )!X9.".XL;(C]:]*_X+;@?\,F>'SCI\4=#Q_W
MU+0!]AU\:?%7XH> OV4/^"FNM_'']I749-(\*>*/A+;:9X4\3W-A--;17$%T
MTEQIX:-&*2,,2A,?-D8R2!7V7393$L9><J$4;F+]!CG/X4 ?GA\'=>^+GPQ_
MX)_>'_V?/ VEWGA_QM\=?'>L6GP]TJ[A:.?0=#NKAYI[YHN#&D-J7F&,%3/&
M:^[_ (1?"WPA\$OAAH/PC\!6'V;1_#NEPV-A%QN*1J!O8C[SL<LS=V8GO7R'
M8>,/&/Q;T#XY_P#!2_PQ&\B:!X(UG0/@:&CW!+*RBE>XU1%/#&XNHR5. WEP
M;#D&O/O"'PV\'_L[>'OV2_VA/@=K^J/XV^*'BC1;'Q_?/KMQ<MXEM-0LS-?R
MW*22,KF&0[@<9C.,\J" #]'Z*** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
C%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>dxcm-20230630_g3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dxcm-20230630_g3.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@"
M@ /H P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@Q;B9PD0U"^:S0L>@WW"H@_.OH.WN(+N!+JUG26*5 \<D;!E=2,@@C@@CO0
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ML'PK\0^,/%_B>.Q%O#H4T"I;S7=PT,$,AD8$.<!S@<*ZGO7PCX=2T_X),_\
M!>V?2[ZX32?AW\3G?RY96\NWBT_4W+Q]?E1+?4(MF3TCB)R,UH?\$DO#NI_\
M%$?^"L_Q*_X*#^,["270_"UY-=Z&MRN0D\X:UTZ$YX)ALXG8D?==(S@9% 61
M]Z_\%!O^"K7[-G_!.^"QT7XCC4=>\5:M;&XTWPIH*H9_(W%1/,[L%@B+*R@G
M+,5.U6"L1Y'^RK_P<#?LQ_'_ .+>G_!3XF_#?Q'\-=8UFXC@T:YU]XY;.>63
M CC>5=K0LY("EDV'/+C(S\%?M&>,?C7KO_!?WQ!X@\$_!6U^)/BG0_%DB^&O
M!6KW2PP72V>F$P$&1E5?*2,7*C(RT>>2>?1/^"C_ ,%?^"LG_!1S_A%]1\8_
M\$TK7POJ_A=YU@UK1O$5I)<7$$NT^0[/<9**R[U_NEFQC<<@61^C7_!1C_@I
M'\.O^"</A+PUXN^(GP]UKQ!%XFU&>SMHM%EA5H6BC5RS>:P&"&QQ7SK\:?\
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M>_@.S\7?&O4KRYU#5G>/0?#6C1+)>Z@R ;V56952-=R[I'8 ;@!N8A3^:?\
MP4UNH9_^#ACX-Q12 M!XH\"I( ?NM_:D;8/X,#^-<I_P6GUSQ_XM_P""T7A7
MPM:?#^'QC)I,?ANU\,^#]1F$=MK&^43_ &1BQ"A)IY7C8Y&0<9XH'8^M?@I_
MP<C_ ++_ (Z\?:=X.^,GP=\5_#VRU=D%AXBU*2.YLT#'"R3;0KI$3_RT57 Z
MG !8?HM;7-O>6\=Y9W"2Q2H'BEC<,KJ1D,"."".<U^/?_!0OPK_P5I_X*&_"
M+2OA;XZ_X)<Z;H,VB:NE]I.N:9XBM)+FV41M&\"[Y^(W#+N7H3&AQE1C]'/^
M"<WA;XQ>!?V'OAIX$^/V@W&F>+-"\-1Z;JEA=SI+)"MN[PPAF1F5CY*1'()Z
M^M F>A_&CXR?#G]GSX6:W\9_BWXCBTGP[X>LC=:G?2J6V("%5549+NS%450"
M69E &2*_.K6/^#G3X*+>76H^$_V2_'6H^'[:X$3:S<7MO 1D\;D42(A(Y"F2
MOL;_ (*1_&#]E[X'_LFZ]XW_ &N_ =MXJ\)B>"!/#%Q8QW#:G>L^8(HUD(4.
M&4OO)&P(S=L'\_\ PU^TW^WQ\</V)=?\*?L1?\$V/!/PW^!=QX9U<2ZEXCU?
MSU:P9)FNI(%DDA:5F_>_,(95W#&>!0"/T4_8D_;D^"'[>_P</QC^"=S?1P6M
MXUEJ^D:M L5WIURJ*YCD5692"K*RNK,K ]00RCY/\$?\')7['WBGP-XA\4ZM
M\,_&&G:EI<]G;Z+X:5+>XO=<FN/.R(51]JI'Y(\QW( \U  S,%/F_P#P:U-*
M?A)\849SL&OZ657/ /V>XR?T'Y5Y'_P:_?#WPGX@_:1^(?C_ %G1+:ZU/P_X
M4MHM(N9X@[6AN)V$CQY^ZQ6(+N'.UF&<,00=D?97[%G_  7N_9S_ &MOCA9_
ML]^(?AGXA\">(=7N6MM#.KS13VUU< $_9V=-K0RM@A59=I(V[@Q4'W3]O3_@
MHI^SY_P3T\ 6?C#XS7E[>:CK$DD?A_PUH\:O>:@R ;V =E5(TW+ND8@#< -S
M$*?S-_X*AZ%I7A?_ (. _A'JN@6,5I/J?B'P5>WTD"!3-/\ VFL7F-CJVR)!
MD]E%1?\ !;&SM?B1_P %H?A/\,OBBQ;PM/!X7L)H)F*QFQN-4E%RWX[Y 6]$
M [# %CM/VL_^"ZOP#_;"_8E^)?P1UCX3^)_ ^M^(_#?_ !2TVJ!;FSU-DN(F
M:-9HP"CX5B,KL.TC>&(!]V_X-J/^4>.H?]E)U+_TFLJ]#_X+@?#'X9:Q_P $
MN?'L>M^'M.MX_"UG877AEEMD0:=<)=P0QK  ,1[D=H<+CY9"M>>?\&U'_*/'
M4/\ LI.I?^DUE0'V3[X\3^(])\'^&M1\6Z_<^38:78S7E[,1GRX8D+NWX*I-
M?A1^R3\&O'/_  7J_;_\7_%C]HOQCJEGX-\/P"[N;"PN!OL[-Y66RTNW+ K"
M"%D9Y I+>7(WWY-P_;CX^>"=2^)?P+\:?#G1W"W?B#PEJ6FVK%L 23VLD2G/
M;EA7Y%?\&P?Q/\/^!/CM\5O@)XJF6PU[Q'I6GW6G6EW^[DD?3I+I9X0&Y,@%
MT&*==L;G&%. 2V/J3]HW_@W?_8/\:_!O4]$_9^\"7W@WQC#8.^AZTOB6^NXY
MKI5RB7$=U+(GENP 8H$8;L@\8/9?\$9/V-_VR?V(?@UKOPC_ &G/&GAW4=$E
MOHKSPAIFCZK/=2Z2SA_M43F2%$6-V\IU5&8!O,/5S7*_\%(/V"/^"F7[1?[0
M9^)G[*'[;]Q\/O"2>'[:V;08_'NLZ:/M,;2&2;RK.-HOF#(-V=QV\]!7SM_P
M;B?M,?M'_'']HGX@:)\:_P!H'QOXPLK+P5'/9V?BGQ7>:A%!*;N-3(B3R.%;
M:2,@ X.* Z'NGBG_ (.,?V5?!/B3Q_X1\4?"OQ7;:CX*O+BRL[;S+=CK5W%=
M&W,<.'_=KPTA=\!40\%BJM[9^RE_P5.^"W[1?[(?B#]L_P <^&]0^'7A+PSJ
M<UGJ5UXBN(Y4D:-(FW0-%\TV6F2,*$#-)\BAC7YJ_P#!)#X0>!OBW_P6Q^)4
MGCSPU9ZK!X9NO%.LV-K?VZRQ+<KJB6Z2%&!!*BY9E)'# ,,$ U[S_P ',\L_
MP]_9B^&_PV\ :+:Z/X;UCQM>WNKVFE6BV\,MU'!NC+K& "6,TSG/WF7<<D9H
M#0U?$O\ P=!?LTV'BJ6Q\*_LX^-M4T2&<(=7FN[6WE=<XWK!EASC(#.I/?;T
MK[A_8Y_;8^ '[=/PM_X6K\ _$\EU;P3"#5=*OX1#?:9.1D13Q9(4D<AE+(P!
MVL<'''_\$[/@#\"-!_X)T_#GX?>'? VBWOA_Q/\ #[3KWQ!!-8QRQZO<7=I'
M+<R7 (/FEG=@0V=H 7@* /S<_P""$9;X;?\ !6;XN?!?X7WTTW@P:9KUMY<<
MS-&UM9ZI$EI.3GE@K; Q[3MZT!H?5GQR_P"#@[X ^!?BWJOP?^!'P*\9_%*[
MT.XD@U+4O#J(EH7C;:YA($CRHK?+OV*A/*E@03Z-^P%_P62_9P_;T\<W7P>T
MGPWK?@WQO:V\DZ>'?$*QD7B1_P"M$$J'YW3JT;*C8!(#!6*_GY9_L4_\%@?^
M"0GQ<\4^)OV,?#4_C+PCK$R"6ZT328-5.I6D3R-;K<V6#<Q2H)'R8@!EF =A
M7J?_  3C_P""HWPJ^)O[<%KX%_:O_81\&^"OC!XHU,VT7Q!TCPW]FO1J#0>6
ML,\5TK7%NTJ )O23YF<!DPQ8 [(^K/V\/^"RW[/7[$'Q,@^!'_"&>(/'7CR6
M"*6?P[X:C3%FLBAHEFD8Y$CJ0RQHCMM(8[0R[N!_9Y_X."OV=_BI\9M-^!OQ
MH^#7B[X7ZMK%U%;:==>(@CVHFD(6-9FPDD(=B '*%!G+,HYKQK_@I)_P3F_X
M*"_#7]OB]_X*,_L"2?VS?ZAY=R]K9O;/?Z9.+);29!;W7R744D:D@*&<;V&P
M!0Q\C7_@K9XYT#XU^'H/^"N7_!-SPOKE_ID?V6UU[6O KV6KV5L9 S2I!?*\
M5P%8[@$$0R<A@3R"LC]OJ_/S_@Y3_P"4=MG_ -E&TS_TGNZ^^=$UK2_$>BVG
MB'0[Q+FRO[6.YL[A,[98G4,C#/8J0?QKX&_X.4_^4=MG_P!E&TS_ -)[N@%N
M?!?_  0[\6ZS^RS_ ,%)?!/ACQ#=&/2OBOX%^S0S/PDBW, NH#CN1=6I@!]2
M?4UWO_!P7XLUC]I'_@H#H_[.'A6Z,D7P[^'-[J-[$/F\J?['/JMT<=LV=M;G
M\*\X_:M\.ZU\#/V9OV)_VZ/!UJ?MVD: MI/,GR@3:?J+7UJK'OO\VX'T2NJ_
M91O'_;1_:&_;1_;GN[6:33-/^$7BV31&N$P]O]NM+B"R5O0K8V\R$4#\SZ5_
MX->)HK?]F'XFW%Q*J1IXXB9W=L!0+*,DDGH*Z?XN_P#!R-^S9X5^(FH^!?@E
M\#?%WQ#MM+DD2?7-.DCM[:<(<-+""'=XO1V5,]0,8)\]_P"#</Q#X$\(_L-_
M&SQ5\49;:/PSINORW7B%[V+S(18QZ:K3[UP=R^6&RN#D<8-4?V6/VY?BEX\U
M_P 7Z9_P16_X)2^'=*TBYU"--;\5>(-06VMI756\KS8EEACB*HQ801SN1OSC
MYN0'N?87_!.W_@K?^SO_ ,%%=0U3P;X#T76/#GBO1['[;>>'M;6-C+:[U1IX
M)8V*R(KO&K A&!<?*0<UP/QH_P""]?[,/P _:+\;_L]?$WX?>)[6?P0MPL^K
M0&"2._GCC5D@@CWAB\C.JC=@#EF(4$CXG_X(P6WQ%T[_ (+9_$&P^*=IIEIX
MG2#Q0GBBUT-0MG'?"]3STA X$0F#;1T  J#1?A1X-^-'_!ROJ/@7X@:#;:GI
M!\>:A?75A>0B2*9K329;J(.C9#KYL,>5(((X(Q0*RN?H;^P__P %?/@Y^V)\
M(?B#\<=>^'^K?#[PU\.%BDUO6=?O(IK5XW21\1O'\S2*(QF,)G,L84L6Q7A\
M'_!S/^S#>>/I],T[]GOQ]<>%+6<)=>*(D@,D,1;:)FM@WRH3R,R!L?PY^6NB
M_P"#AK2[/X;_ /!-[4=.^&WAJRTFU\1?$'2E\2KI5DD ND$<CJ\OE@;SOM[9
M<MD_(@["O0/^"&/P\^&&G?\ !+GP*?#N@:?.OB6'49_$[-;H_P!ON3>W$,BS
M@CY]J(L6&_@0"@-+%O\ 9+_X+'? #]LG]J[5?V7/A'X/UJ7[!8W=[:>*Y)8O
ML5_;P,@#HN?,7>) 0&4$<@@'BO$?#/C[]@"3_@NU+X.T_P" _C2/XR_VU=JW
MC!_$ .E&8:'(SM]GWYP;;=&!M^\0?>OG#_@C/X<\%^#O^"WWQ,\(_#<1#P[I
M7_"66>@B!LH+*+442#:>Z^6JX/I6WX*_Y6DYO^QEU#_U&)J /N']J+_@LC^S
MY^R-^UQ9?LI_%SPGK%KY]C;7E[XM$L7V&R@E5VW.N?,;:$/RJI))  ).*\0U
M/_@YJ_9CTSQ[#I<_[._C]?"]Q-BW\22K;QRS19P9DMF;YD[_ .LSCL#\M?.W
M_!5OP1X=^)?_  7O^&WP\\7Z;'>:3K>J^#K'5+.9<I<6TMXJ2QL.X9"RGZU]
M0?\ !RKX0\,M_P $_/#^IIH=K'/HOQ!L(M+DC@53;1/:W2-&F!\J$*F5'!V)
MQ\HP#LC[]^'OC_PA\5? FC?$SX?ZW%J6AZ_ID&H:3?P@A9[>5 Z. 0",JPX(
M!!X(!&*^??\ @LDWBU?^"9'Q?/@HS_;/^$<C$WV?.[[)]K@^U9Q_#]G\[=_L
MYI/^"-<\UQ_P3'^$$D\A9AX=E4$GLMW.H'X  ?A7TIJFEZ9KFF7.BZUIT%Y9
MWD#P7=I=0K)%/$ZE61U8$,I!(((P02#02?@#^U,WP#'_  2N_99;X%_V#_PL
MP:_>?:?["\G^U_/\V3S/.\O][N^T?9]F_P#V=O&*^[_^"Q_Q'\=?M)?$7X7_
M /!)CX1ZJ8]?^(U_;:G\1+NT^8:?I4+%_G XVYBEN"IP<6L8Z2#/M5W_ ,$Z
M_P#@EY^Q7<:Q^V9'^SGHNB7'@^SGUJ74I+Z[N(K(Q*9-]O;3SM!'*" (PB A
MMH3!Q7Q9^S9\:_'/P8_9Y^./_!>3XP>$(=0\;?$#4_['^&.CZ@6,-K9-<QVZ
M<C#&%61(^"K-'8, P\W-!1^L?PS^'/A'X0?#O0_A7X!TI;'1/#NE0:=I5HG_
M "S@AC"(">YPHR>I.2>36Y7Y.>%O^"DO_!2S]ESQ?\ _BO\ MB>./"/BWX=_
M'Z**X@TG2M$CM;G0K:8VS!P\<:$NL5Y!)M<R!@'3((#U^L=!-@HHHH ****
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M_JVH^(/$VOQQQ:UXGU=421XD)*P0Q)Q#%N.XC+,S8+,0JA?IJ@+GYW_M=_\
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M(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\
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MI.-E;7F35FDM=UO8^?RCB2IC,#4Q>,H^RIQNU)/F32DU96UNK6T6NZW/4/\
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M:2AIJKWZ&&$XDK5\PI8>OA94HUN?D<FKODU?-#>.FJO?H?77_"#Z1_S\WO\
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M@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH Q_^$'TC_GYO?_ MJ/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR7\2?$/QI_9L\$_%+QK:QC5M5T.*>]=8@H>8 HTJCHH?!; X ? XKY&^'?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !117 _M0?'#_AF[X$>(?C9_PC']L_V#!#)_9GVW[-Y^
M^>.+'F;'VX\S/W3TQWS6&)Q%'!X:=>L[0@G)O5V25V[+7;MJ8XBO2PM"=:J[
M1BFV^R2NWIKMV.^HK\[?^'^/_5J/_E]?_<-'_#_'_JU'_P OK_[AKXS_ (B5
MP3_T%?\ DE3_ .0/E/\ 7_A+_H)_\DJ?_('Z)45^=O\ P_Q_ZM1_\OK_ .X:
M/^'^/_5J/_E]?_<-'_$2N"?^@K_R2I_\@'^O_"7_ $$_^25/_D#]$J*_.W_A
M_C_U:C_Y?7_W#1_P_P ?^K4?_+Z_^X:/^(E<$_\ 05_Y)4_^0#_7_A+_ *"?
M_)*G_P @?HE17YV_\/\ '_JU'_R^O_N&C_A_C_U:C_Y?7_W#1_Q$K@G_ *"O
M_)*G_P @'^O_  E_T$_^25/_ ) _1*BOSM_X?X_]6H_^7U_]PT?\/\?^K4?_
M "^O_N&C_B)7!/\ T%?^25/_ ) /]?\ A+_H)_\ )*G_ ,@?HE17YV_\/\?^
MK4?_ "^O_N&C_A_C_P!6H_\ E]?_ '#1_P 1*X)_Z"O_ "2I_P#(!_K_ ,)?
M]!/_ ))4_P#D#]$J*_.W_A_C_P!6H_\ E]?_ '#1_P /\?\ JU'_ ,OK_P"X
M:/\ B)7!/_05_P"25/\ Y /]?^$O^@G_ ,DJ?_('Z)45^=O_  _Q_P"K4?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=?V2=6TC]CWQ%/XQ5M.OM3\(/JFJPWD5U>M#^[C62+RD\MI4&0"HW,_(R<?
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M!PJ@DX/%?FI^TCX+_9]\:?M;_#[X#_L%^$ET/Q7X5U^:R\0ZM;AK:*.:VGC
M8O*V9GB,4S&09+Y !<D ?87[7?[!8_:Y^+W@SQKXO^)K0^&/"^T7G@\Z<S+?
M9FWS,)UF4QF1%CC.$) 3(;GCX[+N(\_Q^%Q<*-&G5K491BI0DU2DY).6LM?W
M?VDKM[(^6P.>YUC</B8TJ4*E6E*,4X2:IMM)O66ON?:2U>R/1/A#^UI^S?\
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MZ\;3_P!+K>O>Z\$_X*@?\F(?$'_KQM/_ $NMZ\7B3_DG<9_UZJ?^D,\G/_\
MD18K_KW/_P!)9^*U%%%?QB?RB%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% ']"_AG_D7-/_Z\8O\ T 5=JEX9
M_P"1<T__ *\8O_0!5VO[EI_PUZ']@T_@7H%%%%66%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P#+ _XBEP__ ,^JO_@,/_DS]FZ*_&3_ (>O_M^_]%[_ /+6TK_Y%H_X>O\
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M2X?_ .?57_P&'_R9^S=%?C)_P]?_ &_?^B]_^6MI7_R+1_P]?_;]_P"B]_\
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M-I_Z76]>]UX)_P %0/\ DQ#X@_\ 7C:?^EUO7B\2?\D[C/\ KU4_](9Y.?\
M_(BQ7_7N?_I+/Q6HHHK^,3^40HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH _H7\,_\BYI_P#UXQ?^@"KM4O#/
M_(N:?_UXQ?\ H J[7]RT_P"&O0_L&G\"] HHHJRPHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\
M8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B
M\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%%
M&/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\
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M_P#0;LO_  &/^-;%%668_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%%
M&/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\
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M[9\SG638C"X6'LJ2]G25IS7+>4V[2>_,XQE^[3MRW6]VSQ^BBBOC#Y0****
M"BBB@ HHHH *_8[_ ()%_P#)B'A3_K^U/_TNFK\<:_8[_@D7_P F(>%/^O[4
M_P#TNFK]4\(/^2HJ?]>I?^E0/T?PO_Y*&?\ U[E_Z5 ^EJ***_I0_?0HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *\$_X*@?\F(?$'_KQM/_ $NMZ][KP3_@J!_R8A\0?^O&T_\ 2ZWKQ>)/
M^2=QG_7JI_Z0SR<__P"1%BO^O<__ $EGXK4445_&)_*(4444 %%%% !1110
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M-!>V-Y"8Y8)%.&5E/((-4J_/91E"3C)6:/AY1E&335F@HHHI""BBB@ HHHH
M**** /Z%_#/_ "+FG_\ 7C%_Z *NU2\,_P#(N:?_ ->,7_H J[7]RT_X:]#^
MP:?P+T"BBBK+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_GH\3?\
M(QZA_P!?TO\ Z&:_H7K^>CQ-_P C'J'_ %_2_P#H9K\.\:/X>!]:G_MA^/\
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M7ZIX0?\ )45/^O4O_2H'Z/X7_P#)0S_Z]R_]*@?2U%%%?TH?OH4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M>"?\%0/^3$/B#_UXVG_I=;U[W7@G_!4#_DQ#X@_]>-I_Z76]>+Q)_P D[C/^
MO53_ -(9Y.?_ /(BQ7_7N?\ Z2S\5J***_C$_E$**** "BBB@ HHHH ****
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MA!_R5%3_ *]2_P#2H'Z/X7_\E#/_ *]R_P#2H'TM1117]*'[Z%%%% !1110
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MRL2=6]A4M% &/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM;%% &/_ ,)+J_\
MT*%[_P!]+1_PDNK_ /0H7O\ WTM;%% &/_PDNK_]"A>_]]+1_P )+J__ $*%
M[_WTM;%% &/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM;%% &/_PDNK_]
M"A>_]]+1_P )+J__ $*%[_WTM;%% &/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H
M7O\ WTM;%% &/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM;%% &/_ ,)+J_\
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M*_C$_E$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP\#ZU/\ VP_'_%CX,'ZU/_;"E1117X0?C84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5^QW_!(O\ Y,0\*?\ 7]J?
M_I=-7XXU^QW_  2+_P"3$/"G_7]J?_I=-7ZIX0?\E14_Z]2_]*@?H_A?_P E
M#/\ Z]R_]*@?2U%%%?TH?OH4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %>"?\%0/^3$/B#_UXVG_ *76]>]U
MX)_P5 _Y,0^(/_7C:?\ I=;UXO$G_).XS_KU4_\ 2&>3G_\ R(L5_P!>Y_\
MI+/Q6HHHK^,3^40HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH _H7\,_\ (N:?_P!>,7_H J[5+PS_ ,BYI_\
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M%%% !1110 4444 %%%% ']"_AG_D7-/_ .O&+_T 5=JEX9_Y%S3_ /KQB_\
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M?2U%%%?TH?OH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?]>I?^E0/T?PO_Y*&?\ U[E_Z5 ^EJ***_I0_?0HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\$_X*@?\F(?
M$'_KQM/_ $NMZ][KP3_@J!_R8A\0?^O&T_\ 2ZWKQ>)/^2=QG_7JI_Z0SR<_
M_P"1%BO^O<__ $EGXK4445_&)_*(4444 %%%% !1110 4444 %%%% !1110
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MW7@G_!4#_DQ#X@_]>-I_Z76]>+Q)_P D[C/^O53_ -(9Y.?_ /(BQ7_7N?\
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M@7_R>I_\F'^H'"7_ $#?^3U/_DS\U?\ AQGJ_P#T7^]_\(=?_D^C_AQGJ_\
MT7^]_P#"'7_Y/K]*J*/^(:\$_P#0+_Y/4_\ DP_U X2_Z!O_ ">I_P#)GYJ_
M\.,]7_Z+_>_^$.O_ ,GT?\.,]7_Z+_>_^$.O_P GU^E5%'_$->"?^@7_ ,GJ
M?_)A_J!PE_T#?^3U/_DS\U?^'&>K_P#1?[W_ ,(=?_D^C_AQGJ__ $7^]_\
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MX275_P#H4+W_ +Z6MBB@#'_X275_^A0O?^^EH_X275_^A0O?^^EK8HH Q_\
MA)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6MBB@#'_X275_^A0O?^^EH_X275_^
MA0O?^^EK8HH Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6MBB@#'_X275_
M^A0O?^^EH_X275_^A0O?^^EK8HH Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_
M +Z6MBB@#'_X275_^A0O?^^EH_X275_^A0O?^^EK8HH Q_\ A)=7_P"A0O?^
M^EH_X275_P#H4+W_ +Z6MBB@#'_X275_^A0O?^^EH_X275_^A0O?^^EK8HH
MQ_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6MBB@#'_X275_^A0O?^^EH_X2
M75_^A0O?^^EK8HH Q_\ A)=7_P"A0O?^^EK@?VH/AIJ_[2/P(\0_!/[/>Z-_
M;T$,?]I_9%N?(V3QRY\OS$W9\O'WAUSVQ7JU%88G#T<9AIT*RO":<6M5=-6:
MNM=NVICB*%+%4)T:JO&2::[IJS6FNW8_-7_AQGJ__1?[W_PAU_\ D^C_ (<9
MZO\ ]%_O?_"'7_Y/K]*J*^,_XAKP3_T"_P#D]3_Y,^4_U X2_P"@;_R>I_\
M)GYJ_P##C/5_^B_WO_A#K_\ )]'_  XSU?\ Z+_>_P#A#K_\GU^E5%'_ !#7
M@G_H%_\ )ZG_ ,F'^H'"7_0-_P"3U/\ Y,_-7_AQGJ__ $7^]_\ "'7_ .3Z
M/^'&>K_]%_O?_"'7_P"3Z_2JBC_B&O!/_0+_ .3U/_DP_P!0.$O^@;_R>I_\
MF?FK_P .,]7_ .B_WO\ X0Z__)]'_#C/5_\ HO\ >_\ A#K_ /)]?I511_Q#
M7@G_ *!?_)ZG_P F'^H'"7_0-_Y/4_\ DS\U?^'&>K_]%_O?_"'7_P"3Z/\
MAQGJ_P#T7^]_\(=?_D^OTJHH_P"(:\$_] O_ )/4_P#DP_U X2_Z!O\ R>I_
M\F?FK_PXSU?_ *+_ 'O_ (0Z_P#R?1_PXSU?_HO][_X0Z_\ R?7Z544?\0UX
M)_Z!?_)ZG_R8?Z@<)?\ 0-_Y/4_^3/S5_P"'&>K_ /1?[W_PAU_^3Z/^'&>K
M_P#1?[W_ ,(=?_D^OTJHH_XAKP3_ - O_D]3_P"3#_4#A+_H&_\ )ZG_ ,F?
MFK_PXSU?_HO][_X0Z_\ R?1_PXSU?_HO][_X0Z__ "?7Z544?\0UX)_Z!?\
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M_)A_J!PE_P! W_D]3_Y,P-,UG5].TVWT_P#X12]?R($CWY4;MH SC/'2I_\
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MT7]HCX/7/@'6=!UVWFGTV!K33;>XF6*:2)E*2[ I+QL!EAV.17T'_P $H/\
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M+Q3I>H_#KQ5)Y7@SQ1%HD-D4BN),65S(\8 8!U:VF!P%?+\*HW=-_P %:?\
M@IA\=?@?\;/ 7[%W[#<=E?\ Q1\47T,NIB>QCNA:PS$QVUN5?*J\A+2LS8\N
M.-6/RR9 .S/O^BOA#]H'PY_P7KTCQO:Z7^SQ\0_A_J^AP:#8)>:IJEC90276
MH^0OVMUC:/*1F;?L4\A=N<G)KY5_8K_;[_X+H_M]6GB*]_9Y\9^ [E/"\EJF
MK?VKH]E:E3<"4Q[=R'=_J7SZ<>M 6/V9HK\P/^"GW_!0'_@HO^PS\(?@!HQ\
M4^'+/X@>,-/U>/QVR:1;W5M+>026(B\K*[44"X;.T '/M6=\6/CC_P ''/[,
M?A"^^,_Q!\'> O$WAWP_ ;O6K?3;*SGV6R#=)(\<#Q3E% )8Q\J,L> 2 +'Z
MH45X'_P3A_;P\&_\%"?V<+7XT^']&_LC5;2\?3?$^A&?S/L-\BJQ"-@%XG1T
M=&(Z,5/*M75?MJ?M0>'_ -C3]F#Q=^TCXCTA]1B\-V"O:Z:DNPWEU+*D$$.[
M!VJTLB!FP=J[FP<8H$>I45^0LG[?O_!=.3]FH_\ !1F/0?AY'\,@WVL>&#ID
M>\V/VCR?/V%_M'E;N,^=OV_/MV_-7U3\2/\ @L!X1\)?\$L='_X*&:1X(0ZI
MXE5=-T3PQ=W),0UKS9H9(G<89H8VM[B7(VL\<8QM+9 .Q]HT5^1-S_P5'_X*
MV_LDZ%\./VK/VRO!7A36/A1\29X7CTO2K"*&[L;>:/SHPI0AHIF@S*BRF0,%
M96*-]WZ;_P""J_\ P5#\:_LH>'?AW\/?V5?"NG^)_'GQ9D4^%YKY&DMH;9VB
M2*01AD\R25YT6,%@HVL6S@*0+'VW17Y7:I_P49_X*G?\$\OC]X!\+?\ !2/1
MO!_B'P9\0;OR5U#P[!$DU@!)$DQC> ("\/GQLR.C!U.$?.6'M_\ P4>_;=_;
M=\(?M)>#OV*/V"_A)!<>)_$]E]JO?&7B#3'>PM1B5_*C=\0ADBA>61FW_*RJ
MJEC0%C[BHK\\/V#?^"CG[9>G?MWW_P#P3;_X*"^'=!NO%K6,ESHGB3PW"J+(
MZ6GVS;((\1O&]N&=754967:RDM\GZ'T""BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA_P!I+]G[X>?M
M3? _Q'\ _BEIWVC1O$FG-;3LH'F6\G#17$9/ DCD"2*>FY!G(R*[BB@#\#/^
M"8_[$NM?M#?\%#YOV2OC_P"/6UWP=^SUJ6LW#:%)([6EU);ZFL#PPQMPD4UT
M4ED!^\B%3RV1^^8 4!5& .@%?!?_  3V_P""=/[1/[-/_!2/XX?M2_$I-#'A
M;X@76MR>'S8:H9;@BZUA+N+S(]@V?NE.>3@\>]?>E V?DGI7_*U9J?\ UXK_
M .H9%7U7_P %[/\ E%/\3_\ KKH?_I[L:XNQ_P""=/[15O\ \%S+W_@H+(FA
M_P#"OI[8)&PU0_;<_P#".QZ?S#LQ_KU/\7W>?:O<_P#@J5^S7\2?VO/V&/&O
M[/GPB6P/B'7GTPV U.Z,$'[C4K6XDW.%;'[N)\<<G [T!U.6_P""(O\ RBU^
M$O\ V#=0_P#3I=U\8_#79+_P=)>('\$ &P477]K?9_N@CPR@FW8_Z>L9_P!K
MWK;^"?[(/_!PW^SY\&='_9^^#WQA^'.A>&]%BEATU UG/+ DLLDK_O);)V/S
MRLV>2.,=,5]%?\$LO^"4NL_L5>*?$W[1'[07Q,A\;?%CQDLB:IK%NTDD%G'+
M*)I@DDH62>26159Y65?NJH4?,6 V/M2OBC_@JI_P5/\ #?[%>F_\*+^ FD1^
M)/C5XMC2'2-&T^U\\Z89ODBN9T0$R2L2/*@Y9S@D!<;OLSQ!-K-MH-[<>'+*
M&YU&.TD:PMKB79'+,%)1&;^%2V 3V!K\8O!?_!)+_@MA\/?VCM1_:U\*>.O
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M#5U=:'@SXTO.)/[..IZ$+4G[OG^7?>;CWVF'/X5^LSJKJ4=05(P01P17A_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHKJY>V61R<!0\RHN2> ,Y).!7NE !1110 4444 %%%% !1110 4444 %%%%
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MAXH\&Z[XA_X(+?!7Q7IYU1=-\)?$>35_$<VC-BYMK$:KJT#SQG!PZ//&02"
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MK^P'XU3X<_$:>\UGX4ZS>!M4TM"7ET:5C@WEJ#^<D0X<#(PP!/\ 01X \?\
M@KXJ>"M,^(WPY\3V>LZ%K-FEUI>J6$P>*XB89#*1^1!Y!!! ((K^3OP!X \:
M_%3QKIGPY^'/AF\UG7-9O$M=+TNPA,DMQ*QP%4#\R3P "20 37]&W_!(_P#8
M-\:_L!_LPI\.?B-\1KS6==UF\&I:II:79?3]&E9<&WM0?SD<<.XR   2!*Q]
M35\[_P#!5']HCQ+^S)^Q%XO^(/@>_>TUV[2'2M&O(CAK::YD$;3*>SI$9'4]
MF5:^B*^??^"H?[-_B7]J;]BOQ;\,_ ]H;C7X4AU/0[53S<7%M()#"/\ :DC$
MB+T&YUSQ026OV-/V*/@?^R/\#=*TH>#M(?7VTI+GQ?XIU*VC>YO+MD#SN\T@
M++$K%MJYVJH]2S'F_$/[)_P#O/VP_!7[5GP+^+7AGP7K>F?:+3Q3I6AI;LGB
MJ"8*J0R)'*BK("6_>;78GR^"8U(@_9M_;I_93_;%_9S;X??%_P =Z+H^N7GA
MZ31?B%X*\2ZH-.NDD:$P7<8#LCM&V7PZ'*A@"5<$#Y(_:&^#W_!._P (_M:_
M ?P#^P5H>F:CXOM_BSI=YXGC\):O>:LMOIT-S&[M)(998DV%2[8.Y51BV *
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M-\1H+/6?BMK-GMU35$ DBT:)ADV=J3^4DHY<C PH /VK110 4444 >3?&?\
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M\O[=I>HP^9#-Y<BRIN7OAT1A[J*W:* (K*SM=.LXM/L8%B@@B6.&)!@(BC
M]@!7C&N_\$X/V%?$WCIOB1KG[+GA*?5I)S--(=/VPRR$Y+O I$+DGDED.223
MG)KVRB@#"\:?#'X>_$7P'<_"[QOX.T_4O#MW;I!<Z+<VX-N\2%61-@XV@JN
M.!M%4O&'P0^$?C_PMH_@GQI\/M,U/2?#]Y;7>BZ?=VX:*RGMU*021C^%D4D
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8H **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>dxcm-20230630_g4.jpg
<TEXT>
begin 644 dxcm-20230630_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\4/ /QH\ Z9\4OA=XF@UGP_K-OY^EZG;*PCN(]Q7<H8 XRI'('2M^@ HHHH
M**** "BBB@ HHJ#4M2T[1M.N-8UC4(+2TM86FNKJYE$<<,:@LSNS$!5 !))X
M % $]%?+'BO_ (+8?\$NO!GB&3PQK'[6VDRW,4AC:32M%U&_M\YQQ/;6TD3#
MW#D>]>Z_ _\ :'^!_P"TKX/'C[X#?%+1O%6DB3RY;K2+Q9#!)C/ERI]^)\8.
MQPK8(..: .RHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBO%?C
M=_P47_8=_9R\5OX%^,W[3'AC1M:B(%SI)NVN+FW)Q@2QP*[1$@@X<+P<].:
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M9".D;7*6JGU)5?XJ^\-+U.PUK3+?6=*NDGM;N!)K:=#\LD;*&5A[$$&O!_\
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M#FRYAA_8!\.022 /-\5=/6-<\G&GZB3^@H%;4]]\??\ !37X;> /^"?.E_\
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M4/B#P]K4*)<V32AC$^8V9)(W\N3:P.?D8%5/%?#O[*W[6_[:?QD^%>H^%?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG67C'1;6TBN]-O[XVD@GM)FEMKRVF*E?,4E5*OM \I""3D5YI^T=_P $J/\
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M^"@<M]X8_P"$$.L2W0A&JR?;]C:,UD/W7E;<^:1_']WGVK]$**!W/SN^+_\
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M^V!^U/\ \)3X&M["\CU#1O\ A.+N^\V5X&6%O)EA56VN5.2>,9K!_P""@O\
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MZKI&EM>RE(1<7%I+#&78 E5W.,D X'8UZ'10!^*_P-_X(V?\%L/V:-,O]&^
M7[17AGPG::I.D^H0:+XSN8EN)%4JK,!:\D D5WOP[_X(&?M@?M$_&#3OB;_P
M4Q_:P3Q+IVGNN[2]-UR\U&\N80VXVPFG2-+.-CU,0<\G 5CN'ZUT4#NRIH.A
M:-X6T*R\,>'-,@LM.TZTCM;"RMHPD=O#&H1(T4<*JJ  .P%6Z**!!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K@/V
MGOCS\$?V;/@IK/Q6_:*U-;7P?;1I:ZN[Z3+?)(MPXA6)H8D<LKLX0Y7;\W)
MKOZYCXT?!WX>?M!?"O7?@O\ %?P^FJ>'O$5@UIJ=D[%=R'!#*PY1U8*ZL.59
M5(Y% 'YR?&#_ ()F_!33OVS-8F_8G^)&N_!B\/P0D\9:3J_@G79HK*6]&H%%
M\U&8_P"B/&%S%&408! P"I^OO^"5_P"TQX^_:[_82\"?'/XHQH?$.H6]U:ZK
M=10B-+R6UNYK;[0%4!5,@B#,% 4,6    KYC3_@C'\:T^. ^%2_MH_$W_A4
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MW9G9CU9B>]<G^VW^R1X4_;@_9VU?]G/QKXIU'1M.U>YM)I=0TM(VFC,$Z3*
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M#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\
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M;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%%
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M[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\
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M #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
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M_#<&JWMY;KI-Q?BY:,P3M$6\P(@.=N?N\9KV:@ HHHH **** "BBB@ HHHH
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M_P $+_&'B.Z_9+\2_!7Q)J\U\?A/\4M:\(:;<7+[I&LK=HI8@3Z+Y[H!V5%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /QW_X*O?L5?M5_LJ?&SQK^US\ [S3]>^'WQ*\8:#?>)?#TS*+N
M'5HM1@EMH]IPTB/=@;6B;<!.ZLH"AS[7HG[0LO\ P5Y_X)[_ !V_9O\ A_\
M! _#GXMZ+!%#XC\'RA8A/>I<_:$ =DC8-+):30LLJ@QNV&8@[CY1_P %/_V,
MOVXOV=?B?XP^.GP-^(MKXH^&OQ'\<Z%?7OAGQ!J,LDNEZLNJQ36L:H[ " 73
ME08V&V*9D91L5Z^F?V+?^";_ .T-\+?AO\:_B/\ &CXW6^F_&CXXO)<7FO\
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M #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
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M_>R@+,_6+_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK\G?^(JW_ *L._P#,H?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %?E7_P=,?\ )'?A)_V,
MVI?^D\5?JI7Y5_\ !TQ_R1WX2?\ 8S:E_P"D\5 UN?B_11106%%%% !1110
M4444 %%%% !1110 4444 %%%% !7]9WP5_Y(YX2_[%FP_P#2>.OY,:_K.^"O
M_)'/"7_8LV'_ *3QT$R.FHHHH)"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *_*O_@Z8_Y([\)/^QFU+_TGBK]5*_*O_@Z8_P"2._"3
M_L9M2_\ 2>*@:W/Q?HHHH+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK^L[X*_\D<\)?]BS8?\ I/'7\F-?UG?!7_DCGA+_ +%FP_\ 2>.@F1TU%%%!
M(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Y5_\'3'
M_)'?A)_V,VI?^D\5?JI7Y5_\'3'_ "1WX2?]C-J7_I/%0-;GXOT444%A1110
M 4444 %%%% !1110 4444 %%%% !1110 5_6=\%?^2.>$O\ L6;#_P!)XZ_D
MQK^L[X*_\D<\)?\ 8LV'_I/'03(Z:BBB@D**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ K\J_P#@Z8_Y([\)/^QFU+_TGBK]5*_*O_@Z
M8_Y([\)/^QFU+_TGBH&MS\7Z***"PHHHH **** "BBB@ HHHH **** "BBB@
M HHHH *_K.^"O_)'/"7_ &+-A_Z3QU_)C7]9WP5_Y(YX2_[%FP_])XZ"9'34
M444$A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?E7_
M ,'3'_)'?A)_V,VI?^D\5?JI7Y5_\'3'_)'?A)_V,VI?^D\5 UN?B_11106%
M%%% !1110 4444 %%%% !1110 4444 %%%% !7]9WP5_Y(YX2_[%FP_])XZ_
MDQK^L[X*_P#)'/"7_8LV'_I/'03(Z:BBB@D**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\
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M -"A>_\ ?2T?\)+J_P#T*%[_ -]+02;%%8__  DNK_\ 0H7O_?2T?\)+J_\
MT*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DN
MK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J_
M_0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2
MZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\
MT*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DN
MK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J_
M_0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2
MZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\
MT*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DN
MK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J_
M_0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2
MZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\
MT*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DN
MK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J_
M_0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2
MZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\
MT*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DN
MK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J_
M_0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2
MZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\
MT*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DN
MK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J_
M_0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2
MZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\
MT*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2UH:;>3WUJ)[BPDMF+$>5*1GZ\4
M6**** "BBB@ HHHH **** "BBB@ HHHH ^8_^"CG[&GQ7_:*G^'GQU_9K\7:
M9H_Q1^$?B"35?"G]NA_L&H12B,7%G.4!91((HP&';<OR[]Z_('@?X!_M_?\
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MJ[^R[\4/VQ_V)?$GP#^#JZ<=?U6_TZ:U&J79@AVPWD4KY<*V#M0XXY-?1U%
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M@L12JMN2J:W[NG!O\6PHHHK]'/O HHHH **** "BBB@ HHHH **** "BBB@
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M110 4444 %%%% !1110 4444 %?E7_P=,?\ )'?A)_V,VI?^D\5?JI7Y5_\
M!TQ_R1WX2?\ 8S:E_P"D\5 UN?B_11106%%%% !1110 4444 %%%% !1110
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M-^25VM4?<GQA_:Q_9R^ 6IP:)\7OBYI.BWUS&)(K&9VDGV$X#F.-695)!PQ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _GV^)G_)2/$'
M_8<N_P#T<]8E;?Q,_P"2D>(/^PY=_P#HYZQ*_AS$?QY^K_,_D"O_ !Y>K_,*
M***R,@HHHH **** "BBB@ HHHH **** "BBB@ K[W_X(._\ )2/B%_V [+_T
M=)7P17WO_P $'?\ DI'Q"_[ =E_Z.DK[3P\_Y++">LO_ $B1]9P-_P E7AO6
M7_I,C]+:***_K0_I@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M  &?_P L#_B*7$'_ #ZI?^ S_P#DS]F_^'K_ .P%_P!%[_\ +6U7_P"1:/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M10 4444 %%%% !1110 4444 %%%% !1110 5^5?_  =,?\D=^$G_ &,VI?\
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M4^%[_3D\7:K) [:=IQGN(4^R#R_F>>3S5B5LJJ2R*,2%62OHO]@+]OKX8?\
M!0'X57WC[P-X?U+0-5T+4SIOB?POK('VG3+H+N )'WT89VMA22K JI4B@+'N
MU%?)?QM_X*\? OX7?MK^!_V(/!FCCQAK_B?6X-,U_4=+U=%@\/3S3+$D<F$;
MS91EF>,%2@"@G+8'UI0 45\S?M^?\%.?AK^PMK'AKX;Q_#C7_'WC_P 8'/A[
MP1X7CW7,T>_8)'(5F4,X*(JH[.RL N%)$O[ '_!3'X8_MX3^)?!=MX!UWP/X
MZ\&S!/$W@GQ-'MNK8%BF]3A2P5P4<,J.C8#*-RD@6/I2BN4^._Q1@^!_P/\
M&7QJNM&?48O!_A34=;DT^.81M=+:6TDYB#D$(6$>W=@XSG!KY9_X)H?\%EO
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MP]_[#E[_ .B8Z_-&OTN_X+Q?\DW^'O\ V'+W_P!$QU^:-?RMXG_\EG7](?\
MI$3^<?$/_DJZWI#_ -)04445\ ?$A1110 4444 %%%% !1110 4444 %%%%
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M,T444""BBB@ HK.U*V\32W1?2]2MHHMHPDL)8Y[\U!]B\;_]!NR_\!C_ (T
M;%%8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"- &Q16/\ 8O&__0;LO_ 8
M_P"-'V+QO_T&[+_P&/\ C0!^!WQ,_P"2D>(/^PY=_P#HYZQ*_1GQ)_P0JU+Q
M#XBO]??]IZ&(WU[+<&+_ (0XG87<MC/VL9QGKBJ7_#A+4/\ HZ6'_P (P_\
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M-V/L^_G.T].E)M15V9U:L*-*52;LHIM^BU9[%17X\_\ $4EXG_Z,W@_\+_\
M^]]'_$4EXG_Z,W@_\+__ .]]<OU["_S?@_\ (^?_ -;N'O\ G]_Y+/\ ^1/V
M&HK\>?\ B*2\3_\ 1F\'_A?_ /WOH_XBDO$__1F\'_A?_P#WOH^O87^;\'_D
M'^MW#W_/[_R6?_R)^PU%?CS_ ,127B?_ *,W@_\ "_\ _O?1_P 127B?_HS>
M#_PO_P#[WT?7L+_-^#_R#_6[A[_G]_Y+/_Y$_8:BOQY_XBDO$_\ T9O!_P"%
M_P#_ 'OH_P"(I+Q/_P!&;P?^%_\ _>^CZ]A?YOP?^0?ZW</?\_O_ "6?_P B
M?L-17X\_\127B?\ Z,W@_P#"_P#_ +WT?\127B?_ *,W@_\ "_\ _O?1]>PO
M\WX/_(/];N'O^?W_ )+/_P"1/V&HK\>?^(I+Q/\ ]&;P?^%__P#>^C_B*2\3
M_P#1F\'_ (7_ /\ >^CZ]A?YOP?^0?ZW</?\_O\ R6?_ ,B?L-17X\_\127B
M?_HS>#_PO_\ [WT?\127B?\ Z,W@_P#"_P#_ +WT?7L+_-^#_P @_P!;N'O^
M?W_DL_\ Y$_8:BOQY_XBDO$__1F\'_A?_P#WOH_XBDO$_P#T9O!_X7__ -[Z
M/KV%_F_!_P"0?ZW</?\ /[_R6?\ \B?L-17X\_\ $4EXG_Z,W@_\+_\ ^]]?
MH!_P3X_:\\9?MX_LU:?^T3#X6M/"RW^I7=I_9#7GVTIY$I3=YOEQ9W8SC:,>
MIK2GB:%:7+!W?S.W Y]E.95O98:IS2M>UI+3YI=SZ&HK'^Q>-_\ H-V7_@,?
M\:/L7C?_ *#=E_X#'_&MSUS8K\J_^#IC_DCOPD_[&;4O_2>*OT\^Q>-_^@W9
M?^ Q_P :^7?^"GG_  3%\2_\%)O"'A3PIJ/QWM?"0\+ZE<W:SIX9-]]H,L:)
MMQ]HAV8VYSDYST% +<_G%HK]=/\ B%5U#_H^>'_PVQ_^6-'_ !"JZA_T?/#_
M .&V/_RQH+NC\BZ*_73_ (A5=0_Z/GA_\-L?_EC1_P 0JNH?]'SP_P#AMC_\
ML: NC\BZ*_73_B%5U#_H^>'_ ,-L?_EC1_Q"JZA_T?/#_P"&V/\ \L: NC\B
MZ*_73_B%5U#_ */GA_\ #;'_ .6-'_$*KJ'_ $?/#_X;8_\ RQH"Z/R+HK]=
M/^(574/^CYX?_#;'_P"6-'_$*KJ'_1\\/_AMC_\ +&@+H_(NBOUT_P"(574/
M^CYX?_#;'_Y8T?\ $*KJ'_1\\/\ X;8__+&@+H_(NBOUT_XA5=0_Z/GA_P##
M;'_Y8T?\0JNH?]'SP_\ AMC_ /+&@+H_(NBOUT_XA5=0_P"CYX?_  VQ_P#E
MC1_Q"JZA_P!'SP_^&V/_ ,L: NC\BZ_K.^"O_)'/"7_8LV'_ *3QU^4O_$*K
MJ'_1\\/_ (;8_P#RQK]5?!OA#QKX0\(:5X33Q+9SC2]-@M!/]B*^8(XU3=C)
MQG;G&3CUH$W<ZNBL?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&@DV**Q_L7C?_
M *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@
MW9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_
M *#=E_X#'_&C[%XW_P"@W9?^ Q_QH ^(?^"\7_)-_A[_ -AR]_\ 1,=?FC7[
M,_MP_L->)?VT_#V@:!J/Q9M=!&A7LUPLJ:&;GSC(BKC'G1[<;>N37SE_PX2U
M#_HZ6'_PC#_\F5^ \=\$\3YSQ-6Q>#P_/3DHV?/!;12>DI)[KL?BG&7"/$.:
M\05<3A:/-!J-GS06T4GHY)[^1^>=%?H9_P .$M0_Z.EA_P#",/\ \F4?\.$M
M0_Z.EA_\(P__ "97Q_\ Q#7C;_H%_P#)Z?\ \F?+_P"H'%O_ $#?^3T__DS\
M\Z*_0S_APEJ'_1TL/_A&'_Y,H_X<):A_T=+#_P"$8?\ Y,H_XAKQM_T"_P#D
M]/\ ^3#_ % XM_Z!O_)Z?_R9^>=%?H9_PX2U#_HZ6'_PC#_\F4?\.$M0_P"C
MI8?_  C#_P#)E'_$->-O^@7_ ,GI_P#R8?Z@<6_] W_D]/\ ^3/SSHK]#/\
MAPEJ'_1TL/\ X1A_^3*/^'"6H?\ 1TL/_A&'_P"3*/\ B&O&W_0+_P"3T_\
MY,/]0.+?^@;_ ,GI_P#R9^>=%?H9_P .$M0_Z.EA_P#",/\ \F4?\.$M0_Z.
MEA_\(P__ "91_P 0UXV_Z!?_ ">G_P#)A_J!Q;_T#?\ D]/_ .3/SSHK]#/^
M'"6H?]'2P_\ A&'_ .3*/^'"6H?]'2P_^$8?_DRC_B&O&W_0+_Y/3_\ DP_U
M XM_Z!O_ ">G_P#)GYYT5^AG_#A+4/\ HZ6'_P (P_\ R91_PX2U#_HZ6'_P
MC#_\F4?\0UXV_P"@7_R>G_\ )A_J!Q;_ - W_D]/_P"3/SSHK]#/^'"6H?\
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MD>%/VX/V=M7_ &<_&OBG4=&T[5[FTFEU#2TC::,P3I,H D!7!* '(Z&O6:*
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MF7^!_G$^WZ***]T_7@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** /Y]O^#A?_E)AX@_[%K2/_285
M\05]O_\ !PO_ ,I,/$'_ &+6D?\ I,*^(*^:Q/\ O$O4_!,]_P"1SB/\<OS"
MBBBL#R@HHHH **** "BBB@ HHHH **** "BBB@ KZ5_X(\_\I,/A#_V,K?\
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MP+_R.9?X'^<3[?HHHKW3]>"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _GV_P"#A?\ Y28>(/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /Y]O\
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MPWVE:A;-F.YMY4#QR*?1E8'\:\R_;L_:ZT7]AK]FS6/VC_$'@NZ\06NCW5I
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M 4444 %%%% !7]!/_!O1_P HS_#_ /V,NK_^E)K^?:OZ"?\ @WH_Y1G^'_\
ML9=7_P#2DUWY;_O#]/\ (^RX%_Y',O\  _SB?;]%%%>Z?KP4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% '\^W_!PO_RDP\0?]BUI'_I,*^(*^W_^#A?_ )28>(/^Q:TC_P!)A7Q!
M7S6)_P!XEZGX)GO_ ".<1_CE^84445@>4%%%% !1110 4444 %%%% !1110
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M7^*/_!1CQW\+M9\,>$==\)V_@OX<Z3XGLC;WM_I:LDMS>20MS&DDD:E/42,
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M8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\ PF/AC_H-0?\
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M %?OY_P;Z^(M$TW_ ()K^'[6^U***0>)-6)1CS@W)K\ Z_H%_P"#>VSM)O\
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M_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\
MA,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[Z
MH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[
MZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!
MJ#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A
M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4
M4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ
M% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_
M]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__
M #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%
M']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]
M^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,
M/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__
M #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[Z
MJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/
M^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!
MJ#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'
M_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 ?S[?\'!5_9ZE_P4H\
M075C<++&?#>D@.O3(MA7Q-7V[_P<)Q10_P#!2WQ D,:HO_"-:1PHP/\ CV%?
M$5?-8G_>)>I^"9[_ ,CG$?XY?F%%%%8'E!1110 4444 %%%% !1110 4444
M%%%% !7TC_P2#NK>R_X*4?".ZNI0D:>)&+.W0#[--7S=7TI_P1\1)/\ @I;\
M(DD0,I\2MD,,@_Z--6E'^-'U1W97_P C.A_CC_Z4C^D+_A,?#'_0:@_[ZH_X
M3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A7U!_013_X3'PQ_P!!
MJ#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A
M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4
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M#N_P_P @_P!0\G_Y^5/OC_\ (G\Z/_#B+_@JQ_T:Q_Y?&A__ "=7N'_!-O\
MX)!?\%$_@%^W)\.?C#\6OV>?[)\.:#KC7&K:C_PEND3^1&8)5W>7#=O(WS,!
MA5)YK]OJ*J.74824DWIZ?Y&N'X)RK#UX58SG>+35W'H[_P H4445WGV(4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=LOVJ29P@. TMH"S'JTOJU>"?LO>./V&_@7\8_A7\-/VM_\ @E!K7PGU>_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7S5_P %AO\ E&?\7O\ L6E_
M]*8:^E:\/_X*2?!_XB_'W]AOXC?![X2^'?[6\1Z]H:V^DZ=]KA@\^03Q-M\R
M9TC7Y5)RS <5G53=*279G%F4)5,NK1BKMPDDEUT9_,/17UU_PXB_X*L?]&L?
M^7QH?_R=1_PXB_X*L?\ 1K'_ )?&A_\ R=7SGU>O_(_N9^'?V-G'_0/4_P#
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M(O\ @JQ_T:Q_Y?&A_P#R=1]7K_R/[F']C9Q_T#U/_ )?Y'R+17UU_P .(O\
M@JQ_T:Q_Y?&A_P#R=1_PXB_X*L?]&L?^7QH?_P G4?5Z_P#(_N8?V-G'_0/4
M_P# )?Y'R+17UU_PXB_X*L?]&L?^7QH?_P G4?\ #B+_ (*L?]&L?^7QH?\
M\G4?5Z_\C^YA_8V<?] ]3_P"7^1\BU_03_P;T?\ *,_P_P#]C+J__I2:_+#_
M (<1?\%6/^C6/_+XT/\ ^3J_8?\ X(W?LX?&?]E3]AO1_@]\?/!O]@^([77-
M1N+C3O[1MKK;'+.6C;S+:22,Y7G ;([XKNP%*K"O>46M.Q]9P;E^/PN;.=:C
M**Y&KN+2W75H^IZ***]D_4@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#X]\%V>M23MJWC7Q!EFNKJ*TDF:YNW\A-S/Y6Q1D*FY54  "OHWX>_M,:O\
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M-UX.73W?N3/!RRGBJF;8>I63O3DZ2_[<A*[^;:/T9HHHKUS])"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ***^7O\ @IE^U/\ &KX':?\ #?X(
M_LU2Z99>/OB_XTC\/:)K^MVXFM=&B^4S71C((D==Z;5((.6.UB I /J&BOS"
M^#=S_P %3/V>O'?C'XC^!OC;JGQUT71/CO)X:\?^![OPO!%<WD)T^PEDU2S=
M&)M=HEV>0I$2E58A]S8^SOV__P!J/5OV6?@/_;'@'3(M2\=^+=9M?#'PYT>7
ME;O6KQO+@W#O''\TK#N(]N06% 'M]%>9>+/C#X2_8]_9NM/B#^UK\;89ET'2
MK>'Q%XMO;*.%M1O2H#-';VT:C=(^=D4:9Q@8.":^;/\ @GI_P4B^+O[;7[;7
MQ)\%ZMX'OO"G@/1?!]AJ'@_0-:TQ8=0ECFE79?3L1N'GQN'5 2@0I@MR[ 'W
M!117R3^U1^U-^TQXW_:\TS]@']B*_P##^C>)(O"Y\1^/?'?B.P-Y#H%@9!'#
M%#;@@2W#LR'#9&V1/]ID /K:BOD+]G/]J#]JGX2_MD1?L'?MQ:QX<\1ZAXE\
M.3:W\-_B!X;TTV*ZND&XW%I<6V2L<R*CR#9@!4YW;@1E>+_VD?VT?VO/VL/'
MG[.?[#WCKPOX#\+?">2"R\7^/=?T'^U)[_5Y0S&SMH&8($CV.CL?F#(3G#*"
M ?:5%?+O["G[6OQP\:_%[X@?L8_M?:9H</Q.^'"VUX-8\.(\=CXATFX4&*]C
MC<DQLNY!(. #(H !# >8_#3]H/\ X*+_ /!1#4?%OQ>_8X^*O@?X;_#+P_XA
MNM'\&R>(/#1U.Z\526_$ES,Q.+>W9B-IC&X<@ABI) /O"BOGS_@G;^V%XK_:
MP^&OB'2_B]X1M/#WQ'^'?BJY\,_$#1-/D+6Z7L!P)X-Q)\F09VY)Y1P"P 8^
ME_M*_'GPE^R_\!/%?[0'CF.233/"NC2WTUO"P#W+J,1P(3P&DD*1@GC+C- '
M<45^?T?Q1_X+.3_LY#]O"'Q?\-38/H?_  DJ_!,^&9-_]C^7Y_E_;M_F_:OL
M_P VSINXZ_)7O'B[X_\ Q0_:4_X)]V?[57[%6O'3?$-WH$/B/1=+N[*&Z2^:
MW.^ZT>8.AYD\N:V+QE'5PK*Z@'(!]$T5P7[+_P"T)X*_:L^ 'A7]H3X?L1IG
MBC2DND@=PSVLH)2:W<C@O%*LD;$<90XXKR?_ (*V_M+_ !7_ &1?V&_$WQT^
M"FJ6MGXATS4--BM+B\LDN(U6:\BB?*.,'*.P]J /I6BOF?\ X)3_ +6OQ$_:
MU_9EN-6^.'V>/XA>$/%6H^'/&\%O;K JWD$NY"(UX4>5)&O'!9'QZ#P'_@MK
M_P %.OVB/V.O&?AKX8_LKW]A!J4&@2:]XVN[W2XKM;:SENH[2S4"3(4M+YN>
M^-IZ9H"Q^BU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !4.H6%IJMA/IE_#YD%S"T4T9)
M&Y&!!&1R,@FIJ* W,#X6_"_P)\%?AYI'PI^&.@+I7A_0;-;32=.2>246\*]%
M#R,SMUZL2:\7\0_L3:OI_P#P42T3]N[X5^+[+2_MWA2?P_\ $C0KFW<G6;<!
M3;31NO"RHT<(.X8*VZ 8R37T/14N$9))]#GJX6A5A&+6D6FK:6:VM;[O30**
M**HZ HHHH **** "O /^"A/['7BG]N7X>>&?@@OCVWT/P@/%]IJ7CN+RG:YU
M2QMSN%G"5^5"S'<7;[IC0@'!!]_HJ914XN+V,<1AZ6*HRI5%>+W\UV(-+TO3
MM$TRVT71[**VM+.!(+6V@0*D4:*%5% X    'H*GHHJC9))!1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5XI^W'^QC\.?VU/ASI7
M@[Q;XQU+POKV@ZY%JW@KQ=H=P([W2=2C!*219(WCN4R"=H(*LJL/:Z^9/^"C
MO[&GQ5_:-;X>_'#]FWQ?IFC_ !0^$?B%]6\)G7 _V"_CE$8N+.<H"RK((8QN
MQT#*=N_>H"/CCX7_ +1G[??_  3;/Q6^+/Q*NO#?Q<^%>B?&V33/B=KT=B=/
MUZ.\DL],B_M&.)#Y(C9);5/+RY,@()0-YE>\_M6^(K+XN_\ !7S]D_P&;Q;G
MP[8^'M>\6V:C[ES.UE*8),'J4-O&Z]QENF:\.\$_ ;_@H#^W_8?%K]F7Q[X+
M\)?#KP)KOQU?4/B[K%IKWV^]-Q!9Z7(VFV,:C!7]S;RB5\#+@9^1E?WC_@I!
MX2LOV<?VF/V9/VV-)LQ:^&_ /BB3P?XJE492PTO5(/LD,[D_=BB+2@D]Y4[X
MR#/LWQ=X%\$_$"P@TKQWX1TS6K6UO8[RWMM5L8[B..XC.8Y0L@(#J>5;&5/(
MP:^-OV<O^4Z'[1/_ &3?PY_Z3VM?;U?-7P@_96^*G@G_ (*<?%S]K'6UT[_A
M$_&G@_1]-T4PWA:Y\^VB@63S(]ORKF-L')SQ0(^E:^'?V4PW_#\']J4ZF/W_
M /PB/A7^S]W_ #[_ -GVN_;[;\9]Z]A_:J^./[0?PH_:9^!?@GX;)X;F\)>/
M/%5UH_BRVOHWDU,E;5[E)+958 1I'!,9'((7,8_B%<5^U1^RQ^TYX+_:\TS]
MOS]B"V\/:OXCF\,?\(YX]\">);YK2#7[!9!)%+%< $17"%4&6P-L:]?F5P9R
M7_!0$,W_  5=_8S&C_\ ']_:'BPW&S[WV?[%;9S[;?-_6E_X(NAAXA_:B.IC
M_B:?\-+^(/M^[[_WEQG_ (%YGZUTG[.7[+W[57Q:_;)A_;S_ &X](\.^'-0\
M->')=$^''P^\-ZD;Y=)2?<+B[N+G 629U=XQLR"K\[=@!R_%_P"S;^VI^R+^
MU?X\_:,_8>\%>%O'GA;XK207WB_P!X@US^R[BQU:-2IO+:X92A23<[.&Y+.1
MC"J0 <EXU&IG_@N7XY_X1'?]I_X9-N/M?D]?-^W)Y><=\^3C\*[K_@@:+ ?\
M$J_AL;/;YAN=;^U;>OF?VS>XS[[-GX8KHOV$OV2/CCX)^,'Q _;0_:^U71)O
MB=\1UMK,:/X<=Y+'P[I-NH$5E'(V#(QVH7/()B4@DEB?,?AM^SW_ ,%&O^">
M&I>+?A)^QS\,/ WQ(^&.O^(+K5_!L/B#Q&VF77A62Y.Y[:52,7%NC %1&=S8
M)RI8J "]_P $TPW_  \=_;3-C_QX?\)EX=V;?N_:/(O_ #L>^[&?PK>_X+X?
MVC_PZM^)'V#=L^T:+]JV_P#//^U[/K[;MM=S^P%^QWX__9-^#_BO5?B+XNL/
M$7Q4^(GB&\\3>--:MD9;1]2F!*019"GR(STR!DNY 4$*+.@_ SX]_M3?L/\
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MYMO\0OC'I6A>")V&5/A[1YVM898_[HFF$SL!P6CSS7W/_P %/OV(?CE^TO\
M!CP!J_[,^N6&D_$_X>:IYFCZE>7I@1;2XM&MKR(2!6P6_=-TY$>.]8O[9_\
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M\-<_'#_HQGQW_P"!,%'_  US\</^C&?'?_@3!7O5% '@O_#7/QP_Z,9\=_\
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MZ,9\=_\ @3!1_P -<_'#_HQGQW_X$P5[U10!X+_PUS\</^C&?'?_ ($P4?\
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M\-<_'#_HQGQW_P"!,%>]44 >"_\ #7/QP_Z,9\=_^!,%'_#7/QP_Z,9\=_\
M@3!7O5% '@O_  US\</^C&?'?_@3!1_PUS\</^C&?'?_ ($P5[U10!X+_P -
M<_'#_HQGQW_X$P4?\-<_'#_HQGQW_P"!,%>]44 >"_\ #7/QP_Z,9\=_^!,%
M'_#7/QP_Z,9\=_\ @3!7O5% '@O_  US\</^C&?'?_@3!1_PUS\</^C&?'?_
M ($P5[U10!X+_P -<_'#_HQGQW_X$P4?\-<_'#_HQGQW_P"!,%>]44 >"_\
M#7/QP_Z,9\=_^!,%'_#7/QP_Z,9\=_\ @3!7O5% '@O_  US\</^C&?'?_@3
M!1_PUS\</^C&?'?_ ($P5[U10!X+_P -<_'#_HQGQW_X$P4?\-<_'#_HQGQW
M_P"!,%>]44 >"_\ #7/QP_Z,9\=_^!,%'_#7/QP_Z,9\=_\ @3!7O5% '@O_
M  US\</^C&?'?_@3!1_PUS\</^C&?'?_ ($P5[U10!X+_P -<_'#_HQGQW_X
M$P4?\-<_'#_HQGQW_P"!,%>]44 >"_\ #7/QP_Z,9\=_^!,%'_#7/QP_Z,9\
M=_\ @3!7O5% '@O_  US\</^C&?'?_@3!1_PUS\</^C&?'?_ ($P5[U10!X+
M_P -<_'#_HQGQW_X$P4?\-<_'#_HQGQW_P"!,%>]44 >"_\ #7/QP_Z,9\=_
M^!,%'_#7/QP_Z,9\=_\ @3!7O5% '@O_  US\</^C&?'?_@3!1_PUS\</^C&
M?'?_ ($P5[U10!X+_P -<_'#_HQGQW_X$P4?\-<_'#_HQGQW_P"!,%>]44 >
M"_\ #7/QP_Z,9\=_^!,%'_#7/QP_Z,9\=_\ @3!7O5% '@O_  US\</^C&?'
M?_@3!1_PUS\</^C&?'?_ ($P5[U10!X+_P -<_'#_HQGQW_X$P4?\-<_'#_H
MQGQW_P"!,%>]44 >"_\ #7/QP_Z,9\=_^!,%'_#7/QP_Z,9\=_\ @3!7O5%
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M@S7_  'XJU*.VO=$TZV@ANM/=XVE^S;X=IBN/+21EW><F8V#'- 6/UGHK/\
M"?B;2/&OA;3/&7A^<RV&KZ?#>V,K+@O#*@="1VRK#BM"@04444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %01Z7
MID6H2:M%IT"W<L826Z6%1(ZCHI;&2!Z5/10 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M50#)N(P ,'@#I6S0(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^'/V?/VA-%U[5$C9QH\D<]E>NBC+.EO=1Q2NH')95('?%>TT %%%% !1110
M4444 %%4!XJ\,'Q.?!*^(K$ZR+'[:=)%VGVD6V\)YQBSN$>XA=V,9XSFL'X<
M?';X2?%SQ%XG\)?#?QQ:ZMJ/@O5SI?BBTMU<-I]V,YA?<H!;Y6Z9''6@#K:*
M** "BBB@ HJ*^OK'2[&;4]3O(K:VMXFEN+B>0(D2*,LS,>%  ))/  KYE\1?
M\%G_ /@F'X6\7-X(U3]KG0Y+U)?+:6PTZ^N[3=G'_'U! \&/]K?CWH ^GZ*R
MO!'CGP9\2_"=CX\^'GBO3M<T74X!-IVJZ5>)/;W,9XW)(A*L,@C@\$$=JU:
M"BBB@ HKDO$?QV^$GA'XM>'?@5XC\<6MIXM\6VUS<>'-#D5_-OH[>-I)F0A2
MH"(K$Y(Z<5UM !117B/QJ_X*0_L/_LZ_$*[^%/QK_:)T7P]XAL8HI+O2[R&X
M,D:R()$)*1L.58'KWH ]NHKYV\(?\%9?^"=7CWQ9I?@7PA^U3X?OM6UK48+#
M2[&*"Y#W%S-(L<<:YB RSLH&2!S7KGAOX[?"3Q?\6?$?P*\-^.+6[\6^$;>U
MG\2:'&K^;81W$:R0LY*A2'1E88)Z\XH ZVBBB@ HHHH **** "BBB@ HHHH
M***^+O\ @NG^UG^T#^QO^R3X=^)W[-_C_P#X1S7+_P"(UII=U??V5:7F^T>P
MU"5H]EU%(@R\$1W!0WRXS@D&*E14H.3Z'+C<73P&$GB*B;C%7=M_T/M&BOYT
M?^'[O_!5C_HZ?_RQ]#_^0:/^'[O_  58_P"CI_\ RQ]#_P#D&N'^TJ'9_A_F
M?)_Z^9/_ ,^ZGW1_^2/Z+J*_!?\ 8]_X+0_\%+?BG^UM\+?ACX\_:3^WZ'XC
M^(VB:7K-C_PAVC1?:+2XOX8IH]\=FKIN1V&Y6##.00>:_>BNJAB(8A-QZ'O9
M/G6%SJG*=",DHNSYDE^38445Q_P8^/WP=_:&T;5?$'P7\>6GB"RT37)]&U6X
MLU<"VOH51I8&WJIW*)$)QD?,.:W/8.PHHHH **** "BBB@ HHKFM9^,?PLT'
MX>:U\6-0\>Z8?#?AV&[EUO6;6Z$\%FMKN^T;S%N^:,HX91RI4@C(Q0!TM%9'
M@#Q[X0^*7@C2OB/X UV+4]#URPBO=)U& ,$N;>10R2+N ."I!Y -:] !1110
M 445ROQB^.'P@_9]\%S?$7XV_$C1_"^B0.$;4-9O5A1G()$:9.9'.#A%!8XX
M!H ZJBOF_P"$_P#P5W_X)P?&WQO!\.OAY^U1HLVL7<X@M+;4["\TY;B4G"I'
M)=P11NS' 4*Q+$@#.:^D* "BBB@ HHKDOAQ\=OA)\7?$7B?PG\-_'%KJVH^#
M-7.E^*+6W5PVGW@SF%]R@%OE;ID<=: .MHHID\\5M ]S.X5(T+.Q[ #)- #Z
M*^9O^'R/_!,C_H[[PW_X#W7_ ,9KM_@=_P % /V.?VD]4U71/@;\>=(\1W6B
M:4^I:K#913@VUHC!6E;?&O + <9//2@#V*BN9^#OQD^&/[0/PXT[XN_!OQ?;
M:]X;U?SO[-U:T5Q'/Y4SPR8#@-\LD;KR.JFNFH **** "BBB@ HHHH ****
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M.DMJ>JZ'\.M;LO#]GI8Y)T\O$C2R2H (V0 2,V5&XD,0#VSP[_P5S^'.H?\
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M;;7M9TC7(M+_ +?B,0\J[CA\TM=0B-8LLIA)#1EP=P)Z_P#X)>_M!_M'ZO\
MM)_%_P#8^^+OQ[T_XQ:'\-8=.?1_B;86$<+/)<(2UG.T19))%^8'+.RM#*"[
M<!0#[@HHHH$%%%% !7YT?\'-_P#R89X2_P"RNV'_ *:]5K]%Z_.C_@YO_P"3
M#/"7_97;#_TUZK7-B_\ =I>AXG$G_(CK_P"$_"ZBBBOG#\*/7?\ @G[_ ,GY
M_!+_ +*[X:_].EM7]1=?RZ?\$_?^3\_@E_V5WPU_Z=+:OZBZ]G+/X<O4_4>
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M<_,JE=IVDM\LD9#99E7Z-\1_\B]?_P#7E+_Z :^+?V9?^4X_[2__ &(GA?\
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MO /QN\#7.L^#_&JW3I))>0Q&X:U:(K@ P&(\D,'D"D9'//\ CK_@J#8>#O\
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M^46OQ:_[!NG_ /ITM*^JZ^5/^"W?_*+7XM?]@W3_ /TZ6E!*W/,/V=OVP/\
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M5_#6;P;XO\&^*KKPWXT\,RW8G%GJ%N%W[) !N0[L8(RK*ZY8*&:Q_P %.?\
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M$_ 'PZTC2_",$%Q!%X<M[)?L8BGD>29#$05*N\DA8'(.\YZUY?X)_P""8/\
MP3\^'7Q"B^*?@S]DWP?9:W;W GM;D:>9([:4'*O%"Y,43 \@H@*D#&,"O>**
M ,OQKX*\)_$?PCJ7@'QYX>M=6T76+*2TU33+Z(/#<P.I5XW4]002*Q=.^ ?P
M8TCX-M^SUIGPSTB#P0^F2Z>WA>.T469M9-WF1>7TVMO8GW)-==10!B?#GX;^
M _A%X)T_X;_#'PG8Z'H.DPF+3=)TV 1P6Z%BQ"J.F69B?<DUXUXD_P""5O\
MP3M\7>.I/B1X@_9$\&SZM-<&>X=; QP32$[F9[=&$+DGD[D.23G.3GZ HH K
MZ5I6EZ%IEMHFB:;;V=E9P)!:6EK"L<4$2 *J(B@!5    & !BK%%% !1110
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3 HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_0a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0a.jpg
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MMS<( / 5TD,_WN]'X-=K.3W$CO@[]W8' / 7I(=^$KX?=@%K8DX9\7?N[0X
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MMYD"4_L/Z,2F35C6CZ9E::M^E<*ZEE"II'$/I^W_!>FAG\ Q7Q<FJ+LOTM+
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M'M@KI:LB73=]1T-O==*#Q\+T5E4E*07,U7I3-*K;KO7K*I10.N>*K8FTZ)E
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M#:0'N +I 0#@# @0D /I 0#@*9 >H O2 P# LR ]P#ZD!P" AT)Z@&5(#P
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MBBOI0?GQSDDP<#JD!P" 0:X'B-&ON#VXP,T@/0  S%(*$+V?\X1_X0&WA/0
M #!.-4!L?MUS_JX$[@KI 0! QUJ,^/BQ#_G[$7@.I <   _+26(H@@!<A_0
M ."'Q !G07H   " &J0'    J$%Z    @!JD!P   *A!>@   ( :I <   "H
M07H   " &J0'    J$%Z    @!JD!P   *A!>@   ( :_P/MW_/=CL)US0
*  !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056246018080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jul. 20, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-51222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DEXCOM, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0857544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6340 Sequence Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">200-0200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 Par Value Per Share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DXCM<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">387,871,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001093557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056243178224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,194.9<span></span>
</td>
<td class="nump">$ 642.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities', window );">Short-term marketable securities</a></td>
<td class="nump">2,441.3<span></span>
</td>
<td class="nump">1,813.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">750.6<span></span>
</td>
<td class="nump">713.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">421.1<span></span>
</td>
<td class="nump">306.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">195.0<span></span>
</td>
<td class="nump">192.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">5,002.9<span></span>
</td>
<td class="nump">3,668.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">1,077.6<span></span>
</td>
<td class="nump">1,055.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">76.3<span></span>
</td>
<td class="nump">80.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">25.8<span></span>
</td>
<td class="nump">25.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangibles, net</a></td>
<td class="nump">154.2<span></span>
</td>
<td class="nump">173.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">417.0<span></span>
</td>
<td class="nump">341.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">66.9<span></span>
</td>
<td class="nump">47.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">6,820.7<span></span>
</td>
<td class="nump">5,391.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,156.5<span></span>
</td>
<td class="nump">901.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and related expenses</a></td>
<td class="nump">108.6<span></span>
</td>
<td class="nump">134.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Current portion of long-term senior convertible notes</a></td>
<td class="nump">773.8<span></span>
</td>
<td class="nump">772.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Short-term operating lease liabilities</a></td>
<td class="nump">21.8<span></span>
</td>
<td class="nump">20.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,069.7<span></span>
</td>
<td class="nump">1,839.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Long-term senior convertible notes</a></td>
<td class="nump">2,430.6<span></span>
</td>
<td class="nump">1,197.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">86.9<span></span>
</td>
<td class="nump">94.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">133.1<span></span>
</td>
<td class="nump">128.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">4,720.3<span></span>
</td>
<td class="nump">3,259.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValueOutstanding', window );">Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at June&#160;30, 2023 and December&#160;31, 2022</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock, $0.001 par value, 800.0 million shares authorized; 394.6 million and 386.1 million shares issued and outstanding, respectively, at June&#160;30, 2023; and 393.2 million and 386.3 million shares issued and outstanding, respectively, at December&#160;31, 2022</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,269.0<span></span>
</td>
<td class="nump">2,258.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(29.3)<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">644.4<span></span>
</td>
<td class="nump">479.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost; 8.5 million shares at June&#160;30, 2023 and 6.9 million shares at December&#160;31, 2022</a></td>
<td class="num">(784.1)<span></span>
</td>
<td class="num">(595.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">2,100.4<span></span>
</td>
<td class="nump">2,131.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 6,820.7<span></span>
</td>
<td class="nump">$ 5,391.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-Sale and Equity Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056243117584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (shares)</a></td>
<td class="nump">800,000,000<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (shares)</a></td>
<td class="nump">394,600,000<span></span>
</td>
<td class="nump">393,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (shares)</a></td>
<td class="nump">386,100,000<span></span>
</td>
<td class="nump">386,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (shares)</a></td>
<td class="nump">8,500,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056237200192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 871.3<span></span>
</td>
<td class="nump">$ 696.2<span></span>
</td>
<td class="nump">$ 1,612.8<span></span>
</td>
<td class="nump">$ 1,325.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">324.9<span></span>
</td>
<td class="nump">246.7<span></span>
</td>
<td class="nump">603.8<span></span>
</td>
<td class="nump">477.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">546.4<span></span>
</td>
<td class="nump">449.5<span></span>
</td>
<td class="nump">1,009.0<span></span>
</td>
<td class="nump">847.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">119.3<span></span>
</td>
<td class="nump">121.7<span></span>
</td>
<td class="nump">238.3<span></span>
</td>
<td class="nump">257.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">297.3<span></span>
</td>
<td class="nump">248.9<span></span>
</td>
<td class="nump">591.9<span></span>
</td>
<td class="nump">467.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">418.3<span></span>
</td>
<td class="nump">372.5<span></span>
</td>
<td class="nump">833.7<span></span>
</td>
<td class="nump">729.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">128.1<span></span>
</td>
<td class="nump">77.0<span></span>
</td>
<td class="nump">175.3<span></span>
</td>
<td class="nump">118.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(5.9)<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="num">(10.5)<span></span>
</td>
<td class="num">(9.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesGainLoss', window );">Income from equity investments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Interest and other income, net</a></td>
<td class="nump">37.1<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">59.0<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">159.3<span></span>
</td>
<td class="nump">75.3<span></span>
</td>
<td class="nump">223.8<span></span>
</td>
<td class="nump">111.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">43.4<span></span>
</td>
<td class="nump">24.4<span></span>
</td>
<td class="nump">59.3<span></span>
</td>
<td class="num">(36.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 115.9<span></span>
</td>
<td class="nump">$ 50.9<span></span>
</td>
<td class="nump">$ 164.5<span></span>
</td>
<td class="nump">$ 148.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share (USD per share)</a></td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.43<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used to compute basic net income per share (shares)</a></td>
<td class="nump">386.7<span></span>
</td>
<td class="nump">392.5<span></span>
</td>
<td class="nump">386.7<span></span>
</td>
<td class="nump">390.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share (USD per share)</a></td>
<td class="nump">$ 0.28<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted net income per share (shares)</a></td>
<td class="nump">431.5<span></span>
</td>
<td class="nump">421.4<span></span>
</td>
<td class="nump">426.6<span></span>
</td>
<td class="nump">429.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056237204336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 115.9<span></span>
</td>
<td class="nump">$ 50.9<span></span>
</td>
<td class="nump">$ 164.5<span></span>
</td>
<td class="nump">$ 148.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Translation adjustments and other</a></td>
<td class="num">(20.2)<span></span>
</td>
<td class="num">(13.9)<span></span>
</td>
<td class="num">(18.8)<span></span>
</td>
<td class="num">(15.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on marketable debt securities</a></td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="num">(8.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive loss, net of tax</a></td>
<td class="num">(22.8)<span></span>
</td>
<td class="num">(16.9)<span></span>
</td>
<td class="num">(17.7)<span></span>
</td>
<td class="num">(23.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 93.1<span></span>
</td>
<td class="nump">$ 34.0<span></span>
</td>
<td class="nump">$ 146.8<span></span>
</td>
<td class="nump">$ 124.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056237725904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common&#160;Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">388.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 2,042.1<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 2,108.7<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 138.7<span></span>
</td>
<td class="num">$ (206.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for Employee Stock Purchase Plan (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for Employee Stock Purchase Plan</a></td>
<td class="nump">10.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone', window );">Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone', window );">Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(189.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversions of 2023 Notes (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversions of 2023 Notes</a></td>
<td class="nump">17.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromExerciseOfNoteHedge', window );">Benefit of note hedge upon conversions of 2023 Notes (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue', window );">Benefit of note hedge upon conversions of 2023 Notes</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">61.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">148.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(23.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">392.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2022</a></td>
<td class="nump">2,255.9<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">2,028.9<span></span>
</td>
<td class="num">(23.0)<span></span>
</td>
<td class="nump">286.9<span></span>
</td>
<td class="num">(37.3)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">388.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 2,042.1<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">2,108.7<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">138.7<span></span>
</td>
<td class="num">(206.2)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Dec. 31, 2022</a></td>
<td class="nump">386.3<span></span>
</td>
<td class="nump">386.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2022</a></td>
<td class="nump">$ 2,131.8<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">2,258.1<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
<td class="nump">479.9<span></span>
</td>
<td class="num">(595.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">392.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Mar. 31, 2022</a></td>
<td class="nump">2,189.3<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">1,996.3<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
<td class="nump">236.0<span></span>
</td>
<td class="num">(37.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">32.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">50.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(16.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">392.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2022</a></td>
<td class="nump">$ 2,255.9<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">2,028.9<span></span>
</td>
<td class="num">(23.0)<span></span>
</td>
<td class="nump">286.9<span></span>
</td>
<td class="num">(37.3)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Dec. 31, 2022</a></td>
<td class="nump">386.3<span></span>
</td>
<td class="nump">386.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2022</a></td>
<td class="nump">$ 2,131.8<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">2,258.1<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
<td class="nump">479.9<span></span>
</td>
<td class="num">(595.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for Employee Stock Purchase Plan (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for Employee Stock Purchase Plan</a></td>
<td class="nump">12.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(189.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(189.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax', window );">Purchase of capped call transactions, net of tax</a></td>
<td class="num">(76.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">74.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">164.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">$ (17.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Jun. 30, 2023</a></td>
<td class="nump">386.1<span></span>
</td>
<td class="nump">386.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2023</a></td>
<td class="nump">$ 2,100.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">2,269.0<span></span>
</td>
<td class="num">(29.3)<span></span>
</td>
<td class="nump">644.4<span></span>
</td>
<td class="num">(784.1)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">387.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Mar. 31, 2023</a></td>
<td class="nump">2,233.0<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">2,305.6<span></span>
</td>
<td class="num">(6.5)<span></span>
</td>
<td class="nump">528.5<span></span>
</td>
<td class="num">(595.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(189.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(189.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax', window );">Purchase of capped call transactions, net of tax</a></td>
<td class="num">(76.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">39.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">115.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">$ (22.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Jun. 30, 2023</a></td>
<td class="nump">386.1<span></span>
</td>
<td class="nump">386.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2023</a></td>
<td class="nump">$ 2,100.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 2,269.0<span></span>
</td>
<td class="num">$ (29.3)<span></span>
</td>
<td class="nump">$ 644.4<span></span>
</td>
<td class="num">$ (784.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid-In Capital, Purchase Of Capped Call Transactions, Net Of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Received From Benefit Of Note Hedge, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_SharesReceivedFromBenefitOfNoteHedgeValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_SharesReceivedFromExerciseOfNoteHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Received From Exercise Of Note Hedge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_SharesReceivedFromExerciseOfNoteHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Achievement Of Milestone</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Achievement Of Milestone</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056237263968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 164.5<span></span>
</td>
<td class="nump">$ 148.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">85.3<span></span>
</td>
<td class="nump">80.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">74.9<span></span>
</td>
<td class="nump">61.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Non-cash interest expense</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Realized (gain) loss on equity investment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(51.5)<span></span>
</td>
<td class="num">(19.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash income and expenses</a></td>
<td class="num">(29.4)<span></span>
</td>
<td class="nump">16.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(37.1)<span></span>
</td>
<td class="num">(47.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(115.0)<span></span>
</td>
<td class="nump">16.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid and other assets</a></td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(82.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet', window );">Operating lease right-of-use assets and liabilities, net</a></td>
<td class="num">(2.1)<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">277.0<span></span>
</td>
<td class="nump">96.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued payroll and related expenses</a></td>
<td class="num">(25.5)<span></span>
</td>
<td class="num">(31.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability', window );">Deferred revenue and other liabilities</a></td>
<td class="nump">4.4<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">345.7<span></span>
</td>
<td class="nump">243.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable securities</a></td>
<td class="num">(2,149.9)<span></span>
</td>
<td class="num">(1,143.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from sale and maturity of marketable securities</a></td>
<td class="nump">1,557.0<span></span>
</td>
<td class="nump">785.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(133.7)<span></span>
</td>
<td class="num">(193.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities</a></td>
<td class="num">(16.0)<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(742.6)<span></span>
</td>
<td class="num">(556.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">12.3<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="num">(188.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of senior convertible notes, net of issuance costs</a></td>
<td class="nump">1,230.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PaymentsForPurchasesOfCappedCallTransactions', window );">Purchases of capped call transactions</a></td>
<td class="num">(101.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(9.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">950.7<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">(5.3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">552.7<span></span>
</td>
<td class="num">(317.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">643.3<span></span>
</td>
<td class="nump">1,053.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">1,196.0<span></span>
</td>
<td class="nump">736.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash, end of period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">1,194.9<span></span>
</td>
<td class="nump">735.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">1,196.0<span></span>
</td>
<td class="nump">736.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Shares issued for conversions of 2023 Notes</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">35.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge', window );">Shares received under note hedge upon conversion of 2023 Notes</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(33.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Acquisition of property and equipment included in accounts payable and accrued liabilities</a></td>
<td class="nump">53.4<span></span>
</td>
<td class="nump">59.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for finance lease liabilities</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 15.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Operating Lease Assets and Liabilities, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsForPurchasesOfCappedCallTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Purchases Of Capped Call Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsForPurchasesOfCappedCallTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-Use Asset Obtained in Exchange for Operating Lease Liability, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Benefit Received From Note Hedge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherDeferredLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056243983520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Significant Accounting Policies</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;border-bottom:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1. Organization and Significant Accounting Policies</span></td></tr></table><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Organization and Business</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DexCom, Inc. is a medical device company that develops and markets continuous glucose monitoring, or CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;Dexcom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Basis of Presentation and Principles of Consolidation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating results for the three and six months ended June&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December&#160;31, 2022 included in the Annual Report on Form 10-K that we filed with the SEC on February&#160;9, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2022, the Company effected a four-for-one forward stock split of its common stock to shareholders of record as of May 19, 2022. The par value of the common stock remains $0.001 per share. Accordingly, an amount equal to the par value of the increased shares resulting from the stock split was reclassified from &#8220;Additional paid-in capital&#8221; to &#8220;Common stock.&#8221; All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in interest and other income, net in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Seasonality</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the revenue we generate from the sales of our products will fluctuate from quarter to quarter. We typically experience seasonality, with lower sales in the first quarter of each year compared to the immediately preceding fourth quarter. This seasonal sales pattern relates to U.S. annual insurance deductible resets and unfunded flexible spending accounts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Significant Accounting Policies</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material changes to our significant accounting policies as described in Note 1 to the financial statements in Part II, Item 8 of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 during the six months ended June&#160;30, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Use of Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Concentration of Credit Risk</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Contract Balances</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable as of June&#160;30, 2023 included unbilled accounts receivable of $9.2 million. We expect to invoice and collect all unbilled accounts receivable within twelve months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance obligations are generally satisfied within twelve months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after twelve months was $21.4 million as of June&#160;30, 2023 and $19.0 million as of December&#160;31, 2022. These balances are included in other long-term liabilities in our consolidated balance sheets.</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized in the period from performance obligations satisfied in previous periods was not material for the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Net Income Per Share</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share attributable to common stockholders is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares consist of shares issuable from restricted stock units, or RSUs, performance stock units, or PSUs, warrants, and our senior convertible notes. Potentially dilutive common shares issuable upon vesting of RSUs, PSUs, and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per share for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income - diluted</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential common stock outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior convertible notes</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding anti-dilutive securities not included in the diluted net income per share attributable to common stockholders calculations were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Recent Accounting Guidance</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU No. 2021-08,</span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This guidance is intended improve the accounting for acquired revenue contracts with customers in a business combination. The new guidance requires that the acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. ASU 2021-08 is effective for public business entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The amendments should be applied prospectively to business combinations occurring on or after the adoption date. We adopted ASU 2021-08 in the first quarter of 2023 and there was no impact to our consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not expect any recently issued accounting pronouncements will have a material effect on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056247921888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Development and Other Agreements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Development and Other Agreements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2. Development and Other Agreements</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Collaboration with Verily Life Sciences</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, &#8220;Verily&#8221;), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily dated August 10, 2015, as amended in October 2016, including the royalty obligations provisions under that original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily have agreed to continue to jointly develop a certain next-generation CGM product, and potentially one or more additional CGM products, for which we will have exclusive commercialization rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Collaboration Agreement also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside of the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#8217;s other intellectual property rights to develop, manufacture and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. The Restated Collaboration Agreement requires us to use commercially reasonable efforts to develop, launch and commercialize the CGM product(s) that are the subject of the collaboration according to certain timing and other objectives, and provides for one executive sponsor from each of Dexcom and Verily to meet periodically and make decisions related to the collaboration (within a limited scope of authority) by consensus.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of Verily&#8217;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we made upfront, incentive, and the product regulatory approval payments, and will make potential payments for contingent sales-based milestones upon the achievement of certain revenue targets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for the contingent milestones payable in shares of our common stock as equity instruments within the scope of ASC Topic 718. The product regulatory approval and sales-based milestones are accounted for as performance-based awards that vest when the performance conditions have been achieved and are recognized when the achievement of the respective contingent milestone is deemed probable. The value of the contingent milestones is based on our closing stock price on December 28, 2018, which was $29.57 per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Upfront and Incentive payments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the fourth quarter of 2018, we made an initial payment for an upfront fee of $250.0 million through the issuance of 7,363,772 shares of our common stock. We recorded a $217.7 million charge in our consolidated statements of operations during 2018 relating to the issuance of this common stock because this milestone payment did not meet the capitalization criteria. The value of the charge was based on our closing stock price of $29.57 per share on December 28, 2018, the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. In 2019, we made a cash incentive payment of $3.2 million due to the completion of certain development obligations and we recorded these payments as research and development expense in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent milestones</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2021, we determined the achievement of the regulatory approval milestone to be probable and recorded an $87.1 million research and development charge in our consolidated statements of operations. This charge is associated with IPR&amp;D obtained in an asset acquisition prior to regulatory approval and therefore does not have an alternative future use.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we received regulatory approval and issued 2,945,508 shares of our common stock in connection with our achievement of the related milestone.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2022, we received FDA approval and determined the achievement of the sales-based milestones to be probable. As such, we capitalized the full value of the sales-based milestones, $152.4 million, as an intangible asset. The sales-based milestones are contingent upon the achievement of certain revenue targets. The value of the sales based milestones is based on: 1) 5,154,640 shares of our common stock, as agreed upon in November 2018 and 2) our closing stock price on December 28, 2018 of $29.57 per share. December 28, 2018 is the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. The intangible asset will be amortized using the straight-line method over its estimated useful </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">life of 64 months through March 2028. The related amortization expense is recognized in Cost of Sales in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All milestones may be paid in cash or shares of our common stock, at our election. If we elect to make these milestone payments in cash, any such cash payment would be equal to the number of shares that would otherwise be issued for the given milestone payment multiplied by the value of our stock on the date the relevant milestone is achieved, and adjusted to give effect to any stock splits, dividends, or similar events. We intend to pay the sales-based contingent milestones in shares of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Collaboration Agreement will continue until December 31, 2028, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party. Upon achievement of the first sales-based milestone event and payment of the corresponding milestone fee by us, the term of the Restated Collaboration Agreement will be extended until December 31, 2033, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056237252720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3. Fair Value Measurements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement dates, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values provided by our investment managers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of June&#160;30, 2023, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,640.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,640.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,441.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,441.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,482.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,407.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2022, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.1&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> transfers into or out of Level 3 securities during the three and six months ended June&#160;30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Senior Convertible Notes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using Level 1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,418.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of outstanding senior convertible notes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,988.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,451.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on the carrying values of our senior convertible notes, see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Convertible Notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Note 5 &#8220;Debt&#8221; to the consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency and Derivative Financial Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency forward contracts to hedge monetary assets and liabilities denominated in foreign currencies. Our foreign currency forward contracts are not designated as hedging instruments. Therefore, changes in the fair values of these contracts are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. The duration of these contracts is generally one month. The derivative gains and losses are included in interest and other income, net in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023 and December&#160;31, 2022, the notional amounts of outstanding foreign currency forward contracts were $61.0 million and $62.0 million, respectively. The resulting impact on our consolidated financial statements from currency hedging activities was not significant for the three and six months ended June&#160;30, 2023 and June&#160;30, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency exposures vary but are primarily concentrated in the Australian Dollar, the British Pound, the Canadian Dollar, the Euro, and the Malaysian Ringgit. We monitor the costs and the impact of foreign currency risks upon our financial results as part of our risk management program. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management. We do not require and are not required to pledge collateral for these financial instruments and we do not carry any master netting arrangements to mitigate the credit risk.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with authoritative guidance, we measure certain non-financial assets and liabilities at fair value on a non-recurring basis. These measurements are usually performed using the discounted cash flow method or cost method and Level 3 inputs. These include items such as non-financial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment.&#160;In general, non-financial assets, including goodwill, intangible assets, and property and equipment, are measured at fair value when there are indicators of impairment and are recorded at fair value only when an impairment is recognized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$35.0&#160;million as of June&#160;30, 2023 and $19.0 million as of December&#160;31, 2022. We include them in other assets in our consolidated balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant effect on the fair values.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no significant impairment losses during the three and six months ended June&#160;30, 2023 and June&#160;30, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//820/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056249812768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Balance Sheet Details</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4. Balance Sheet Details</span></td></tr></table><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Short-Term Marketable Securities</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term marketable securities, consisting of available-for-sale debt securities, were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,640.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,444.9&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,441.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813.9&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the estimated market value of our short-term debt securities with contractual maturities up to 12 months was $2.44&#160;billion. As of December&#160;31, 2022, the estimated market value of our short-term debt securities with contractual maturities up to 12 months was $1.81&#160;billion. Gross realized gains and losses on sales of our short-term debt securities for the three and six months ended June&#160;30, 2023 and June&#160;30, 2022 were not significant.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically review our portfolio of debt securities to determine if any investment is impaired due to credit loss or other potential valuation concerns. For debt securities where the fair value of the investment is less than the amortized cost basis, we have assessed at the individual security level for various quantitative factors including, but not limited to, the nature of the investments, changes in credit ratings, interest rate fluctuations, industry analyst </span></div>reports, and the severity of impairment. Unrealized losses on available-for-sale debt securities at June&#160;30, 2023 were primarily due to increases in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, we have not recorded an allowance for credit losses. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.<div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Inventory</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Prepaid and Other Current Assets</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Property and Equipment</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and land improvements</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,505.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(428.3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Other Assets</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Accounts Payable and Accrued Liabilities</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable trade</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued tax, audit, and legal fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Accrued Payroll and Related Expenses</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued wages, bonus and taxes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued payroll and related expenses</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:18pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Other Long-Term Liabilities</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></div></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056247860720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5. Debt</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Senior Convertible Notes</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal amount</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,232.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of senior convertible notes</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,204.4&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,970.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal was as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,649.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,361.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total by which the notes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> if-converted value exceeds their principal amount</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,790.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual coupon interest </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense recognized on senior notes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rate:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:22.5pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year. Interest on the 2028 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">0.75% Senior Convertible Notes due 2023</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we completed an offering of&#160;$850.0 million&#160;aggregate principal amount of unsecured senior convertible notes with a stated interest rate of&#160;0.75%&#160;and a maturity date of&#160;December&#160;1, 2023&#160;(the &#8220;2023 Notes&#8221;). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and costs directly related to the offering, were approximately&#160;$836.6 million. The initial conversion rate of the 2023 Notes is&#160;24.3476&#160;shares per&#160;$1,000 principal amount of notes, which is equivalent to a conversion price of approximately&#160;$41.07&#160;per share, subject to adjustments. We entered into transactions for a convertible note hedge (the &#8220;2023 Note Hedge&#8221;) and warrants (the &#8220;2023 Warrants&#8221;) concurrently with the issuance of the 2023 Notes. The 2023 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2023 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2023 Notes includes customary terms and covenants, including certain events of default after which the 2023 Notes may be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2022, holders of $17.5&#160;million in aggregate principal amount of the 2023 Notes elected conversion at their option. We settled these conversions using treasury stock. We issued 425,552 shares to settle the converted 2023 Notes. We received 287,492 shares of common stock from the exercise of a portion of the 2023 Note Hedge that we purchased concurrently with the issuance of the 2023 Notes, as described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">second quarter of 2023, holders of $532.2&#160;million in aggregate principal amount of the 2023 Notes exercised their conversion option. We elected to settle these conversions through a combination of cash for the principal amount and common stock for any amount due in excess of the principal amount. The conversions will settle in the third quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From July 1, 2023 through July&#160;26, 2023, holders of $7.8 million in aggregate principal amount of the 2023 Notes exercised their conversion option.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes have the right to require us to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the notes). We will also be required to increase the conversion rate for holders who convert their 2023 Notes in connection with certain fundamental changes occurring prior to the maturity date or following the delivery by Dexcom of a notice of redemption.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert all or a portion of their notes at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding September&#160;1, 2023, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during any calendar quarter commencing after March&#160;31, 2019 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the 2023 Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the 2023 Notes for each day of that five-day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the 2023 Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">if we call any or all of the 2023 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after September&#160;1, 2023, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2023 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Circumstance (1) listed above occurred during the quarters ended December&#160;31, 2022 and March&#160;31, 2023. As a result, the 2023 Notes were convertible at the option of the holder from January&#160;1, 2023 through June&#160;30, 2023. Circumstance (1) listed above also occurred during the quarter ended June&#160;30, 2023 and as a result, the 2023 Notes will remain convertible at the option of the holder from July 1, 2023 through September 30, 2023. See above for a description of conversion activity related to the 2023 Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom did not have a right to redeem the 2023 Notes prior to December&#160;1, 2021. On or after December&#160;1, 2021 and prior to September&#160;1, 2023, Dexcom may redeem for cash all or part of the 2023 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2023 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Note Hedge</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions with two of the initial purchasers of the 2023 Notes (the &#8220;2023 Counterparties&#8221;) entitling us to purchase up to&#160;20.7 million&#160;shares of our common stock at an initial price of&#160;$41.07&#160;per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was&#160;$218.9 million and we accounted for it as an equity instrument by recognizing $218.9 million in&#160;additional paid-in capital&#160;during 2018. The 2023 Note Hedge will expire on December&#160;1, 2023. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge.&#160;The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. An assumed exercise of the 2023 Note Hedge by us is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share. See above for a description of conversion activity related to the 2023 Notes and shares received as the result of exercising a portion of the 2023 Note Hedge.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Warrants</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we also sold warrants to the 2023 Counterparties to acquire up to&#160;20.7 million shares of our common stock. The 2023 Warrants require net share settlement and a pro rated number of warrants will expire on each of the 60 scheduled trading days starting on March&#160;1, 2024. We received&#160;$183.8 million&#160;in cash proceeds from the sale of the 2023 Warrants, which we recorded in&#160;additional paid-in capital during 2018. The 2023 Warrants could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2023 Warrants. The strike price of the 2023 Warrants is initially $49.60 per share and is subject to certain adjustments under the terms of the warrant agreements. We use </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the treasury share method for assumed conversion of the 2023 Warrants when computing the weighted average common shares outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">0.25% Senior Convertible Notes due 2025</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we completed an offering of $1.21 billion aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 0.25% and a maturity date of November&#160;15, 2025 (the &#8220;2025 Notes&#8221;). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and estimated costs directly related to the offering, were approximately $1.19 billion. The initial conversion rate of the 2025 Notes is 6.6620 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $150.11 per share, subject to adjustments. The 2025 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2025 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on the 2025 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2025 Notes includes customary terms and covenants, including certain events of default after which the 2025 Notes may be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a fundamental change (as defined in the indenture related to the 2025 Notes), holders of the 2025 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to 100% of the principal amount of the 2025 Notes, plus any accrued and unpaid interest. Holders of the 2025 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 5:00 p.m., New York City time, on the business day immediately preceding August&#160;15, 2025, holders of the 2025 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during any calendar quarter commencing after September&#160;30, 2020 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that five day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;On or after August&#160;15, 2025, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2025 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom may not redeem the 2025 Notes prior to May&#160;20, 2023. On or after May&#160;20, 2023 and prior to August&#160;15, 2025, Dexcom may redeem for cash all or part of the 2025 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2025 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">0.375% Senior Convertible Notes due 2028</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, we completed an offering of $1.25&#160;billion aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 0.375% and a maturity date of May&#160;15, 2028 (the &#8220;2028 Notes&#8221;). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and estimated costs directly related to </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the offering, were approximately $1.23&#160;billion. The initial conversion rate of the 2028 Notes is 6.1571 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $162.41 per share, subject to adjustments. The 2028 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2028 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on the 2028 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2028 Notes includes customary terms and covenants, including certain events of default after which the 2028 Notes may be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a fundamental change (as defined in the indenture related to the 2028 Notes), holders of the 2028 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to 100% of the principal amount of the 2028 Notes, plus any accrued and unpaid interest. Holders of the 2028 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 5:00 p.m., New York City time, on the business day immediately preceding February&#160;15, 2028, holders of the 2028 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during any calendar quarter commencing after September&#160;30, 2023 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that five day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after February&#160;15, 2028, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2028 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom may not redeem the 2028 Notes prior to May&#160;20, 2026. On or after May&#160;20, 2026 and prior to February&#160;15, 2028, Dexcom may redeem for cash all or part of the 2028 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2028 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Capped Call Transactions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, in connection with the offering of the 2028 Notes, we entered into privately negotiated capped call transactions (the &#8220;2028 Capped Calls&#8221;) with certain financial institutions. The 2028 Capped Calls will cover, subject to anti-dilution adjustments substantially similar to those applicable to the 2028 Notes, the number of shares of our common stock that will initially underlie the 2028 Notes. The 2028 Capped Calls are expected generally to reduce potential dilution to our common stock upon conversion of the 2028 Notes and/or offset any cash payments that we are required to make in excess of the principal amount of converted 2028 Notes, as the case may be, with such reduction and/or offset subject to a cap. The 2028 Capped Calls have an initial cap price of $212.62 per share, subject to adjustments, which represents a premium of 80% over the closing price of our common stock of $118.12 per share on the Nasdaq Global Select Market on May&#160;2, 2023. The cost to purchase the 2028 Capped Calls of </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$101.3 million was recorded as a reduction to additional paid-in capital in our consolidated balance sheets as the 2028 Capped Calls met the criteria for classification in stockholders&#8217; equity.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Revolving Credit Agreement</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms of the Revolving Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, we entered into the First Amendment to the Second Amended and Restated Credit Agreement (the "Amended Credit Agreement"), which we had previously entered into in October 2021. The Amended Credit Agreement is a five-year revolving credit facility, that provides for an available principal amount of $200.0 million which can be increased up to $500.0 million at our option subject to customary conditions and approval of our lenders (the &#8220;Credit Facility&#8221;). The Amended Credit Agreement will mature on October&#160;13, 2026. Borrowings under the Amended Credit Agreement are available for general corporate purposes, including working capital and capital expenditures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to availability and outstanding borrowings on our Amended Credit Agreement is as follows as of the date indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.959%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available principal amount </span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letters of credit sub-facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding borrowings </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding letters of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available balance</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans under the Amended Credit Agreement bear interest at our choice of one of three base rates plus a range of applicable rates that are based on our leverage ratio. The first base rate is the Alternate Base Rate (&#8220;ABR&#8221;) and loans comprising each ABR borrowing shall bear interest at the ABR plus the applicable rate between 0.375% to 1.000%. The ABR is the highest of (a) the prime rate last quoted by The Wall Street Journal, (b) the Federal Reserve Bank of New York rate plus one half of 1%, and (c) the Adjusted Term Secured Overnight Financing Rate (&#8220;Term SOFR&#8221;) for a one month interest period plus 1%. The second base rate is the Term Benchmark rate and loans comprising each Term Benchmark borrowing shall bear interest at the Adjusted Term SOFR, the Adjusted Euro Interbank Offered Rate, the Adjusted Stockholm Interbank Offered Rate, the Adjusted Canadian Dollar Offered Rate, Adjusted Australian Dollar Rate, the Adjusted Bank Bill Benchmark Rate or the Adjusted Tokyo Interbank Offered Rate, as applicable based on the currency denomination borrowed, plus the applicable rate between 1.375% to 2.000%. The third base rate is the Adjusted Daily Simple RepoFunds Rate (&#8220;RFR&#8221;) and loans comprising each Daily Simple RFR Loan shall bear interest at a rate per annum equal to the applicable Daily Simple RFR for Sterling or Dollars (as applicable) plus the applicable rate between 0.0326% to 0.100% depending on the loan denomination. We will also pay a commitment fee of between 0.175% and 0.250%, payable quarterly in arrears, on the average daily unused amount of the revolving facility based on our leverage ratio.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Amended Credit Agreement are guaranteed by our existing and future wholly-owned domestic subsidiaries, and are secured by a first-priority security interest in substantially all of the assets of Dexcom and the guarantors, including all or a portion of the equity interests of our domestic subsidiaries and first-tier foreign subsidiaries but excluding real property and intellectual property (which is subject to a negative pledge). The Amended Credit Agreement contains covenants that limit certain indebtedness, liens, investments, transactions with affiliates, dividends and other restricted payments, subordinated indebtedness and amendments to subordinated indebtedness documents, and sale and leaseback transactions of Dexcom or any of its domestic subsidiaries. The Amended Credit Agreement also requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of June&#160;30, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, we also have a guarantee facility related to our international operations which is collateralized by a $5.5&#160;million term deposit that is included in non-current &#8220;Other assets&#8221; on our consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056242702240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Contingencies</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6. Contingencies</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Litigation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability, intellectual property and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2023, we and certain Abbott Diabetes Care, Inc. (&#8220;Abbott&#8221;) entities have previously served complaints for patent infringement, validity and other patent related actions against each other in multiple jurisdictions, inside and outside the United States. In June and July 2021, we initiated patent infringement litigation against Abbott in the United States and in Germany over certain of Abbott's continuous glucose monitoring products. In both the United States and Germany, we seek injunctive relief and monetary damages. In July 2021, Abbott initiated patent infringement litigation against Dexcom in the United States, United Kingdom, and in Germany over certain of Dexcom's continuous glucose monitoring products. Abbott seeks injunctive relief and monetary damages. In response to the suits in the United Kingdom, Dexcom brought infringement counterclaims there. One trial on liability has already been conducted in the United Kingdom, and the parties are awaiting a ruling.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, Abbott filed a breach of contract suit against Dexcom in the United States alleging that Dexcom breached the parties' 2014 Settlement and License Agreement. Dexcom&#8217;s patent infringement claims in the United States are stayed pending resolution of Abbott&#8217;s breach of contract claims. A jury trial on Abbott&#8217;s breach of contract claims commenced on July 10, 2023. On July 14, 2023, the jury awarded a verdict finding Abbott was not licensed to several claims of certain Dexcom patents and that Abbott was licensed to a few claims. We will continue to enforce the remaining claims in the patents asserted in Delaware and elsewhere.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott&#8217;s U.S. patent infringement action against Dexcom is currently scheduled for trial on November 5, 2023. In February and March of 2023, Abbott initiated additional patent infringement litigation against Dexcom in both the United States and in Germany. Abbott seeks injunctive relief and monetary damages. Due to uncertainty surrounding patent litigation processes in the U.S. and Europe, we are unable to reasonably estimate the ultimate outcome of any of the litigation matters at this time. We intend to protect our intellectual property and defend against Abbott&#8217;s claims vigorously in all of these actions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe we are party to any other currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056243938912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7. Income Taxes</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate our annual effective tax rate to be 28.5% for the full year 2023, which differs from the U.S. federal statutory rate due to state and foreign income taxes, nondeductible executive compensation, and increases to unrecognized tax benefits, partially offset by federal tax credits generated. Our actual effective tax rate of</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.5% for the six months ended June&#160;30, 2023 was primarily due to income tax expense from normal, recurring operations, partially offset by discrete excess tax benefits recognized for share-based compensation for employees, net of disallowed executive compensation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056249731808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8. Stockholders&#8217; Equity</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our share-based compensation expense is associated with RSUs, PSUs, and our Employee Stock Purchase Plan, or ESPP. The following table summarizes our share-based compensation expense included in our consolidated statements of operations for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2023, unrecognized estimated compensation costs related to RSUs, PSUs and ESPP totaled $272.5 million and are expected to be recognized through 2027.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Award Activity</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total vest date fair value of RSUs and PSUs that vested during the six months ended June&#160;30, 2023 was $127.3 million and $9.9 million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program and Treasury Shares</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 26, 2022, a duly authorized committee of our Board of Directors authorized and approved a share repurchase program of up to $700.0&#160;million of our outstanding common stock, with a repurchase period ending no later than June 30, 2023 (the &#8220;Share Repurchase Program&#8221;). Shares of common stock repurchased under the Share Repurchase Program become treasury shares. Repurchases of our common stock under the Share Repurchase Program may be made from time to time, on the open market, in privately negotiated transactions or by other methods, at our discretion, and in accordance with the limitations set forth in Rule 10b-18 promulgated under the Exchange Act, and other applicable federal and state laws and regulations. We repurchased approximately $557.7 million of our outstanding common stock throughout the duration of the Share Repurchase Program. The Share Repurchase Program and the remaining authorization of approximately $142.3&#160;million expired on June 30, 2023. There were no share repurchases under the Share Repurchase Program in 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, we used a portion of the proceeds of the 2028 Notes to repurchase 1.6 million shares of our common stock for $188.7 million for an average per share price of $118.12, via privately negotiated transactions, independent of the Share Repurchase Program.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repurchased shares of our common stock are held as treasury shares until they are reissued or retired. We have not yet determined the ultimate disposition of repurchased shares and consequently we continue to hold them as treasury shares rather than retiring them. Authorization of future stock repurchase programs is subject to the final determination of our Board of Directors.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056242702240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segment and Geographic Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9. Business Segment and Geographic Information</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reportable Segments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An operating segment is identified as a component of a business that has discrete financial information available and for which the chief operating decision maker must decide the level of resource allocation. In addition, the guidance for segment reporting indicates certain quantitative materiality thresholds. None of the components of our business meet the definition of an operating segment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently consider our operations to be, and manage our business globally within, one reportable segment, which is consistent with how our President and Chief Executive Officer, who is our chief operating decision maker, reviews our business, makes investment and resource allocation decisions, and assesses operating performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate revenue by geographic region and by major sales channel. We have determined that disaggregating revenue into these categories achieves the ASC Topic 606 disclosure objectives of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by geographic region</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2023 and June&#160;30, 2022, no individual country outside the United States generated revenue that represented more than 10% of our total revenue. The following table sets forth revenue by our two primary geographical markets, the United States and International, based on the geographic location to which we deliver the components, for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,612.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by customer sales channel</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our CGM systems through a direct sales organization and through distribution arrangements that allow distributors to sell our products. The following table sets forth revenue by major sales channel for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,612.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056248736064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 115.9<span></span>
</td>
<td class="nump">$ 50.9<span></span>
</td>
<td class="nump">$ 164.5<span></span>
</td>
<td class="nump">$ 148.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056244756304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trading Plans</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023, none of our directors or officers informed us of the adoption or termination of a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;non-Rule 10b5-1 trading arrangement,&#8221; as those terms are defined in Regulation S-K, Item 408, except as described in the table below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Character of Trading Arrangement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adoption Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rule 10b5-1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Rule 10b5-1**</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Shares to be Sold</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expiration Date</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donald M. Abbey</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Global Business Services, IT Quality and Regulatory Affairs</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/5/2023</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,258</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/6/2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven R. Altman</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/30/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,568</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/30/2025</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bridgette P. Heller</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/13/2023</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/13/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">* Intended to satisfy the affirmative defense of Rule 10b5-1(c)</span></div></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">** Not intended to satisfy the affirmative defense of Rule 10b5-1(c)</span></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Except as indicated by footnote, each trading arrangement permitted or permits transactions through and including the earlier to occur of (a) the completion of all purchases or sales or (b) the date listed in the table.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=dxcm_DonaldMAbbeyMember', window );">Donald M. Abbey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Donald M. Abbey<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Executive Vice President, Global Business Services, IT Quality and Regulatory Affairs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">5/5/2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrTerminationDate', window );">Termination Date</a></td>
<td class="text">5/6/2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">3,258<span></span>
</td>
<td class="nump">3,258<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=dxcm_StevenRAltmanMember', window );">Steven R. Altman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Steven R. Altman<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Director<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">5/30/2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrTerminationDate', window );">Termination Date</a></td>
<td class="text">5/30/2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">9,568<span></span>
</td>
<td class="nump">9,568<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=dxcm_BridgettePHellerMember', window );">Bridgette P. Heller [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Bridgette P. Heller<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Director<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">6/13/2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrTerminationDate', window );">Termination Date</a></td>
<td class="text">6/13/2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrSecuritiesAggAvailAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrSecuritiesAggAvailAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrTerminationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrTerminationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=dxcm_DonaldMAbbeyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=dxcm_DonaldMAbbeyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=dxcm_StevenRAltmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=dxcm_StevenRAltmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=dxcm_BridgettePHellerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=dxcm_BridgettePHellerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056237205744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Basis of Presentation and Principles of Consolidation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating results for the three and six months ended June&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December&#160;31, 2022 included in the Annual Report on Form 10-K that we filed with the SEC on February&#160;9, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2022, the Company effected a four-for-one forward stock split of its common stock to shareholders of record as of May 19, 2022. The par value of the common stock remains $0.001 per share. Accordingly, an amount equal to the par value of the increased shares resulting from the stock split was reclassified from &#8220;Additional paid-in capital&#8221; to &#8220;Common stock.&#8221; All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in interest and other income, net in our consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Basis of Presentation and Principles of Consolidation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating results for the three and six months ended June&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December&#160;31, 2022 included in the Annual Report on Form 10-K that we filed with the SEC on February&#160;9, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2022, the Company effected a four-for-one forward stock split of its common stock to shareholders of record as of May 19, 2022. The par value of the common stock remains $0.001 per share. Accordingly, an amount equal to the par value of the increased shares resulting from the stock split was reclassified from &#8220;Additional paid-in capital&#8221; to &#8220;Common stock.&#8221; All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in interest and other income, net in our consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Use of Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Concentration of Credit Risk</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Contract Balances</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Contract Balances</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable as of June&#160;30, 2023 included unbilled accounts receivable of $9.2 million. We expect to invoice and collect all unbilled accounts receivable within twelve months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance obligations are generally satisfied within twelve months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after twelve months was $21.4 million as of June&#160;30, 2023 and $19.0 million as of December&#160;31, 2022. These balances are included in other long-term liabilities in our consolidated balance sheets.</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized in the period from performance obligations satisfied in previous periods was not material for the periods presented.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Net Income Per Share</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share attributable to common stockholders is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares consist of shares issuable from restricted stock units, or RSUs, performance stock units, or PSUs, warrants, and our senior convertible notes. Potentially dilutive common shares issuable upon vesting of RSUs, PSUs, and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Guidance</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Recent Accounting Guidance</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU No. 2021-08,</span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This guidance is intended improve the accounting for acquired revenue contracts with customers in a business combination. The new guidance requires that the acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. ASU 2021-08 is effective for public business entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The amendments should be applied prospectively to business combinations occurring on or after the adoption date. We adopted ASU 2021-08 in the first quarter of 2023 and there was no impact to our consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div>We do not expect any recently issued accounting pronouncements will have a material effect on our consolidated financial statements<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056243932464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Income per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per share for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income - diluted</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential common stock outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior convertible notes</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Outstanding Anti-dilutive Securities Excluded from Diluted Net Income per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding anti-dilutive securities not included in the diluted net income per share attributable to common stockholders calculations were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056247721568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Fair Value Hierarchy for Financial Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of June&#160;30, 2023, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,640.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,640.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,441.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,441.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,482.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,407.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2022, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.1&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Estimated Fair Values of Debt Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using Level 1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,418.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of outstanding senior convertible notes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,988.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,451.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal amount</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,232.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of senior convertible notes</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,204.4&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,970.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056237243376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Short-Term Marketable Securities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term marketable securities, consisting of available-for-sale debt securities, were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,640.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,444.9&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,441.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813.9&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock', window );">Schedule of Prepaid and Other Current Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and land improvements</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,505.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(428.3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of Other Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Other Assets</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable trade</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued tax, audit, and legal fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock', window );">Schedule of Accrued Payroll and Related Expenses</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued wages, bonus and taxes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued payroll and related expenses</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock', window );">Schedule of Other Long-Term Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></div></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid And Other Current Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Accrued Payroll and Related Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056242807424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using Level 1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,418.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of outstanding senior convertible notes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,988.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,451.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal amount</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,232.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of senior convertible notes</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,204.4&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,970.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Schedule of Converted Value of Notes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal was as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,649.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,361.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total by which the notes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> if-converted value exceeds their principal amount</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,790.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual coupon interest </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense recognized on senior notes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rate:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:22.5pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year. Interest on the 2028 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Availability and Outstanding Borrowings on Credit Agreement</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to availability and outstanding borrowings on our Amended Credit Agreement is as follows as of the date indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.959%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available principal amount </span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letters of credit sub-facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding borrowings </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding letters of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available balance</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056247752624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our share-based compensation expense is associated with RSUs, PSUs, and our Employee Stock Purchase Plan, or ESPP. The following table summarizes our share-based compensation expense included in our consolidated statements of operations for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056247837424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Revenue from External Customers by Geographic Areas</a></td>
<td class="text">The following table sets forth revenue by our two primary geographical markets, the United States and International, based on the geographic location to which we deliver the components, for the periods shown:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,612.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text">The following table sets forth revenue by major sales channel for the periods shown:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,612.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -SubTopic 10<br> -Topic 280<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056244851216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 10, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stock split ratio</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (USD per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, long-term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.4<span></span>
</td>
<td class="nump">$ 19.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_ContractPaymentTermsNumberofDays', window );">Contract payment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_ContractPaymentTermsNumberofDays', window );">Contract payment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ContractPaymentTermsNumberofDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract Payment Terms, Number of Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ContractPaymentTermsNumberofDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Organization And Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056239835632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Earnings Per Share, Basic and Diluted (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 115.9<span></span>
</td>
<td class="nump">$ 50.9<span></span>
</td>
<td class="nump">$ 164.5<span></span>
</td>
<td class="nump">$ 148.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestOnConvertibleDebtNetOfTax', window );">Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToParentDiluted', window );">Net income - diluted</a></td>
<td class="nump">$ 119.7<span></span>
</td>
<td class="nump">$ 52.5<span></span>
</td>
<td class="nump">$ 170.0<span></span>
</td>
<td class="nump">$ 153.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share (USD per share)</a></td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.43<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share (USD per share)</a></td>
<td class="nump">$ 0.28<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (shares)</a></td>
<td class="nump">386.7<span></span>
</td>
<td class="nump">392.5<span></span>
</td>
<td class="nump">386.7<span></span>
</td>
<td class="nump">390.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding (shares)</a></td>
<td class="nump">431.5<span></span>
</td>
<td class="nump">421.4<span></span>
</td>
<td class="nump">426.6<span></span>
</td>
<td class="nump">429.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units and performance stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (shares)</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (shares)</a></td>
<td class="nump">12.2<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">11.9<span></span>
</td>
<td class="nump">10.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Senior convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (shares)</a></td>
<td class="nump">31.7<span></span>
</td>
<td class="nump">18.9<span></span>
</td>
<td class="nump">26.9<span></span>
</td>
<td class="nump">26.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestOnConvertibleDebtNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestOnConvertibleDebtNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToParentDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent, and includes adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToParentDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056243135344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Anti-dilutive Securities Excluded from Calculation of Net Income (Loss) per Share (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dxcm_RestrictedAndPerformanceStockUnitsMember', window );">Restricted stock units and performance stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Senior convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dxcm_RestrictedAndPerformanceStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dxcm_RestrictedAndPerformanceStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056246157680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Development and Other Agreements (Details) - Verily Life Sciences - Collaborative Arrangement - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 28, 2018</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">64 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=dxcm_VerilyLifeSciencesMember', window );">Initial Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing stock price (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_CollaborativeArrangementUpfrontFee', window );">Initial payment on collaborative agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with acquisition, shares (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,363,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_CollaborativeResearchAndDevelopmentFee', window );">Collaborative research and development fee</a></td>
<td class="nump">$ 87.1<span></span>
</td>
<td class="nump">$ 217.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=dxcm_VerilyLifeSciencesMember', window );">Milestone Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_CollaborativeResearchAndDevelopmentFee', window );">Collaborative research and development fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues', window );">Potential future common stock issuable (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,154,640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Sales-based milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 152.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=dxcm_VerilyLifeSciencesMember', window );">Approval Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues', window );">Potential future common stock issuable (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,945,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CollaborativeArrangementUpfrontFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Upfront Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CollaborativeArrangementUpfrontFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CollaborativeResearchAndDevelopmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Research and Development Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CollaborativeResearchAndDevelopmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potential Future Common Stock Issuable, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PotentialFutureCommonStockIssuableSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=dxcm_VerilyLifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=dxcm_VerilyLifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementInitialPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementInitialPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementApprovalMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementApprovalMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056245169504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 952.1<span></span>
</td>
<td class="nump">$ 420.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">2,441.3<span></span>
</td>
<td class="nump">1,813.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">14.4<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">3,407.8<span></span>
</td>
<td class="nump">2,244.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">1,640.5<span></span>
</td>
<td class="nump">1,530.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">419.7<span></span>
</td>
<td class="nump">119.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">381.1<span></span>
</td>
<td class="nump">163.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">911.4<span></span>
</td>
<td class="nump">375.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">14.4<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">925.8<span></span>
</td>
<td class="nump">386.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Corporate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">40.7<span></span>
</td>
<td class="nump">44.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">2,441.3<span></span>
</td>
<td class="nump">1,813.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">2,482.0<span></span>
</td>
<td class="nump">1,858.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">1,640.5<span></span>
</td>
<td class="nump">1,530.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">419.7<span></span>
</td>
<td class="nump">119.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Corporate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">381.1<span></span>
</td>
<td class="nump">163.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Corporate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056245969968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_FairValueAssetsLevel3TransfersAmount', window );">Transfers into or out of Level 3 securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">35,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign exchange forward | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivative instrument</a></td>
<td class="nump">61,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair value, nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_FairValueAssetsLevel3TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Assets, Level 3 Transfers, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_FairValueAssetsLevel3TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056242729696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value of Convertible Senior Notes (Details) - Senior Notes - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of outstanding senior convertible notes:</a></td>
<td class="nump">$ 4,988.7<span></span>
</td>
<td class="nump">$ 3,451.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of outstanding senior convertible notes:</a></td>
<td class="nump">2,418.9<span></span>
</td>
<td class="nump">2,136.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of outstanding senior convertible notes:</a></td>
<td class="nump">1,290.7<span></span>
</td>
<td class="nump">1,314.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of outstanding senior convertible notes:</a></td>
<td class="nump">$ 1,279.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_FairValueDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Fair Value Disclosures [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_FairValueDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056244825856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Short-Term Marketable Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt securities, available-for-sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 2,444.9<span></span>
</td>
<td class="nump">$ 1,819.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(4.2)<span></span>
</td>
<td class="num">(5.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">2,441.3<span></span>
</td>
<td class="nump">1,813.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt securities, available-for-sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,643.1<span></span>
</td>
<td class="nump">1,535.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">1,640.5<span></span>
</td>
<td class="nump">1,530.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt securities, available-for-sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">419.9<span></span>
</td>
<td class="nump">119.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">419.7<span></span>
</td>
<td class="nump">119.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt securities, available-for-sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">381.9<span></span>
</td>
<td class="nump">164.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">$ 381.1<span></span>
</td>
<td class="nump">$ 163.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056248726832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale securities current</a></td>
<td class="nump">$ 2,440.0<span></span>
</td>
<td class="nump">$ 1,810.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">$ 66.9<span></span>
</td>
<td class="nump">$ 47.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056244730064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Inventory (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 240.4<span></span>
</td>
<td class="nump">$ 159.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">36.4<span></span>
</td>
<td class="nump">17.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">144.3<span></span>
</td>
<td class="nump">130.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 421.1<span></span>
</td>
<td class="nump">$ 306.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056242708016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Prepaid and Other Current Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">$ 55.0<span></span>
</td>
<td class="nump">$ 48.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PrepaidInventoryCurrent', window );">Prepaid inventory</a></td>
<td class="nump">62.7<span></span>
</td>
<td class="nump">67.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DeferredCompensationPlanAssetsCurrent', window );">Deferred compensation plan assets</a></td>
<td class="nump">14.4<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivables</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">38.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">57.9<span></span>
</td>
<td class="nump">26.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid and other current assets</a></td>
<td class="nump">$ 195.0<span></span>
</td>
<td class="nump">$ 192.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DeferredCompensationPlanAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Plan Assets, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DeferredCompensationPlanAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PrepaidInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Inventory, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PrepaidInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056239864608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Property and Equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</a></td>
<td class="nump">$ 1,505.9<span></span>
</td>
<td class="nump">$ 1,418.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(428.3)<span></span>
</td>
<td class="num">(363.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Total property and equipment, net</a></td>
<td class="nump">1,077.6<span></span>
</td>
<td class="nump">1,055.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember', window );">Land and land improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">29.0<span></span>
</td>
<td class="nump">26.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">139.5<span></span>
</td>
<td class="nump">54.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">34.8<span></span>
</td>
<td class="nump">32.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer software and hardware</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">58.7<span></span>
</td>
<td class="nump">48.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">549.6<span></span>
</td>
<td class="nump">449.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">273.4<span></span>
</td>
<td class="nump">264.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">$ 420.9<span></span>
</td>
<td class="nump">$ 542.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056242763648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Other Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">$ 35.0<span></span>
</td>
<td class="nump">$ 19.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_LongTermDeposits', window );">Long-term deposits</a></td>
<td class="nump">19.1<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OtherLongTermAssets', window );">Other assets</a></td>
<td class="nump">12.8<span></span>
</td>
<td class="nump">11.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total other assets</a></td>
<td class="nump">$ 66.9<span></span>
</td>
<td class="nump">$ 47.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LongTermDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long -Term Deposits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LongTermDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_OtherLongTermAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Long -Term Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_OtherLongTermAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056349808816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable trade</a></td>
<td class="nump">$ 269.1<span></span>
</td>
<td class="nump">$ 237.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AccruedTaxAuditAndLegalFees', window );">Accrued tax, audit, and legal fees</a></td>
<td class="nump">60.4<span></span>
</td>
<td class="nump">44.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PharmacyRebates', window );">Accrued rebates</a></td>
<td class="nump">763.6<span></span>
</td>
<td class="nump">556.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Accrued warranty</a></td>
<td class="nump">11.2<span></span>
</td>
<td class="nump">12.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrent', window );">Deferred compensation plan liabilities</a></td>
<td class="nump">14.4<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">37.8<span></span>
</td>
<td class="nump">39.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Total accounts payable and accrued liabilities</a></td>
<td class="nump">$ 1,156.5<span></span>
</td>
<td class="nump">$ 901.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AccruedTaxAuditAndLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of accrued current tax, audit and legal fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AccruedTaxAuditAndLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PharmacyRebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Rebates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PharmacyRebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483070/710-10-25-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483043/710-10-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056243157296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Accrued Payroll and Related Expenses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract', window );"><strong>Employee-related Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AccruedWagesBonusesAndTaxesCurrent', window );">Accrued wages, bonus and taxes</a></td>
<td class="nump">$ 76.9<span></span>
</td>
<td class="nump">$ 96.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Other accrued employee benefits</a></td>
<td class="nump">31.7<span></span>
</td>
<td class="nump">37.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Total accrued payroll and related expenses</a></td>
<td class="nump">$ 108.6<span></span>
</td>
<td class="nump">$ 134.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AccruedWagesBonusesAndTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Wages, Bonuses and Taxes, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AccruedWagesBonusesAndTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056246105760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Other Long-Term Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease obligations</a></td>
<td class="nump">$ 58.5<span></span>
</td>
<td class="nump">$ 59.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, long-term</a></td>
<td class="nump">21.4<span></span>
</td>
<td class="nump">19.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OtherTaxLiabilitiesNoncurrent', window );">Other tax liabilities</a></td>
<td class="nump">35.9<span></span>
</td>
<td class="nump">32.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">12.5<span></span>
</td>
<td class="nump">12.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">$ 133.1<span></span>
</td>
<td class="nump">$ 128.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_OtherTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Tax Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_OtherTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056349835376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Senior Convertible Notes (Details) - Senior Notes - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="nump">$ 3,232,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,982,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance costs</a></td>
<td class="num">(27,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Carrying amount of senior convertible notes</a></td>
<td class="nump">3,204,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,970,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="nump">774,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">774,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="nump">1,207,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,207,500,000<span></span>
</td>
<td class="nump">$ 1,210,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056244911536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Conversion Value of Convertible Notes (Details) - Senior Notes - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="nump">$ 1,790.8<span></span>
</td>
<td class="nump">$ 1,395.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="nump">1,649.5<span></span>
</td>
<td class="nump">1,361.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="nump">84.6<span></span>
</td>
<td class="nump">33.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="nump">$ 56.7<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056239782784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_CashInterestExpenseAbstract', window );"><strong>Cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual coupon interest</a></td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
<td class="nump">$ 4.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_NonCashInterestExpenseAbstract', window );"><strong>Non-cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense recognized on senior notes</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 8.7<span></span>
</td>
<td class="nump">$ 7.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_NonCashInterestExpenseAbstract', window );"><strong>Non-cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as a percent)</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Senior Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_NonCashInterestExpenseAbstract', window );"><strong>Non-cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as a percent)</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member', window );">Senior Convertible Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_NonCashInterestExpenseAbstract', window );"><strong>Non-cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as a percent)</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CashInterestExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Interest Expense [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CashInterestExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_NonCashInterestExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Cash Interest Expense [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_NonCashInterestExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056232636240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 02, 2023 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 26, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Nov. 30, 2018 </div>
<div>USD ($) </div>
<div>purchaser </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>d</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,230,600,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions', window );">Number of Initial purchasers | purchaser</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PaymentsForPurchasesOfCappedCallTransactions', window );">Purchases of capped call transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,300,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositAssets', window );">Deposit assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Repurchase and conversions of notes (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromExerciseOfNoteHedge', window );">Shares received from Note Hedge | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,232,300,000<span></span>
</td>
<td class="nump">3,232,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,982,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000<span></span>
</td>
<td class="nump">774,800,000<span></span>
</td>
<td class="nump">$ 774,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">774,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 836,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible notes (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled', window );">Debt instrument convertible principal amount exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 532,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromExerciseOfNoteHedge', window );">Shares received from Note Hedge | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentCovenantRepurchasePricePercentage', window );">Holder's repurchase price percentage in event of fundamental change (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock', window );">Proportion of conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Stock counterparties to acquire with warrants purchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from sale of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants or rights (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0243476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2023 | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares', window );">Stock issued upon conversion of senior notes (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of 2025 Notes issuance, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 218,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2023 | Term one | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2023 | Term one | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2023 | Term two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2023 | Term two | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2023 | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled', window );">Debt instrument convertible principal amount exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2023 | Common&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Repurchase and conversions of notes (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425,552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,210,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,207,500,000<span></span>
</td>
<td class="nump">$ 1,207,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,207,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,190,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible notes (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock', window );">Proportion of conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.006662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2025 | Term one | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2025 | Term one | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2025 | Term two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2025 | Term two | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250,000,000<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible notes (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentCovenantRepurchasePricePercentage', window );">Holder's repurchase price percentage in event of fundamental change (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock', window );">Proportion of conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0061571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare', window );">Capped call, cap price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 212.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage', window );">Sale of stock premium (Percentage)</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing stock price (USD per share) | $ / shares</a></td>
<td class="nump">$ 118.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PaymentsForPurchasesOfCappedCallTransactions', window );">Purchases of capped call transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2028 | Term one | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2028 | Term one | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2028 | Term two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Convertible Notes due 2028 | Term two | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity of revolving credit agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount', window );">Option to increase revolving line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity fee (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.175%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity fee (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Federal Reserve Bank Of New York Rate (NYFRB)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Secured Overnight Financing Rate (SOFR) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Secured Overnight Financing Rate (SOFR) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Simple Risk Free Rate (RFR) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0326%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Simple Risk Free Rate (RFR) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Cap Call Transaction, Cap Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentCapCallTransactionCapPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares1</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Capped Calls Initial Cap Price, Premium Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Principal Amount Exercised, Not Settled</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentCovenantRepurchasePricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Repurchase Price, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentCovenantRepurchasePricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Maximum Borrowing Capacity, Option to Increase, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Initial Purchasers For Convertible Note Hedge Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsForPurchasesOfCappedCallTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Purchases Of Capped Call Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsForPurchasesOfCappedCallTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_SharesReceivedFromExerciseOfNoteHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Received From Exercise Of Note Hedge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_SharesReceivedFromExerciseOfNoteHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481284/470-20-25-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-7<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -SubTopic 470<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=dxcm_FederalReserveBankOfNewYorkRateNYFRBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=dxcm_FederalReserveBankOfNewYorkRateNYFRBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=dxcm_SimpleRiskFreeRateRFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=dxcm_SimpleRiskFreeRateRFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056248521072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Total available balance</a></td>
<td class="nump">$ 192,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Letters of credit sub-facility</a></td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Outstanding borrowings</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Letter of credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Letters of credit sub-facility</a></td>
<td class="nump">25,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Outstanding letters of credit</a></td>
<td class="nump">$ 7,300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056248740608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent', window );">Estimated annual effective tax rate (as a percent)</a></td>
<td class="nump">28.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate (as a percent)</a></td>
<td class="nump">26.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated Annual Effective Income Tax Rate, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056243037200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Share-Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 39.7<span></span>
</td>
<td class="nump">$ 32.6<span></span>
</td>
<td class="nump">$ 74.9<span></span>
</td>
<td class="nump">$ 61.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">7.2<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">11.8<span></span>
</td>
<td class="nump">10.9<span></span>
</td>
<td class="nump">22.9<span></span>
</td>
<td class="nump">21.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=dxcm_SellingGeneralAndAdministrativeMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 24.0<span></span>
</td>
<td class="nump">$ 18.9<span></span>
</td>
<td class="nump">$ 44.8<span></span>
</td>
<td class="nump">$ 35.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dxcm_SellingGeneralAndAdministrativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dxcm_SellingGeneralAndAdministrativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056244715808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 26, 2022</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized estimated compensation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 272,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188,700,000<span></span>
</td>
<td class="nump">188,700,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=dxcm_ShareRepurchaseProgramMember', window );">Share Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="nump">$ 557,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units and performance stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total vest date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total vest date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=dxcm_ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=dxcm_ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056247924272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140056237086496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information - Summary (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 871.3<span></span>
</td>
<td class="nump">$ 696.2<span></span>
</td>
<td class="nump">$ 1,612.8<span></span>
</td>
<td class="nump">$ 1,325.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">Proportion of revenue (as a percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember', window );">Distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 738.8<span></span>
</td>
<td class="nump">$ 585.1<span></span>
</td>
<td class="nump">$ 1,357.7<span></span>
</td>
<td class="nump">$ 1,112.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">Proportion of revenue (as a percent)</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">84.00%<span></span>
</td>
<td class="nump">84.00%<span></span>
</td>
<td class="nump">84.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember', window );">Direct</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 132.5<span></span>
</td>
<td class="nump">$ 111.1<span></span>
</td>
<td class="nump">$ 255.1<span></span>
</td>
<td class="nump">$ 212.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">Proportion of revenue (as a percent)</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 616.6<span></span>
</td>
<td class="nump">$ 511.0<span></span>
</td>
<td class="nump">$ 1,142.6<span></span>
</td>
<td class="nump">$ 962.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">Proportion of revenue (as a percent)</a></td>
<td class="nump">71.00%<span></span>
</td>
<td class="nump">73.00%<span></span>
</td>
<td class="nump">71.00%<span></span>
</td>
<td class="nump">73.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 254.7<span></span>
</td>
<td class="nump">$ 185.2<span></span>
</td>
<td class="nump">$ 470.2<span></span>
</td>
<td class="nump">$ 362.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">Proportion of revenue (as a percent)</a></td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_RevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_RevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>dxcm-20230630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:dxcm="http://www.dexcom.com/20230630"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dxcm-20230630.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2023-07-20</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2022-06-10</startDate>
            <endDate>2022-06-10</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2022-06-10</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-28</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementApprovalMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-07-26</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-02</startDate>
            <endDate>2023-05-02</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-02</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dxcm:SimpleRiskFreeRateRFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dxcm:SimpleRiskFreeRateRFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dxcm:FederalReserveBankOfNewYorkRateNYFRBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-26</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-26</startDate>
            <endDate>2022-07-26</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:DonaldMAbbeyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:DonaldMAbbeyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:StevenRAltmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:StevenRAltmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:BridgettePHellerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:BridgettePHellerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="purchaser">
        <measure>dxcm:purchaser</measure>
    </unit>
    <unit id="segment">
        <measure>dxcm:segment</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-25">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-26">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-27">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-28">0001093557</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-29">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1 contextRef="c-160" decimals="7" id="f-811" unitRef="number">0.0243476</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1 contextRef="c-178" decimals="7" id="f-812" unitRef="number">0.0061571</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1 contextRef="c-172" decimals="7" id="f-813" unitRef="number">0.006662</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-197"
      decimals="INF"
      id="f-814"
      unitRef="number">0.005</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">000-51222</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">DEXCOM, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">33-0857544</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">6340 Sequence Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">200-0200</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common Stock, $0.001 Par Value Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">DXCM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-24" unitRef="shares">387871796</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-5" id="f-30" unitRef="usd">1194900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-5" id="f-31" unitRef="usd">642300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities contextRef="c-3" decimals="-5" id="f-32" unitRef="usd">2441300000</dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities>
    <dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities contextRef="c-4" decimals="-5" id="f-33" unitRef="usd">1813900000</dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-3" decimals="-5" id="f-34" unitRef="usd">750600000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-5" id="f-35" unitRef="usd">713300000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="c-3" decimals="-5" id="f-36" unitRef="usd">421100000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-5" id="f-37" unitRef="usd">306700000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-5" id="f-38" unitRef="usd">195000000.0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-5" id="f-39" unitRef="usd">192600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-5" id="f-40" unitRef="usd">5002900000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-5" id="f-41" unitRef="usd">3668800000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-3" decimals="-5" id="f-42" unitRef="usd">1077600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-5" id="f-43" unitRef="usd">1055600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-5" id="f-44" unitRef="usd">76300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-5" id="f-45" unitRef="usd">80000000.0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-3" decimals="-5" id="f-46" unitRef="usd">25800000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-5" id="f-47" unitRef="usd">25700000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-3" decimals="-5" id="f-48" unitRef="usd">154200000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-5" id="f-49" unitRef="usd">173300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-3" decimals="-5" id="f-50" unitRef="usd">417000000.0</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-4" decimals="-5" id="f-51" unitRef="usd">341200000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-5" id="f-52" unitRef="usd">66900000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-5" id="f-53" unitRef="usd">47100000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-5" id="f-54" unitRef="usd">6820700000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-5" id="f-55" unitRef="usd">5391700000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-56" unitRef="usd">1156500000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-57" unitRef="usd">901800000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-58" unitRef="usd">108600000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-59" unitRef="usd">134300000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c-3" decimals="-5" id="f-60" unitRef="usd">773800000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c-4" decimals="-5" id="f-61" unitRef="usd">772600000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-5" id="f-62" unitRef="usd">21800000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-5" id="f-63" unitRef="usd">20500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-3" decimals="-5" id="f-64" unitRef="usd">9000000.0</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-5" id="f-65" unitRef="usd">10100000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-66" unitRef="usd">2069700000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-67" unitRef="usd">1839300000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleLongTermNotesPayable contextRef="c-3" decimals="-5" id="f-68" unitRef="usd">2430600000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleLongTermNotesPayable contextRef="c-4" decimals="-5" id="f-69" unitRef="usd">1197700000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-5" id="f-70" unitRef="usd">86900000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-71" unitRef="usd">94600000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-3" decimals="-5" id="f-72" unitRef="usd">133100000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-5" id="f-73" unitRef="usd">128300000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="-5" id="f-74" unitRef="usd">4720300000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-5" id="f-75" unitRef="usd">3259900000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-76" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-77" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-78"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-79"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="-5" id="f-80" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="-5" id="f-81" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-3" decimals="INF" id="f-82" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="INF" id="f-83" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-84" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-85" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValueOutstanding contextRef="c-3" decimals="-5" id="f-86" unitRef="usd">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:PreferredStockValueOutstanding contextRef="c-4" decimals="-5" id="f-87" unitRef="usd">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-88"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-89"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="-5" id="f-90" unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="-5" id="f-91" unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="-5" id="f-92" unitRef="shares">394600000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="-5" id="f-93" unitRef="shares">386100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="-5" id="f-94" unitRef="shares">393200000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="-5" id="f-95" unitRef="shares">386300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValueOutstanding contextRef="c-3" decimals="-5" id="f-96" unitRef="usd">400000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding contextRef="c-4" decimals="-5" id="f-97" unitRef="usd">400000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-3" decimals="-5" id="f-98" unitRef="usd">2269000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-4" decimals="-5" id="f-99" unitRef="usd">2258100000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-5" id="f-100" unitRef="usd">-29300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-5" id="f-101" unitRef="usd">-11600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-5" id="f-102" unitRef="usd">644400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-5" id="f-103" unitRef="usd">479900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares contextRef="c-3" decimals="-5" id="f-104" unitRef="shares">8500000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="-5" id="f-105" unitRef="shares">6900000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-3" decimals="-5" id="f-106" unitRef="usd">784100000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-4" decimals="-5" id="f-107" unitRef="usd">595000000.0</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-3" decimals="-5" id="f-108" unitRef="usd">2100400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-5" id="f-109" unitRef="usd">2131800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-5" id="f-110" unitRef="usd">6820700000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-5" id="f-111" unitRef="usd">5391700000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-112" unitRef="usd">871300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-113" unitRef="usd">696200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-114" unitRef="usd">1612800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-5" id="f-115" unitRef="usd">1325000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-5" decimals="-5" id="f-116" unitRef="usd">324900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-6" decimals="-5" id="f-117" unitRef="usd">246700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-5" id="f-118" unitRef="usd">603800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-7" decimals="-5" id="f-119" unitRef="usd">477400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c-5" decimals="-5" id="f-120" unitRef="usd">546400000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-6" decimals="-5" id="f-121" unitRef="usd">449500000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-5" id="f-122" unitRef="usd">1009000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-7" decimals="-5" id="f-123" unitRef="usd">847600000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-5" id="f-124" unitRef="usd">119300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-6" decimals="-5" id="f-125" unitRef="usd">121700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-5" id="f-126" unitRef="usd">238300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-7" decimals="-5" id="f-127" unitRef="usd">257600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-5" decimals="-5" id="f-128" unitRef="usd">1700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-6" decimals="-5" id="f-129" unitRef="usd">1900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-130" unitRef="usd">3500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-7" decimals="-5" id="f-131" unitRef="usd">3900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-5" decimals="-5" id="f-132" unitRef="usd">297300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-6" decimals="-5" id="f-133" unitRef="usd">248900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-5" id="f-134" unitRef="usd">591900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-7" decimals="-5" id="f-135" unitRef="usd">467800000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-5" decimals="-5" id="f-136" unitRef="usd">418300000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-6" decimals="-5" id="f-137" unitRef="usd">372500000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-5" id="f-138" unitRef="usd">833700000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-7" decimals="-5" id="f-139" unitRef="usd">729300000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-5" id="f-140" unitRef="usd">128100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-5" id="f-141" unitRef="usd">77000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-5" id="f-142" unitRef="usd">175300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-7" decimals="-5" id="f-143" unitRef="usd">118300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="c-5" decimals="-5" id="f-144" unitRef="usd">5900000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-6" decimals="-5" id="f-145" unitRef="usd">4700000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-5" id="f-146" unitRef="usd">10500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-7" decimals="-5" id="f-147" unitRef="usd">9300000</us-gaap:InterestExpense>
    <us-gaap:DebtAndEquitySecuritiesGainLoss contextRef="c-5" decimals="-5" id="f-148" unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss contextRef="c-6" decimals="-5" id="f-149" unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss contextRef="c-1" decimals="-5" id="f-150" unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss contextRef="c-7" decimals="-5" id="f-151" unitRef="usd">200000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="-5" id="f-152" unitRef="usd">37100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-6" decimals="-5" id="f-153" unitRef="usd">3000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-154" unitRef="usd">59000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-5" id="f-155" unitRef="usd">2200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-156" unitRef="usd">159300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-6" decimals="-5" id="f-157" unitRef="usd">75300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-158" unitRef="usd">223800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-7" decimals="-5" id="f-159" unitRef="usd">111400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-160" unitRef="usd">43400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-161" unitRef="usd">24400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-162" unitRef="usd">59300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-163" unitRef="usd">-36800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-164" unitRef="usd">115900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-165" unitRef="usd">50900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-166" unitRef="usd">164500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-167" unitRef="usd">148200000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-168"
      unitRef="usdPerShare">0.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-169"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-170"
      unitRef="usdPerShare">0.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-171"
      unitRef="usdPerShare">0.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-172" unitRef="shares">386700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-5" id="f-173" unitRef="shares">392500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-174" unitRef="shares">386700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-5" id="f-175" unitRef="shares">390700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-176"
      unitRef="usdPerShare">0.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-177"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-178"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-179"
      unitRef="usdPerShare">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-5" id="f-180" unitRef="shares">431500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="-5" id="f-181" unitRef="shares">421400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-182" unitRef="shares">426600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-5" id="f-183" unitRef="shares">429100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-184" unitRef="usd">115900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-185" unitRef="usd">50900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-186" unitRef="usd">164500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-187" unitRef="usd">148200000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-188" unitRef="usd">-20200000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-5" id="f-189" unitRef="usd">-13900000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-190" unitRef="usd">-18800000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-5" id="f-191" unitRef="usd">-15300000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-5" decimals="-5" id="f-192" unitRef="usd">-2600000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-6" decimals="-5" id="f-193" unitRef="usd">-3000000.0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-5" id="f-194" unitRef="usd">1100000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-7" decimals="-5" id="f-195" unitRef="usd">-8200000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-196" unitRef="usd">-22800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-5" id="f-197" unitRef="usd">-16900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-198" unitRef="usd">-17700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-5" id="f-199" unitRef="usd">-23500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-5" id="f-200" unitRef="usd">93100000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-5" id="f-201" unitRef="usd">34000000.0</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-5" id="f-202" unitRef="usd">146800000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-5" id="f-203" unitRef="usd">124700000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="-5" id="f-204" unitRef="shares">387600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-5" id="f-205" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-5" id="f-206" unitRef="usd">2305600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-5" id="f-207" unitRef="usd">-6500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-5" id="f-208" unitRef="usd">528500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-5" id="f-209" unitRef="usd">-595000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-13" decimals="-5" id="f-210" unitRef="usd">2233000000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan contextRef="c-14" decimals="-5" id="f-211" unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-14" decimals="-5" id="f-212" unitRef="shares">1600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-15" decimals="-5" id="f-213" unitRef="usd">189100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-5" decimals="-5" id="f-214" unitRef="usd">189100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax contextRef="c-16" decimals="-5" id="f-215" unitRef="usd">76300000</dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax contextRef="c-5" decimals="-5" id="f-216" unitRef="usd">76300000</dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-16" decimals="-5" id="f-217" unitRef="usd">39700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-5" id="f-218" unitRef="usd">39700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-17" decimals="-5" id="f-219" unitRef="usd">115900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-220" unitRef="usd">115900000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-18" decimals="-5" id="f-221" unitRef="usd">-22800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-222" unitRef="usd">-22800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-19" decimals="-5" id="f-223" unitRef="shares">386100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-5" id="f-224" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-5" id="f-225" unitRef="usd">2269000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-5" id="f-226" unitRef="usd">-29300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-5" id="f-227" unitRef="usd">644400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-5" id="f-228" unitRef="usd">-784100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-5" id="f-229" unitRef="usd">2100400000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-24" decimals="-5" id="f-230" unitRef="shares">392500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-5" id="f-231" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-5" id="f-232" unitRef="usd">1996300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-5" id="f-233" unitRef="usd">-6100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-5" id="f-234" unitRef="usd">236000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-5" id="f-235" unitRef="usd">-37300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-5" id="f-236" unitRef="usd">2189300000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan contextRef="c-30" decimals="-5" id="f-237" unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-31" decimals="-5" id="f-238" unitRef="usd">32600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-6" decimals="-5" id="f-239" unitRef="usd">32600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-32" decimals="-5" id="f-240" unitRef="usd">50900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-241" unitRef="usd">50900000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-33" decimals="-5" id="f-242" unitRef="usd">-16900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-5" id="f-243" unitRef="usd">-16900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-34" decimals="-5" id="f-244" unitRef="shares">392600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-34" decimals="-5" id="f-245" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-5" id="f-246" unitRef="usd">2028900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-5" id="f-247" unitRef="usd">-23000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-5" id="f-248" unitRef="usd">286900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-5" id="f-249" unitRef="usd">-37300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-5" id="f-250" unitRef="usd">2255900000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-40" decimals="-5" id="f-251" unitRef="shares">386300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-5" id="f-252" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-5" id="f-253" unitRef="usd">2258100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-5" id="f-254" unitRef="usd">-11600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-43" decimals="-5" id="f-255" unitRef="usd">479900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-44" decimals="-5" id="f-256" unitRef="usd">-595000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-5" id="f-257" unitRef="usd">2131800000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan contextRef="c-45" decimals="-5" id="f-258" unitRef="shares">1200000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-45" decimals="-5" id="f-259" unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-46" decimals="-5" id="f-260" unitRef="usd">12300000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-1" decimals="-5" id="f-261" unitRef="usd">12300000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-45" decimals="-5" id="f-262" unitRef="shares">1600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-47" decimals="-5" id="f-263" unitRef="usd">189100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-1" decimals="-5" id="f-264" unitRef="usd">189100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax contextRef="c-46" decimals="-5" id="f-265" unitRef="usd">76300000</dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax contextRef="c-1" decimals="-5" id="f-266" unitRef="usd">76300000</dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-46" decimals="-5" id="f-267" unitRef="usd">74900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-5" id="f-268" unitRef="usd">74900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-48" decimals="-5" id="f-269" unitRef="usd">164500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-270" unitRef="usd">164500000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-49" decimals="-5" id="f-271" unitRef="usd">-17700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-272" unitRef="usd">-17700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-19" decimals="-5" id="f-273" unitRef="shares">386100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-5" id="f-274" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-5" id="f-275" unitRef="usd">2269000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-5" id="f-276" unitRef="usd">-29300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-5" id="f-277" unitRef="usd">644400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-5" id="f-278" unitRef="usd">-784100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-5" id="f-279" unitRef="usd">2100400000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-50" decimals="-5" id="f-280" unitRef="shares">388000000.0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-50" decimals="-5" id="f-281" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-51" decimals="-5" id="f-282" unitRef="usd">2108700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-52" decimals="-5" id="f-283" unitRef="usd">500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-53" decimals="-5" id="f-284" unitRef="usd">138700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-54" decimals="-5" id="f-285" unitRef="usd">-206200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-55" decimals="-5" id="f-286" unitRef="usd">2042100000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan contextRef="c-56" decimals="-5" id="f-287" unitRef="shares">1500000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-56" decimals="-5" id="f-288" unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-57" decimals="-5" id="f-289" unitRef="usd">10100000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-7" decimals="-5" id="f-290" unitRef="usd">10100000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone contextRef="c-56" decimals="-5" id="f-291" unitRef="shares">2900000</dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone>
    <dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone contextRef="c-57" decimals="-5" id="f-292" unitRef="usd">-189300000</dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone>
    <dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone contextRef="c-58" decimals="-5" id="f-293" unitRef="usd">189200000</dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone>
    <dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone contextRef="c-7" decimals="-5" id="f-294" unitRef="usd">-100000</dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-56" decimals="-5" id="f-295" unitRef="shares">400000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-57" decimals="-5" id="f-296" unitRef="usd">4200000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-58" decimals="-5" id="f-297" unitRef="usd">13200000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-7" decimals="-5" id="f-298" unitRef="usd">17400000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <dxcm:SharesReceivedFromExerciseOfNoteHedge contextRef="c-56" decimals="-5" id="f-299" unitRef="shares">300000</dxcm:SharesReceivedFromExerciseOfNoteHedge>
    <dxcm:SharesReceivedFromBenefitOfNoteHedgeValue contextRef="c-57" decimals="-5" id="f-300" unitRef="usd">33500000</dxcm:SharesReceivedFromBenefitOfNoteHedgeValue>
    <dxcm:SharesReceivedFromBenefitOfNoteHedgeValue contextRef="c-58" decimals="-5" id="f-301" unitRef="usd">-33500000</dxcm:SharesReceivedFromBenefitOfNoteHedgeValue>
    <dxcm:SharesReceivedFromBenefitOfNoteHedgeValue contextRef="c-7" decimals="-5" id="f-302" unitRef="usd">0</dxcm:SharesReceivedFromBenefitOfNoteHedgeValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-57" decimals="-5" id="f-303" unitRef="usd">61700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-7" decimals="-5" id="f-304" unitRef="usd">61700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-59" decimals="-5" id="f-305" unitRef="usd">148200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-306" unitRef="usd">148200000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-60" decimals="-5" id="f-307" unitRef="usd">-23500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-5" id="f-308" unitRef="usd">-23500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-34" decimals="-5" id="f-309" unitRef="shares">392600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-34" decimals="-5" id="f-310" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-5" id="f-311" unitRef="usd">2028900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-5" id="f-312" unitRef="usd">-23000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-5" id="f-313" unitRef="usd">286900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-5" id="f-314" unitRef="usd">-37300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-5" id="f-315" unitRef="usd">2255900000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-316" unitRef="usd">164500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-317" unitRef="usd">148200000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-5" id="f-318" unitRef="usd">85300000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-7" decimals="-5" id="f-319" unitRef="usd">80400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-5" id="f-320" unitRef="usd">74900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-7" decimals="-5" id="f-321" unitRef="usd">61700000</us-gaap:ShareBasedCompensation>
    <us-gaap:PaidInKindInterest contextRef="c-1" decimals="-5" id="f-322" unitRef="usd">3600000</us-gaap:PaidInKindInterest>
    <us-gaap:PaidInKindInterest contextRef="c-7" decimals="-5" id="f-323" unitRef="usd">3200000</us-gaap:PaidInKindInterest>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal contextRef="c-1" decimals="-5" id="f-324" unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal contextRef="c-7" decimals="-5" id="f-325" unitRef="usd">200000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-326" unitRef="usd">-51500000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-327" unitRef="usd">-19800000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-5" id="f-328" unitRef="usd">29400000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-7" decimals="-5" id="f-329" unitRef="usd">-16000000.0</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-5" id="f-330" unitRef="usd">37100000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-7" decimals="-5" id="f-331" unitRef="usd">47100000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-5" id="f-332" unitRef="usd">115000000.0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-7" decimals="-5" id="f-333" unitRef="usd">-16700000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-5" id="f-334" unitRef="usd">3400000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-7" decimals="-5" id="f-335" unitRef="usd">82500000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet contextRef="c-1" decimals="-5" id="f-336" unitRef="usd">2100000</dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet>
    <dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet contextRef="c-7" decimals="-5" id="f-337" unitRef="usd">3400000</dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-5" id="f-338" unitRef="usd">277000000.0</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-7" decimals="-5" id="f-339" unitRef="usd">96000000.0</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-1" decimals="-5" id="f-340" unitRef="usd">-25500000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-7" decimals="-5" id="f-341" unitRef="usd">-31100000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability contextRef="c-1" decimals="-5" id="f-342" unitRef="usd">4400000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability contextRef="c-7" decimals="-5" id="f-343" unitRef="usd">5700000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-5" id="f-344" unitRef="usd">345700000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-7" decimals="-5" id="f-345" unitRef="usd">243800000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-1" decimals="-5" id="f-346" unitRef="usd">2149900000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-7" decimals="-5" id="f-347" unitRef="usd">1143700000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-1" decimals="-5" id="f-348" unitRef="usd">1557000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-7" decimals="-5" id="f-349" unitRef="usd">785600000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-5" id="f-350" unitRef="usd">133700000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-7" decimals="-5" id="f-351" unitRef="usd">193100000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-1" decimals="-5" id="f-352" unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-7" decimals="-5" id="f-353" unitRef="usd">3200000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-1" decimals="-5" id="f-354" unitRef="usd">16000000.0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-7" decimals="-5" id="f-355" unitRef="usd">2300000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-5" id="f-356" unitRef="usd">-742600000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-7" decimals="-5" id="f-357" unitRef="usd">-556700000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-5" id="f-358" unitRef="usd">12300000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-7" decimals="-5" id="f-359" unitRef="usd">10100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-5" id="f-360" unitRef="usd">188700000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-7" decimals="-5" id="f-361" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-1" decimals="-5" id="f-362" unitRef="usd">1230600000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-7" decimals="-5" id="f-363" unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <dxcm:PaymentsForPurchasesOfCappedCallTransactions contextRef="c-1" decimals="-5" id="f-364" unitRef="usd">101300000</dxcm:PaymentsForPurchasesOfCappedCallTransactions>
    <dxcm:PaymentsForPurchasesOfCappedCallTransactions contextRef="c-7" decimals="-5" id="f-365" unitRef="usd">0</dxcm:PaymentsForPurchasesOfCappedCallTransactions>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-1" decimals="-5" id="f-366" unitRef="usd">-2200000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-7" decimals="-5" id="f-367" unitRef="usd">-9100000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-5" id="f-368" unitRef="usd">950700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-7" decimals="-5" id="f-369" unitRef="usd">1000000.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-5" id="f-370" unitRef="usd">-1100000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-5" id="f-371" unitRef="usd">-5300000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-5" id="f-372" unitRef="usd">552700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-7" decimals="-5" id="f-373" unitRef="usd">-317200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-5" id="f-374" unitRef="usd">643300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-55" decimals="-5" id="f-375" unitRef="usd">1053600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-5" id="f-376" unitRef="usd">1196000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-39" decimals="-5" id="f-377" unitRef="usd">736400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-5" id="f-378" unitRef="usd">1194900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-39" decimals="-5" id="f-379" unitRef="usd">735400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash contextRef="c-3" decimals="-5" id="f-380" unitRef="usd">1100000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash contextRef="c-39" decimals="-5" id="f-381" unitRef="usd">1000000.0</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-5" id="f-382" unitRef="usd">1196000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-39" decimals="-5" id="f-383" unitRef="usd">736400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="c-1" decimals="-5" id="f-384" unitRef="usd">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="c-7" decimals="-5" id="f-385" unitRef="usd">35900000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge contextRef="c-1" decimals="-5" id="f-386" unitRef="usd">0</dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge>
    <dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge contextRef="c-7" decimals="-5" id="f-387" unitRef="usd">-33500000</dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c-1" decimals="-5" id="f-388" unitRef="usd">53400000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c-7" decimals="-5" id="f-389" unitRef="usd">59800000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <dxcm:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet contextRef="c-1" decimals="-5" id="f-390" unitRef="usd">4100000</dxcm:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet>
    <dxcm:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet contextRef="c-7" decimals="-5" id="f-391" unitRef="usd">-800000</dxcm:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-1" decimals="-5" id="f-392" unitRef="usd">1500000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-7" decimals="-5" id="f-393" unitRef="usd">15700000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-394">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:98.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#32ad10;border-bottom:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;1. Organization and Significant Accounting Policies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Organization and Business&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DexCom, Inc. is a medical device company that develops and markets continuous glucose monitoring, or CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Unless the context requires otherwise, the terms &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; the &#x201c;company,&#x201d; or &#x201c;Dexcom&#x201d; refer to DexCom, Inc. and its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating results for the three and six months ended June&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December&#160;31, 2022 included in the Annual Report on Form 10-K that we filed with the SEC on February&#160;9, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 10, 2022, the Company effected a four-for-one forward stock split of its common stock to shareholders of record as of May 19, 2022. The par value of the common stock remains $0.001 per share. Accordingly, an amount equal to the par value of the increased shares resulting from the stock split was reclassified from &#x201c;Additional paid-in capital&#x201d; to &#x201c;Common stock.&#x201d; All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in interest and other income, net in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Seasonality&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expect that the revenue we generate from the sales of our products will fluctuate from quarter to quarter. We typically experience seasonality, with lower sales in the first quarter of each year compared to the immediately preceding fourth quarter. This seasonal sales pattern relates to U.S. annual insurance deductible resets and unfunded flexible spending accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no material changes to our significant accounting policies as described in Note 1 to the financial statements in Part II, Item 8 of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 during the six months ended June&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Use of Estimates&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with GAAP requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable as of June&#160;30, 2023 included unbilled accounts receivable of $9.2 million. We expect to invoice and collect all unbilled accounts receivable within twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our performance obligations are generally satisfied within twelve months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after twelve months was $21.4 million as of June&#160;30, 2023 and $19.0 million as of December&#160;31, 2022. These balances are included in other long-term liabilities in our consolidated balance sheets.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized in the period from performance obligations satisfied in previous periods was not material for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Net Income Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income per share attributable to common stockholders is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive common shares consist of shares issuable from restricted stock units, or RSUs, performance stock units, or PSUs, warrants, and our senior convertible notes. Potentially dilutive common shares issuable upon vesting of RSUs, PSUs, and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income per share for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.069%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income - diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive potential common stock outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding anti-dilutive securities not included in the diluted net income per share attributable to common stockholders calculations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Recent Accounting Guidance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU No. 2021-08,&lt;/span&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. &lt;/span&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This guidance is intended improve the accounting for acquired revenue contracts with customers in a business combination. The new guidance requires that the acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. ASU 2021-08 is effective for public business entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The amendments should be applied prospectively to business combinations occurring on or after the adoption date. We adopted ASU 2021-08 in the first quarter of 2023 and there was no impact to our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not expect any recently issued accounting pronouncements will have a material effect on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-395">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating results for the three and six months ended June&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December&#160;31, 2022 included in the Annual Report on Form 10-K that we filed with the SEC on February&#160;9, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 10, 2022, the Company effected a four-for-one forward stock split of its common stock to shareholders of record as of May 19, 2022. The par value of the common stock remains $0.001 per share. Accordingly, an amount equal to the par value of the increased shares resulting from the stock split was reclassified from &#x201c;Additional paid-in capital&#x201d; to &#x201c;Common stock.&#x201d; All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in interest and other income, net in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-396">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating results for the three and six months ended June&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December&#160;31, 2022 included in the Annual Report on Form 10-K that we filed with the SEC on February&#160;9, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 10, 2022, the Company effected a four-for-one forward stock split of its common stock to shareholders of record as of May 19, 2022. The par value of the common stock remains $0.001 per share. Accordingly, an amount equal to the par value of the increased shares resulting from the stock split was reclassified from &#x201c;Additional paid-in capital&#x201d; to &#x201c;Common stock.&#x201d; All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in interest and other income, net in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="c-61"
      decimals="INF"
      id="f-397"
      unitRef="number">4</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-62"
      decimals="INF"
      id="f-398"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-399">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Use of Estimates&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with GAAP requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-400">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-401">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable as of June&#160;30, 2023 included unbilled accounts receivable of $9.2 million. We expect to invoice and collect all unbilled accounts receivable within twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our performance obligations are generally satisfied within twelve months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after twelve months was $21.4 million as of June&#160;30, 2023 and $19.0 million as of December&#160;31, 2022. These balances are included in other long-term liabilities in our consolidated balance sheets.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized in the period from performance obligations satisfied in previous periods was not material for the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <dxcm:ContractPaymentTermsNumberofDays contextRef="c-63" id="f-402">P30D</dxcm:ContractPaymentTermsNumberofDays>
    <dxcm:ContractPaymentTermsNumberofDays contextRef="c-64" id="f-403">P90D</dxcm:ContractPaymentTermsNumberofDays>
    <us-gaap:UnbilledContractsReceivable contextRef="c-3" decimals="-5" id="f-404" unitRef="usd">9200000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-3" decimals="-5" id="f-405" unitRef="usd">21400000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-406" unitRef="usd">19000000.0</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-407">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Net Income Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income per share attributable to common stockholders is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive common shares consist of shares issuable from restricted stock units, or RSUs, performance stock units, or PSUs, warrants, and our senior convertible notes. Potentially dilutive common shares issuable upon vesting of RSUs, PSUs, and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-408">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income per share for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.069%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income - diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive potential common stock outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-409" unitRef="usd">115900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-410" unitRef="usd">50900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-411" unitRef="usd">164500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-412" unitRef="usd">148200000</us-gaap:NetIncomeLoss>
    <us-gaap:InterestOnConvertibleDebtNetOfTax contextRef="c-5" decimals="-5" id="f-413" unitRef="usd">3800000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax contextRef="c-6" decimals="-5" id="f-414" unitRef="usd">1600000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax contextRef="c-1" decimals="-5" id="f-415" unitRef="usd">5500000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax contextRef="c-7" decimals="-5" id="f-416" unitRef="usd">5500000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:NetIncomeLossAttributableToParentDiluted contextRef="c-5" decimals="-5" id="f-417" unitRef="usd">119700000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted contextRef="c-6" decimals="-5" id="f-418" unitRef="usd">52500000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted contextRef="c-1" decimals="-5" id="f-419" unitRef="usd">170000000.0</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted contextRef="c-7" decimals="-5" id="f-420" unitRef="usd">153700000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-421"
      unitRef="usdPerShare">0.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-422"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-423"
      unitRef="usdPerShare">0.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-424"
      unitRef="usdPerShare">0.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-425"
      unitRef="usdPerShare">0.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-426"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-427"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-428"
      unitRef="usdPerShare">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-429" unitRef="shares">386700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-5" id="f-430" unitRef="shares">392500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-431" unitRef="shares">386700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-5" id="f-432" unitRef="shares">390700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-65" decimals="-5" id="f-433" unitRef="shares">900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-66" decimals="-5" id="f-434" unitRef="shares">500000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-67" decimals="-5" id="f-435" unitRef="shares">1100000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-68" decimals="-5" id="f-436" unitRef="shares">1000000.0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-69" decimals="-5" id="f-437" unitRef="shares">12200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-70" decimals="-5" id="f-438" unitRef="shares">9500000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-71" decimals="-5" id="f-439" unitRef="shares">11900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-72" decimals="-5" id="f-440" unitRef="shares">10500000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-73" decimals="-5" id="f-441" unitRef="shares">31700000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-74" decimals="-5" id="f-442" unitRef="shares">18900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-75" decimals="-5" id="f-443" unitRef="shares">26900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-76" decimals="-5" id="f-444" unitRef="shares">26900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-5" id="f-445" unitRef="shares">431500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="-5" id="f-446" unitRef="shares">421400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-447" unitRef="shares">426600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-5" id="f-448" unitRef="shares">429100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-449">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding anti-dilutive securities not included in the diluted net income per share attributable to common stockholders calculations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-77" decimals="-5" id="f-450" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-78" decimals="-5" id="f-451" unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-79" decimals="-5" id="f-452" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-80" decimals="-5" id="f-453" unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-73" decimals="-5" id="f-454" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-74" decimals="-5" id="f-455" unitRef="shares">8000000.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-75" decimals="-5" id="f-456" unitRef="shares">7700000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-76" decimals="-5" id="f-457" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-5" decimals="-5" id="f-458" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-6" decimals="-5" id="f-459" unitRef="shares">8200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="-5" id="f-460" unitRef="shares">7700000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-7" decimals="-5" id="f-461" unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-462">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Recent Accounting Guidance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU No. 2021-08,&lt;/span&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. &lt;/span&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This guidance is intended improve the accounting for acquired revenue contracts with customers in a business combination. The new guidance requires that the acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. ASU 2021-08 is effective for public business entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The amendments should be applied prospectively to business combinations occurring on or after the adoption date. We adopted ASU 2021-08 in the first quarter of 2023 and there was no impact to our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;We do not expect any recently issued accounting pronouncements will have a material effect on our consolidated financial statements</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="c-1" id="f-463">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;2. Development and Other Agreements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Collaboration with Verily Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, &#x201c;Verily&#x201d;), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily dated August 10, 2015, as amended in October 2016, including the royalty obligations provisions under that original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily have agreed to continue to jointly develop a certain next-generation CGM product, and potentially one or more additional CGM products, for which we will have exclusive commercialization rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Collaboration Agreement also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside of the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#x2019;s other intellectual property rights to develop, manufacture and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. The Restated Collaboration Agreement requires us to use commercially reasonable efforts to develop, launch and commercialize the CGM product(s) that are the subject of the collaboration according to certain timing and other objectives, and provides for one executive sponsor from each of Dexcom and Verily to meet periodically and make decisions related to the collaboration (within a limited scope of authority) by consensus.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In consideration of Verily&#x2019;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we made upfront, incentive, and the product regulatory approval payments, and will make potential payments for contingent sales-based milestones upon the achievement of certain revenue targets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for the contingent milestones payable in shares of our common stock as equity instruments within the scope of ASC Topic 718. The product regulatory approval and sales-based milestones are accounted for as performance-based awards that vest when the performance conditions have been achieved and are recognized when the achievement of the respective contingent milestone is deemed probable. The value of the contingent milestones is based on our closing stock price on December 28, 2018, which was $29.57 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Upfront and Incentive payments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In the fourth quarter of 2018, we made an initial payment for an upfront fee of $250.0 million through the issuance of 7,363,772 shares of our common stock. We recorded a $217.7 million charge in our consolidated statements of operations during 2018 relating to the issuance of this common stock because this milestone payment did not meet the capitalization criteria. The value of the charge was based on our closing stock price of $29.57 per share on December 28, 2018, the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. In 2019, we made a cash incentive payment of $3.2 million due to the completion of certain development obligations and we recorded these payments as research and development expense in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent milestones&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2021, we determined the achievement of the regulatory approval milestone to be probable and recorded an $87.1 million research and development charge in our consolidated statements of operations. This charge is associated with IPR&amp;amp;D obtained in an asset acquisition prior to regulatory approval and therefore does not have an alternative future use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2022, we received regulatory approval and issued 2,945,508 shares of our common stock in connection with our achievement of the related milestone.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2022, we received FDA approval and determined the achievement of the sales-based milestones to be probable. As such, we capitalized the full value of the sales-based milestones, $152.4 million, as an intangible asset. The sales-based milestones are contingent upon the achievement of certain revenue targets. The value of the sales based milestones is based on: 1) 5,154,640 shares of our common stock, as agreed upon in November 2018 and 2) our closing stock price on December 28, 2018 of $29.57 per share. December 28, 2018 is the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. The intangible asset will be amortized using the straight-line method over its estimated useful &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;life of 64 months through March 2028. The related amortization expense is recognized in Cost of Sales in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All milestones may be paid in cash or shares of our common stock, at our election. If we elect to make these milestone payments in cash, any such cash payment would be equal to the number of shares that would otherwise be issued for the given milestone payment multiplied by the value of our stock on the date the relevant milestone is achieved, and adjusted to give effect to any stock splits, dividends, or similar events. We intend to pay the sales-based contingent milestones in shares of our common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Collaboration Agreement will continue until December 31, 2028, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party. Upon achievement of the first sales-based milestone event and payment of the corresponding milestone fee by us, the term of the Restated Collaboration Agreement will be extended until December 31, 2033, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:SharePrice
      contextRef="c-81"
      decimals="INF"
      id="f-464"
      unitRef="usdPerShare">29.57</us-gaap:SharePrice>
    <dxcm:CollaborativeArrangementUpfrontFee contextRef="c-82" decimals="-5" id="f-465" unitRef="usd">250000000.0</dxcm:CollaborativeArrangementUpfrontFee>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-83"
      decimals="INF"
      id="f-466"
      unitRef="shares">7363772</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <dxcm:CollaborativeResearchAndDevelopmentFee contextRef="c-83" decimals="-5" id="f-467" unitRef="usd">217700000</dxcm:CollaborativeResearchAndDevelopmentFee>
    <us-gaap:SharePrice
      contextRef="c-81"
      decimals="INF"
      id="f-468"
      unitRef="usdPerShare">29.57</us-gaap:SharePrice>
    <dxcm:CollaborativeResearchAndDevelopmentFee contextRef="c-84" decimals="-5" id="f-469" unitRef="usd">3200000</dxcm:CollaborativeResearchAndDevelopmentFee>
    <dxcm:CollaborativeResearchAndDevelopmentFee contextRef="c-85" decimals="-5" id="f-470" unitRef="usd">87100000</dxcm:CollaborativeResearchAndDevelopmentFee>
    <dxcm:PotentialFutureCommonStockIssuableSharesNewIssues
      contextRef="c-86"
      decimals="INF"
      id="f-471"
      unitRef="shares">2945508</dxcm:PotentialFutureCommonStockIssuableSharesNewIssues>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-87" decimals="-5" id="f-472" unitRef="usd">152400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <dxcm:PotentialFutureCommonStockIssuableSharesNewIssues
      contextRef="c-88"
      decimals="INF"
      id="f-473"
      unitRef="shares">5154640</dxcm:PotentialFutureCommonStockIssuableSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="c-81"
      decimals="INF"
      id="f-474"
      unitRef="usdPerShare">29.57</us-gaap:SharePrice>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="c-89" id="f-475">P64M</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef="c-1" id="f-476">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;3. Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement dates, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values provided by our investment managers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of June&#160;30, 2023, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,640.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,640.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,441.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,441.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,482.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,407.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2022, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,244.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;no&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; transfers into or out of Level 3 securities during the three and six months ended June&#160;30, 2023&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Senior Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using Level 1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,418.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,279.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of outstanding senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,988.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,451.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For more information on the carrying values of our senior convertible notes, see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Convertible Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in Note 5 &#x201c;Debt&#x201d; to the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency and Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into foreign currency forward contracts to hedge monetary assets and liabilities denominated in foreign currencies. Our foreign currency forward contracts are not designated as hedging instruments. Therefore, changes in the fair values of these contracts are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. The duration of these contracts is generally one month. The derivative gains and losses are included in interest and other income, net in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023 and December&#160;31, 2022, the notional amounts of outstanding foreign currency forward contracts were $61.0 million and $62.0 million, respectively. The resulting impact on our consolidated financial statements from currency hedging activities was not significant for the three and six months ended June&#160;30, 2023 and June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our foreign currency exposures vary but are primarily concentrated in the Australian Dollar, the British Pound, the Canadian Dollar, the Euro, and the Malaysian Ringgit. We monitor the costs and the impact of foreign currency risks upon our financial results as part of our risk management program. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management. We do not require and are not required to pledge collateral for these financial instruments and we do not carry any master netting arrangements to mitigate the credit risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with authoritative guidance, we measure certain non-financial assets and liabilities at fair value on a non-recurring basis. These measurements are usually performed using the discounted cash flow method or cost method and Level 3 inputs. These include items such as non-financial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment.&#160;In general, non-financial assets, including goodwill, intangible assets, and property and equipment, are measured at fair value when there are indicators of impairment and are recorded at fair value only when an impairment is recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;are&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$35.0&#160;million as of June&#160;30, 2023 and $19.0 million as of December&#160;31, 2022. We include them in other assets in our consolidated balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant effect on the fair values.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no significant impairment losses during the three and six months ended June&#160;30, 2023 and June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c-1" id="f-477">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of June&#160;30, 2023, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,640.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,640.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,441.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,441.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,482.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,407.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2022, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,244.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-90" decimals="-5" id="f-478" unitRef="usd">911400000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-91" decimals="-5" id="f-479" unitRef="usd">40700000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-92" decimals="-5" id="f-480" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-3" decimals="-5" id="f-481" unitRef="usd">952100000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-93" decimals="-5" id="f-482" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-94" decimals="-5" id="f-483" unitRef="usd">1640500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-95" decimals="-5" id="f-484" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-96" decimals="-5" id="f-485" unitRef="usd">1640500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-97" decimals="-5" id="f-486" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-98" decimals="-5" id="f-487" unitRef="usd">419700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-99" decimals="-5" id="f-488" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-100" decimals="-5" id="f-489" unitRef="usd">419700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-101" decimals="-5" id="f-490" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-102" decimals="-5" id="f-491" unitRef="usd">381100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-103" decimals="-5" id="f-492" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-104" decimals="-5" id="f-493" unitRef="usd">381100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-90" decimals="-5" id="f-494" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-91" decimals="-5" id="f-495" unitRef="usd">2441300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-92" decimals="-5" id="f-496" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-3" decimals="-5" id="f-497" unitRef="usd">2441300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-90" decimals="-5" id="f-498" unitRef="usd">14400000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-91" decimals="-5" id="f-499" unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-92" decimals="-5" id="f-500" unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-3" decimals="-5" id="f-501" unitRef="usd">14400000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-90" decimals="-5" id="f-502" unitRef="usd">925800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-91" decimals="-5" id="f-503" unitRef="usd">2482000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-92" decimals="-5" id="f-504" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-3" decimals="-5" id="f-505" unitRef="usd">3407800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-105" decimals="-5" id="f-506" unitRef="usd">375900000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-106" decimals="-5" id="f-507" unitRef="usd">44800000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-107" decimals="-5" id="f-508" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-4" decimals="-5" id="f-509" unitRef="usd">420700000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-108" decimals="-5" id="f-510" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-109" decimals="-5" id="f-511" unitRef="usd">1530700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-110" decimals="-5" id="f-512" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-111" decimals="-5" id="f-513" unitRef="usd">1530700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-112" decimals="-5" id="f-514" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-113" decimals="-5" id="f-515" unitRef="usd">119400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-114" decimals="-5" id="f-516" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-115" decimals="-5" id="f-517" unitRef="usd">119400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-116" decimals="-5" id="f-518" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-117" decimals="-5" id="f-519" unitRef="usd">163800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-118" decimals="-5" id="f-520" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-119" decimals="-5" id="f-521" unitRef="usd">163800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-105" decimals="-5" id="f-522" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-106" decimals="-5" id="f-523" unitRef="usd">1813900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-107" decimals="-5" id="f-524" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-4" decimals="-5" id="f-525" unitRef="usd">1813900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-105" decimals="-5" id="f-526" unitRef="usd">10200000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-106" decimals="-5" id="f-527" unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-107" decimals="-5" id="f-528" unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-4" decimals="-5" id="f-529" unitRef="usd">10200000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-105" decimals="-5" id="f-530" unitRef="usd">386100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-106" decimals="-5" id="f-531" unitRef="usd">1858700000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-107" decimals="-5" id="f-532" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-4" decimals="-5" id="f-533" unitRef="usd">2244800000</us-gaap:AssetsFairValueDisclosure>
    <dxcm:FairValueAssetsLevel3TransfersAmount contextRef="c-6" decimals="0" id="f-534" unitRef="usd">0</dxcm:FairValueAssetsLevel3TransfersAmount>
    <dxcm:FairValueAssetsLevel3TransfersAmount contextRef="c-5" decimals="0" id="f-535" unitRef="usd">0</dxcm:FairValueAssetsLevel3TransfersAmount>
    <dxcm:FairValueAssetsLevel3TransfersAmount contextRef="c-7" decimals="0" id="f-536" unitRef="usd">0</dxcm:FairValueAssetsLevel3TransfersAmount>
    <dxcm:FairValueAssetsLevel3TransfersAmount contextRef="c-1" decimals="0" id="f-537" unitRef="usd">0</dxcm:FairValueAssetsLevel3TransfersAmount>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock contextRef="c-1" id="f-538">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using Level 1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,418.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,279.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of outstanding senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,988.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,451.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,232.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,982.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount of senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,204.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,970.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-120" decimals="-5" id="f-539" unitRef="usd">2418900000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-121" decimals="-5" id="f-540" unitRef="usd">2136200000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-122" decimals="-5" id="f-541" unitRef="usd">1290700000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-123" decimals="-5" id="f-542" unitRef="usd">1314900000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-124" decimals="-5" id="f-543" unitRef="usd">1279100000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-125" decimals="-5" id="f-544" unitRef="usd">0</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-126" decimals="-5" id="f-545" unitRef="usd">4988700000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-127" decimals="-5" id="f-546" unitRef="usd">3451100000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DerivativeNotionalAmount contextRef="c-128" decimals="-5" id="f-547" unitRef="usd">61000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-129" decimals="-5" id="f-548" unitRef="usd">62000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:LongTermInvestments contextRef="c-130" decimals="-5" id="f-549" unitRef="usd">35000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments contextRef="c-131" decimals="-5" id="f-550" unitRef="usd">19000000</us-gaap:LongTermInvestments>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-1" decimals="0" id="f-551" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-7" decimals="0" id="f-552" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-6" decimals="0" id="f-553" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-5" decimals="0" id="f-554" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock contextRef="c-1" id="f-555">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;4. Balance Sheet Details&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Short-Term Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term marketable securities, consisting of available-for-sale debt securities, were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,643.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,640.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,444.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,441.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, the estimated market value of our short-term debt securities with contractual maturities up to 12 months was $2.44&#160;billion. As of December&#160;31, 2022, the estimated market value of our short-term debt securities with contractual maturities up to 12 months was $1.81&#160;billion. Gross realized gains and losses on sales of our short-term debt securities for the three and six months ended June&#160;30, 2023 and June&#160;30, 2022 were not significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We periodically review our portfolio of debt securities to determine if any investment is impaired due to credit loss or other potential valuation concerns. For debt securities where the fair value of the investment is less than the amortized cost basis, we have assessed at the individual security level for various quantitative factors including, but not limited to, the nature of the investments, changes in credit ratings, interest rate fluctuations, industry analyst &lt;/span&gt;&lt;/div&gt;reports, and the severity of impairment. Unrealized losses on available-for-sale debt securities at June&#160;30, 2023 were primarily due to increases in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, we have not recorded an allowance for credit losses. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Prepaid and Other Current Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land and land improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer software and hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,505.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(428.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable trade&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued tax, audit, and legal fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rebates &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,156.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Accrued Payroll and Related Expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued wages, bonus and taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Other Long-Term Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue, long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock contextRef="c-1" id="f-556">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term marketable securities, consisting of available-for-sale debt securities, were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,643.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,640.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,444.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,441.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-96" decimals="-5" id="f-557" unitRef="usd">1643100000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-96" decimals="-5" id="f-558" unitRef="usd">500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-96" decimals="-5" id="f-559" unitRef="usd">3100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-96" decimals="-5" id="f-560" unitRef="usd">1640500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-100" decimals="-5" id="f-561" unitRef="usd">419900000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-100" decimals="-5" id="f-562" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-100" decimals="-5" id="f-563" unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-100" decimals="-5" id="f-564" unitRef="usd">419700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-104" decimals="-5" id="f-565" unitRef="usd">381900000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-104" decimals="-5" id="f-566" unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-104" decimals="-5" id="f-567" unitRef="usd">900000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-104" decimals="-5" id="f-568" unitRef="usd">381100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-3" decimals="-5" id="f-569" unitRef="usd">2444900000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-3" decimals="-5" id="f-570" unitRef="usd">600000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-3" decimals="-5" id="f-571" unitRef="usd">4200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-3" decimals="-5" id="f-572" unitRef="usd">2441300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-111" decimals="-5" id="f-573" unitRef="usd">1535100000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-111" decimals="-5" id="f-574" unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-111" decimals="-5" id="f-575" unitRef="usd">4600000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-111" decimals="-5" id="f-576" unitRef="usd">1530700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-115" decimals="-5" id="f-577" unitRef="usd">119600000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-115" decimals="-5" id="f-578" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-115" decimals="-5" id="f-579" unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-115" decimals="-5" id="f-580" unitRef="usd">119400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-119" decimals="-5" id="f-581" unitRef="usd">164300000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-119" decimals="-5" id="f-582" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-119" decimals="-5" id="f-583" unitRef="usd">500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-119" decimals="-5" id="f-584" unitRef="usd">163800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-4" decimals="-5" id="f-585" unitRef="usd">1819000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-4" decimals="-5" id="f-586" unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-4" decimals="-5" id="f-587" unitRef="usd">5300000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-4" decimals="-5" id="f-588" unitRef="usd">1813900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-3" decimals="-7" id="f-589" unitRef="usd">2440000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-4" decimals="-7" id="f-590" unitRef="usd">1810000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-591">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-3" decimals="-5" id="f-592" unitRef="usd">240400000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-4" decimals="-5" id="f-593" unitRef="usd">159000000.0</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-3" decimals="-5" id="f-594" unitRef="usd">36400000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-4" decimals="-5" id="f-595" unitRef="usd">17200000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-3" decimals="-5" id="f-596" unitRef="usd">144300000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-4" decimals="-5" id="f-597" unitRef="usd">130500000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet contextRef="c-3" decimals="-5" id="f-598" unitRef="usd">421100000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-5" id="f-599" unitRef="usd">306700000</us-gaap:InventoryNet>
    <dxcm:PrepaidAndOtherCurrentAssetsTableTextBlock contextRef="c-1" id="f-600">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dxcm:PrepaidAndOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-3" decimals="-5" id="f-601" unitRef="usd">55000000.0</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-4" decimals="-5" id="f-602" unitRef="usd">48900000</us-gaap:PrepaidExpenseCurrent>
    <dxcm:PrepaidInventoryCurrent contextRef="c-3" decimals="-5" id="f-603" unitRef="usd">62700000</dxcm:PrepaidInventoryCurrent>
    <dxcm:PrepaidInventoryCurrent contextRef="c-4" decimals="-5" id="f-604" unitRef="usd">67800000</dxcm:PrepaidInventoryCurrent>
    <dxcm:DeferredCompensationPlanAssetsCurrent contextRef="c-3" decimals="-5" id="f-605" unitRef="usd">14400000</dxcm:DeferredCompensationPlanAssetsCurrent>
    <dxcm:DeferredCompensationPlanAssetsCurrent contextRef="c-4" decimals="-5" id="f-606" unitRef="usd">10200000</dxcm:DeferredCompensationPlanAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable contextRef="c-3" decimals="-5" id="f-607" unitRef="usd">5000000.0</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable contextRef="c-4" decimals="-5" id="f-608" unitRef="usd">38900000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherAssetsCurrent contextRef="c-3" decimals="-5" id="f-609" unitRef="usd">57900000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-4" decimals="-5" id="f-610" unitRef="usd">26800000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-5" id="f-611" unitRef="usd">195000000.0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-5" id="f-612" unitRef="usd">192600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-613">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land and land improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer software and hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,505.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(428.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-132" decimals="-5" id="f-614" unitRef="usd">29000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-133" decimals="-5" id="f-615" unitRef="usd">26900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-134" decimals="-5" id="f-616" unitRef="usd">139500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-135" decimals="-5" id="f-617" unitRef="usd">54300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-136" decimals="-5" id="f-618" unitRef="usd">34800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-137" decimals="-5" id="f-619" unitRef="usd">32600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-138" decimals="-5" id="f-620" unitRef="usd">58700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-139" decimals="-5" id="f-621" unitRef="usd">48800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-140" decimals="-5" id="f-622" unitRef="usd">549600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-141" decimals="-5" id="f-623" unitRef="usd">449200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-142" decimals="-5" id="f-624" unitRef="usd">273400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-143" decimals="-5" id="f-625" unitRef="usd">264400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-144" decimals="-5" id="f-626" unitRef="usd">420900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-145" decimals="-5" id="f-627" unitRef="usd">542600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-3" decimals="-5" id="f-628" unitRef="usd">1505900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-5" id="f-629" unitRef="usd">1418800000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization contextRef="c-3" decimals="-5" id="f-630" unitRef="usd">428300000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-5" id="f-631" unitRef="usd">363200000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-3" decimals="-5" id="f-632" unitRef="usd">1077600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-5" id="f-633" unitRef="usd">1055600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock contextRef="c-1" id="f-634">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:LongTermInvestments contextRef="c-3" decimals="-5" id="f-635" unitRef="usd">35000000.0</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments contextRef="c-4" decimals="-5" id="f-636" unitRef="usd">19000000.0</us-gaap:LongTermInvestments>
    <dxcm:LongTermDeposits contextRef="c-3" decimals="-5" id="f-637" unitRef="usd">19100000</dxcm:LongTermDeposits>
    <dxcm:LongTermDeposits contextRef="c-4" decimals="-5" id="f-638" unitRef="usd">16200000</dxcm:LongTermDeposits>
    <dxcm:OtherLongTermAssets contextRef="c-3" decimals="-5" id="f-639" unitRef="usd">12800000</dxcm:OtherLongTermAssets>
    <dxcm:OtherLongTermAssets contextRef="c-4" decimals="-5" id="f-640" unitRef="usd">11900000</dxcm:OtherLongTermAssets>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-5" id="f-641" unitRef="usd">66900000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-5" id="f-642" unitRef="usd">47100000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-643">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable trade&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued tax, audit, and legal fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rebates &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,156.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c-3" decimals="-5" id="f-644" unitRef="usd">269100000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c-4" decimals="-5" id="f-645" unitRef="usd">237900000</us-gaap:AccountsPayableTradeCurrent>
    <dxcm:AccruedTaxAuditAndLegalFees contextRef="c-3" decimals="-5" id="f-646" unitRef="usd">60400000</dxcm:AccruedTaxAuditAndLegalFees>
    <dxcm:AccruedTaxAuditAndLegalFees contextRef="c-4" decimals="-5" id="f-647" unitRef="usd">44800000</dxcm:AccruedTaxAuditAndLegalFees>
    <dxcm:PharmacyRebates contextRef="c-3" decimals="-5" id="f-648" unitRef="usd">763600000</dxcm:PharmacyRebates>
    <dxcm:PharmacyRebates contextRef="c-4" decimals="-5" id="f-649" unitRef="usd">556400000</dxcm:PharmacyRebates>
    <us-gaap:StandardProductWarrantyAccrual contextRef="c-3" decimals="-5" id="f-650" unitRef="usd">11200000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual contextRef="c-4" decimals="-5" id="f-651" unitRef="usd">12800000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="c-3" decimals="-5" id="f-652" unitRef="usd">14400000</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="c-4" decimals="-5" id="f-653" unitRef="usd">10200000</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-654" unitRef="usd">37800000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-655" unitRef="usd">39700000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-656" unitRef="usd">1156500000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-657" unitRef="usd">901800000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <dxcm:ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock contextRef="c-1" id="f-658">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued wages, bonus and taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dxcm:ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock>
    <dxcm:AccruedWagesBonusesAndTaxesCurrent contextRef="c-3" decimals="-5" id="f-659" unitRef="usd">76900000</dxcm:AccruedWagesBonusesAndTaxesCurrent>
    <dxcm:AccruedWagesBonusesAndTaxesCurrent contextRef="c-4" decimals="-5" id="f-660" unitRef="usd">96800000</dxcm:AccruedWagesBonusesAndTaxesCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c-3" decimals="-5" id="f-661" unitRef="usd">31700000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c-4" decimals="-5" id="f-662" unitRef="usd">37500000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-663" unitRef="usd">108600000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-664" unitRef="usd">134300000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock contextRef="c-1" id="f-665">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue, long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-3" decimals="-5" id="f-666" unitRef="usd">58500000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-667" unitRef="usd">59600000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-3" decimals="-5" id="f-668" unitRef="usd">21400000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-669" unitRef="usd">19000000.0</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-3" decimals="-5" id="f-670" unitRef="usd">4800000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-4" decimals="-5" id="f-671" unitRef="usd">4900000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <dxcm:OtherTaxLiabilitiesNoncurrent contextRef="c-3" decimals="-5" id="f-672" unitRef="usd">35900000</dxcm:OtherTaxLiabilitiesNoncurrent>
    <dxcm:OtherTaxLiabilitiesNoncurrent contextRef="c-4" decimals="-5" id="f-673" unitRef="usd">32700000</dxcm:OtherTaxLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent contextRef="c-3" decimals="-5" id="f-674" unitRef="usd">12500000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent contextRef="c-4" decimals="-5" id="f-675" unitRef="usd">12100000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-3" decimals="-5" id="f-676" unitRef="usd">133100000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-5" id="f-677" unitRef="usd">128300000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-678">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;5. Debt&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Senior Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,232.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,982.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount of senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,204.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,970.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal was as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,649.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,361.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total by which the notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; if-converted value exceeds their principal amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,790.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,395.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual coupon interest &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense recognized on senior notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective interest rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:22.5pt;text-indent:-7.2pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year. Interest on the 2028 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;0.75% Senior Convertible Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, we completed an offering of&#160;$850.0 million&#160;aggregate principal amount of unsecured senior convertible notes with a stated interest rate of&#160;0.75%&#160;and a maturity date of&#160;December&#160;1, 2023&#160;(the &#x201c;2023 Notes&#x201d;). The net proceeds from the offering, after deducting initial purchasers&#x2019; discounts and costs directly related to the offering, were approximately&#160;$836.6 million. The initial conversion rate of the 2023 Notes is&#160;24.3476&#160;shares per&#160;$1,000 principal amount of notes, which is equivalent to a conversion price of approximately&#160;$41.07&#160;per share, subject to adjustments. We entered into transactions for a convertible note hedge (the &#x201c;2023 Note Hedge&#x201d;) and warrants (the &#x201c;2023 Warrants&#x201d;) concurrently with the issuance of the 2023 Notes. The 2023 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2023 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2023 Notes includes customary terms and covenants, including certain events of default after which the 2023 Notes may be due and payable immediately.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the twelve months ended December&#160;31, 2022, holders of $17.5&#160;million in aggregate principal amount of the 2023 Notes elected conversion at their option. We settled these conversions using treasury stock. We issued 425,552 shares to settle the converted 2023 Notes. We received 287,492 shares of common stock from the exercise of a portion of the 2023 Note Hedge that we purchased concurrently with the issuance of the 2023 Notes, as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;second quarter of 2023, holders of $532.2&#160;million in aggregate principal amount of the 2023 Notes exercised their conversion option. We elected to settle these conversions through a combination of cash for the principal amount and common stock for any amount due in excess of the principal amount. The conversions will settle in the third quarter of 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From July 1, 2023 through July&#160;26, 2023, holders of $7.8 million in aggregate principal amount of the 2023 Notes exercised their conversion option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at the Option of the Holders&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the 2023 Notes have the right to require us to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the notes). We will also be required to increase the conversion rate for holders who convert their 2023 Notes in connection with certain fundamental changes occurring prior to the maturity date or following the delivery by Dexcom of a notice of redemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the 2023 Notes may convert all or a portion of their notes at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding September&#160;1, 2023, in multiples of $1,000 principal amount, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;during any calendar quarter commencing after March&#160;31, 2019 (and only during such calendar quarter), if the last reported sale price of Dexcom&#x2019;s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the 2023 Notes on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the 2023 Notes for each day of that five-day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#x2019;s common stock and the applicable conversion rate of the 2023 Notes on such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;if we call any or all of the 2023 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;upon the occurrence of specified corporate transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after September&#160;1, 2023, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2023 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Circumstance (1) listed above occurred during the quarters ended December&#160;31, 2022 and March&#160;31, 2023. As a result, the 2023 Notes were convertible at the option of the holder from January&#160;1, 2023 through June&#160;30, 2023. Circumstance (1) listed above also occurred during the quarter ended June&#160;30, 2023 and as a result, the 2023 Notes will remain convertible at the option of the holder from July 1, 2023 through September 30, 2023. See above for a description of conversion activity related to the 2023 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at Our Option&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dexcom did not have a right to redeem the 2023 Notes prior to December&#160;1, 2021. On or after December&#160;1, 2021 and prior to September&#160;1, 2023, Dexcom may redeem for cash all or part of the 2023 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2023 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Note Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions with two of the initial purchasers of the 2023 Notes (the &#x201c;2023 Counterparties&#x201d;) entitling us to purchase up to&#160;20.7 million&#160;shares of our common stock at an initial price of&#160;$41.07&#160;per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was&#160;$218.9 million and we accounted for it as an equity instrument by recognizing $218.9 million in&#160;additional paid-in capital&#160;during 2018. The 2023 Note Hedge will expire on December&#160;1, 2023. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge.&#160;The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. An assumed exercise of the 2023 Note Hedge by us is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share. See above for a description of conversion activity related to the 2023 Notes and shares received as the result of exercising a portion of the 2023 Note Hedge.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, we also sold warrants to the 2023 Counterparties to acquire up to&#160;20.7 million shares of our common stock. The 2023 Warrants require net share settlement and a pro rated number of warrants will expire on each of the 60 scheduled trading days starting on March&#160;1, 2024. We received&#160;$183.8 million&#160;in cash proceeds from the sale of the 2023 Warrants, which we recorded in&#160;additional paid-in capital during 2018. The 2023 Warrants could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2023 Warrants. The strike price of the 2023 Warrants is initially $49.60 per share and is subject to certain adjustments under the terms of the warrant agreements. We use &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the treasury share method for assumed conversion of the 2023 Warrants when computing the weighted average common shares outstanding for diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;0.25% Senior Convertible Notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, we completed an offering of $1.21 billion aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 0.25% and a maturity date of November&#160;15, 2025 (the &#x201c;2025 Notes&#x201d;). The net proceeds from the offering, after deducting initial purchasers&#x2019; discounts and estimated costs directly related to the offering, were approximately $1.19 billion. The initial conversion rate of the 2025 Notes is 6.6620 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $150.11 per share, subject to adjustments. The 2025 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2025 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No principal payments are due on the 2025 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2025 Notes includes customary terms and covenants, including certain events of default after which the 2025 Notes may be due and payable immediately.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at the Option of the Holders&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event of a fundamental change (as defined in the indenture related to the 2025 Notes), holders of the 2025 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to 100% of the principal amount of the 2025 Notes, plus any accrued and unpaid interest. Holders of the 2025 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to 5:00 p.m., New York City time, on the business day immediately preceding August&#160;15, 2025, holders of the 2025 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;during any calendar quarter commencing after September&#160;30, 2020 (and only during such calendar quarter), if the last reported sale price of Dexcom&#x2019;s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the Notes on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that five day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#x2019;s common stock and the applicable conversion rate of the Notes on such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;upon the occurrence of specified corporate transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;On or after August&#160;15, 2025, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2025 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at Our Option&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dexcom may not redeem the 2025 Notes prior to May&#160;20, 2023. On or after May&#160;20, 2023 and prior to August&#160;15, 2025, Dexcom may redeem for cash all or part of the 2025 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2025 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;0.375% Senior Convertible Notes due 2028&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2023, we completed an offering of $1.25&#160;billion aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 0.375% and a maturity date of May&#160;15, 2028 (the &#x201c;2028 Notes&#x201d;). The net proceeds from the offering, after deducting initial purchasers&#x2019; discounts and estimated costs directly related to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the offering, were approximately $1.23&#160;billion. The initial conversion rate of the 2028 Notes is 6.1571 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $162.41 per share, subject to adjustments. The 2028 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2028 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No principal payments are due on the 2028 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2028 Notes includes customary terms and covenants, including certain events of default after which the 2028 Notes may be due and payable immediately.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at the Option of the Holders&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event of a fundamental change (as defined in the indenture related to the 2028 Notes), holders of the 2028 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to 100% of the principal amount of the 2028 Notes, plus any accrued and unpaid interest. Holders of the 2028 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to 5:00 p.m., New York City time, on the business day immediately preceding February&#160;15, 2028, holders of the 2028 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;during any calendar quarter commencing after September&#160;30, 2023 (and only during such calendar quarter), if the last reported sale price of Dexcom&#x2019;s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the Notes on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that five day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#x2019;s common stock and the applicable conversion rate of the Notes on such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;upon the occurrence of specified corporate transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after February&#160;15, 2028, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2028 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at Our Option&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dexcom may not redeem the 2028 Notes prior to May&#160;20, 2026. On or after May&#160;20, 2026 and prior to February&#160;15, 2028, Dexcom may redeem for cash all or part of the 2028 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2028 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2028 Capped Call Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2023, in connection with the offering of the 2028 Notes, we entered into privately negotiated capped call transactions (the &#x201c;2028 Capped Calls&#x201d;) with certain financial institutions. The 2028 Capped Calls will cover, subject to anti-dilution adjustments substantially similar to those applicable to the 2028 Notes, the number of shares of our common stock that will initially underlie the 2028 Notes. The 2028 Capped Calls are expected generally to reduce potential dilution to our common stock upon conversion of the 2028 Notes and/or offset any cash payments that we are required to make in excess of the principal amount of converted 2028 Notes, as the case may be, with such reduction and/or offset subject to a cap. The 2028 Capped Calls have an initial cap price of $212.62 per share, subject to adjustments, which represents a premium of 80% over the closing price of our common stock of $118.12 per share on the Nasdaq Global Select Market on May&#160;2, 2023. The cost to purchase the 2028 Capped Calls of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$101.3 million was recorded as a reduction to additional paid-in capital in our consolidated balance sheets as the 2028 Capped Calls met the criteria for classification in stockholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Revolving Credit Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Terms of the Revolving Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2023, we entered into the First Amendment to the Second Amended and Restated Credit Agreement (the "Amended Credit Agreement"), which we had previously entered into in October 2021. The Amended Credit Agreement is a five-year revolving credit facility, that provides for an available principal amount of $200.0 million which can be increased up to $500.0 million at our option subject to customary conditions and approval of our lenders (the &#x201c;Credit Facility&#x201d;). The Amended Credit Agreement will mature on October&#160;13, 2026. Borrowings under the Amended Credit Agreement are available for general corporate purposes, including working capital and capital expenditures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to availability and outstanding borrowings on our Amended Credit Agreement is as follows as of the date indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.959%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available principal amount &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Letters of credit sub-facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding borrowings &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding letters of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving loans under the Amended Credit Agreement bear interest at our choice of one of three base rates plus a range of applicable rates that are based on our leverage ratio. The first base rate is the Alternate Base Rate (&#x201c;ABR&#x201d;) and loans comprising each ABR borrowing shall bear interest at the ABR plus the applicable rate between 0.375% to 1.000%. The ABR is the highest of (a) the prime rate last quoted by The Wall Street Journal, (b) the Federal Reserve Bank of New York rate plus one half of 1%, and (c) the Adjusted Term Secured Overnight Financing Rate (&#x201c;Term SOFR&#x201d;) for a one month interest period plus 1%. The second base rate is the Term Benchmark rate and loans comprising each Term Benchmark borrowing shall bear interest at the Adjusted Term SOFR, the Adjusted Euro Interbank Offered Rate, the Adjusted Stockholm Interbank Offered Rate, the Adjusted Canadian Dollar Offered Rate, Adjusted Australian Dollar Rate, the Adjusted Bank Bill Benchmark Rate or the Adjusted Tokyo Interbank Offered Rate, as applicable based on the currency denomination borrowed, plus the applicable rate between 1.375% to 2.000%. The third base rate is the Adjusted Daily Simple RepoFunds Rate (&#x201c;RFR&#x201d;) and loans comprising each Daily Simple RFR Loan shall bear interest at a rate per annum equal to the applicable Daily Simple RFR for Sterling or Dollars (as applicable) plus the applicable rate between 0.0326% to 0.100% depending on the loan denomination. We will also pay a commitment fee of between 0.175% and 0.250%, payable quarterly in arrears, on the average daily unused amount of the revolving facility based on our leverage ratio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our obligations under the Amended Credit Agreement are guaranteed by our existing and future wholly-owned domestic subsidiaries, and are secured by a first-priority security interest in substantially all of the assets of Dexcom and the guarantors, including all or a portion of the equity interests of our domestic subsidiaries and first-tier foreign subsidiaries but excluding real property and intellectual property (which is subject to a negative pledge). The Amended Credit Agreement contains covenants that limit certain indebtedness, liens, investments, transactions with affiliates, dividends and other restricted payments, subordinated indebtedness and amendments to subordinated indebtedness documents, and sale and leaseback transactions of Dexcom or any of its domestic subsidiaries. The Amended Credit Agreement also requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of June&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, we also have a guarantee facility related to our international operations which is collateralized by a $5.5&#160;million term deposit that is included in non-current &#x201c;Other assets&#x201d; on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-120" decimals="-5" id="f-679" unitRef="usd">774800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-121" decimals="-5" id="f-680" unitRef="usd">774800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-122" decimals="-5" id="f-681" unitRef="usd">1207500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-123" decimals="-5" id="f-682" unitRef="usd">1207500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-124" decimals="-5" id="f-683" unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-125" decimals="-5" id="f-684" unitRef="usd">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-126" decimals="-5" id="f-685" unitRef="usd">3232300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-127" decimals="-5" id="f-686" unitRef="usd">1982300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-126" decimals="-5" id="f-687" unitRef="usd">27900000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-127" decimals="-5" id="f-688" unitRef="usd">12000000.0</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:ConvertibleNotesPayable contextRef="c-126" decimals="-5" id="f-689" unitRef="usd">3204400000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="c-127" decimals="-5" id="f-690" unitRef="usd">1970300000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="c-1" id="f-691">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal was as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,649.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,361.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total by which the notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; if-converted value exceeds their principal amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,790.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,395.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-146" decimals="-5" id="f-692" unitRef="usd">1649500000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-147" decimals="-5" id="f-693" unitRef="usd">1361500000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-148" decimals="-5" id="f-694" unitRef="usd">84600000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-149" decimals="-5" id="f-695" unitRef="usd">33600000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-150" decimals="-5" id="f-696" unitRef="usd">56700000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-151" decimals="-5" id="f-697" unitRef="usd">0</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-152" decimals="-5" id="f-698" unitRef="usd">1790800000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-153" decimals="-5" id="f-699" unitRef="usd">1395100000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock contextRef="c-1" id="f-700">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual coupon interest &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense recognized on senior notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective interest rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:22.5pt;text-indent:-7.2pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year. Interest on the 2028 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization contextRef="c-5" decimals="-5" id="f-701" unitRef="usd">3000000.0</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization contextRef="c-6" decimals="-5" id="f-702" unitRef="usd">2200000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization contextRef="c-1" decimals="-5" id="f-703" unitRef="usd">5200000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization contextRef="c-7" decimals="-5" id="f-704" unitRef="usd">4400000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-5" decimals="-5" id="f-705" unitRef="usd">2000000.0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-6" decimals="-5" id="f-706" unitRef="usd">1400000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-5" id="f-707" unitRef="usd">3500000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-7" decimals="-5" id="f-708" unitRef="usd">2900000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestExpenseDebt contextRef="c-5" decimals="-5" id="f-709" unitRef="usd">5000000.0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-6" decimals="-5" id="f-710" unitRef="usd">3600000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-1" decimals="-5" id="f-711" unitRef="usd">8700000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-7" decimals="-5" id="f-712" unitRef="usd">7300000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-154" decimals="3" id="f-713" unitRef="number">0.011</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-155" decimals="3" id="f-714" unitRef="number">0.011</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-154" decimals="3" id="f-715" unitRef="number">0.011</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-155" decimals="3" id="f-716" unitRef="number">0.011</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-156" decimals="3" id="f-717" unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-157" decimals="3" id="f-718" unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-156" decimals="3" id="f-719" unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-157" decimals="3" id="f-720" unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-158" decimals="3" id="f-721" unitRef="number">0.007</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-158" decimals="3" id="f-722" unitRef="number">0.007</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-159"
      decimals="INF"
      id="f-723"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-159" decimals="INF" id="f-724" unitRef="usd">850000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-159"
      decimals="INF"
      id="f-725"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-160" decimals="-5" id="f-726" unitRef="usd">836600000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-159"
      decimals="2"
      id="f-727"
      unitRef="usdPerShare">41.07</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled contextRef="c-147" decimals="-5" id="f-728" unitRef="usd">17500000</dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-161"
      decimals="INF"
      id="f-729"
      unitRef="shares">425552</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <dxcm:SharesReceivedFromExerciseOfNoteHedge
      contextRef="c-147"
      decimals="INF"
      id="f-730"
      unitRef="shares">287492</dxcm:SharesReceivedFromExerciseOfNoteHedge>
    <dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled contextRef="c-162" decimals="-5" id="f-731" unitRef="usd">532200000</dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled>
    <dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled contextRef="c-163" decimals="-5" id="f-732" unitRef="usd">7800000</dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled>
    <dxcm:DebtInstrumentCovenantRepurchasePricePercentage
      contextRef="c-120"
      decimals="INF"
      id="f-733"
      unitRef="number">1</dxcm:DebtInstrumentCovenantRepurchasePricePercentage>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-164" decimals="INF" id="f-734" unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-165" decimals="INF" id="f-735" unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger contextRef="c-164" decimals="2" id="f-736" unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-166" decimals="INF" id="f-737" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-167" decimals="INF" id="f-738" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-167" decimals="INF" id="f-739" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="c-167"
      decimals="INF"
      id="f-740"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock contextRef="c-146" decimals="2" id="f-741" unitRef="number">1.30</dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-164" decimals="INF" id="f-742" unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-165" decimals="INF" id="f-743" unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c-146"
      decimals="INF"
      id="f-744"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <dxcm:NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions
      contextRef="c-168"
      decimals="INF"
      id="f-745"
      unitRef="purchaser">2</dxcm:NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions>
    <dxcm:DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares
      contextRef="c-169"
      decimals="-5"
      id="f-746"
      unitRef="shares">20700000</dxcm:DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-159"
      decimals="2"
      id="f-747"
      unitRef="usdPerShare">41.07</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt contextRef="c-170" decimals="-5" id="f-748" unitRef="usd">218900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt contextRef="c-170" decimals="-5" id="f-749" unitRef="usd">218900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-160"
      decimals="-5"
      id="f-750"
      unitRef="shares">20700000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-160" decimals="INF" id="f-751" unitRef="d">60</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c-160" decimals="-5" id="f-752" unitRef="usd">183800000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-159"
      decimals="2"
      id="f-753"
      unitRef="usdPerShare">49.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-171"
      decimals="INF"
      id="f-754"
      unitRef="number">0.0025</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-171" decimals="-7" id="f-755" unitRef="usd">1210000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-171"
      decimals="INF"
      id="f-756"
      unitRef="number">0.0025</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-172" decimals="-7" id="f-757" unitRef="usd">1190000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-171"
      decimals="2"
      id="f-758"
      unitRef="usdPerShare">150.11</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <dxcm:DebtInstrumentCovenantRepurchasePricePercentage
      contextRef="c-173"
      decimals="INF"
      id="f-759"
      unitRef="number">1</dxcm:DebtInstrumentCovenantRepurchasePricePercentage>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-174" decimals="INF" id="f-760" unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-175" decimals="INF" id="f-761" unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger contextRef="c-174" decimals="2" id="f-762" unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-176" decimals="INF" id="f-763" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-177" decimals="INF" id="f-764" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-177" decimals="INF" id="f-765" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="c-177"
      decimals="INF"
      id="f-766"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock contextRef="c-148" decimals="2" id="f-767" unitRef="number">1.30</dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-174" decimals="INF" id="f-768" unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-175" decimals="INF" id="f-769" unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c-150"
      decimals="INF"
      id="f-770"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-173"
      decimals="INF"
      id="f-771"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-173" decimals="-7" id="f-772" unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-173"
      decimals="INF"
      id="f-773"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-178" decimals="-7" id="f-774" unitRef="usd">1230000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-173"
      decimals="2"
      id="f-775"
      unitRef="usdPerShare">162.41</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <dxcm:DebtInstrumentCovenantRepurchasePricePercentage
      contextRef="c-173"
      decimals="INF"
      id="f-776"
      unitRef="number">1</dxcm:DebtInstrumentCovenantRepurchasePricePercentage>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-179" decimals="INF" id="f-777" unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-180" decimals="INF" id="f-778" unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger contextRef="c-179" decimals="2" id="f-779" unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-181" decimals="INF" id="f-780" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-182" decimals="INF" id="f-781" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-182" decimals="INF" id="f-782" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="c-182"
      decimals="INF"
      id="f-783"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock contextRef="c-150" decimals="2" id="f-784" unitRef="number">1.30</dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-179" decimals="INF" id="f-785" unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-180" decimals="INF" id="f-786" unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c-150"
      decimals="INF"
      id="f-787"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <dxcm:DebtInstrumentCapCallTransactionCapPricePerShare
      contextRef="c-183"
      decimals="INF"
      id="f-788"
      unitRef="usdPerShare">212.62</dxcm:DebtInstrumentCapCallTransactionCapPricePerShare>
    <dxcm:DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage
      contextRef="c-183"
      decimals="INF"
      id="f-789"
      unitRef="number">0.80</dxcm:DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage>
    <us-gaap:SharePrice
      contextRef="c-184"
      decimals="INF"
      id="f-790"
      unitRef="usdPerShare">118.12</us-gaap:SharePrice>
    <dxcm:PaymentsForPurchasesOfCappedCallTransactions contextRef="c-178" decimals="-5" id="f-791" unitRef="usd">101300000</dxcm:PaymentsForPurchasesOfCappedCallTransactions>
    <us-gaap:DebtInstrumentTerm contextRef="c-185" id="f-792">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-186" decimals="INF" id="f-793" unitRef="usd">200000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <dxcm:LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount contextRef="c-186" decimals="INF" id="f-794" unitRef="usd">500000000</dxcm:LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock contextRef="c-1" id="f-795">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to availability and outstanding borrowings on our Amended Credit Agreement is as follows as of the date indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.959%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available principal amount &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Letters of credit sub-facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding borrowings &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding letters of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-186" decimals="INF" id="f-796" unitRef="usd">200000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-187" decimals="-5" id="f-797" unitRef="usd">25000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit contextRef="c-186" decimals="-5" id="f-798" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LettersOfCreditOutstandingAmount contextRef="c-187" decimals="-5" id="f-799" unitRef="usd">7300000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-3" decimals="-5" id="f-800" unitRef="usd">192700000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-188"
      decimals="INF"
      id="f-801"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-189"
      decimals="INF"
      id="f-802"
      unitRef="number">0.01000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-190"
      decimals="INF"
      id="f-803"
      unitRef="number">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-191"
      decimals="INF"
      id="f-804"
      unitRef="number">0.01375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-192"
      decimals="INF"
      id="f-805"
      unitRef="number">0.02000</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-193" decimals="6" id="f-806" unitRef="number">0.000326</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-194" decimals="5" id="f-807" unitRef="number">0.00100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage contextRef="c-195" decimals="5" id="f-808" unitRef="number">0.00175</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage contextRef="c-196" decimals="5" id="f-809" unitRef="number">0.00250</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:DepositAssets contextRef="c-3" decimals="-5" id="f-810" unitRef="usd">5500000</us-gaap:DepositAssets>
    <us-gaap:LegalMattersAndContingenciesTextBlock contextRef="c-1" id="f-815">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;6. Contingencies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Litigation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability, intellectual property and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the six months ended June 30, 2023, we and certain Abbott Diabetes Care, Inc. (&#x201c;Abbott&#x201d;) entities have previously served complaints for patent infringement, validity and other patent related actions against each other in multiple jurisdictions, inside and outside the United States. In June and July 2021, we initiated patent infringement litigation against Abbott in the United States and in Germany over certain of Abbott's continuous glucose monitoring products. In both the United States and Germany, we seek injunctive relief and monetary damages. In July 2021, Abbott initiated patent infringement litigation against Dexcom in the United States, United Kingdom, and in Germany over certain of Dexcom's continuous glucose monitoring products. Abbott seeks injunctive relief and monetary damages. In response to the suits in the United Kingdom, Dexcom brought infringement counterclaims there. One trial on liability has already been conducted in the United Kingdom, and the parties are awaiting a ruling.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, Abbott filed a breach of contract suit against Dexcom in the United States alleging that Dexcom breached the parties' 2014 Settlement and License Agreement. Dexcom&#x2019;s patent infringement claims in the United States are stayed pending resolution of Abbott&#x2019;s breach of contract claims. A jury trial on Abbott&#x2019;s breach of contract claims commenced on July 10, 2023. On July 14, 2023, the jury awarded a verdict finding Abbott was not licensed to several claims of certain Dexcom patents and that Abbott was licensed to a few claims. We will continue to enforce the remaining claims in the patents asserted in Delaware and elsewhere.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Abbott&#x2019;s U.S. patent infringement action against Dexcom is currently scheduled for trial on November 5, 2023. In February and March of 2023, Abbott initiated additional patent infringement litigation against Dexcom in both the United States and in Germany. Abbott seeks injunctive relief and monetary damages. Due to uncertainty surrounding patent litigation processes in the U.S. and Europe, we are unable to reasonably estimate the ultimate outcome of any of the litigation matters at this time. We intend to protect our intellectual property and defend against Abbott&#x2019;s claims vigorously in all of these actions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not believe we are party to any other currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-816">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;7. Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate our annual effective tax rate to be 28.5% for the full year 2023, which differs from the U.S. federal statutory rate due to state and foreign income taxes, nondeductible executive compensation, and increases to unrecognized tax benefits, partially offset by federal tax credits generated. Our actual effective tax rate of&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.5% for the six months ended June&#160;30, 2023 was primarily due to income tax expense from normal, recurring operations, partially offset by discrete excess tax benefits recognized for share-based compensation for employees, net of disallowed executive compensation.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <dxcm:EstimatedAnnualEffectiveIncomeTaxRatePercent contextRef="c-1" decimals="3" id="f-817" unitRef="number">0.285</dxcm:EstimatedAnnualEffectiveIncomeTaxRatePercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-818" unitRef="number">0.265</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-819">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;8. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our share-based compensation expense is associated with RSUs, PSUs, and our Employee Stock Purchase Plan, or ESPP. The following table summarizes our share-based compensation expense included in our consolidated statements of operations for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2023, unrecognized estimated compensation costs related to RSUs, PSUs and ESPP totaled $272.5 million and are expected to be recognized through 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Award Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total vest date fair value of RSUs and PSUs that vested during the six months ended June&#160;30, 2023 was $127.3 million and $9.9 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchase Program and Treasury Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 26, 2022, a duly authorized committee of our Board of Directors authorized and approved a share repurchase program of up to $700.0&#160;million of our outstanding common stock, with a repurchase period ending no later than June 30, 2023 (the &#x201c;Share Repurchase Program&#x201d;). Shares of common stock repurchased under the Share Repurchase Program become treasury shares. Repurchases of our common stock under the Share Repurchase Program may be made from time to time, on the open market, in privately negotiated transactions or by other methods, at our discretion, and in accordance with the limitations set forth in Rule 10b-18 promulgated under the Exchange Act, and other applicable federal and state laws and regulations. We repurchased approximately $557.7 million of our outstanding common stock throughout the duration of the Share Repurchase Program. The Share Repurchase Program and the remaining authorization of approximately $142.3&#160;million expired on June 30, 2023. There were no share repurchases under the Share Repurchase Program in 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2023, we used a portion of the proceeds of the 2028 Notes to repurchase 1.6 million shares of our common stock for $188.7 million for an average per share price of $118.12, via privately negotiated transactions, independent of the Share Repurchase Program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Repurchased shares of our common stock are held as treasury shares until they are reissued or retired. We have not yet determined the ultimate disposition of repurchased shares and consequently we continue to hold them as treasury shares rather than retiring them. Authorization of future stock repurchase programs is subject to the final determination of our Board of Directors.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-820">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our share-based compensation expense is associated with RSUs, PSUs, and our Employee Stock Purchase Plan, or ESPP. The following table summarizes our share-based compensation expense included in our consolidated statements of operations for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-198" decimals="-5" id="f-821" unitRef="usd">3900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-199" decimals="-5" id="f-822" unitRef="usd">2800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-200" decimals="-5" id="f-823" unitRef="usd">7200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-201" decimals="-5" id="f-824" unitRef="usd">5100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-202" decimals="-5" id="f-825" unitRef="usd">11800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-203" decimals="-5" id="f-826" unitRef="usd">10900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-204" decimals="-5" id="f-827" unitRef="usd">22900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-205" decimals="-5" id="f-828" unitRef="usd">21200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-206" decimals="-5" id="f-829" unitRef="usd">24000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-207" decimals="-5" id="f-830" unitRef="usd">18900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-208" decimals="-5" id="f-831" unitRef="usd">44800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-209" decimals="-5" id="f-832" unitRef="usd">35400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-5" id="f-833" unitRef="usd">39700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-6" decimals="-5" id="f-834" unitRef="usd">32600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-5" id="f-835" unitRef="usd">74900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-7" decimals="-5" id="f-836" unitRef="usd">61700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-3" decimals="-5" id="f-837" unitRef="usd">272500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-210" decimals="-5" id="f-838" unitRef="usd">127300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-211" decimals="-5" id="f-839" unitRef="usd">9900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-212" decimals="INF" id="f-840" unitRef="usd">700000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-213" decimals="-5" id="f-841" unitRef="usd">557700000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-214" decimals="-5" id="f-842" unitRef="usd">142300000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-215" decimals="0" id="f-843" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-216"
      decimals="-5"
      id="f-844"
      unitRef="shares">1600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-216" decimals="-5" id="f-845" unitRef="usd">188700000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-216"
      decimals="2"
      id="f-846"
      unitRef="usdPerShare">118.12</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-847">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;9. Business Segment and Geographic Information&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reportable Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An operating segment is identified as a component of a business that has discrete financial information available and for which the chief operating decision maker must decide the level of resource allocation. In addition, the guidance for segment reporting indicates certain quantitative materiality thresholds. None of the components of our business meet the definition of an operating segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We currently consider our operations to be, and manage our business globally within, one reportable segment, which is consistent with how our President and Chief Executive Officer, who is our chief operating decision maker, reviews our business, makes investment and resource allocation decisions, and assesses operating performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We disaggregate revenue by geographic region and by major sales channel. We have determined that disaggregating revenue into these categories achieves the ASC Topic 606 disclosure objectives of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue by geographic region&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended June&#160;30, 2023 and June&#160;30, 2022, no individual country outside the United States generated revenue that represented more than 10% of our total revenue. The following table sets forth revenue by our two primary geographical markets, the United States and International, based on the geographic location to which we deliver the components, for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.338%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;871.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,612.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue by customer sales channel&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sell our CGM systems through a direct sales organization and through distribution arrangements that allow distributors to sell our products. The following table sets forth revenue by major sales channel for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.338%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;871.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,357.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,112.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,612.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-848"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="c-1" id="f-849">The following table sets forth revenue by our two primary geographical markets, the United States and International, based on the geographic location to which we deliver the components, for the periods shown:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.338%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;871.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,612.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-217" decimals="-5" id="f-850" unitRef="usd">616600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-217" decimals="2" id="f-851" unitRef="number">0.71</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-218" decimals="-5" id="f-852" unitRef="usd">511000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-218" decimals="2" id="f-853" unitRef="number">0.73</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-219" decimals="-5" id="f-854" unitRef="usd">254700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-219" decimals="2" id="f-855" unitRef="number">0.29</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-220" decimals="-5" id="f-856" unitRef="usd">185200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-220" decimals="2" id="f-857" unitRef="number">0.27</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-858" unitRef="usd">871300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-5" decimals="2" id="f-859" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-860" unitRef="usd">696200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-6" decimals="2" id="f-861" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-221" decimals="-5" id="f-862" unitRef="usd">1142600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-221" decimals="2" id="f-863" unitRef="number">0.71</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-222" decimals="-5" id="f-864" unitRef="usd">962200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-222" decimals="2" id="f-865" unitRef="number">0.73</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-223" decimals="-5" id="f-866" unitRef="usd">470200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-223" decimals="2" id="f-867" unitRef="number">0.29</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-224" decimals="-5" id="f-868" unitRef="usd">362800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-224" decimals="2" id="f-869" unitRef="number">0.27</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-870" unitRef="usd">1612800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-1" decimals="2" id="f-871" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-5" id="f-872" unitRef="usd">1325000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-7" decimals="2" id="f-873" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-874">The following table sets forth revenue by major sales channel for the periods shown:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.338%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;871.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,357.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,112.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,612.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-225" decimals="-5" id="f-875" unitRef="usd">738800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-225" decimals="2" id="f-876" unitRef="number">0.85</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-226" decimals="-5" id="f-877" unitRef="usd">585100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-226" decimals="2" id="f-878" unitRef="number">0.84</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-227" decimals="-5" id="f-879" unitRef="usd">132500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-227" decimals="2" id="f-880" unitRef="number">0.15</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-228" decimals="-5" id="f-881" unitRef="usd">111100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-228" decimals="2" id="f-882" unitRef="number">0.16</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-883" unitRef="usd">871300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-5" decimals="2" id="f-884" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-885" unitRef="usd">696200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-6" decimals="2" id="f-886" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-229" decimals="-5" id="f-887" unitRef="usd">1357700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-229" decimals="2" id="f-888" unitRef="number">0.84</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-230" decimals="-5" id="f-889" unitRef="usd">1112200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-230" decimals="2" id="f-890" unitRef="number">0.84</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-231" decimals="-5" id="f-891" unitRef="usd">255100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-231" decimals="2" id="f-892" unitRef="number">0.16</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-232" decimals="-5" id="f-893" unitRef="usd">212800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-232" decimals="2" id="f-894" unitRef="number">0.16</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-895" unitRef="usd">1612800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-1" decimals="2" id="f-896" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-5" id="f-897" unitRef="usd">1325000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-7" decimals="2" id="f-898" unitRef="number">1</dxcm:RevenuePercentage>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-1" id="f-899">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Trading Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2023, none of our directors or officers informed us of the adoption or termination of a &#x201c;Rule 10b5-1 trading arrangement&#x201d; or &#x201c;non-Rule 10b5-1 trading arrangement,&#x201d; as those terms are defined in Regulation S-K, Item 408, except as described in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.993%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.133%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Character of Trading Arrangement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Title&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Adoption Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Rule 10b5-1*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Rule 10b5-1**&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Shares to be Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expiration Date&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Donald M. Abbey&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Executive Vice President, Global Business Services, IT Quality and Regulatory Affairs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/5/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;X&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,258&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/6/2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Steven R. Altman&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Director&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/30/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;X&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,568&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/30/2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bridgette P. Heller&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Director&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/13/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;X&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/13/2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;* Intended to satisfy the affirmative defense of Rule 10b5-1(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;** Not intended to satisfy the affirmative defense of Rule 10b5-1(c)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Except as indicated by footnote, each trading arrangement permitted or permits transactions through and including the earlier to occur of (a) the completion of all purchases or sales or (b) the date listed in the table.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-5" id="f-900">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-5" id="f-901">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:TrdArrIndName contextRef="c-233" id="f-902">Donald M. Abbey</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-233" id="f-903">Executive Vice President, Global Business Services, IT Quality and Regulatory Affairs</ecd:TrdArrIndTitle>
    <ecd:TrdArrAdoptionDate contextRef="c-233" id="f-904">5/5/2023</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-234"
      decimals="INF"
      id="f-905"
      unitRef="shares">3258</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:TrdArrTerminationDate contextRef="c-233" id="f-906">5/6/2024</ecd:TrdArrTerminationDate>
    <ecd:TrdArrIndName contextRef="c-235" id="f-907">Steven R. Altman</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-235" id="f-908">Director</ecd:TrdArrIndTitle>
    <ecd:TrdArrAdoptionDate contextRef="c-235" id="f-909">5/30/2023</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-236"
      decimals="INF"
      id="f-910"
      unitRef="shares">9568</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:TrdArrTerminationDate contextRef="c-235" id="f-911">5/30/2025</ecd:TrdArrTerminationDate>
    <ecd:TrdArrIndName contextRef="c-237" id="f-912">Bridgette P. Heller</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-237" id="f-913">Director</ecd:TrdArrIndTitle>
    <ecd:TrdArrAdoptionDate contextRef="c-237" id="f-914">6/13/2023</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-238"
      decimals="INF"
      id="f-915"
      unitRef="shares">600</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:TrdArrTerminationDate contextRef="c-237" id="f-916">6/13/2024</ecd:TrdArrTerminationDate>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>74
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M/$!9SU[6F3>EOS%Y5[4*E/(M# 2_D PYO'P<+K38]>_O;H36HNF_;CD#\,8
M[M\*V!&,%^:5X/X5\.9?4$L#!!0    (  ")^U:G,")6%0,  ,,*   8
M>&PO=V]R:W-H965T<R]S:&5E=#,N>&ULK99O;YLP$,:_BL6FJ96Z\"\A29<@
MM:FJ;=*DJ%FW%]->N. $JV SVR3M/OW.AK+04$*GY46"S3T/OSN.<+,=%_<R
M(42AARQE<FXE2N7GMBVCA&18#GA.&)Q9<Y%A!4NQL64N"(Z-*$MMSW$".\.4
M6>',["U%...%2BDC2X%DD658/%Z2E._FEFL];=S03:+TAAW.<KPA*Z)N\Z6
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M@ST <T,C2!$ <SR_TX#/8] 1N7@T!K]SJ8ASH_F Q+$Y!VQ4Z * V3XQ6BT
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M8GT'Y'LA6=6 U0HJ3,TO?&ITZ  4CQT0-H"P#XA? $0-('KM#'$#B%\[0](
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MF2WM'>\]L5 +H%#5!)::G@(GSU-B/E )1QYZ#!) D8 =,+U,1@:B2, .0I&
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MW4]_;'\:1GYZ#K[R6FTE^+4N:7DX?JK=Z'V!/WSY"),3_K.I)P#-/@ X@RB
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M^W!9^T;QO7T^ZXXKQ7?VY982G;S&0'^_X3I!NS?F!_I'_-;_ U!+ P04
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M@,7F)01Q;*VHT (K)?DXT 'C&\HB(-US\W&-6B!M'?=">42.'K$'IS)V/RT
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M7/@,U]SDG.M(VD]&9X/G3YTBT-,+*@!)?X32?_'LB7,Z\>JBTZ="MFT/0I[
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MRK\X0:'/'E1I5"XS[I%19NQ1"R-*ZP?4@GV0)>(B><Z>,"@ 0VO8O^_FQFH
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MN!(XKIH$,+]0:.B:%]J@^]IW^U]02P,$%     @  (G[5HV73/7'%@  M&(
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M;P3#+R?X_Y\IW( 5_U=%8 & #;HH*IF&0/*L #H?!1?>Y;$X\@-O>"RNVVQ
MDF[DP"'N-3SSSN 3['8QA-W ^FQG&YAFL5KH<$&LTK,3,P2@NY,QX*KN0Z5
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M.A^$&< I0?4@R ))Q[TB'5<X#2Q("M>*AL<>;.2($]@F8K& 6V1+NK8=!F,
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MEMVK168MC,&W9?OQ7FH*OJ3RV_P4(XJ0UDX0MU^+8',W4\>2AXK!BH%9G#Z
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MRTQU7U)O<V'B[LUAG0VOQ!S63T5"70IFBHVI]K%3%NX=5JI&3Q>.F3H\N_2
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M-B74:;9;0YTV.)@#LUME9M,;^?9](=_59L$Y%"PV_U!E:>)](XP@!B=6($6
MKT-[VX^!?:>>>SON+(=O3^/WL#7LL(;I4/B7@7?A6(4XD^E>_)VB(M4!F1'D
M<)%9\YZ:/!-?<H=O=35OS>/0#KY@<8U+_S:HX &D@"@\4U(;PZ58F3IYCOQF
M29Z1-:K71H81Q#' E.*%5WCK!C\=&<VX>G73>FL28XN%^9P/U%-:#Z,:,J,C
MHN!V#5W:"@820FL)-X$S5>4*DPC3:<*@V!M"6&S4$*8:@!>0=2E^^N=('MM
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M QV6CY))$AVW4:U]LR*@2QOQA6 =HSZWIEKEA&<2M<R>;;C-V(Q:/PV)7,$
M6P,C(T*P)9>6K;FJ!.7GI@434/F<^[ 5^K/*!D9"A4/^BSK_(N1_+QALPY'A
M&"A&>_"/WB& S40?R!UY@B2I;517(-)?[JK"FI7E11#\@M/65;:I4\<^:QA4
M6Y:<!(,):@SH,,$KGQL;HH' %])[$9RB&K@R% D,/D@$S1OKNMM#>,O2FC4-
M:G( X@Y.V<"!?%52[(\FPR&HU?K7&,&IC_+2&06*$&#%4;7WZ[; ]U2&,J,
MTFYM&-&"*I#K!_%\33&GEI4,SYX*5%B.S]Y$;9" J(N@8SD#63-1U_J3<5^
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M+.:F2-V ?D<RV(?@?YL;QSMP:9>>DB<TRV#D*!V\"@D\D/4!O0-492V>BR>
M8H2F")_Q&F%LD3>TE/V0Q5)H3.#G!K/"+)&.)PPDGRND@/VTN\(WQOI-^E'I
M8,AYS@KK4 Z",^0M@@TL"+:N0XU>/LJD"GGY8[522!CC&$9AC>-U[,.-#8_G
M9P[WPR'XIC?2^8[!!TK;P;DZ>N&<Y+\]@W@(C$.U!W2CG,@R*S/19OT.Q-&5
MY#RGNT-.3[V_?*)LUSDX#,2%*1R4XCW31Q1,E%QH+8M0L%QLN+@@"<8\FB7T
MPQXZN]7B*XWB@0P.=8;=S%@%-,%I0_"!)I?WU_1@UC _&\U"3Q7&519%7KZ7
MX548.)9*B 1LKA8K:N$AALR4IN+R>E7R,7M?Z8;9H'#HFMH;/DJ$RVF%5SS<
M@!&Q6L&(# %+\,*4<&2%L6HL*']W+$TWE65[[ JW20WOU".5];M$\KN$\":0
MW9L@B.SOQ'W2)C3D1J45!DC"L5AX77G7=O];=!&0[GWHV4QJ+KY,N[!" 4!X
M'N6:#TICPZZF:/1]VZ#>>. W.@-ZR'D\@&K;$$33*>AGT DML4>0H+PUM+:*
M/X?V,@$\['R 5O^ HQSK:_AC=:"C*/KALR1%?]93:I?1CO!@2]VE6Z98@>+;
M3^9-/PPUW@/UE4D=83YM]2D"XAKLO\</;?V(85FJHN"F^HDN W4HY.@AY.?S
MG>=!O:!9-!O,:!Y!Y@5-HV@PHOD8BV>A4CR=#.84G^ @6DP',<5S/#[LUP#J
MBWDT&*-(HP V.YE!L%[=@T?/'/]LX]LCB?K1)-[%<C*+8?Y +)/YB /@6,:0
M61R.)>K/(CYLHXGZXWB*Y-3KO4ZJ/Q;E)Z.%)PN^@8M M^M7;\@]84*7/".L
MJ;(<;^!46?1JHX;/>Z'5/\VK5J>='":(MVI9U0?6"IW)^L4?^H2GZW8GA#9G
MTG66U]:D58+KPU<TR(%!^5^3]&87#U(_'R]0B,6TIBCH%]%B@L5-G<!H' ^F
M%/%Q!/Y&%,W^=VX^#P#<F<[1/\'K0-2(N;D?1#R=MI['->\.!7&4E(>^=8=[
M-Q1P- OW,%>/Y?JRTNUV5[W+^H:S$Z_OB6^$S10^7PJY@NIH,)_VR-9WKWKA
MS3K<=Y;&HR'"8X[KJK0L@/.5,;Y=L('N GSQ+U!+ P04    "   B?M6\VY4
MO7D"  "V!P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6RM56UOTS 0
M_BM6F!!(4.>M990TTMIT J2A:M/@LY=<&VN.'6RGW?X]MI.&;F35-/8E\9WO
M>1[?V;I+=D+>JA) H[N*<37S2JWK*<8J+Z$B:B1JX&9G+61%M#'E!JM: BD<
MJ&(X]/T)K@CE7IHXWTJFB6@THQQ6$JFFJHB\GP,3NYD7>'O')=V4VCIPFM1D
M U>@K^N5-!;N60I: 5=4<"1A/?/.@NDRMO$NX">%G3I8(YO)C1"WUOA6S#S?
M'@@8Y-HR$//;P@(8LT3F&+\[3J^7M,##]9[]W.5N<KDA"A:"_:*%+F?>J8<*
M6).&Z4NQ^PI=/F/+EPNFW!?MVMAQ[*&\45I4'=B<H**\_9.[K@X' ,,S# @[
M0/@8\)1"U &BYRK$'2!^KL*X [C4<9N[*UQ&-$D3*79(VFC#9A>N^@YMZD6Y
M?2=76II=:G Z79%[M%5H!=*].9X#RJC*F5"-!/0175]EZ-W)>W2"*$<7E#%S
MNRK!VDA; IQW,O-6)GQ")D(7@NM2H24OH!C 9\?QDR-X;%+N\P[W><_#HX3?
M&SY"D?\!A7X8#9QG\7QX.)3._ZDO7ZS^H!A1_P@BQQ>]Y!$,779+%P_3V=8V
M537)8>:9WJ5 ;L%+W[X))OZ7H4J_)EGVFF3+5R)[<"=Q?R?Q,?;TAYD1E.>B
M&KR %CMQ6#L*MFD0C$>?$[P]K.R_46/_<5 V0#6)1^.'4<N!J/AT%/91;8[X
MH!%5(#=N BB4BX;K]CGVWG[(G+G>^L@_#Z:+8,"?F:'4SI"_].U$NR!R0[E"
M#-9&RA]],GU2ME.B-;2H71N\$=HT5;<LS6 %:0/,_EH(O3>L0#^JTS]02P,$
M%     @  (G[5C(^6PI!!@  :!X  !D   !X;"]W;W)K<VAE971S+W-H965T
M,3@N>&ULM5EM;]LV$/XK!Q<HTL"))#IVG#0QX*3=F@TILB3K!@S[0$MG6Z@D
M>B25EW^_HR1+=DK3B6M_:"/*O$?W'(]W#Z6S1R&_JRFBAJ<TR=1Y:ZKU[-3S
M5#C%E*M#,<.,?AD+F7)-0SGQU$PBCPJC-/&8[_>\E,=9:W!6W+N1@S.1ZR3.
M\$:"RM.4R^<+3,3C>2MHS6_<QI.I-C>\P=F,3_ .]9^S&TDCKT:)XA0S%8L,
M)([/6\/@])(=&X-BQK<8']7"-1@J(R&^F\%5=-[RC4>88*@-!*<_#WB)26*0
MR(__*M!6_4QCN'@]1_^E($]D1ESAI4C^BB,]/6_U6Q#AF.>)OA6/7[ BU#5X
MH4A4\3\\EG,[)RT(<Z5%6AF3!VF<E7_Y4Q6(!8.^O\* 50;LM0:=RJ!3$"T]
M*VA]XIH/SJ1X!&EF$YJY*&)36!.;.#/+>*<E_1J3G1Y<T8)$*.%>\BC.)C"4
MDF<3I(72ZLS3] 0SSPLKM(L2C:U Z\"UR/14P><LPLAB?^FV[SGL/6)6TV-S
M>A?,"?A;GAU"QV\#\UD'U)1+M-&Z_%F4)><Z=>P[!6QG!:PMYFT8/<-5%L4/
M<93SQ+8$)>B1'=1L^U,UXR&>MVA?*Y0/V!J\?Q?T_(\VXEL"6^)_5/,_<J$/
MKKE&&?,$[E&F"L38EH6V"#AAWQH!MX]SCVX2GBGXE$LST%.D?Q(1TC)=T:0K
M4)I@G29MR 0-B93()42QI+HE)+&4=&\<ATC7<6;J,%GF!7L#RR,Q*^H;S:/H
MT([GY7 ,'-Z_ZS/F?[S-$X3 'W4/ M"5?[R)6#$K^&@0*@/RY&"-47MNQ17Y
M(1063U<T!4U5I*A$Y"[<XB1/2H_N#GYOPY7&%([\?AOP*<29-N81JE#&H]*@
M"!4?T;-'IF6<PB7M'JK=*%>L-WSE*<)]K,ED. \&E3:$!0;[\'69TOX^W M-
MJ717;$[0@IX'=R*)X//3+):\@=D+/L GD7'ZZ?H0AJ,1/M,<#'/33^ ;K0S<
M$ 1518H*_)J($<%>Y(I"H!3<43K1%-JG5_?P!^W06#\#SZ)Y9(1\AN%XS&-:
MWJ[7]8J*\3=TVJS;IQL]<^,([C0^($63GI_HE)-G57[0E(X_-SII=WO]^DX7
M+F0<35 3AYM#^$*=CX)8&_:\H#,W[/E^/3Z"?:HGNLQ0"HNB4*CQ<YELE(BF
M%1KBM,C4G(N$78CK7O@!]DVT-2WFSX"8J'^N4R2F A?28D2FVHV%T)G02#G$
MPZDM.6%F=H(V\XEI.5!F8J9XH09,SDJ13Z;%4L19F.31?*,BETE,D2*W11CF
M1=[M\0_%;Z%(9PG6&RQ)8);+<$JRH-BHBB?EQ=ZHG!^9!$IBI5\D]Z&C&G;K
M:MAU5IH7&;VT)XJ-8&VH%V[0,4\4VJJ>TVS#NM^KF?8V9GI?U3P[63?N2K).
MLPW)'M=DCYU.O2PU_UQC.D+YKXV>$^FM?6U+8$ND^S7I_BZ437^;_+<$ML3_
MI.9_XLYPZF$V@FZK%ZEB(^4$V)!4X#=G!=\MADQ7MIX*W'8[::_6TX73CTWC
MLW"6"IP\E_2*-4YN^[E@L%)SFFY*C374F'OI%[3H2G9NB+GZL;)SFF[*KCF(
M!<YSSF XF4B<F.8^?.!Q8EJZE6")TBU0S N2AT&'=-V9][#$9<VL91^;PU+@
M/HG\H!E=G<2-]=92NBVT9>:-, JZN^@FP98T3A6#72BFH)%,P1K-M**CK#%[
MF3169KN01T&CCP*W0%K=5-8(J^KD8Z6T"_$3-.HG<(J+5_0!MWU]"+1RVX6P
M"1IE$[A%RJL:@1NB/M%:Z>U"XK!&XC"W5'EE)ZA0%FO\"1W67W2"=;.6?6QD
M!G/+!-M[ %<S<,.]M1!N"VV9?"-$&-M%,V!;$AA5#'8A5U@C5YA;KJQJ!FO,
M+'EC);>+=\*LT3ELS1O75?U@C9VK'[A--Z74"!CF?@NSMA^LL:_?[5FY[4*8
ML$:8,+?">$T_6 -1OZJTTMN%.F&-.F%NE?':?G#\0Z7O^?[+=N">5'KH+7S+
M2U%.BD^<"D*19[K\K%??K3^C#HN/AUXSO?P&>\WE),X4)#@F4__PF)XLR\^:
MY4"+6?%E<"2T%FEQ.44>H303Z'?S9G8^, ^H/RX/_@=02P,$%     @  (G[
M5@D%MLBQ#0  S3   !D   !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL[5MM
M<]LV$OXK&#?3:6=D679>FJ1)9FPW[>7NVOKBYG(W-_<!(B$)"4FP &A9^?7W
M["Y 4HZL.KVO_A*+)+!8+':??7;)O%@[_S&LC(GJNJZ:\/)@%6/[_.@H%"M3
MZS!UK6GP9.%\K2,N_?(HM-[HDB?5U=');/;DJ-:V.7CU@N]=^%<O7!<KVY@+
MKT)7U]IOSDSEUB\/C@_RC;=VN8ITX^C5BU8OS:6)[]H+CZNC7DII:],$ZQKE
MS>+EP>GQ\[/C&4W@$?^T9AU&OQ5M9>[<1[IX4[X\F)%&IC)%)!$:?Z[,N:DJ
MD@0]?D]"#_HU:>+X=Y;^(V\>FYGK8,Y=]=Z6<?7RX.F!*LU"=U5\Z]9_,6E#
MCTE>X:K _ZIU&CL[4$47HJO39&A0VT;^ZNMDB+M,.$D33EAO68BU_$%'_>J%
M=VOE:32DT0_>*L^&<K:A4[F,'D\MYL57O_JE;NPG+29J2G5IEXU=V$(W49T6
MA>N::)NENG"5+:P)ZIO\Z]L71Q$*D)BC(BUV)HN=W++8$_6S:^(JJ-=-:<KM
M^4=0O-?^)&M_=K)7X%^[9JH>SB;J9';R<(^\A[TU'K*\AW>PQD2=NR9@L^5@
MG MO@FFBW' +]:-M=%-87:E+W#3PUAC4?T[G(7JXVW]W64@4>+1; 8K!YZ'5
MA7EYT-):_LH<O/KZJ^,GL^_W;.]1O[U'^Z2_.M/!!M)[O(]=2OX),<D^%N9H
M*\./M^WWWJB5OC(*^VJU-Z6**X.@+%S=ZF9#/M8UNBMMQ*.BGXF+16_D,!C9
M-CS7EWAD$#-QI=Y-+Z=J:1KC=55MZ+%I:;X>O+CM]9LHY]5/IZ<7$P5H@[AH
MO*U':]E&("]OC9<@E6V#T^T84X**3A$XJ./9X3]XV*F/MJ@,;I %+DW1>1LI
M;NCAZ^MBI9NE@67JVH; 7H;5+U^?3]1;L^PJ6>_R\%]3#CY?0NMJ,Z&%-ZIT
MJG$1"A155\)V545KB$[;RI8V%)4+'<X'T/E[9\G>\PUOF/=+5J],-#N-.U5O
M&A;K6MLD3Z]U Y"FQQ->6)<? $X\?*+6*UNL>KU< ^LWI$^%Q6$ 3Z8?3>#C
MM:4AI1I3F!"0#U@MK1;:>M6._&HB7C,WILDKE%/U:XM3YB/%4 !PX.FD<UQY
M8]@(P5ZK6O#&$-XHH(7IT4+!!]F<60,+K6U3 ODH3V3+9O%QI2.,L($BRERW
MR"GDF6G-C=&>UB!]?H"X>FZ\>G@L"TW5;RMLYPX^'5:NJTI:@?(KN3CF?.@:
MR5^] ]X]2,@*WE0\ %LUM U8'4Y[4W,,N*GX26]NTH0&GS9-AP7>FM;YB&/N
M7?]O8IXUN5-E1K$"Q^9Q9NX[.N-G7VJ2[%,9*SJZB:/YP5PCAB9PU&+*VW2=
MAQLZ"GRW;B N='/XF,6Y&CCT*5PVC#(;QWN"'F3UBE!$[ 7D;H).X3VXGJDL
MLB\K*N<R(-NTAS9X>Z41U@M+QV-\U 13M6@-I[ZRK@O0T+,%110IOG/K."4L
M0W%-/\D %$IXM!4>"(5&'/M8'/N$P8(0AO=F%@OQ5806ECJ$O$.'T?B[UAYF
MBJ[XJ$);V4AVM1R=-<(F/<'28850@6D1L&Q[[!+ I#1?_(R0.)9C/>%C50!W
M=:6KK@^A+7G>$%4,ZL%L.IL=*X2QR+^!=SK;30&]8)=D@<]DPS\0*X'.FZ2$
M%*\4B OO:AXSWN):A^U3XE%??_7TY&3V_6F)P()-L5ZK;7E(!ZU;&W7% XZ_
M)S72V//1IJ;Y,7L9Z<&>U.]M"YY7T( ]"G'HG9!2RE8,CY05'9%=(JV?*<\(
MB24@V+HR9#\@/(0'EH!S#Q^58%DDV,!>Q&V8O,%JY&_L_8U.S\>10DF"_-2L
MR80DR#17UKN&?!(!!O101@/L^TD;2JJUP*<DWY@BB6"R@9J%#JLI8<6^=1&[
MX3:MR82D2N6*K0<30AR.5X(XV?9N$(%1F1V4  @-+^X"LP&VXZ%A75-F%O79
MTB&8A*&5U7-;#7D<L>Z1#7?-8N.(8+Z&,4W3F0FB(,2170*ATGLS %S:!C9_
MF"%[G#(9=&J<^(HJHBN>Z&IQ-.%"7=W)-$<@?V,TR$#(,$Y\(&Y42'51\HDM
M+$Z(J+BN$$53U"\Y>MDH$+DCX,;PR7E BAC"#IH%:Y3.IWQ*!UN:QHV1=>2L
MO \,;&[QZ U+Y&4SV&[A^I8N^:$)41(&2Q<K3D "8@;C+4.,O(CL)*P# Z9[
MV/CCGHT_WDNC]Y#E79Q\O[![3G[/R>\Y^3TGO^?D]YS\GI/?<_)[3G[/R>\Y
M><_)G_2<_,E>&OTN,(R]#A'Q __91<2_3(+@+_/K_K7!G:AT2C3D%GQFS!,3
M<:1H(52J]4?3V]GT2W(\A-#5;6+$?+"<=21KI_1W,^?=C;V0A#&9K75ILA]O
MU0Y,;Y!$*!LDS>GV..</.N>@\V9.UQ,*9'! HN)N#JV(&-L&KAJ=SS%/*U+J
MZ0V;!U"V*@KPFTH0@'!B*:.P1XJ,C%993,IL*?#6SE?EVA(&Z&N<GKNR(?-X
M8:"ZLI\$@#8TJ30+X[F PGA!J2D(44"F,CV\-ZP C@V[UO/*AA5C! '5C</K
M J\1$%ES%"ZCLZ2-Q8Y9O)!@XK^EQ=EZB3I:K!>V+R2^ZT/BN[T.C8JQ@.J#
M]YYCG\A\;VWXN"L\_KRTT>LT*>C$YZ22:1T;D,M(9*D/Y,M=9F2#2,:$0F1Z
MDLEU38BCC$@#D/XF_"\C+WQ(BB:P?1\/*6?#KOZCB6S^T%>,XB\]Z07^&DS&
M&(9CHJ-1#N"ZY>!@]4;*().WE2XH"CC>2 ')%E<F9Q4.=C!#LX8.'YS?JG]Q
ML+$3M.L9+IQ\Y%+PP64'SR7#DX9+S00./H($&3CNQBEFO'+R;A1[<)Y<(X^2
M @6NL"'BBXPYJ7B';C2YUM<PP2>R!*R*76]2FB+R0J+AUB/E)"5#(6X-T'Q<
M+38T4/@UH9LNKP 4E-F)7GIF+UAX8TU5AF2\E$(&FB,4(&1<&W*$9*?>H#@E
M9I?[XN1I'R=/_\BS^:VO.DNERZ[@^$(1JK_3UT/ ;*&8XR)&*.=.&-^F#407
MD2DL)]IU<B#.R0F_EHY8++R.WCU;6K O=(0RJ%2E]M=$GHF:]QT$G6$.X=FA
MC$WCTTY&=>:-G?4]E,_#2QHH&6,3?YNJ"[UA#DP!&Y )0'P18;WDN&EE)O^@
ML,\ZT\VA*^69+S)Z/IR1XL]FJM2;,,T?0&RKPA"SW;?HJ_*N04ZHS$Z,H&D/
MGDU/5(TAN4:5O@4MBDAT,+CX+S@QW:;*8J]( @M*O6M3X2"ELS*FAC=M)N>?
M#]YPY)1"QO5@N 1!6^9BK&K%X$+_10TBMUZ5'9$<2[[A>G]*5 <E5<4>!<<(
M"]TS7$FDPH\1H%R.D:<ZX-@R%])PY]W/1(?A$$6Z39V.FS89:E-+.638*@6)
MU,B?F6H4<J(DMG:;+M)KP3E1IVA012\BN?^6)E3N/C@YGC[*?K#3H\CD#XZ?
M36<W1GW6$<KQ-#1,O%'C+I&0ZLHU2TELX\+ICP%CJMXF<Y!'@;A]&GI/N:2B
MP+G-,(,M.%M(NZ6OELD6U.\CLN+I7'(/[/-R>@]"/^L1^ME>>/T%!<4;*=$N
M8))+Z@/L NDOEZ*H_5ZDBH4?#8T&':.W\TZH!-.5H4N1.SB6*O*J2,7BG!C=
ME2USN3\2>Q=A<\Z@"'+Z(,V4A[DR;CIV' Y*F27M&==%D ?IE):=SZO*$8#%
MVJKC9N6NS5EN3;4\0 KX\=+J_UJ:8F B@%62#L":R4 #MR2-61S2PH@JYIDW
M%LZL$!JE.Q8<FZW*[DQ\PMM"RDWJ]G0 #GE!\?;R'7Z,_?WFB L>L=8>.!@3
M9Z0P@R=;[O.#<_EH:;%4(MU!XUZ_KL5-(FW,(A=)'UE36AFHMJU4H5F'1.!2
M,VI\5/F$Q(R \,)\UC,9DGBDHJ1#FI4MUR:NR$6^6'TQ01CQT-ML<[OF=G&8
M1N-VUN1-TT,'!)/+2DN$VU*H*/N7-.T?J]PW*\7#]3AOE:.@X#[.$!("8=0Y
MRYKH(#T>*<#7^84"#L8>YK7WX=OQ;/B8<[87F]X:JH3&WVW^!+I-3KKS8\T_
M*TS)(YCNM'3\/F_\I:AW#7X7J6. $_FUB(["'^GJ6#KA/YY>GK%+T-3+=^H7
M-^6GA[.G$W5&9TRE_[FKY[9)B>2;WUP+B'TZ>_SM\_%R9.Z>)9\._<'^WM]'
M^8Z/-#])I=9Y[H51)@6>+?,F;9"JG?-H34V K7<>>7%=I'=YF3<4V_*'7AOU
M!-4\[ZX8=B<$I$&-U"_>-WJ86<BR?,</B5AJ)H[($9\>]4C[>UO-TJSOK>KL
M>I$KUG\R>S+E TN'1382MZ;P(6NT'9)_,8BE(!/3<R4;J%M,+[BHX;ZT3<.O
M(9DE]<SF^'%^:2(TAH;D=\$]<4@<3SK4([$) [7G_KUK93\<GRC.N2__&[=[
M<*XWW_#IMJV(J>"H0VOR6P!DV5U& L 4^3TJX8+/9(^DYX6%7;Y/=Y*S][9+
M/53KD8A^[[2/DB)[_L<O!A-'(@_44BC<J5,W'6+T38JS6T/T%S"P?P/(4C#O
M0J*CT1?F\.4E?T=/]H!$^=B\O]M_JW\J7Z@/P^5#_Y^U7U*_NC(+3)U-OWM\
MH+Q\.R\7T;7\O?K<100._UP9C11$ _!\X8#=Z8(6Z/\'PZO_ 5!+ P04
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M_A #&"OL*;8D%J_1;MWL([OLX!4M/(GP^!Z><?"<O)=&"E>%0:K:R&OR6&J
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M!1SODSZ]0B6F=2Z8FK,-\!^DT%PGV1U#;;+WLN1E(GG.3HP1UCQEQ'XUUYF
MI!QE*LL%LQ3_5:W*[_#/O%7 G0)F,V[94K"BR9N4@9P3O%L'CTH.99O46I,\
ME(XT8"4C$%'11K3'DAP2Y5Q"A*0Z391.H4J@%&P&-6)3;+:V^I#MRMT;0PH/
M+DH43)ZC]DV7_29N1<Z"U1JNUHA=*PN+SKC)F/A:2^AP(EZS21!X,=;8]T98
MWKP:AT'XCC8&H1>P<S&SS)!UTDIA>HS?<IF3S]XB&F\-Y!RR&^_*8PMU*W1)
MR!BZ'#P(7QX$W59BT!M"Q^ 1?::*0FCG\(I70K<'XF "2-O4F=*5TMP*="0
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M25L:^"!SS(_C0T+<PX[WL*_CLPE_:>401M$ XB@>G<DWZK=AY/.-WLBW9_^
MC=*VD@7\OEP;JTDT?YRBVV4;G\[F&NG*-#S#>4"=8E _8[#XX3N61C^>P3KN
ML8[/95^LJ#'S5B"H#>%]1MDB;+2JX<.+12VY@!NO&]0&UE\.#W-);6M.T3E?
M\+&D DI0_[J-L4X$8- :,FI;4FMV&*B6:C78K8)&5Z[%H>AK$RJR/%'4 "SE
M^RPKBSFL++=HO.CNI$?OE,;%P+=:#J0ZY_V:!X3*.C5:!5LRE+!%:D-!O:V]
M;Z;J1DDZ3*I$ +VM05VIW( IU59>P6.I$8\D><KT[DY2QPE!Q<Q[6-:J)8%\
M[W;]45GB\[7EF-0%I"P=IC!AY',!"6/#""8CFAQ1A3@9#R<07]("FR;#&.()
M#;N,^[V]@.F$#4? HL@G2R]3<NQFJ^KE&/A7AG_/A W8.'[E<IG&5/X$E_$D
M<@0<EQ'Y3$]S88.4N<4]&S88Q0EMCI^?Z9"D[Y#DFSODMC*\*#06G6I>>^94
M'YQ/^^U]4/,_27F&T]<2LI)+B>*_UB+QMKI:MY;*7M!136F_ITFG1%(9@^F8
M)K>5INL1V"@>)L#<,B.9,F#I_R[!8P(DD61";>)1>STR)\%#$G&2[)''G;Q.
MD?C'V@L/+E?ZIA;^"4''ZO!V]VQO[5\IR^YR?G7OGCB?N"XJ:4#@AD*CX83T
MIKMG0S>QJO%7]5I9^H#[84DO+=3.@=8W2MG]Q!7HWVZ+OP%02P,$%     @
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MW354'<7S\O2]XDJ?Y<OF%G *PACH]VO.U4O'!&AN?*+_ %!+ P04    "
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MQU^A"FAB^8A@ROU'QTHW\! IE!99!38>9)273_Q0)>($8'C: 6$%")\"QL\
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M1-8J@%L5P-6QKSXE\ Q$_](=6C,A5:D6\4$>GS6,\\KQ/,^<+ZQS,XD"-F_
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M.#OUB&IF3+,QLG;7="X-7GJW+'$L@[()^'XAI7G>V)O?#?KL#U!+ P04
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M<!I6RR7^KT!9!_P^E])L-W8DMG_ ]"]02P,$%     @  (G[5I4M*F80 P
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M,'P"F88'%AYNPSWM0&M#V-H06KYH#]^]6&)&_F#36J=HK$OBE.2X[C26HZD
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M&](."_T- V$"]/Z"<_4R,==D^U5,_P)02P,$%     @  (G[5K$IO?,2 P
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MH0SF>$7E/=M\ACJ>GO:7,BK,+]K4MJZ%TI60+*_%BB G1?6/G^H\; F\\(#
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M"M5TI3F%\F$4=4WKT($35+,=WT8X'7LF?E'==(C.-!V^H3SDIWLG!FU!H)I
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M0R"FC<$+Q LGN;36G+C8EW:3^/#83IJ%+8U@HGF1V+'O?[\[G^.$&R%OU1(
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M%K?^%-:7YUSF"\.:G^X52S9N4J'K6LH;7W:GOFA>'+YU.'RG\>$_4$L#!!0
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MJ[_^.=K<TTH7]3&?M7^@IY]02P$"% ,4    "   B?M6!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M  ")^U9=G)[+[P   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    (  ")^U:97)PC$ 8  )PG   3
M  "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @  (G[5@'"
MQ;S)!0  NAX  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    (  ")^U8:1<V:$0<   X>   8
M  " @0T.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "
MB?M6IS B5A4#  ##"@  &               @(%4%0  >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&UL4$L! A0#%     @  (G[5E/I98+K!0  $QH  !@
M         ("!GQ@  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0
M   (  ")^U9H=QZLMP,  )<-   8              " @< >  !X;"]W;W)K
M<VAE971S+W-H965T-2YX;6Q02P$"% ,4    "   B?M6^]4L+,P+   ,<0
M&               @(&M(@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!
M A0#%     @  (G[5OBCAM6?"   [B<  !@              ("!KRX  'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    (  ")^U:Q#J&C2A
M %4L   8              " @80W  !X;"]W;W)K<VAE971S+W-H965T."YX
M;6Q02P$"% ,4    "   B?M6B# 1P% *   8'0  &               @($$
M2   >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @  (G[5O.T
M^-3A"@  ;Q\  !D              ("!BE(  'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6Q02P$"% ,4    "   B?M66W 'H0((  #Y$P  &0
M    @(&B70  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (
M  ")^U:-ETSUQQ8  +1B   9              " @=ME  !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&UL4$L! A0#%     @  (G[5K6'>:"E!@  0!$  !D
M             ("!V7P  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"
M% ,4    "   B?M6-.5;81H#  #M!@  &0              @(&U@P  >&PO
M=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    (  ")^U:)* \B708
M !@/   9              " @0:'  !X;"]W;W)K<VAE971S+W-H965T,34N
M>&UL4$L! A0#%     @  (G[5KG].B'S!0  # \  !D              ("!
MFHT  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    "   B?M6
M\VY4O7D"  "V!P  &0              @('$DP  >&PO=V]R:W-H965T<R]S
M:&5E=#$W+GAM;%!+ 0(4 Q0    (  ")^U8R/EL*008  &@>   9
M      " @726  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%
M  @  (G[5@D%MLBQ#0  S3   !D              ("![)P  'AL+W=O<FMS
M:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    "   B?M6$DV\B5$$  "W"@
M&0              @('4J@  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+
M 0(4 Q0    (  ")^U:!.*RJ:04  'L/   9              " @5RO  !X
M;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @  (G[5LPL@,X<
M!P  3A0  !D              ("!_+0  'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6Q02P$"% ,4    "   B?M6X$8XW.,%  #<$0  &0
M@(%/O   >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    (  ")
M^U95U0N;-P,  .X&   9              " @6G"  !X;"]W;W)K<VAE971S
M+W-H965T,C0N>&UL4$L! A0#%     @  (G[5F;)7=ZT P  QPD  !D
M         ("!U\4  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M    "   B?M62JG)L=,#  #]$0  &0              @('"R0  >&PO=V]R
M:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    (  ")^U:I]QX/@ 4  /H<
M   9              " @<S-  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL
M4$L! A0#%     @  (G[5O]\J/2? P  W1   !D              ("!@],
M 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    "   B?M64A)G
MNJ\%  "W+0  &0              @(%9UP  >&PO=V]R:W-H965T<R]S:&5E
M=#(Y+GAM;%!+ 0(4 Q0    (  ")^U9NT)5%V 8  -<X   9
M  " @3_=  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @
M (G[5O#<T]HG!   QQ8  !D              ("!3N0  'AL+W=O<FMS:&5E
M=',O<VAE970S,2YX;6Q02P$"% ,4    "   B?M6XMN= " #  "P#0  &0
M            @(&LZ   >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4
M Q0    (  ")^U8; _PN2@0  +$4   9              " @0/L  !X;"]W
M;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @  (G[5C+DXRN% @
M] 4  !D              ("!A/   'AL+W=O<FMS:&5E=',O<VAE970S-"YX
M;6Q02P$"% ,4    "   B?M6]FU_$;@"   -!P  &0              @(%
M\P  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    (  ")^U:5
M+2IF$ ,  (X(   9              " @2_V  !X;"]W;W)K<VAE971S+W-H
M965T,S8N>&UL4$L! A0#%     @  (G[5K[P3 2O!   /1D  !D
M     ("!=OD  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  ")^U:F%GV^^ ,  "X;   9              "
M@9L* 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @  (G[
M5H[HG9!J P  T X  !D              ("!R@X! 'AL+W=O<FMS:&5E=',O
M<VAE970T,RYX;6Q02P$"% ,4    "   B?M61,-.P%T$  "8&   &0
M        @(%K$@$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0
M   (  ")^U:=] I\"QL  ._* 0 9              " @?\6 0!X;"]W;W)K
M<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @  (G[5CCY1]B[ @  (@D
M !D              ("!03(! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q0
M2P$"% ,4    "   B?M6#6L%N3L"   V!0  &0              @($S-0$
M>&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    (  ")^U9$Q9LN
M"00  #<5   9              " @:4W 0!X;"]W;W)K<VAE971S+W-H965T
M-#@N>&UL4$L! A0#%     @  (G[5MS$]AOE!    AX  !D
M ("!Y3L! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    "
MB?M6[R>EZ3<"  # !   &0              @($!00$ >&PO=V]R:W-H965T
M<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (  ")^U;9+8LVSP0  #D=   9
M          " @6]# 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#
M%     @  (G[5E/[S8)K P  PQ<   T              ( !=4@! 'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    "   B?M6EXJ[',     3 @  "P
M    @ $+3 $ 7W)E;',O+G)E;'-02P$"% ,4    "   B?M6:$-OF%D$   K
M(@  #P              @ 'T3 $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @  (G[5J&7ZI3) 0  H!X  !H              ( !>E$! 'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @  (G[5BBT:!/# 0  B1X
M !,              ( !>U,! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/ #L .P 4$   ;U4!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>238</ContextCount>
  <ElementCount>280</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>57</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited</Role>
      <ShortName>Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statements of Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Organization and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies</Role>
      <ShortName>Organization and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Development and Other Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DevelopmentandOtherAgreements</Role>
      <ShortName>Development and Other Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Balance Sheet Details</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetails</Role>
      <ShortName>Balance Sheet Details</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Business Segment and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformation</Role>
      <ShortName>Business Segment and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9954701 - Disclosure - Organization and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Organization and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9954702 - Disclosure - Organization and Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables</Role>
      <ShortName>Organization and Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9954703 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/FairValueMeasurements</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9954704 - Disclosure - Balance Sheet Details (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsTables</Role>
      <ShortName>Balance Sheet Details (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BalanceSheetDetails</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9954705 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/Debt</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9954706 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/StockholdersEquity</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9954707 - Disclosure - Business Segment and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables</Role>
      <ShortName>Business Segment and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BusinessSegmentandGeographicInformation</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954708 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954709 - Disclosure - Organization and Significant Accounting Policies - Earnings Per Share, Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Earnings Per Share, Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954710 - Disclosure - Organization and Significant Accounting Policies - Anti-dilutive Securities Excluded from Calculation of Net Income (Loss) per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Anti-dilutive Securities Excluded from Calculation of Net Income (Loss) per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954711 - Disclosure - Development and Other Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails</Role>
      <ShortName>Development and Other Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/DevelopmentandOtherAgreements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954712 - Disclosure - Fair Value Measurements - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails</Role>
      <ShortName>Fair Value Measurements - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954713 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954714 - Disclosure - Fair Value Measurements - Fair Value of Convertible Senior Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value of Convertible Senior Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954715 - Disclosure - Balance Sheet Details - Short-Term Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails</Role>
      <ShortName>Balance Sheet Details - Short-Term Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954716 - Disclosure - Balance Sheet Details - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails</Role>
      <ShortName>Balance Sheet Details - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954717 - Disclosure - Balance Sheet Details - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails</Role>
      <ShortName>Balance Sheet Details - Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954718 - Disclosure - Balance Sheet Details - Prepaid and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails</Role>
      <ShortName>Balance Sheet Details - Prepaid and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954719 - Disclosure - Balance Sheet Details - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails</Role>
      <ShortName>Balance Sheet Details - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954720 - Disclosure - Balance Sheet Details - Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsOtherAssetsDetails</Role>
      <ShortName>Balance Sheet Details - Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954721 - Disclosure - Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954722 - Disclosure - Balance Sheet Details - Accrued Payroll and Related Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails</Role>
      <ShortName>Balance Sheet Details - Accrued Payroll and Related Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954723 - Disclosure - Balance Sheet Details - Other Long-Term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Details - Other Long-Term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954724 - Disclosure - Debt - Senior Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails</Role>
      <ShortName>Debt - Senior Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954725 - Disclosure - Debt - Conversion Value of Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails</Role>
      <ShortName>Debt - Conversion Value of Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954726 - Disclosure - Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails</Role>
      <ShortName>Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954727 - Disclosure - Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954728 - Disclosure - Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails</Role>
      <ShortName>Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954729 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/IncomeTaxes</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954730 - Disclosure - Stockholders' Equity - Share-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails</Role>
      <ShortName>Stockholders' Equity - Share-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954731 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954732 - Disclosure - Business Segment and Geographic Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails</Role>
      <ShortName>Business Segment and Geographic Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="dxcm-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954733 - Disclosure - Business Segment and Geographic Information - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails</Role>
      <ShortName>Business Segment and Geographic Information - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 4 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:DebtInstrumentBasisSpreadOnVariableRate1, us-gaap:DebtInstrumentConvertibleConversionRatio1 -  dxcm-20230630.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="dxcm-20230630.htm">dxcm-20230630.htm</File>
    <File>dxcm-20230630.xsd</File>
    <File>dxcm-20230630_cal.xml</File>
    <File>dxcm-20230630_def.xml</File>
    <File>dxcm-20230630_lab.xml</File>
    <File>dxcm-20230630_pre.xml</File>
    <File>dxcm6302023ex1002-edgepark.htm</File>
    <File>dxcm6302023ex1003-byramhea.htm</File>
    <File>dxcm6302023ex1004-edgepark.htm</File>
    <File>dxcm6302023ex1005-byramhea.htm</File>
    <File>dxcm6302023ex1006-firstame.htm</File>
    <File>dxcm6302023ex1007-byramhea.htm</File>
    <File>dxcm6302023exhibit3101.htm</File>
    <File>dxcm6302023exhibit3102.htm</File>
    <File>dxcm6302023exhibit3201.htm</File>
    <File>dxcm6302023exhibit3202.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>dxcm-20230630_g1.jpg</File>
    <File>dxcm-20230630_g2.jpg</File>
    <File>dxcm-20230630_g3.jpg</File>
    <File>dxcm-20230630_g4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="776">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="18">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>80
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dxcm-20230630.htm": {
   "axisCustom": 2,
   "axisStandard": 22,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 776,
    "http://xbrl.sec.gov/dei/2023": 29,
    "http://xbrl.sec.gov/ecd/2023": 18
   },
   "contextCount": 238,
   "dts": {
    "calculationLink": {
     "local": [
      "dxcm-20230630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dxcm-20230630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "dxcm-20230630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dxcm-20230630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dxcm-20230630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "dxcm-20230630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    }
   },
   "elementCount": 526,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2023": 4,
    "http://xbrl.sec.gov/dei/2023": 5,
    "total": 9
   },
   "keyCustom": 35,
   "keyStandard": 245,
   "memberCustom": 17,
   "memberStandard": 39,
   "nsprefix": "dxcm",
   "nsuri": "http://www.dexcom.com/20230630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.dexcom.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.dexcom.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Balance Sheet Details",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.dexcom.com/role/BalanceSheetDetails",
     "shortName": "Balance Sheet Details",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Debt",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.dexcom.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Contingencies",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.dexcom.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.dexcom.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Stockholders' Equity",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.dexcom.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Business Segment and Geographic Information",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformation",
     "shortName": "Business Segment and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "shortName": "Pay vs Performance Disclosure",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:MtrlTermsOfTrdArrTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "shortName": "Insider Trading Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:MtrlTermsOfTrdArrTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ConsolidationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954701 - Disclosure - Organization and Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "19",
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies",
     "shortName": "Organization and Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ConsolidationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Consolidated Balance Sheets (Unaudited)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited",
     "shortName": "Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "lang": "en-US",
      "name": "dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954702 - Disclosure - Organization and Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "20",
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables",
     "shortName": "Organization and Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954703 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://www.dexcom.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954704 - Disclosure - Balance Sheet Details (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsTables",
     "shortName": "Balance Sheet Details (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954705 - Disclosure - Debt (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.dexcom.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954706 - Disclosure - Stockholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.dexcom.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954707 - Disclosure - Business Segment and Geographic Information (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables",
     "shortName": "Business Segment and Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "us-gaap:ConsolidationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-61",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954708 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)",
     "menuCat": "Details",
     "order": "26",
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Organization and Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "us-gaap:ConsolidationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-61",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954709 - Disclosure - Organization and Significant Accounting Policies - Earnings Per Share, Basic and Diluted (Details)",
     "menuCat": "Details",
     "order": "27",
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails",
     "shortName": "Organization and Significant Accounting Policies - Earnings Per Share, Basic and Diluted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestOnConvertibleDebtNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954710 - Disclosure - Organization and Significant Accounting Policies - Anti-dilutive Securities Excluded from Calculation of Net Income (Loss) per Share (Details)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails",
     "shortName": "Organization and Significant Accounting Policies - Anti-dilutive Securities Excluded from Calculation of Net Income (Loss) per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-89",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954711 - Disclosure - Development and Other Agreements (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails",
     "shortName": "Development and Other Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-89",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical",
     "shortName": "Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954712 - Disclosure - Fair Value Measurements - Summary (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails",
     "shortName": "Fair Value Measurements - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "dxcm:FairValueAssetsLevel3TransfersAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "dxcm:FairValueAssetsLevel3TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954713 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "dxcm:FairValueAssetsLevel3TransfersAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "dxcm:FairValueAssetsLevel3TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-126",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtFairValueDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954714 - Disclosure - Fair Value Measurements - Fair Value of Convertible Senior Notes (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails",
     "shortName": "Fair Value Measurements - Fair Value of Convertible Senior Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-126",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtFairValueDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954715 - Disclosure - Balance Sheet Details - Short-Term Marketable Securities (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails",
     "shortName": "Balance Sheet Details - Short-Term Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954716 - Disclosure - Balance Sheet Details - Narrative (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails",
     "shortName": "Balance Sheet Details - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954717 - Disclosure - Balance Sheet Details - Inventory (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails",
     "shortName": "Balance Sheet Details - Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "dxcm:PrepaidAndOtherCurrentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954718 - Disclosure - Balance Sheet Details - Prepaid and Other Current Assets (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails",
     "shortName": "Balance Sheet Details - Prepaid and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "dxcm:PrepaidAndOtherCurrentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954719 - Disclosure - Balance Sheet Details - Property and Equipment (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
     "shortName": "Balance Sheet Details - Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954720 - Disclosure - Balance Sheet Details - Other Assets (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsOtherAssetsDetails",
     "shortName": "Balance Sheet Details - Other Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "lang": "en-US",
      "name": "dxcm:LongTermDeposits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954721 - Disclosure - Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails",
     "shortName": "Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Statements of Operations (Unaudited)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited",
     "shortName": "Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "dxcm:ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "dxcm:AccruedWagesBonusesAndTaxesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954722 - Disclosure - Balance Sheet Details - Accrued Payroll and Related Expenses (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails",
     "shortName": "Balance Sheet Details - Accrued Payroll and Related Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "dxcm:ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "dxcm:AccruedWagesBonusesAndTaxesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954723 - Disclosure - Balance Sheet Details - Other Long-Term Liabilities (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails",
     "shortName": "Balance Sheet Details - Other Long-Term Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-126",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954724 - Disclosure - Debt - Senior Convertible Notes (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
     "shortName": "Debt - Senior Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-126",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnamortizedDebtIssuanceExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-152",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954725 - Disclosure - Debt - Conversion Value of Convertible Notes (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
     "shortName": "Debt - Conversion Value of Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-152",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954726 - Disclosure - Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
     "shortName": "Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954727 - Disclosure - Debt - Narrative (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.dexcom.com/role/DebtNarrativeDetails",
     "shortName": "Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-168",
      "decimals": "INF",
      "lang": "en-US",
      "name": "dxcm:NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "purchaser",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954728 - Disclosure - Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
     "shortName": "Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "dxcm:EstimatedAnnualEffectiveIncomeTaxRatePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954729 - Disclosure - Income Taxes (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.dexcom.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "dxcm:EstimatedAnnualEffectiveIncomeTaxRatePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954730 - Disclosure - Stockholders' Equity - Share-Based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails",
     "shortName": "Stockholders' Equity - Share-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954731 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Statements of Comprehensive Income (Unaudited)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited",
     "shortName": "Consolidated Statements of Comprehensive Income (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954732 - Disclosure - Business Segment and Geographic Information - Narrative (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails",
     "shortName": "Business Segment and Geographic Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954733 - Disclosure - Business Segment and Geographic Information - Summary (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails",
     "shortName": "Business Segment and Geographic Information - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-5",
      "decimals": "2",
      "lang": "en-US",
      "name": "dxcm:RevenuePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-50",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
     "shortName": "Consolidated Statements of Stockholders' Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-56",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Cash Flows (Unaudited)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Organization and Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies",
     "shortName": "Organization and Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Development and Other Agreements",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.dexcom.com/role/DevelopmentandOtherAgreements",
     "shortName": "Development and Other Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dxcm-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 57,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dxcm_AccruedTaxAuditAndLegalFees": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of accrued current tax, audit and legal fees.",
        "label": "Accrued Tax Audit And Legal Fees",
        "terseLabel": "Accrued tax, audit, and legal fees"
       }
      }
     },
     "localname": "AccruedTaxAuditAndLegalFees",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_AccruedWagesBonusesAndTaxesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Wages, Bonuses and Taxes, Current",
        "label": "Accrued Wages, Bonuses and Taxes, Current",
        "terseLabel": "Accrued wages, bonus and taxes"
       }
      }
     },
     "localname": "AccruedWagesBonusesAndTaxesCurrent",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments To Additional Paid-In Capital, Purchase Of Capped Call Transactions, Net Of Tax",
        "label": "Adjustments To Additional Paid-In Capital, Purchase Of Capped Call Transactions, Net Of Tax",
        "negatedTerseLabel": "Purchase of capped call transactions, net of tax"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_BridgettePHellerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bridgette P. Heller",
        "label": "Bridgette P. Heller [Member]"
       }
      }
     },
     "localname": "BridgettePHellerMember",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_CashInterestExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Interest Expense [Abstract]",
        "label": "Cash Interest Expense [Abstract]",
        "terseLabel": "Cash interest expense:"
       }
      }
     },
     "localname": "CashInterestExpenseAbstract",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_CollaborativeArrangementApprovalMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Approval Milestone",
        "label": "Collaborative Arrangement, Approval Milestone [Member]",
        "terseLabel": "Approval Milestone"
       }
      }
     },
     "localname": "CollaborativeArrangementApprovalMilestoneMember",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_CollaborativeArrangementInitialPaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Initial Payment [Member]",
        "label": "Collaborative Arrangement, Initial Payment [Member]",
        "terseLabel": "Initial Payment"
       }
      }
     },
     "localname": "CollaborativeArrangementInitialPaymentMember",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_CollaborativeArrangementMilestonePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Milestone Payments [Member]",
        "label": "Collaborative Arrangement, Milestone Payments [Member]",
        "terseLabel": "Milestone Payments"
       }
      }
     },
     "localname": "CollaborativeArrangementMilestonePaymentsMember",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_CollaborativeArrangementUpfrontFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Upfront Fee",
        "label": "Collaborative Arrangement, Upfront Fee",
        "terseLabel": "Initial payment on collaborative agreement"
       }
      }
     },
     "localname": "CollaborativeArrangementUpfrontFee",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_CollaborativeResearchAndDevelopmentFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Research and Development Fee",
        "label": "Collaborative Research And Development Fee",
        "terseLabel": "Collaborative research and development fee"
       }
      }
     },
     "localname": "CollaborativeResearchAndDevelopmentFee",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_ContractPaymentTermsNumberofDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Payment Terms, Number of Days",
        "label": "Contract Payment Terms, Number of Days",
        "terseLabel": "Contract payment term"
       }
      }
     },
     "localname": "ContractPaymentTermsNumberofDays",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dxcm_ConvertibleNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Notes Due 2023 [Member]",
        "label": "Convertible Notes Due 2023 [Member]",
        "terseLabel": "Senior Convertible Notes due 2023"
       }
      }
     },
     "localname": "ConvertibleNotesDue2023Member",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_ConvertibleNotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Notes Due 2025 [Member]",
        "label": "Convertible Notes Due 2025 [Member]",
        "terseLabel": "Senior Convertible Notes due 2025"
       }
      }
     },
     "localname": "ConvertibleNotesDue2025Member",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_ConvertibleNotesDue2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Notes Due 2028",
        "label": "Convertible Notes Due 2028 [Member]",
        "terseLabel": "Senior Convertible Notes due 2028"
       }
      }
     },
     "localname": "ConvertibleNotesDue2028Member",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_DebtInstrumentCapCallTransactionCapPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Cap Call Transaction, Cap Price Per Share",
        "label": "Debt Instrument, Cap Call Transaction, Cap Price Per Share",
        "terseLabel": "Capped call, cap price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentCapCallTransactionCapPricePerShare",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "dxcm_DebtInstrumentConversionTermAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Conversion Term [Axis]",
        "label": "Debt Instrument Conversion Term [Axis]",
        "terseLabel": "Debt Instrument Conversion Term [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentConversionTermAxis",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_DebtInstrumentConversionTermDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Debt Instrument Conversion Term [Axis]",
        "label": "Debt Instrument Conversion Term [Domain]",
        "terseLabel": "Debt Instrument Conversion Term [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentConversionTermDomain",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_DebtInstrumentConversionTermOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Conversion Term One [Member]",
        "label": "Debt Instrument Conversion Term One [Member]",
        "terseLabel": "Term one"
       }
      }
     },
     "localname": "DebtInstrumentConversionTermOneMember",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_DebtInstrumentConversionTermTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Conversion Term Two [Member]",
        "label": "Debt Instrument Conversion Term Two [Member]",
        "terseLabel": "Term two"
       }
      }
     },
     "localname": "DebtInstrumentConversionTermTwoMember",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares1",
        "label": "Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares",
        "terseLabel": "Stock issued upon conversion of senior notes (shares)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Capped Calls Initial Cap Price, Premium Percentage",
        "label": "Debt Instrument, Convertible, Capped Calls Initial Cap Price, Premium Percentage",
        "terseLabel": "Sale of stock premium (Percentage)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Principal Amount Exercised, Not Settled",
        "label": "Debt Instrument, Convertible, Principal Amount Exercised, Not Settled",
        "terseLabel": "Debt instrument convertible principal amount exercised"
       }
      }
     },
     "localname": "DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_DebtInstrumentCovenantRepurchasePricePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant Repurchase Price, Percentage",
        "label": "Debt Instrument, Covenant Repurchase Price, Percentage",
        "terseLabel": "Holder's repurchase price percentage in event of fundamental change (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantRepurchasePricePercentage",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock",
        "label": "Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock",
        "terseLabel": "Proportion of conversion price (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-Sale and Equity Securities",
        "label": "Debt Securities, Available-for-Sale and Equity Securities",
        "terseLabel": "Short-term marketable securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecurities",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_DeferredCompensationPlanAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Compensation Plan Assets, Current",
        "label": "Deferred Compensation Plan Assets, Current",
        "terseLabel": "Deferred compensation plan assets"
       }
      }
     },
     "localname": "DeferredCompensationPlanAssetsCurrent",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_DonaldMAbbeyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Donald M. Abbey",
        "label": "Donald M. Abbey [Member]"
       }
      }
     },
     "localname": "DonaldMAbbeyMember",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated Annual Effective Income Tax Rate, Percent",
        "label": "Estimated Annual Effective Income Tax Rate, Percent",
        "terseLabel": "Estimated annual effective tax rate (as a percent)"
       }
      }
     },
     "localname": "EstimatedAnnualEffectiveIncomeTaxRatePercent",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dxcm_FairValueAssetsLevel3TransfersAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Assets, Level 3 Transfers, Amount",
        "label": "Fair Value, Assets, Level 3 Transfers, Amount",
        "terseLabel": "Transfers into or out of Level 3 securities"
       }
      }
     },
     "localname": "FairValueAssetsLevel3TransfersAmount",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_FairValueDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Fair Value Disclosures [Table]",
        "label": "Fair Value Disclosures [Line Items]",
        "terseLabel": "Fair Value Disclosures [Line Items]"
       }
      }
     },
     "localname": "FairValueDisclosuresLineItems",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_FairValueDisclosuresSeniorConvertibleNotesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Disclosures, Senior Convertible Notes [Table]",
        "label": "Fair Value Disclosures, Senior Convertible Notes [Table]",
        "terseLabel": "Fair Value Disclosures [Table]"
       }
      }
     },
     "localname": "FairValueDisclosuresSeniorConvertibleNotesTable",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_FederalReserveBankOfNewYorkRateNYFRBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Reserve Bank Of New York Rate (NYFRB)",
        "label": "Federal Reserve Bank Of New York Rate (NYFRB) [Member]",
        "terseLabel": "Federal Reserve Bank Of New York Rate (NYFRB)"
       }
      }
     },
     "localname": "FederalReserveBankOfNewYorkRateNYFRBMember",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Operating Lease Assets and Liabilities, Net",
        "label": "Increase (Decrease) in Operating Lease Assets and Liabilities, Net",
        "negatedLabel": "Operating lease right-of-use assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Maximum Borrowing Capacity, Option to Increase, Amount",
        "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Option To Increase, Amount",
        "terseLabel": "Option to increase revolving line of credit"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_LongTermDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long -Term Deposits",
        "label": "Long -Term Deposits",
        "terseLabel": "Long-term deposits"
       }
      }
     },
     "localname": "LongTermDeposits",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_NonCashInterestExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Cash Interest Expense [Abstract]",
        "label": "Non-Cash Interest Expense [Abstract]",
        "terseLabel": "Non-cash interest expense:"
       }
      }
     },
     "localname": "NonCashInterestExpenseAbstract",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Initial Purchasers For Convertible Note Hedge Transactions",
        "label": "Number Of Initial Purchasers For Convertible Note Hedge Transactions",
        "terseLabel": "Number of Initial purchasers"
       }
      }
     },
     "localname": "NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization And Summary Of Significant Accounting Policies [Line Items]",
        "label": "Organization And Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Organization And Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization And Summary Of Significant Accounting Policies [Table]",
        "label": "Organization And Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Organization And Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "OrganizationAndSummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_OtherLongTermAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Long -Term Assets",
        "label": "Other Long -Term Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherLongTermAssets",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_OtherTaxLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Tax Liabilities, Noncurrent",
        "label": "Other Tax Liabilities, Noncurrent",
        "terseLabel": "Other tax liabilities"
       }
      }
     },
     "localname": "OtherTaxLiabilitiesNoncurrent",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_PaymentsForPurchasesOfCappedCallTransactions": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Purchases Of Capped Call Transactions",
        "label": "Payments For Purchases Of Capped Call Transactions",
        "negatedTerseLabel": "Purchases of capped call transactions",
        "terseLabel": "Purchases of capped call transactions"
       }
      }
     },
     "localname": "PaymentsForPurchasesOfCappedCallTransactions",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_PaymentsUnderCollaborationAgreementsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments Under Collaboration Agreements [Axis]",
        "label": "Payments Under Collaboration Agreements [Axis]",
        "terseLabel": "Payments Under Collaboration Agreements [Axis]"
       }
      }
     },
     "localname": "PaymentsUnderCollaborationAgreementsAxis",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dxcm_PaymentsUnderCollaborationAgreementsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments Under Collaboration Agreements [Domain]",
        "label": "Payments Under Collaboration Agreements [Domain]",
        "terseLabel": "Payments Under Collaboration Agreements [Domain]"
       }
      }
     },
     "localname": "PaymentsUnderCollaborationAgreementsDomain",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_PharmacyRebates": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Rebates",
        "label": "Pharmacy Rebates",
        "terseLabel": "Accrued rebates"
       }
      }
     },
     "localname": "PharmacyRebates",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_PotentialFutureCommonStockIssuableSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential Future Common Stock Issuable, Shares, New Issues",
        "label": "Potential Future Common Stock Issuable, Shares, New Issues",
        "terseLabel": "Potential future common stock issuable (shares)"
       }
      }
     },
     "localname": "PotentialFutureCommonStockIssuableSharesNewIssues",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid And Other Current Assets",
        "label": "Prepaid And Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Prepaid and Other Current Assets"
       }
      }
     },
     "localname": "PrepaidAndOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dxcm_PrepaidInventoryCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Inventory, Current",
        "label": "Prepaid Inventory, Current",
        "terseLabel": "Prepaid inventory"
       }
      }
     },
     "localname": "PrepaidInventoryCurrent",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_RestrictedAndPerformanceStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted And Performance Stock Units",
        "label": "Restricted And Performance Stock Units [Member]",
        "terseLabel": "Restricted stock units and performance stock units"
       }
      }
     },
     "localname": "RestrictedAndPerformanceStockUnitsMember",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_RevenuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Percentage",
        "label": "Revenue, Percentage",
        "terseLabel": "Proportion of revenue (as a percent)"
       }
      }
     },
     "localname": "RevenuePercentage",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability, Net",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability, Net",
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Accrued Payroll and Related Expenses",
        "label": "Schedule of Accrued Payroll and Related Expenses [Table Text Block]",
        "terseLabel": "Schedule of Accrued Payroll and Related Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dxcm_SellingGeneralAndAdministrativeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The allocation of expenses to selling, general and administrative",
        "label": "Selling General And Administrative [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeMember",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase Program",
        "label": "Share Repurchase Program [Member]",
        "terseLabel": "Share Repurchase Program"
       }
      }
     },
     "localname": "ShareRepurchaseProgramMember",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_SharesReceivedFromBenefitOfNoteHedgeValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares Received From Benefit Of Note Hedge, Value",
        "label": "Shares Received From Benefit Of Note Hedge, Value",
        "terseLabel": "Benefit of note hedge upon conversions of 2023 Notes"
       }
      }
     },
     "localname": "SharesReceivedFromBenefitOfNoteHedgeValue",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_SharesReceivedFromExerciseOfNoteHedge": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares Received From Exercise Of Note Hedge",
        "label": "Shares Received From Exercise Of Note Hedge",
        "negatedTerseLabel": "Benefit of note hedge upon conversions of 2023 Notes (shares)",
        "verboseLabel": "Shares received from Note Hedge"
       }
      }
     },
     "localname": "SharesReceivedFromExerciseOfNoteHedge",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dxcm_SimpleRiskFreeRateRFRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Simple Risk Free Rate (RFR)",
        "label": "Simple Risk Free Rate (RFR) [Member]",
        "terseLabel": "Simple Risk Free Rate (RFR)"
       }
      }
     },
     "localname": "SimpleRiskFreeRateRFRMember",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_StevenRAltmanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Steven R. Altman",
        "label": "Steven R. Altman [Member]"
       }
      }
     },
     "localname": "StevenRAltmanMember",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "domainItemType"
    },
    "dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Achievement Of Milestone",
        "label": "Stock Issued During Period, Shares, Achievement Of Milestone",
        "terseLabel": "Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAchievementOfMilestone",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Achievement Of Milestone",
        "label": "Stock Issued During Period, Value, Achievement Of Milestone",
        "terseLabel": "Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAchievementOfMilestone",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Benefit Received From Note Hedge",
        "label": "Treasury Stock, Value, Benefit Received From Note Hedge",
        "terseLabel": "Shares received under note hedge upon conversion of 2023 Notes"
       }
      }
     },
     "localname": "TreasuryStockValueBenefitReceivedFromNoteHedge",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dxcm_VerilyLifeSciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Verily Life Sciences [Member]",
        "label": "Verily Life Sciences [Member]",
        "terseLabel": "Verily Life Sciences"
       }
      }
     },
     "localname": "VerilyLifeSciencesMember",
     "nsuri": "http://www.dexcom.com/20230630",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "localname": "Additional402vDisclosureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToCompAmt": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "localname": "AdjToCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AdjToCompAxis": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "localname": "AdjToCompAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "localname": "AdjToPeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AggtErrCompAmt": {
     "auth_ref": [
      "r675",
      "r686",
      "r696",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "AggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "auth_ref": [
      "r678",
      "r689",
      "r699",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AllAdjToCompMember": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "localname": "AllAdjToCompMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllExecutiveCategoriesMember": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "localname": "AllExecutiveCategoriesMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllIndividualsMember": {
     "auth_ref": [
      "r682",
      "r690",
      "r700",
      "r717",
      "r725",
      "r729",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "localname": "AllIndividualsMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllTradingArrangementsMember": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "localname": "AllTradingArrangementsMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AwardExrcPrice": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "localname": "AwardExrcPrice",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "perShareItemType"
    },
    "ecd_AwardGrantDateFairValue": {
     "auth_ref": [
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "localname": "AwardGrantDateFairValue",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AwardTmgDiscLineItems": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "localname": "AwardTmgDiscLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AwardTmgMethodTextBlock": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "localname": "AwardTmgMethodTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "localname": "AwardTmgMnpiDiscTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "localname": "AwardTmgPredtrmndFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "auth_ref": [
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "localname": "AwardUndrlygSecuritiesAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "AwardsCloseToMnpiDiscIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "localname": "AwardsCloseToMnpiDiscTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "localname": "ChangedPeerGroupFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CoSelectedMeasureAmt": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "localname": "CoSelectedMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_CoSelectedMeasureName": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "localname": "CoSelectedMeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "auth_ref": [
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "auth_ref": [
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "auth_ref": [
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "auth_ref": [
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "auth_ref": [
      "r675",
      "r686",
      "r696",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "localname": "ErrCompAnalysisTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompRecoveryTable": {
     "auth_ref": [
      "r672",
      "r683",
      "r693",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "localname": "ErrCompRecoveryTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ExecutiveCategoryAxis": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "localname": "ExecutiveCategoryAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "auth_ref": [
      "r679",
      "r690",
      "r700",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "auth_ref": [
      "r679",
      "r690",
      "r700",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "auth_ref": [
      "r679",
      "r690",
      "r700",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "auth_ref": [
      "r679",
      "r690",
      "r700",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ForgoneRecoveryIndName": {
     "auth_ref": [
      "r679",
      "r690",
      "r700",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "ForgoneRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_IndividualAxis": {
     "auth_ref": [
      "r682",
      "r690",
      "r700",
      "r717",
      "r725",
      "r729",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "localname": "IndividualAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_InsiderTradingArrLineItems": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "localname": "InsiderTradingArrLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "auth_ref": [
      "r671",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "localname": "InsiderTradingPoliciesProcLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "auth_ref": [
      "r671",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "auth_ref": [
      "r671",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_MeasureAxis": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "localname": "MeasureAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_MeasureName": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "MeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "localname": "MnpiDiscTimedForCompValFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "auth_ref": [
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonNeosMember": {
     "auth_ref": [
      "r679",
      "r690",
      "r700",
      "r717",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "localname": "NonNeosMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "auth_ref": [
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "auth_ref": [
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoMember": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "localname": "NonPeoNeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "auth_ref": [
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "localname": "NonRule10b51ArrAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "auth_ref": [
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "localname": "NonRule10b51ArrTrmntdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_OtherPerfMeasureAmt": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "localname": "OtherPerfMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "auth_ref": [
      "r677",
      "r688",
      "r698",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "OutstandingAggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "auth_ref": [
      "r680",
      "r691",
      "r701",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "localname": "OutstandingRecoveryCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryIndName": {
     "auth_ref": [
      "r680",
      "r691",
      "r701",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "OutstandingRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "localname": "PayVsPerformanceDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "localname": "PeerGroupIssuersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "auth_ref": [
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "localname": "PeoActuallyPaidCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoMember": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "localname": "PeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_PeoName": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "localname": "PeoName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_PeoTotalCompAmt": {
     "auth_ref": [
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "localname": "PeoTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PvpTable": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "localname": "PvpTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PvpTableTextBlock": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "localname": "PvpTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "auth_ref": [
      "r672",
      "r683",
      "r693",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDateAxis": {
     "auth_ref": [
      "r673",
      "r684",
      "r694",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "localname": "RestatementDateAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDeterminationDate": {
     "auth_ref": [
      "r674",
      "r685",
      "r695",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "localname": "RestatementDeterminationDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "dateItemType"
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "auth_ref": [
      "r681",
      "r692",
      "r702",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "auth_ref": [
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "localname": "Rule10b51ArrAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "auth_ref": [
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "localname": "Rule10b51ArrTrmntdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "auth_ref": [
      "r676",
      "r687",
      "r697",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TabularListTableTextBlock": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "localname": "TabularListTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TotalShareholderRtnAmt": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "localname": "TotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "auth_ref": [
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TradingArrAxis": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "localname": "TradingArrAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TradingArrByIndTable": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "localname": "TradingArrByIndTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrAdoptionDate": {
     "auth_ref": [
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "localname": "TrdArrAdoptionDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrDuration": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "localname": "TrdArrDuration",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "durationItemType"
    },
    "ecd_TrdArrIndName": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "TrdArrIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrIndTitle": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "localname": "TrdArrIndTitle",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "auth_ref": [
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "sharesItemType"
    },
    "ecd_TrdArrTerminationDate": {
     "auth_ref": [
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "localname": "TrdArrTerminationDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "auth_ref": [
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "localname": "UndrlygSecurityMktPriceChngPct",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "pureItemType"
    },
    "srt_CondensedFinancialStatementsCaptionsLineItems": {
     "auth_ref": [
      "r188",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Financial Statements, Captions [Line Items]",
        "terseLabel": "Condensed Financial Statements, Captions [Line Items]"
       }
      }
     },
     "localname": "CondensedFinancialStatementsCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r186",
      "r187",
      "r312",
      "r338",
      "r460",
      "r625",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r298",
      "r362",
      "r492",
      "r516",
      "r536",
      "r537",
      "r588",
      "r590",
      "r592",
      "r593",
      "r601",
      "r615",
      "r616",
      "r632",
      "r640",
      "r651",
      "r655",
      "r806",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r298",
      "r362",
      "r492",
      "r516",
      "r536",
      "r537",
      "r588",
      "r590",
      "r592",
      "r593",
      "r601",
      "r615",
      "r616",
      "r632",
      "r640",
      "r651",
      "r655",
      "r806",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r298",
      "r355",
      "r362",
      "r391",
      "r392",
      "r393",
      "r468",
      "r492",
      "r516",
      "r536",
      "r537",
      "r588",
      "r590",
      "r592",
      "r593",
      "r601",
      "r615",
      "r616",
      "r632",
      "r640",
      "r651",
      "r655",
      "r658",
      "r801",
      "r806",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r298",
      "r355",
      "r362",
      "r391",
      "r392",
      "r393",
      "r468",
      "r492",
      "r516",
      "r536",
      "r537",
      "r588",
      "r590",
      "r592",
      "r593",
      "r601",
      "r615",
      "r616",
      "r632",
      "r640",
      "r651",
      "r655",
      "r658",
      "r801",
      "r806",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r186",
      "r187",
      "r312",
      "r338",
      "r460",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfCondensedFinancialStatementsTable": {
     "auth_ref": [
      "r188",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Financial Statements [Table]",
        "terseLabel": "Condensed Financial Statements [Table]"
       }
      }
     },
     "localname": "ScheduleOfCondensedFinancialStatementsTable",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r240",
      "r241",
      "r532",
      "r533",
      "r534",
      "r589",
      "r591",
      "r594",
      "r602",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r618",
      "r642",
      "r658",
      "r807",
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r240",
      "r241",
      "r532",
      "r533",
      "r534",
      "r589",
      "r591",
      "r594",
      "r602",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r618",
      "r642",
      "r658",
      "r807",
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities [Abstract]",
        "terseLabel": "Accounts Payable and Accrued Liabilities [Abstract]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued liabilities",
        "totalLabel": "Total accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r16",
      "r18"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable trade"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r243",
      "r244"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Employee Benefits, Current",
        "terseLabel": "Other accrued employee benefits"
       }
      }
     },
     "localname": "AccruedEmployeeBenefitsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r31",
      "r32",
      "r95",
      "r161",
      "r506",
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r2",
      "r9",
      "r32",
      "r428",
      "r431",
      "r459",
      "r517",
      "r518",
      "r761",
      "r762",
      "r763",
      "r773",
      "r774",
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "Balance Sheet Details"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r399",
      "r400",
      "r401",
      "r530",
      "r773",
      "r774",
      "r775",
      "r813",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "terseLabel": "Equity component of 2025 Notes issuance, net of issuance costs"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r61",
      "r62",
      "r365"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r395",
      "r402"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r99",
      "r330",
      "r454",
      "r768"
     ],
     "calculation": {
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r6",
      "r48",
      "r50"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "verboseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r130",
      "r160",
      "r184",
      "r220",
      "r229",
      "r234",
      "r278",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r422",
      "r424",
      "r444",
      "r503",
      "r558",
      "r654",
      "r666",
      "r804",
      "r805",
      "r815"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r153",
      "r165",
      "r184",
      "r278",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r422",
      "r424",
      "r444",
      "r654",
      "r804",
      "r805",
      "r815"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r251"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r252"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r248",
      "r286",
      "r502"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Abstract]",
        "terseLabel": "Debt securities, available-for-sale:"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r249",
      "r286",
      "r498",
      "r778"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Estimated Market Value",
        "verboseLabel": "Debt securities, available-for-sale"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r246",
      "r286"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Current",
        "terseLabel": "Available-for-sale securities current"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r38",
      "r155",
      "r619"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r38",
      "r108",
      "r182"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash, end of period:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r1",
      "r108"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r756",
      "r827"
     ],
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price of warrants or rights (USD per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r139",
      "r141",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Development and Other Agreements"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementMember": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Collaborative Arrangement"
       }
      }
     },
     "localname": "CollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r118",
      "r660",
      "r661",
      "r662",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r27",
      "r77",
      "r505",
      "r545"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r656",
      "r657",
      "r658",
      "r660",
      "r661",
      "r662",
      "r663",
      "r773",
      "r774",
      "r813",
      "r830",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common\u00a0Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r86",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r10",
      "r86",
      "r546",
      "r564",
      "r832",
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)",
        "terseLabel": "Common stock outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValueOutstanding": {
     "auth_ref": [
      "r86",
      "r546"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.",
        "label": "Common Stock, Value, Outstanding",
        "terseLabel": "Common stock, $0.001 par value, 800.0 million shares authorized; 394.6 million and 386.1 million shares issued and outstanding, respectively, at June\u00a030, 2023; and 393.2 million and 386.3 million shares issued and outstanding, respectively, at December\u00a031, 2022"
       }
      }
     },
     "localname": "CommonStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r33",
      "r170",
      "r172",
      "r177",
      "r499",
      "r513"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer software and hardware"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r79",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r65",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r342",
      "r343",
      "r354"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r342",
      "r343",
      "r354"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue, long-term",
        "verboseLabel": "Deferred revenue, long-term"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r647",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r647",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "terseLabel": "Fair value of outstanding senior convertible notes:"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "auth_ref": [
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.",
        "label": "Convertible Debt Securities [Member]",
        "terseLabel": "Senior convertible notes",
        "verboseLabel": "Senior convertible notes"
       }
      }
     },
     "localname": "ConvertibleDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.",
        "label": "Convertible Debt [Table Text Block]",
        "terseLabel": "Schedule of Converted Value of Notes"
       }
      }
     },
     "localname": "ConvertibleDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertibleLongTermNotesPayable": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.",
        "label": "Convertible Notes Payable, Noncurrent",
        "terseLabel": "Long-term senior convertible notes"
       }
      }
     },
     "localname": "ConvertibleLongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayable": {
     "auth_ref": [
      "r14",
      "r133",
      "r826"
     ],
     "calculation": {
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable",
        "totalLabel": "Carrying amount of senior convertible notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayableCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.",
        "label": "Convertible Notes Payable, Current",
        "terseLabel": "Current portion of long-term senior convertible notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r648",
      "r650",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r102",
      "r494"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndEquitySecuritiesGainLoss": {
     "auth_ref": [
      "r98",
      "r100"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in debt and equity securities.",
        "label": "Debt and Equity Securities, Gain (Loss)",
        "terseLabel": "Income from equity investments"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r39",
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "terseLabel": "Shares issued for conversions of 2023 Notes"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r39",
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Stock counterparties to acquire with warrants purchased (in shares)"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r117",
      "r183",
      "r308",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r324",
      "r331",
      "r332",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r14",
      "r82",
      "r83",
      "r131",
      "r133",
      "r188",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r455",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r119",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Conversion price of convertible notes (USD per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r24",
      "r55",
      "r121",
      "r122",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Conversion ratio"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.",
        "label": "Debt Instrument, Convertible, If-converted Value in Excess of Principal",
        "terseLabel": "Total by which the notes\u2019 if-converted value exceeds their principal amount"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Number of trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Proportion of applicable conversion price (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r73",
      "r75",
      "r309",
      "r455",
      "r636",
      "r637"
     ],
     "calculation": {
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ConvertibleNotesPayable",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Total principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r23",
      "r73",
      "r335",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r23",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate on convertible notes (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [
      "r188",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r333",
      "r455",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r25",
      "r188",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r455",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r25",
      "r55",
      "r56",
      "r72",
      "r73",
      "r75",
      "r78",
      "r120",
      "r122",
      "r188",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r333",
      "r455",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Schedule of Short-Term Marketable Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCompensationLiabilityCurrent": {
     "auth_ref": [
      "r59",
      "r124"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.",
        "label": "Deferred Compensation Liability, Current",
        "terseLabel": "Deferred compensation plan liabilities"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r405",
      "r406"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r6",
      "r125",
      "r146",
      "r416",
      "r417",
      "r772"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r405",
      "r406",
      "r504"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositAssets": {
     "auth_ref": [
      "r757"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.",
        "label": "Deposit Assets",
        "terseLabel": "Deposit assets"
       }
      }
     },
     "localname": "DepositAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r6",
      "r224"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [
      "r535",
      "r537",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r559",
      "r560",
      "r561",
      "r562",
      "r573",
      "r574",
      "r575",
      "r576",
      "r579",
      "r580",
      "r581",
      "r582",
      "r595",
      "r596",
      "r599",
      "r600",
      "r656",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r67",
      "r68",
      "r69",
      "r70",
      "r535",
      "r537",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r559",
      "r560",
      "r561",
      "r562",
      "r573",
      "r574",
      "r575",
      "r576",
      "r579",
      "r580",
      "r581",
      "r582",
      "r595",
      "r596",
      "r599",
      "r600",
      "r627",
      "r656",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r810",
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "verboseLabel": "Notional amount of derivative instrument"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as hedging instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [
      "r353",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r353",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r363",
      "r368",
      "r396",
      "r397",
      "r398",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per common share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r178",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r202",
      "r204",
      "r210",
      "r211",
      "r212",
      "r214",
      "r435",
      "r436",
      "r500",
      "r514",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r178",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r204",
      "r210",
      "r211",
      "r212",
      "r214",
      "r435",
      "r436",
      "r500",
      "r514",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r42",
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r445"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate (as a percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued payroll and related expenses",
        "totalLabel": "Total accrued payroll and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee-related Liabilities, Current [Abstract]",
        "terseLabel": "Employee-related Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccruedPayrollandRelatedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r809"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized estimated compensation costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r10",
      "r150",
      "r173",
      "r174",
      "r175",
      "r189",
      "r190",
      "r191",
      "r193",
      "r199",
      "r201",
      "r215",
      "r279",
      "r280",
      "r341",
      "r399",
      "r400",
      "r401",
      "r412",
      "r413",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r459",
      "r517",
      "r518",
      "r519",
      "r530",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r764",
      "r765",
      "r768"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "negatedTerseLabel": "Realized (gain) loss on equity investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [
      "r437",
      "r438",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r437",
      "r438",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r71",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Hierarchy for Financial Assets"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r322",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r438",
      "r465",
      "r466",
      "r467",
      "r636",
      "r637",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r437",
      "r438",
      "r439",
      "r440",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r322",
      "r356",
      "r361",
      "r438",
      "r465",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r322",
      "r356",
      "r361",
      "r438",
      "r466",
      "r636",
      "r637",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r322",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r438",
      "r467",
      "r636",
      "r637",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r322",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r465",
      "r466",
      "r467",
      "r636",
      "r637",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "verboseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Fair value, nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r457"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r287",
      "r288",
      "r289",
      "r333",
      "r339",
      "r433",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r512",
      "r633",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r791",
      "r792",
      "r793",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r113",
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Sales-based milestones"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Amortization period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [
      "r552",
      "r556",
      "r561",
      "r575",
      "r581",
      "r597",
      "r598",
      "r599",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign exchange forward"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r158",
      "r292",
      "r497",
      "r634",
      "r654",
      "r796",
      "r797"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r101",
      "r184",
      "r220",
      "r228",
      "r233",
      "r236",
      "r278",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r444",
      "r631",
      "r804"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r11",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r6",
      "r51",
      "r115"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Impairment losses"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r96",
      "r135",
      "r220",
      "r228",
      "r233",
      "r236",
      "r501",
      "r510",
      "r631"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r293",
      "r294",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r294",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r185",
      "r404",
      "r409",
      "r410",
      "r411",
      "r414",
      "r418",
      "r419",
      "r420",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r138",
      "r147",
      "r200",
      "r201",
      "r225",
      "r407",
      "r415",
      "r515"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r76",
      "r759"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income tax receivables"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued payroll and related expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherDeferredLiability": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred obligations classified as other.",
        "label": "Increase (Decrease) in Other Deferred Liability",
        "terseLabel": "Deferred revenue and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherDeferredLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r205",
      "r206",
      "r207",
      "r212",
      "r367"
     ],
     "calculation": {
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive potential common stock outstanding (shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r47",
      "r49"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangibles, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r74",
      "r137",
      "r176",
      "r223",
      "r453",
      "r570",
      "r664",
      "r831"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r104",
      "r328",
      "r336",
      "r638",
      "r639"
     ],
     "calculation": {
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "totalLabel": "Total interest expense recognized on senior notes"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r106",
      "r329",
      "r638",
      "r639"
     ],
     "calculation": {
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Contractual coupon interest"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.",
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "terseLabel": "Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes"
       }
      }
     },
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestOnConvertibleDebtNetOfTax": {
     "auth_ref": [
      "r203",
      "r208",
      "r212"
     ],
     "calculation": {
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAttributableToParentDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash.",
        "label": "Interest on Convertible Debt, Net of Tax",
        "terseLabel": "Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes"
       }
      }
     },
     "localname": "InterestOnConvertibleDebtNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r112",
      "r622"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r162",
      "r620",
      "r654"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r112",
      "r624"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r112",
      "r623"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandAndLandImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate held and assets that are an addition or improvement to real estate held.",
        "label": "Land and Land Improvements [Member]",
        "terseLabel": "Land and land improvements"
       }
      }
     },
     "localname": "LandAndLandImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Outstanding letters of credit"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r20",
      "r184",
      "r278",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r423",
      "r424",
      "r425",
      "r444",
      "r544",
      "r630",
      "r666",
      "r804",
      "r815",
      "r816"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r91",
      "r134",
      "r508",
      "r654",
      "r771",
      "r795",
      "r814"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r22",
      "r154",
      "r184",
      "r278",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r423",
      "r424",
      "r425",
      "r444",
      "r654",
      "r804",
      "r815",
      "r816"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r14",
      "r133",
      "r826"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Outstanding borrowings"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r19"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Letters of credit sub-facility",
        "verboseLabel": "Maximum borrowing capacity of revolving credit agreement"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r19"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Total available balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r19",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Unused capacity fee (as a percent)"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r156"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-Term Investments",
        "terseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherAssetsDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r25",
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r181"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r181"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r108",
      "r109",
      "r110"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r97",
      "r110",
      "r136",
      "r152",
      "r168",
      "r171",
      "r175",
      "r184",
      "r192",
      "r194",
      "r195",
      "r196",
      "r197",
      "r200",
      "r201",
      "r209",
      "r220",
      "r228",
      "r233",
      "r236",
      "r278",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r436",
      "r444",
      "r511",
      "r566",
      "r583",
      "r584",
      "r631",
      "r664",
      "r804"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAttributableToParentDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss)",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToParentDiluted": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent, and includes adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.",
        "label": "Net Income (Loss) Attributable to Parent, Diluted",
        "totalLabel": "Net income - diluted"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToParentDiluted",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Guidance"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [
      "r834",
      "r835",
      "r836",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "auth_ref": [
      "r39",
      "r40",
      "r41"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired",
        "terseLabel": "Acquisition of property and equipment included in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r220",
      "r228",
      "r233",
      "r236",
      "r631"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r457"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Short-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r457"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r456"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r81",
      "r126",
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization and Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r164",
      "r654"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of other assets.",
        "label": "Other Assets, Fair Value Disclosure",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "totalLabel": "Total other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsNarrativeDetails",
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherAssetsDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r4",
      "r8",
      "r127"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Translation adjustments and other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r4",
      "r8",
      "r127",
      "r169",
      "r172"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive loss, net of tax",
        "totalLabel": "Total other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r166",
      "r167",
      "r277"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Unrealized gain (loss) on marketable debt securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities",
        "totalLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash income and expenses"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Interest and other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesNoncurrent": {
     "auth_ref": [
      "r84",
      "r132"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.",
        "label": "Other Sundry Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaidInKindInterest": {
     "auth_ref": [
      "r6"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Paid-in-Kind Interest",
        "terseLabel": "Non-cash interest expense"
       }
      }
     },
     "localname": "PaidInKindInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r745",
      "r766"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other investing activities"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Purchases of treasury stock",
        "terseLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r34",
      "r179",
      "r245"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "negatedLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance stock units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r85",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r85",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r85",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r85",
      "r546",
      "r564",
      "r832",
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValueOutstanding": {
     "auth_ref": [
      "r85",
      "r546"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.",
        "label": "Preferred Stock, Value, Outstanding",
        "terseLabel": "Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at June\u00a030, 2023 and December\u00a031, 2022"
       }
      }
     },
     "localname": "PreferredStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r760"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid and other current assets",
        "totalLabel": "Total prepaid and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r163",
      "r290",
      "r291",
      "r621"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPrepaidandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from issuance of senior convertible notes, net of issuance costs",
        "verboseLabel": "Proceeds from Convertible Debt"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r3"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Net proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r3"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "terseLabel": "Proceeds from sale of warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r746",
      "r767"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r179",
      "r180",
      "r779"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from sale and maturity of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r747",
      "r748",
      "r800"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedTerseLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r748",
      "r798"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r744",
      "r758",
      "r799"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r114",
      "r157",
      "r509"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r80",
      "r403",
      "r823"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r756",
      "r769",
      "r824",
      "r827"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units and performance stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails",
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r88",
      "r123",
      "r507",
      "r520",
      "r522",
      "r527",
      "r547",
      "r654"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r150",
      "r189",
      "r190",
      "r191",
      "r193",
      "r199",
      "r201",
      "r279",
      "r280",
      "r399",
      "r400",
      "r401",
      "r412",
      "r413",
      "r427",
      "r429",
      "r430",
      "r432",
      "r434",
      "r517",
      "r519",
      "r530",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings [Member]",
        "verboseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r221",
      "r222",
      "r227",
      "r231",
      "r232",
      "r238",
      "r240",
      "r242",
      "r352",
      "r353",
      "r494"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "verboseLabel": "Total revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r148",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Contract Balances"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue from External Customers by Geographic Areas"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r458",
      "r653"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for finance lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred directly to consumer.",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "terseLabel": "Direct"
       }
      }
     },
     "localname": "SalesChannelDirectlyToConsumerMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred through intermediary.",
        "label": "Sales Channel, Through Intermediary [Member]",
        "terseLabel": "Distributor"
       }
      }
     },
     "localname": "SalesChannelThroughIntermediaryMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "verboseLabel": "Schedule of Outstanding Anti-dilutive Securities Excluded from Diluted Net Income per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments",
        "verboseLabel": "Schedule of Estimated Fair Values of Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables",
      "http://www.dexcom.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Basic and Diluted Net Income per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Share-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r17",
      "r92",
      "r93",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "terseLabel": "Schedule of Availability and Outstanding Borrowings on Credit Agreement"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, classified as other.",
        "label": "Schedule of Other Assets and Other Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Long-Term Liabilities"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Schedule of Other Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r364",
      "r366",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails",
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR)"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r226",
      "r230",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segment and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes [Abstract]",
        "terseLabel": "Senior Convertible Notes"
       }
      }
     },
     "localname": "SeniorLongtermNotesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueofConvertibleSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total vest date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [
      "r364",
      "r366",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails",
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Closing stock price (USD per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StandardProductWarrantyAccrual": {
     "auth_ref": [
      "r802",
      "r803"
     ],
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.",
        "label": "Standard Product Warranty Accrual",
        "terseLabel": "Accrued warranty"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r10",
      "r29",
      "r150",
      "r173",
      "r174",
      "r175",
      "r189",
      "r190",
      "r191",
      "r193",
      "r199",
      "r201",
      "r215",
      "r279",
      "r280",
      "r341",
      "r399",
      "r400",
      "r401",
      "r412",
      "r413",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r459",
      "r517",
      "r518",
      "r519",
      "r530",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r215",
      "r494",
      "r525",
      "r531",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r546",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r565",
      "r567",
      "r568",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r585",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r215",
      "r494",
      "r525",
      "r531",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r546",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r565",
      "r567",
      "r568",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r585",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r10",
      "r28",
      "r55",
      "r123",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Repurchase and conversions of notes (in shares)",
        "verboseLabel": "Conversions of 2023 Notes (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.",
        "label": "Stock Issued During Period, Shares, Employee Benefit Plan",
        "terseLabel": "Issuance of common stock under equity incentive plans (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeBenefitPlan",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r10",
      "r85",
      "r86",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock for Employee Stock Purchase Plan (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r10",
      "r85",
      "r86",
      "r123",
      "r526",
      "r585",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "verboseLabel": "Issuance of common stock in connection with acquisition, shares (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r10",
      "r29",
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversions of 2023 Notes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r10",
      "r85",
      "r86",
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock for Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r86",
      "r89",
      "r90",
      "r111",
      "r548",
      "r564",
      "r586",
      "r587",
      "r654",
      "r666",
      "r771",
      "r795",
      "r814",
      "r832"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.",
        "label": "Equity, Attributable to Parent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r63",
      "r64",
      "r66",
      "r150",
      "r151",
      "r174",
      "r189",
      "r190",
      "r191",
      "r193",
      "r199",
      "r279",
      "r280",
      "r341",
      "r399",
      "r400",
      "r401",
      "r412",
      "r413",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r446",
      "r447",
      "r451",
      "r459",
      "r518",
      "r519",
      "r529",
      "r548",
      "r564",
      "r586",
      "r587",
      "r604",
      "r665",
      "r771",
      "r795",
      "r814",
      "r832"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "terseLabel": "Stock split ratio"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r452",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r452",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r452",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash investing and financing transactions:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r333",
      "r339",
      "r433",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r512",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r791",
      "r792",
      "r793",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Shares Acquired, Average Cost Per Share",
        "terseLabel": "Average price per share (in dollars per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury stock (shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r30",
      "r57",
      "r58"
     ],
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "negatedLabel": "Treasury stock, at cost; 8.5 million shares at June\u00a030, 2023 and 6.9 million shares at December\u00a031, 2022"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r10",
      "r86",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Purchases of treasury stock (shares)",
        "terseLabel": "Shares repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r10",
      "r57",
      "r123"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "auth_ref": [
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Government Corporations and Agencies Securities [Member]",
        "terseLabel": "U.S. government agencies"
       }
      }
     },
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ConvertibleNotesPayable",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "negatedTerseLabel": "Unamortized debt issuance costs"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnbilledContractsReceivable": {
     "auth_ref": [
      "r493"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.",
        "label": "Unbilled Contracts Receivable",
        "terseLabel": "Unbilled accounts receivable"
       }
      }
     },
     "localname": "UnbilledContractsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r44",
      "r45",
      "r46",
      "r140",
      "r142",
      "r144",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [
      "r656",
      "r657",
      "r660",
      "r661",
      "r662",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r203",
      "r212"
     ],
     "calculation": {
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used to compute diluted net income per share (shares)",
        "totalLabel": "Diluted weighted average shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r202",
      "r212"
     ],
     "calculation": {
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used to compute basic net income per share (shares)",
        "verboseLabel": "Basic weighted average shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org//450/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org//470/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-12A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org//1943274/2147483070/710-10-25-9",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org//810/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "https://asc.fasb.org//820/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org//606/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "https://asc.fasb.org//808/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org//280/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(4)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org//718/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org//740/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iv)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(i)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-22",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(4)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(f)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(14))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(15))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(17))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(19))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(9))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13B(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13B(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r667": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r668": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r669": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r671": {
   "Name": "Form 20-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "16",
   "Subsection": "J",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r672": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r673": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r674": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r675": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r676": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r677": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r678": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r679": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "iii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r681": {
   "Name": "Form 20-F",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r682": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r683": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r684": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r685": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r686": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r687": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r688": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r689": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r691": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r692": {
   "Name": "Form 40-F",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r693": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r694": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r695": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r696": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r697": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r698": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r699": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r701": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r702": {
   "Name": "Form N-CSR",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r703": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r704": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r705": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r706": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r707": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r708": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r709": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "vi",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "3",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r711": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "4",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r712": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r713": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r714": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r715": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r716": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r717": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r718": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r719": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r721": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r722": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r723": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r724": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r725": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r726": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r727": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r728": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r729": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "A",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r731": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "C",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r732": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "D",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r733": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "E",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r734": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "F",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r735": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r736": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r737": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "A",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r738": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "B",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r739": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "C",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "D",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r741": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r742": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-11",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "460",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(5)",
   "Topic": "460",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org//205/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(i)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>81
<FILENAME>0001093557-23-000174-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001093557-23-000174-xbrl.zip
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M!6;Y5K)X)C*GDET^/KD58+D-:PO %@?LQ63BN2_$GBK;G1Y0+K&[18_;@+N
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M2ZHC%]P&3;AG0ZG2P&U<HQ ;?@LM>&N5E@5N8PW\T;U4O'/K_Q>B^]?0<ZP
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MN9RL*>9V[4CP=AN+XZXOE3JWEA8XR,\CKU59U<J:9I[3XM4GEUJ&/J@5102
MM@!0?5-61<'$7<VZ4CL)Y1=,[(F"B4)LCE!LMBR8V!,%$X74')_4;%DPL2<*
M)A:;QQ'*3+T$9LM2B;U]E4H4*;L?LIPU.F69NK.]HCA']Y,-K/N%M2_'_:2
MO)WE<>%W62U0O&-/[R@IWA#I=;6EZER"_]&#AVV6@B 1\U^A'T2[I\0Q)1<%
M8YM^LI7)[BO4F63%*5_3F83IE84MZ&@Y^.IZ\&WG,O0\ZACOC /19R\<<XX?
M%U-VP$IR.WPD;W>NQRX$@6<]A6S;]=&](_":M'XG/>R$**<L+_G[G?!WQ$G
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M0X;FK8K(DDB3'+TQD+=OR"WD1LA-9>2F7UQNAJXW)L&O#>LM.'/"<=-T69(
MOB--J/#X\XDFZV)!$H)5<<$J=K96SGFB,=_:U&T,.I4XHRBD1TC/]D<+,LX6
MY).97F.@JSW14$*(3L5%I]C"HY:Z\/1!B/KZ5C7MA/P(^:G.TJ/MVB4"RQ!<
M(E5+*Q3)Z<I4P<(3^9!Q[?LABX2[0RRX-G;QL\!@B>6Z2Y0Q&.M14 </S$@3
M&[ZUTQ8NE:B N),XN-+.(7G(,&K.5S",@N)7XXGMOE/Z&W7HT KN@$]IHJ=@
MB$\4T*P$?-CVKWHN>"-X(W@C>"-X(W@C>"-X<QC>;'#80=PI[BSK3@$_<2>_
M\*M"(F3ZNG(7>L:(^)2=S@Z2M&X_[]F9>O=?VW9S8K,P3Y)</Y?Q>&'\$5H>
M-=,B.E@W;*O63J)+'[\&G."-X(W@C>"-X(W@S2Y3)C(*@R^8)'\C=D@3B^32
M]8/O-!BYJ;8)UDKL]5/VFX1U4F&T[ @L;:[ (@(.XDY^ P[\#5C<6:<[:YOO
ME,2[6+X3F4PHS(_8MA3,^MCG:S,I]J?XVI\2O!&\J2!OBKEI:QK#F&_&^.S"
M_%?H!ZS2ZJ,[*^"$M9NNG;AJ4Z+];H>73/==@NI[G--\']2]!Q=QT.VT-#ZZ
M(0M$"6D7O!&\$;PY"MZ4$9[:RR+9X6F1K&W2 ML4;SX!CW!BXPD%WC!8T#?\
M>:5QJHCZBOT;P1O!FX,<I\QHYIEG16+ZCJF[RSEM=X^'\WPKH _4>[$,&IT&
MNZ>&^^RPM["]E[15JML8:/WM.Y@)L E%('@C>"-X(WBSNP4T(]O@$.MGC[OU
ML[;[=>!L8_4!=[R94W>$L1(1QQ*\$;P1O!&\$;SAS993,EJQPVH?-6#'WC=I
MEE>_,5 4O=47!6RJ  TAMOSRID07+$MJ59D_J:WMWEC42<Q8Z"1F U^V3FH\
MPC"%""$)W@C>"-[4B3?%$DY7VLJL*:7,5IV%]I4SBR#)E[ES/?S@11!XUE/(
M.M(_NG?$HTZ09C0HC8&JMGI\G 83@!+"+G@C>,--3N/^]+#*DQZNP3Y79D/*
M]7WO#Q#.B"NK1P0YTX!MIAL"8J;5U8^Q8:62T36L8,=*5<..E9W2RG*7Q[,#
MQ]T.#$X^ CKY.U643Y4JB6J:^[)!=[]5Z6R7TA53R*:032&;,]E45]H#EMUF
M1M59FYE.?_LV,T)XA?#677@+^:/J2G_";7JLJ=@CMU_&L3DAH4)":RNAA01T
MI0GB)G*)37?;;6'\"ND4TEGN^KG29'&K];/7&'1[[:U*)PH1%2):=Q$M(J$[
M[X*J]M$]A8'5:'EEVS.G;$L)_FM:+X//[)]H'D_>Z6 ZI^1B,JLQ\9XM)QE\
M!_@9_P5'VV&BS=X[I4(T%Z" 328^/4M^.$_*&5H. P![Z'SQ[?ID91YLGM'E
M\U?+#$8(F98<P2;><(J_'%]NL4M+O(FNJ5I+4_2UE^66LN$U75O_T8^>_&BP
MO9:B;/96,=:/Q]KI5P4#BM+J=JHRV"J!H-O2NOV*C%616QVYD^NU&=OPF1O/
M16[MK]R;8FYA>VKJ[=+"Z.7:QG\<>91*W^&^D2]=.28U%[;SU84E/:9B,K#X
M16H[6NP6R>6YK\M[]CSD-+#7G.$9:\O(XR-=.Q*\W<8R6BNN2<[IKD7*#"A%
M[!P>413E#T1&X$/>5EQYYOR10*:0O.ITG)4#8+8GU@1H7COLY[@R0$$,"B*G
M$-DPPG%HDP!T773X9"'_3,+4,T'FK<E\3P,"?S2E*^(Y,%9!TQ)6ZZ3?8::2
M%03-1U WB'7M?'R$92%WS]G?HUA)#C-(4=/,H)K0*<H*W,>J7A."78S=T ER
M$"R5)C4X[)F9-?R=>,9(TI3(SY .?<3S&-."U8S&K@73@C49RTRI+;VD.E/<
M[-QDP&RWT*K:QDSA25=)CM)V1C.$*->&J*:4DK,K!$<(3G4$)Z-*Q_8[EAJV
M&C_I]],*W O)$I)5)<DJEJVS4L-[FVP=36L,T@Y[%3Y0*:1'2$\%UJ6,FF_Y
M9*;=&*A:9_N3'$)TA.A4:.')6W\EGQ#IC8'6W>J8A1 ?(3[567DV./Y;T"/J
ML!S.7MK9)4X7IAI4T$A'QK7OARP8CIV=6:05/@L,!H@ 127*&(RUY*D3X+[T
MQ(9O';J\1DTCX5J>P[W(,&I^"3T@0-1[(8J*7XTGMOM.Z6_4H4,KN ,^I8E>
M%T-\997,X.C@0AWA(PH!"]X(W@C>"-X(W@C>"-X<E#<9'E!R?@R,2OHQ.\6=
MXL[B=PKXB3L%_,2=QWFG@)^X4\!/W'F<=PKXB3OYA5\5SL&DQQ38QE&3=?C&
MO;]IBV^)ON'/F_6./L*>%*)?B."-X,V."XNME,Y=W!N_,/\5^L&8.H'_Z,XJ
M&&#Q@FLG+EO ]!U3=Y=SVNX><QQ\*Z /U'NQ#!IMJM]3PWUVV%O^1NR0INVE
M]QH#36UU2LIA$6 3BD#P1O!&\$;P9@<+Z,IAG,.OGWWNUD\1:1!W5BG24)4L
MXQL:8 ZQ.]XLIB#R/7*J0I&+(W@C>"-X(W@C>+/#6%Q&EQQ8[6?]DU,,_[;<
M&.ARJR].H50!&4)J^>5-B0& 3*%5N!/:VF[,1@6!C86"P#:PY41RP)%RAU)
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M[A_9U;%_I-KII_1D%<(KA%<([^;^J)K7(<VWQ'9 4OME')L3$BHDM+826DA
MU3),WVYCT&FWA?$KI%-(9[GKIU;J^HD'$GKMK4HG"A$5(EIW$2TBH2L"6KI[
MVD?W% 96H^65;<^<LBTE^*]IO0P^LW^B>3QYIX/IG)*+R:S&Q'NVG&3P'>!G
M_!<<;8>)-GOOE K17( "-IGX]"SYX3PI9V@Y# #LH?/%M^N3E7FP>4:7SU\M
M,Q@A9%IR!)MXPRG^<GRYQ2XM\2:ZIFHM3='77I9;RH;7=&W]1S]Z\J/!]EJ*
MLME;Q5@_'FNG7Q4,*$JKH_0K,M@J@:#;TM7*@$!N=>1.KM=F;,-G;CP7N;6_
M<F^*N6506+N]75H8O5S;^ _6F_0=[AKYTI5C4G-A,U]=6-!C&B;#BE^CMJ.E
M;I%8GONZO&//0T8#>\T9GK"VC#P>TK4CP=MM+**UXICDG.Y:G,Q@4L3*X1%#
M4?9 9 (^Y&W$E6?.'XEC"LFK3L=9,0!F>6)%@.:UPWZ.ZP(4Q* @<@J1#2,<
MAS8)0-=%1T\6LL^D*/U,^H0):$5E7M![E=[W-"#P1U.Z(IX#8_4%3;>F:=*P
M1,K4MH*@^0CJ!K'2G0^3L&3D[CG[>Q0RR6$/*6J:/503.D7)@?M8WFM"L(NQ
M&SI!#H*ETN08DH>_4(..GV 9UA3F<R@2)QG$1Y4@K&<D-Q5,$.[)F"#<*SN/
MJ2Y[.$>Y15/_'9@L(<JU-=I3=I"]*P2' R@)P5DK.!GU.K;?N^RIT=YE+^5<
MF) L(5FUE:PRLNIZ&BY)917#$8(C!*<"@K-!.LVJX&"'8$VL.4)TJBXZA7)%
M]7:9N:(]/!4E=UIJ:;FB0GXX0-1QR4\A\=%W[@WA\:43N:V6?8)_QXF:=2Q_
M>.W[(8N%8W]G%F6%SP*# 2) 48DR!F-%>>H$N#\]L>%;HA[B;J+@&:V/F.0A
MPZCY)?2  %$'AB@B?C6>V.X[I;]1APZMX [XE"9Z73 )M_>E1,6C?<!'5*,2
MO!&\$;P1O!&\$;P1O#DH;VJ0#%30 P*G5DJLZBC544I:74MH7A\Z4:@JT#V$
M%\1N2KB%S$KKL]#KX<9263$(C@)X=421Z(W"+V\*A1>[&XDWZRVY5KK3A!M;
M'PGIK@B"A'0+W@C>"-[4B3=%5L4]+8I]F;M%\?AVUBP'F>_0"!6O5C"2B#&R
MZ O%KMQXNT>?\8BHZ[U+9#+QW!=BXT%P"L\[=-J8S$H^8+A^(/;D]NN-FF_&
M^&-7]&+&T]OA]X1[:4*I- 8J5]W1!7SXC<,)WI24);:RY"YEB7TDX6SAS2_@
MV!*FMUV]7H$@(=V"-X(W?/*FD.)=T].\1'VK1?IV-657@(=#\!1:MO>X:K?3
M=X=X[..6U/!T<"H?(D[<*>XL?J> G[B37_A5-_?DTG5@##X6>,2('C:PE&[<
M(%^-(Q%CWV]NR8Q9M\/HY\!ZLND#->#6P*)I*29]O<QR&F+#AD,/4_"&.P]S
MB]VTC82\TQBTM_<V!9"$D O>"-[PR9LR0GP[4\!XJE$3&KA^2-KW2MX#('6Y
MLM=KFQ\3'U1&O]<!EU<:4?.92N'$9>DQ);K%(J2^998+>^2>&M1ZH>97SQU?
MO5'/L'QZ.T2N_!D9ER9,??1]Q:8W[V 1&ZO\\J8,MW>-$,?Z=TZ&V;*Y*LB:
MC.64-5$UHAJ0$>(L>"-XL^OLP14/-S4/81NEJZQ1NL)\X@LW);BS1<$R7VYM
M:+U1L_EOZKEI(%*G.H>CQ;NVV[F,A<TGXE.<V'A"'9\P3- W_)F*75T1!Q:\
M$;SA82G*VB2],/\5^@&F2?J/[H69M(;$KI#73MP/DND[INXNY[3=/1:-]*V
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MW)G%#YBBQ(VR.(*PF;ZLLVF383(SBMZX#M(S@GZ,^S3 8^7&?LI6AZB@RQ=
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M"F(]9;&%; K/D(@\,#F/"6E^2"84%<')L[( B*/XQ[+\A#Z$F(@]Y$VUX #
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M#XYT,E\I2KU$V,(T!K?Z6*+4E:+42\0M3+-W*-6E4U W>U[<?+*\XM5,;G[
MNF3NXUJ@7RBI'9:5+*YL(\6KCJRLP:T)"F57IE9WUWA!MK_$W>YRHMO@[AAP
M5]=&IL1=B;M]R,AN@[LVXNZXLRE/$G<E[AZ5#]X&=QW$7??XE(_>X"[3Y-\P
MRP3^WP\?;XNC 7C@TKSB#L2?F]QB%<9?O"GU\QG]&-Q%6>B+G.XOU,N3, MI
M^NMW;Y;[U'^?Q',PD19@%"'\/@;KQ<)?X26_S&+OVQ+X[D"A<"4+>%V6Y)C*
M"OLM8#PGR4,8%: < WJ)3Q!VXP*]P\@'*^NMKH\L1GMG064=4;F"6 H!T-P4
ML%'2$CCH<<8FQ0Q"\ \EF])B;A*;>EEI8,PH8&/^935C?AK/ '=2!:[>RV<,
MS"G8,OBK5 GBV2Q^2I>9].SJ6\ 3ZYS96PL<YY@*0)R114K?%O_XJ<@^#B,&
M%/:CGU971_-O#4O9;?&O?WH*_6R*'&&D<JX@+$_Q9O'UB'VU1GG\.],=N;JQ
M]6MUI&W];M>R&*=QK8.6W?V=96Q_J=QL#S<[5O6]EFWPFS1J!N[&HS7"VZ,X
M'^^4TMM9XWAVK?#^.DTH57Z'YZ:I\BLP7O_G2?+F]I]Y1!5#'>Y1PW-=\/@2
M?M\3&GNBR0O4<KG%2=DR;\,,7N'MH<C]\"%28/49RJ ?]ZG>:J'W]/&N=54W
MNCKF/D55EP\NO0M^<%40D0AT! )=;Z^3\]:T'3&;ZU*=" U>A"/MVKLY0#D;
M*.RBLO][$'[/W@;A=^K?_(<F<8W/P5('M__K;XZNZ3]=Q*RK%P@WOT(D;2A.
MZ0A)-Y&1C0PY0>_0*T?$J\;%AOJ0LS-,_6P,\QI1]6KQU&DH.CD9SS0NAV?*
M?AM]Z;=Q,7U[.DV<O_:2DH;$^;.+2K,S42EKF'J)< UI]2>3>=;@UCF^CETB
M52^1JB$W\V1(-1[<VL<7 $FDZB52-21-GETTVGT4C:]CJMC7.".S#KS6,CVN
M34K]V2G,.9&?Y@)20;MWY$A<;Y."?S(5Q46]MV-?C\1GB<\-:?FGPN>QVHG*
M+?%9XG.K5/V3X?,IXI?]3M_'OQ'V890S:/$L;X1'Z%&5!K;F4MNFICJQB.'8
M@>432BW35C7[?\;VH%AV;16^@&;#[XW)Q-',B6EZ*@ETQU758#*96+KE.(.6
MU0-_T*<[S\.[ \!\2N((_NGQPNA/ #OOF?]WLS9@K',$@^U1_PZU3THG>N!3
MTW-4V_1]CS@32P-4M2W+435C?$PMP=ESWUUW9&K6(:GOV-Y"/4'.LURVU;*U
M=KMFK>??"9S0&"?),,7K;X9.?&UG#EY;HUVLN+\ T!N3?NN3\CY33 ]4EA2M
M_",/?<Q.VTS56^5A[6BQBS.J[<^H+\\X>U;N_'B!%U8Y[2H#.[C29N_*)=W"
M_W5>N?0A4CYZ63RAB:*KNC9D54GO[[[\HH1IFN.1O_RI_!&/V+<WJE/FLG>Z
MQ?T3SMFFE5_R%#Y,4P44A4D8B?*G'[[&"Q!#CFK]^+9Z54&<P(-1AOJ <I>F
M5&14EI_]%I))..-56@&H'^4WJ?(49E/E/D_A]FB2CI23''_G8;].PU1Y$+0%
MMZ*$(&4C5D,V7R3Q(V571E:/2[Q_YV$"SR3TD8+89/*S<B*O.!$6HA%E4L#3
M6\)SI'R%=2/ZM'QY0MFJ*;R19.*U[),$OO+BAPB.Q2 [IR3-D^5;%;*$>OG9
MK +U<K];M\.^@4,F?"OL%/R^Q^IXQ-!4H"C"B 8!]5@!'D)C 7H;/%@NBQ-H
M^&7#ET&(BJ3R3 E 8T*!-B-6QA=D<*QWP &PD%31K"&NKP]%"1\^@A>1A'/,
MS UCGT.6U?7%*5U9=L@.#O\"5D*0E;#SI/C#>8B2@,,:M*7(9^Q$2:=Q/O-A
M.PI9+&8A  :N.EWP,\$J65P+I%2)/="G$]P=O (1@1V#757Q8I]D=*3\)3X1
M)%["CM<E!F&29LJ_<Y+@S^, OS?8*>!;N-@G@O6,B(%XD[";.&=9 DP))KAH
M %N*/!STDX(BS[GDZ)B"Q%X(@@^"*6Z3 \ J,^7_T*R0&*L'7M?>+TA.U)L(
MC7KX+:"9'[/25_H=T1=PZ!F9!0>GD#$5YK58!>=3.)LI4P)T3)0Y07(#A.+$
MS1!\'ZS;-))&F]>R:40)L HHF#KO;;F(TQ"?>9M0K+I]I,L"UK^OVAGB*M7E
M3\@$-IIGVW^R'Q*L%&>\<.&SIJ^!LO+?_2U16RTMT6DY=GE!'NC-)*'DVPUC
M8F_)[(D\IX,WJR #Z*Q=T:'0[8;'-):T -SXK?D@,A.&<&]SN, $GX(]D)?=
M@#)-T'[_VQZW!KH),Y1_?D,N:]MQ<'%;9BHIYV:P\QJ::^6*N4<?QH1MZ9%6
M.M2] Z5E%J/J5N.%,=:],,3U7,.$;?I.8*JN/]&H9@>^Y1D3G1J>>K 7QI5>
M&+ELYUZ8#4=O]]X7D0QR@/=E=P'D" P1T/OC!1(I4\,_HAZNW#TD=,T!L>%T
MD60DEY7.S-T$5I&'8%4PW\+_AK7!0ODM#*CRQ0LIF"0[B.QT?K\3*>X?(S!5
M'[EO0U?1MZ$Y0^6)*LRL8(X8L.IA-W=S[FQ"IH/5R<S,6H47?O4;:#%12I<<
M:3L4E=]^NU=^P*5GBRF9@+&,X3ZP"W]D*XF??$ #BRT\#_&5/R"K*OP?0P5S
MBW3U)_XP^T/[Z4<XP#3TIG@,4*W0[Q%C.R1T:&S9>KE=],"$*?P,N* 'CZ%E
M&2<AW!C8DFV/RVW1N_PA3S-%X]"UAK@5(J 95MVNVKCJ5<+=)O$SF67/2CP!
M&A&>'?3UA2G[)],AN1.NW"-9GN13GJ0YB9A?9I^SLWNO@)[;V_BMS]M.<:4/
M__VO.&2&N\_%$5CE'I S@>-$B,\/-*)B]?M__(Y;]G,OX^ZO<O(S_#R.*#JG
MYC'VJP)V@;] ."]_DPZ9<ZZ\SZ4C@&*<.$77'O;#H@E:^^%_^$M94/4(-]-+
M4^77/6Y+(;,TYMC@ S'EPJ,+6UQ"9B;0$VXLA_]#1R4CGAR #+]<P)T]HU=/
M7'A"TWS&?<?H_4:<\:HOYQ=8W+3XT8(P>V18MC);:BA#94ZB/"#PPH0*I^_Z
M5<';)[,X]F\FV"P;L8&Y4U/TS,(N'V:YAV[4>1R%69P(UQ###(XV'-40F7Y(
M\\F_*'=#%GL4H !B*7@"-E3#GLX -'PW[AC1+0CIS$?*##/TR/(6:[ H([$T
M@PW^.%(^; ,Z6%PWFU#G6"BH=,FA-/NG5(F9WE9_(>)W< P!R]UPI,+3_ WP
M-<4S[8)9]0+AW#?B"UP0L!LO)(V#[ FA%.21QPF2.<FY;[H1*\O80)X6:+?<
M+,,QDL*:J(O2 $A[[: S F^=UIZ15OG"#^F/G/'A3O&[XO+%G7JKK)H%#!A7
M7>)&!A*%]>GSQ6W$; 6X0>&H+Z\9.1"R*OJ=>J*=WP*]C0FG$TI@Q_#>=X "
M\&>%@\+;YA0$&X\,H+:#GG\,C)!OE.7&<$;.G(B<RVYN_@<13R" 6%P&IAY@
M"KZ1Y'#U29B!R)P\,P\H(%Y^P8SO0\1. 5!/2O:P1CG5_B?P+;9%J8K'0B92
M+J.J[$@!F1X5"-(L#/$I0<JI\H"3(_D-Y6D1 %E&:HI5-\4P$ZIS MPF7P"V
MX <@XU$"/M)AN5!!A@E]P"Z.<?*, 1_ /^0+?(" 0$HF !GZE(*T?((A*A?3
M#[BIE,QH*A@K7!&<&+ 80 3(*Z)VTQ# 4QR@((PB5I@!:M!+%J-_E?%0!AE.
M6B5T*A ! #*.!(<OVOX'(JBP;+6)T@&9&W#H,$JS)"]"$R+:1Y=T>??E7@0E
M;3"Y&./<=<-XKUONBO7_Y&? L 9&\E9(0/R" ,?V13P6^!>HH5/*]U0E%S@\
MU[%2KD)-*(T*).":/;ZN#.'ZRU76,(7IIK2(0]8"%:6HCR3 ^.@$P<L! 0?.
MZ9)-UUT'_%1H R*T,XM39-7\&A9)B*0?+8.RNE,:+EQ/!!C]U]9<Q3SUBQ3"
MC>X!*QFX'_YXO]'Y%G_U"3=0YAVJ2\\HSO!P1]9F)NVRF>L%A#[K:>E/SKT8
MEGPH&%C)>2Z61<!9>* ;\ P4N95(M["$&?,FF'@05KDM)\:H8.M*0!E6[\2[
M#7S;,GW0_^[-MSKGQ4V\I[0N]]4"'+34FJK<HC4C'#>)\X<I.S8&7@M)VK;3
MAM%$*TBM/%#^+D<M]!/3@G@+[C_H$_LJ7:TEBO+YC1^S0 DN7$=D6!\Z-,;&
MT+8W4WQWL&^6ZH"\+6%NC)87M:6F?_.B0*^@)/&F=Y%?\=5NN2P;+DNK2[TO
M+\N;HA!&P;01XUY&MMEQ%T)E K;+H,T0F&N60O%=O_!L6EHZ@K5.J$=08V??
M+%EY@?%^Z+,0/M-I&?LF"\9 A"WG@2J*H?DZ1L_/@9RYF;4W4-&)N+?3S+VW
M2!UF]L)EX->EIR*>H#)%N7X7P8_2E"3/=?*?ZY,)70#FLNLLUUL3X#?*BK1G
M;;YYZL0(^1ALQJUP++B==+I4-LM;;,VDMK07:(7[^Q!YA3#<P:U1D\%?DH7/
MW5!<A9@O9K0P%@H=MJKV5\T#ID)7^ "LD"[%&"I7B3@$>[2Z#":N1&D[6KQ8
M<7]?IYA=K)3?(>0QU_4);?$,D_ *>JW5=S<5]R6+Q$0\6FJZ@J +61.U)+@M
M-;PG)#C,O''LFI$7)<5M)8L#))1PLA>_1+)+8R]DOV'^M ^?/O\O,E_\]&[)
M1=$!$O'\49XERI.I4&3$S,&_S;!BB8H!N@K]6$Q?X(YM6&T&EQX1GA^:,^<:
M2+_+M7<_;$_:U(>"[='PD:4#UP-+).*U507'6P0OP]A/A9_B/0.QF)E8*(=(
M+D>JA+8&DGOHFM;04ITV*B$B%9PDHMXRWH?/U%(_]]"5%'_Y6%+'#-?0Y/V[
MNU7\:&:36_P8J_QQI-RE2II[4_:Z4HL4JP;Y;+:J/=8O.FS)5AO*$=^C@4=_
MPX-_B#*PMK#-&2\3^$<2IW53.VV<+6SI-2/:"K[)HWUH/!8K<A[&5>0=3I^*
M9Z2MOVY3^V;O43;>4_&SO%6T'UN3O?.R9&\,;JVA9IG#L5EC[FXG>WXG/*[)
M8!NN!,'!:D)4UW]LY7MZ(:O%WL?G5+/;,.V%U8*8NDX:W,6-)0_S.,D85\C3
M(B*>9@E!7G:#? T,T6P: _H^8BP-M@"('<X9GP8Y#FQ$V3OO7J9W[TSO-K:G
M=\M,[4O*'Y:9VGW*U-ZLI&G,I>Z 0$[$)&:8W+7T(]>GH#MN"[7K,YV#, +6
M?\<E 8,3]R)K*]H";-E[Z^<)B/ALNI2-UN!V;*YS?84]E)9N\-^950NZKPC4
M%9H^J;QSZ?M)J^$QS*&(4Z:+?6$:UGE<0R\M#>YFLZH6.2?/3+<G(8,(\SK&
MR6[]*V,?TAFWO$;*AX#E',Y$^@Z+;W/7W(87.BU>,F0U9&A%\'<6_LVGHF22
M_AO3:H2;,&*#0'$[8F,L5LJ?9>D?3V&*$='"!"X"Q@^ F%&-+WR.F5*\)'/R
MS)XL-6X\&E<7A=Y>:D6 6_21K(=)BP@L#_ 3_U]Y*E(-\.5%F1M+PWP6"Z?P
M9LP( *P) 0U\^">"/(1U"<#UD5598L"#%PGCCV'C&[;4EO#KKBCXY:+M7NE+
M3/<L,QVQ&'&VU)X-C17_@@Z=1S,LN>7&,%L0D("&+(UH03")BQD6>>3EF$1;
MEBRB=L23A?;)02DP*UZN.U+^7,11G>'-O3ZU%B5'")[3M P"<.=Y@G'\F(\L
M7?X @YGP\CSEP0T\Y]Z;+M1WN&V>Y%H+1<-X22CN4_BY9\VB6^V>LW_IU7L2
M)O\;.<;OO$8>=_HA6N19NJOX"ANHKA9?V0:9C"VJ:6-JF^- =<<V%N&Z8^KX
M$]/49?'59==A7-:R5UQ\98P4I%F%$:U2H=HNRT%>N+]!I2E*M1>*.*R/>EL%
M!BB'@/L6C29^(6EXN2%"T)4*[Q$7IWC.%97N-PQZ*5JEMT E#;":7LXZE+"@
M$ASQ&\4ON0,KCTKE[M]YS,()[ 'N5N3IFZC.,4ROKGZY2M=?A4MQ#:@BJ;H$
MJ]X,5CXW?0.T+ 6;( CGZ*E<)'$ 2@4O)$&X,N<MO,BC7.7/,9UW#_"S5-HY
MJ LB,[2R)] PIKSP)@(-/&%IYQ, T&/1?"4H7B!6WMBVX"4"%*73591=A.G.
M8W@L=)FRB$J93%,\,X]].DLQ<S.AH/@0T,52X)AA (>*RGWR(Z&V42TY N3'
M)HR\< F_05.H^ ,X0S;C"I7X9$(C;XH'4IZQ>@(!0Q=@-*/MDA"?/9+$WT!C
M\"FHI0D'2KENN@ USE]9)RV[0,*G(;-JP/A)4KP,KKZ)&RN,=-@)&?*:CN7!
M\.8 1!.,ZB<LCH5P'?(;39*8J8A,V1Q6?R:6QB49*J3Y!!3+HE2I#$Q5=6$1
MROF+&7]A:>;58I>H)F Z+N+]$F'%Y<(^,+C $OD1[PJ7=Y5H5EB1+M[ 5;02
M= K>01#/0D 0,F/)7ON^FSP01/2-UZ[_/HPPR9C;P20B#]@2:Y5%':8+<_E3
MB)N/42E<F&RI48?M=758#1S#U!W7\,:@! >.,S$=BWJJ3CTRF:C^,1TA7YJ7
M?F51V]DL?F*HP:\]G\,F89&TPD!%ERWNX:!%%RXFOJMB#<5W4HKO"8(8(V.
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M:"292C(]-!BXGZW1Z.:V5(.YN1U]M#F^65*QI&))Q:<,H7;A,3A5+HDD8$G
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M7I)RH;,B9)A@$=*LT&"%5$H7\!M?G !EW-IB?BF^PO1;BO(U]D*F"3/5-EV
M?@BZ4V7/H$][@'CXKMGS4C+CV@EB)&II@ >@I<1/!#0$)HDK2@6N -J,'[.?
MX#D0MC&\839#&*<KDI;M.V1Z CX.R@$%,?V- EB8RH ?PC\RW,<3J*3*A,(V
M_ITSC::RZLJ:$^:S9-N%ZWP6 AZTE$WE V'[- V]*<#U&1>'5PD=_WE4(Z\W
M]$N&F8W$Z&J#XD>UJ-V(JFNH;5++(JI/=<LR3<M47=O77"-P/%^W35<+6@@Q
M]P4Z.;KNR-2L0QHY:L[(54_0P4\NVVK9VC0;3-M?Q2"!$QKS F;(=0IYV4&O
MF@H.:V97FIBF-[;^JV^=]0'X3P2&QW--]Y>C^ZRN>+W64^?6_09?O"GU\QG]
M&)1[$BX"IGE]A9_^,HN];TM/ "Q!4X\L8)$LR>G9V<$1C5W'SDBU].Y)P1BY
MEG,I[4=AL^,CZ/95M=R\@"Y\J#$JA;+8XDA[="F[@-,?U3/V@ML.?B9/J'E2
M7&FC9^6>4;?FQI/7&#S>X]27'AYNZ'A?"GI HM\+'/J#9A^#SV!O)8^U>?$N
MMK,WU<Y*(=LT/[V - U)2U=*2PVI%H?1$G;ELSI/33X=+9V[Q^CY4.&O./EV
M P;((HD]FF[O_OQ:2ZWV%24(QP_1)P[%1OPW![?&^'A1(DOS>H<O^[++=OB"
MQ1QVKUHU7J]E\3Z,PG2*N1MQ[!_&$*^YW<B^#+$ XS\0BHT(CNWES Y:+<C^
M-+U#F'TY8CN$P79L1EUANVQ,<XYBVG##?[^G[#D\X?DZ[<GNP7+I_&)? 0,L
MHHXQ.(-;4]<Z:_?>W<7TO &P)$Q)F-T(\BV$Z8+-JXX[ZQ_\\H2Y&J=>*[78
ME<&Z9Q*,N3L)IC&I92T)QE()-4R#V [536<\=M2Q.U9UWU95.W!U72;!R&6O
M,@GF)?-</B5T04*?Y>U]9+4#(KE$N4M3FJ6;T=J3)[[XW[WY6[&ON\AGNQ*;
MXGNJSWL9JZK,>Y%Y+S+OI2^9'S+OY37FO10"A7Y?T*AF7*L,U[_N<'V#]T2@
MSZ\<>\I:V'5K;:QJ@UO+NIP O4QVD=1S>A?'WM0#QK3I=-TD1*:W'"XNM\8K
M7GW"PA:!4;42UPLCZC#>&-R.]5X-!Y,9+2?EB6T1Q 0$L2^IJ_0%&PGO:$"3
MA-5MSE%4<:_Q8H:%J)MN)YFDL)L+%M"\KP#S$\"2>\MVH#QF;9F]FITC<UI.
MSQ,/1A?,@>JNSZO4"W==]H<(6"-5,O(=Z]YI^(A.:9G]W#H7 Z'XE7RGZ><2
MBG6HS3J?'NU,D,IA[Q"D,2=@3P1Q!K=&!P:SU [WN%\>A_1$'%(JA(=P/@;#
M1HGN MNS.W,#206P/^C1P/?V0@]LJ:2/CS>)^Z?P740*\Z*2FA'OP1)E J5,
MH#QC;*Y(S6GD(CBEU.U.NW[YO$J9\"SIM1?TVBH:N#>]ZDBO^FA\-?1ZZCQH
M>W<>=&->\UH>M.-;KNE2U0T\PW0"W1T3U1@;[D2SB.]10^9!RV6O,@^ZM\T
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M'ICA#FXM:WR\+.Q??EV/V=P321(29<]2QVOG)_B2@8Y,$O]3$ONYE_TEP,C
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M\W((*M<.?_T."D^84A\NYPOG5ZT%+0X^MK?& X6P12ZX6V5<PQ,Z T&QRLZ
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M=_,$\"CV&G(M,)N&R09J7"YE(VM6_ID#4Q-NB?(&\$-A](Z'1Q/ EI'N9R<
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MY:S:!:>#]P>*^HNE@W< @]9<V3%D.KA,!Y?IX#(=_-K3P:L)L]M< 7T87WF
M\T&FAK^:U/"-B,YZ[O=X=VKX>#4U?!LAM$X.=WJ5'+Z:POJ2R>&.^5+)X>=T
M SG6RR2'G]7YXXQE<OA)D\,=^^A 4>^2P_LG-AFP[L$0 XC<(S/__]E[T^[&
MC6-A^*_@*.-<)R\%D^#NB><<>19'B6?D*XVOS_,IIPDT2=@@0&.1Q/SZMZJZ
M&PL)KB(E@.J[)!H2;'17U[[F9YO55F@6$K!+@GKY1*HRL;4\X&].D]^0$GW0
MHV)79-$*J)&]5!CUMY+DFX-O-N*.-I+F5+@@;&S,>L+A7&Z<"/4ZR\_)+R'H
M%A,;PF)FS[I<"GP(53XYGB!R =!,FFIHIN7L\)4HMJ" ;&#(AE%TY.6AO66C
M$&0J(%]:==W),&DEG8PUX3X/:95L1E8V'RL]*'RYLA6R9S;F$VT;E"4.<[1I
M69E&) 9/V!BE%1DE#8$*Y.$(159WX"_M+W_+B'CKX"?F:V3S .'13+4Z+'EM
ML$]& )OC/G(\!#Y1O%XNORI)::R=9?:L U+85#8?:). EB+Q"<7ES$UFAQ01
M['7:7*8>70+=@1S%F1Y<[&6+K!M>O!N4BKI[&1=&?TKFB"VCOL,O>%OA(/V,
M#E-R>T.LX6H-S-:FVU-6\A<6.>Q/XR<O& %RWG$/+_0S"__@L9C*H\R3_/ \
MFNZ8GP$:EZ(^7K:N7CA2]8*EJQ=T]8*N7CA]]4*-JQ&>5&Q0G+[\B]2Z/@6A
M&F$=W8PSH;IV;/4.D]*&+;0C6^9J[4$Z:0\#=>FH,QR5F]/#2-U8._3,]:4@
M5JG/L "(-O2N@N3C'-61:(W FG&14&N'+C!/EPFG&D[Y<L>@C0L<D=)=.H95
M89^8#?ND(N68&$,JU.#HX27@B\?F$?]>_?'6<:.YQQ;?NS[=/_WH;7%U9.BD
M!@'@I1 CBA)?2UX_')J=5A?9?1S"_SOJQ5(2F"0)OHN=DN\&YK"Y_NNFV5K_
M4[WLT9;]CNY-W!U@!^+=#Q<MH.(B!DF<:,UC Z@2J4'Q;!EV^MZ:/QJMHLZ#
MD:AE%!(+'<DY8NU?3$]@N>7W@7>/:O=[8 AN;%RIB78IY:6P^8YHHWX- [[F
M)_?M<. :NH+^E?@\*\8O.';PT)_<$ R,*SBE,Y.E8/CQG8CHT>?277C+9:WZ
M,G2$R^="/;O\]<7?<C,UIPPC+OS>#9+(6Q2W ^S^QHX#,1K7:@G[9]VJF '(
ME('[!2Q2L-!6;+O2J;:9"8NWOYH2XR1AFA*CI*A,A+E<<!8J22I?^@[$I<(;
M6VQRS&S7 Q'5$'Z4U#E-\0O?8/?,]4@ E3E.]E,L!MN:C?X,. '*!&WLD]S7
M9_;HSI+9CT$84K8U"&;X)E[LK5RTT87:-$L" :ER01=OPZE'/$W0=\3@XF,=
ME92H?<XI@J)?@VNYGWT:1>1.W[EXU]U\>ED1* * A7FB::T6DIDK/*?41P$+
M+N^9IYP<F/:*,?&\5U62@CIEL7_"6GHAUR1%W,DA(2E-!CO;*EZ:PBH_WW3M
MFC0L-<5F1&_IM<QE3,P3^"OBA0HTH*\_1%JO4"2I5$W^C0Y0! GL<SE$OY'8
M5_PV,AGA9ER"&BZ/OL)O?_0H5*DN%-@%AVN>PRK (?:<5?CRK%Z@+R619559
M\GH(4PC.^9K047;;@=#E-[+;2!9HT)]2:%(X#DZ-.CMW=JW4J(!2WD+2%?K?
MOEHY3I[NK%<Z#U9(V^:P.SQ<(6VG^JB"$5 +W_$G1]10]T7PX?[1.[JW;T&[
MD9PV^EM!)]W[B-+Q>,)#;G7&T)%(65/E-:MJ]OKK&S'[CTD(8LRYE!L<V=QA
MXV-:'L=G7'3FJ_7JT/*E;CNL9!K(4M ((Z^$@?LN@*%I5!<8;TYTY/Q1J>BV
M F=]245W59OKK=-EA8ITFGO!K_:\G\.XP9C^IP;<X&<>QS()5%I3H#9?*HMJ
M+9>W]CM[*0NH)UWTRSW+QR(++&KL/ITJRO'O>7"_-I+PIEPU/PCI2PY]1DC?
MVQWIBV;]V'WDSN5_>1B4(?L .Z4/K);U]DA20//Z7?'=6^;[FM7OS>H%"!7B
MYZ"K'%RK&#^\>-<O"0YJ[G[\N_X:D*LKM79DI/0I+.6L+)FSLE?:^VMEMWS&
M7&S+MH->-FABXMG0,OM5$U3%2.!2J*1._M0L&N@%L,PN[O 19V&63B^=__8T
M4$F+OJSLA>>!^B-.Q;Z13,R'?V!')=%T424DBP<HBH2^]A$%3Z2KUN.R^1]E
M[@CO_YBB>>G:Z+6E'7NP)Q\_^!&_PJ;/QK<RFG#UXVV:E8W^87%:[#88NI1T
M2:7L\%2FDF):(]5.+!V77@4/TH&62IQI.R,>/V QT]YYJ8-3-K<>-#?T:3^@
M+F2P7[G1WKNE!N7-LN(0&0*"*Y 7/P6$QLL!K/J6_4TE:\_D=5 EVI])0'D[
M"_KM;WBQ=S%@:&S\"[#,9U[#^'8D?OJ).Q3<N>5 4_>(3#YEWJ:5H2+@@[>/
MN Y(,L:O6]^(<I]O;;',%24PPSLQ_HJ19FJ4?@/8[%,[N$^B' #PK("HXNF;
M3QFZ4CR57C6#&YAFN"C+C6@G^][><+^J'B H-[J;AYPY-_[_,> [@.VX[U;I
MW;7A[M;=FZRB7:%>.OB/W+>GP"$ED-=3ZM+3NQ%M\48 QHWBYQ^3,# (44=X
MYS=8/0(?WU+=;N').YFP-=OM\??,9XX+//T#QG?"I4?3QZ[@OP#S<@^6K$7H
M^".&.;/C$P8%X=(I@S\6ZX^#*7 9WTI9+B6KB>KP!2"('\Q4'U@!8NXTCL_X
MAOLUC]D3&:DM\='8WG"_EAU[[A6K*C<QO7CJAB6TD][Y!U"[%\:=B[,H#*Q=
M_00"/2IRF-M/NXC"XDJ?;HV? ]1)RJF+29Y(O70 <%FUX1*:K*R*S.TNIES<
M"6*PP/N(6BYFO_O;"7"NH+OVCGJ+/12TS;;5.Q+*%8HWMF3[[+G5/FZUO 33
MX?.E9F:( 7F>0)V?*>,"=A9@797H'3USJ7#'&'/1'N30*^IN/'>9=?&KGT28
M3BPLBO?I5C[QS96H@^:  +%V\L?>>^\]X]Z'N'>K6W*)C;2%L6PI!]3G8M-1
MP(\P2CM;J ;;#I%G0AM9JKC-TK]4E&*CGE[;7$)L)Q&,P.X3+:YWS0^: '@9
M8(#0,1$@_-&-8E'A[ACCA#*2L,.LM[@,'K"3K!/,<%R+396;+J@'H4O%@Y@?
M%9*>1!KC"(F*+)Y+:N* D*?O\(^4";O^4@%HKJT/=>:.LH9-:6\FN>D@+*0M
MK6D](A/2TU>F]:&EYQ"GIEW'+@^I.PG8TL5G"F78@&&8?!\&($5D$@^^RL/Z
ML23_S;=I;_]"Q:2/<XJP(A]$BS/AVQ+%D%Z92X)/-@\7!JCG MFE-;N(AR,0
MK-C=J '?<9] =<^S#N;YJF#137@\!OI@5 D*B.\")CL"'@$U0U#-U[F35J)2
MY6,0.LA7*4\T>ZO !Y6X2N7NZY]U CN1"^+/J.L&B7C,_T.O2'&[&48$H@D>
M?("M/$IO= L\20+((MI(-KA&3P^!$1LL4S!NB4VHH4JN3U]2V *;+H<3+FJ?
M<X8_BAJ<AD&EWJ _N%2 H4J](YZ[2)&WA5DFQ4ZN]>5*5VM.1-G.!'I1%9SQ
MH8Q-Y]+DD%R)?H7\Q@1,H"G)Z5*RHB2T&&U@V*%D0'LEL6YQ"W[@5%=Y16QI
MSWS40:MY\:YKKIM;IE)2<38 *C#X'D'7;CI#@-H?PD\OA9T3JX13,1]!,$NI
M("OAMJ'VQ]0%J<<J2&VO+TC%@XE:NFU5>BVK?Z'+6'49JRYC?5H9Z^XIZ#^#
MXN5]9A25O?*QO1*JO=A9O23]?- Z//U\J(L:];)'+VI<B14>OYA1)@X<4,RX
M,8VZ9QH%8CMNP:*F,[VL+A[>3($_@S(N'$5'I+V7UL-_$PVQ<LZ5>Q9B)2LV
M+G!G44/8WVC;1]*[,,&4'^E4D&%\%Z=:T6!C#,1B) #_6\XL\M'DP_*Y)"QV
MD"X,<,/Y+*%JF):$:'0UTO;D8/^/9/EIN9N(QB'#/@-RL:16\$PH*J9Q[:=-
M'QHE.WV0K;NH?9PX.'I)1-,MBBH_1 DZ2]@$W4AQ"B01HL%FJ:Z:?QUR;+(<
MRW%\E #(9*PE2%(/J_#I4+&D @O:GEM L^68M?5X?)+AS,A]%'%O&JT")RL4
M#PG_!]952H?=U0A/9'P [."85/*>^HI=^[:9I8+0(VD(C,9KN6I<6ZYJFZ+_
M3A[9Q]0%-Z9"07^,F$&^KP;<O><Z:>DA^1'D<^H^%'4H;*$8FW@R-T;*^#T!
MO'#D9$:\\<AU>%K0B'\C3'X%)*0@-*,V>ZK\'1_[5^)13\06049AJU.V;<-+
MN5>Z+0D^2::%]TB/K/$3!]I%7^%];F09X*KXZ?]$:A0OTL+$2VQL/@@7Z,9!
M*)J;$?V*;<,OIFO>)%]#QX@X_P->_7OBV^3A!:"Z?$R/P<H\1J)QV QL? 6-
M% CI@?8$A/2+E@&BH?[Y;UC "6:-;9 1:^T!&;EI/':TS[F1SV!K6A5X%0RJ
M>(9TT_*$(]!],1VE !":* \,1K ]Q%*.3::Q>2WR'(!3RGZI=S/S,-ZX$#V<
M,;TCL>-L5EX9N"A'1_)(JJ]^8*Z(EAAA@L'@^G(NN(@/W*9!8D4D'+O8-)X9
MZ(="ZJ?VD3$Z,.FF=L$]#,[PB6@2S.+L#G%!7H#J_\"[6QWCCL;\"@\]@/UG
MU^:((*G?WEP>XE%&'Q(/RC>$JD+,%DA:,EP,:!C(OITI7TC7+SF\6![0'MG?
M(L.Q77^I)KF)8"01?TMY_+$UNOBDHR0&GH%>!#@GND$90+#(=+%%*YU 7ACV
MC,*^U9Z &KG0(PI@>*E*,$XI735I)@!&$LM9G%\LOQ SQOPA/;L*I*LYYO@$
MQUIW6XX056FS2Y>1OBV*1!]2VHB'1Q,"@7L1?R "KBU!+>'!K^:=68JF,C*Q
M3$:13&B*4::GLQM0EJ>8]@58-M%K5Z$-$+'JE$]@_,Q"@7L"AU;$2J%_V)X2
M9H,4S*3*@5+A@T E>%9@*0:/ 1KH[R"9(_::V]X<!\(#,F7DCN#&Q3$[;LX;
MJF%NXJMFPMA=),!_+0P,&\Z8G-^-2@W] W07.*K(^O73&7BYEZ9:,09K,*<)
M-'"B"53M?2(7V%>,.K0*894K_ X?X_-%=28;4"1(Y]Z=!*'0\3 VF0;*L4MR
MW6>> ,R<@)C6"-'BGJOK0K&P$!VD%U+QS,A"<6YAR1$*4"MZV1DZ=W^RTTV0
M>(X*.>(5$R$Q!ULQ<S7'0,;.,OLE:X"=MH,Q:-90!)@BT@G2:"1%FT.N>NKX
M 4V0)QM0<-4TO0+'[XKLBI7=IU:61.42"RL;710*J#R@X4JL&(%XTB.N1@Z7
MBPAV#'FUFVG(:R_//9A%<*U?V>,'-\+FPP#$$H=]3SOLZ^V:J]>R9^RP[Z->
M09P4:.ZH_OH*B)U4]"-'Q"Q@[')%;)+&I+!'D:\KQG7LFTZ93RAI%SJB?92O
M=:[HE1_5&U/>AKFO,G^R+'FRA:7_@Y*$DF^$BHCE1@E( ^R)IUQ.) ,=%_/I
M(^DZ5(K26!:/8!/!! S[A3BU(]0P:BTH4N-D/IPK\"%&?&A@5HHCNM(BR^2/
M:L@,^J# <&!R()\8*D--W2*AW6%GVXE/Z3H(Z1'W^=C%-#"R!BDA4$X9&"W2
M/>*3H@HYDAW- (PF#=1B0K<JN3\,=Z^=9L>YU;<Z1\<N8\,K3X301T%0)6?+
MD5+$[A)@63>I3E"*H3@[H;<10TN=I$M3S-'^Q*HHT(EHDCDA9(9^HB.=<MH+
M!WT#.R:#DDAJ5KK'<J0"^0VX%',U-"./AD8./7'+-"_@4J0/YU%;S)0E9S8G
M<N#D'(>E&39D@Z?+26('34IG8.V2@=4Y2@96NZTSL'0&EL[ >K8,K,Q\H^F$
M*5^\%<&G]T$41S3@!>NB'=6(O\34&VI3K][&4[V6/6-3;V"F-<+YH0X?J8;F
M?#K+$U>Y)+9BY#G/43H:?Y2:X!T/[X&K9APL_Z8KT S%((V;\6VJ9OY"I?'$
M^%;9G-6L<P=D-,_6*M!*B:<^QE%@B^ $):'<WOT**O4O])\BH2 T%(0%KAIJ
M+HOQB\? S@1E_./=+[_(GAO4$YDBCX+))S,T)?Z+<P)WVE&N^&*EI(+L8E'?
M5'"1I@:.:'40P6N"!_]UM%_N#,VAU3X^>VZ:W6'WH&4W?]=MGT"6Z,V>;K.]
MIG6XE%[M-]U$29Q;+WUT6*?6U%^I;=%GX4OYB+Z4?XS"[]*.U7OTWSX/>-RY
MCSM"0W=>7]L,N:0?<A7O>J4;^Q..N1;[SPI<UB[@VM9'<A=0K5OC#&"X$\H]
MZ?RO',#6/FRZQIU'T=JCZ>7,6XJM/J61_?(]GU4STMU/7?=.I:WAFMFDRNT@
M_0C<*7<S?!1F;$E# JMU\:YM#D\]4*&$WQS4OO1 LE_FH9J>7CL]#4]%3Q;V
MP!MH>M+T](KHR6HV3T5/;4P\LS0]:7IZ5?34.A4]X4!4<[6]<47IZ7SGJF!_
M;JK*$84?]]P+YBMSN_5(%:0%ZU2TT+UXUVH]75D[XF258SOA7B_2;.GB=SC2
M] !IFD^WF#725!!I.J="&DS3MS32G"72=$^%-)@YWWJZ[:,'?^UPY7?<P[X-
M#5E*(CK3, =[^^)4"\RNUR,>5U!_RXC'PU%_B.G\1YOS6R'+7B--<\N$Q(.1
M!NN(,7U7(\T9(LVIXE_MUL6[3N=H#GN--%5"FE,%>=K6Q;MVU^Q4"&F.Y"@3
M=V^95K>26IH8S[HM6WM?S;C8W+--S3T3S+-6QWAE[O;C@Z7NK.14)A[6FK:'
M3Q\0>_0;>V&O@J983;%/H]A36:;M#E"L9:[.QM,4JRE64^Q3<K).1;'=BW?]
MSM%\[YIB-<5JBB6*/9DCKW?QKM<Z(ZVXI$A^0Y>?JI=P7\6EH_P*;;Q4.[4E
M ]W&DO;\2+^LK%LT:;W[Y1?X&(Q\^/J80_MV*L;_$M!H3.Y<86OEB)P-^>^Q
M1.-+$/\_'F>E^ME*XD<TAN_KE/DW<]D2:[\!@6V,%/>MDGY9JI@O';&*W@Y;
MPG'$\UVJXBFU1<>+Z1_>#/:%FS.(9A,&@=6XP@9D^=X3=6LQ2.//R7N%*&9@
MXP!CS-P0AR\DU,OU5A$!40-UB178:#A)*'JF[]XJ;2_:L5I;LG?7]*X(0R8[
M1/^X6&G00_<F[C ;[[U"'O]')[SV1<<+HKA/ )7_0Z"44<?@XET+<+J]F3KV
M//T6S;,ZIQ]>O!N6*++J[ TUJL6]Y]ZBMH1/P#1N^3SMYQ$&DY")P<]?L6\D
MMK^GIZ+:\@/5V-_J$=5:#8,!G>/DZR2>!B&Q<3&+/N;I,)T? ^2%.)/#!6Z/
MDZ_SCY-<F,_#X)ZF I"7'# B!>-<@A%^G\Q1:.Q))H4TS.LOGU;H!+NP9-<F
M;^TJW> 5361O[2L1.TVPW[ 1R9:AN1)&.&DF9GXZ:"C "X6-->1XZP)$B.X,
MV3[<#PP:'(R\UR\.ZC&^1>8K)_"LPT\UD\>4N"EF/60[R+W9R0UF7XON(RZZ
M6RJ,IPN-S-RCZ1#SPFMV6)IF0^&(**=DS%4#&X-3PW%@=O!,^ >/<9@/]M^\
M!P !DOI\$LC1 <61W"'-CZ?^[#,.%^]@NQ[1]EZVV,SU@#68;8/J79B$+2:8
MR_XYV)P3D 6^@8=O$U#96\W196N J#Q+O EM(#ONQT<X)?!DU!8:N6%&0!3
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M@L")Y"6" '%Q0^[8Y219&<6/ E]J'"R;>$8.<IS>FH[NR*:7N=GE@XK&7(]
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M0SL-HCDZ4,%RBV.R,S^"#A4G8-XM2.V9L874 _#$F7*&\1N #2)I)'B@M/A
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M]LVQK?641IR(;NA_VP$#RB?IX"%J<N%'.>/!(X>V &K7CG [5@V>!HK?H+M
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M#ZX33^7K\C\4 /J^F?V$C:( '0-K?S)CX<3U+^4O>_ Z^0FB;:]X)X@2/"R
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M_I7X7)BM[6;#L)I6&XAM-F<A? <*WUK5H.K'6);-ZRW6WK-;K-LSB_=)Y-N
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M<'>.\+P&8;=EF99\<;E!6.B,7OBR*TA_@\%SX)=MM:4CK]MJGFC#5G.@07$
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M* H0IFK9<35I,W:&3_;[#"0I>V=Y)I/@7$6?F[8K5NJ-<!]NW ,D7ISO^6@
M)YXP@\O8,,/.,+IU)K :6_6[:,'BJN.N=QF?=*MXF(]U(U:>[CP[$PG8WX 2
MLB/!HQJX;1[44[X>JKC>1!O$1$>)JR<.'+/T</F3^@]F-B-70GGJ^ [#=;T5
MC\[N?<H@E'@/00.36A^UZ!OBT'2[>K,:HB&LNEOJE*"$>YIMG,0-#8XL3U=
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MZD)0\/SEJR()&]B2H=\+%S]IB9;[$$/&#0X>V8]?R'Y\R?MQ<"S]U8%YM70
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MI T][D,<!%49[P@GG6P&W>0T]3,?C;$MH.W$F^"[XSZL'F-W/+'#F??J7Y&
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M=C .Q[I-8)&IG4)A;O)ATL:*UXL'CH'E['EI>VO'E2Q=7?2I=#>/ZU&K,H0
MI/YUUQ"9[8H[;X>:MB!W*$=+P..">MY#13+/M:RZ F%&O&MI=SX+G'0K$1)E
M,AV>0)*037 < +/,+]DCC,@PC]["DT6/ZR(12/L;Y9QC.8N6RT@PB3"CS?@B
MM_%U#5]'U]>ZZI2_3!C3'K+!D][OA._S?=;4O.OX!DM3\<& ]%=EJ^!G=&6G
M251;"'?/-E$VF\"'VJ31*)^8QH_@#\9MO^Z2LFNV +PC8O.NNG3*8/"F.^%S
M67"Y/CCM8O233YJPC?>_Y=Y$H:&>^:%6WK4%-._6GN\(_VFW%PT1XRH"<B74
M'PY4JHS./;!5/Y#5_X)7NHX@N+WP'W$P^Z ]T/DZKP=\+,:CD':T6AI3R;F[
M8.42QT;P<$?HNV[6-+R518"SC4T0PZCF:)ODK)&=L=;1-IVOOB_@S3O!FW]:
MP)L+>',!;RX:D;_0#&(\87MJN!*ZS<S#:0^[M43229M&B'^,4GON!#**S25K
M?V\39S/2$#E7*<U;=\Z&QDNFYX1)9X&MI2#_ON9M/JQ(3MI)8%'P_*J#3.&
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M,%D2A"OXKYQHPYM-.S]F#/@E2IE">SJ9./L=RHEB>S/\!_(^H],$,:3NL/K
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MBA UCD0&WJ9KCDY T<0*1Z:H9&*W&9<<?'GF/7!K?9H!W^!)<=JA!^R3S3M
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MV:NJ@G1P1TIYUA/+814%0#+2SAB'AO+7[%I5\30@_ULN7H^%,F645/L\#'R
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M>P^'@9ZCG:KKJE5%,+1. '(HY,FWH6M(X/MX@Q^^^6G$LV"Z-]PWQ!?@TOB
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M>LKCT82+C&^\$%M_ZDM0WB0*:.JL3YB"AJJ..^J?0;B!UAGJ<4\[[,(+\%S
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M)-Y_^)=RQKKSG$T,983)<^*2!*@[5!F-96$:T#T#!A:NB%EFS7BU#E"&(^Z
MWBATS.,;=I4>5O*<DQC*)EW#O$ 58O/,KH@6B'05C#JYGX+,IS\L)6(04<?
MX,JJ4Z-SA8_;\>E6)(&_/9S672O83EQ6OR^H#R#]N&PHRBBBYB&<@+D0DB%G
M1#*<E[>I1I[L*I=5P2 @LD+:6."7Q&S%FIA:>5D1;E6G04] *D2 SU;Z:0\?
M/(0C&TWZLB6O'HO%P&-:^==)Y#P^S$M<Q-&[X'J2*0U-LZ*+%PL"N<#NT4AF
M:Q+W=T#Q;  '%, Y!%5/-:!(FBU]K8HMJ8EES29O'23+-MDKW8P9F5-+BVN0
M=J?LBQ\>DV@32#:*__X_#[]X\'73\O\7O@)'7-'ES!5ITN?^H7V[31@V'TUR
M6+LV#G*>JO;C]VS\TC;@E6M?=]U792+Y&4X:3T_QG\32<C_/<O3.[UJ=N^8J
MP&RF:F.T@PP<@4+4]!:;VEX%^;V+ZPM1FU6/P4M,#W<?X]?)S"[#ALA36[;'
M4BMUBKLH0V9D>4F)+=LLR=NY*UU"0=<OP6=>).:\G"[/.O;Q3IV'(:$CC3_0
M4*ED-8Z.)*@&8LW&Z*!TF8G=^P!Y.X@<+);S5LISZ-09@8YB6SPI*''UN#V2
ML?AAFN2R.-GHD/)+1XU0+E[KJ_E3E^;!-*B%=N_IM%I;W.7L]76U3HI_DA7:
MEMW.QBD1#69Z?/)YP3H%-[3TKE1+5+IQPML8+AH=T;-OOBTDZE!;7,,W&*[-
M<3"<D0'PH,>K90/O@HY>,P9X5Y5@7C:A$WZ'LDXKG2ZM[@9U0+9IH<37N08$
M0]X;CV>T.U/\'B-RI?\H(_@+4%4UQJMVD&4J%1)LC(T$QUB;#W)VQH^W354+
MY)H@?>$H&]H9&G$4&O'9&1IQAD:<H1'_6="(CQ;H/1'Z':D@>DGU:'F[12GZ
M"JXU6LMK*4=]2%C%->!OQ^[C"0=(WSBU+],=\/31A\@QU%G(!>+$W\WSA_'E
MKT7K'M\A/J2]WLH2_9059$</@$MF51# J_DE69\2JLV[G;!9,,5^])N],,.@
MPWJQ)R1$6/2M*@]62*"P6U1R9S"Z<YI%S[X<3FWMAK[JJV72UHFC<[H3/^C'
MX*$F9MGX]H\>/'KD(._1H=:R&]AX:4C R/M\4U?S.$X_4>I\ S"#_3H.W=-O
MGO_T6"( W_%,F;/ZBAKRD''E#AV&X=(]Z/=8>=_):&>DXYA'M'PU7)3A53#P
MPV=+TD#OT*'&931T]!%3"'U/"@17C7KL#IOD$=U<W<G2OYCYMD3:!&MC=QWO
MR\)I=+MML[767_CI2;P+-MHNSZ[Y('PXX?54[YUJR4[)"[ QK_(1X?(I*Q 8
MU4HF2&-F)&NW\X0FCD-G0'^"YAJJ5E.^=5E1I$-QIS8JKKVY/\ST0N1L63V3
MJP64&%>" %S2RB A<2;G)"^(QJ1<QG,.<I]$JNU-);Z\;,O;>D*F3?,.CMKG
M/9@:IR3R7/1]@.7Z4I!IR82B0D19BF;Q1IM,L<9%67,HIT/#K+337M6#2*-;
MW^[&91[6%%# %Z4"%@IMJ;0!U<ZGH[0Y7B#%@C)I%Y4>NFZ45)"\C C(8YBS
MXC?S+ZV&]6Z:T30@T=I))D56"O]5)1I"73$I &I>W*P< _U/<X72G!Q7-?U2
M:NFZN552(9,$U>/[L)]S=639RYDV9CK*4B<G6PF@S2B)FV#^#F<F%;"6YO8
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M%S_CR"JSDPQB>:9&=:^O>*KD5\]11?)\;$GEYMV5)BUJDQI!,X!46)5-JU;
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M013QOHMFL,*1Y;5=,0AXAEMTL*L !PBD,+/GFZ]R4)2.9-81S:$%NL*J3NI
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MSQDG]+JYC1Y37"[3#VI/0Y/OYK?$UW _>QE[ WONR]GCFZ82KD/W.OK53C/
MI'X0]HWD8T22THE,X' <_!PXB-04G)8JJ;\+"\I.U?GBQY2CH%.\9U*K]?K
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M(#6/)[+4+9#[U'! ;=+6L,J=C(#GR:(X6:OY6KJW6=^+]@W UU";K802)8V
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MJWHP7:Q7QSHTY,*X$*:MG&#%@*7^G0%T&<6DBO@\:CA%#P[PJB(#)5^<#5N
M;EW!LE7Q)W$Y96?D\FE^:G5-RXN:4@ ',CF@&(#^R6Z0L>SN7&.!M9[011]4
M 0LI "EQ\-Q<L0!?M][1F160C&HD8![X1D(:8%(!*^P#H[@NJ]0M@\O9G=5Z
M:&H5CD09B,+U"F+(\V +5WT$/$QT&LF#0I^5J@W0=UR&@R6#R-0Z*5T^*H(H
M&H0(9!>&!A7'@DE12Q\O'Y3L-B3DOQ]0=EBAWY.&D+BP \ARE%DR2S/.U]UC
MZT_.P$]0>,>&K[!;9AMT070H<V\>S[P<3'_1K4 ZL U"D:-.=?61TW)L*Z1"
M,7T'8LH*WHKJ@9>5C"FO .CUM!;QK=#ZTW$PM6S!H=%[[5I>6Q+JC(=QC'W0
MA75Y VEKH4JGQ"") 76K431^;D'$^!CVIF;<E-J!<9/J*D<F:UK3'#$F[/!E
M+L5FU2JD2Y=AD\4W#$WWPQ&_0)JRP7&;";-KH$)8.C1CIPV*,XF&!'Z@"(ZV
M))D'-H80'# ).SI66K)>(K20 HI-&_K!3A*_BA> .92.A;JFS>*^SFG$B!*X
M/X U"K&"(J(\(4<5X<L6X[.4K$SE/J(OZ!1.:I"I0V;^TA=B>N>*&GWZX-9/
MPFZ4#QAUVU!GR!FA+.7P^@+QKR08C2 1O;;<K+K;;2FQ":O+0\[S\(SWHB-X
M:"TRENHC*I0-9DP6TB:W<\<,9IC@#QB'EWF@!EY50D-)U+9 %1B@9F&[O=3W
M-02C]1TC%DJ@&FV?K7VPM%L(CKCD>3BT.R$=-P1N5-S =N]):$C+VZ39^_+Q
M9N,$H1F1SQK5AP(G=_9#M+J3YO%")?YQZ4++)+/5Q,<&=L5)2A788(/)UIUX
MOF8AE]J6T%53A*0J\[^A3+-45SN\8>\S""HICY(XPGJ1PC@:[8._2DQ>.E-J
M.40LVUVE(+(MT ZY&A'/BMT67%[ 9HSIJ.'R EQ>@,L+>*%Y =?CG!R8<&%H
M^^ACM6L892 'D.PRW1U90^MEJ' $D91[*A!FZ8$ZS=IBZ@I+C@+8PLJ/T;8T
MNF#U=;ZAT_0>0M,3STXIK%K4^:Q7+E?_,+52:GM+0HSE8]8[?&/-;K$42M:4
M^*:HA"H&T0<'/LB(V;K74NQ!DV)!?8O#N2QMK>F(+:5C6TBEN&Q T5I)_>M:
M=:[6KEQ2+KL*S[WNG14T7:?<WE>YK8!X65W 6<H&J10@9'-9#71#D6G+R=CG
M$0=?,6S'+..3*:44(]PNN,P^B,T;3ZHK.X!P.?Q6(LRJ/AO:-65Y&I:TUP"P
M;* 5DDK<0]22NU0*("L[70ZA5!S=T?RC-&H%F4K('O9OQ3M+=X@L5EW112+O
M:5)Q!"B!!N<LQ/32HHVOT_H+OL)$=:70:#:HX" ;RE7A0;A*4[D($(%ZS\I9
MZ:P7D*YW]P49!WWXX$SFBF&.B.P\J H*)QR:B5(HSXI<2YE< U:M0[[9F((Q
M\(UTEMP$-PA+#&K$'.,R4"NR/)\NTB &J9T$:,6OP;&=GY+6^W!'&O!@E19E
M3C>A'"_NR9(3'/A_W[M;36]UA*)^SW./+2#_1BV@M0\@$038QZJ?:<K?J#_>
M^D$Z%;-X$T1X>/&AM_FW@_V+*K00U]+F1ZY"EZ5I?'Q<[S2[8!UGB?A_7WU8
M&LYU-)P/,K_DVE']N+'\<J/>7/ZH>^W67GN ZT9K)W8'[-:_[S6[>X4=)/=$
M4P@J/\8&%DH*RS:D;UK3[UXS[R*"SJ3%+40O>@IO2K-UEXV-)+M$&/M+4U!U
M%MT$21P1*ZQY5[%. /H%@\^8G/>)\G\*UK0F\ $>L.HI0(6YIV;N(SUWC#J=
M7?U24]U7*!0UC4,(AJ<2G5:S65)^L8A-R=Q(\&Y,\<06 M75>LY)0(O3 *5[
MNA>-( :!9LM@->32XJ]"[POC.<^EF*4@1)2J@J6J\6!&T"D14%EGFL$CJNP/
M2J1#+ K4(@Y%MC8?<FN#CUK?D3!%K+SFDRRP/***G0FOK8*:U5A2M06FWI"(
MM9\EE*"+2<,I5[VBU1,3%C%*%R&K'Y_,,*\-K.@I%FN =3BG'HX9MI""K%VT
MP D<.S]%>UJ%-#&0@QS;6==DQC 9W;[TY,"_!+'W-8%9QN2 L?Z #.I\Y<%-
M'-Y0L$^] 4TQEO@+51!79Z<:$5 <#3@*@ON& 5A5^IOF/5()E$CKN'J!V+0L
MD0^S$$%G: -AI#Y2>8E60Z1^["\VSLRU9L \6KE1,84"5EV8U#&I:#XL8M"?
M8=4$^<,@J1Q</3*+ O]=PP+;&8W7L &)^PYDX+B1+9Z@< $"J+0!(U@JA6)3
MS*!,0[Q,_# 18Y-[ #> @N::2Y\(_R:U9/R$:IRIOD&&19!(NX2Z$*A*9T@\
M4)L1*&Z(D@O6JWI:P'? 2J ;J*C5#<\I2RJ-O3]CRG076T(8\5!N 1,>"1XW
MI8SE9,2BX+^*5=HNQTN>3L'% DK<>Y7Y>1(*DURP6G6X"^2CC0F(^H3+5(06
M0.V]AL6QV&)3 E08\'#I7S%9JNKXB('<<"MG-4?]47##%9(('*OO5B$Q+N,<
M/AU$.LT4O!/BXH".NUQ9"7%N^E--Q/Q5#1*\2DP47 Q4([Y0!D$CHLR'_ 4"
M/YK96\JZW]@\>H?&MCE00R\)'0;9,B>>VDA6:EADW<Q20TDTXT,^PGQ<R@88
M029RAG?9WK<Q2R;*?SS+).X+6A0R/4XU-012Z,JBRKI3<E55V@D6\1$CL /L
M##^0+6 T/\U))SRV8R:XM]C2^2SN /;@1!IC<$*L(U%#EVF1JX]B!G@+1A@L
M\'Q:5"E>BS=8LJ"Z.HLLZ !O]2P27 U*VN11S+&42)(+)(H0:45:**U$8A0(
M ><-,;T*CY7NY"RSN4KTE3QARSZL-\PR-F7O ?(39'PPC@3Y1G"\H41'.E+4
M77#3Q"YH&<3BE)*EKXH%U57FWU!=#Z &6ZF>8L=R76:JQSB 4-- K(.O'2,,
M?$)L &4^/@!-#.:RO0!ZO"/+5VW(8Q4:"64BD^FTK \0.$#G.ZFFFD/$(TSE
M4HR(\E'E'9+[]U$/PY"%5%MPZ$8]TF_179NHC9@/Y8'Q%)4IJ7V$JI12J__@
MBS=MF8SZB,=<$A"].-/,J 2E@JS8:7"A$?B*-4@'@HT"V2/MMI7)WH9VT&R.
M"(-H?XD$0]*Z2BP3L/$F"CH55H(XAYET7J]D6)NDUIV.!^V-C&PIZMH(>>V8
M]SX8!X+ AOIE0!@+7 WA!U&3%FQ5K&P@DP-EB551YBBN;)7-VK6VM)^2^#8;
M&_(60T<_T@;UJ;.:2?56&\R*]YJ@",DF%?"]NV;*Y>VLS-MINKP=E[?C\G9>
M:HN+/\9!B)V]E=D.=G:$+8;0LV/9QS)=1[#"D:S4"2PS@KJ."LT!7).91 A4
MOA1M^MZ"2VL0C\1+N?8V)%S*8O@SRN2K+"BM_%NHP!'"._KC ;;T!#,0.J"?
M8)4Y/<@!R8I11UOTTP5X3, M-IKKRCU2N@E>"L=SR]4+<U(&K$;J<SR4]<XQ
MZ)^JXQ;])*Q&']V*@ 9,H<= 88_ES6TA5B@&>"I$@G@\"H2Z(A;UOW%$7JY/
M+!1L-F"Z,'P1UN*+6,!@.H7A(15O9B&X_)3QG:<<:=1%)UQN /@I.8::[8J1
M36;)M>!CPC(VWL._0 ]&O2YC"L6?1=&,M!=,$A(/W0:A/X0(KP^#2?)Q5*%6
M]2W@KVDHG@=\S0B2,M2_IO$MEI!E;&1"U*6K!YD/^'"(^ 2TS1%S5GY\C/D7
M87R[#S5BV"A7P?@)M3^935%'C$#Q"NW27T5_!"X>2V>1*?PUVHEV*N>AER5F
M(@XZPS7"H5)X&O]$/\8XEKY70=&YBA&+,6J;"" )3PN>2@R!+C@YK34<)H3Z
M-J?JH0Q\@X):E'Q"3RLGD3C;9B[PFJ_UJWJMN.5JA2V*+YJP/[%G^@CHI&9/
M1@#"#0X3!HUV!]2G5P=V#1&AV)'6H'#Z$.YO'"3^/D$3:H^2[A )+S*K5?"E
M&M<0.:7(EP:&:Q)@$1'@6@"KR+)$VC'"_$M5V:]=(1ZG%-+7Z"PX8PA^/P<'
MT1\:ND3R2YG)F3&322:QS\EWAO3TJ;:*$I),3T[!>GSEX"0^1&EA=D@K%S,8
M6!6[M$020,?"*Z'@177=/9_1\$LY2P9C\FV1\3Y1X!F"<T=X7HSY&D1HHU,2
M#1!5NFSUP<%N#\D$\%7Z ;I;!@2)(%?$0O 9L_^RQ(=8G[ZL&UKG@#[M( :.
M$[! Q4GV7ADN,^20B!A*WPBQW5A\^K47LEN(>6'F' E@L\SYDF&QV#4]*WA3
MC+5[TNV'P168JQDW7"F?);F :,_H*)?MH42;'QWYNGF)V&HPUN(@T:UP$\1J
MS, V\Z'8,6=A1DN8LB$73 G?@XE'>3?(F"/@@CY//IN &*L)$2F(JQ$NB+6(
M#P%S]@/MO-8>.CTE9'="HNDT0>W-1I/91F-3OMV"]5Q2,:>A96C6?,WYYD&V
M+'QU7+29T'L\GB2Q( G$T&B;6V"UQ$JH[+^>C_33^Q45L?8?LXHA!B9X"62G
M@2X(+I8:0;+ *H^$R .MSUIJ(JP5[<20'JFMX!LSJU!08LWZEQT1^_0)*@[#
M@%S8FMU1Y%"'_\2:1SY+Z>"&)!2-XX=<J;GY4[A*2'O).ZDC2!%TAI &%L*4
M,IA"'*1F'1^ /5H\/?K< <B38C$3X%LF/4]K8PHFQ:!2T<#@[--6^F@P(:R(
ME=B-MUYLX:G1B4E*A( .S)0YQO)5GNN&:-;,^^HVGGG>U_$/YB:U5Z0FI6)C
MF\PD>1U(M'CQGFE+XB6/E86$9/U%)E! -A( 5D#,7>^IRJ<5G<KT\UDD8TT9
MVL1:QJ.[N0!+CKQ2,2X;I!QR5E.PBBA4+TYR@AAQ*D@$O)("WBIF*Y2>"9F*
MRG0HAK%(7Y?O1;:ODE\0XAN40D)!5Z=?5LP'"'FMN%HXEZFO=B)*I55'RP]
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M>U8=VQ5!5B3I@/(*%D,9V-\F@>< %Y__#JF<;PGD,L9&C-]5QS@MYY]6).F
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MOU%Q.05. ^=)OPK8"7G\*+X(41*5H?KU"P_"Z<=6U)Q*\%M6].;@Y4<K+IW
M)Y3=X4W%:?F6\:RB:LD>P#3D]@37[4>N_,4WZ%=*TPBUXCWOQ:F&>,<[K9%+
M/+%0J;"]69OH(PHRN36*ZK_8#QA165'%Z(H?,!R,?%X%-@G8TT'/DSYA!K3R
MFNX.I.H8W8*CQL< IQ+^C$$J^]9W'^#ESX!_4W65AS]O!U?EJM7AT BWS)2M
M0E!O$R_7TD#4",56]E&B+>S"L9;;MJ'C[%KM!8Z":.+N883$QKK%UZG+ R9O
M 0K5K$+:4*TU0IBBI_:H'@)F&^90 ]7ZNMJZ:K,K9>.IOY=W&$L_H?H$,WGE
M89YD6CTJL=CE<)6)F IJ1QMGR?G:N(SFJ:]*#8D'O>B\DIPOFQ1JOP:GAOK]
M#;B T*W42AY1<(2D*8:H2-U8W4?R#@5S_0V(Y;:9GJ1G5!2M3F:Z+7B\(R\=
MZJMW;@=Z-5K5$H5CN%TUV!4#L &G9.>6!_[G&7";"L"X 9?67\$9%T_H%:FW
M/L!C);7T#9:L+]0#(=$A'LE</W!ABCIJLFE$'%+4ZSN5/!(O[O-ZFN?S:(3:
MBZ=UEA4!D;]1JI>CPGBZ+IOM#.T)MN1V.((-AG9^D'RV3F1]UBAHR^;7/C-4
M(BH2-T+1?##.UT'PO%&*Q>?\?B=C$%<!"X5ZY-W1.V"FD*(*:5/CZCS?TT ]
MXI"VZ91X/5^=@$T640<!'(*4GOJ40$FHN3;/.L[PW[54P(CG?.F-1C WC.><
MEDTHY?R&TKSY/75A:%- DQF"B^+VC1BQGY&MK\[A]A@+B9<ZBA3O@*OJTB.Z
M6-G8K<=DEWI/(R&5RHHJ>10"YYR;4*V\C[H#.B;HV1,*SYJ@[RZBP.)H>0U6
MC1VA12%A;SKEP3/Q%CJL%UD6LFG$:+CB%!,;B<[Z*W@>\'(=BUHW89HJ\,DH
ML=N.?Y?S^MZYX4.HP.B[22H3[^!P<9L)\74V^X0N*E!W[$)Q_6<SIC7"EQH6
MH4S"&'@%DPQ Y1BVGJ<=Q%!ODJJG!!2^7U$EPU)6G;X1@_EU!/4,#&V;WLRC
M=K(JD9)B2&T^V\9YK?4M_;(GA"O>!.^[I>^GNJ=,9Z:%);!-N>YJ5JB:.\=9
M!H8D/?5A+%3A'L;$NX62HF\I35-3DH':"0VKN'=.RV9$:.I#9J\.R_=B%0JC
MCC*2[^U[K^81,KTFGI=:(?!*,I7HI;7JA%2!T0XCDN2U=)NDR3TA IL2_<)%
M3I]US)A>.I-E-XHXZJ?,=?GO9J&N'+H,[0DXH0=]=_5)S5[F2<V*FW;K,VS2
M%EXNM.CK4W#4 !!Q4+;P?@X^#?TU%OCUF.]VC.URU2\ME&_"L3DU\^0,Q@U,
M T%+3FQD&S9T$S/9D\+,(TE#1-]=>FRE?*8>D\;6+%2 B=W6,FZ)K9^0^4)F
MU _]Q7,QJ!3>D?/^5,E^"NX8]@GUC:JHQ?ZP!=9-C1$3]+_JIY66!1L<Z(LW
M?Y;MAU>G;_*^^!4P<*E,;6SKPEV-O?%"#HT=, \J2*P=79NHOG> 7<4?;W3U
M8!./3C@THL8QH.,).MY7 ?KH37\DD0Z<._9YAK,Y&ZNC27WL$U&K\[V:E)(C
M:_,'*)[U-F6[@>/O=-%\XOHMG'-=L=*#-!Z[Z>%L/AY3ETU3S=%S_A4*&7U.
M*>@YCG[J0!W[4,?#<56C<EGC+ H+$.^^^T1FQ>63K0IIJBG+CA\\O03KGUU(
M$3=BQBGK:_GD6H6R$2JJ[\&J[L>K@>I?7"((W!LR+PZGS80[6B(3HMKX#< !
M7X>M25T[3FG[[A(@G?'>$Z%JW@&7X*C#KOJB:N7C*-$38<7\>KLBFU&J?,28
MT"?V?  C]9J,XGSK=;NFI@8KV[?JH1."$S2F_ZD/!51^(*"$O*FS>9+!W4#T
M+V6KT4YTSIFP]'OSRN*IM?DU-H/(.S]IW#TR$'WW_ $C-J:J?+>AQ*ZEYAFU
M^:W?"ZYSOP=XT;OA)>.\/J?O77.F_M2# 17?;C'14>=U!K<#P]-V922-6,@7
M_A:-KWLU^YSHN-+%9<90^:E&_/T'J'[.5]@3\,FG'_X#4$L#!!0    (  &)
M^U;5FT<^'2$  (4_ 0 5    9'AC;2TR,#(S,#8S,%]C86PN>&ULY7UK<ULW
MDO;W^15>[]=%C/LE-9DMQY=Y4Z\3NVQGL]]8N#0L;BC2RXMC[:_?QB$E41(E
M46(?Z=@[E9$MB3[G0?<#H!O=Z/[[OW\]GCSY O/%>#;]Z:GX@3]] M,\*^/I
MIY^>_O[Q-?-/__T??_O;W_^%L?_\^?V;)R]G>74,T^63%W.(2RA/_AHOCYXL
MC^#)'[/YG^,O\<F[25S6V?R8L7]T_^S%[//)?/SI:/E$<JE./W;ZV_F/JDJE
MN/),R."8+IJS%(ID6CK.BZW@*_S;IQ^S4-I$75@Q.C-M\!->^,J<SS$[*%5P
MZ!XZ&4___+%]27$!3W!XTT7W[4]/CY;+SS\^>_;77W_]\#7-)S_,YI^>2<[5
ML]-//]U\_.N5S_^END^+$,*S[K=G'UV,=WT0'RN>_>>O;S[D(SB.;#Q=+.,T
MMQ<LQC\NNA^^F>6X[*1^*ZXGUWZB?<=./\;:CU",3(D?OB[*TW_\[<F3M3CF
MLPF\A_JD_?G[^U\NO++ USP[_@'__ZS]^MF+V70QFXQ+T^[/<=)@?S@"6"Y^
MG\95&>-/<13=4Y<GG^&GIXOQ\><)G/[L: [UIZ?E:SYF3=W<*MZP_.L>3WUV
MCC?'25Y-.O&\P>\WSV[P2*'#UR5,"ZPE=?KNR2Q?^-"DZ6DV/_V7DYA@TOUT
MM%JP3S%^'KT9QS2>C)=C6(RL$3SDG)BMA3-=DV*QZ,"0X377(J3.^J*LVG@6
M.*!.L34N4J?=S;.?-2$^@\ER<?J33JR=2'>\?BU#DI&\6,WG.,]'$%RR6D=F
M1;),Q^B8-TZRG&J(6E@5:^UO0!L4%\>UQ8[G\_QD-B\PQ[7KZ9._H*TSFV5L
M#2G.\Q7:7)Q"FT\\6ZR.C[MG,B3*\>F_K_/9,8VVES-26:]5BN /U3E.&ES_
ME^,T@3>SZ:>/,#_^;;:$Q;MX$O%GHZ!+K,Y[EHH#7'AC90%29:(Z(U4U*09/
M3(!;(.W#!OF-L8%2"V34>/L9YBB$Z:<W@-O+Z5!/?IM-\X:QW)ED= FL2N2I
MKMRPH' 'ARA,]=;X0KXZW IJ'WJH;XP>M)J@(P@:?O.M,6[A*9X;&8-@6>)
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M2"F]52Y0NX+K-]/@/SWMCL796HMG(DH<A@H5!^0\4T7F[$/17I ;CML AN3
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M*\;U+1JBRG)_=),5RO,O:+Q^@M]6QPGF;^OFS1V:Q=O5<K%$. AQ%*7AWMG
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MK<^<29E$NZ32' U1F5 @-9=5N4"=W;,3R$&^2_?$-[/IIY8LN>E)+D5%5LK
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MLM\CD<B5]N#.>!,*B@H_@;\M[Z&+#VQR'^@=\;W>UI<3?O>A$CG@KU!@LQ.
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MF.:J,&]S8B465[QU60KJ(5Z'94B># 4CKJX=!#H@VUY^G\;3LF\=L,5BU?;
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MQ$^3ET?0Y@HRMHF<KS$3[T<OA73*2/(O8O4T#%KZRA0F;0PR%S(&;.NC=B_
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M[>3<04^NJ[?K7P[SN]$0+G_RF;Z:0*KB7G)U$[A=E9-M!_4XU64-E'RS7.<
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MQ8,N;B7"Y,O/_S[OTUDR<XJFKV \_DXH9POL%:X,N4CU.EST3%O-&=A(3A*
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M23$1LD#/LG.I3E SS)?L6"Y)"8DEZ=1\IOEZ.$^/"JUD?YL6ID%GZEK DZJ
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MRL44$J3,'$_$>^Y<;=HLF?:T!>9*_N;#,A]ZWJH3'FPCY\/FK6*LJ7I=F,C
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M0!R0#*0#.4 >4 B4 A5 += $? $Z@3[@&S &3 'SP JP!>P!)P "! +A@TA
ME" Z$#.('<0#$@*)@V1!BJ '(&W08] 3D!W(%>0-"@*] $6"$D#IH'>@0E Y
MJ![T!=0#&@;]!"V -D 'H',L;"QB+"HL1BP.+ $L<2QY+'4L72Q3+#LL=ZP
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MF\]OEMV<825D%6>U94UB_<JZQ\;,IL$6Q%;,-LE^A5V<W9X]E;V+_92#D\.
MXQ5'+<<Z)RVG*F< 9S'G-!<)EQR7.]=[KN^W\&Z)WW*ZE77K&S<6MPBW/7<&
M]Q /%H\HCP-/%L\P+RZO!*\K[WO>"3YB/GD^'[YBO@7^:_P/^)_SU_+#!-@$
MC 3B!;H$4+=%;CO?SKL])4@AJ";X7+!!\$"(6\A**$/HNS")L)(P1+A.>/\.
MSQV;.]EW?HA0BFB(O!+Y*G(A*B;J(5HJNB'&)O9$+%-L0IQ*_)%XE'BW!*[$
M/0F(1),$7%)4TDNR0G)7BD_*2:I(:EV:4]I&.D]Z2>:FC(7,.YEY61;9)[)O
M9>?E;LA9R+V76[S+>M?Z[H>[:_*WY!WE/\G#[MV^YW&O^MZI@J1"L$+K?>S[
MRO<C[@\J4BCJ*:8KSBK=5+)3*E;:4Q91#E1N5<%545>)5YE0952U4BU4W5,3
M4PM6:U<G5M=13U=??,#]P.-!@P:6AII&HL;T0_:'K@]K-0%-5<U$S9E'G(_<
M'S5JX6D]TLK06M46U [2[M*AU#'7*=(YT;VG&ZL[I<>EYZWW59]4WT2_4/_4
MX+Y!@L&\H8!AL&'?X^N/'1[7&>$;Z1M],#HV5C1.-EXQ$3$),QDWY33U,^TQ
MNV[F;-9L3FIN85[Y!/>)P9.B)T@+38OW%L>6JI:9EGM6"E:I5EO6=ZV3K#=L
M9&P2;-9L96P3;-?M9.P2[3;LY>Q3[+<=%!S2'?8=51QS'$^=-)T*G-#.!LYE
M+@0N3USJ72E<G5S;P4Q@/_"P&X];F-N\NZ1[LON>A[K'!T^0IZEGG1<5!DSU
M>W-YAWHO^,CZ9/B<^>K[5OJ1^[GZ]?MS^X?[KP4H!>0'X@1:!7X-NA'T+&@A
M6#[X70@HQ#+D*X05\A*R\E3YZ<=GA,^<G@T\O_T\X?G1"X,7#2\97SY]N12J
M'%H<=C7,(VSBE=2KG-<XKQU>#X8+AZ>%HR*L(WHC;T>F1"*CK*)ZHP6CWT2C
M8VQC!F-%8[/C\.)<X\;CY>(_)I G!"0L)6HDUB2Q)$4D'26;)_>DW$G)225,
M]4Z=?_/@35T:6UI<&C+=/GTLXUY&629#9GCF:99UUDCVW>S2',:<R)SSMPYO
M?[Q3?E?SGN-]2BY>KD_N:IY^7E>^>'[AA^L?(C]<%+@6S'_4_MA>*%986,10
M%%N,5>Q=O/')Y-.WDOLE=:5\I>_*KI5%?@8^>W_>+']2/EZA7O&U4KRRM(J]
M*K.:LCJB!E3C7[-7:U\[7_>X;KA>K?YK@U1#=2-_8T'3C::,9NKFV!;"EI<M
M:&@ ]+C5K77[B]V7I:_F7Z?:#-N^MVNU#W:H=W1W*G6V=<EW0;MENIMZ)'OJ
M>\5[:_M$^VKZ1?JK!T0&J@=%!VN&Q(;JODE\:QB6'FX9D1OY,GI_M/.[ZO>^
ML8=CP^-ZXS\F3";F?UC_6/_I_'-_TF<2,?5T&G<Z8H9L)F668?;]W*VYLGG1
M^>:%^PO]BSJ+4TM62UO+GLO(E9>K)*LI:\QKA>M"ZTT;2AO?-HTW5[;<MA#;
M83OD.YDP+EC5[MW=_CW#O95]CWWT0=0AW6'!T9VCK\>/CF=/7$X0IQ%G=&<?
MX>+PKG.#\S6$+Q(?^>;BUD4#2ATUC79!H]$PX*J\-=C2!K#^A1_04X "@(6%
MA8N%BX^+BT^ CX=/<.4* >8@(KPL1,1$OPKQ9;EZ]5=%3$K\]_7E0T#8.#B$
MN(2DA(2DI+_:_:7"))?+BIR<BOQ7=5F3_UZY? C6__)#6@%R I#GE5!L@!P
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M^W^FPL=>C(TP8GXA_042#*:*=YF[MC=*\F,*D31SH_N)G\Y!UIQO^DIQ>*A
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ME_5P]4X=],A<T&^#QPON_I]SQ7];@11TQUR.5(P6-PWG0P4;5!FU:-A *99
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M;"L2)[ZB!$J5?NJT<6LL6M&O,??H.NUK2]8!O+S&@I5 V2'3[(]S)0^?_LY
MG+&>S*.!-YH7+9 =0GCFUC8:F)I#.,#7KJ&!/B@B' W4,&-/].=D_[-3[.:
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M+!)UE-. .-HX#3HR'?KFQJ#^L#K78#HU>/'$&%;=<L[>%%OJ-"W;_6?>G,3
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MZ,BQE"[-P710*=Y#_+X;>G:"1<^=-C__.#,8MD?(C4+7ED/24NUTRULV3VW
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M_-5*+=,"3HVM>G^4".<CP3#!U4/79.XFW!6^:13^16''E%7Q2TC:B@D5@K%
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M=-[>;!DGT9W/F0SU#7#)DMY%N)MT"P7\OFM7M?#?:, %Q&X0#<!R;ES&#-$
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MBE)NELM4>O^.[A ^6-'7X?]5WN_T>]]\K./O6L!G=T%S_>:@F-.9!-LGAY6
M%$![Z7!V7-QQ-[L"JJ:WA(2'9T*X>!D97CE(#OH%9]S"2<FC#VZ41._!F18*
M]OX>G&'T5$2/";\8:PMW'E][F_4JGB25N(6C,EY?V\,S?@NOS3_GGT%HK"_L
M!&Y7:@MJ6(I%_FE%LX(D"2;!:S8$<VQ4S-F3DQ,O#414NW0[W:^=.E7(&*_A
M:]4AS67Z*ZRT3:T0[F\O^CF5U2[ 0<CLEME8JB"!D1@0/4&P>6(TTH?KV%+8
MY0<J5:\]*K3YZ+U26-, 0")$PTC(2S/R87.",LP<461]X4V=^C7FUF#\#A2V
MVGZ](+_SQ[^J@O+X/3>/;4A,Y.X]R&'Y7:3SQ-$/'VVFSXFDV*W!]93?D2<_
M$H=C%X9WMT!T2*.!V.0Q Y=A9Y278+'L?F=EH&LHM$YJ L1FD41_6(:W((7+
M 'A#QPNNIK]16';X/&^RTF[N#J^+C(,N+!""=OLFO"TM5!_(JN)6-1P[M&)7
M1EW0)Q5N"@2$]OQ7\<KQ->'&]G%=P0T#T>OJ+#P[DG))^NT<7ZS<.XWTF&HO
MG\\0\9J4V#UWV0<2K=\PWCP)S;UE!$J0QE2:#$DIE\40HB"IB!?[#5P#[:!R
M[]D,1,-V<L;&F3*<E]AWE%L"R(>BKA37N!XY]U6\HEJE++'D<Z44%(_F$])X
M8TTI.W,%K+D>,.R2MHA7H %L7G\C5O^;QYQR&P;50[ G=3^]SQ56S?^FB96+
MX%_<D%^]29R*,IQFK>F%MT?3*V7YB?O GM. 9S%K*D;7TU(<D)62_N8ZOAOA
M.I@.\A 2#I+9;TT^T@#[: 'D<_+5-[<[3J$AQ3'E96$Z]"PG@&5EM,_'J?OQ
MR>[@6A+1'N9@T.7HN/&3"I%?4/+EW0IH5<V1!H\B8=Y#5J2?,S[+T (3+ +Y
M/Z>K_/^I*O;M[POX78008H"."&T<I@&H+LH'B'QJ,&)WC^FZ@%0F<41?&N !
MVJ[_VY;J_[]B-0);>P[_3W#RC).81%[?#[:4@9AATY >]&)=+PVXD0D-":'R
MP^J%6H4J9G"U67N/FJ !'S-^<.W!4.\]GS6'XT1/0_IABW4K>U^O]IQ$A\JL
MMJ\[I+ZE 0>R*($(*KRK 4O>).]_J2EI<?L"#8AY-D>M$J$!W3],*F-IP#$:
M$$+U4&L/@47+D+9IP.9GH4^E6W,+?_K,H-9=4S]E*H<;NVJ'<X4S+Y=UF>JR
M+4@DAVGFZ"&.\FF;TS%/RX.">J)5E;<B:C"]#E2W'T0KD;I=)_YV/P6I GSQ
MIODHR7D4:H1I1,3LES;BMHIK_#ZN:]-E</#9-[FD2SG%/-'M$I]=Y5K,-&]^
MN\R:Q?#8>F%7/-L'%@JI7:FU@>8:*X 2;FT7^PSE!W[JWO6 I M5_CXP] KU
M1T!?P$ZXMW@Z*^>#HV]JZ2L83"U7]0^^B5\V87CBR?AM:J[+6-<7-0+_%9.J
MR"DXXP)3*%TYD4X#.#],&<VEG=HO%:H(VD;]=65+8/U1Y?,1HB-PRRM?FQ2%
MI)@CZ?\_]MX['LYUZQL?89-(D28A)$2)!"&(&DP:(A(31(DV273"Z-U,)$BB
M!D&B3:)$$";J8)C1>XG>>^\,AJE^8Y_G/.^[]Y;=LI_GG//^]E_WAS'W?;NN
MM;YK?==:UUI9B4'LQ^+ZD;2Y3^6'!5/J[KKE;P- ==RX0Z<_+'R9G7=#\L$*
M]>J2X,W$_QJ@L3LX_<G\\)]6D!V_*!0Q<P)]/B^R'L<;/632SV/]-3@QM)9S
M)'T/JPX]W>&#9NK1GSYOW*G.8^D.\.ELUTTA>[5\G"'%; VN*,Z/GNZ:')2(
M$SM"-V'/!.;7M^6AE9(5]-]_GDZ&KW+<%G2(6$6E&4K3> HX9*KWSI>CR_3D
M7FA(R]J@DTKY?).\Y\__DS_9%UULI67L(*9R4?3B[8$GPQ%A7/5-Q_UM:RNA
M!Y)\!0,#-5T>>N%.%2&8>=<,X!M;',@1D:SJ=DWNY$UMU2:;7&)7W^6%S/]>
M(!K\.%'/$VR@?FV4>%++_QR3"]<5!_[(/7OHC_N,#GAN XK[Y)5>>>.?=)]L
M(A8L(#<6R4[K0(DQ_98XXEZY8\71$">82WY,R49^D]CH'+YBY)<1R_5E7QCC
M,EH0O%]/+9MG)U]=?_-%X6QA\]Z;="<XL9\RYWM]RQN."%PL0@]WWW0O=#:0
M=<0;)8"/%_%2O*+ *GF$Z1$8;0_I2M9.!6THGV!-5&CS3@6MC8-W>"G@AWN?
MTA*7S%N#6+ UD'D-W)US1UENG;_V0+@$O=Q"835WZBSL^Z7T>5/:SYRG"KA1
MQ4D/8^QD8:\U1P/*Y2W,-6XOZTN5-7:C+*;\XL9Z1,Y'8HD\F4I(X'+P,;G@
M,[J]]:VZ8*^NE@4J@C$98471+"3S70!)DG3APS:@'/1)MP>"I;3;';^RBH*\
M'96TKFT6BS4V^ZA@=?M,VVVY/K!'5KM?XF(*B^% 6R $O2@L-+VDD)SD?"3I
M4D(-NR7SD:N:FFI/TQ@ -*6T3Z40K6'Y+\E+(FI:NCR?PUIULN[L6EOX*Q>\
M)*ZJN__."LDYE3_=P("K&"8T[2]N<8AFFG&,J[&@C#]I](OGG:&4BU=<K$"\
MB)T*R@0D+_-QRH7T#*&VNY2#%[6C'-88T5*DI-UR,KWD5^M *IWQI9#<)%8K
M<CBH=(:(-*/2&9'G<;VU_2U?)[X6)PO5"9<,K\LO^\P,.<3A_(,PE53(SX?R
M_5H?5(8(3[M6H^YB\=2*"P_3K7A*4P%+3]UJI1F>U=*Z"+S>*\4=P';(W1Z4
M W/&?)@P78_0E[M)M0<E5VJ&P/X=)!/$4^#A7=;D=[>7GW#5T-_Q>$!YF-Y)
M\L>A"_EFSL,BM(N#WK%FK*4M^HSD4U0N>A^51-EPV&P4AUCO;>Z:"C2QWE3&
M__-PX5\5GU@,*8?C3ZXC""NY5$MW ?SA$>P%QTH-5FFIT&7E I6(%\!FSR^G
M?UJ__O/M^;/=<GY/>N/*W)S<X?]7XPREJX8OM@'[Y.%.CS -Q+O%7Y:K%]&/
MCP\BN:6:[4+CWS%'Z'C<*MB\ZS57(W\N)-_G@X>#HAJ:^+$8!??=P)=M[=T]
M.6NT@JSB6'DWXRPY!9)0MFYO\D(YB :%>Q;<$^$J&/EA7  [AKE>H8G[$H@L
MTM[HI? M%3ISSQ]_=&6P(!VE-Z0K'Y &-<C]Q<I_2)M[/1.)'=27J'T8-!'Z
M1;5#0; &<-261@H0WG-,X\+Y<T-U!J3 N?OWQR8O'M>PQO.Z9&V!OCT4<\UT
M.1T(G_R-4S<#'"\(^GWG0E+Z!H3JWN<@@Q5JKQAP:3YZ?4N*,_#9M85;B%9S
MA?(C(*?C\#J.XI'4(L</K.;C>S\6=ZA[G':R<=[%:?KSKO3OE"XO Z6$79]J
M;$7X >%_T22[Y)4I\IUS'9LC]Z<)^[U2_*5^6C3>=+0/.CZF"<AIB&0HBH^-
MBCMVI6X#P ZS1<!S%$G/(T5;2DZ%+G=3[E1>DV9_WET?Q;X/T,RTG^M9/<VA
M5ZM2 \<JT*L>P%8\!18UCL_7$*1#E6&<P8EKI$T#]96B-1#\Y\N+ S\#GDC:
M4DKU>I^N8B'Z<HE+BS.B^<:G6@TN!Z3+#P_:+V#<"2R"VIV37NVMB.X.'#:V
M;H3? 7(B@Q<:UZV2&;6F:SB]P)P\X+*:]+6HCMV?]?0M$Y-'K^N5_M'C"H%2
M)23BWM8I&UA&%UEI_MBQ09;I'X6VC(@[.X6VEB?UPKHOE&A;[!3:GIS08KLV
M&&5<+\I0\RZDBFPHXPFREM\D.\UXXES>D17AJ-7Z.1FPE0&N54YV,5$;R"TP
M&E+]2]< !_;!T#D)!X2)(/L/)MU)OUCY=)$N-.*J/,E;=;%0DY8M3O+C\HW]
MSR*YK8\.8N:U/-QL-#3.D >YHHOCAP)0^?G$OB*@MBS3B ?'"V>1'AVE;)[)
MMUBL=/4LSY.#S;:BK@! &C/S?:^,4R*)9W06R9;0$I_R&_M^V"O NXD<W.G7
M?O$;_=IIU\9Q/:O"[^Q29OW;#H;6V7%-;UI/24:Q5KLY82<G0MX Z98>RH.E
M4S\;30Q'%@G7P6/M3#SJCV^T2LOWH82C<XBDWI42S]Z5W?1^';X0EU"7YOIQ
MW^M/>CIFT5>5Z]3]#I\$3"Q%@*38;K!/ PAX?>FTE%[)+;T-^42_6>FQ8V!3
M44C; "8VE% (MH06_Z% P(\NO2.E_]1TG_A!^0I3V1BW<\/PDFET$\JN>IA/
MNJYYX:'U]*38NR&U$./AH44"1[2=B57SX?Q6>\Q6' ;74KD5C7;=NKH;=90@
M!UU&9)N+#5S6.^-1TW_V#BOWS4 A-E9C[37 Q-/^TK)!\*,WBE]M^NOF)\+(
MD"UXFFV>O*Z0%O+R4/X@3R19W04_0)@JJ5C8-=7]8XR4!94;5J[D9VP^$>1?
M=(F_OMY6TWOBL"LGEHD9GZC5"F^Q#PC(:4TQC0^>=+^Y&_6:2UD(S819N3Z6
M<K8F\E9^G98>+GBU:40+(0P63"]-RXYX?=24MW1>Z"/#-#::3V4L7IK5&WF3
M.(_#X.8]0S[.]\A_^MM\_R>;[_.TJQQCJD_1)[L0"V'G_*1L/NHD6O<>@9P3
MTIOB_-CV67D@24+5 1PW=H$H76=MNCCK!:1="?3B>*1E>[M.54N5"+Y+RC#K
M=GB9Z?!TM[6XBS$*.0ZSG''0D8U)RBFXHF$C<>/2$.820,+XV!GE1U]'G;5[
M3)C=WH^3$"ON%!?@_5%/);F3]!L^^?FMD>DI4 @PXI?3L&6%<6'=_164$VCS
M29V)=^ITS0,%$9W&"@<[WA8WPR_=:Q1!<C<U6MJK1ZGT>BV#RZ>]X5HX';?>
MWMR$_*[%<WD4ZI+(OYC@];RP5;J[^S$,_LCQM>Q_$3&8^CE\@5CA6?#&J,4V
M($$=<[U\&W (.!HR$3)HOSRBL0U V&X#VM2&M=5FON$._'L99D((SHO\/FG+
MFFN6\/QRM'Y0V61T[UOLC,S;NJE;-=*-+R67'GC%T@-[/+*W8,);I[N;W,BF
M*G&R;!/QN?T;=E[=44YKNH/ CE_I"V>\TQ?NR#_[PM6(C8>PZU"Y<!B%<C>4
MCS&1RH6=:TY-V#@\]RX%G'C\Z7/%J<Y$1=FV?L+7B:JQ49_GL8-AQ/Z%XFW
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M>AVI"'/C.6MPBD_(Y<%<9P-PF(&+8=R3D!KPF:UR"(>EBTSLN-7 +1UAAL>
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M4K<>WNJ7QNJO*)W5CUA@HWLFRF3#Z!G!U>V()@,UNNOYBW3\K6$RNKBHHFT
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M)LJ1(/FN"M@[G)7KA^$@5''N/I2-JEC@.-]I4:MU]WLX.[6%,&)$R/"7#J]
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MTBZF,D92(\5M=W? '+U_UG;V#%O;N+=SXH.*LZQ\TQ$WL\\HRZ)RC-XW P
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M[.KC_J[+(:6:,U)96RY&O&12#)<JLY(P=^QBL'CMP#0#[5. 8)7: S_F=,5
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MWMV)05L3"\ZB9V@ C!^49EANWXX]FI=[EY"72@S6?J'C?LE?/Z-:Z':79Y/
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M V^?Z[4Q8<T?-+9:5EGPW#"7RYW?T484>.P(+__J@/[#>OB_RGK@2P:6L;;
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MIZ$V!50-#U%15[?8$)%R<A3J!]F6F+$NNC19D#X<U)YG_32<*RZ2]XZV(3;
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MX;'(I_4+"^G:WFT_SGT4,O<3*M%FB7_6Z33Z)GWZXPF;Z "%BWX<]S4LT[R
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MF,2&6PFK1.BVNMQ1!%QA"/)P!Y?53Z:]"1ND&$.7TH!6'25<UI^[SITEI@T
M-Y9W=[%2OZFQSQ3FV,@!XPG5]7=E+K4-?)V@'J9S4NN>Q8ND0ZX80,I TN)E
M1Z&XW(I9:Z/JI[E=6;G#&_9BY)Y(V 7JC_*S[E".USP6HT=U2^X&21 B8R]Z
MB>=IC@[?MKX&:;S,.C$IX]VBY;!7ECE/ _!/N5;K'Q/**K#SR(O6K[#* 95W
MU.R1(?E^KNN2-1=B(7H+)I?O77Q?]_5PROUS(2"@=UCC0SL W3B(Y[Y/)3"Z
M8L9Z4G26&%*PDEZ^)Q7CWUM,2J2>HJ21=28XN*H=LW9DN%9*KCPVADJ"$@ 3
M@;DY*]S?.HX.QCZZCS GZ8")P+?]P3VN9U0QTK7].U7F7JM^T>#X7=:U=U-C
MB>MF*@B)_+7'S&FM)ZY\>]@KS]G)HR81Q/3J7$>%H\+W1U=[&Y^K8LCEZ'E8
M1*R=['H[C@FY5H$T]BC;,EO(M!3'51FG^_XY"G"><T_-3P(:<EU)W3D'FC_2
M52Z0,[WEO?/>Y9P/4TX\AW0GNS92@2^8L%:,=4!W["Y9UW47KQ;TE<(NHUIL
M%PLPA@LYQIZ:OV4A^\[5181%^PFAQ*Y%Z4I#FKWO'7VXI]?&S]3*OL%N,<>4
MK&9[LS:%@6MM%1RT@C;\J3!)?.K1LSWT$L[CJ^YE@\-RGF5#JDN]YMO/;F#P
M?OJ.[/@/N7+5'?L.Q^=SK SOU5IM+T@7BMZX$+)GYL&N[I%CM_3=4:/:8'PE
MH1>YM&HI_VOO:S_0GH6?*;6MPI*QV0DDKSO;3(IB0XOK;JS/KHS>L(6\"W[
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MT8W4U:.3>,>F4OS&=2C1;.P"#? IGP:@'NFB 9H&<6;9Y#X:H Y!2H8/R]$
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M1$*"U1;<<(;DM*NP$K-PGOAGXK OZNLR__,O'N&*WTM0)W-RT@0_I@#HHT"
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MQ5NL^X1-S'!M;FTB,N'.,KD8&0H4/"A&UH\;NC49[=V@"Y%<B,,;,;[C8\S
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MIU>"CK,MPX);DB[:DV*]B\2L M4F0ILQGR7SOSKO6N9O#2_I[6+3#JQW<RA
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MIN;ITM8R,=<2F)'6.S'9^R(-_*>(TE%GBJ6O&F)?[! =%JL-XKH\X9AQV%1
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MG'MRWM!OB8G+.*?(8@4L/I'1D_Q9/L_ZB!O/$ZH)=-C5:INW*EDRC@9@1RQ
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M9GD7M)[(9- DQ-%MIE#H7^H=^E[M7ZZV9U=B\^KJ"$:J2=C"[-2LI+KH$\<
M>4E5/D)B>(X\DSSOWK3GW=K;N#-]<S'261_6A9;)TU-3N:!UTB!!4"RJ1>XO
MA@=71,3;\[.3\2*MQ$-NTXBF_4KM:.W6I49\&,JA(RTH4##0E(#TKICS?O=3
M=2PGR45C]Q$\,\ZIPKYD\??CU_[U@BG6CWX\[LQ9H![@><7$!5CZ';C)$ I(
M7MO[_='W1_\_'X7=9.Q@H0W\%U!+ P04    "  !B?M62PEDFF.7   -V0
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M7NLR2=CSSB<>$07M)47R7]7^2;/_F&)Q_RG-_D_%_H=>L\!^-A9H\M@$ !A
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MD6[[Z#K^D&I("[E0@OX;VX<%%9@ K1RWC*8G(?V90-GNN2P/B/\A%%-9(-\
M,$8ZU< YJKKQ:S\)"%!W_7^FWFU_ZV$U8FTTOK _;]^%N5(+=LN=1%?VU^/E
MMU6W94G!_,3X%?BL%<5B$B6&M)I2^OP3DY1?JA?=]"),.=)G0BFCL>K=8*[W
MR3$Q)5 ^(XP=4PXCO.C4AYQD;_"T_?)N.M(Z2DKD$U)_LF9%\PVKQ7IC]CXY
M\6_?AR3XPX5_,P$(J5A0P[66)#L0G!(A\D%[P=[IT]UMBS0:]NPKIVS+YW\2
M.Y)ANSQL+_X,PF/P?\U2_W]KE@<O_H59UKV6;';L7Z+P4! .3L/4?\.2.='[
M>T]G=#B@Z95!Y>H3; =>*'/7/N/2;UO/L-U'A3-XKD.S[0T-<0OU 5-;GL$X
MB5#!VY(B4K2MM>?]1$][*.??[6QG9V\XZ:;/M<<]?>IZ[+69KL,_T:2;F/N=
M1\!TBBXY(I%F$QEB&+_$!"2U#:6REU*OLN>21PP$'GT2GO&>U=/>B9KZBB>F
M0B/]E"59:\R6G"-%$,][58-C2YU53""@[@M-5=._6:*LZD%=\5-'GS1$NK)?
MJJ[C1?/V7NR.6=8M%!M2%9+Q)#C8AW_C\UA$AA^=J/=L/:E\POE]]=>Y=XI%
M9I[>I_=9Y1VWJAXX/S /1/-KTU_ ",N[,U%+OOV\3" )QH42!O.6[?TU+61*
M7FUD#_(]]/L@U;4C_=+D</S12>.,:LT'-A_A;X)I0E,4*+#$)8+&]I.&^\_^
MS$NY:QZ_Q1"8$I;KB#EE9/[JU9#"Q=[@)^5K9^:KS+F^8QG[*LE>E!50G=0[
M(*- SX)=MY9=OKR5_]TUT%"I[4MQ8TOSR7,9N0A_X2;^$T,3[$/X8)DQR!@D
M.@17PG,4!S1:/9;HOL($9E@8DB"LORZ@M_^4RZUJ/XICR+SST&&3*T]:'3ON
M<W6YL=X#SK!_HFCLR$(+,!@TH]ZE^9)A7>KR2\DI';++:-[IH;#0<D2:.:^E
M7.%Y/8W<07[).E;^7V\SG:%1DM#=5PT/0&O$@'9]R2:Y4P-$8Q'5;F3WAJE3
ML[[)^;*:BXH//3,+S7L- _.N\!8^P<S!N!@+]R[B21=AH#K4 Q,(?"8C[TO
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M-(@ZDIM>^H,#@>U0),M[C*^W-2^MW/^V]/6^D=FY[)D8?J_3;Z-.[\#(<DR
MP1,(X:.@C5ZIDZD[94TJCYES%+GS4G"!,"%7>T4&LQG!=T+F^<.NYRA?J.+E
MK$&_&R,W,SJT^>G\MEC(-/Z[X!ECRDU0DIQE#QXAX9;,4AGR6VV*\[EM-5^3
MR+U^]0/FV6<*=R/33JB\/WC4;/B]+K803?BB7Q"HCEY)7%O=%#KIW\8[HI8A
M;&>\Q9YM [!\"'P.:E'O^<L<I3^G^99!\!.&$7+OB516/<G%NY+[=[:O!VK+
M!#Y9>,XG%$XVW_KP_'W6X7.6K$]L9=8_HTDVD-G4X3MKU$B:.3K.!1W_$\^%
M>#=G%>)3&GA#U[/3/-9?1+S$X%V:>)J>\FQIYO09F]EX!J\K50_UC@DTYN!W
MZLFAW7HT+IN)Y8Y.\MEVHR^U);.2.78RNR?GR6*VNN% &'9,=D:?(;J,[NYS
M$1XD*A?[Z=EDW=(9&:)9>2W=Y!7SR>N=,)PFC18.C'1\N]EZQ^+#)1Q-*&H)
MEVRH@>[N*1(%_5>D]?1'Y9W)_ DU/UV5G91#;WHV:_;U4E_%/J9*L ZOXW'_
MI(E:<$_6W$H?ZM1$ SSAWJ\$;0R[WZ##YPXS+-Q5IS"\_9U,J"J_XG!UIZ$/
MKU!"RZS6JLQ)R,WFP7R(6LL.4XF=TK1]Y,%T ]AU^>CJOB;N_2;+]DE%JA'Z
M&='=#XN56EPH_* :-EG;)E&69+6;(3'6$\RYV:9.9#PLW?RUMS%[-WQ7_>'G
MFN=^\P//Z]2T+CV7$?9&7COD$0R!81JAL41Y2F6#(T;.301)NGXQ"(P63<$Z
MZFB=3)0[V$6<\ASH[KG+>>/,[_OG_;V:02CX<?33G\+\=N>XSM$?&1X$S>"?
MF<"20J+W1,?5BW:SOM03>#V#FXN>'5$>G&XA<J?M1B-MB*$KN]-L%R%8CR .
M]> .,=C "7L0>ZIQJ?%3AWTY&&/R<N[]>/F,,V&1E_V,VBG:]"Y<![F?%-R+
M3X:RS%!QJ'Z:DW1U%YD::.M.&N\WZ@W6VHC0=+N0UG'8>=%A]H2H&. E_!&"
MV3GTFA<\$4?1!$\S ;/!<^.?J6.4K]# =4@I>KSA&1!&P/3ML@:*8I>WS[S.
M<VEHC=-WW>>Q]ESCY,-8EO \!?0^+ <(50-<&HP1A@ 91PE.Z&0#5_ID1$6#
M6!%U.DF3QWM.R5@A?'0?1L40)>\E8HN@\F$M4X[_(&I.EONN9/:%B,Z#:8M&
MY>RJ6_;*=+[H$LAD@^!U$A,X!\EA D[UYO,G:%-5^7F.)R!U_8,"JF6>-5^I
M;Y:Q95NEOZ\S&R2U'_@:ZRQK3P/ 7=(4I0#4?TX+ XUKGAGW+LK54TT2=@7,
MW+04'K9AVN7,[V?H]AY9_?D:3<$'BY3O7"?[T]A]&;.R?&&]9=%YAL$8"G=3
M)&(=%=*,%][SI4F^-9A =VMI[UM[4->_'.WNQ4[_1,F>EDU5(F-;][%?RXC_
M+,%1#RL:C6*(IS.DU(NC\Q@"6:"S+*EYE6HZ)D]U/5.@7TO%J^XLPN&/]*.6
M.]<@I=)1GV"BKYC -5@L[@TZ3K$%LPR%/!L>/Q?3ZEO?!<Z^K6ULMIIZ_-/F
MU(WO3]X,YE'B:9R=CS[C"(]AI(O!G."?;<K]2<@#:O!=A6]F6U0M+,Q[+!Q_
M=M/K?=;)>JWHAPZW764</V4L=YZD%QIJ69-#EW&#8^#QW7[8_K%H:$6V.7Q)
M)OF:M ]S7IT8<107SU)543TQSX9W6WG<SS9/5Z'GHGTQG(QA>#T^$>8[QFH*
MJZ>=+!T,N'4J*+#U@T=4DG2^LXL%?WO1)'YJI0-'NC(&JN1UPZ!J\ ",4 P7
M1SH0GJ&7T'T:PC;E&."JGT7PV4)EA975)X<?.N?.$@9&U9[,)O;>.HS";<R^
M3<*5S ;.7EGTJ2$V1(B,>TF6A.TO)[/;\HGX%:>Q"]F9 /^5) Q5Q$V8G5!2
M'F4=Y*^@<8'MP9HN\^;->AZ5?ERSVNV?]\NWIA1ILFGF&&CJ*V_G_TP[QD:.
MQ1'N0POO*F[FD?$7!B_J@ZPD\O0R)GEV/HN2*??U#YO_[9KNR)LZQXK$2J]Q
M(NOH7.]#!M,0*XQ]4.G&P4<O,I LIR%;0)\EN%3GP\K!B I0TJP]S[;%S\L'
M:<5:BO9+35$A=^U0;=@JX1LJ:5SAD;X[#F3T,F80-Y/>@Q8UU*3)977-?FLN
M_[V'N*6[P!@36:XUG#+QZ^CC/9RQ6MS"D<H)%1E_2_?'3*#AUR 65-F-AP7)
MLN%!9P/9Y]N+$AV=]ZF.N?J]THE]EVV:3O(JZ]L2)9,NZ3EMT(5XEN"9*#4(
MN:J0S[ABH$AU!;<IC^@%*#6$3<\OPR-DQ]K(EP&.*)66N,V;W[ZM/I8G-NE;
M.+IW'7JW%4BYG,9*@<DBST/ICCO4!PXUZ>3H(4A_PP2"Z'IH'M?Y5_7G3Z=B
M?YY]!5LK=HFT,U&($633KQ0G? _\L4(QH^=TBC &9%E^P&<@SRE<6/W2_]C8
MV;5/G,N,S0^;MVY< XX3-P!;X7,\S_DMBV/G5??B*6+0./:H"7P]EB8L.8!I
MDLW:I:DQ!*=^R@K8>,E@JJT4":[;+W.E/S6H/"?*1[R_'1WX Y7&CG"B"3E1
MCI!\B7M4S6U9CK ]CM>U8M2(A,9*>Z5+GQ_:Y*[&V.02GJRRZ9K=1':;_UYG
M<"M1V5 S\+K@7I@$8P3>6(<P@X/7EZ/$9S],6$W=:,G]XC\QU-8\32K_II2:
M>B8XY^,#&*(O^I<)@+)$6#&X(8MPW("D#:-9D]7PI$NRF8:RDS3I90LMRME;
M@6'/["(B31''2TY&?DI244SM#)F\(AV_""/DX$E64(ZD0;D%-B[;S-93!L"5
MH[B58,'&WDQ>B\D;V</BKV61OYRX]F5_B'0PL3E^8C2N[_58Q\;S"$,HR,;U
MH+L-&\? 8["=T4 ")CG4/W=1F_2M5>3%TLA;EQMI(J;TR??\<M4YCIG-I'*-
M_5ZQCZY" #>%@4>90!J.4 1G1YJ4(Z]BS%O)V+2?W8:5H25NVA\'?5EO-L7H
M%XL<[O@NPZ7EU12XDW9,@(2A"=<SN!67L7.N_8O2]%(<I+"L"P*^G)QX/4WL
M1F>^^1%<FOC%CR?R%6_$+2N+IQF.'R!PVU:9Q8!3#&[(TW&\I;>%,0%>A ;E
M PB!8/< :-\K.G)'1_WHUKR;^*DGL\MG7GG9Z*U<O_;2-/.*OI?DD]/;#D('
M=D \@R<=PMT/\"'5!M7-$*4_POF>O33ZFJ;S>C.[-VR9Z.D^X3([:\,2J31-
M5'CO;60A>U(MU*.7RHYD(X_M3%&%$:(4-)BJ'K_=*?718\PV^M126;.FN/?U
MVIDK#Y.E<H1W?MC*[XTP]CV$AGE++X,"IHP.5$2D&!K@$3?\#*S+IN<V>\]-
M*K1<(PUI&9+(1S\ENWF=W1Y&Z4)K20Y&>($'8,%GHRA0T1)WAW;^XV78H8"I
MYF5UT^_'7KXY?=^[M2E?-656F;#8]T+\&BOMQ8.3="\(Y;1H.I0G$E)D29>#
M9T\/,D3 WV1?2AP)FT$+-8@!*Q86SS[+S0L2>E@0:*5X?YK3=O_.H+=7**GT
M6P25G\$#A2'V1BB+CKM/T_V$-9!=3C_+-EATR/]^?,76OH$OW[C#GZK?VG^M
MK=+;U)FUUDAR[<AH--J$)1QE JY3V"&^WZC/'NR?<#=@LUPKY8E$@T,OW><Z
M_LQMO=&>DF.C5BI$^:$^W1G*'):]M<[S82XFY$\(]222:QR*6O 8A@0H60I6
M7YFR[_V#2 H*=&GUOQ7\\H9OKJ_:>]/U&T<TC8Y/2AU[_3V-/5*6.$-5W81\
M<OE.&10D9^JH?5P6: 'GOIMA)V7(06'LY/ES.\\SA[Y>B(U9K;P9FD;[^?>.
M"@9'<H?%P/DU8-[\[+2;)%@"2G9A\8,WV<#IY**-K]#@+Z(/]85>WN\GG (/
MWIO[#2W 7WVV%87IPP@/8"0K_EDX@WN&:@%27<E?ZY=J7+L]#H_+#%I^ODLW
M-;Y'Y)N.\E>(+>8I6-8489D+/,AIIOWWV7TP37"%DDO/A::E%".(#F "J1&+
M8H]Z&&KQ[M;'SVHY9+L^#]8Y<\L3+WGA!3I"\E:OE-2!>U,;B4('UM<C:"*!
M#.X0JA5J$2^!9%EA K%3BV)I@[UZ!KEM*5-ASNJKQZ?DSK]1N"06]%,^GR(+
MJIK1#FE!3B N"RDU<;>&K<^Q33:3IARB,YC8Z+KJ%2PW7'6T$7--K79H;2"B
MPC-3[/!!9YLO0I"61Y'R?TM/B'4:>1,TA'GOS@93BL<;T(FS[C&Q-X."@[X%
MAYDON<W-_B9W*?I%5+'Z/EJS/3!T*A%;C".D0FDZ.@M&LL$E=>J2,(-1;UD#
ML0*!N<WW(C_JB!\_:":EEMG1X1^??0+0H:P)<?3@8#!"!8YT0?HTI1],90)\
MZM0SB#]3W6A!_L>S*6_W!$>NY!YF=^(T/Y\]NV14L2?L=L)D.(EC;$-:B->+
M/.%,3_B[/0 FY2=+JNBPIEXRUU:"UX^BF,!!88/IVH;?CXQE9TLOZR4-R>MR
MZ?P8I F6,/9ARE!='J?S5@;[,.E\R\%2\_YWI@>#2[L^;C8)6%X9@BK\CI;0
M-\"./'#H^Z$DV<A/Y[ZA(F@RD$G<&..=?Q^SC0;*-C<U1R_%$Z*(7HYM<<=T
M+"28@,]HPANS)QGGSR^NP&!L2D4Y%"<(22=I>O1:0P"13HD$2Z1*K*:(#H[?
MYF3"<GK.9$NF#*W<,Z^:-CC!<<E8P"/3A!5V&/FW](?R[[@-1E^32WDW9AH*
MIQ]?=PA4NELHV)M$!<GFX>(/)_WA"K38M];Y@?B.*T1>YP>.)AC*X.8(I1Y
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M5G^W)71!PSU#<-F!T16+<H$2KY.7G?E&VTX$J[^^.<[M*/DL-JZN+7>NMX*
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M$!&WP&9I>^&?,J:TT@U"Y+XUZ";S$0NBI\;@[O^3%" X =98MPDJ91C:2K\
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M$XYO\D/_5"K7\HOU2WEZT^'S)_<JPA/*V((Q#<;L3$,VX[&VL**Q%L<#=GH
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M*83WJ*D;J=W;NU[(*Q0(:\%_"]JT"T:*H_QIP;2@'N8>/(*FUXDLNHU?6EK
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MR*7OGM3T!CXY:&-J.:F^S_O09*-?#MN39(T'Z&%D<2+X1-VPD&Q,O1X+XH+
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MO8D+<-*!U)PCE9*!0P_JNN\^X]T_.;Y#^GB=[G-:*'W/MS %VBZ G=3:$'K
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M75"3;BC.0F42W\ZFIDN1HWY0KN(LBNX9=<><OE-X!Z[ME^.W4B[=7\M'OTX
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M.?,+-$U[H+%9"4#W6';G*Y;BBAVS?*JF4J<+;8RZO&W8(JX]-/"OKZ&(49>
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MBU,(1(_AY.APK7+R203>J=[G8>VS.SYYDO<?;>..)#O.'RWA!G)&;3_GT[Z
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M<CQB(S>5,XPS4K1BRX ED/(TT%,**D^W66*K'=R93OFKZ ,4Q_5?=Q4<=-G
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MBQNQVD%^-#SF^06-@C$?R6V$\H2]^;/;3Q^'7JWG%D)E88@U)<<_F>B!-T5
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M CI,9;/KM MXMKH79R)FX =W][WF9/%Y4[9(R<5_407E,&7C3L7';N44.^S
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M[+R56NQ"5O"R3!!O4PQ9/L=$E]Z99SS$@ <MUF?@ZPN48=HK,(,ZW;]X M=
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M=Q63BI%C*!.QB=0YFPK":JNYS/HYFV-.WLK/A%+E<MOJ^YM]%/<NM'VIF^R
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MCSSGD!&/SFO>J776@J>C7W::'VZE*]4N%JU_WGQ1]Y$ 8G*8KCDL!(+9;\&
M#[-JH*ZH7<<BU4%@(_5^+_S77C:0=XD-?!&YQP80H#4K'O/S')9QYX^R&3J&
M#?0S,*L3F)]_V,#&?CB)!?]]#;X3A]D6AE'WM*NPXG%_U][&U#&4V8 I?$?9
MEG6*N:<49X3YUTLI; #VIP7&Z,;1DW/ -'=Q:"WB'VOATRP((CW!,O(JV( "
M.LT.48S[MZO_M?1G:_FAQ77_M!CV@PWP8S[9LJP<V,!=^-G_.UW+6 >=N=C
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M<+AIG5GK[=+@<[>S9&7%\F,KO#26/O7:27XFWD0!TE6O*$:T"(I2$'8OD!9
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M1>I98*(:5[]?R4NIK[U-SPT1]3I-#S]J*=X.J[]4KWC#].UDRWC*FX58LU?
MU2*/=81Y;;\^0I5@Z]L]=FZ7Y<]QXR&II*HO_E". -C+@GT0JO?J5]+OJ/!5
MCU@A\@/FMG%Z5T;%$?NW91AE:\:>_)']Y?W[EE/)!J>',9+0FC=DG*%&UP7*
MC5HU$*.2]U+8JRK%O-*M9Z5]ZVOUAH1O.0B(!&W;=_TR?)]81"7].MAN2WS
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MSXJ1:P.QT%Y($<V(" 1"Y(5]C@6+,V>8L&!Y90@P><X],O^7RBTW;R!KA>9
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M[K0[*$"Z/5J5 ,C@YEPH8Q<^=/JXQO:.^@<5EO,_^;IL[+>3]D[2HJ$@SZ]
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M1\U=%Y0E/_/N^.!,6>X0X95B&E<#4N>LF<XV)IT<)>XU1X>\#)!I'+AS].^
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M(.L8^I+C9+GZ^65M>JU1Z$ _7WU7[:BTT('K':J_O\?;O,SXAI5@WP"M6(=
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M%W6/V??B8;:<#U?XU\*&Z ^NZ10R^*W\U%&&R&?S]#B;DMG*%9).D;XC!O]
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M8W($%8\0('A\=Z]%(I+:3I1C:]7B]>C/&''YFH\5[IN9WEV<^I:>.W(EOJV
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MA0<B<KN(:?-(3CP!:Q)2?'8;EIS6=;#O7KO$$S7>5]'1UV>'>54C5?2K%UG
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M*/8JG,O^U&M@4[Q'(X+[)\[_D,'_^>ZJ_^^-OR9<$2B:^%Z"_]9?U8 3>)Q
M9ZD*8R/-'\U&TLQ;?^TNE+<J'OOFJ%1N^$L?7FQNT+7WBB<80:0^Q@/7;SVB
M.G(>&>""P$H -</MTLXD$]OD'\Q]2U?>=6O7W,^_%RZ%?VA5]5IKEI58(B,
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MT=WF6X\'C)XJI+&C8JX9^?*(H +JOC1)"]R^O/B",">BNW/X+HY:A&ITH[,
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M=1VK>Y@G1X*W NSXY8 JMKQ]+P4HQ)S@X)$!F82L8GQ"4ZX2>G8;=H811JQ
M)P?GSRZ?BRI=GJD5%E5>*STL^BU:77,GQ#2F-YAZG-0_N$SEZ%[*S#!79!\#
M03-_LJ#_K0/O@%"L:?8YW43?\7U>M]7TR.,;=C;9L+A1!XP,X_2A21RU @F<
M(BAS!^;-P 2:H?$"@H036_ZY.BN8VIQ^S>V.V2-P\HS"_E[[)A>I "&AGL/.
M&A'5"-BK#LC^?!!J2BQ<1M9QTQ@JO0<WNRD9\Z+MD]8*E>A''OG,</A*"_;2
M<+C8F'2_0*I.7,6?@/570SR;47)_OP#A5 Z!+3?,3 3)C$O,-,9F!GZ!#+%[
MM?-HXX6E) R2II]]</!RHX>%<G*GO;Z+_D;Z1$'7W1?OSHA2<*2#F!"& C6-
M'LB(Y0HW,^"T$_4TCDD7L\56'8RL1:?^^(RJS;V9WCD6[+9?R.]L'D3%6^,5
MKCZW0@2/GL\E;\,RE7%=N 3L?G#FY;F_3*X4\)9;K]6Y%D,);(W!U,7*Z\K&
M%H.GF9Z0@C>.L\*Y'[90]!C6,>X(4@JY<(UM7U_@,]KA5(ZN_3Z&$'/2-_$F
M!X:JW)DT.R1S3P.\<^JUN%WN:+'^=V-0,Y=NPE!@/N#DGUI:- ,[&%4);#?<
M D+^*HR'^>&-^6'M [S?@RK3(M99.0+7+8U!8VQ;#3J:*URP:./5L_7V4_;$
M[=H<Z>]#"^5YAR;4^01.";VCQ:_$W7? >$,>. &F+*H8)W+-.'FV>B%3RFD9
MMF+@[))K;/6 ][?VL?6'M==J7?<9V*_CPV[O5F<B]D ]L >EV*F%WJ!=[H2!
M 32._?&13@GT[?YM6%]D<.L-A^\K[7WOG4)#M+LMY>L>WBL=6GS+6[^U#7.0
M/:G^__J/[?\G';6\$-OX!3@QKX%[7K$].>7-9LU 7%-P2/6;Y?T4S<SK-+GT
M)^FJ#6\.V-^?^W7#KI;;EIN-$,2J84=0(G\H$%&58]L65Z5U.%R8+"XIJ/=]
M=]U>7\+]4V)[W3?O,SD.,.P-S 4H5J^P9<>)UP8OAD_C:8YO@(L 6[*@_]P)
M K7D5M"KRK?*"0Z_W!]LP\JM_2-E R0O2.X5P1.(U/O;L"9R+C&$..W:A5?E
MZO:G]1Y,>?NIMCI*=K=I1^'D>DAX$_])N6.)ZA]E^<7.PF [.B^Y@1J(_B:0
M:BMG3'_*L.#*0;'$N1,%-__ LIOFO(D8L=Z&$;_^Q=ENP_2O4+XLAG] 83%J
MH!, (7SC'G$X=:F;""=7@K$][;>]EV_MJP\W,EO_&!-]T=5$M?"*9KY+6> [
MBA3NVP4WB'\RPZ)Q6S<Z"*TA[YHI,[S=YS;IS>78N5\@P?UXR!% LU0AR?%(
M[EJ#W:\/^^[G6&Q\K+B@>D&$1J16(,2PNABW$:[B,E$0X[#HNO/&'*TESYPB
M,F#J2;BB+8Z>O5=/U7IY[M5'7D0I:@_LXK1Z!JZIM0L.ZA#IAJRK:)5N1!.F
M<&NS-P[>8[*BI@S85AG4!$9?N%R ^6EW^OUC02<K[[:?;9XB(4O_>6+1A4BB
M-"#(B!D*,Y]38(OXP15F?-OL%[?J*5@NE:K+Z3>,/-XFII-S5ETD=]-S-^F&
MYQ+?8VW*"^(UW+3"PB8]\A482#NB9L403,"J@WJ!.&%PLSM:=.>W8B(EU:[K
MU4C+B9.+&WOY!*]_;B6%@]I9?JK@<@5W;!O6#*?KT(A9G?N!";A"<A5#JTF^
M&'OGO/_WQ"&>NF-.[":=N@.?7[X7^P4UC!BGQ'];>XG-PXEFSV9B:^?0/N?&
MY;8&@UIR=DY]\EB_=#A6;0\R^)O:OP7RK]A!+&(,_A"9PA:E';]T5NKGA9;2
MR>^SVN%V8[7S<2%3N*N0ZCK?DUCV&/>1;5@0(16O9.T$$&G1:4V;XVOLP 5_
MU=25O@>M,V$UWU2,-,0^=DGO]2GI@FES\G 74.+<C_/6# 09J<P^RX#WXM-+
M#5MSYLXSAC..A>QM.BPR.]>C.!<NX2%L=^*HL;I>/,\B'K"_KZ8(Z)!SDV<;
MA?[@Q;FCMNJ^CC.=H)-K0,YA&\4>=<'.][9\QFPM'."'R^[4&;U3/-R#%&S*
M5CA3;.MI]2;=T,A=6#5L1H7!'=B9?1M.AH/:3?/Z(*,:.XYHU*%;TH:32O<R
M;"H\N7N+>EKJ?*=7+^YJL:QL?APJ\Q+0%)Q8C+2RB&,I8_M0$-B_!!=<V7)+
MB>)<ZL6J,TZ\FJW*Z@BD^3RQ?5HSWX*+T8_?6]W64D8-N^ARY8JZ%([DR#9^
M"7Y@"H+DA4$)@<)U7)KR&Y\>Q0_. R$::[QM5M<%7[RB@%I+&::Y<E"SZQ2[
MNN4P<>,0O*?&?,C)45%ZSJ[E9]*Z9CII4Z =-5/$O%# O%G'P):\P%QFN&4_
M902FKYO=L/:)9>:N?;T'"U47M+IP_GKG]XX=FUPA1NS"H^.Q"X2UOZQPMC,8
M#1![-PO<JC&6HRD=(UV-!4OV@9'JOPPUKCOK\5Z6>1.U0Q=J&4*+!\E=PYEX
M&4.!F\,*V!&UW1._O;W6W:Y^N):YNY3:T+X-Z]+;AK%5I;9ANNV,5D[*[W#.
M 1+J-$881 !SS%#0Z0D&#CJ4B5OTS.]LD)^-J_WYT='5.H=<E/?EX4RNY\78
M*1U6*'= 39;S&AD8BF)&,@@943M53GQ:#]4N.CDV9EYLPK>\/UZ3__I1V(V#
MRH(3?Z'"-E_ ^D?J3G4(,LCG.W./ X'D\)3<<G3I_\+>NX=#]:]_XZM43DE"
M<IP*44Y%2&1221)".<8D2<@I9\:LD)Q""*%,$9+#Y!QAG*62\VG$&$.2TPP9
MBSD]8^_K>K[?Y_/9>_^>_3S7]>SO_O[ZX[XNES7WO=;[/KU?]_M]K_>B.$3=
M'#I9Z)/%'<WQPWK<(51G/HVF;4TO\N%!M,-(>L913*#*XW&15/@-:)Z<,=Q:
M*-Y(7ZQZDF;HEC?&/V[*\5D)D6J/> VKEEE@(W50%B'V7!H'%#YE:ZP?JSNH
M@/G5Y7K9DM&_H_0"Z8EZF%K=_5/VO\Y$P"J5:/Q4@L>B)O70'+XTMR-*%<8#
MN5Y*N!)KA-:_A+MK7WK=TF';0(G:&_:8[;-UO;H"'%O;P5\'ZE3R?U9?7)H*
M3KGU\I9<6$Z"_56PF?<UV-VUS-A9><_D[ $67@Z?@ZVN!C.!4#<]VL%-/1IM
M@A7$-N9M ML2F "'=B(3@*MCH?T#OSE_<_[F_,WYF_,WYV_._^:<@Z_RYGJ<
MS;/[QJ<==QLYWN] >YO_Z\^0^4V_Z3?]IM_T7YEHC*W-0[#IGA+6*2$F"+.P
M3E5$[L62\3%()3!?)K;2ZJ!??P7Q3.M1BLX,K5LKRZ6U..5:JNZ!)X72P?X+
M6TWI%^A96.?ET9PV6,6+E0E(;:SQB ]Y*0Y3XG[2*09^?/;FE[>->Q_*WG%T
MQ!UP>RD?(J.+\KO+FMV\A)I3!W]U"P4,4RY"Z00F$)$Q430D8MQ*G><92CYU
MZ_7"M9$QOU*?&&?Q<U6"46TANE0WQCB6![R%'DV!.]-=]3-;<;J#,T]%KE<E
M^(MD+E?0/I(_XH\BY$^F+PG%L-\)CA,D>2R,LAZQ:VM-"A\O(00I.%%%D>=Z
MNJ/7I"H2K ?"Z!G#GE*7I@]N!*PMVR(665/JSD<DBX5^\D_CT4B"TL(:D3<6
M=:J_@A R)2[9O+><1Y'M0/+L4;&2+Y*W$]]E7K>]/YD$R*DL!,FU8^T3QA(F
M9Q<W2(;:*K2#5,>W34%#IX=B"]X6#V7ZO2UR"'E=>-3<W,+LD?E"4XHK:@)?
M%9>_H$ *-H)J@DFQ"'+V3PFIR$LB%I%G55IO5[_/_'HO?(57TGG=]R6O>S96
M><T#TK @,$(5ZDXO+^B113J7I5<6]RT%Y*A@8<=VZ;Q?.26V(O<+HX=-OM;G
MYJMQ+[?*-?-V2G'^#2W=I_L>:_(]AWF=W7\7$ZJM!38%,L1I +W: ^Z V8]D
MPP;X, $!2V=UA@*"[V+I>?'&T(SI1ONODE9E%J FKZ3J I9DI@0=A8>#DYF(
M/4@-H@<?\LQ[LN%LM&]U:5F?@J]JA;V 9T52=WT.,N*(]%C"ALN>@&ENF(&)
MG0J5C3%RVF-QF'IR#E[AESQI15/?51@<Z%YKV ;5W/W"7Z%;UQBUQV]VB9Q!
M<?F7M^7_LW2LH;3(65NBS[V2'FQ6759:6AT<.S96DWKJ9;1 ^<>EUIW7K^K?
M\@2D!F-(,.B8<3,B!A2'W^2-QG-K<]MT>TT9FITS?F<UIB;UX5+)H0Q7GS5G
M^_A+S4R #^G_DE?=&%*<I?&_8"CEMQA#-OTE3REXF3C$A3I;^?' !L0HK66/
M%\T.I?4<A 51V8P&?.@.QN'F?1ZO:BMK(^Y4U50]U?*^V*A<6S:M_$1GAZ<.
MYE/WZ/)?FOA1C![\?I]E5FQ,/<:!#TYJ@'<^TMBF>#F@YG&?U/Y*QP'!K"&U
M]U>S/)F C=B#I?'*J'W;<WX!2'[R5H?"Z!ZE!TR@]"O6R:WHKC67\P37 -+5
M2_K;_I?'N5:5"YQW>*7BMB>NO&P2NZI2/(#2H$GU-9R8PY<O,H'XHO[VH*H$
MM4)[ J$F/^G3$=SJ\^U\_K=Y6MT/E;[(%W=$V:.^8LMA,=@[<$B1-\(''PT7
M]4V(0BF1+9HTZ?YM6;*#O0[\$_7?>NZ%27]\M".>HU>R$V"+R^'"YE=P?-=6
M0MZ%C$G<C>OP?0TG:3I]=2JOK)6+<%D8OW<=]0T_%0/][XD=#NL08[M1O3!/
M=4%]PE:BQ\PH?A#Q%90=HL&&M[*ZTNF]G3]44N=842@G$35>0]3 /&,"+CQ"
ME^BY+ 1>@>"$.\&B<,C3F' :&^GK>OO*7?72R,H/ [GO4X=D4E5:L^P^VGH_
MV4/H?78 G,R3$"!5+_13K1E=L$H\R[9[1N]F#"ZW:7KL9-U0>=R>,="WMG.D
M]^O>;3*IA4<-Q[EYETJVH:T8/8A*]04R]1CDCF_#5JBW=8DVIUHD5?@9%GR#
MJ<T-;/\L<&EWTA,.F5O/;SL)%S#84'WX;7 77LY.(KAEV*J$J7IESKK,]%^%
MQ5T>1Y3W67Z5."+Y1%Q',K$-F4C2;$'!Z 7PR0JX&-*;#+]8-53$X YP/=^C
M)>A0<*[\?/[G0&[C,\V2V[/-I+P?0%]'3XS<)/M'UIVA*C"!)B]M,;"YH->M
MPE".B&ZA6W]NP]UYP1&#^[G9K%&24W>B1.CKX5/]GL(;S];\I-CFT#A)"I&>
MA+U-I2I(4AY!Y%<!MZ@F"5_*^Y>^.RO>3I!&=A^1]N>;YJM[<R-,I:EDF.#1
MAGX$BM;Q.9$E";SQO[!\/]1_&N85OK:3)WW4:5&<T5+.XGHN*+F##;$?;#J"
MA!&,<9I3:8L\5&>:$6DFM7)*W(FX)X=0?'C^6J4^KD6O-!YV>$)A<L/%]+9Y
MNWJ@7%:*$^5(7P5F%,O@&B6O4PPA[_R./$@)0:I*)\8IZ53:IN)\QP+WV@;*
M:EL.Z:&EKP$[[KX$7EYE'_<E8/FVNM2P[YR:X=%E2'$HCFH*F1F0!?@WA%+Y
M[5)M]+W#Q5:RGTW:9YE?--6<JD6,G9\J*26I;TUT9+ E.3 (':G%4X!WON^@
MJ9B$.\\M1MEW3Y6 (%T!1_HGI3MH_ 9-66+DY18>F!T8Q1 T=&VWR"B.,?1Z
MVX7*N[_RJ?&#\NN8MZ.?%G;L#7RI-YPJ1!$I?BB2EQ;,TU7\14ZALJLNE)BJ
M!A06[A&^=##LU,%A57(A,;(Y8728L(AO\XA#J5:2UB.+'&,TZTW)-SKX]0_&
M;>,H"O0SZ:]';KU8K42.C%K"WL;NHPF2CV!4R9 QV<":]"C3ZS[UM:N<7XQE
MJ';L;.VV49.SC8 9?'(R84-W. Z[H)0#SK5SL0]L8@FPMN5'6 EM"6?L?NV]
M <W]=J3O)4EJF856^U=F.24O0-^V[3A]^LG9@P4EWI1(>@GV#G[T=(?! '@7
M$QOD%&$_]#U5X6CEMD/J"@?,#IJ(E&Z<SS,ZKLYKO>'-X%B69P+E3" !M=7W
MJ>T;G7Z+9!Q]B*P4EG1'JBKR;7.YU%TPZ@+U/&SY*RI\&H04VP;QB])D_BG_
MUE,E=L:[:;NJ>NJ.YBYZSQB4N/AO_TG1/8,[)1G/;M=Z]*5" 57W__$N-QL9
MS^"JIPJB!L&R_/9N$<8P'%@^20\FK+=B#MQ5GY F_?J2O21NK7"1TRT'Y]DG
M.1Y:F>W6:/3ST_9([>%L5$\92PUVX&06$Q#?.K\WDF4_WA9T;) \W_DI./NG
M_8?._+Q!?P7X71HY669MR"W_=K?[R)V#2]HF+*P#IS_&NBN-#D^!C[5/(WF@
M6->IA$=8/IKW*X0=Y-0J\KC,(/?GY[=MJD4N\8T<._M3=JF)WDI/?'K/ I,'
MWL)#1YC (@^IFH!MQT8Q 1%M=9LYK(CVJ;HTH0PF\)"-0TM#EE\5FW3)=,;Q
M>7EH:*6@P'.AFR613=@*F<7(PI]XDIZFQX@F@IZD??!'@Q+IL#-E0F'0-X%'
M-$1%[Q&.KF8K_/R1U9T[,>*/8U-?D#IFQA>Q0N#M;AR>LM5XHLWX N?69O^!
M\X7*'@VMVZ59#O8-'@SCD*JH\/[PW8?O\O3#G>]R@*2=EF2/!4W6<)OH^0U\
MEJAF; 4FH8X/UC(?XJ6HVAVM_!,3\M9EB/SUSH5[#1MA54.Z=U])=1P(! 1_
MH1<[6 "F9W-V@4[J;@9)QO@$$4R8+^;AB;'S.3^27%?'G#<7BSBY.L1'$M;O
M?\H;M[KRYN/$[;<CO$\XR'+@F!"#RW#KY2YZ)4J8QD6OTY:&#*:$PE!R$QWY
M<]9ID3Z7[F5>2L^+P:^CKNU-.IQTUT"N*#,'6;AKQVXF $FU)KGB258PW'QK
MT"3^C?5\4$I*11EONEN:I0\7;]['0TR@0=>G@9O^D)6/6%B\JF,QG+3^EU->
MDD<AN68<;W.ZZ?Q9$CI\Z4H7&)#TNODB?:&)+S?FR)/T/>;2NH_=G?B12'HX
MB_LEO-QB<7QJ><R#P5F5Q3OL "7FU6.CZTY,==)>.7L=BGN=?EY?Y./N1,Z4
MAZ$I+P9RCFX\Z)F!3^+3I?I YV[<YZ;:RXN]"W5>+FZ'=*((A]?-=2I\A"^8
M_-*90[RY3E:G\0\S.&?)RQ11>H*VS$GM$_U*# WDN<J&@?8<-OG4U(QG5<\L
M+]A=&U/LG'863U?CEU,4ME!80)=14JCWK5 =U4$>BR8E<]8);4.5 VWU0\_=
MB-5.VDXC[6[$2\.P(Y<0)7=W(5]058@,KF"6I1W)F$6%*2*%"3S"EL]T4&1:
MBD\C,B9"KGTH: !H)?ZZ4M1W!^[T,P)CZ$<P2=C)Q_A2XU;\"()B6 _9DS.-
MWX6W;F(>*ZFZG9U;SYX1EI ]G+#^8#?MW:QXM';E6O%VITD/F@#[9#K430U!
MC?2/X@*K&;RDZ]AH^>,UHQ37%X).'O>L/WNZYM'?-+ \KZ6+<0BI&34!WK5$
MJM&?KN$%(0S/AX]#[8F>3O"( 34VF2Q4RCIO"PR2D6E;A@+S%W>2J5./TO+
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M_&7[*EK><YN6Q<]ZU%VPZ0)2GRH(S5.<H1 WJOQ<@[#$T0]#Q6!I!9Z[:>^
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M <']Z\:UI@[/Y K?'.3K33$>,//!1DJP]=:Q"S7/\W):8B+MWU$%@N13IPS
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MH6.1LWIGP_#5_J7]EJ^!24+:^X-AI\,X3AUNN$//@SLQ@5$/2O"PE@T50;.
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M2+T%W*FZ-0J2"2].J=FZ.M+C<'^="6EJU;A\0%%!_*;S;=LS5XL>NDE;NA^
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MNI[!8.]-TJ_5*Z52]^U%NYXZIA-W7@9>/J]B'WH*F"!44'@TR0S]"/NNJI2
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M=YBB) =L\Y5LL*B[]EO++JNL?46S&&!G;/+FFJ+TIS=-^S*KTN@/6+D^U1M
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MV.$=@>Y_SXQ9"U_;_!^UQ08$Z$.L#)0W*IR-*"VE,$7$Z694TZ2)%Z6X**%
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M\&THZF%"V&F48,DJJMR8&X[GYFP :RUNJ4MZ"R-'$K7YXK):N'SB;BZ\XDI
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MDNF]-OSF49]Y[*2VL\1[.0OGZ=(C.R83>G?L1JQ%QC#K0+UKL.<XRLJH"IA
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M.\C7A+G0[(N7F<? RV5]X6>HX\;^ICL[?44D2*[Q+9I%/P_L&.64N\G!Q_V
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MFPOW"C9BX? RCB&[3&3MUOUYGV.43.U#R:"^-X4$P("QUQ:.<J[1ZJ$XCV8
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M*3^5+/GK"U;'CUOP9!SGC3[Q7FL! I!M&."* S7X.DD*+< J99'F4-C_T6M
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MQ4,H;R#:QTE?(BRJ<>#=.XN@(2M^#UFQPID=*V:Z<OAM_K.YF\3IQ7:<,")
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M\@41L!9+VD+RX:XBIE%46D:NTJ\Y:;!E7N>:PL'KFK4B0:^G^M2TN0[M?2/
MG3:Q-(:]@FLQQOV0P=7HLC-Q>Q"_NH*\G_[==5*#TL620G($;9AV&/[1;5@
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MP!3"XS0H!V^RZ0EXGTG)T< K*R+1'G<>YVRMO:M>]EHF$_T74JM0Y%^O9Z<
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M9 C5(L66<W=O7=/Z=^N8?>#BK?62^?9%FU?MNBQ_?OF8TV:2KKF'<>S=N8G
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MF1 W:,6J5<%DBU<3<[OK6*/W!B8T8[68C=[PMR6C6=U>'@[2A+HI#V$0Q&+
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MQNY/7\\^/TPE/K.Z28HCLZ9U4Y+>%4U"TC95QX+1! >(,.B$GI .$E,8NT$
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M"9BYC8E[25V:C)FM.<W6>IOIY=-0E_^+FD[S4'>B!AG[@'= 6YAD0#(_[K7
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M@@DC+&$^XKYG="?2',+<5&D#%> -5C-%&M ,>@(U+KDCZY7T6I#HP1H^2%_
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M;HK_E.7LH_BW:L%#XC''\Z!#(P(1"QA,X@!!+W#$X$F9[U.MH)'&-<]M2-N
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M(S6_9NOM(I#E;4R2+ =XG33WJ9,T%[=)<Y=#$Q@/:4Z]F<3(C32R1K6 1=<
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M6>3BKZ0IOTD,UORY]>+'"4OB1&:/<_P4HBA(Q @@(\V%,><TPM(AP2@9C2&
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MS>NYD!TQMM=E[-CSYK%;VM!X+^^_DP=Y0B^=0!8AX=3#,1<K#\^%*(I2F*#
MA7Z"G(B[ 4.^UK3F5 5SF\*L,8(U2.6YI!_!Y2B)_3W?!C5C;U":L6(4QZ7/
M]$&17(X6.%DLESYSNM%<>I\;&))2A:#;I!Q_EU5D6<@,XXLX3J(H=AET'4PA
M2D@,TX"Z,/0YQ2'U@A3%)IL()VN:VY9"<WK;Q)L$CVV^=3G2<X&]B1H'Q P
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M/3GJ,-PD:MS!#AKPX(V$_\,5$!9(3T]A@\6)TS#R;$VG#&N?=I(UC)J#J=?
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MOT\^-ZP;?\R)O/G$WK'F_Q_S=B%4W>(768],7==D'OJ4-:.R#$&=!LQ+F>M
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M_57(PR==EDN$Y-,*8;6.\9,X/*P/ZX86,<F#*/1\&&49@<*7)[)KI =I3./
M9XR'@:_#HZT^M=9W:@(&;6EPJ*ROV[0E=>+_=3+;+F0\MPYJ'QHWZ#K^2HP4
M+NZ$[Q4N.J]6'$#,;97BN8GG4)TX (AB5>+0"->2L\BQ2['0+UVX^8BC(<B$
MOYZ3&$9!+(Q8)/XG#6,/ACB*_%2,G1"MDA35B>?F:O?9&G:2FY)GC&"N9K!<
M(.G87)T%L=<?:A(>"S6TK%-4C$S[2NP3:F!<)I90?-^(M7\I_MPTKWOFMY7P
M]AZX=/$^E<+^X67'7MVE;Z51P#(_S"%AB$%$_!2F)(Q@0#G'(2(Y]96Z=&O/
M/#<SU<FX95/7XJ'7P'O80CE%T7F(M"<VZ,E] XZP-2'>TP)9B_C?#=B3-0&P
M![IN1P!]X$:Z V@,.&6G 'T]C[H&& Q@0MC)<RZ^)*Q/W'PG?BP'/0T7S//C
M(.<^Q'DN.[:$/LRBA,* 1!$1AC\3OJFRO5>:<FZ&?BLTH'V&ZR?Q3->'5(<.
M5 ES!9MO'4GG:0(=B <TX5)B<-2[U#J:.GRKME&=BH+U>G0UV5EU@!HF;%4:
M:4(.5QW-#FE=M=ZTD6+6<'Q[***Y3U/((RH,M.^E,",R=H!IC!$)TC#3(BDZ
MG6)^!OD@Y4B+*GT 2+58P'7P.+>R6LA<F5FE2I=NG"PU'7'ZN(+#*4U7D*?O
MTP_.NWW=$47R,'LQ0S +/;'-<THA3K, )G'F(480)DQKFP]/-[<M?_'8HIN-
M-(BQF@6PA]QK'; M'NWT0+&6=30XV<0)1RJ*G^8:*;VE7U[:XP2Y?7BH/U3-
M;>_M8ZU:;GIQ@+F9A)Z@0$A:\0?9NTS(NRKY:K,^=(5O'V6W"_5RU<LP#ML(
M:P@Z-@TVP=.J>AT%QZ@*]O*HDU7%CBK6KY(=?]C,A_B0YUS>6W99'??XUW>Q
MKK(-95%NQ&0=Y^JJ7"^PGY ,8P1#%A*( C^$&*4<)GF2$.P31,) QY]0GWIN
MAF0G.:CQ+TF!<5T!B<8:J/D;;I!U;&#VH':I=$)L27_!P7<N=U.Q+!J9;[:%
M(?9<$7V\++DE&A-/ZJ+H W+LKAB,8'@(:BI^/V+Y^ZA?FF,Y13R-J>?!& 4R
MOA&%,,NS!/H>HFF6\S"(] X^)U/,S2!UY>E;$8WB&V> 5#S=7 6/ZQ.-'C+Z
MIYB+RMLZN9Q.,.UIY:*")R>4RT\:LK)3*MW(;<GM;<G$OU0;SCX7F,A)"KX-
MDHK_]E7HT_UEVQV!>!YF(<XA);X/440BB /N02_Q6>YSYF>^5G[4M0+-S6QL
M]=E6FS>)Z9U*H*>32C\%-RNH9H&F7!?']LKFDNASIEO"T197^K7B3,N1;@F\
M$VYT6^.:&>'>+(L\HP$G*(0DR"*(PI!#<1X49T$_C9$O_*PP2722YGMC:YG&
M";+BV^;3R[V >H:OCYJ:#3/$PK$Y^JP @+:9.:.J)8O1'WG2S7]&I>-]?.X1
MPZ+0Z@&7Q;^:XY,X4:U7RX+AKO+F3JS^-GO@6_ZQ*+$X.>-E4YG:U!^^+]9T
MN5IOJEY.,_)#2B-Q5HJ\'$')7P2)EV4P3$+L\R2,HC34JONT+.#<_*:^?LT'
M^D?Q4!9Y07%9@\Y>RSAI0Q"F;3NL+Z^: 7K-17,=N^ZIUM"-[)5KEJ^OGDQ_
MWRD(]AJ"O8K@#R=9\*X6P%:AI6WQIJVE= 3N2;FDJWGT+_8:%Z8A(9!T*;SZ
M7I=_7]]Q7OVU6FV>]N9!\9I/<;BYV>K6D>O)#;[S>E.5X.^R!Y7X:R.^^CV?
M*JKCMWX. '5L1]6PM&P>#: RNA%4G6.R^T%-I?NWA;JO&MX=/CXM5R^<_^#5
M<T%Y,]];O#[,9[Q=-DO;F#QYD2,<I7]Q2=Y4K,1SZWK]>==)+XDEG1U.(44Q
M@XCF'B18+A-*_9P'.4=JA4*.Y)N;96OT$0C)@N)M!<9!><:'7U)+\5^EC_,.
M/Q7B1R&5N^GNYZ_HGFA[Z17O-5]O01U;UG8MW[I>2_V;43>(V[H^M2S=M'>L
M;J ]N8AU-(W9)^-322LN9G_/V__[J11.\1,NV#85OON="V^Y(1YI,^$78O_X
M7/88#_TPA<@/$YBF/($ACC'S?!;GC"_*)B5)L2^=F2!*%B-K+49?''>&HY-Z
MSRJE56%TY;*H66V'4$]CG+<*@#=;%7Z3/"E;Z#OQFR5HF:%NAY= VPI?AZ E
M8VLHQ*0V]3J@CDWGE:,97WIO'C=+:3HN42]UN>>$,8Y)0B'*DABB/*(P2U,?
M8I3Q-(B#-"-<\W9;;>:Y.<(]P<$Y:C9)R:9];ZVX",H7U/:A=7T3_>W=IPO,
M<PZJ ;01LG?'K#COU)?)>G"<N376'$ _P&A6+C#O&@'K=0':Q0"SK0"8-.O?
M8JK_:^7WCR?U6\WD_XB+JJ$>_B)\E4W5Q T^5OQ_-I*>\?WJ$1?E(LZS$'&?
MPX0EL@]6PB')&(=>REB.J<<33ZN#I<*<<]O@/4G!3E3P1RNL9A1,!7(U!\$R
MD(XM@2&&VDZ!!BJ6W &5&2=U!#0@.'8!=%XU^/@OEQ]^<;J1.?[OQ$?A8545
M?*W7J')HC+G9#2$KV D+]M)J> )#B"GX!9; <NTE7,#)<B],%33,O(6A@:?S
M'134._ D5)XW[H37Y)'^5U'_?+=9U^+D4&USV5[VZ:8+XB'*(\(A]K,8HB3.
M8(8"#_(H"#+DIRF/@\4SK\A*HRF>RLPZ/_[^_.[VP(Y<I^+/O-SPFWU[/.TN
M>$K8)UQX=EY$H!^S$"+JR_@X0Y"DA##,Q"^$Z/8WM8W\I+Q;4^&NYMPY0-.Q
M$=]*#/X4(H.MS#>[ H27&["7VVIK0AV@[/4H5)IUZF:%.E"<Z5JH];J^_R<&
M^;Y9<M\CD7];5;=L]51S]G&)'U2]O\LCS,VN"$FA%!5(6:%_0(S2B:WN!@X
M-^X$VL',L?50@ O\(66VY N.@V+D"0X,.YD?.*Y:WPM4>-J<1&Z?G+JKSO.#
M-&,X8C"FPMM#"18N'\,QQ#S'&0]9AI@6(\3Y:>9F#1K*M'XVN&%QY 50U7R*
MZZ%R; 0,4#(BE[L,@D6"N3.33$XR=UG1<T1S T^;F0#92Y=7]8ODIY2%AA_^
M9U,\29-^+\;K8ITYIADA>0RIYR-A#PB!61)1:1D2A&@:^[%6'9'"G',S#I_E
M@>.S.(4S<"_^O>GHW>0%&(:856!7LQB6P71L/J[ 4=N,:"!CR::HS#BI@=&
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M11'.&20DIQ#%60@)XL+89SS#69S%2>AWX'XHV730;B>;!%@NG%)[D*K:ZVM
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M6H&F@;GF=L+8BBKI8&3P;PVJG:QZ=GX(8#4[;0DVQW9VA]A.3/!]'#)M>ZD
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M^@+NWY[;SCUM=R<;E!<"(*Z8]S^ U'BTY'J07#M$ _B /Z2P#AH!GB)Q=1?
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MT6_TMLR 3?VBND14FQ]=6'*[@I^D%*R*O.EQ\3JHV^8><T?7#PX(FO3:PAV
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MERKE6]3D@@]J;Q#=>D93;7@-<0;.;B%R.4@CRXN&MBNPH^XB."PB;"Z"9:*
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M<]C\<]O FOBJ0+@N9EB7^BTU4R#3':WS7!E'VNRM3O%DQU$=VOSXNM2?XW=
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M8Z7UQCJB9,1+4$U>F57=^+;W/I7,(@WA=@++:EG,Y)9SE"=JN=N0K0/.&_+
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M6^H>0%>7Z]Y =],)G;U0-<#$E4#LFFI:86; ])$@,GG'3H@PG=56O"_^_+[
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M=/'0=GZ;88O+8UCZM>Q@1$;>I>?!<%8D\2S[PXJE[HTT77744PSLE4,]^<"
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M2N%9JOI-&72$J\K*: %>MP^X%E%JZ;<\A2\PG@V_PK+8^>UD5NJ<W^?/_ML
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MVP.H#E!#HX#:O!/)7&6+SB2)OA11>HM!E&&&".XEY;AGDJ]=V?H,27UG<7N
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M=W%U"M.OPPBS3Y-1&D@+SD24%U7)$RE<)$%H2T"S:)2B(D%MU#U-3;])^"[
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MK)Z?/]7 QH/'=I65T:9AVJ>T\U0EJWV5KGX'):P0P&DP@2@,"H@LTXP=TY&
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MF:FSE3O6==_.]AU&"UO()W[^:#%F<O%H^M6W\HSZ 9/.)(GBU!CC9KKJ$YJ
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M'+_#18#I0"8AN.=EV$^9JV%!$1\H$*Z]SDBVM;N9[UW@L5RR'X <H:S[ZCY
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M&Z&X@_=W1@+GO%>)> F+5)PB/@4@.0>F4PA&YMVBL;V7[K>-4 =XZE;X#1R
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MW!8\P#7COU[??/GW(4Q+Y'3]ML1-B_M]34/R3%L2-"^50$80FR(R29GSW$A
MQ[<KR&ZEK!$\GA8V3X&WG@Y;0N;FF?:0O]4M&Z59X 9G) 0,MZ1/I8P[9K0
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M&6\/1](K(PB#ZY4U(B&>:Q^<UA))$A13&+:L+_W<K@-9=?%6' I=H=93+PU
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M#C (JK"$.A/W*T2>3T'@DS>H@VBQ=LAF;57^;J_B_/5TL@1# A)=-7"]=W1
M-IY8.*9L0MPDBQR)%DGEDS3,Q;3==^YPY._ M^IB;" -[XCTE1)W&WYEYF@C
MN]=Q$M/HOB=F8#IY!GX&RVUI>.X7Y\"]04Q3K;0'CUF5?@%PF**Z,>9A(3:
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M]J5.^!"MGTGEA=HR0NX:ZQ(%$A&Y ;,';P]X<CA()(AB&D?%N55G8Z3F\3.
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M^7T=,HE"^&"=0]'F8IA$%=(4?&_FL&<L$6%IZ??2!PFJ;%:KX^5IP+20\AI
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M\!9]_8/\-V?G\?_]K_\/4$L#!!0    (  &)^U;=$#&.Q <  +\\   >
M9'AC;38S,#(P,C-E>#$P,#(M961G97!A<FLN:'1M[5MM4^)*%OZ^O^(LULZ=
MNP5(0!'!L2I"'*FKP8(X[OVTU20=TVM(ISJ-ROWU>[H35 0<O,J+.E*%).G3
MW>><Y[PF.0CD(#P\""CQ#O]Q\,]" 5K<'0YH),$5E$CJP3!AT15<>C2YAD(A
M&]7D\4BPJT!"N52NP"47U^R&I-<EDR$]',]SL)T>'VSK10[ZW!L='GCL!ICW
M+<=H:<^HDA(M^WUWI]KWR;[?]VBU[-?V#+_?K_S7R"$I#D]I$CD*Z;?<@$6%
M@*KUZWOE6#9NF2>#NE$J_2LW.8Z(*QS:YU+R0;U4+-5PL*1WLD!"=A75-0M(
MXG-D.*-Q><A%?:ND_QKJ2L$G Q:.ZK^9@I'PMWQ"HJ204,'\]'+"_J)UP\"I
M]>%MMC&D#EE$QQLURKNX.^LN8'TFP<#-E ^V%<$L_EZP;Q2I.'S13"MEN&EU
M';-M0[-C'[=;ENVTS5-HV\>=[IGIM#OZ@AI@M? L."?M'K0ZS8LS')F',[/[
M!UXX^A.^;.T;C7_K/_Q9:>3AQ.S!D679T#EK.XX:937-BYX%;0=P$KOC(+EC
M==5ZIMU2YYP3"YP_S_'KQ'3T4=?ZWNXY7=/&PZYE.CW 6<^[[1](J:D>;[LX
M*>4I63]2D(O(I^)O:ZCQOJ9Z@J3ROOJ\.9),Q$1+X0+LB[,CJPO6J?7#LN>R
ML-[=.AT-,+MC%ZS_-$\O>NT?%K04V-I'%QKXYO>N92E^%E3"@^4^K[I'?/]O
MF$CFCU+%L<A#,=0KU7D>X-62V'DJ">V0G8 E,$=Y\ (QP=<O6[5RN=08<[X2
M96H63(QD7AK-EK?T;.EIGHW&[X!"'!"/ O5]ZDIV0X$DP'TX(\(-P-C-IZ%X
M X0$UOT66YA"K%%F_1&0R(,^E;>41M"B=TT^R$,[<HMK%%2ZC36*1<GDF>5?
MG0G,7K[[_00LY8=CP1*:Y.'TM E>GX#E7=&8B&LXHQYS20B]81R'C":K%Q%\
M73T<,ARV6"(%ZP\E%^N#1A&:)&82H\=?F/JCK@8)%@#X,Z""L@AP>Q!Q"1[U
M<0X/DH"$(00$35T&% :41*I:((F+K*@9N#H_ "15U\TK0:ER$<471*^7!KW5
M!OL4VE:S[9BGO;?F:C(!J$ZF8!L1W"]/+,R;>_G,MVK7\@C)$ MZP_@P"4>@
MU8*88)%&!<$2DPI)$!HVCPK6G1MBJ:EBQIB<\>@!,9/DZ-@5GLZ)D.@GLDBX
M>I=FHBL+H5)2L;=4>VX#2Q+_5^1<"2(A XIFF&"HPSBGE# @(SP HH(R2LT7
MJ!S)<)02/O[/:[K,]]Q+>>P'OFSM[C?@ ^/2HPD36AC^4* D1"JI22^55\ :
M<!SG#T-$,!)E?BUUAPMYL36XHY]7%J_WLANA9;MSJ<J'KG7<Z5IS=4V4/I4J
M?1Z&_#9!<-<:;RV:F'@>AKY"2/U4$#\SB8(QMQ6S)%@8Q54G-XT)J=2*M9VQ
M7#SJ<D&4BZ\/41Y"4>8.>VY O6%(83^OZIIK*J$7$+2_+HVYD$O=_YR$<-5+
M+B:>U0LBCX$7([32YH;*I&"N0RJW </R&XMS(B51>]&Q0?*\.J=^JAK4\^YS
MX45RX$5\R4=Q2N6-=THVA^,L1SCC'O.Q1%5#5@^V(@!FR3268RCAGE5FG*";
M]-$]!FF9I;IMXU8,9C!8GW&]^;2:4\'1Y9''% \Z;9X 95;1"3I0B?DP&FB.
M$;V*#L^H1$@MYE)])FU&+;.:V\0B<%X-O6\LIYNDYZGKLMQ=I-&BE8?X5=H]
M)U<4VI$""BJ<J#3V*"31=9;AHSA[*"\BAX*F8X_3)&D=/8C]RORT[/'MOI@G
M&KYU04.B^HQS;P".[U\\D)!^PL.AG$_R@OLEC[\#\>!TKVBA+RBY+A ?Z>LD
MO"6C)+?T.YAS=S@O(ABUYT++4ZV[ZO/F_K]MPV7;L:U>#W3-UCG./YM?O'87
ML[&G?&"<-1-T-XO>47>H;G]/^M.I[KMVGG,:WV_N%F>"84JC;SN5)'U,KN[-
M2:!;*: N0A(GM#[^T?!8$H=D5&>1EJTF:DRNL8L+W% 4L4O"C'<MAO1R9@#[
MU>).N:9L0.+FI3=>.#./HC:/;>E-7ZL6]_;F7RT5C;G7GINU4BON5I<P;;%6
MJ;WYK$L407FA:;>UTE+%(322F$3?<M7<$]]3+\=W8$QZ'H6XI^A(@;'2AQ4>
MWR"Z-YV,ZWN&*E,,E10[N1E#WQ7OT_<?'BOU21PV=E/O\/?DLNE#9P)YFF83
ME#D5S[0RCT:33:Z?\[^YO'S9VMEK)/H;FH% F/(8HVZ3J*26R[>PT_<DCH^J
MVN^86_ (3HA %<_R0.^739L,Z*)*RU(LQ#B&5G2R@.4*\T!MK;'YG/ZRST^D
M[ ]LL8YZ9OES:/''>1Z.642BK*77Y")675"T8*056.%1\=EL^!.IOT<CQ@6T
MF* NIOYYZ$FE_"OF0H\/A8N[_UBFK3HS+U3M?9?DB7;?M^9W=-Z5?JM'1S^;
MD?\"0B:(2@J!RFPD:(/?UAV]=]B67_Q%H\K#FT;OI)<_]7K TE[0*"_007KV
M)GWSQ&I=G%H/#RZLD9E%VF'/,9,]933C^92EO$TSR^B;2-87[+7%]^0K5>_V
MUMOB-KZS\\O&EV_C#P_B?$@KAV,N!N27L:_'V+?3%XBW]8O+_P=02P,$%
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M3Z1E%"Q)AIY*42 ,T@@R%"_-?ET?1Y>0>,#I!WB;UXUL [KZC+XTAY]N)&Y
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M79)W70%$H[T#/WM!$HK)4L@ +IV'("M/AO\ZOOS8%6<7Q[VND.)$^?)61DK
MBR[TNR+EU382_BB,HO!614W2'4ESKG!.L0"]XT3>! @]47YX*Q8R2I9B!J1/
MPBX1_1^?/EZ./@PNQ/$O@_%0' TN_MD5%X.KL\N+P;D8C,>7QV?T"=<BH!>6
MOIC(X LJ-AG'H>/I-8&][-UX;BI]?]G=QM6!=PVC:QDTN3JP'Z0+"MB+$YS@
MC1+R&@V&:1@55@ZH*>+4F0E'+J3C)4M>V"VDZJ#X.H/K1N5.3XC/@:]B$#M
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MJMFT;,]5(PAPMUMME)<!76$J;8T5Q]V)R:8U%O$LO(U#+,?FT.-,!?JC0VA
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MB[A,RJ^B9<AAYE+@E2H,O'R":$[X8@EZ;</2KNCOB>/>:6]D3]'V#O9Z;_=
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MYQ.];Y6/B/Z@;8KV3*6?I73=4L?$K4T;_-I,'G[P@TSL[Z9&(^3(VH6#\E7
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MG;U@'CU6V 2)E6[;$,H"CZ"96-9DW5A6O9_:Y>(!1.' S65QTJG:S65+-.]
M%YWALE<.]FWL1-YD^W+'C>B4G9V;)H1G(K^HH!H4R+"L"J$([7-.3>"F$E.A
MHIY,EAK9:XO-R(^"91S#;O%<3T;4+^YA_FJ;3K2IPX'C3\TG\)FS,@5+1+UA
M;-\_6X47)#FTZ@R@6AB4WS[NGO[;CK%@5W0FUA8I&)O(G3I3+YRG_C7'-[+
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MBJVYB>$!%[Y_^<LI$\<0_*\*:587TC1 HNGC*@@S>6X:"LU$M9TC#HK_7TE
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MFVY2BX=,/S);D=?P%MAM.8I\W.W.:1( ;K?GB/C?]CQ#2QFG\BE=,91YF+:
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M5HI3QK:#84G=6KCH=$I0N04>&Q6,(Q)#D/P>&R:^BDT Q.D)<J^,61NB15J
M-ZF\H@Y_ ;7$--K+U2N4(QS>KG7PI?JDA^]V])M?LHP3!C0SVR_#ZJ!;0W2N
MP8M/I4>GU%16+UEONII(:;$ER;#(< V"!3P-!V&ZSKX[PT2Q28F"QMB)+*"0
MDZOB1E\3J+Q-;X"ML4  U2ML(Z.Q^(R8T8=8H+K 4@SYQH?M9R!0<V.JVN,.
M+[OCW./.-!,24,8>6[ZLNL:^47.0"!P(P1>5,.=T3=4:"XP?%DP:0.%-KW'J
MK18^@;KR00$SS05"\N.LF$LJAZ.8?\#VK9*4:QRY ,*@EL*#VM,'@7BE]*"9
M69YSJ\:Q[@.-- L$_HXBGZ>."D!6C<A16W.W,_]P<'$0+33\+54JV(S1*U*&
M9<6P7M3$"&Y1E.=S4SY/#\+C]Y@)(>ZO46#81H*)U!A^B(VE.,XIP^05)9]]
M=:=[3.'K\S*IK4IZUI\H)?Z,I)VD,MB^;@8FF7OG'/PRO& ^N81+Z"K<8'26
MM>IP6/CV*7QBRFV/#XY^&@1US FS_Z;8?*IH<X4[*B9$[W4=\GCTV97^Z]G3
M)?_ARZ]W;#=SKQG%6Q]D5=O-+I3$Y@I^0]9:9*FGCDU'A"OYN9Z]UP%1_0P]
M4+0GTW=O^!4+4=(K1%@"RL_:,<*"\Z-C%9,9O$*+C]9O7P5KLAB*A&"2<&S@
MGJ<+J\37)Y>G8W&<TP=C<=SWY6>0_ _M7HC^J#B7<O3LAR/$#2B:Y54$_PA:
M7F)I5'0VEV"'GEA/VIBRID.-6R2E' Y<@<KWA&UX]QI5.+4IEY:O!CL"3)PQ
MV[!C#CYYB: %H3J>QE[S*!T4"PJE!"T7V\,EE>U#-NW,+C 00+OT]!_@$AV!
M!87L&WYDWXRT2*LYUX7+7(IR Z>2K3(4!!N&E4,.,02?,<!PH:4IWO_2!Y:Q
M$Q6(":$-R:\-;=ZJ -7;BT632G<@:.2,AK >B1&(L=GI$7;\D/O]J\STVHUV
M</AB@"SO&%+;D>"+2?@:7FT5G=FH[AZ413J*LD1M.%Y#16(^$Q1[]+_]_OK\
MI8 (%8(J +]QWH(\Y((>,F >G2$*+5FDF%?SL-DKZ22TG)T&KF"E\EP3-(!$
MG&?@6FGJ_@,/1"(?-"-[_W_K&2+^1=OZPEWEG_P\!^GD\UF3D?[2- F_4IOP
MH45UN'!\^*RX8-R<M ]41X:!;@@6'3)M^."\3>9Q0:O"?^\F[1$1+RF%FOX+
MU@[6P<[IA">I*!W6!<%"()26!'3]JVV4SN^7#DVU\4C?K68[)\ ^#/NI<@#)
MZU9ZTT3PO;/]5Y36HFM/F8%2S;<?<L0/8G?@PF*\GZQ@7G,U2LV.I,:BBK^C
MV%2Y#Q(SOTKUPN,CX;!9&4=448V0E,0WBN+ %Q';ITF<2$+ Q=M*]DHP,U2*
M8\(U4S;Y/=9:/Y94T<8EU-)]$"PG4I6=EYQ:BZ;,V2;9\\A]%3T_.#P:AJAF
MWVA>!\D9C4IB5TJBK!#Q3><)Q;B<8?IJ>&<L^E5A&U(<'1\>'XYO?$=O/"N*
M9%CD[B_?B30 E.=7'6#[\>#H<%3J7_,6WPL?8F:[V[D[%><58T2$$&A-9(:K
M;X+,$9'/4:IGXK),^I.>6T:F\ >">%\DEJ<[YJR3J18H=:XM_$YP*Q_*?-J+
MZ7.2_,%$5-2Q?_'N-8,*Q.X+'VL@CBZ]OR_\?YR^>G<.O_KP2O[]\I\O?^4
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MRU=K)M="R9!0;R4P<!+MM95:X<Q&/I1=67+G%T-;;P[N*8"1)\''<OUSQHP
M%Y3*WT<;?D=OOJH:VKLJ_SBT"/SC_:_$.H,Z!H-<<[56<S1MQ?@D-$[J+N@R
MJJ&^(9T?FQC9=\%:;-''*GM^^*OF4[;NX9%LTV OP&0>(!,612=H-7I; /V:
MV,@?1J)++24N9:GR)9_;! A9<B2DA]N/^E8$.78&_M1B 0Z:X<1@N\N[8]LH
M;@-4^M>:[1*V' @*W96[4\<5[L[2S2_\*:S)&?J;+BF!.RNUG29WSFJ&Y<]Z
MQ1X)FCQA?B/P0OU11H6^&X7>P\X[M%XWD04*.K0(#7^7,*H@;IDB%M ']+%]
M&N9E(+:6-3T8,50SAV?:OM@C)F8N8[]\GRXEUN11Y!Y-Y+QU'SS):L0O0=5^
MARPB*1Y)%GA7(&^BL))T8538)"Q#C+CHX9H.A!QQSO!OQIV#3Y#TFI*N1IZ5
MU)*)X^.HNEU7NXGC+7 DWS/RO?O*BXA(/6$K^"!#7L )!EN,1K[!)C#K@;KV
MT9C]>1J')V@CI%>PK.AV&NCDK+C!?_;-VXLV)@Q'[^<>X8'I@8*'F$:P^G?M
M8(\Y95NHPY@^?*^#T",V%/(N4A%[ZW,NCJ\(B#O$9JIRI6_!6G[W]3-'WUG]
MS!==72.0=E=CA0=R-GU*$;POX^(X0@(L3<,X]E?T@4LX[(F%@]2OS+%+JA 1
M?YFP KN5319U/!EW=#**1SNT!68]ZU/"%6"_XS<E2 @GX$#.4_K7^.)W\^);
M%/%#OW_5Z8JEZ@+?\?6C]UT>\E$N=B879Y] #3?ET%Z9A=W&HX0MHJI9B?\E
M+<X!?&^3)Z6ZP7;H#/%=SO[3I->85JH-BJ]?$M@-.)@.?SJYV&^;]=YGZ_BM
M/569W!18E=A]L]&U25*E*[HJ<>W?,PUVW:);G.A-2I >O#=D6\.9)=M;+V<F
MXGGJ9<S?ZQ(M,L_$YR).?]3@IN.^VLV^XE?T7I7#:]O^WC^>8>PCAS#AE5^T
MQ4^15O%V3C5BB&!\^E%X=BD\3\Z9/T/>SMA&_> VZJ=C&_57OPL&QX)!R><=
M:$F"BCV3^/F53AHX[(\/#@>@N[#TYP%I*4,HD55"%M$,IK[24OZ[B9AO*#3R
M<W3\8"?8X/@)XIVM.4+F%Z3E(<P9%TMQ<XG)\7S67<#B^L!L+U11 D^.I5X.
M1@<; M.2:93#I)C(JB,NH$Q8U?%J1MVP*]T0NH-#*XE>"D]):?K21X%?V\PS
M2L/C2(-71;QWIC<53X?Y=E8VMNZY+RE/IA:*TVV5)N(P2D5=I%8&8*QS3XOJ
M<<O*895=I:D,&RLTQR,OJ*M&+VA!'2G^6T)+F?(?E+^[\TRC. ._);?2MDDN
M&!D&1L_^UO?%$?=SO40KI;3,R1QVJ+<0^HPZ:$<Z2%!-T^'1"^DP*JH*#16!
MG?'Z6T$H2L7F$7\Y1>#DE6($94&!(89L^T ^0O,H+[N2%SUT%J8_+D2L:#[N
M-WRV LVT!,% 2=',)5@V"%F4I5BBL,YT@E]>;=9H+!OH<)W/F]6L9/)0;I1F
MO&AAI/=076/!SS1GGYF$'Y&UEU.5]S7Q=3.+9\9\IPXFLP.K;=&S8\L7S_3V
MQ2U(VY925=CDD6N,?@0.#9<3$#6JE*]3P%J!BP,'%E9QS$V5@*IZ89NF 8ZW
M>VK3J"D=.V%UNZP=<=%19[Y!YB[D2)E3X-NAGA,H$Z\8V)YE(HY1^\73[=W@
MXR;?U28'AQ$D<?_0W]I9!\=WZB5>FASW6YD2ST4"[CN2Y1*"4\PX3MKF1'QP
MA.H*U,43<H_MCQ!XC<NO[HG(X"H.:GT?WL519'<DLC["\."F3.@O^^B"E7@
M!D[P*IVA#''$1[J]3S%S5Q-(N7DBEF]ZR%]\ '=2IF6!J!]%N1'VB#"PI?QI
M&"X))-P5-&;L#M)ES0U4.O0#0&CA5,@E-(V3O!&BUV G^+6 [YVBII1+M%#7
M?$)N,^5QOG_[R[,??I:"/0E*W8;)N"H2V_#%;!G-&D[S@!2<V;Y3;()R6(V9
M7L*J%FN8!/Y20AWA8UI80EZ_4++BZ,/I:81%WOF2*+R1_M9L<P.>WPFI2$T?
M3]>\'H\:8Z;K&RT5O(%^Z9078'*W%,P:_7#G6);8$;,:^$-2@QZ#POUGM&7Q
M<&E)U?6VF80B:F21JC'AI'_H*^'^8.Y8H1W$EQE6ZY6B!3'\%2P>:- @W<H-
MKHGKLM.?$,//H_K];JL3C\?JQ,=;W9Z"BE"#QD:IZM4Z*S9:]UV"\I[H#'6<
MZUSO5;%&0TMBO&]S^2>6T1,P2%ZI.:L$2BS ;"BYRQPOTOGC.E/([F^/Y#9Z
MR / %5+!1ZV.'/@;5"="1<S1=;#')6I\>Y#6YO T4, A>F^%#9#R+_^8L(0<
MX6$2C,;3H<?KAL$C$_%JL1M4SJ>2\G97>BTFJYDIEJY4/(A;0TXY50;>=X2B
MW:F-*.9340YM(])!%6QXERJT;!V^;S&*P>[%8&@/UR2!"5_#F?8M8B.C+GJL
M7(R"DD)6UD%]!R9=BB&D,PL2\(J\4;4JQ&X,=T)E#;N^LR.VG30SG>M%6M]E
MRWN&VH50@J&$2_#'M_N6A@(L\#IB#X/*H1L$FG>V:1\J['9,5&6RW9(]N.=9
M- V_\\@!=_7@W5.!CBFD19,S*O'/)^9B<SE\/J0L9 C63N*!-)8^[E8MR/L:
M7BNTO"XZ+.R&'5_Y[E[Y7KSK#"<2]!1($*03\QRK,AY?*+!#^A(TZ]"2@<VN
MO^F;Z/>B_!B=8NJ)]'X'.8AQ+SVPL;)=X]_NT$VH-Z!BW*_H8I/D&@S0DP;/
MM"Q5.[N/'=&T._ MX9Z715G06?\NK\&Z+79VRU.5JZ1UP^MI]&^=8<BNQF03
MKNG_T\C>F>SLMOZ8[LYPXY=E4U4ZJW9VI[.F+&AL6L6/F]TM'38S4A;O&M\0
M(P7L:FR%S<0::6@,&"*\%VPTP9]3!K2J"X-;2@ZQ=W]VPW%3P)WS!-_A6;YT
M[X_Q^#QK*2^$RN66"I+IJ#!WI3#SY1."!'RE9T-7K@E0I >DCA(5;^?C1;QO
MHGQ#.'6$-+Y!1&+#]^Q_GTPQ9X\/2SE"RP<\RM%NY.A7S'EA!>!)@DD;+?[K
MX *%^0.>F)*).1R%H,?/,(#'7!%1688N2@KYW.-2F:$R5_)QO_1RK3YJIH$&
M.2V8>-U@L5S#.B<IWT#GX+O.M66L#BBXPO2)S0FY1%")N$.IKFYU>%'G&R/5
MU7*.>V&W>\%794/OA$"M3KQPI1$JEIY.MF]*R0P_NQB20?@X8"W:B-B*KG?-
MO78**OS<:X==EZ#3T[4K,$:B;09^^>OQ\QA6#_]KPX#"K4QR%Z_L?2VQ#^C5
MOHU909ES$9+4]V71[5.TJ=WIRV!Y^EMIJ>=-?4I7S<I[?GGJR3*E(C!185(\
ME\,KHV"C7?@I6V+M"9)EYLV0\8IGVD7=L&\%H62D(JXUX1L$\S7)<HQ:CCV\
MCZ$[N%!Q'W@SWLWK GDNCI[&T?'A\8OQ)>_J)?,&'Q:7[FMML3UZ-O;7?K62
M7Q3)QA0[#:W>@LF 58#5HIA0$W3E&#Z:CT2!3[^S4J)QKYJ]VF1U*A5,9?0^
M&Q[!"[SY8$[K3)$_38!O'*H,0)5AS"-P\B=/"7[R[/S-Q<FHR'<C'+_I&M5C
M,7BBI9\,.B "1#+"E.9*W378IC;UJ_OO13 8;V,8W!J>9%(@BSYN7+)2^\0U
M4BJ$<+\>K]$^&EY'!X<O!@!Z\+D\O)>(6WZ>UE/C6QLTH?F\I/YWGV^-ZE H
M7\&U><IW@K'.O0)1*I>F;IX9-]Q;MO7+VYW]V,;Q[I[B)* Y<F-,'0;Z'9&%
M*^KNBHJ;'$:\2M>V2RVFN,C:-ML((R<3I!H "YDATN+-ZX;:R!!%-[UV&9?;
M@@:6-;VD=AU0H"#=>5+Y#6 )AAN1C=66S",)(/X,Y,I\I[$PHD3/P_9Z^@O:
M\PB,[3F'.P@52FD1_>XW$P/T[C].1;AI,CKCLJ%>J&NW'*@H[!RQD+;DE?,"
M0L%;=3V!W3(E";6826?JIL50UIK@>%[MZ+PJ\B>G( /8;TG0?/B.!CNZO@M:
MCMOB"PZ4=V_##(?'DV1$\OIZ-_SOK\]?#NVPH/B_U@EU YYK&/*:<8=1]9OB
MH/&%[_"%[P/51XMLH>X2>_AB\;I!D\55>W?A_AT(NL?=\>Y:@^T$,V!YPE&(
M+6_[K]$D]286&096,G]:C)+&(TI7F$MFQ/5^]LEIGY>3+F#4W)''$D\\,<&O
M&S"9JBMQNMI3:4^CC7CF7G%WFY6&-D)%"UG:!2VMUP85_:<I)'%U= 03__'G
MP\-(':P.@H5J6\.]"72JY&[?:E86'_DMPQC%,@<)2B(+!UP152R/F^XQ96P\
M@)>W3^NP:$JTY8= >#*[QZOW4-CK6JDT,;NHBJK"CU[88(* "(+'@8PKL=MZ
M6TBI\"K:,1V6D+$L^3'.)IMI^+<&[V[P8XJDZX:G8H2-%2P"BM?UFA0D]?;3
M_]S<W!SD^F8#)@MHO8.B7-HV5TO !Z+9E",OY:[$YIV++^Q+RQN^[E]LYY<!
MO9< ;%'ZQ7"FC>J=5S9C._3OW_V\I8^KU:1%766F)XTHH IGW+@FLU$R=RV9
M@V=Q40";?(TGI*O?HF!=8L/!^+=<XQ"]O-*WV' K&'X"_J#GYPMM,%J0>OS3
M6N<$>6?I%@RH!8C(*F<@.P=2Y!>048XAJ,D+X/)XCG@1WQ%G0ESIS"J&,\?6
M>JK%E\@D\@*6S;J>$WEG5637^&UL[%D.%=O&>1,A!:M/2NEBP2?A<OR%A=R
M)RUNN*61_J1(I64;LS_'0L'6\_7 ^?E5K&;K2AV;^<H@R&SO:>W F(@"DE6G
MYH$U]V4C;0!8M1SGILA^EK&GA40"^A.,33T0!L?2 @ZT&G#I%F5:R>(+XHBA
M*/ )"N+HCR(5@ &-1'(9")/D^!V;-S\(\4[QTC:Y_ ,![A#!2]7F"_?OF/'2
MS!?R#\I 49,A-7F8:<Y<L-HK9C919[]!-;:_H>?@ZGD)8V_IPEUL1701Y*!6
M[:/WWJ57CH+AWJYQHAD6F\ILPAMW06GLKQU.4A646&I*#\Q-6[:@"HT'PHX.
M!.E;_U9\QP<^?J@LACX2_]'D.CKZ 8LVC\:BS5U).&F74P>]<ZD^#=YLW@^G
M>J[!"DKIA*%)1ND*'?R$>T_@XB83?,XU_$-T+V9T=>EC"QD8,3KH[9@6+.$/
M,$6J).5KZ0Z6[Q3N&F1$W:"5/6H<W:H;6D!.C9<0.Q<A;I,Y8/LIG&DT:Z[6
M\(^-AGF&;"A/\L3=+S#\ :-P8$[UX,3*#W2.6+3<#6F1)OS0HM_;[7IXDFX:
MF+QF, ?X2#,Y,97[T+3V5W$7$*YHHU^,)8K/'J#BQA+%;TXG[X,B)G_0UZ8-
M&O,8_%^ML0^U*>EC Y9()2X(E9\O4W"G2"$5I?!0$SZE7\7"2IS+>$ILD>;L
M X9<?$9+454,,D.U,ZA&":)9].C&ZDP&R!8M9<SODF#\K9_@#47Z<EU[ZE)<
MB5M49@"!TSJFXCZ]*,5+ME(I>&P=]1_ ]FSK'H2B7056VZNZ"KZAI?.U]S[E
M(DPYPO'!T4]?7L+'+OM=Z:GMV=K!#<A.LII21F!KK5'5$/ ^O.6KJ+#/$"8]
M*;QEO]--63! 28@_V4*4$)0-C%%\.+@X> +ZB,PKC&&1\ELL$#626SC)#BFH
M]I"[^6E$A LC-8%3+2B+T4YVV1R99'(EO='BF+'?M!,T7;BN*3VM2V++KW.D
M[*(D2#=!WKDW5F[:Y<+GI77$G]'T)Z+;$P%2LX#D!H6,!^*G1 8?@ITDPC&:
M5=^:C/MXY_MX_[8N%I;T<FMP[W#_!HP]D:+:$5-C<O^1D&[(5; :@)@XE',2
M[>Z&W(9-T [P6@@^"G R!%]OW;W1'R"KB%ZTB4I"F2W$NZ+MAGM#@V8:J=YW
MMS$HE(^IER'9S[[F@E-N6/KIX/#99#Y6G7X+^\"2HHT;8MP0XX:@-.NO>H5X
M$A?U\-83630KG@\E?4UJ$2'ZUHA6]P%I1CC\8#82?F=H$3-ULVC !#>(>#W6
M2(8:(%-^44QK=)^.Z\QP>*$-]FN1:XP2\74'VQDM1G%\F#C6>T QU)^UX?Y
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MJXB.T(CK)E8%>.NEQ@Q9ML%V;^.KRVL:-<&.-,&[P?M53=7]FK9GWJPBL/I
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M@H9%7*N->=X9#6VFUGGR(A\K38\>H$C&2M,'KB[&L# "MFW3R'=\,F"*8EZ
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M+5Q+YRAF@VLT<9J<1A.*E05%/;LJ.!:_AT)MX)7E3Y"1PV]!8]<2J]/0=]O
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M()G;'W1ESA.Y;\6 _F'/#.B."W?"(9]!S&5I#G'B2!N!&B."R(T+UW1=4*^
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MZ<>?P1I<'ZP.XN@W?<,W^KV T4ZI=ROE;F;8NM'DZ90M2T<$X=<4OC2%J*_
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MM2V%OGG@"TA6;>NTVW0%I^;R$E]+_"A;+:W%[V$N&'XZ<R&X(G"V=1E]/P7
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M[%N"UHQ^ITF$@!0;6CZU-OV"2!O8AW8B@SV;EGVRO8Z8]88WD%Q]EV(K,HG
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M?5<5"(NB6F-&S R6V2\WJ@?0:OZPNKBKD('OPARW831INPS"#XX\!!SQ9LE
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M6!!1 :*W3_IP9_CY?V 1P __F>[3,C-_>%L#2@&^LW0%.O>JL8TU"_FDHIL
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MYP\:=>:MJA^?S7&SW?])'IB@TZ<_PCNG_2#)VRI?$+YP@;-/O03VO,>5O<I
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M+=2%:*(9BV)!-")ZG=B_ ,5A2K+W4,>VU(9(9:5RC+UN=2A@\IIJ) -AOL'
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M+-[M) Q&[#U>F/M@>ZGP%8F,";+O.2V3)54RR%LUKF%C'OM$7RG!YHLR(Q5
M_(4QFI:WC6Z^Y)OG)"5G/O"F-!'O10X.YYO2?+3M2"H2Z'Q=B,HW=(+!/N?>
M(91/T;CEA"E46+/SNX=S/KF#53P^..?$JN>PXBF.];C"9.,MK28JKW;9)';C
MFNWB]&LK12R'6Q-B-R+M! % M8-T7QW'Z/$]#D\')_,01Y:U0QL;6,)A#M6)
MWDY/E$?EM3HYR>38?<B^Z%$X,=>&&/S)V=_F=-3TSI8IB#G,J)S_;9EPAR3+
M_\8.!4\M>K$VB[_:0<;@KRJGEE?[R1SEG7?";$HT30NU7&-)M4&#FR-M<V?,
M:W'<#M>,&FCGM N<R.@K$1E]83MUIO&VWFQ[\1NT"KIR5+1'QNP6J]P5 5.[
MI!MF3>U;8_+O!'XW0Q-ETTO^+$UGJ*P/MLV17]SU=(F+JJ/PPSUD]K%'DJ8C
MF0)Q&F]_)NM!QL?UN W<C# 0<]I#+UTCMCGK[(1C#Z99()-FU5Y [=!VB@-"
M;9UMF/3'6[D#)JT@XO>Q(WRQSNJ6V#2<BB$4$*!8:CR-#17O'?0MOC60I[7I
M0,\HQV;4:@]XN:U/O+%<$.TNYML6OYG]6*ZA^_,/U$&J71SK[@]M_O2(-Q+T
MIVUK+BDEVSK#@(OD*#?5OM78-7<=8J]G72<.!W4KJQM)VZCO^ZY^C4P]$K'E
MK+)MQ2B9@7;7R(35&1!V00F&GQ\\>BR!MC!ZL^66?P'P A-8_-=$T'A558,9
M?E6M.^<'M, +")_"GN4UT:I2 3*KJ=<8R[[-@K,0MRYNRX4TS#<Q.H]P.]QB
M!19%MR)X9+:&&5#SKPW>Q-;L<<F9&]W<\7U2)UVJKQPFJ.3 S*1;S+%9<-U2
M8;B88'%PVQ,7-4O9]I5%+'1@KFALA0Y]/@4=G;^D7*77_/YCENUIJ:OY".?*
MO!'6<JWP5)U=Y> $#_"GI'7>..)KHD*1:XQ52!2G_CRG[\GY!$?T43N$]Z\^
M?RP.X;8 >1>S2]Y:.N")Z@HSWF[W_F#_].]T<C7=/@.%P,PGAV[FYB6IH^7G
M"09K9JT^TU SAOS@1VVQ%=#IR<R 3N^RMJLA4GG+X@13V,LWVX2#+]1;V5MQ
M.E%=L:5)5%//;+^,5F6)L^']H76!%!&O_6KF*"7KJKLP'O@GXW7E7/=@KF?P
MSK.VVFX9O!(-R?GNKC%DR[^A%#W)010L -> )"F!$L'MMR]2$R-0MK&4=UQL
M666*Y$Y]G/7E)2]FOYV#6;TRFP 3 5"I7A<I./3;.NTV78'U'J <2IM\DR5:
MU9XJ85=5CD!A^#]ZF0B(WF,8E)5KB'O,^YBO- W6B&F $@)V;R"!89G_ZPZ@
M3F;5-?CGK==YQZ.C)L<KB4"%*VO;@FH@'N9XC%0K@%ER54T5S14Z5:^1BLKW
M!(<"\9X2\-9V4%S#C<*M7J%"$$5Z!"O?<+3K57H"Y#E!Q0L8C34.KM088VOA
M,I7:?58Z4:+#!X!#277FBB+#G(R1\E*F.')<\XN9O#K;I6:*7$&AC A<R.DD
MI-\.=>&:0HDE_):I\G6)ZZS(L02"V+L#=_SC%!\\Q<;XPIZEVCM:/3N:_IY]
M*%['TYEY'8#P@3WT/C,3L68IL_?7Z=X-_32!VVM%-FVVFL-TR'E \$Q!*7GO
M8 PY'F]FZ^/O_=?!1$]"&]UEMWGKO^]6YA3.,7_$-SJX%)"X$AKY4'A&8OM1
M*=GKWK.:^P;/EUB5/L;ZPJF+"2>D)(2[IQ?FTQ=83;; 3WC(WM7U@=J?6?^\
M[5<.X-GZXQ'*R7JS<R)B#;L4).S1;^E*_H<9=,9V<0D!7@O$':$D#8=P#5]%
M>UMQ?Q=G/PD4@W60P5O[\V4N9N9G##'8ASK3K*588L%L,Y1A+J&;2GH \77@
M*$@M+AK_@BO.?+';(62$75Y)X6ZHO0T=%P2A;,CK"+NGOF#Z^,S950VJ\1)*
M!4 JS =JP>4CE2Q[ZG9-3(0C1^I@JC'!-:XA>[XU7TGF6V;1"81)F N2PV96
M6K)']J?MSB[2=;8Y?<1A/GW0.$S)\V+8^V\_ +#I;[T!]]P:PC[=XPR\>/?A
MS<O?7R_>O'F#[ZC><PY[_UVDI/C?MJ1XS/ZD5XNTE5.O:-K<"CO4\!XX:E$A
MXJA;W,3-?GIZ-K<NQC_JB[3,_S<E]53H='H+DS>A:ZW:;-';R]GW;U%%PKI]
M\.L</)@"W$%\"?#C,)UE?F4!S0AD+:E+WP;F4O',%D5Z;2$"?W5UWFSRM01Z
MV)NOQB>A)F@4=37.GSF-@)$)ECI"#;KVLC+^,=9WUV:QWT"!':ZQ$M[W%##A
MUXCZZ=9,T&,!"-?878=@MC0O6&]B8SS:"N #9L'GFPY1!I65U+'>-C@ZP#,%
M^1]?R#K[M.?<9>5)T?Y=$ 8O-I"&D^)_ F,*DM7YEG.HY@GL\^<E06@P<1@,
M*?PM,Y>Z\8>1W@I=#;XLIR64[-V#"*'-WIY;XOX%K4B]N5^7F$M,5R8T:6\F
M:ZCZ8$Z"AA)B!.QAI00-Q+*M^[#B,,!2L" , ^TGS,OOX?UY.])77'H-;01O
M3Z8_0P8,"\APW\<-F6_MTC1><ENM/T+_/6QS?&(IWCIO&,R"NU/V*5MWO+LE
M.H]P%G$RF+JF4" )5)$+-F'XYU7.0!WK;??1:IG,:)$-T0) K-0DNNTJ=0"2
ME65= 3-C'.NKK(2?3<3JF;X=#) 90&C*%+$N-)XDN 6/28PCE2/D9)8]<[(#
MC1-, O4ER&/P'T1!OB 6/ACZ%I_@(JTW!8,U)7Q'"J$-9_BQVE!)UR[D8O&[
MF#-IX?$>BFF96W;N/X#E"Q6]X0A!_&5:,-7J/ZJ%X"RF:]GT+,Q)NB1E>'.8
MT1%)XN1::Y.RYO@>9KGAZF/GE)39(9D#V09,T7G5*4[LKVXH=></C3@%]IAG
M071EGJH5IRA0)G3#0-.Z5_X!,\B'-/Y,U]O:9VM\B-D^JQ&>^GN>@<B+<0M"
M8FOK9EF090*J@C14&-7#8%WE52'=J^]<T@OVY._IM38E7(L;RUV:&ZR';H!D
MG,Y#8<8D]M50/Q?WH?&,$@>0=+U/3D)0_F;,65OCBUE+2BFRZ$.290U=3%+9
M,;]-FR9KJ3@)7;= -T1O+%J_3LT572VWPJ0N0^5!G.'5S5T>@G'+FW#@W&@A
M# )FF!=KOI-DB93)816(#C&^BOW#H<_ Z^TNR^FA6-]G,[.^#EUO.QRLZ>TY
M]B\Q3SR)(39VUX<G@Z,$^Z2M$%'/J7"7_;6<@=AY"-X(81.,EU*@3V,^G%&6
MP 0>;69Y)8W_4.TRSUMKQ!E 1PL8);=%=0T0#]Y'!*D6*CCJ(FK69N1NLA1*
M))"5?F4LZFYEGOSI>;)X<O;DS.S%SHPX^7.O:V-A%O_Z?Y[^_+?%_U0= '=_
M?XO16K;/<-F:#6)\MS6Z99TY$=#&2@OM+8]AXJ6Z94>Q]<E_XP_[GUV9+9Z>
MX8.>2Q]#3H^*(WH)['1;NW@J:LTP$_4>#B7W!S6VG,*!F+0NB/P@"E!/;!L6
M7<+:'RJ4@Z'"]ZS,L:327FI> L]6=:"J=>#99H6)A[\VCM8/R^$HU!'EROJ/
M%R_>>OXP#.(/&0;Q0'%)+&,[F[K"6'O59%S_V595:^PO=6*'?21J[! '(]QZ
M\RH_S$#WYJ@/ASEQN+S/85U&+!7Q-=G@M*R(,1" 7%=94>W%;5KGM3FPN5D<
MBYMHIU/T2(G ?#BIA'[L8#YII!IT!+.L7( ?9^8"O*W!DNIZP;V?[*/96K#<
MGK&&)849PS9O,59 5YIR'05TIB#'88[@O:;E7*,Y:?*6.,WQJGL$.F+& %__
MQAU$R/SI<JV)CH]V.0A) %GHFOA3^1E@J7-(B#<&V*)+FW"2#-.YE+'M97/7
M"-$$7(7+Z5(]G;GV^2BRDR5G?%X[V*#QH<UI2;'&K;E@WH_CB=Y;]N0Q;\DY
M&=X7UFEYE]ECO]=?V-L>O.)HDC"LI36/2QZ6A]T@\-<_2_0VW[?HX6RS#:?2
M*#^!>; WY@(%4*%V9J[?RL[@I93.635T;7S_SKPL&-CY59QZ-JRZ+BD#D#<+
MX]6;0)CV6X>]Q<98?:A-=&]VT4?SL9?5_H82H(FY:FN=24I2Q.=L"U1WZ!<7
MX-8S>(I"[A/ZXG>/KGCVH-$5$[-<F2.QY/6&P/T6;,]\=5^>3])XM'0\VEWC
MX'U<X#FD<+VILH;=CBW@,!G&C;P!5#/Q&+6HO\-S:13_)EV!0DXB++BW<O%1
MNQ+*NW\^,^_^=V.*N> '*^AU>977E=04_DYLZU-F]""S74._ Q<_L+I(< E5
MD$/N7?,;RY\!I >KO,5"(OPA7BI90.X,H1L7*:3P%P!AY03AQ[*Z+K+-182V
M WABX9B%PJO]HJI.WB7K3Y)9(Y'O(7OLL"TDYSI:7KC"J[Q9%Q5X%CS12U&@
MH'PAL?:50!60N9>2G#L7++SZUU'OTCDY_*^=_8W.5$+4R >%!6;OC(+\(5ZV
M75R,M^=#85VD^:ZOA&+^XAN*WW,)8<WE8>?88V65-JKY<.A;ENI1HM+('6W)
MS0I '+(U#@EB#T(K^:-8CF[JDQ>\@V!H(:ZF^T#/I<CM148CO>:(GLJT4'K,
M$5-.G0+^=\EG2B0X<#5)6UJVI"FNK-F[H5E&OZI'96B^AF\,3YKY[DOUW:^Y
M@DY>\87OOI2.VP+-B#Z2<KVMR!GUNM%B25]N%.%="!:ILQ:J9\(.WL*TNAK1
M-$H.R16[+?W _<F?9N9/O@0[E;L"V.\(W *^SSGTTBDFMUC6A="FZ^ 5\*0M
M"@U):>*8E!R=HAR+F9QGL2<;9I@%5@*E6=>,YW(U#D?2^$"2_I6_$IKW*YV/
M9H3_864Z<,>B,%K-V,2\D59S\T8/9>O]/+.M]Z:\RJB6#)Q;>_3RT 1/LN'^
M<0=_B9C!F1HW=Z^QIM=@7M@%B=MQCUU"I +64S$+NBLHD.V4ZFE_3%Y0M^'Y
M+\_.'LI*_&5F*_%#^FFB:N%!9A[,$S2[&DNW1=\<A6"[QA)KT&\QS9Y^,BL+
M6&D:QI< -D8Q$DH-#%T@_AY"PD',.N]?&G_)5\Z&KH,?0BB-M?(66$K?(_&\
M&CZ/>&@S-EG#FH]:)I(I2_<UM@?KA(D@6+3 HQ<EXJ\TGC)MU'%';IFE;+$-
M*%7UT:GWP<F1U5=4<+1XSPC_Y6?7'P\[FA[&-C\_F]DV?_WNS?L74QTN>'.6
M;_7\#2J:J26CUPO)M5+D<7UI"5':ZH(P_Q1? WM3:P4FU)T:M64*&['><KOD
M#M'*V"HF0A4"R9D O\ND:I>:N^PZ4EE>9:4Y(MN(TBLVMKPMS!8_62'!/9<!
MTJ;I=GO^)/P>7M$A!;94$!8@M@.$OB"@(;9T0VM66F\:,S&GM,E__FFYV.2X
M?1.5IW*QI-^H'T4$LNPFW(&P[,0ED+!\FE@-2 K5'S,U*/Q:6>M@>_CBGD#;
MK9G7@U-#%C;Y.9/#'\,Y E8J8#\K@)/U?F:)O:@&F!Q*G(YJXUKGN. 4V/[9
MS*R5U^N/WC>9ZF%_\7LIB?_XG97$9W/VSZV;F]-YQF&;K#KX#]0N)YO ?GD2
M-3>)EB=H7*I<.(8T2XQK%*"*(I(=7J;%MH<:'R,7Z)&H&0>]S)2N/'RSS"ZJ
M-A\@^UH@C% Z.EW'SXFQN#LTT>3J-)TQR_@-?F3.([DW,IZT?:FET-0T^'P6
MT@B\B?K\ -TF?'M1>L>_^M_!SWA]8*BH&2#3F30HD=13@2U,/)8:#BQN"I/L
M &_]-22VH(LIP2C /&21I=)_Z3T+EQ:H-<41_9";%]0>S)__(J/OUHH:KT $
M0U%+5&5QLW!T_7J,K].&J/#K?@B&ISAU@ZDS?&7F-KN2C@D.#NWAE'EB;"=Y
MRW$>',\7R#^@'H1?R'8X._VXJSR[)MT-F*S&MONIM(GF>>I*V"=0=!) B>6G
M6F-C%NO$8=AY4['7T^NB1A["JDCH$:%R;]Z;**W6X(2)F"3%L$R1FJ^-CU3K
MM@[U5L+[ ^A<(E^@[Q*F37H^@.G0; P01D!>*S?1\@ERU&3<Z+,9KCU6N90%
MM3SJS-"<"MD'(E?)EJX FSH*O,B\;4<LK;3E\)/H7Y,8S'5I'+?+?+]X:6V_
MQP)&[8O[.J^L*1]^0MMP.F+0/>MM_C&DN"%]3$>]Q)1G,CLN"F.R?GAIQKQ#
M4^LJ4.^-99E.;^Y#"-C#=%^^<Z<W/*,M^5NVU\6^*D .B=X!,W@;J""QRB;%
M+ED)GIBN7$4@@DDL]>Y@@[PN4:XNAP5; <R$._<@-#/7KFXR_DYZ87DD%X,C
MKJIC=O!=N/QYSR8/1)P7\J#TV0AR*\!B@3L3>Y%$VN##XM^=WFVP9Q%35N2M
M@N?J/U02 G+"6LGXS& SA[Q2PIG6Q0&#0?=-+X2S_,ZHM1S3&ZUX8^MTGZXQ
M']8WCXC-H^0'<4Y2&SFT0!K7A-)H8'U7!3G?X#4"S0%4ANSX0G"/^%3* "K@
M&3V+Y@^(S)NB*_9F[:$8XKDQ=[P0,GN7C5+2W7.H2E+=<?PY'\KJF!NSP,MT
MG[?@SCOPL38QDZR..8V/ZE@Z?W;_H[' '"OU<AT",Z5SS?JZY/>"<]-"S-_8
MD+],=T)I3]5Z]-'YL+)1MTA(>G0N*[B!\JK5U9&ZBK^S+E+B<?)%*,V:$K*H
M$ <MMUUJZJ[71.GP1MI$$Z*&P@ 8ZD.B^FIBV\BGT9T0AD#Z3*(5V!+DV[GA
M<G )V?3R!TAL-PU55Q$3=%W:H@&8)::UJK:8!Z@MT1<=BL;[ "/#F:'9MM]-
ML9B9"&.]I)S*S9Y$2LU@M3<QN5+' Q?S?D!2E58 QJ.T '!BE,)>;T'P9/;H
M>%S5_\0OC./R,GX4E/]I/9DMDUU!HB9,:>%'*QOQVM;F98^0CL!8]HE3I$89
M68@/IW@^M[;ZU^BRHR6=LLWFX,YBUXC3M'7^$4*-HEI_A#6/>>BBNMY UZIM
MB;E57$":;X::;L)HQ;7=<#A]674F_+FNZH^RLS9"@=40^Q6$QC;:NP/=*VY*
M*W%CXAD*+2CG%$T]R]5_@ZKE[^D*B,QMO?7%VI8$+$A?PA#NLTXH:8Z#FA8L
M3&3FJ@1N01/KIY83CG8[]T$\G/TYM\:XWVA>8%L A,G\7_"%DT4N6DK,BC'I
MC6)6S>\9K OX[4L*KRT^'U$#@%[)G<)!8LDN*;$@*&'Y5V+;+1AJ0)$_]%SD
M!83F;E](&ZD8$SM:=F<$ _IK9?9&LG!*6_H['Y+%G[@Y_[^'$G_-#:C_)Q%)
MO>5U-%E.5"]D,<^."XN6<Z/6LUZ^\Z:<X/S7CZ=G/\])5/A[@:H\?X2J3&/I
M?CZ=VS[L:AV+@:%X6160*C;GT>D$N94A;3Q7/Q3[IXC(+=<I4Z(2B3=^DKBM
MB$RCHA)$B\KK\I)(\)M>55:X:$ .BMN-+4Z1/HPCB*JL7*LA<FV(F8FBU7*+
M"Q6PKT").O/R</Z#@>HG3(_YA+Z3$OWQ><<EN$ <H'.B@]B=!B"O-P0MD$=F
M+32L^6+D#V)F#NP[\(B"P \8&"'?]=82E[PNS>2L$.30V&B& WE+H!'_. ,3
M,>3P'PT/0'RH0Z:OIU2JQJ?@ZH>WOB"A9@E8>-80XV)"*6/E(060!UJH[K?2
MWNN 5?AL0"BU# =@\(DO4^(FT;S4EK#$ED+]N^)(1K;OD1O-N;7P(%[Z!2)M
M6:REKB[S%3*$11D?[M-\:N2?%\X?T&7&6;\-; 1JNP$V0.X]V\-;I_S6U'1V
MH@0C=EE:<JH9\ZYVC'3LPIP]999SECECG08$ES&FCSKB8-\!F,6J_9GX2K/)
M8UO/;D_@<5&2\9NPW>;$!TP_\O/9F%!.$LCZR8T(RA(&BH(Q3,C'#KC'(2]H
MWF-G+.'>+07UN/R XO8^.WL.%Z?FB4K]_I>??I27?5EMCIN<U6W@)V??9B?@
M=?X-*V7K@_;&G(S(>];XF"RX[%$\^R@&[/U!)?%K8P4HP4G/W!Y4]/K<M3M!
M./1"A.K^:XXZ=99<_J@UZ<0:/)N?^-KP&IYL;P9-4*TBY1<LN<L%\0?>F$-,
MY(Z1< %*69$DD</+DZ KI?*1W,9IJ$-;5*%ZET0Q757^3$14%-4UM]CR$@5'
MHC$/WF"E]012JBDRWT3XW^>T!O@$ILZO7Z;A,T2%Q6/>XR;LFPVV>DZ+BS>>
MG\'P\Q:369IH['G"?"K0'MEDQ9(M!8;AELL*J%\0KX@V84\%>U056;![?_*"
M8"\=G.BN0.,E<QBGZ[424>>&5$9/?EW:;J0,\.FH0((V)@6XY\UHM]$)V2WH
M86!$_&*;?G)]3AGT6M95F:_)7X=N'XGAY>'@?ZA0OH#<9O\EEKKAA($+C7SY
MM@&P)#B^:MVZVN=!7=8EN:B#Q7Z6TS)C16H7"F'!RDR;><\*0ZV6J1:((P%*
MQ0+EUTF3.>TGI=I]-D&(O4]OA-0(TY#U1J&R<!'P<&)N#X?RJ .Y.;7,S&D9
MHIC7^RRMUY<383('#7C,7E,KJ)4 2J4)'5^CP=>0/&XHP:LU*$<Q81'16=>1
MW@>8F#\#I .97&W>G!^%7J'.KD!U @@F;0;?5=)'KJU(FD,B;6/BYK2,IF71
MQK1RWJPOC1VZ<^>7EU4'N_A#M=TN"LZ>R1&[X7.+6VX//+F/VV3.B*QR3FO]
M-Y+(3/Y_]MZUN6TCVQK^*Z@Z\YP2JV"5[TF>^:3(2D9U%-NO9$^>? 0)4$(,
M CP *)GSZ]_>M^[=#8"D$MD$;56=,[$D$I>^[-Z7M=>"G+#5]:0H]A)AN_#7
M_9%CR4K5=1U6_X!<--"D+;*:)?]2*[0&3!VR12:.MHH1R*I:YCPXLSDH!N?J
MDZ+>\'RQ0;]6D7&)2FK&##\$@*:8FYP3X->ENN@#USI5=4RD+8-73K-F5N=3
M.G^HVYVL"]E[E(?#IE'6[]1\QH3=]B#I(;J7;'OV&1K1FV+]:.4'M1+H/)WB
M$B">S C7M%.N[:KMTDI*#K[5YRC=MSD>IP?['O'$W0X-JFI>@8IG]!ZUW+G.
MR9]_"T'C^#U>R% @+$$SG%C2"JD+=KH1-.\@L!+R2X<BNQ8[HWA)M@?B 9L:
M5@:QA(F:J=$2*S*P)UTTJ7$$-N8WNWA:0*87 _:PE8'[7Q]EBG[XSH!N7W5T
M!6X-&X0\!E3@<8(%"3&PZ%R3^0O6V"=V7VW*WNVPY[(RK6K NR(8H5H13YOY
M7C9QFP02FE!^ );;7!HBW&;"S-]<3D3YUD0<L. %#_LHS!Z/PMX<?6%,FCD1
M3M5908?>J15P/O4!7>>EN="2KT6?_16XC:ZDSTU?ZS!.RR0$K069GCBBPVI+
M7@#S0;*Y6/:ZR4P(T@J%0]/DT [8NE\+@Q(]&I0.Z%'6DKB"<T8*HG!![)&
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M6_7/QZW:2YIT=1*]/_EP>?[N Y"ZQ=%9.]M+< B%K/NXA'%T]'D"HB*%B7E
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MQ'A2.F5[R/%E0 2CG/?AV/,.5INQ+;F<TY#GC:JZ/ZT+7G]2L/<-M%Y%'*W
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M73X!P227WV^")A_<TOK/0+$VS9"TV R865MT>%Y79B^;]T+]/?,X*51:6UB
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M8VXY(FW=-?;,K';=='(>+R.Z'1J,H1_1I4\'7-G=$BP 7;U.ZK1@HCB+>9)
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ML<SP+QX^+,VH8,P5,:Q&43ZRK,HGYO6SA+K=+._\YD)M@C54/(.OZZII@M>
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M[GM!4KS^SI 4C]QD6U''85X)PC@)CSZ5U9W9\==V^TGS:X?@2KBY1#52U$7
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MUH:9$:KW,R4O5=:AL,X!6D^N<$PK5#4^_KB'"+GJ)IH2CV3!91PLY]P<J;S
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MS\!)+9+JFJ0N^K(^/5"J/871\00AGBFLJ5]UH9=JEL=:Y>[F.-8IE+"L3N3
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M3",UEGI@+F S)7)&^FN]O\0NX97C8(4^@TR-3Z(R:MTY1D!ZP?PN'"2MMQ%
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MO5FET48IE\UFH+T!' Q#"K\M&N?!'A2&F3SEK'M%@R=<UXU&%%B:H0<+87A
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M9:QNKJ&U^E7:'1V:E?I\>WO3PY697JAMFD1H%#\\NM8U%=*A9>_(9L"E+9J
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M6]<(I.U8[0&=Z8B1R[6?@A'AB@##&)<3& 33  1'%':G+GG1'1]91"E?./0
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MEGNGQ[8+>^_HOT_//I_TCW_5-P11P"OPIW8$^/XJ=B@C[_K]4USQ3T<PS?3
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M9$<;+_%B.?O]!:L[0"JEZ_=/YG"%D)_8TB"6NP VA:+J)#F5\KM*O1KW&Z%
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M@#VB,.M9UGV+LO;#H?*O^XSIP'X^]1=02P,$%     @  8G[5H N<X_.!P
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M$(J&O#";LQ"<!6*^DP=(56@(0,V,I'&5""J1.3G4@><UO(@#6B3<!:]$R'D
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MJM_R?MAV]]*_ %!+ 0(4 Q0    (  &)^U9]@F6V>'," (#G&P 1
M      "  0    !D>&-M+3(P,C,P-C,P+FAT;5!+ 0(4 Q0    (  &)^U9_
M*?3MIP\  &>?   1              "  :=S @!D>&-M+3(P,C,P-C,P+GAS
M9%!+ 0(4 Q0    (  &)^U;5FT<^'2$  (4_ 0 5              "  7V#
M @!D>&-M+3(P,C,P-C,P7V-A;"YX;6Q02P$"% ,4    "  !B?M6/#]=%PY'
M   N^0( %0              @ '-I ( 9'AC;2TR,#(S,#8S,%]D968N>&UL
M4$L! A0#%     @  8G[5H?VU_;3'@$ A+$! !0              ( !#NP"
M &1X8VTM,C R,S V,S!?9S$N:G!G4$L! A0#%     @  8G[5DL)9)ICEP
M#=D  !0              ( !$PL$ &1X8VTM,C R,S V,S!?9S(N:G!G4$L!
M A0#%     @  8G[5E:FR>%"G   "N   !0              ( !J*($ &1X
M8VTM,C R,S V,S!?9S,N:G!G4$L! A0#%     @  8G[5FZ# TE'%P$ :X@!
M !0              ( !'#\% &1X8VTM,C R,S V,S!?9S0N:G!G4$L! A0#
M%     @  8G[5OF>\FQ;Z   QYP) !4              ( !E58& &1X8VTM
M,C R,S V,S!?;&%B+GAM;%!+ 0(4 Q0    (  &)^U90W>F02(0  +D3!@ 5
M              "  2,_!P!D>&-M+3(P,C,P-C,P7W!R92YX;6Q02P$"% ,4
M    "  !B?M6W1 QCL0'  "_/   '@              @ &>PP< 9'AC;38S
M,#(P,C-E>#$P,#(M961G97!A<FLN:'1M4$L! A0#%     @  8G[5A=?AFCO
M!P  AD$  !X              ( !GLL' &1X8VTV,S R,#(S97@Q,# S+6)Y
M<F%M:&5A+FAT;5!+ 0(4 Q0    (  &)^U8O U3X/ @  ,,[   >
M      "  <G3!P!D>&-M-C,P,C R,V5X,3 P-"UE9&=E<&%R:RYH=&U02P$"
M% ,4    "  !B?M6:Y^_%,L'  #$.   '@              @ %!W < 9'AC
M;38S,#(P,C-E>#$P,#4M8GER86UH96$N:'1M4$L! A0#%     @  8G[5D3:
MF3*;,@( V8P1 !X              ( !2.0' &1X8VTV,S R,#(S97@Q,# V
M+69I<G-T86UE+FAT;5!+ 0(4 Q0    (  &)^U;?&83M*P@  %(\   >
M          "  1\7"@!D>&-M-C,P,C R,V5X,3 P-RUB>7)A;6AE82YH=&U0
M2P$"% ,4    "  !B?M6&L0"7<T'  !%)0  &@              @ &&'PH
M9'AC;38S,#(P,C-E>&AI8FET,S$P,2YH=&U02P$"% ,4    "  !B?M6@"YS
MC\X'  #Z(P  &@              @ &+)PH 9'AC;38S,#(P,C-E>&AI8FET
M,S$P,BYH=&U02P$"% ,4    "  !B?M6JZHC%18$  !7#P  &@
M    @ &1+PH 9'AC;38S,#(P,C-E>&AI8FET,S(P,2YH=&U02P$"% ,4
M"  !B?M6K?SI/QH$  ">#@  &@              @ '?,PH 9'AC;38S,#(P
G,C-E>&AI8FET,S(P,BYH=&U02P4&     !0 % !Z!0  ,3@*

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
